<SEC-DOCUMENT>0001213900-15-007386.txt : 20150930
<SEC-HEADER>0001213900-15-007386.hdr.sgml : 20150930
<ACCEPTANCE-DATETIME>20150930162035
ACCESSION NUMBER:		0001213900-15-007386
CONFORMED SUBMISSION TYPE:	POS AM
PUBLIC DOCUMENT COUNT:		14
FILED AS OF DATE:		20150930
DATE AS OF CHANGE:		20150930

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OptimizeRx Corp
		CENTRAL INDEX KEY:			0001448431
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		IRS NUMBER:				261265381
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		POS AM
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-203820
		FILM NUMBER:		151134132

	BUSINESS ADDRESS:	
		STREET 1:		400 WATER ST., STE. 200
		CITY:			ROCHESTER
		STATE:			MI
		ZIP:			48307
		BUSINESS PHONE:		248-651-6558

	MAIL ADDRESS:	
		STREET 1:		400 WATER ST., STE. 200
		CITY:			ROCHESTER
		STATE:			MI
		ZIP:			48307
</SEC-HEADER>
<DOCUMENT>
<TYPE>POS AM
<SEQUENCE>1
<FILENAME>posam2015a1_optimizerx.htm
<DESCRIPTION>POST EFFECTIVE AMENDMENT NO. 1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"></P>



<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SECURITIES
AND EXCHANGE COMMISSION </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Washington,
D.C. 20549 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B> FORM S-1 </B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B> (POST EFFECTIVE AMENDMENT NO.
1 </B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B> TO FORM S-1/A) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif"><B>REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OF 1933</B><FONT STYLE="font-weight: normal"> </FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>OPTIMIZERX
CORP.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(Exact
name of registrant as specified in its charter)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 32%; text-decoration: none; font: 10pt Times New Roman, Times, Serif; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Nevada</B></FONT></td>
    <TD STYLE="width: 2%; padding: 0 0 1.5pt; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 32%; text-decoration: none; font: 10pt Times New Roman, Times, Serif; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>7389</B></FONT></td>
    <TD STYLE="width: 2%; padding: 0 0 1.5pt; text-indent: 0; text-decoration: none"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 32%; text-decoration: none; font: 10pt Times New Roman, Times, Serif; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>26-1265381</B></FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(State
                                         or other jurisdiction of</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">incorporation
        or organization)</FONT></P></td>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Primary
                                         Standard Industrial</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Classification
        Code&nbsp;Number)</FONT></P></td>
    <TD STYLE="padding: 0; text-indent: 0"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(I.R.S.
                                         Employer</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Identification
        No.)</FONT></P></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> 400
                                         Water Street, Suite 200 </B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> Rochester,
        MI 48307 </B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> (248)
        651-6568 </B></FONT></P></td>
    <TD STYLE="padding: 0 0 1.5pt; text-align: center"></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0 0 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </FONT></td>
    <TD STYLE="padding: 0 0 1.5pt; text-align: center"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> Doney
                                         Ventures, Inc. </B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> 4955
        S. Durango Rd., Ste. 165 </B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> Las
        Vegas, NV 89113 </B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> (702)
        982-5686 </B></FONT></P></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Address,
    including zip code, and telephone number, including area code, of principal executive offices)</FONT></td>
    <TD STYLE="padding: 0; text-align: center"></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0"></td>
    <TD STYLE="padding: 0; text-align: center"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Name,
    address, including zip code, and telephone number, including area code, of agent for service)</FONT></td></tr>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Approximate
date of commencement of proposed sale to the public:</B></FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">From time to time after this registration statement
becomes effective.</FONT></P>



<P STYLE="margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under
the Securities Act of 1933, check the following box.&nbsp;&#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the
same offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer&rdquo; and &ldquo;smaller
reporting company&rdquo; in Rule 12b-2 of the Exchange Act. (Check one):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; line-height: 115%; text-indent: 0; width: 25%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Large&nbsp;accelerated&nbsp;filer</FONT></TD>
    <TD STYLE="padding: 0; line-height: 115%; text-indent: 0; width: 3%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9744;</FONT></TD>
    <TD STYLE="padding: 0; line-height: 115%; text-indent: 0; width: 44%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; line-height: 115%; text-indent: 0; width: 25%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Accelerated&nbsp;filer</FONT></TD>
    <TD STYLE="padding: 0; line-height: 115%; text-indent: 0; width: 3%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;
    &#9744;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Non-accelerated
    filer</FONT></TD>
    <TD STYLE="padding: 0; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9744;</FONT></TD>
    <TD STYLE="padding: 0; line-height: 115%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Do not
    check if a smaller reporting company)</FONT></TD>
    <TD STYLE="padding: 0; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Smaller&nbsp;reporting&nbsp;company</FONT></TD>
    <TD STYLE="padding: 0; line-height: 115%; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp; &#9746;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to Rule 429 under the Securities
Act of 1933, the prospectus included in this Registration Statement is a combined prospectus relating to 804,139 shares of common
stock issuable upon the exercise of warrants held by placement agents in our March 2014 Private Placement, which were registered
for a fee of $179.41 on Registration Statement No. 333-195210 previously filed by us on Form S-1 and declared effective May 28,
2014. There are no other shares outstanding under Registration Statement No. 333-195210. This Registration Statement, which is
a new registration statement, also constitutes a Post-Effective Amendment on Form S-1 to such Registration Statement No. 333-195210,
and such post-effective amendment shall hereafter become effective concurrently with the effectiveness of this Registration Statement
in accordance with Section 8(c) of the Securities Act of 1933.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>THE
REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL
THE REGISTRANT SHALL FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THE REGISTRATION STATEMENT SHALL THEREAFTER BECOME
EFFECTIVE IN ACCORDANCE WITH SECTION 8(A) OF THE SECURITIES ACT OF 1933, OR UNTIL THIS REGISTRATION STATEMENT SHALL BECOME EFFECTIVE
ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SECTION 8(A), MAY DETERMINE. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>With
copies to: </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Scott
Doney, Esq. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>The
Doney Law Firm </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>4955
S. Durango Rd. Ste 165</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Las
Vegas, NV 89113</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Telephone:
(702) 982-5686 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;&nbsp;</B></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #DE1A1E"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; color: #DE1A1E"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; color: #DE1A1E"><FONT STYLE="color: Black"><B> Explanatory
Note </B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> On May 4, 2015, we filed with
the Securities and Exchange Commission a registration statement on Form S-1 (File No. 333-203820), which was amended by a pre-effective
amendment filed on June 1, 2015, to register the offer and sale of 849,139 shares of our common stock, $0.001 par value per share,
of which 804,139 shares of common stock are issuable upon the exercise of warrants. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> The Registration Statement was
declared effective by the Commission on June 16, 2015. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> This Post-Effective Amendment
No. 1 to the Form S-1/A is being filed to include a revised audit opinion from our independent auditor, KLJ &amp; Associates,
LLP. All securities offered hereby are being offered on a delayed or continuous basis. We are not registering any additional securities
under this Post-Effective Amendment. All filing fees payable in connection with the registration of these securities were previously
paid by us in connection with the filing of the Form S-1. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #DE1A1E"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #DE1A1E">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>The
information in this prospectus is not complete and may be changed. This prospectus is included in a registration statement that
we filed with the Securities and Exchange Commission. The Selling Shareholders cannot sell these securities under this registration
statement until this registration statement becomes effective. This prospectus is not an offer to sell these securities and is
not soliciting an offer to buy these securities in any state where the offer or sale is not permitted. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> Subject
to Completion, dated September 29, 2015 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>OPTIMIZERX
CORP. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>849,139
Shares of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>



<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">This prospectus relates to the resale
by the Selling Shareholders of up to 849,139 shares of our Common Stock, par value $0.001 per share (the &ldquo;Common Stock&rdquo;).
Of the Common Stock offered herein, 804,139 shares are issuable upon the exercise of warrants held by placement agents that were
issued in connection with our March 2014 Private Placement (described below) and 45,000 shares that were issued to Merriman Capital,
Inc. under an Advisory Agreement dated February 23, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Selling Shareholders may offer and sell or otherwise dispose of the shares described in this prospectus from time to time through
public or private transaction at prevailing market prices, at prices related to such prevailing market prices, at varying prices
determined at the time of sale, at negotiated prices, or at fixed prices. See &ldquo;Plan of Distribution&rdquo; beginning on
page 11&nbsp;  for more information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
will not receive any of the proceeds from the Common Stock sold by the Selling Shareholders, unless the warrants described herein
are issued for cash and not on a cashless basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
have agreed to pay certain expenses in connection with this registration statement and to indemnify the Selling Shareholders against
certain liabilities. The Selling Shareholders will pay all underwriting discounts and selling commissions, if any, in connection
with the sale of the shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>





<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> Our Common Stock is traded on the
OTCQB under the symbol &ldquo;OPRX.&rdquo; On September 29, 2015, the last reported sale price of our Common Stock was $0.99 per
share. </P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Investing
in our common stock involves risks. See &quot;Risk Factors&quot; beginning on page 4. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or
determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> The
date of this prospectus September 29, 2015 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="toc" TITLE="Table of Contents"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Table
of Contents</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="img_001.jpg" ALT=""><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left; background-color: White"><A HREF="#About">ABOUT THIS PROSPECTUS</A></TD><TD STYLE="width: 1%; background-color: White">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="width: 9%; text-align: center; background-color: White">1</TD><TD STYLE="width: 1%; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; background-color: White"><A HREF="#forword-look">ABOUT FORWARD-LOOKING STATEMENTS</A></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: center; background-color: White">1</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: White"><A HREF="#summary">SUMMARY</A></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: center; background-color: White">2</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; background-color: White"><A HREF="#risk">RISK FACTORS</A></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: center; background-color: White">4</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: White"><A HREF="#use">USE OF PROCEEDS</A></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: center; background-color: White">9</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="background-color: White"><A HREF="#determination">DETERMINATION OF OFFERING PRICE</A></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: center; background-color: White">9</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; background-color: White"><A HREF="#selling">SELLING SHAREHOLDERS</A></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: center; background-color: White">9</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="background-color: White"><A HREF="#plan">PLAN OF DISTRIBUTION</A></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: center; background-color: White">11</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; background-color: White"><A HREF="#legal">LEGAL PROCEEDINGS</A></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: center; background-color: White">12</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; background-color: White"><A HREF="#directors">DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS</A></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: center; background-color: White">13</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; background-color: White"><A HREF="#security">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</A></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: center; background-color: White">18</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="background-color: White"><A HREF="#description">DESCRIPTION OF SECURITIES</A></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: center; background-color: White">18</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; background-color: White"><A HREF="#interests">INTERESTS OF NAMED EXPERTS AND COUNSEL</A></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: center; background-color: White">21</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; background-color: White"><A HREF="#disclosure">DISCLOSURE OF COMMISSION POSITION OF INDEMNIFICATION FOR SECURITIES ACT
    LIABILITIES</A></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: center; background-color: White">22</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: White"><A HREF="#business">DESCRIPTION OF BUSINESS</A></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: center; background-color: White">22</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; background-color: White"><A HREF="#certain">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS</A></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: center; background-color: White">32</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; background-color: White"><A HREF="#market">MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS</A></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: center; background-color: White">32</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; background-color: White"><A HREF="#executive">EXECUTIVE COMPENSATION</A></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: center; background-color: White">35</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; background-color: White"><A HREF="#financail">FINANCIAL STATEMENTS</A></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: center; background-color: White">39</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; background-color: White"><A HREF="#changes">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS</A></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: center; background-color: White">40</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; background-color: White"><A HREF="#available">AVAILABLE INFORMATION</A></TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: center; background-color: White">40</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 2px; border: Black 1.5pt solid; width: 100%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="About"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ABOUT
THIS PROSPECTUS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">This
prospectus is part of a registration statement we filed with the Securities and Exchange Commission, or the SEC. Under this registration
process, the selling shareholders may, from time to time, offer and sell up to 849,139 shares of our common stock, as described
in this prospectus, in one or more offerings. This prospectus provides you with a general description of the securities the selling
shareholders may offer. You should read this prospectus carefully before making an investment decision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">You
may only rely on the information contained in this prospectus or that we have referred you to. We have not authorized anyone to
provide you with additional or different information. This prospectus does not constitute an offer to sell or a solicitation of
an offer to buy any securities other than the shares of our common stock offered by this prospectus. This prospectus does not
constitute an offer to sell or a solicitation of an offer to buy any common stock in any circumstances or any jurisdiction in
which such offer or solicitation is not permitted. You should not assume that the information contained in this prospectus is
accurate as of any date other than the date on the front cover of this prospectus regardless of the time of delivery of this prospectus
or any sale of our common stock. The rules of the SEC may require us to update this prospectus in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">As
used in this prospectus, unless the context requires otherwise, the terms &ldquo;we&rdquo;, &ldquo;us&rdquo;, &ldquo;our&rdquo;,
or &ldquo;the Company&rdquo; refer to OptimizeRx Corp. and its subsidiaries on a consolidated basis. References to &ldquo;Selling
Shareholders&rdquo; refer to those shareholders listed herein under &ldquo;Selling Shareholders&rdquo; and their successors, assignees
and permitted transferees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="forword-look"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ABOUT
FORWARD-LOOKING STATEMENTS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">This
prospectus contains forward-looking statements within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended
(the &ldquo;Securities Act&rdquo;), and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;), about the Company and its subsidiaries. These forward-looking statements are intended to be covered by the safe harbor
for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are
not statements of historical fact, and can be identified by the use of forward-looking terminology such as &ldquo;believes&rdquo;,
&ldquo;expects&rdquo;, &ldquo;may&rdquo;, &ldquo;will&rdquo;, &ldquo;could&rdquo;, &ldquo;should&rdquo;, &ldquo;projects&rdquo;,
&ldquo;plans&rdquo;, &ldquo;goal&rdquo;, &ldquo;targets&rdquo;, &ldquo;potential&rdquo;, &ldquo;estimates&rdquo;, &ldquo;pro forma&rdquo;,
&ldquo;seeks&rdquo;, &ldquo;intends&rdquo;, or &ldquo;anticipates&rdquo; or the negative thereof or comparable terminology. Forward-looking
statements include discussions of strategy, financial projections, guidance and estimates (including their underlying assumptions),
statements regarding plans, objectives, expectations or consequences of various transactions, and statements about the future
performance, operations, products and services of the Company and its subsidiaries. We caution our shareholders and other readers
not to place undue reliance on such statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
businesses and operations are and will be subject to a variety of risks, uncertainties and other factors. Consequently, actual
results and experience may materially differ from those contained in any forward-looking statements. Such risks, uncertainties
and other factors that could cause actual results and experience to differ from those projected include, but are not limited to,
the risk factors set forth in the section entitled &ldquo;Risk Factors&rdquo; beginning on page 4 of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">All
written or oral forward-looking statements attributable to us or any person acting on our behalf made after the date of this prospectus
are expressly qualified in their entirety by the risk factors and cautionary statements contained in and incorporated by reference
into this prospectus. Unless legally required, we do not undertake any obligation to release publicly any revisions to such forward-looking
statements to reflect events or circumstances after the date of this prospectus or to reflect the occurrence of unanticipated
events.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

</DIV>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 2px; border: Black 1.5pt solid; width: 99%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT><BR CLEAR="ALL"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="summary"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SUMMARY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>The
following summary highlights selected information contained elsewhere in this prospectus and in the documents incorporated by
reference in this prospectus and does not contain all the information you will need in making your investment decision. You should
read carefully this entire prospectus and the documents incorporated by reference in this prospectus before making an investment
decision, especially the information presented under the heading &ldquo;Risk Factors.&rdquo; </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Business
Summary </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
provide unique consumer and physician platforms and strategies to help patients better afford and comply with their medicines
and healthcare products, while offering pharmaceutical and healthcare companies more effective ways to expand physician and patient
awareness, access and adherence to their medications and available product support.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
core product offering is our SampleMD&trade; software application which delivers an automated system that replaces traditional
physical drug samples by enabling doctors or other healthcare providers to automatically print and electronically distribute sample
vouchers or co-pay discount coupons within their ePrescribing/ EHR (electronic health record) system or from their computer desktops.
Through SampleMD, pharmaceutical and biotech manufacturers have a digital paperless platform to directly offer patient's critical
cost savings, patient education and adherence tools-- right at point of prescribing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
consumer support website, www.OPTIMIZERx.com and our subscriber base exceeding 2.5 million patients&nbsp;, continues to grow each
month and we believe is quickly becoming the preferred way to access branded prescription vouchers, co-pay savings and other support
programs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>The
Shares Underlying Warrants Issued in Connection With the March 2014 Private Placement Financing </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
March 17, 2014 (the &ldquo;March 2014 Private Placement&rdquo;), we entered into a Stock Purchase Agreement (the &ldquo;Purchase
Agreement&rdquo;) with certain accredited investors (the &ldquo;Purchasers&rdquo;) pursuant to which we: (i)&nbsp;sold to the
Purchasers an aggregate of 8,333,333 shares of our Common Stock at a price per share of $1.20 (the &ldquo;Common Shares&rdquo;)
for aggregate gross proceeds of $10 million and (ii)&nbsp;issued warrants to purchase up to 804,139 shares of the our Common Stock
to our placement agents (the &ldquo;Agent Warrants&rdquo;). Placement Agents also received commissions equal to approximately
9.7% of the gross proceeds, for an aggregate commission of approximately $970,000, including reimbursements for their reasonable
out of pocket expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to Rule 429 under the Securities
Act of 1933, the prospectus included in this Registration Statement is a combined prospectus relating to the Agent Warrants, which
were registered for a fee of $179.41 on Registration Statement No. 333-195210 previously filed by the Registrant on Form S-1 and
declared effective May 28, 2014. There are no other shares outstanding under Registration Statement No. 333-195210. This Registration
Statement, which is a new registration statement, also constitutes a Post-Effective Amendment on Form S-1 to such Registration
Statement No. 333-195210, and such post-effective amendment shall hereafter become effective concurrently with the effectiveness
of this Registration Statement in accordance with Section 8(c) of the Securities Act of 1933.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>The
Shares Issued in Connection with the Merriman Capital, Inc. Advisory Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
February 23, 2015, we entered into an advisory agreement (the &ldquo;Advisory Agreement&rdquo;) with Merriman Capital, Inc. (&ldquo;Merriman&rdquo;).
In exchange for advisory services pertaining to capital market interactions, we agreed to issue to Merriman 45,000 shares of common
stock upon execution of the Advisory Agreement, with 45,000 additional shares of common stock due on or before August 15, 2015
and 60,000 shares of common stock as a bonus if we successfully up-list to a national exchange.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> In August 2015, we and Merriman
agreed to terminate the Advisory Agreement as it pertains to the issuance of any additional shares. <FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
have issued and delivered to Merriman the 45,000 initial shares, which are being registered herein as a condition of the Advisory
Agreement (the &ldquo;Advisory Shares&rdquo;).</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif"> <FONT STYLE="font-size: 10pt">The
sale of these shares has been completed and Merriman bears the market risk in connection with these shares.</FONT></FONT> </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 2px; border: Black 1.5pt solid; width: 100%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>The
Offering </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 34%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Common
    stock offered by the Selling Shareholders </FONT></td>
    <TD STYLE="width: 2%; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify; width: 64%">849,139
    shares of common stock, consisting of Agent Warrants to purchase up to 804,139 shares of our common stock and 45,000 Advisory
    Shares of our common stock. &nbsp;</td></tr>

<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Selling
    Shareholders </FONT></td>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">See
    &ldquo;<I>Selling Shareholders</I>&rdquo; beginning on page 9. </FONT></td></tr>

<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Common
    stock outstanding </FONT></td>
    <TD STYLE="padding: 0; text-indent: 0"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 28,960,925
    shares of common stock as of September 29, 2015. </FONT></td></tr>

<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Use
    of proceeds </FONT></td>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
    will not receive any proceeds from the sale or other disposition of the shares of common stock covered by this prospectus.
    However, upon any exercise of the Agent Warrants for cash, such Selling Shareholders would pay us the exercise price of the
    warrants. Cash received from exercise of Agent Warrants will be used for general corporate purposes. Additionally, the Warrants
    are exercisable on a cashless basis. If any Agent Warrants are exercised on a cashless basis, we would not receive any cash
    payment from such Selling Shareholders upon any exercise of such Agent Warrants. See &ldquo;<I>Use of Proceeds</I>&rdquo;
    on page&nbsp;9. </FONT></td></tr>

<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">OTC
    Bulletin Board Symbol </FONT></td>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
    Common Stock is quoted on the OTCQB under the ticker symbol &ldquo;OPRX&rdquo;. </FONT></td></tr>

<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Risk
    Factors </FONT></td>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">You
    should consider the matters set forth under &ldquo;<I>Risk Factors</I>&rdquo; beginning on page 4, as well as other cautionary
    statements throughout or incorporated by reference in this prospectus, before deciding to invest in shares of our common stock.
    </FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Summary
Financial Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="border-bottom: black 1.5pt solid; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> Balance
    Sheet Data </B></FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> December&nbsp;31,
    2014 </B></FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> December&nbsp;31,
    2013 </B></FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> June
    30,<BR>
 2015 </B></FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="width: 64%; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Cash </FONT></TD>
    <TD STYLE="width: 1%; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="width: 1%; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> $ </FONT></TD>
    <TD STYLE="width: 9%; text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 3,446,973
    </FONT></TD>
    <TD STYLE="width: 1%; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="width: 1%; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="width: 1%; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> $ </FONT></TD>
    <TD STYLE="width: 9%; text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 1,118,243
    </FONT></TD>
    <TD STYLE="width: 1%; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="width: 1%; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="width: 1%; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> $ </FONT></TD>
    <TD STYLE="width: 9%; text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 3,645,979
    </FONT></TD>
    <TD STYLE="width: 1%; line-height: 107%"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Total Assets </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> $ </FONT></TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 7,028,806 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> $ </FONT></TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 3,952,765 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> $ </FONT></TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 6,981,962 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Liabilities </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> $ </FONT></TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 2,418,722 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> $ </FONT></TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 2,284,563 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> $ </FONT></TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 2,279,242 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Total Stockholders&rsquo; Equity </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> $ </FONT></TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 4,610,084 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> $ </FONT></TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 1,668,202 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> $ </FONT></TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 4,702,720 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> Statement of Operations </B></FONT></TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> Year
    Ended December&nbsp;31, 2014 </B></FONT></TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> Year
    Ended December&nbsp;31, 2013 </B></FONT></TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B> &nbsp; </B></P><P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B> Six
                                         Months Ended </B> <BR>
                                         <B>June 30,</B><BR>
                                         <B>2015</B> </P></TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B> &nbsp; </B></P><P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B> Six
                                         Months Ended </B> <BR>
                                         <B>June 30,</B><BR>
                                         <B>2014 (restated)</B> </P></TD><TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; background-color: White"> Revenue </TD><TD STYLE="width: 1%; background-color: White"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; background-color: White"> $ </TD><TD STYLE="width: 9%; text-align: right; background-color: White"> 6,502,962 </TD><TD STYLE="width: 1%; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="width: 1%; background-color: White"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; background-color: White"> $ </TD><TD STYLE="width: 9%; text-align: right; background-color: White"> 4,679,741 </TD><TD STYLE="width: 1%; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="width: 1%; background-color: White"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; background-color: White"> $ </TD><TD STYLE="width: 9%; text-align: right; background-color: White"> 3,193,010 </TD><TD STYLE="width: 1%; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="width: 1%; background-color: White"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; background-color: White"> $ </TD><TD STYLE="width: 9%; text-align: right; background-color: White"> 2,716,236 </TD><TD STYLE="width: 1%; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> Income (Loss) for the Period </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> (1,025,393 </TD><TD STYLE="text-align: left"> ) </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> (267,290 </TD><TD STYLE="text-align: left"> ) </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> (268,426 </TD><TD STYLE="text-align: left"> ) </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> (961,733 </TD><TD STYLE="text-align: left"> ) </TD></TR>
</TABLE>


&nbsp;</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="risk"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>RISK
FACTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Readers
and prospective investors in our common stock should carefully consider the following risk factors as well as the other information
contained or incorporated by reference in this prospectus. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>If
any of the following risks actually occurs, our financial condition, results of operations and liquidity could be materially adversely
affected. If this were to happen, the value of our common stock could decline, and if you invest in our common stock, you could
lose all or part of your investment. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>The
discussion below highlights some important risks we have identified related to our business and operations and an investment in
shares of our common stock, but these should not be assumed to be the only factors that could affect our future performance and
condition, financial and otherwise. We do not have a policy of updating or revising forward-looking statements except as otherwise
required by law, and silence by management over time should not be construed to mean that actual events are occurring as estimated
in such forward-looking statements. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I><U>Risks
Relating to Business and Financial Condition</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Because
we have historically experienced losses, if we are unable to achieve profitability, our financial condition and company could
suffer.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Since
the inception of our business we have historically incurred losses. While we have increased revenues significantly, we have not
yet been able to achieve profitability due to significant investments in our growth. Our ability to achieve consistent profitability
depends on our ability to generate sales through our technology platform and advertising model, while maintaining reasonable expense
levels. If we do not achieve sustainable profitability, it may impact our ability to continue our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Our
business and growth may suffer if we are unable to attract and retain key employees.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
success depends on the expertise of our executive officers and certain other key technical personnel. It may be difficult to find
sufficiently qualified individuals to replace management or other key technical personnel in the event of death, disability or
resignation, thus frustrating our ability to implement our business plan, which could negatively affect our operating results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Furthermore,
our ability to expand operations to accommodate our anticipated growth will also depend on our ability to attract and retain qualified
media, management, finance, marketing, sales and technical personnel. However, competition for these types of employees is intense
due to the limited number of qualified professionals. Our ability to meet our business development objectives will depend in part
on our ability to recruit, train and retain top quality people with advanced skills who understand our technology and business.
We believe that we will be able to attract competent employees, but no assurance can be given that we will be successful in this
regard. If we are unable to engage and retain the necessary personnel, our business may be materially and adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Our
failure to obtain retain or attract additional customers could prevent us from successfully executing our business plan.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
currently work with many leading pharmaceutical companies, including Pfizer, Eli Lilly, Auxilium, Actavis, AstraZeneca, Alcon,
Daichi Sankyo, Shire, Activis, and others. Our failure to retain existing customers or expand with new customers could negatively
impact our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>We
are dependent on a concentrated group of customers</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
revenues are concentrated in approximately 25 customers, primarily large pharmaceutical manufacturers and large advertising agencies.
Approximately 64% of our revenue came from our largest five customers. Loss of one or more of these customers could have a significant
negative impact on our operating results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>We
may be unable to support our technology to further scale our operations successfully.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
plan is to grow rapidly through further integration of our technology in electronic platforms. Our growth will place significant
demands on our management and technology development, as well as our financial, administrative and other resources. We cannot
guarantee that any of the systems, procedures and controls we put in place will be adequate to support the commercialization of
our operations. Our operating results will depend substantially on the ability of our officers and key employees to manage changing
business conditions and to implement and improve our financial, administrative and other resources. If we are unable to respond
to and manage changing business conditions, or the scale of our products, services and operations, then the quality of our services,
our ability to retain key personnel and our business could be harmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>If
we are unable to maintain our contracts with electronic prescription platforms, our business will suffer.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
are reliant upon our contracts with leading electronic prescribing platforms, including Allscripts, Dr. First, Quest Diagnostics,
and others. We will need to maintain these relationships as well as diversify them. The inability to do so could adversely impact
our business. Loss of any of these contracts would adversely affect our revenue and impede our ability to grow revenues.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Our
agreements with electronic prescription platforms are subject to audit, which could subject us to additional costs that might
affect our results of operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
agreements with our electronic prescription platform partners provide for revenue sharing payments to the platform partners based
on the revenue we generate through the platform. These payments are subject to audit by our partners, at their cost, and if there
is a dispute as to the calculation, we may be liable for additional payments. If an underpayment is determined to be in excess
of a certain amount, for example 10%, some agreements would require us to pay for the cost of the audit, as well.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Developing
and implementing new and updated applications, features and services for our portals may be more difficult than expected, may
take longer and cost more than expected and may not result in sufficient increases in revenue to justify the costs. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
have completed the development and migration of SampleMD 2.0&rsquo;s on-demand, rule based content delivery platform. The system
can now manage up to 1 million rules and return the appropriate content within 1 second. This allows unsurpassed response time
to avoid delays, and the ability to meet the upcoming dramatic scale we expect. Despite the launch of Sample MD 2.0, attracting
and retaining users of our portals requires us to continue to improve the technology underlying those portals and to continue
to develop new and updated applications, features and services for those portals. If we are unable to do so on a timely basis
or if we are unable to implement new applications, features and services without disruption to our existing ones, we may lose
potential users and clients. The costs of development of these enhancements may negatively impact our ability to achieve profitability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
rely on a combination of internal development, strategic relationships, licensing and acquisitions to develop our portals and
related applications, features and services. Our development and/or implementation of new technologies, applications, features
and services may cost more than expected, may take longer than originally expected, may require more testing than originally anticipated
and may require the acquisition of additional personnel and other resources. There can be no assurance that the revenue opportunities
from any new or updated technologies, applications, features or services will justify the amounts spent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>If
we are unable to adhere to the regulatory and competitive climate in which we operate, we could be materially and negatively impacted.
</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Do
to the labyrinth of regulations in healthcare space, state and federal, as well as political sensitivity of healthcare delivery
our business model could be negatively impacted or fail.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
markets in which we operate are competitive, continually evolving and, in some cases, subject to rapid change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
                                         portals face competition from numerous other companies, both in attracting users and
                                         in generating revenue from advertisers and sponsors. We compete for users with online
                                         services and Web sites that provide savings on medications and healthcare products, including
                                         both commercial sites and not-for-profit sites. We compete for advertisers and sponsors
                                         with: health-related web sites; general purpose consumer web sites that offer specialized
                                         health sub-channels; other high-traffic web sites that include both healthcare-related
                                         and non-healthcare-related content and services; search engines that provide specialized
                                         health search; and advertising networks that aggregate traffic from multiple sites.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
                                         healthcare provider portals compete with: providers of healthcare decision-support tools
                                         and online health management applications; wellness and disease management vendors; and
                                         health information services and health management offerings of healthcare benefits companies
                                         and their affiliates.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Many
of our competitors have greater financial, technical, product development, marketing and other resources than we do. These organizations
may be better known than we are and have more customers or users than we do. We cannot provide assurance that we will be able
to compete successfully against these organizations or any alliances they have formed or may form. Since there are no substantial
barriers to entry into the markets in which our public portals participate, we expect that competitors will continue to enter
these markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Developments
in the healthcare industry could adversely affect our business</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Most
of our revenue is derived from the healthcare industry and could be affected by changes affecting healthcare spending. We are
particularly dependent on pharmaceutical, biotechnology and medical device companies for our advertising and sponsorship revenue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">General
reductions in expenditures by healthcare industry participants could result from, among other things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">government
regulation or private initiatives that affect the manner in which healthcare providers interact with patients, payers or other
healthcare industry participants, including changes in pricing or means of delivery of healthcare products and services;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">government
                                         regulation prohibiting the use of coupons by patients covered by federally funded health
                                         insurance programs;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">consolidation
                                         of healthcare industry participants;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">reductions
                                         in governmental funding for healthcare; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">adverse
                                         changes in business or economic conditions affecting healthcare payers or providers,
                                         pharmaceutical, biotechnology or medical device companies or other healthcare industry
                                         participants.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Even
if general expenditures by industry participants remain the same or increase, developments in the healthcare industry may result
in reduced spending in some or all of the specific market segments that we serve or are planning to serve. For example, use of
our products and services could be affected by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">changes
                                         in the design of health insurance plans;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a
                                         decrease in the number of new drugs or medical devices coming to market; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">decrease
                                         in marketing expenditures by pharmaceutical or medical device companies, including as
                                         a result of governmental regulation or private initiatives that discourage or prohibit
                                         advertising or sponsorship activities by pharmaceutical or medical device companies.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
addition, our customers&rsquo; expectations regarding pending or potential industry developments may also affect their budgeting
processes and spending plans with respect to products and services of the types we provide.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
healthcare industry has changed significantly in recent years and we expect that significant changes will continue to occur. However,
the timing and impact of developments in the healthcare industry are difficult to predict. We cannot assure you that the markets
for our products and services will continue to exist at current levels or that we will have adequate technical, financial and
marketing resources to react to changes in those markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Because
we are embroiled in various lawsuits from time to time with uncertain consequences, the outcome of potential judgments may negatively
affect our financial condition and results of operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
are currently involved in litigation and other disputes, as described in Item 3 of this report. As we continue to grow, we can
expect to have to deal with lawsuits that affect our business. Lawsuits are uncertain and involve a substantial degree of risk.
If we are unable to successfully prosecute or defend these actions, our financial condition and results of operations could suffer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Our
success is dependent in part on obtaining, maintaining and enforcing our proprietary rights and our ability to avoid infringing
on the proprietary rights of others. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
seek patent protection for those inventions and technologies for which we believe such protection is suitable and is likely to
provide a competitive advantage to us. Because patent applications in the United States are maintained in secrecy until either
the patent application is published or a patent is issued, we may not be aware of third-party patents, patent applications and
other intellectual property relevant to our products that may block our use of our intellectual property or may be used in third-party
products that compete with our products and processes. In the event a competitor or other party successfully challenges our products,
processes, patents or licenses or claims that we have infringed upon their intellectual property, we could incur substantial litigation
costs defending against such claims, be required to pay royalties, license fees or other damages or be barred from using the intellectual
property at issue, any of which could have a material adverse effect on our business, operating results and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
also rely substantially on trade secrets, proprietary technology, nondisclosure and other contractual agreements, and technical
measures to protect our technology, application, design, and manufacturing know-how, and work actively to foster continuing technological
innovation to maintain and protect our competitive position. We cannot assure you that steps taken by us to protect our intellectual
property and other contractual agreements for our business will be adequate, that our competitors will not independently develop
or patent substantially equivalent or superior technologies or be able to design around patents that we may receive, or that our
intellectual property will not be misappropriated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Our
business will suffer if our network systems fail or become unavailable.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">A
reduction in the performance, reliability and availability of our network infrastructure would harm our ability to distribute
our products to our users, as well as our reputation and ability to attract and retain customers. Our systems and operations could
be damaged or interrupted by fire, flood, power loss, telecommunications failure, Internet breakdown, earthquake and similar events.
Our systems could also be subject to viruses, break-ins, sabotage, acts of terrorism, acts of vandalism, hacking, cyber-terrorism
and similar misconduct. We might not carry adequate business interruption insurance to compensate us for losses that may occur
from a system outage. Any system error or failure that causes interruption in availability of our product or an increase in response
time could result in a loss of potential customers, which could have a material adverse effect on our business, financial condition
and results of operations. If we suffer sustained or repeated interruptions, then our products and services could be less attractive
to our users and our business would be materially harmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>If
we are unable to manage growth, our operations could be adversely affected. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
progress is expected to require the full utilization of our management, financial and other resources. Our ability to manage growth
effectively will depend on our ability to improve and expand operations, including our financial and management information systems,
and to recruit, train and manage personnel. There can be no absolute assurance that management will be able to manage growth effectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If
we do not properly manage the growth of our business, we may experience significant strains on our management and operations and
disruptions in our business. Various risks arise when companies and industries grow quickly. If our business or industry grows
too quickly, our ability to meet customer demand in a timely and efficient manner could be challenged. We may also experience
development delays as we seek to meet increased demand for our products. Our failure to properly manage the growth that we or
our industry might experience could negatively impact our ability to execute on our operating plan and, accordingly, could have
an adverse impact on our business, our cash flow and results of operations, and our reputation with our current or potential customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Our
business is subject to changing regulation of corporate governance and public disclosure.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Because
our common stock is publicly traded, we are subject to certain rules and regulations of federal and state entities charged with
the protection of investors and the oversight of companies whose securities are publicly traded. These entities have continued
to develop additional regulations and requirements in response to laws enacted by Congress, most notably the Sarbanes-Oxley Act
of 2002. Complying with these new regulations has resulted in, and is likely to continue to result in, increased general and administrative
costs and a diversion of management time and attention from revenue generating and other business activities to compliance activities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I><U>Risks
Relating to Our Securities</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>If
a market for our common stock does not develop, shareholders may be unable to sell their shares.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
common stock is quoted under the symbol &ldquo;OPRX&rdquo; on the OTCQB operated by OTC Markets Group, Inc., an electronic inter-dealer
quotation medium for equity securities. We do not currently have an active trading market. There can be no assurance that an active
and liquid trading market will develop or, if developed, that it will be sustained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
securities are very thinly traded. Accordingly, it may be difficult to sell shares of our common stock without significantly depressing
the value of the stock. Unless we are successful in developing continued investor interest in our stock, sales of our stock could
continue to result in major fluctuations in the price of the stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Because
we are subject to the &ldquo;Penny Stock&rdquo; rules, the level of trading activity in our stock may be reduced.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Securities and Exchange Commission has adopted regulations which generally define &quot;penny stock&quot; to be any listed, trading
equity security that has a market price less than $5.00 per share or an exercise price of less than $5.00 per share, subject to
certain exemptions. The penny stock rules require a broker-dealer, prior to a transaction in a penny stock not otherwise exempt
from the rules, to deliver a standardized risk disclosure document that provides information about penny stocks and the risks
in the penny stock market. The broker-dealer must also provide the customer with current bid and offer quotations for the penny
stock, the compensation of the broker-dealer and its salesperson in the transaction, and monthly account statements showing the
market value of each penny stock held in the customer&rsquo;s account. In addition, the penny stock rules generally require that
prior to a transaction in a penny stock, the broker-dealer make a special written determination that the penny stock is a suitable
investment for the purchaser and receive the purchaser&rsquo;s written agreement to the transaction. These disclosure requirements
may have the effect of reducing the level of trading activity in the secondary market for a stock that becomes subject to the
penny stock rules which may increase the difficulty Purchasers may experience in attempting to liquidate such securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>We
do not expect to pay dividends in the foreseeable future. Any return on investment may be limited to the value of our common stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
do not anticipate paying cash dividends on our common stock in the foreseeable future. The payment of dividends on our common
stock will depend on earnings, financial condition and other business and economic factors affecting it at such time as the board
of directors may consider relevant. If we do not pay dividends, our common stock may be less valuable because a return on your
investment will occur only if our stock price appreciates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Provisions
in the Nevada Revised Statutes and our Bylaws could make it very difficult for an investor to bring any legal actions against
our directors or officers for violations of their fiduciary duties or could require us to pay any amounts incurred by our directors
or officers in any such actions. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Members
of our board of directors and our officers will have no liability for breaches of their fiduciary duty of care as a director or
officer, except in limited circumstances, pursuant to provisions in the Nevada Revised Statutes and our Bylaws as authorized by
the Nevada Revised Statutes. Specifically, Section 78.138 of the Nevada Revised Statutes provides that a director or officer is
not individually liable to the company or its shareholders or creditors for any damages as a result of any act or failure to act
in his or her capacity as a director or officer unless it is proven that (1) the director&rsquo;s or officer&rsquo;s act or failure
to act constituted a breach of his or her fiduciary duties as a director or officer and (2) his or her breach of those duties
involved intentional misconduct, fraud or a knowing violation of law. This provision is intended to afford directors and officers
protection against and to limit their potential liability for monetary damages resulting from suits alleging a breach of the duty
of care by a director or officer. Accordingly, you may be unable to prevail in a legal action against our directors or officers
even if they have breached their fiduciary duty of care. In addition, our Bylaws allow us to indemnify our directors and officers
from and against any and all costs, charges and expenses resulting from their acting in such capacities with us. This means that
if you were able to enforce an action against our directors or officers, in all likelihood, we would be required to pay any expenses
they incurred in defending the lawsuit and any judgment or settlement they otherwise would be required to pay. Accordingly, our
indemnification obligations could divert needed financial resources and may adversely affect our business, financial condition,
results of operations and cash flows, and adversely affect prevailing market prices for our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="use"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>USE
OF PROCEEDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">All
of the shares of common stock covered by this prospectus are being sold by the Selling Shareholders. See &ldquo;Selling Shareholders&rdquo;
below. We will not receive any proceeds from these sales of shares of our common stock. A portion of the shares covered by this
prospectus are issuable upon exercise of the Agent Warrants to purchase our common stock. Upon any exercise of the Agent Warrants
for cash, such Selling Shareholders would pay us the exercise price of the warrants. Cash received from exercise of Agent Warrants
will be used for general corporate purposes. Additionally, the Warrants are exercisable on a cashless basis. If any Agent Warrants
are exercised on a cashless basis, we would not receive any cash payment from such Selling Shareholders upon any exercise of such
Agent Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Selling Shareholders will pay any underwriting discounts and commissions and expenses incurred by the Selling Shareholders for
brokerage, accounting, tax, or legal services or any other expenses incurred by the Selling Shareholders in disposing of the shares.
We will bear all other costs, fees, and expenses incurred in effecting the registration of the shares covered by this prospectus,
including, without limitation, all registration and filing fees, and fees and expenses of our counsel and our accountants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="determination"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>DETERMINATION
OF OFFERING PRICE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Selling Shareholders will determine at what price they may sell the offered shares, and such sales may be made at prevailing market
prices, or at privately negotiated prices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="selling"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SELLING
SHAREHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>



<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">We have prepared this prospectus to
allow the Selling Shareholders or their successors, assignees or other permitted transferees to sell or otherwise dispose of,
from time to time, up to 849,139 shares of our Common Stock. Of the shares of common stock being offered under this prospectus
804,139 shares are able to be acquired pursuant to the Agent Warrants we issued in connection with our March 2014 Private Placement,
which Agent Warrants are currently exercisable. The remaining 45,000 Advisory Shares were issued in connection with an Advisory
Agreement with Merriman. We have issued and delivered to Merriman the 45,000 shares of common stock that were earned under the
Advisory Agreement as of the date of execution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Agent Warrants and Advisory Shares were sold pursuant to an exemption from registration provided by Rule 506 of Regulation D under
the Securities Act. In connection therewith, the investors made to us certain representations, warranties, covenants, and conditions
customary for private placement investments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>



<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> The
table below presents information regarding the Selling Shareholders and the shares of our Common Stock that they may sell or otherwise
dispose of from time to time under this prospectus. Percentages of beneficial ownership are based upon </FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">28,960,925
shares of Common Stock issued and outstanding as of September 29, 2015. Beneficial ownership is determined under Section&nbsp;13(d)
of the Exchange Act and generally includes voting or investment power with respect to securities and including any securities
that grant the Selling Shareholders the right to acquire Common Stock within 60 days of September 29, 2015. Unless otherwise noted,
each person or group identified possesses sole voting and investment power with respect to the shares, subject to community property
laws where applicable.</FONT> </P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
do not know when or in what amounts the Selling Shareholders may sell or otherwise dispose of the shares covered hereby. We currently
have no agreements, arrangements or understandings with the Selling Shareholders regarding the sale of any of the shares by them
other than the registration rights agreement described below. The Selling Shareholders might not sell any or all of the shares
covered by this prospectus or may sell or dispose of some or all of the shares other than pursuant to this prospectus. Because
the Selling Shareholders may not sell or otherwise dispose of some or all of the shares covered by this prospectus and because
there are currently no agreements, arrangements or understandings with respect to the sale or other disposition of any of the
shares, we cannot estimate the number of the shares that will be held by the Selling Shareholders after completion of the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Each
Selling Shareholder has indicated to us that neither it nor any of its affiliates has held any position or office or had any other
material relationship with us in the past three years except as described in the footnotes to the table.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
shares of common stock being offered under this prospectus may be offered for sale from time to time during the period the registration
statement of which this prospectus is a part remains effective, by or for the accounts of the Selling Shareholders named below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares of Common Stock</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Name of Selling Shareholder</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Beneficially<BR> Owned&nbsp;Prior&nbsp;to<BR>
    the Sale of all<BR> Shares&nbsp;covered&nbsp;by<BR> this Prospectus</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Covered by<BR> this&nbsp;Prospectus</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Beneficially<BR> Owned&nbsp;After<BR>
    the&nbsp;Sale&nbsp;of&nbsp;all<BR> Shares&nbsp;covered&nbsp;by<BR> this Prospectus</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As&nbsp;a&nbsp;Percent&nbsp;of<BR>
    Total&nbsp;Outstanding<BR> After the Sale of<BR> Shares covered by<BR> this&nbsp;Prospectus</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 52%; text-align: left">Merriman Capital, Inc.(1)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">45,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">45,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">Merriman Capital, Inc.(2)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">591,613</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">591,613</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">Taglich Brothers, Inc.(3)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">212,526</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">212,526</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(1)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Consists
                                         of 45,000 shares of common stock issued under an Advisory Agreement with Merriman Capital,
                                         Inc. Merriman is a registered broker-dealer that served as the placement agent in connection
                                         with our March 2014 Private Placement. Jon Merriman is the CEO of Merriman and an affiliate
                                         of a registered-broker-dealer. Mr. Merriman has voting and dispositive power with respect
                                         to the shares.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Consists
                                         of warrants received as our placement agent in our March 2014 Private Placement.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(3)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Consists
                                         of warrants received as our placement agent in our March 2014 Private Placement. Taglich
                                         Brothers, Inc. is a registered broker-dealer that served as the placement agent in connection
                                         with our March 2014 Private Placement. Michael N. Taglich is a stockholder and executive
                                         officer of Taglich Brothers, Inc. and an affiliate of a registered-broker-dealer. Mr.
                                         Taglich has voting and dispositive power with respect to the warrants.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">As of the time of the purchase of the
securities to be resold under this Prospectus, the Selling Shareholders either received their securities as compensation in connection
with investment banking services provided in connection with the March 2014 Private Placement, or purchased the securities in
the ordinary course of business and represented to us that they did not have any agreements or understandings, directly or indirectly,
with any person to distribute the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Selling Shareholders, or their partners, pledgees, donees, transferees or other successors that receive the shares and their corresponding
registration in accordance with the registration rights agreement to which the Selling Shareholder is party (each also a selling
shareholder for purposes of this prospectus), may sell up to all of the shares of our common stock shown in the table above pursuant
to this Prospectus in one or more transactions from time to time as described below under &ldquo;Plan of Distribution.&rdquo;
However, the Selling Shareholders are not obligated to sell any of the shares of our common stock offered by this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Information
about the Selling Shareholders may change from time to time. Any changed information with respect to which we are given notice
will be included in prospectus supplements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="plan"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>PLAN
OF DISTRIBUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
are registering the shares of Common Stock to permit the resale of these shares of Common Stock by the Selling Shareholders and
any of their transferees, pledgees, assignees, donees, and successors-in-interest from time to time after the date of this prospectus.
We will not receive any of the proceeds from the sale by the Selling Shareholders of the shares of Common Stock. Upon any exercise
of the Agent Warrants by payment of cash, however, we will receive the exercise price of the Agent Warrants. We will bear all
fees and expenses incident to our obligation to register the shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Each
Selling Shareholder (the &ldquo;Selling Shareholders&rdquo;) of the securities and any of their pledgees, assignees and successors-in-interest
may, from time to time, sell any or all of their securities covered hereby on the OTC Bulletin Board, OTCQB or any other stock
exchange, market or trading facility on which the securities are traded or in private transactions. These sales may be at fixed
or negotiated prices. A Selling Shareholder may use any one or more of the following methods when selling securities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ordinary
                                         brokerage transactions and transactions in which the broker-dealer solicits purchasers;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">block
                                         trades in which the broker-dealer will attempt to sell the securities as agent but may
                                         position and resell a portion of the block as principal to facilitate the transaction;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">purchases
                                         by a broker-dealer as principal and resale by the broker-dealer for its account;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">an
                                         exchange distribution in accordance with the rules of the applicable exchange;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">privately
                                         negotiated transactions;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">settlement
                                         of short sales entered into after the effective date of the registration statement of
                                         which this prospectus is a part;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">in
                                         transactions through broker-dealers that agree with the Selling Shareholders to sell
                                         a specified number of such securities at a stipulated price per security;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">through
                                         the writing or settlement of options or other hedging transactions, whether through an
                                         options exchange or otherwise;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a
                                         combination of any such methods of sale; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">any
                                         other method permitted pursuant to applicable law.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Selling Shareholders may also sell securities under Rule 144 under the Securities Act of 1933, as amended (the &ldquo;Securities
Act&rdquo;), if available, rather than under this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Broker-dealers
engaged by the Selling Shareholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive
commissions or discounts from the Selling Shareholders (or, if any broker-dealer acts as agent for the purchaser of securities,
from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an
agency transaction not in excess of a customary brokerage commission in compliance with FINRA Rule 2440; and in the case of a
principal transaction a markup or markdown in compliance with FINRA IM-2440.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
connection with the sale of the securities or interests therein, the Selling Shareholders may enter into hedging transactions
with broker-dealers or other financial institutions, which may in turn engage in short sales of the securities in the course of
hedging the positions they assume. The Selling Shareholders may also sell securities short and deliver these securities to close
out their short positions, or loan or pledge the securities to broker-dealers that in turn may sell these securities. The Selling
Shareholders may also enter into option or other transactions with broker-dealers or other financial institutions or create one
or more derivative securities which require the delivery to such broker-dealer or other financial institution of securities offered
by this prospectus, which securities such broker-dealer or other financial institution may resell pursuant to this prospectus
(as supplemented or amended to reflect such transaction).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Selling Shareholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be &ldquo;underwriters&rdquo;
within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers
or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts
under the Securities Act. Each Selling Shareholder has informed the Company that it does not have any written or oral agreement
or understanding, directly or indirectly, with any person to distribute the securities. In no event shall any broker-dealer receive
fees, commissions and markups which, in the aggregate, would exceed eight percent (8%).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the securities. The
Company has agreed to indemnify the Selling Shareholders against certain losses, claims, damages and liabilities, including liabilities
under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Because
Selling Shareholders may be deemed to be &ldquo;underwriters&rdquo; within the meaning of the Securities Act, they will be subject
to the prospectus delivery requirements of the Securities Act including Rule 172 thereunder. In addition, any securities covered
by this prospectus which qualify for sale pursuant to Rule 144 under the Securities Act may be sold under Rule 144 rather than
under this prospectus. The Selling Shareholders have advised us that there is no underwriter or coordinating broker acting in
connection with the proposed sale of the resale securities by the Selling Shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by the Selling
Shareholders without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without
the requirement for the Company to be in compliance with the current public information under Rule 144 under the Securities Act
or any other rule of similar effect or (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under
the Securities Act or any other rule of similar effect. The resale securities will be sold only through registered or licensed
brokers or dealers if required under applicable state securities laws. In addition, in certain states, the resale securities covered
hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the
registration or qualification requirement is available and is complied with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Under
applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not
simultaneously engage in market making activities with respect to the common stock for the applicable restricted period, as defined
in Regulation M, prior to the commencement of the distribution. In addition, the Selling Shareholders will be subject to applicable
provisions of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of
purchases and sales of securities of the common stock by the Selling Shareholders or any other person. We will make copies of
this prospectus available to the Selling Shareholders and have informed them of the need to deliver a copy of this prospectus
to each purchaser at or prior to the time of the sale (including by compliance with Rule 172 under the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><A NAME="legal"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>LEGAL
PROCEEDINGS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> Aside from the following, we are
not a party to any material pending legal proceeding. We are not aware of any pending legal proceeding to which any of our officers,
directors, or any beneficial holders of 5% or more of our voting securities are adverse to us or have a material interest adverse
to us. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> In September 2014, we initiated
litigation against Shadron Stastney, the Company&rsquo;s previous CEO, in the U.S. District Court in the Eastern District of Michigan
as a result of a dispute related to his separation agreement. Mr. Stastney alleged damages related to the non-registration of
shares that he was granted as part of his separation agreement signed in September 2013. Under the terms of the contract we are
not obligated to register the shares and we deny any obligation to do so. We have requested declarative relief from the court
and also requested an injunction from the court preventing Mr. Stastney from continuing to pursue his claims. Mr. Stastney has
filed a counterclaim requesting damages of $450,000 related to the nonregistration of his shares. The parties are currently in
the discovery process. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> In March 2015, we initiated litigation
against LDM Group, LLC and PDR Network, LLC in the U.S. District Court in the Eastern District of Missouri related to the breach
by LDM, and PDR as successor, of the settlement agreement signed February 28, 2014 related to previous litigation with LDM. LDM
has failed to live up to its obligations under the settlement agreement including, but not limited to, not allowing us to distribute
our eCoupon programs in the LDM network, not allowing us to distribute the LDM patient education programs, and not providing other
information required under the settlement agreement. We are seeking enforcement of the settlement agreement and we are seeking
damages in an amount at least equal to the amounts paid to date to LDM under the settlement agreement, which approximates $1.0
million, as well as damages for lost income and business value as a result of LDM&rsquo;s breach of the agreement. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> In March 2015, we also initiated
litigation against PDR Network, LLC in the U.S. District Court in the District of New Jersey as a result of PDR&rsquo;s breach
of the Master Services Agreement between the parties requiring PDR to exclusively use our eCoupon solution. We assert that PDR&rsquo;s
acquisition of LDM and the use of the LDM network to distribute coupons by PDR violates the agreement between the parties and
we are seeking damages in an amount at least equal the amounts paid to date by us to LDM under the settlement agreement, which
approximates $1.0 million, as well as damages for lost income and business value as a result of PDR&rsquo;s actions. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> In May 2015, we filed an amended
complaint in the Missouri case to consolidate the two cases and withdrew the case against PDR Networks in the U.S. District Court
in the District of New Jersey, without prejudice. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> &nbsp; </P>

<P STYLE="margin: 0pt; text-align: justify"> In July, 2015, the U.S. District Court for the Eastern District of Missouri dismissed
the case, citing lack of Federal jurisdiction in the matter. We are in the process of refiling the consolidated case against PDR
Network and LDM group in State court in Missouri. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;<FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="directors"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>DIRECTORS,
EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> The following information sets forth
the names, ages, and positions of our current directors and executive officers as of September 29, 2015. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 23%; border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp;<B>Name</B> </FONT></TD>
    <TD STYLE="width: 1%; text-align: center; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="width: 8%; border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> Age </B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="width: 67%; border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> Positions
    and Offices Held </B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> David A. Harrell </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: center; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 48 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Chairman, Chief Executive Officer,
    Chief Strategic Officer and Director </FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> David Lester </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: center; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 57 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Vice President, Channel Management,
    Secretary and Treasurer </FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Terence J. Hamilton </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: center; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 49 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> VP of Sales and Director </FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Douglas Baker </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: center; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 58 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Chief Financial Officer </FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Gus D. Halas </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: center; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 64 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Director </FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Jack Pinney </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: center; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 58 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Director </FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Lynn O&rsquo;Connor Vos </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: center; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 59 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Director </FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Set
forth below is a brief description of the background and business experience of each of our current executive officers and directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>David
A. Harrell</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Mr.
Harrell founded the Company in January of 2006. He became a director when the Company changed from a limited liability to a corporation
in 2007. He has served as our Chairman since September 20, 2013, our Chief Strategic Officer since August 14, 2013 and our Chief
Executive Officer since September 20, 2013. Mr. Harrell was the Vice President of Development for Meridian Incorporated from 2003-2005
and, prior to that, had been Vice President of Sales and Marketing since 1999 at Advance Graphic Systems. Mr. Harrell has spent
two decades leading sales, marketing and business development units within the pharmaceutical and national retail industries.
Prior to his work at Advance Graphic Systems, Mr. Harrell served for ten years at SmithKline Beecham, specializing in the managed
markets healthcare segment. As part of the Integrated Health Division, Mr. Harrell was responsible for contracting and achieving
regional revenue growth for SmithKline Beecham's four business units: Pharmaceuticals, Consumer Health, Clinical Labs and Diversified
Pharmaceutical Services (PBM). During his tenure with SmithKline Beecham, he was a recipient of numerous national awards and served
as a member of the Division's Strategic Planning Committee. Mr. Harrell graduated from Oakland University with a Bachelor of Science
in Business Administration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Aside
from that provided above, Mr. Harrell does not hold and has not held over the past five years any other directorships in any company
with a class of securities registered pursuant to Section 12 of the Exchange Act or subject to the requirements of Section 15(d)
of the Exchange Act or any company registered as an investment company under the Investment Company Act of 1940.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>



<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Mr.
Harrell is qualified to serve on our Board of Directors because of his sales, marketing and business development experience in
the pharmaceutical sector.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>David
Lester</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Mr.
Lester served as our Secretary since July 28, 2010, and Chief Operating Officer since January 14, 2013 until he transitioned to
Vice President, Channel Management in January 2015. Mr. Lester is a business veteran whom has accumulated over thirty years of
executive experience in the areas of business, marketing, sales, operations, technology, and leadership. Prior to accepting his
new role with us, Mr. Lester held the title of Director, Consumer &amp; Industrial Products Marketing for Deloitte LLP. During
his tenure at Deloitte, he established Deloitte as a leader through innovative programs and strategic partnerships. Prior to Deloitte,
he worked with Sun Microsystems as Director, Industry Strategy &amp; Marketing, and Manufacturing Industries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">David
Lester has worked with Governor Tommy Thompson, former Secretary of Health &amp; Human Services, on health care reform and cost
control; partnered with Governor Tom Ridge, former head of Homeland Security on defending cyber security initiatives; and as an
active participant within the National Association of Manufacturers and the Manufacturing Institute worked with former Michigan
Governor John Engler, now President of the National Association of Manufacturers, on challenges inhibiting the competitiveness
of manufacturers like health care reform, trade policy, renewable energy, business tax reform, and sustainability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Aside
from that provided above, Mr. Lester does not hold and has not held over the past five years any other directorships in any company
with a class of securities registered pursuant to Section 12 of the Exchange Act or subject to the requirements of Section 15(d)
of the Exchange Act or any company registered as an investment company under the Investment Company Act of 1940.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Terence
J. Hamilton</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Mr.
Hamilton joined the Company as a Director and VP of Sales in February 2008. Prior to that, Mr. Hamilton was Manager at MedImmune
since 2005 and was Senior National Account Manager for Glaxo SmithKline pharmaceuticals for 13 years prior to that. Mr. Hamilton
has spent the last 19 years working in the pharmaceutical and biotech arenas within various sales, marketing and managed markets
management positions. He also has held many positions within the pharmaceutical and biotech industries, including District Manager,
Brand Manager, Managed Market Specialist, Contract Manager, and Government Account Manager.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Aside
from that provided above, Mr. Hamilton does not hold and has not held over the past five years any other directorships in any
company with a class of securities registered pursuant to Section 12 of the Exchange Act or subject to the requirements of Section
15(d) of the Exchange Act or any company registered as an investment company under the Investment Company Act of 1940.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Mr.
Hamilton is qualified to serve on our Board of Directors because of his sales, marketing and business development experience in
the pharmaceutical sector.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Gus
D. Halas</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Mr.
Halas has served as CEO of several companies. He was Chief Executive Officer and President of the Central Operating Companies
at Central Garden &amp; Pet Company from April 2011 through May 2013 and currently serves as a consultant to that Company. Mr.
Halas was President and Chief Executive Officer of T-3 Energy Services, Inc. from May 2003 to March 2009 and also served as Chairman
of the Board of Directors from March 2004 to March 2009. From August 2001 to April 2003, Mr. Halas served as President and Chief
Executive Officer of Clore Automotive, Inc. He also serves as a director for Triangle Petroleum Corp. and Hooper Holmes, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Aside
from that provided above, Mr. Halas does not hold and has not held over the past five years any other directorships in any company
with a class of securities registered pursuant to Section 12 of the Exchange Act or subject to the requirements of Section 15(d)
of the Exchange Act or any company registered as an investment company under the Investment Company Act of 1940.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Mr.
Halas is qualified to serve on our Board of Directors because of his experience and expertise as an executive and a director with
companies implementing &ldquo;turnaround&rdquo; strategies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Jack
Pinney</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">From
2007 to the present, Dr. Pinney has served as Team Physician to the Great Lakes Loons baseball team in the LA Dodgers organization.
From 2011 to the present, he has served as Medical Director for WellSport MidMichigan Medical Center. From 1992 to the present,
he has served as Assistant Clinical Professor of Family Medicine for the Department of Family Medicine at Michigan State University
College of Human Medicine. From 1992 to 2012, he served as Assistant Director for the Midland Family Practice Residency Program
at MidMichigan Medical Center.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Aside
from that provided above, Dr. Pinney does not hold and has not held over the past five years any other directorships in any company
with a class of securities registered pursuant to Section 12 of the Exchange Act or subject to the requirements of Section 15(d)
of the Exchange Act or any company registered as an investment company under the Investment Company Act of 1940.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Dr.
Pinney is qualified to serve on our Board of Directors because of his expertise medicine and prescription practices of physicians.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Douglas
Baker</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Mr.
Baker has served as our CFO since May 19, 2014. Mr. Baker is a Certified Public Account with a Masters Degree in Business Administration.
He has extensive business experience including 9 years in public accounting with Plante Moran, 4 years as CFO as CFO of a privately
held printing company, 5 years in a variety of divisional financial roles at MascoTech, Inc., a Fortune 500 automotive supplier,
and from 1996 to 2014 as Chief Financial Officer of Applied Nanotech Holdings, Inc., (&ldquo;APNT&rdquo;) a publicly held nanotechnology
research and licensing company. Mr. Baker was also a member of the Board of Directors of APNT from 2006 through 2014. He is also
currently Chairman of the Board of Total Health Care, Inc., a Detroit based Health Maintenance Organization and has been a member
of that Board since 1987.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Aside
from that provided above, Mr. Baker does not hold and has not held over the past five years any other directorships in any company
with a class of securities registered pursuant to Section 12 of the Exchange Act or subject to the requirements of Section 15(d)
of the Exchange Act or any company registered as an investment company under the Investment Company Act of 1940.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B> Lynn O&rsquo;Connor Vos </B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> Ms. Vos is, and has been since 1989,
the Chief Executive Officer of Grey Healthcare Group, a healthcare advertising and communications company and has been its President
and Chief Executive Officer since 1994. Previously, she held officer positions with Phase Five Communications, a medical education
firm, of which she was also the founder, and with Pfizer Inc. Ms. Vos previously served on the compensation committee of Vogel
Farina LLC, a privately held pharmaceutical communications firm, affiliated with Grey Healthcare Group. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> Ms. Vos has been a director of Ntelos
Holdings Corp., a reporting company, since October 2011. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> Aside from that provided above,
Ms. Vos does not hold and has not held over the past five years any other directorships in any company with a class of securities
registered pursuant to Section 12 of the Exchange Act or subject to the requirements of Section 15(d) of the Exchange Act or any
company registered as an investment company under the Investment Company Act of 1940. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> Ms. Vos is qualified to serve on
our Board of Directors because of her experience and expertise as an executive in the healthcare and marketing industries. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>



<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> Our bylaws authorize no less than
three (3) and no more than seven (7) directors unless changed by the Board of Directors. We currently have five (5) directors. </P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Term
of Office</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
Directors are appointed for a one-year term to hold office until the next annual general meeting of our shareholders or until
removed from office in accordance with our bylaws. Our officers are appointed by our board of directors and hold office until
removed by the board, subject to their respective employment agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Significant
Employees</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
have no significant employees other than our officers and directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Family
Relationships</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">There
are no family relationships between or among the directors, executive officers or persons nominated or chosen by us to become
directors or executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Involvement
in Certain Legal Proceedings</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">During
the past 10 years, none of our current directors, nominees for directors or current executive officers has been involved in any
legal proceeding identified in Item 401(f) of Regulation S-K, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.
Any petition under the Federal bankruptcy laws or any state insolvency law filed by or against, or a receiver, fiscal agent or
similar officer was appointed by a court for the business or property of such person, or any partnership in which he or she was
a general partner at or within two years before the time of such filing, or any corporation or business association of which he
or she was an executive officer at or within two years before the time of such filing;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2.
Any conviction in a criminal proceeding or being named a subject of a pending criminal proceeding (excluding traffic violations
and other minor offenses);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3.
Being subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction,
permanently or temporarily enjoining him or her from, or otherwise limiting, the following activities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">i.
Acting as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker,
leverage transaction merchant, any other person regulated by the Commodity Futures Trading Commission, or an associated person
of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated person,
director or employee of any investment company, bank, savings and loan association or insurance company, or engaging in or continuing
any conduct or practice in connection with such activity;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ii.
Engaging in any type of business practice; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">iii.
Engaging in any activity in connection with the purchase or sale of any security or commodity or in connection with any violation
of Federal or State securities laws or Federal commodities laws;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.
Being subject to any order, judgment or decree, not subsequently reversed, suspended or vacated, of any Federal or State authority
barring, suspending or otherwise limiting for more than 60 days the right of such person to engage in any type of business regulated
by the Commodity Futures Trading Commission, securities, investment, insurance or banking activities, or to be associated with
persons engaged in any such activity;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5.
Being found by a court of competent jurisdiction in a civil action or by the SEC to have violated any Federal or State securities
law, and the judgment in such civil action or finding by the Commission has not been subsequently reversed, suspended, or vacated;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">6.
Being found by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated
any Federal commodities law, and the judgment in such civil action or finding by the Commodity Futures Trading Commission has
not been subsequently reversed, suspended or vacated;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">7.
Being subject to, or a party to, any Federal or State judicial or administrative order, judgment, decree, or finding, not subsequently
reversed, suspended or vacated, relating to an alleged violation of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">i.
Any Federal or State securities or commodities law or regulation; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ii.
Any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent
injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal
or prohibition order; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">iii.
Any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">8.
Being subject to, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory
organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26))), any registered entity (as defined in
Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29))), or any equivalent exchange, association, entity or organization
that has disciplinary authority over its members or persons associated with a member.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Audit
Committee</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
do not have a separately-designated standing audit committee. The entire board of directors performs the functions of an audit
committee, but no written charter governs the actions of the board of directors when performing the functions of that would generally
be performed by an audit committee. The board of directors approves the selection of our independent accountants and meets and
interacts with the independent accountants to discuss issues related to financial reporting. In addition, the board of directors
reviews the scope and results of the audit with the independent accountants, reviews with management and the independent accountants
our annual operating results, considers the adequacy of our internal accounting procedures and considers other auditing and accounting
matters including fees to be paid to the independent auditor and the performance of the independent auditor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">For
the fiscal year ending December 31, 2014, the board of directors:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.
Reviewed and discussed the audited financial statements with management, and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2.
Reviewed and discussed the written disclosures and the letter from our independent auditors on the matters relating to the auditor's
independence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Based
upon the board of directors&rsquo; review and discussion of the matters above, the board of directors authorized inclusion of
the audited financial statements for the year ended December 31, 2014 to be included in this Prospectus filed with the Securities
and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Section
16(a) Beneficial Ownership Reporting Compliance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Section
16(a) of the Exchange Act requires our directors and executive officers and persons who beneficially own more than ten percent
of a registered class of the Company&rsquo;s equity securities to file with the SEC initial reports of ownership and reports of
changes in ownership of common stock and other equity securities of the Company. Officers, directors and greater than ten percent
beneficial shareholders are required by SEC regulations to furnish us with copies of all Section 16(a) forms they file. To the
best of our knowledge based solely on a review of Forms 3, 4, and 5 (and any amendments thereof) received by us, the following
persons have failed to file, on a timely basis, the identified reports required by Section 16(a) of the Exchange Act during fiscal
year ended December 31, 2014:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid">Name and principal position</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Number of <BR> late reports</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Transactions not <BR> timely reported</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Known failures to <BR> file a required form</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 64%; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">David A. Harrell </FONT><BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>CEO, Chairman, Chief Strategic Officer and Director</I></FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">David Lester </FONT><BR><FONT STYLE="font: 10pt Times New Roman, Times, Serif">
    <I>COO, Secretary, Treasurer and Director</I></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Terence J. Hamilton </FONT><BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>VP of Sales and Director</I></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Jack
                                 Pinney</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Director</I></FONT></P></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="security"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>



<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> Set forth below is certain information
with respect to beneficial ownership of our common stock as of September 29, 2015, by each executive officer and director, by
each person known by us to beneficially own more than 5% of the our common stock and by the executive officers and directors as
a group. Unless otherwise indicated, each person or member of the group listed has sole voting and investment power with respect
to the shares of common stock listed. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> Except as otherwise indicated, the
address of each person named in this table is c/o OptimizeRx Corp.., 400 Water Street, Suite 200 Rochester, MI 48307. </P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Name </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Options
    Included </FONT> <BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif">in Beneficial </FONT><BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Ownership (1)</FONT> </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Shares
    Related to Stock Awards and Note Payable (2) </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Common
    </FONT> <BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Shares </FONT><BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Owned</FONT> </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Common
    Stock </FONT> <BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Beneficial </FONT><BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Ownership</FONT> </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Percentage
    </FONT> <BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif">of Class</FONT> </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: right; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: right; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: right; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: right; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 40%; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> David A. Harrell </FONT></TD>
    <TD STYLE="width: 1%; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="width: 1%; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="width: 9%; text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 246,850 </FONT></TD>
    <TD STYLE="width: 1%; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="width: 1%; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="width: 1%; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="width: 9%; text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 600,917 </FONT></TD>
    <TD STYLE="width: 1%; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="width: 1%; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="width: 1%; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="width: 9%; text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 2,583,750 </FONT></TD>
    <TD STYLE="width: 1%; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="width: 1%; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="width: 1%; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="width: 9%; text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 3,431,517 </FONT></TD>
    <TD STYLE="width: 1%; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="width: 1%; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="width: 1%; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="width: 9%; text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 11.8 </FONT></TD>
    <TD STYLE="width: 1%; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> % </FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Terence J. Hamilton </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 122,000 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 384,188 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 364,500 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 870,688 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 3.0 </FONT></TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> % </FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> David Lester </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 49,000 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 50,000 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 373,348 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 472,348 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 1.6 </FONT></TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> % </FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Douglas P. Baker </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 50,000 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 0 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 20,000 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 70,000 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> * </FONT></TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp;% </FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Gus D. Halas </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 0 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 0 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 32,519 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 32,519 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> * </FONT></TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp;% </FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Jack Pinney </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 0 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 0 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 764,579 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 764,579 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 2.6 </FONT></TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> % </FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Lynn O&rsquo;Connor Vos </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 0 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 0 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 0 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 0 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 0 </FONT></TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> % </FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> All Executive Officers and&nbsp;Directors
    as a group (7&nbsp;persons) </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 467,850 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 1,035,105 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 4,113,696 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 5,641,651 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 19.5 </FONT></TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> % </FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> 5% Shareholders </B></FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"> WPP Luxembourg Gamma Three S.&agrave; r.l. </P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"> 200 Fifth Avenue </P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"> New York, NY 10010 </P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"> 212.886.3000 </P></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 0 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 0 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 6,011,106 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 6,011,106 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 20.7 </FONT></TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> % </FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 35px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Less
    than 1%</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 35px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> (1) </FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> This
    column lists shares that are subject to options exercisable within sixty (60) days of September 29, 2015, and are included
    in common stock beneficial ownership pursuant to Rule 13d-3(d)(1) of the Exchange Act. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 35px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> (2) </FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> This
    column lists shares that are obtainable as result of stock awards for shares not yet issued or notes that are payable in stock
    as of September 29, 2015. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="description"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>DESCRIPTION
OF SECURITIES </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
following descriptions are summaries of the material terms that are included in our amended and restated articles of incorporation
(as amended) and our bylaws (as amended) as well as the specific agreements such descriptions relate to. This summary is qualified
in its entirety by the specific terms and provisions contained in our restated articles of incorporation, bylaws and the specific
agreements described herein, copies of which we have filed as exhibits to the registration statement of which this prospectus
is a part, and by the provisions of applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Overview
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Authorized
Capital Stock </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>



<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> Our authorized capital stock consists
of 500,000,000 shares of common stock and 10,000,000 shares of preferred stock, par value $0.001 per share. As of September 29,
2015 there were 28,960,925 shares of our common stock issued and outstanding and 0 shares of our preferred stock issued and outstanding. </P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Common
Stock </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
common stock is entitled to one vote per share on all matters submitted to a vote of the stockholders, including the election
of directors. Except as otherwise required by law or provided in any resolution adopted by our board of directors with respect
to any series of preferred stock, the holders of our common stock will possess all voting power. Generally, all matters to be
voted on by stockholders must be approved by a majority (or, in the case of election of directors, by a plurality) of the votes
entitled to be cast by all shares of our common stock that are present in person or represented by proxy, subject to any voting
rights granted to holders of any preferred stock. Holders of our common stock representing fifty percent (50%) of our capital
stock issued, outstanding and entitled to vote, represented in person or by proxy, are necessary to constitute a quorum at any
meeting of our stockholders. A vote by the holders of a majority of our outstanding shares is required to effectuate certain fundamental
corporate changes such as liquidation, merger or an amendment to our Articles of Incorporation. Our Articles of Incorporation
do not provide for cumulative voting in the election of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Subject
to any preferential rights of any outstanding series of preferred stock created by our board of directors from time to time, the
holders of shares of our common stock will be entitled to such cash dividends as may be declared from time to time by our board
of directors from funds available therefore.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Subject
to any preferential rights of any outstanding series of preferred stock created from time to time by our board of directors, upon
liquidation, dissolution or winding up, the holders of shares of our common stock will be entitled to receive pro rata all assets
available for distribution to such holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
the event of any merger or consolidation with or into another company in connection with which shares of our common stock are
converted into or exchangeable for shares of stock, other securities or property (including cash), all holders of our common stock
will be entitled to receive the same kind and amount of shares of stock and other securities and property (including cash). Holders
of our common stock have no pre-emptive rights, no conversion rights and there are no redemption provisions applicable to our
common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Preferred
Stock </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
board of directors may become authorized to authorize preferred shares of stock and to divide the authorized shares of our preferred
stock into one or more series, each of which must be so designated as to distinguish the shares of each series of preferred stock
from the shares of all other series and classes. Our board of directors is authorized, within any limitations prescribed by law
and our articles of incorporation, to fix and determine the designations, rights, qualifications, preferences, limitations and
terms of the shares of any series of preferred stock including, but not limited to, the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(1)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    number of shares constituting that series and the distinctive designation of that series, which may be by distinguishing number,
    letter or title; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(2)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    dividend rate on the shares of that series, whether dividends will be cumulative, and if so, from which date(s), and the relative
    rights of priority, if any, of payment of dividends on shares of that series; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(3)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Whether
    that series will have voting rights, in addition to the voting rights provided by law, and, if so, the terms of such voting
    rights; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(4)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Whether
    that series will have conversion privileges, and, if so, the terms and conditions of such conversion, including provision
    for adjustment of the conversion rate in such events as the Board of Directors determines; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(5)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Whether
    or not the shares of that series will be redeemable, and, if so, the terms and conditions of such redemption, including the
    date or date upon or after which they are redeemable, and the amount per share payable in case of redemption, which amount
    may vary under different conditions and at different redemption dates; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(6)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Whether
    that series will have a sinking fund for the redemption or purchase of shares of that series, and, if so, the terms and amount
    of such sinking fund; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(7)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    rights of the shares of that series in the event of voluntary or involuntary liquidation, dissolution or winding up of the
    corporation, and the relative rights of priority, if any, of payment of shares of that series; and </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(8)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Any
    other relative rights, preferences and limitations of that series. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Registration
Rights </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>The
Shares Underlying Warrants Issued in Connection With the March 2014 Private Placement Financing</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
connection with the March 2014 Private Placement, we entered into a Registration Rights Agreement. The Registration Rights Agreement
required us to file a registration statement with the Securities and Exchange Commission in connection with shares sold in the
March 2014 Private Placement. We filed a registration statement that went effective on May 28, 2014 to comply with the terms of
the Registration Rights Agreement. In addition, we granted piggyback registration rights to the Placement Agents in the March
2014 Private Placement, which comprise the shares of common stock underlying the Agent Warrants that are being registered herein.
We are filing this registration statement to maintain the registered status of those shares underlying the Agent Warrants.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;<FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>The
Shares Issued in Connection with the Merriman Capital, Inc. Advisory Agreement</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 23, 2015, we entered into the
Advisory Agreement with Merriman. We granted registration rights to Merriman concerning the 45,000 shares in the Advisory Agreement.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I> WPP Luxembourg Gamma Three
Sarl </I></B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> On September 24, 2015, in connection
with the sale of 6,011,106 shares of our common stock to WPP Luxembourg Gamma Three Sarl (&ldquo;WPP Luxembourg&rdquo; or the
&ldquo;Investor&rdquo;), we granted demand registration rights to the investor at any time after 2 years. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B> Investor Rights Agreement </B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B> &nbsp; </B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> On September 24, 2015, we entered
into an Investor Rights Agreement with WPP Luxembourg (the &ldquo;Rights Agreement&rdquo;), pursuant to which we agreed to the
following: </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &#9679; </FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I> Demand
                                         Registration Rights </I> . We granted the Investor registration rights for the 6,011,106
                                         acquired from us and any securities acquired in connection with an Amended and Restated
                                         Co-Marketing Agreement after a period of two years. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &#9679; </FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I> Inspection
                                         Rights </I> . So long as the Investor owns not less than 25% of the Shares, we granted
                                         the Investor an annual right to inspect our books and records. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &#9679; </FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I> Observer
                                         Rights </I> . So long as the Investor owns not less than 25% of the Shares, we will
                                         allow the Investor to choose a representative to attend our board meetings as a nonvoting
                                         observer. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> ` </FONT></TD><TD STYLE="width: 18pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &#9679; </FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I> Board
                                         Seat </I> . So long as the Investor owns not less than 25% of the Shares, we agreed
                                         to appoint a nominee of the Investor as a member of our board of directors. We also agreed
                                         to a five member Board of Directors provided that it is not prohibited by the rules and
                                         regulations of an exchange that we trade on. We also agreed to enter into an Indemnity
                                         Agreement with the nominee. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &#9679; </FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I> Budget
                                         Review </I> . So long as the Investor owns not less than 25% of the Shares, we agreed
                                         to review our budget plans with the Investor&rsquo;s nominee prior to submission to the
                                         Board of Directors, at the request of the Investor. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &#9679; </FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I> Right
                                         of First Refusal </I> . We agreed that, in the event that it proposes to sell new
                                         securities, we will first offer such new securities to the Investor. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &#9679; </FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I> Special
                                         Approval Matters </I> . So long as the Investor owns not less than 25% of the Shares,
                                         and provided that it is not prohibited by the rules and regulations of an exchange that
                                         we trades on, we agreed that 80% Board approval will be required for certain decisions,
                                         including: </FONT></TD></TR>                                                                                                                                 <TR STYLE="vertical-align: top">
<TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </FONT></TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 54pt"></TD><TD STYLE="width: 18pt"> o </TD><TD STYLE="text-align: justify"> the incurrence of any indebtedness
                                         in excess of $1.5 million in the aggregate during any fiscal year </TD></TR>
<TR STYLE="vertical-align: top">
<TD> &nbsp; </TD><TD> &nbsp; </TD><TD STYLE="text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 54pt"></TD><TD STYLE="width: 18pt"> o </TD><TD STYLE="text-align: justify"> the sale, transfer or other disposition
                                         of all or substantially all of our assets; </TD></TR>
<TR STYLE="vertical-align: top">
<TD> &nbsp; </TD><TD> &nbsp; </TD><TD STYLE="text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 54pt"></TD><TD STYLE="width: 18pt"> o </TD><TD STYLE="text-align: justify"> the acquisition of any assets or
                                         properties (in one or more related transactions) for cash or otherwise for an amount
                                         in excess of $1.5 million in the aggregate during any fiscal year; </TD></TR>
<TR STYLE="vertical-align: top">
<TD> &nbsp; </TD><TD> &nbsp; </TD><TD STYLE="text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 54pt"></TD><TD STYLE="width: 18pt"> o </TD><TD STYLE="text-align: justify"> capital expenditures in excess of
                                         $1.5 million individually (or in the aggregate if related to an integrated program of
                                         activities) or in excess of $1.5 million in the aggregate during any fiscal year; </TD></TR>
<TR STYLE="vertical-align: top">
<TD> &nbsp; </TD><TD> &nbsp; </TD><TD STYLE="text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 54pt"></TD><TD STYLE="width: 18pt"> o </TD><TD STYLE="text-align: justify"> making, or permitting any subsidiary
                                         to make, loans to, investments in, or purchasing, or permitting any subsidiary to purchase,
                                         any stock or other securities in another corporation, joint venture, partnership or other
                                         entity; </TD></TR>
<TR STYLE="vertical-align: top">
<TD> &nbsp; </TD><TD> &nbsp; </TD><TD STYLE="text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 54pt"></TD><TD STYLE="width: 18pt"> o </TD><TD STYLE="text-align: justify"> the commencement or settlement of
                                         any lawsuit, arbitration or other legal proceeding related to our intellectual property
                                         or involving an amount in controversy greater than $1.5 million; and </TD></TR>
<TR STYLE="vertical-align: top">
<TD> &nbsp; </TD><TD> &nbsp; </TD><TD STYLE="text-align: justify"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 54pt"></TD><TD STYLE="width: 18pt"> o </TD><TD STYLE="text-align: justify"> the issuance of new securities,
                                         except for securities issued under an equity incentive plan and any issuance of common
                                         stock to vendors, advisors, financial institutions, suppliers or joint venturers that
                                         do not exceed, individually or in the aggregate 5% of then issued and outstanding capital
                                         stock of the Company. </TD></TR></TABLE>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt"> &nbsp; </P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Provisions
in Our Articles of Incorporation and By-Laws That Would Delay, Defer or Prevent a Change in Control</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
articles of incorporation authorize our board of directors to issue a class of preferred stock commonly known as a &quot;blank
check&quot; preferred stock. Specifically, the preferred stock may be issued from time to time by the board of directors as shares
of one (1) or more classes or series. Our board of directors, subject to the provisions of our Articles of Incorporation and limitations
imposed by law, is authorized to adopt resolutions; to issue the shares; to fix the number of shares; to change the number of
shares constituting any series; and to provide for or change the following: the voting powers; designations; preferences; and
relative, participating, optional or other special rights, qualifications, limitations or restrictions, including the following:
dividend rights, including whether dividends are cumulative; dividend rates; terms of redemption, including sinking fund provisions;
redemption prices; conversion rights and liquidation preferences of the shares constituting any class or series of the preferred
stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
each such case, we will not need any further action or vote by our shareholders. One of the effects of undesignated preferred
stock may be to enable the board of directors to render more difficult or to discourage an attempt to obtain control of us by
means of a tender offer, proxy contest, merger or otherwise, and thereby to protect the continuity of our management. The issuance
of shares of preferred stock pursuant to the board of director's authority described above may adversely affect the rights of
holders of common stock. For example, preferred stock issued by us may rank prior to the common stock as to dividend rights, liquidation
preference or both, may have full or limited voting rights and may be convertible into shares of common stock. Accordingly, the
issuance of shares of preferred stock may discourage bids for the common stock at a premium or may otherwise adversely affect
the market price of the common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Dividend
Policy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
have never declared or paid any cash dividends on our common stock.&nbsp;&nbsp;We currently intend to retain future earnings,
if any, to finance the expansion of our business. As a result, we do not anticipate paying any cash dividends in the foreseeable
future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Share
Purchase Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>



<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">We had warrants outstanding to purchase
1,854,139 shares of our common stock at a weighted average exercise price of $1.69 as of September 28, 2015.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Options</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>



<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> We
had options outstanding to purchase </FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">1,172,500 shares of our
common stock at a weighted average exercise price of $1.06 as of September 28, 2015.</FONT> </P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Convertible
Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> We
have not issued and do not have outstanding any securities convertible into shares of our common stock or any rights convertible
or exchangeable into shares of our common stock. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Certain
Anti-Takeover Provisions </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Nevada
Anti-Takeover Laws</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Nevada
Revised Statutes sections 78.378 to 78.379 provide state regulation over the acquisition of a controlling interest in certain
Nevada corporations unless the articles of incorporation or bylaws of the corporation provide that the provisions of these sections
do not apply. Our articles of incorporation and bylaws do not state that these provisions do not apply. The statute creates a
number of restrictions on the ability of a person or entity to acquire control of a Nevada company by setting down certain rules
of conduct and voting restrictions in any acquisition attempt, among other things. The statute is limited to corporations that
are organized in the state of Nevada and that have 200 or more stockholders, at least 100 of whom are stockholders of record and
residents of the State of Nevada; and does business in the State of Nevada directly or through an affiliated corporation. Because
of these conditions, the statute currently does not apply to our company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Listing
of Common Stock </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our common
stock is currently traded on the OTCQB under the trading symbol &ldquo;OPRX.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Transfer
Agent and Registrar </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
transfer agent and registrar of our common stock is Empire Stock Transfer, 1859 Whitney Mesa Dr, Henderson, NV 89014, telephone:
(702)&nbsp;974-1444.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="interests"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>INTERESTS
OF NAMED EXPERTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">No
expert or counsel named in this prospectus as having prepared or certified any part of this prospectus or having given an opinion
upon the validity of the securities being registered or upon other legal matters in connection with the registration or offering
of the common stock was employed on a contingency basis, or had, or is to receive, in connection with the offering, a substantial
interest, direct or indirect, in the registrant or any of its parents or subsidiaries. Nor was any such person connected with
the registrant or any of its parents or subsidiaries as a promoter, managing or principal underwriter, voting trustee, director,
officer, or employee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Doney Law Firm, our independent legal counsel, has provided an opinion on the validity of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">KLJ
&amp; Associates, LLP has audited our financial statements included in this prospectus and registration statement to the extent
and for the periods set forth in their audit report. KLJ &amp; Associates, LLP has presented their report with respect to our
audited financial statements. The report of KLJ &amp; Associates, LLP is included in reliance upon their authority as experts
in accounting and auditing.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Silberstein Ungar PLLC has also audited our
financial statements included in this prospectus and registration statement to the extent and for the periods set forth in their
audit report. Silberstein Ungar PLLC has presented their report with respect to our audited financial statements. The report of
Silberstein Ungar PLLC is included in reliance upon their authority as experts in accounting and auditing.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="disclosure"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>DISCLOSURE
OF COMMISSION POSITION ON INDEMNIFICATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<B>FOR&nbsp;SECURITIES
ACT LIABILITIES</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Insofar
as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to our directors, officers and controlling
persons pursuant to the following provisions, or otherwise, we have been advised that in the opinion of the Securities and Exchange
Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable.&nbsp;&nbsp;In
the event that a claim for indemnification against such liabilities (other than the payment by us of expenses incurred or paid
by a director, officer or controlling person in the successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the shares being registered, we will, unless in the opinion of its
counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of
such issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="business"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>DESCRIPTION
OF BUSINESS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Company
Highlights For 2014</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
2014 and into 2015, our company continues to be focused on four key operational areas:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Expand
                                         pharmaceutical brands and budgets</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">2<FONT STYLE="font: 10pt Times New Roman, Times, Serif">.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Expand
                                         physician utilization in our current EHR Network</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Expand
                                         our promotional network in other EHRs and platforms</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0">4<FONT STYLE="font: 10pt Times New Roman, Times, Serif">.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Expand
                                         infrastructure and resources to fully support and exploit each of the above three</FONT></TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Per
this focus, we were able to demonstrate success in each during 2014 through:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">increased
                                         sales of approximately 39% over 2013</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">increased
                                         promotional transactions of approximately 26% over those in 2013.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">distributed
                                         eCoupons related to approximately 80 different brands.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">generated
                                         operating income of approximately $400,000, excluding non-cash expenses. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">successfully
                                         launching our SampleMD e-coupon solution within Quest Diagnostics&rsquo; Care360 EMR
                                         and eHealthline networks.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">continued
                                         acquisition of new pharmaceutical manufacturers and brands promoting through our platforms.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">hiring
                                         of key senior level personnel, including a highly experienced financial executive as
                                         CFO and a former global marketing director from AstraZeneca to lead east coast sales,
                                         while expanded our Board of Directors with seasoned executives.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">acquisition
                                         of $10 million dollars in new capital to exercise the negotiated buyout of Vicis, which
                                         netted out an additional $2.8 million dollars to us, and a reduction of approximately
                                         7 million in potential fully diluted shares.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">completion
                                         and launch of the SampleMD 2.0 technology platform to support growth and are upgrading
                                         to Oracle database software to further improve system and reporting capacity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">conducting
                                         and proving an outstanding Return on Investment associated with our pharmaceutical promotions
                                         through three independent analytics firms involving multiple pharmaceutical brands and
                                         manufacturers.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">unveiling
                                         VoucherDVM and engaged leading platforms to offer automated vet product savings. The
                                         company has formalized an agreement with National Veterinary Associates, a leading national
                                         hospital network, to beta launch in second quarter of 2015.</FONT></TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
generated positive cash flow from operations in 2014, excluding working capital fluctuations, and we expect to continue to do
so in 2015, as well as to be profitable during the upcoming year based on the expected escalation of revenues.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
success in acquiring, integrating and expanding into new promotional EHR/eRx platforms continues to grow as well. We are in the
process of completing the initial rollout of brands into the Practice Fusion network, as well as discussing 2015 rollout dates
with other potential networks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
the fourth quarter of 2014, we signed an agreement with Practice Fusion, the largest cloud-based electronic health records (EHR)
platform, to integrate and automate our patient savings and support system to enable Practice Fusion prescribers to more efficiently
help patients better afford and adhere to their prescribed medications. Practice Fusion&rsquo;s EHR is used by a community of
more than 112,000 active medical professionals monthly with over 91 million patient records and should have a significant impact
on our prescribing reach and sales once live. We anticipate that the integration will be completed early in the second quarter
of 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
are enforcing our agreements to integrate our promotions within LDM/PDR&rsquo;s network of over 100,000 physicians and work collectively
to integrate into NextGen. This delay in implementation of agreed terms has resulted in significant loss of revenue and profits
to OptimizeRx. Thus we are aggressively seeking multiple strategies, including legal, to address and resolve this.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
March 2015, we signed an agreement with HCA Information Technology &amp; Services, Inc.to pilot our eCoupon promotional system
within their network. HCA is the largest hospital system in the nation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
also signed our first agreement with National Veterinary Associates (NVA), one of the largest veterinary hospital systems in the
nation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Pharmaceutical
Sales and Marketing Updates</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
sales team continues to expand opportunities within existing and new clients. We are focused on adding additional brands at existing
clients, expanding the utilization of our network for existing brands, and obtaining new clients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Additionally,
we are expanding our non e-Coupon services as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
                                         will focus on our New Drug File Integration.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
                                         will begin a test rollout of our demand drug rep and sample request with two Urology
                                         EHR platforms to provide immediate access to assigned drug reps. Drug rep access via
                                         cold calling has become a very inefficient way to support and market to physician offices.
                                         This provides a novel, potentially ground breaking new way to increase access and meaningful
                                         support by reps in a more efficient, effective manner.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ePrescribe
                                         Training &ndash; we have multiple opportunities pending to leverage our partnership with
                                         WPP/Grey to train representatives on understanding and leveraging EHR sales opportunities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">VoucherDVM
                                         - we continue to advance our negotiations with each of the leading veterinarian technology
                                         platforms and have signed an agreement with National Veterinary Associates, one of the
                                         largest veterinary groups in the U.S., to initiate a beta launch within the second quarter
                                         of 2015.</FONT></TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
are also continuing to ramp up our marketing efforts as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Held
                                         multiple meetings generated through Pharma to bring on new Health Systems/ePrescribe
                                         Platforms.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Spoke
                                         at Coupon and Co-Pay Off-set Strategies Conference.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Spoke
                                         at the Noble Financial Capital Markets Eleventh Annual Equity Conference at Club Med.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Sponsored
                                         the 2nd Annual ePrescribe/EHR Conference.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Developed
                                         and distributed a White Paper to demonstrate the eCoupon ROI to Pharmaceutical Manufacturers.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Through
                                         our partnership with Grey Healthcare, rebranded our promotional marketing items, including
                                         new brochures, presentations, and digital media.</FONT></TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">With
the growth of both our pharmaceutical products and our distribution network, we expect that our distribution of e-coupons will
continue to increase substantially over last year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Financial
Update</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
generated positive cash flow from operations, when ignoring working capital fluctuations, of approximately $400,000 in 2014 as
set forth in the following table.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Years Ended <BR>
    December 31</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2014</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2013</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: transparent">
    <TD STYLE="width: 76%; text-align: left">Net Revenue</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">6,502,962</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">4,679,741</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: transparent">
    <TD STYLE="padding-bottom: 1.5pt">Revenue Share Expense</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,221,534</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,861,316</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: transparent">
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: transparent">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Gross Margin</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,281,428</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,818,425</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: transparent">
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: transparent">
    <TD STYLE="text-align: left">Total Operating Expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,307,756</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,085,961</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: transparent">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Less Noncash operating expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,439,877</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">717,173</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: transparent">
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: transparent">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Cash operating Expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,867,879</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,368,788</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: transparent">
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: transparent">
    <TD STYLE="text-align: left; padding-bottom: 4pt">Income from Operations excluding noncash expenses</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">413,549</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">449,637</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Operational
Update</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
2015, we are intensively focused on increasing physician utilization of our partner networks. Prior to the launch of the Practice
Fusion network, the total reach of our partner networks was approximately 300,000 providers. However, only approximately 100,000
providers have access to eCoupon functionality. Approximately 65,000 providers have used our eCoupon functionality at least once,
but only approximately 20,000 providers actually use the networks regularly at the present time. We are working individually with
each of our partners based on their particular situation to improve workflow to increase coupon utilization by those providers
that have access, obtain access for those providers that currently do not have e-coupon access, and increase overall revenue derived
from each channel. We believe there is significant revenue growth available within our existing brands by better utilization of
our existing partner networks in addition to the revenue growth provided by new brands and new network partners. &nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Technology
Updates</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">To
support our growth, we have completed the development and migration of SampleMD 2.0&rsquo;s on-demand, rule based content delivery
platform. The system can now manage up to 1 million rules and return the appropriate content within 1 second. This allows unsurpassed
response time to avoid delays, and the ability to meet the upcoming dramatic scale we expect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
have launched downloadable &ldquo;wrapper&rdquo; code, which streamlines the integration requirements for our solution from a
few weeks to a few days, if EHR channel partners choose to utilize this method. This addresses one of the biggest hurdles we face
in getting health systems and EHRs to implement our system, given the extensive demand on their available technical resources.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
top of building out our updated software solution, we also updated our infrastructure by replacing and updating our computers
in a high availability environment, taking greater precautions for security and building out the architecture to facilitate disaster
recovery with a secondary facilitated computer environment. We believe this technology investment will increase performance, simplify
integrations, insure availability and protect the investments of our shareholders. We will also be migrating our platform to Oracle
database software to support our anticipated growth requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Other
Key Events in 2014</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">During
2014, we also successfully completed a $10 million capital raise and exercised the option to redeem Vicis Capital Master Fund&rsquo;s
holdings in our company. By successfully executing these initiatives we reduced potential fully diluted shares by approximately
7 million and provided an additional $2.8 million in working capital to support our growth and eliminate dividend payments and
other unfavorable provisions of Vicis&rsquo; preferred stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
added two new outside members to our Board of Directors. Gus Halas has an extensive operating background at a variety of companies
across a wide range of industries. He brings broad based business and investor perspectives to our senior leadership and is a
real asset to us as we hone our strategy and further position ourselves for growth acceleration. Dr. Jack Pinney brings broad
based medical knowledge and extensive experience in physician practice and an important user perspective to our Board of Directors
and works with us to better understand how we can help more healthcare providers utilize our automated access to needed information
and support for their practice and patients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
expanded our senior leadership team by adding Ed Berger, a former AstraZenica global marketing director with extensive contacts
throughout the pharmaceutical industry to lead our sales efforts on the east coast. We also added Doug Baker as our Chief Financial
Officer, a certified public accountant with extensive financial experience with public companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
August 2014, we settled litigation related to a patent infringement case with Physicians Interactive Holdings, Inc. and Skyscape.com.
All actions and claims have been released. We believe this settlement will reduce legal expenses moving forward.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Summary</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Despite
the lengthy sales cycle involved in creating this new e-coupon market, we remain very excited about our core e-coupon business
and expect acceleration to continue with the launch of additional channels and our joint pursuit of leading health systems with
our pharmaceutical partners. We expect our active network to grow substantially in 2015 and feel confident our active users will
double by the end of the second quarter of 2015 based on anticipated contractual and platform commitments being implemented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
are also pleased with the status of our current discussions with, and the value recognized by, leading veterinary platform providers
that are interested in partnering to deliver similar automated savings to animal owners&mdash;while allowing veterinarians to
remain competitive in their pharmacy business. These discussions are leading to expanded ways we can offer savings directly to
veterinarians&mdash;as well as to their pet owners outside of the vet clinics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Principal
Products and Applications</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
principal products and applications can be summarized as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">SampleMD
                                         is a revolutionary virtual &quot;Patient Support Center&quot; that allows doctors and
                                         staff to access a universe of sample vouchers, co-pay coupons and other patient support
                                         through their EMR and/or e-Prescribe systems to search, print or electronically dispense
                                         directly to patients and a national network of pharmacies. SampleMD eliminates the need
                                         for physicians to manage and store physical drug samples by offering a more convenient
                                         and efficient way to allocate, administer and track samples and co-pay savings provided
                                         to their patients. Today, almost 60% of doctors&rsquo; offices ban or limit drug representatives
                                         and the samples they offer. Although samples are still valuable, many healthcare systems
                                         and doctors are looking for an easier, more effective way to increase affordable access
                                         and adherence to their prescribed branded medications. Over 90% of our revenue comes
                                         through activities related to our SampleMD platform.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">OPTIMIZEHR
                                         &ndash; Our consulting practice focused on educating and working with pharmaceutical
                                         manufacturers on identifying, formulating, and implementing new eRx media strategies
                                         for promoting their products. Our consulting services include: 1) Drug File Integration
                                         - a service to insure that the manufacturer&rsquo;s drug is present in every ePrescribing
                                         platform available; 2) Sales Force Training &ndash; a service to educate the extended
                                         field sales force on this new integrated solution and what to look for within their client
                                         base to insure maximum exposure of their bands; and 3) Strategy Development &ndash; a
                                         service that assists manufactures in identifying and building a competitive strategy
                                         to take advantage of this new digital frontier. Currently, this activity results in less
                                         than 10% of our revenue, but we believe this represents a significant growth opportunity
                                         for us.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">OPTIMIZERx.com
                                         &ndash; Our Direct to Consumer Website is a portal to healthcare savings for patients
                                         to centrally review and participate in prescription and healthcare savings and support
                                         programs. To date, we have over 2.4 million members who have registered. We strive to
                                         provide all the information and guidance that patients undergoing long-term pharmaceutical
                                         treatments may require. Patients can search by their medication or their condition in
                                         order to access educational information regarding their condition, information regarding
                                         their medication, coupons for instant savings when they purchase their medications, information
                                         on free drug trials, and guidance to any other savings programs available to them.&nbsp;At
                                         the present time, we generate no revenue through this site, but we believe it represents
                                         a significant potential future revenue source.</FONT></TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Marketing
and Sales</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
continue to extend our marketing efforts to build both brand and capabilities awareness in the market. As previously discussed,
we continue to actively participate in industry and partner events such as exlPharma and the ACE &ndash; Allscripts Users Conference
as well as taking a lead sponsor position in the CBInet eRx and EHR conferences in March and October of 2014. We are also a cosponsor
of the March 2015 conference. During the course of the year, we also initiated and delivered successful email marketing campaigns,
which generated viable leads for our sales force.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
2013, we also announced our strategic partnership with WPP/Grey Health Group, a leading agency within the healthcare marketplace.
We plan to continue to increase our marketing efforts with all of our strategic partners, as we intend to continue to promote
SampleMD and OPTIMIZERx primarily through the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Industry
                                         and Partner Events;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Email
                                         Campaigns;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Internet
                                         Marketing;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Public
                                         Relations Campaigns;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Physician
                                         Offices;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Direct
                                         to Consumer Marketing;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Trade
                                         Media Advertising;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Pharmacy
                                         Partners;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Physician
                                         Organizations and Associations; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Strategic
                                         Relationships.</FONT></TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Additionally,
in 2014, we hired a highly seasoned Sales and Marketing Executive, who has decades of global pharmaceutical marketing and sales
experience at AstraZeneca and elsewhere, as our Eastern Vice President of Sales. We continue to be alert for qualified sales personnel
and will expand our sales force as revenues continue to grow.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Competition</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
SampleMD platform competes in the highly competitive pharmaceutical and healthcare advertising industry that is dominated by large
well-known companies with established names, solid market niches, wide arrays of product offerings and marketing networks. Coupon
offerings compete for pharmaceutical budgets with a variety of other forms of advertising and promotion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Despite
these overall competitors, we do not have major competition in our space of the market. We have been experiencing a growing list
of potential partners whom either have content that want to deliver through the SampleMD engine and network, or whom have complementary
technology and want to integrate our solution as a channel partner, expanding our reach to clinicians. The primary competitors
in our space of the market are PDR Network, LLC and Physicians Interactive Holdings, Inc. However, we believe our breadth of brands
offered, extensive list of pharmaceutical clients, and the vast reach of our network give us a substantial advantage and allows
us to achieve a dominant position in the marketplace.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Intellectual
Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
2012, we were awarded a patent for our innovative SampleMD solution (US Patent No. 8,341,015). This award was a result of our
extensive research and development efforts. The awarded claims cover our ability to electronically process, display and distribute
eligible prescription savings on the medications and therapies healthcare providers wish to prescribe for their patients. We have
also submitted and will be preparing additional filings to protect our intellectual property on forthcoming solutions that will
further assist and support physicians, pharmacists and patients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
addition, we have hired Harness, Dickey &amp; Pierce, a nationally ranked IP firm, to further expand and protect our intellectual
property. Through them, we have filed two additional patents on our technology. We believe our current and expanding IP will allow
us to continue being the leader in this rapidly growing space.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">OPTIMIZERx
and SampleMD are both licensed trademarks of ours.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Government
Regulation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Fraud
and Abuse Laws</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Anti-Kickback
Statutes</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
federal healthcare program Anti-Kickback Statute prohibits persons from knowingly and willfully soliciting, offering, receiving
or providing remuneration, directly or indirectly, in exchange for or to induce either the referral of an individual for, or the
furnishing, arranging for or recommending a good or service for which payment may be made in whole or part under a federal healthcare
program such as Medicare or Medicaid. The definition of remuneration has been broadly interpreted to include anything of value,
including for example gifts, discounts, the furnishing of supplies or equipment, credit arrangements, payments of cash and waivers
of payments. Several courts have interpreted the statute's intent requirement to mean that if any one purpose of an arrangement
involving remuneration is to induce referrals or otherwise generate business involving goods or services reimbursed in whole or
in part under federal healthcare programs, the statute has been violated. The law contains a few statutory exceptions, including
payments to bona fide employees, certain discounts and certain payments to group purchasing organizations. Violations can result
in significant penalties, imprisonment and exclusion from Medicare, Medicaid and other federal healthcare programs. Exclusion
of a manufacturer would preclude any federal healthcare program from paying for its products. In addition, kickback arrangements
can provide the basis for an action under the Federal False Claims Act, which is discussed in more detail below. The Anti-Kickback
Statute is broad and potentially prohibits many arrangements and practices that are lawful in businesses outside of the healthcare
industry. Recognizing that the Anti-Kickback Statute is broad and may technically prohibit many innocuous or beneficial arrangements,
the Office of Inspector General of Health and Human Services, or OIG, issued a series of regulations, known as the safe harbors,
beginning in July 1991. These safe harbors set forth provisions that, if all the applicable requirements are met, will assure
healthcare providers and other parties that they will not be prosecuted under the Anti-Kickback Statute. The failure of a transaction
or arrangement to fit precisely within one or more safe harbors does not necessarily mean that it is illegal or that prosecution
will be pursued. However, conduct and business arrangements that do not fully satisfy each applicable safe harbor may result in
increased scrutiny by government enforcement authorities such as the OIG. Arrangements that implicate the Anti-Kickback Law, and
that do not fall within a safe harbor, are analyzed by the OIG on a case-by-case basis. Government officials have focused recent
enforcement efforts on, among other things, the sales and marketing activities of healthcare companies, and recently have brought
cases against individuals or entities with personnel who allegedly offered unlawful inducements to potential or existing customers
in an attempt to procure their business. Settlements of these cases by healthcare companies have involved significant fines and/or
penalties and in some instances criminal pleas. In addition to the Federal Anti-Kickback Statute, many states have their own kickback
laws. Often, these laws closely follow the language of the federal law, although they do not always have the same exceptions or
safe harbors. In some states, these anti-kickback laws apply with respect to all payors, including commercial health insurance
companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>False
Claims Laws</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Federal
false claims laws prohibit any person from knowingly presenting, or causing to be presented, a false claim for payment to the
federal government or knowingly making, or causing to be made, a false statement to get a false claim paid. Manufacturers can
be held liable under false claims laws, even if they do not submit claims to the government, if they are found to have caused
submission of false claims. The Federal Civil False Claims Act also includes whistle blower provisions that allow private citizens
to bring suit against an entity or individual on behalf of the United States and to recover a portion of any monetary recovery.
Many of the recent highly publicized settlements in the healthcare industry related to sales and marketing practices have been
cases brought under the False Claims Act. The majority of states also have statutes or regulations similar to the federal false
claims laws, which apply to items and services reimbursed under Medicaid and other state programs, or, in several states, apply
regardless of the payor. Sanctions under these federal and state laws may include civil monetary penalties, exclusion of a manufacturer's
products from reimbursement under government programs, criminal fines and imprisonment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Privacy
and Security</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Health Insurance Portability and Accountability Act of 1996, or HIPAA, and the rules promulgated there under require certain entities,
referred to as covered entities, to comply with established standards, including standards regarding the privacy and security
of protected health information, or PHI. HIPAA further requires that covered entities enter into agreements meeting certain regulatory
requirements with their business associates, as such term is defined by HIPAA, which, among other things, obligate the business
associates to safeguard the covered entity's PHI against improper use and disclosure. While not directly regulated by HIPAA, our
customers or distributors might face significant contractual liability pursuant to such an agreement if the business associate
breaches the agreement or causes the covered entity to fail to comply with HIPAA.&nbsp;&nbsp;It is possible that HIPPA compliance
could become a substantial regulatory burden and expense to our operations, although we do not believe that this will occur as
a general website publisher.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Employees</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2014, we had 12 full time employees and 1 part time employee, in addition to contracted programmers, as needed,
through our established relationship with Simple eSolutions, a technical and programming resources partner. Additionally, we have
one contracted business development individual targeting new EMR channel and pharma clients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Subsidiaries</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
conduct our operations through our wholly-owned subsidiary, OptimizeRx Michigan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Description
of Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Currently,
we do not own any real estate. Our principal executive offices are located at 400 Water Street, Suite 200, Rochester, Michigan,
48307. We initially entered into a 3 year lease for this 2,886 square foot facility, with a cost of $5,049.25 per month. We renewed
that lease for a two year period on December 1, 2014 for a monthly rental rate of $5,201.50. We believe that our properties are
adequate for our current needs, but growth potential may require larger facilities due to anticipated addition of personnel. We
do not have any policies regarding investments in real estate, securities or other forms of property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Management&rsquo;s
Discussion and Analysis of Financial Condition and Results of Operations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B> Company Highlights through August,
2015 </B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 27px"> &nbsp; </TD>
    <TD STYLE="width: 27px; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 1) </FONT></TD>
    <TD STYLE="text-align: justify; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Our
    sales for the first six months of 2015 approached $3.2 million, an 18% increase over the same period in 2014. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD STYLE="line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 2) </FONT></TD>
    <TD STYLE="text-align: justify; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Our
    sales for the second quarter of 2015 exceeded $1.7 million, an increase of 20% over the same period in 2014 and a 15% increase
    over the first quarter of 2015. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD STYLE="line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 3) </FONT></TD>
    <TD STYLE="text-align: justify; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> We
    generated positive cash flow from operations of approximately $250,000 during the six month period of 2015. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD STYLE="line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 4) </FONT></TD>
    <TD STYLE="text-align: justify; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Our
    cash balance increased to in excess of $3.6 million. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD STYLE="line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 5) </FONT></TD>
    <TD STYLE="text-align: justify; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Our
    balance sheet continued to improve with working capital of approximately $3.4 million and a working capital ratio of 2.5 to
    1. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD STYLE="line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 6) </FONT></TD>
    <TD STYLE="text-align: justify; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Excluding
    non-cash expenses, the first six months of 2015 generated operating income of $251,372. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD STYLE="line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 7) </FONT></TD>
    <TD STYLE="text-align: justify; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> We
    initially launched our SampleMD e-coupon solution in April 2015 within Practice Fusion&rsquo;s EMR and we are now fully integrated.
    We also began running key campaigns through NextGen in August 2015. Additionally, we have actively engaged and advanced with
    other leading platforms to position and prioritize integration of services. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD STYLE="line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 8) </FONT></TD>
    <TD STYLE="text-align: justify; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> We
    signed an agreement with Allscripts to integrate our eCoupon functionality into their Touchworks platform, which serves many
    large health systems throughout the country, and to become their exclusive eCoupon provider in all of their platforms. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD STYLE="line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 9) </FONT></TD>
    <TD STYLE="text-align: justify; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> We
    sponsored the ePrescribe/EHR conference held in Philadelphia in March 2015, which generated significant leads for our sales
    force. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD STYLE="line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 10) </FONT></TD>
    <TD STYLE="text-align: justify; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> We
    continued to add new brands in 2015 at both existing customers such as AstraZenica and Lilly, as well as at new customers
    such as Otsuka and Shionogi. AstraZeneca extended their contract and budget for two years to promote 15 of their leading brands. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD STYLE="line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 11) </FONT></TD>
    <TD STYLE="text-align: justify; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> We
    continued to prove an outstanding return on investment on our pharmaceutical promotions through independent analytics firms. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD STYLE="line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 12) </FONT></TD>
    <TD STYLE="text-align: justify; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> We
    have made substantial progress toward completing major technical upgrades, including migration to a new Oracle database to
    allow for very robust growth and performance. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> The company continues to make significant
progress on growing both sides of our business, including expanding new brands and agreements with pharmaceutical companies looking
for new ways to promote and reach doctors and patients at point of prescribe; as well as our networks with the dramatic announcement
of Allscripts agreeing to exclusively work with OptimizeRx to manage their patient savings within all platforms that will soon
include their largest platform Touchworks. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> With the addition of Allscripts,
we now are the<B> EXCLUSIVE&nbsp;delivery platform of over 200 other&nbsp;EHRs&mdash;which represent two thirds of our network.</B> </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-indent: -18pt; color: #606060"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> Simply put, OptimizeRx has now created
the largest promotional network that engages more healthcare providers at point of prescribe than any other company, including
promotion of our programs within over 350 leading EHRs and growing. This also provides a huge barrier to entry to any potential
competitors. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #606060">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> All of these advancements will have
meaningful consequences to further accelerate our growth in the second half of year and into 2016. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #002060"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> However, to further leverage this
huge market opportunity of bringing savings and patient support right into physicians workflow, we are seeking top notch sales
executives on both sides to help us: </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #002060"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Wingdings; color: #002060"> &sect; </FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"> Expand
                                         pharma sales account executives, just hired one who has strong specialty products knowledge
                                         and 10+ years of pharma experience. Initiating search for Regional VP of Sales. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Wingdings; color: #002060"> &sect; </FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"> On
                                         the business development side of our channels, we will also be searching for additional
                                         support to grow our network, including a new operational manager to interact daily with
                                         key clients and assess performance, as well as an additional key business development
                                         executiveto work with the team. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 54pt; text-align: justify; color: #002060"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> We also will be expanding our Investor
and Public Relations efforts in the 3<SUP>rd</SUP> quarter, including attendance at the Liolios Group's 2015 Gateway Conference
in San Francisco, as well as hiring a Public Relations firm. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #002060"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> For our Board of Directors, we are
interviewing proven seasoned executives to further add outside guidance and leadership, as well as additional governance. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #002060"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> We are also involved in many strategic
partnership discussions with some of the largest healthcare companies in the world to look at new opportunities to leverage our
proprietary technology and grow our business.<BR>
<BR> </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> We generated positive cash flow
from operations for the six months ended June 30, 2015, and we expect to continue to do so each quarter for the rest of the year.
We expect to achieve profitability in future quarters based on the expected escalation of revenues, unless we make positive decisions
to invest in development activities to expand our network reach or commit additional marketing resources to customer procurement
activities. The outlay of these funds may negatively affect our profitability in the short term, but we are confident the investment
will escalate our revenues in the long term and put us in a better position to attain and increase profitability. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> We also generated positive income
from operations, when excluding non-cash expenses, as set forth in the table below. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="background-color: White"><B> &nbsp; </B></TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"><B> &nbsp; </B></TD>
    <TD COLSPAN="6" STYLE="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> Six
    Months Ended June 30 </B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"><B> &nbsp; </B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="background-color: White"><B> &nbsp; </B></TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"><B> &nbsp; </B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> 2015 </B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"><B> &nbsp; </B></TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"><B> &nbsp; </B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> 2014 </B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"><B> &nbsp; </B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="width: 78%; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Net Revenue </FONT></TD>
    <TD STYLE="width: 1%; background-color: White"> &nbsp; </TD>
    <TD STYLE="width: 1%; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> $ </FONT></TD>
    <TD STYLE="width: 8%; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 3,193,010 </FONT></TD>
    <TD STYLE="width: 1%; line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="width: 1%; background-color: White"> &nbsp; </TD>
    <TD STYLE="width: 1%; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> $ </FONT></TD>
    <TD STYLE="width: 8%; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 2,716,236 </FONT></TD>
    <TD STYLE="width: 1%; line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Revenue Share Expense </FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 1,638,768 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 1,291,551 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Gross Margin </FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 1,554,242 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 1,424,685 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Total Operating Expenses </FONT></TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 1,823,269 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 2386,747 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Less Noncash operating
    expenses </FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 520,399 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 743,182 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Cash operating Expenses </FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 1,302,870 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 1,643,565 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White; padding-bottom: 4pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Income (loss) from
    Operations excluding noncash expenses </FONT></TD>
    <TD STYLE="padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> $ </FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 251,372 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> $ </FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> (218,880 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White; padding-bottom: 4pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> ) </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> Our success in acquiring, integrating
and expanding into new promotional EHR/eRx platforms continues to grow as well. We launched our initial brands into Practice Fusion
on a limited basis in April 2015 and we fully integrated the rollout at end of June 2015. We are also working extensively with
our existing platforms to expand the reach of our eCoupon product to all of their providers, as well as increasing the utilization
of the eCoupon functionality by their existing users. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> With the growth of both our pharmaceutical
products and our distribution network, we expect that our distribution of e-coupons will continue to increase throughout the year
and over the levels of last year. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I> Operating Results </I></B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> We finished the first six months
of 2015 with a loss of approximately $268,000 a substantial reduction over the same period last year, and we generated positive
cash flow from operations during 2015. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B> Results of Operations for the
Three and Six Months Ended June 30, 2015 and 2014 </B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I> Revenues </I></B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> Our total revenue for the three
months ended June 30, 2015 was approximately $1.7 million, an increase of 20% over the approximately $1.425 million from the same
period in 2014. Our total revenue for the six months ended June 30, 2015 was approximately $3.2 million, an increase of 18% over
the approximately $2.7 million from the same period in 2014. These increased revenues result from both increased pharmaceutical
brands being promoted and expanded distribution channels. We expect continued quarter over quarter revenue increases for the balance
of 2015. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B> Cost of Sales </B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> Our cost of sales, comprised of
revenue share expense, increased over the same period in 2014 as a result of both the revenue increases and the LDM settlement
signed in February 2014. In addition, revenue share expense as a percentage of revenue in 2015 increased over the same period
in 2014 as a result of the LDM settlement. In the three month period, revenue share expense increased slightly to approximately
51.7% of sales in 2015 from approximately 51.1% in the same period in 2014 as a result of product mix. In the six month period,
revenue share expense increased to approximately 51.3% of sales in 2015 from approximately 47.5% in the same period in 2014 as
a result of the LDM settlement. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> As discussed, these increases in
revenue share expense as a percentage of revenue result from a combination of factors, including product mix whereby a larger
percentage of overall revenues are subject to revenue share, the LDM agreement which resulted in increased revenue share payments,
and increased distributions at channel partners with financial incentives to increase distributions that result in higher payments
per distribution. We expect revenue share expense as a percentage of revenue in future quarters to continue at levels similar
to that of the quarter ended June 30, 2015 as revenues subject to revenue share expense continues to increase as a percentage
of our overall revenues. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I> Operating Expenses </I></B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> Operating expenses increased from
approximately $900,000 for the three month period ended June 30, 2014 to approximately $980,000 for the same period in 2015, an
increase of approximately 9%. Operating expenses decreased from approximately $2.4 million for the six month period ended June
30, 2014 to approximately $1.8 for the same period in 2015, a decrease of approximately 24%. The detail by major category is reflected
in the table below. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> Three
    Months Ended </B></FONT> <BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>June 30,</B></FONT> </TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> Six
    Months Ended </B></FONT> <BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>June 30,</B></FONT> </TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> 2015 </B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> 2014 </B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> 2015 </B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> 2014 </B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="width: 52%; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Salaries,
    Wages, &amp; Benefits </FONT></TD>
    <TD STYLE="width: 1%; background-color: White"> &nbsp; </TD>
    <TD STYLE="width: 1%; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> $ </FONT></TD>
    <TD STYLE="width: 9%; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 387,074 </FONT></TD>
    <TD STYLE="width: 1%; line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="width: 1%; background-color: White"> &nbsp; </TD>
    <TD STYLE="width: 1%; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> $ </FONT></TD>
    <TD STYLE="width: 9%; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 374,180 </FONT></TD>
    <TD STYLE="width: 1%; line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="width: 1%; background-color: White"> &nbsp; </TD>
    <TD STYLE="width: 1%; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> $ </FONT></TD>
    <TD STYLE="width: 9%; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 782,273 </FONT></TD>
    <TD STYLE="width: 1%; line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="width: 1%; background-color: White"> &nbsp; </TD>
    <TD STYLE="width: 1%; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> $ </FONT></TD>
    <TD STYLE="width: 9%; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 723,276 </FONT></TD>
    <TD STYLE="width: 1%; line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Professional
    Fees </FONT></TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 81,405 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 119,403 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 154,825 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 180,020 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Board
    Compensation </FONT></TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 12,500 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> - </FONT></TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 25,000 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> - </FONT></TD>
    <TD STYLE="background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Investor
    Relations </FONT></TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 6,991 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 20,809 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 32,953 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 52,745 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Consultants </FONT></TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 8,698 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 16,905 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 29,813 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 32,719 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Advertising
    and Promotion </FONT></TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> - </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 20,951 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 37,150 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 50,551 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Depreciation
    and Amortization </FONT></TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 79,668 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 56,922 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 159,337 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 115,828 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Development
    and Maintenance </FONT></TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 56,445 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 36,023 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 106,860 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 68,157 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Office,
    Facility, and other </FONT></TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 32,233 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 32,884 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 71,290 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 66,360 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Travel </FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 34,174 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 30,937 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 62,706 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 69,737 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 10pt; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Subtotal </FONT></TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 699,188 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 709,014 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 1,462,207 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 1,359,393 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Stock-based
    compensation </FONT></TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 281,471 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 187,515 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 361,062 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 627,354 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Lawsuit
    settlement </FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> - </FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> - </FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> - </FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 400,000 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: right; line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Total
    Operating Expense </FONT></TD>
    <TD STYLE="padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 4.5pt double; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> $ </FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 980,659 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 4.5pt double; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> $ </FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 896,529 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 4.5pt double; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> $ </FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 1,823,269 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 4.5pt double; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> $ </FONT></TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right; line-height: 107%; font-size: 10pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 2,386,747 </FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> The main reasons for the decrease
in operating expenses in 2015 are the lawsuit settlement in 2014, which resulted in a $400,000 payment to the plaintiff, and the
reduction in stock-based compensation from 2014 to 2015. Ignoring those two items, operating expenses increased approximately
8%, however the majority of those increases related to things implemented after the first quarter of 2014, as opposed to new items
in 2015. This would include new hires, as well as the addition of outside Directors and related compensation. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> <BR>
We expect our operating expenses to continue to increase slightly as we further implement our business plan and expand our operations,
however, we do not expect those increases to be significant in the near future unless we make the proactive decision to increase
marketing dollars spent on customer procurement activities or spend more on development activities to increase our overall reach.
We expect development expenditures to increase significantly in the fourth quarter based on planned initiatives. Professional
fees are significantly affected by litigation, and we do have litigation in progress, causing those fees to fluctuate from quarter
to quarter. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B> Net Loss </B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> Our net loss for the three months
ended June 30, 2015 was approximately $157,000 as compared to a loss of approximately $200,000 during the same period in 2014.
Our net loss for the six months ended June 30, 2015 was approximately $268,000 as compared to a loss of approximately $962,000
during the same period in 2014. The reasons for specific components are discussed above. Overall, the decreased loss for the six
month period is primarily explained by the decrease in operating expenses. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B> Liquidity and Capital Resources </B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> As of June 30, 2015, we had total
current assets of approximately $5.6 million, compared with current liabilities of approximately $2.3 million, resulting in working
capital of approximately $3.4 million and a current ratio of approximately 2.5 to 1, similar to, but improved over, the working
capital of approximately $3.2 million and current ratio of 2.3 to 1 at December 31, 2014. We are currently generating positive
cash flow from operations and we expect our working capital balance to continue to improve in future quarters as we continue to
generate positive cash flow from operations. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> Our operating activities generated
approximately $250,000 in cash flow during the six months ended June 30, 2015, compared with cash used in operating activities
of approximately $150,000 in the same period in 2014. This increase is primarily the result of the reduced loss for the period. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> We used approximately $50,000 in
investing activities in the six months ended June 30, 2015 compared with approximately $215,000 in the same period in 2014. These
investment activities relate to improvements being implemented in our SampleMD website, as well as protection and expansion of
our patent portfolio. These items both represent important components of our business strategy moving forward. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> There were no cash flows from financing
activities in 2015, however financing activities provided approximately $2.8 million during the six months ended June 30, 2014.
This resulted from a $10 million equity raise in March 2014, partially offset by costs of the raise and redemption of all the
common stock, preferred stock, and warrants held by a major shareholder that significantly reduced the fully diluted shares count,
even when considering the new equity issued. With the financing and cash on hand, we have sufficient cash to operate our business
for more than the next twelve months and we do not anticipate the need to raise additional equity for operating purposes, however
we may consider a strategic investments that would allow us to accelerate the growth of the business. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B> &nbsp; </B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B> Off Balance Sheet Arrangements
</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> As of June 30, 2015, there were
no off balance sheet arrangements. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B> Critical Accounting Policies </B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> In December 2001, the SEC requested
that all registrants list their most &ldquo;critical accounting polices&rdquo; in the Management Discussion and Analysis. The
SEC indicated that a &ldquo;critical accounting policy&rdquo; is one which is both important to the portrayal of a company&rsquo;s
financial condition and results, and requires management&rsquo;s most difficult, subjective or complex judgments, often as a result
of the need to make estimates about the effect of matters that are inherently uncertain. Our accounting policies are discussed
in the footnotes to our financial statements included in our annual report on Form 10-K for the year ended December 31, 2014,
however we consider our critical accounting policies to be those related to revenue recognition, revenue share expense, stock-based
compensation, capitalization and related amortization of intangible assets, and impairment of assets. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B> Recently Issued Accounting Pronouncements </B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"> &nbsp; </P>

<P STYLE="margin: 0"> The Company does not expect the adoption of recently issued accounting pronouncements to have a significant
impact on the Company&rsquo;s results of operation, financial position or cash flow. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;<FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="certain"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>



<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> Other than described below or the
transactions described under the heading &ldquo;Executive Compensation&rdquo; or &ldquo;Description of Securities&rdquo; (or with
respect to which such information is omitted in accordance with SEC regulations), there have not been, and there is not currently
proposed, any transaction or series of similar transactions to which we were or will be a participant in which the amount involved
exceeded or will exceed the lesser of $120,000 or one percent of the average of our total assets at year-end for the last two
completed fiscal years, and in which any director, executive officer, holder of 5% or more of any class of our capital stock or
any member of the immediate family of any of the foregoing persons had or will have a direct or indirect material interest. </P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
March 17, 2014, we raised gross proceeds of $10,000,000 in an unregistered offering (the &ldquo;Offering&rdquo;) with certain
accredited investors. We used a portion of the net proceeds of the Offering to exercise the Securities Redemption Option Agreement,
as amended, with Vicis Capital Master Fund (&ldquo;Vicis&rdquo;) that provides us with an option to purchase all of the outstanding
shares and derivative securities held by Vicis for total payment of six million dollars ($6,000,000). The shares and derivative
securities include the Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Common Stock, and warrants
to purchase shares of common stock held by Vicis in our company. In connection with this fundraising, we agreed to grant 200,000
shares of fully vested common stock to officers David, Harrell, David Lester, and Terry Hamilton.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
February 2014, we agreed to grant 337,500 shares of common stock, half of which vested immediately and half of which vested in
August 2014, to both David Harrell and Terry Hamilton as bonuses based on their efforts to recapitalize the company to secure
approximately $3 million in working capital while reducing potential fully diluted shares by approximately 7 million shares. Stock-based
compensation related to these bonuses was $570,375 during the year ended December 31, 2014. These shares have not yet been issued
and are recorded as stock payable, but can be requested by the officers at any time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="market"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>MARKET
FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Market
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
common stock is quoted under the symbol &ldquo;OPRX&rdquo; on the OTCQB operated by OTC Markets Group, Inc.&nbsp; Only a limited
market exists for our securities. There is no assurance that a regular trading market will develop, or if developed, that it will
be sustained. Therefore, a shareholder may be unable to resell his securities in our company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
following tables set forth the range of high and low prices for our common stock for the each of the periods indicated as reported
by the OTCQB. These quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not necessarily
represent actual transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="9" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Fiscal Year Ending December 31, 2013</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid">Quarter Ended</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">High $</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Low $</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 76%">December 31, 2013</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1.65</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0.91</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>September 30, 2013</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.80</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.88</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>June 30, 2013</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.91</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.12</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>March 31, 2013</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.42</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.96</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="9" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Fiscal Year Ending December 31, 2014</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid">Quarter Ended</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">High $</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Low $</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 76%">December 31, 2014</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1.15</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0.80</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>September 30, 2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.54</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.10</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>June 30, 2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.80</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.42</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>March 31, 2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.95</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.41</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>



<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"> On September 29, 2015, the last sales price per share
of our common stock was $0.99. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Penny
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
SEC has adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Penny stocks are
generally equity securities with a market price of less than $5.00, other than securities registered on certain national securities
exchanges or quoted on the NASDAQ system, provided that current price and volume information with respect to transactions in such
securities is provided by the exchange or system. The penny stock rules require a broker-dealer, prior to a transaction in a penny
stock, to deliver a standardized risk disclosure document prepared by the SEC, that: (a) contains a description of the nature
and level of risk in the market for penny stocks in both public offerings and secondary trading; (b) contains a description of
the broker's or dealer's duties to the customer and of the rights and remedies available to the customer with respect to a violation
of such duties or other requirements of the securities laws; (c) contains a brief, clear, narrative description of a dealer market,
including bid and ask prices for penny stocks and the significance of the spread between the bid and ask price; (d) contains a
toll-free telephone number for inquiries on disciplinary actions; (e) defines significant terms in the disclosure document or
in the conduct of trading in penny stocks; and (f) contains such other information and is in such form, including language, type
size and format, as the SEC shall require by rule or regulation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
broker-dealer also must provide, prior to effecting any transaction in a penny stock, the customer with (a) bid and offer quotations
for the penny stock; (b) the compensation of the broker-dealer and its salesperson in the transaction; (c) the number of shares
to which such bid and ask prices apply, or other comparable information relating to the depth and liquidity of the market for
such stock; and (d) a monthly account statement showing the market value of each penny stock held in the customer's account.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
addition, the penny stock rules require that prior to a transaction in a penny stock not otherwise exempt from those rules, the
broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive
the purchaser's written acknowledgment of the receipt of a risk disclosure statement, a written agreement as to transactions involving
penny stocks, and a signed and dated copy of a written suitability statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">These
disclosure requirements may have the effect of reducing the trading activity for our common stock. Therefore, stockholders may
have difficulty selling our securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Holders
of Our Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>



<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> As of September 29, 2015, we had
28,960,925 shares of our common stock issued and outstanding, held by 321 shareholders of record at our transfer agent,  with
additional shareholders in street name. </P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Dividends</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
currently intend to retain future earnings for the operation of our business. We have never declared or paid cash dividends on
our common stock, and we do not anticipate paying any cash dividends in the foreseeable future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
the event that a dividend is declared, common stockholders on the record date are entitled to share ratably in any dividends that
may be declared from time to time on the common stock by our board of directors from funds legally available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">There
are no restrictions in our articles of incorporation or bylaws that restrict us from declaring dividends. The Nevada Revised Statutes,
however, do prohibit us from declaring dividends where, after giving effect to the distribution of the dividend:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
    would not be able to pay our debts as they become due in the usual course of business; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
    total assets would be less than the sum of our total liabilities, plus the amount that would be needed to satisfy the rights
    of shareholders who have preferential rights superior to those receiving the distribution.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Securities
Authorized for Issuance under Equity Compensation Plans</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
June 13, 2013, our Board of Directors adopted the 2013 Equity Incentive Plan (the &ldquo;Plan&rdquo;). The purpose of the Plan
is to attract and retain the best available personnel for positions of substantial responsibility with us, to provide additional
incentive to employees, directors and consultants, and to promote our success. Under the Plan, we may issue up to an aggregate
total of 1,500,000 incentive or non-qualified options to purchase our common stock or stock awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Equity
Compensation Plans as of December 31, 2014</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; padding-left: 10pt; text-indent: -10pt">Plan
    Category</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of&nbsp;Securities
    to<BR> be issued upon exercise<BR> of outstanding options</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted-average<BR> exercise
    price of<BR> outstanding options</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of Securities<BR>
    remaining available<BR> for&nbsp;future issuance under<BR> equity compensation plans</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">(a)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">(b)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">(c)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 64%; text-align: left; padding-left: 10pt; text-indent: -10pt">Plan approved by shareholders (2013 Equity
    Compensation Plan)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">552,500</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1.51</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">410,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt">Plan not approved by shareholders
    (Other Equity Compensation (includes options and warrants))</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,609,139</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1.54</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">3,161,639</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1.53</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">410,000</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Recent
Sales of Unregistered Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
January 2015, we issued 12,500 shares of restricted common stock to our outside Directors as part of our director compensation
package for services rendered in the fourth quarter of 2014.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
March 2015, we signed a capital markets advisory agreement whereby we agreed to issue 90,000 shares of common stock in two increments
as payment for the advisory services. The first 45,000 shares were issued in March 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> On June 24, 2015, our Board of Directors
resolved to award our CEO, David Harrell, 79,042 restricted shares of our common stock in recognition of his contributions to
our company. We also resolved to award our Vice President of Sales, Terry Hamilton, 118,563 restricted shares of our common stock
in recognition of his contributions to our company. The awards are subject to the terms of our 2013 Incentive Plan and to their
respective Restricted Stock Award Agreements. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> On June 24, 2015, our Board of Directors
resolved to grant our CFO, Doug Baker, an option to acquire 100,000 shares of our common stock with an exercise price of $1.05
per share in recognition of his contributions to our company. The option will vest over a one year period and will expire in five
years. The grant is subject to the terms of our 2013 Incentive Plan and to the Stock Option Agreement in favor of Mr. Baker. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> On June 24, 2015, our Board of Directors
approved an amendment to Mr. Baker&rsquo;s May 19, 2014 option to acquire 100,000 shares of our common stock with an exercise
price of $1.72 per share (the &ldquo;Old Option&rdquo;). The amendment modifies the Old Option&rsquo;s exercise price to $1.05
per share. The amendment did not change the option&rsquo;s vesting schedule or any other terms. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="margin: 0; text-align: justify"> On September 24, 2015, we issued 6,011,106 shares of our common stock to WPP Luxembourg Gamma Three Sarl,
an accredited investor, at $0.7875 per share for total proceeds of $4,733,746. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">These
securities were issued pursuant to Section 4(2) of the Securities Act and/or Rule 506 promulgated thereunder. The holders represented
their intention to acquire the securities for investment only and not with a view towards distribution. The investors were given
adequate information about us to make an informed investment decision. We did not engage in any general solicitation or advertising.
We directed our transfer agent to issue the stock certificates with the appropriate restrictive legend affixed to the restricted
stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="executive"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>EXECUTIVE
COMPENSATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
table below summarizes all compensation awarded to, earned by, or paid to our former or current executive officers for the fiscal
years ended December 31, 2014 and 2013.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name
    and principal position</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Year</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Salary
    ($)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Bonus
    </FONT><BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif">($)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Stock
    </FONT><BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Awards </FONT><BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif">($)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Option
    </FONT><BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Awards </FONT><BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif">($)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">All
    Other </FONT><BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif">Compensation </FONT><BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif">($)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Total
    </FONT><BR>
    <FONT STYLE="font: 10pt Times New Roman, Times, Serif">($)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; width: 16%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Shad
    Stastney</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 11%; text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2014</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-0-</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">252,500</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 9%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 9%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">252,500</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Former
    Chairman, President, CEO and Director</I></FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2013</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">126,762</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">252,500</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">379,262</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">David
    A. Harrell</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2014</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">183,750</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">100,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">394,969</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">678,719</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Chairman,
    Chief Executive Officer, Chief Strategic Officer and Director</I></FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2013</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">180,104</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">19,151</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">199,255</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">David
    Lester</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2014</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">163,438</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">70,000</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">94,500</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">327,938</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>COO,
    Secretary, Treasurer and Director</I></FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2013</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">157,500</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">15,000</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">172,500</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Terence
    J. Hamilton</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2014</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">163,438</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">70,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">458,906</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">692,344</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>VP
    of Sales and Director</I></FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2013</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">157,500</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">11,000</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">168,500</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Douglas
    Baker</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2014</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">78,125</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">131,110</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">209,235</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>CFO</I></FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2013</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-0-</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-0-</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Narrative
Disclosure to the Summary Compensation Table</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
September 20, 2013, we entered into a Separation Agreement with Mr. Stastney regarding the terms and conditions of his departure
from the Company (the &ldquo;Agreement&rdquo;). Pursuant to the provisions of the Agreement, we agreed with Mr. Stastney as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">As
    of the date of the Agreement, Mr. Stastney was no longer an officer or director of our company and all prior agreements with
    Mr. Stastney were terminated in their entirety;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Mr.
    Stastney received 500,000 shares of our common stock, half in September 2013 and the balance in January, 2014;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
    agreed to use our best efforts to register Mr. Stastney&rsquo;s shares on Form S-8 by March 1, 2014 if such shares were eligible
    for S-8 registration;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
    paid Mr. Stastney $126,762 and his reasonable out of pocket expenses incurred on our behalf;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    parties agreed to a mutual release of all claims and Mr. Stastney further agreed to certain covenants as provided for in the
    Agreement; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Mr.
    Stastney was involved with the company as a consultant for one year to assist us on financing activities, strategic and legal
    initiatives, and to help the transition with several ongoing projects.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
June 1, 2008, we entered into an employment agreement with Mr. Harrell to serve as our CEO. The agreement was amended on January
14, 2013 to account for his new positions as CSO and Vice Chairman. The terms of his compensation, was an annual salary of $144,000
with a 5% cost of living increase on each 12 month anniversary. Mr. Harrell is also eligible for additional quarterly and annual
bonus compensation, stock options, and stock grants based on performance metrics outlined by our board of directors. He is entitled
to vacation and sick days, and other benefits included in the agreement. On March 18, 2010, we entered into an addendum to the
employment agreement to increase his compensation to $152,004 annually.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
July 28, 2010, we amended Mr. Harrell&rsquo;s employment agreement to include a covenant not to compete covering the term of employment
and continuing for a period of two years thereafter. As a result of the same amendment, Mr. Harrell is entitled to severance payments
if he is terminated with or without cause. Such payments would be due monthly at his then current salary rate for a period of
24 months following termination. On August 14, 2013, we amended the employment agreement with Mr. Harrell Pursuant to the terms
and conditions of the Amendment to Employment Agreement with David Harrell:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Mr.
                                         Harrell will serve as Vice Chairman of the Board and Chief Strategy Officer of our company;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
                                         term of Mr. Harrell&rsquo;s employment shall be for one year, and shall automatically
                                         renew for each year thereafter unless terminated on thirty days&rsquo; notice before
                                         the end of the term; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Mr.
                                         Harrell will earn a base salary of $183,750 per year;</FONT></TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Mr.
Harrell&rsquo;s contract also contains a provision providing for a 5% annual salary increase, which he waived on various occasions
in the past. On August 14, 2013 we granted restricted stock awards under our 2013 Incentive Plan. Mr. David Harrell was awarded
121,875 shares of our common stock. The award vested in 2014 and was valued at $1.69 per share. Mr. Harrell was granted an additional
restricted stock award of 100,000 shares under our 2013 Incentive Plan on January 9, 2014. This award was fully vested at the
time of grant and was valued at $1.89 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
April 6, 2009, we entered into an employment agreement with Mr. Lester to serve as our Chief Executive Officer. The agreement
was amended on January 14, 2013 to account for his new positions as COO, Secretary and Treasurer. Under the agreement, we agreed
to compensate Mr. Lester $150,000 annually and we granted him options to purchase 500,000 shares of our common stock, with 25%
vesting immediately and 25% vesting after the completion of each quarter of hire. Mr. Lester is also eligible for additional quarterly
and annual bonus compensation, stock options, and stock grants based on performance metrics outlined by our board of directors.
He is entitled to vacation and sick days, and other benefits included in the agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
August 14, 2013, we amended the employment agreement with Mr. Lester. Pursuant to the terms and conditions of the Amendment to
Employment Agreement with David Lester:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Mr.
                                         Lester will serve as Chief Operating Officer of our company; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Mr.
                                         Lester will earn a base salary of $157,500 per year.</FONT></TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
March 16, 2014, Mr. Lester&rsquo;s salary was increased to a base salary of $165,000, but no formal contract amendment was signed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Mr.
Lester was granted a restricted stock award of 50,000 shares under our 2013 Incentive Plan on January 9, 2014. This award was
fully vested at the time of grant and was valued at $1.89 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Effective
February 1, 2015, Mr. Lester&rsquo;s employment contract was terminated. On that date, he moved from Chief Operating Officer to
the role of Vice President, Channel Management and his new salary is $135,000 per year. He continues to be entitled to vacation,
sick days, and the other benefits afforded to all employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
August 1, 2008, we entered into an employment agreement with Mr. Hamilton to serve as our VP of Sales. Under the agreement, we
agreed to compensate Mr. Hamilton $120,000 annually and we granted him options to purchase 150,000 shares of our common stock
in 2009. Mr. Hamilton is also eligible for additional quarterly and annual bonus compensation, stock options, and stock grants
based on performance metrics outlined by our board of directors. He is entitled to vacation and sick days, and other benefits
included in the agreement. On March 18, 2010, we entered into an addendum to the employment agreement to increase his compensation
to $150,000 annually.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
July 28, 2010, we amended Mr. Hamilton&rsquo;s employment agreement to include a covenant not to compete covering the term of
employment and continuing for a period of one year thereafter. As a result of the same amendment, Mr. Hamilton is entitled to
severance payments if he is terminated with or without cause. Such payments would be due monthly at his then current salary rate
for a period of 12 months following termination. On August 14, 2013, we amended the employment agreement with Mr. Hamilton. Pursuant
to the terms and conditions of the Amendment to Employment Agreement with Terry Hamilton:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Mr.
                                         Hamilton will earn a base salary of $157,500 per year.</FONT></TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
March 16, 2014, Mr. Hamilton&rsquo;s salary was increased to a base salary of $165,000, but no formal contract amendment was signed.
His salary remains at that level as of the date of this filing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
August 14, 2013 we granted restricted stock awards under our 2013 Incentive Plan. Mr. Hamilton was awarded 215,625 shares of our
common stock. The award vested in 2014 and was valued at $1.69 per share. Mr. Hamilton was granted an additional restricted stock
award of 50,000 shares under our 2013 Incentive Plan on January 9, 2014. This award was fully vested at the time of grant and
was valued at $1.89 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
May 12, 2014, we entered into an employment agreement with Mr. Baker, our new Chief Financial Officer. Under the agreement, we
agreed to compensate Mr. Baker $125,000 annually and we granted him options to purchase 100,000 shares of our common stock, with
50% vesting after one year and 50% vesting after two years of hire. The options were valued at 1.3111 per share, or a total of
$131,110, for financial statement purposes using the Black-Scholes pricing model.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Mr.
Baker is also eligible for additional quarterly and annual bonus compensation, stock options, and stock grants based on performance
metrics outlined by our board of directors. He is entitled to vacation and sick days, and other benefits included in the agreement.
&nbsp;As of April 1, 2015, Mr. Baker&rsquo;s base salary will be increased to $150,000, but no formal contract amendment has been
signed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Outstanding
Equity Awards at Fiscal Year-End</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
table below summarizes all unexercised options, stock that has not vested, and equity incentive plan awards for each named executive
officers as of December 31, 2014.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>OUTSTANDING
    EQUITY AWARDS AT FISCAL YEAR-END</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="19" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">OPTION
    AWARDS</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="14" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">STOCK
    AWARDS</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Number
    of Securities Underlying Unexercised Options (#) Exercisable</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Number
    of Securities Underlying Unexercised Options (#) Unexercisable</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Equity
    Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Option
    Exercise Price ($)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Option
    Expiration Date</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Number
    of Shares or Units of Stock That Have Not Vested (#)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Market
    Value of Shares or Units of Stock That Have Not Vested ($)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Equity
    Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0; text-align: center; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Equity
    Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested (#)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">David</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 6%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">200,000</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 6%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 6%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$</FONT></TD>
    <TD STYLE="width: 6%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.81</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 9%; text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4/26/15</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 6%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 6%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 6%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 6%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Harrell</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">46,850</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.00</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5/31/16</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">David
    Lester</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">49,000</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.00</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5/31/16</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD NOWRAP STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Douglas
    Baker</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">100,000</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.72</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5/19/19</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Terence
    J. Hamilton</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">122,000</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.00</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5/31/16</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Director
Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
table below summarizes all compensation of our directors as of December 31, 2014.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid">Name</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Fees Earned or Paid in Cash ($)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Stock Awards ($)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Option Awards ($)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">All Other Compensation ($)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Total ($)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 40%; text-align: left">Gus D. Halas</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">9,986</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">11,827</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right"></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right"></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">21,813</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">Jack Pinney</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,579</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,315</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,894</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Narrative
Disclosure to the Director Compensation Table</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Pursuant
to our Director Compensation Plan, non-employee directors (&ldquo;Outside Directors&rdquo;) shall receive (a) a $25,000 annual
cash retainer, payable in equal quarterly installments, and (b) reimbursement for expenses related to Board meeting attendance
and any committee participation. Directors are expected to attend four meetings per year as well as spend an additional 10 &ndash;
20 hours per month on company matters. In addition, Outside Directors shall receive 25,000 shares of Common Stock, payable in
equal quarterly installments, which shall vest immediately. Directors that are also employees of our company shall not receive
additional compensation for serving on the Board. Both the cash retainer and stock awards are prorated for partial quarters of
service when a new Director joins the Board. Both Dr. Pinney and Mr. Halas joined the Board in August, 2014.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="financail"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>FINANCIAL
STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Index to Financial Statements Required by
Article 8 of Regulation S-X:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding: 0; text-indent: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Audited
                                         Financial Statements:</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%; padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">F-1 and </FONT> F-2</TD>
    <TD STYLE="width: 91%; padding: 0; text-indent: 0"><A HREF="#report"><FONT STYLE="font-size: 10pt">Reports of Independent
    Registered Public Accounting Firms;</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">F-3</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><A HREF="#balance"><FONT STYLE="font-size: 10pt">Consolidated Balance Sheets as of
    December 31, 2014&nbsp; and 2013;</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">F-4</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><A HREF="#operations"><FONT STYLE="font-size: 10pt">Consolidated Statements of Operations
    for the years ended December 31, 2014 and 2013;</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">F-5</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><A HREF="#equity"><FONT STYLE="font-size: 10pt">Consolidated Statement of Stockholders&rsquo;
    Equity as of December 31, 2014;</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">F-7</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><A HREF="#cashflow"><FONT STYLE="font-size: 10pt">Consolidated Statements of Cash Flows
    for the years ended December 31, 2014 and 2013; and</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">F-8</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><A HREF="#consolidated"><FONT STYLE="font-size: 10pt">Consolidated Notes to Financial
    Statements.</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>Unaudited Financial Statements:</B></P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"> &nbsp; </P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> F-24 </FONT></TD>
    <TD STYLE="width: 91%; line-height: 107%; font-size: 10pt"> <A HREF="#a_1"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Consolidated
    Balance Sheets as of June 30, 2015 and December 31, 2014;</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> F- </FONT> 25 </TD>
    <TD STYLE="line-height: 107%; font-size: 10pt"> <A HREF="#a_2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Consolidated
    Statements of Operations for the three and six months ended June 30, 2015 and 2014;</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> F- </FONT> 26 </TD>
    <TD STYLE="line-height: 107%; font-size: 10pt"> <A HREF="#a_3"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Consolidated
    Statements of Cash Flows for the six months ended June 30, 2015 and 2014; and</FONT></A> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> F- </FONT> 27 </TD>
    <TD STYLE="line-height: 107%; font-size: 10pt"> <A HREF="#a_4"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Consolidated
    Notes to Financial Statements.</FONT></A> </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #A2224B"><FONT STYLE="color: Black"><U>Silberstein Ungar,
PLLC CPAs and Business Advisors</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; color: #A2224B"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="color: Black">30600 Telegraph Road,
Suite 2175</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="color: Black">Bingham Farms, MI
48025-4586</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; color: #A2224B"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="a_001"></A><B>&nbsp;REPORT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="color: Black">To the Board of
Directors</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="color: Black">OptimizeRx Corporation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="color: Black">Rochester, Michigan</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: -0.1pt; text-align: justify"><FONT STYLE="color: Black">We
have audited, before the effects of the adjustments for the correction of the errors described in Note 17, the accompanying consolidated
balance sheet of OptimizeRx Corporation as of December 31, 2013, and the related consolidated statements of operations, stockholders&rsquo;
equity, and cash flows for the year then ended (the 2013 financial statements before the effects of the adjustments discussed
in Note 17 have been withdrawn and are not presented herein). The 2013 financial statements are the responsibility of the Company&rsquo;s
management. Our responsibility is to express an opinion on these financial statements based on our audit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="color: Black">We conducted our
audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require
that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material
misstatement. The Company has determined that it is not required to have, nor were we engaged to perform, an audit of its internal
control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for
designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the
effectiveness of the Company&rsquo;s internal control over financial reporting. Accordingly, we express no such opinion. An audit
includes examining on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also
includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="color: Black">In our opinion,
except for the errors described in Note 17, the consolidated financial statements referred to above present fairly, in all material
respects, the financial position of OptimizeRx Corporation as of December 31, 2013, and the results of its operations and cash
flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="color: Black">We were not engaged
to audit, review, or apply any procedures to the adjustments for the correction of the errors described in Note 17 and, accordingly,
do not express an opinion or any other form of assurance about whether such adjustments are appropriate and have been properly
applied. Those adjustments were audited by KLJ &amp; Associates, LLP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="color: Black"><U>/s/ Silberstein
Ungar, PLLC</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="color: Black">Silberstein Ungar,
PLLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="color: Black">Bingham Farms,
Michigan</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="color: Black">March 20, 2014</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 44; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;<IMG SRC="image_001.jpg" ALT="" STYLE="width: 401px; height: 96px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><A NAME="report"></A><FONT STYLE="background-color: white">REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white"> To
the Board of Directors and </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white"> Stockholders
of OptimizeRx Corporation </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white"> We
have audited the accompanying consolidated balance sheet of </FONT> &nbsp;OptimizeRx Corporation<FONT STYLE="background-color: white">
as of December 31, 2014 and the related consolidated statements of operations, stockholders&rsquo; equity, and cash flows for
the year then ended. OptimizeRx Corporation&rsquo;s management is responsible for these consolidated financial statements. Our
responsibility is to express an opinion on these financial statements based on our audit.</FONT> </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white"> We
conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards
require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements
are free of material misstatement. The company is not required to have, nor were we engaged to perform, an audit of its internal
control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for
designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the
effectiveness of the company&rsquo;s internal control over financial reporting. Accordingly, we express no such opinion. An audit
also includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated statements, assessing
the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement
presentation. We believe that our audits provide a reasonable basis for our opinion. </FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white"> In
our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position
of OptimizeRx Corporation as of December 31, 2014, the results of their operations, and their cash flows, for the year ended December
31, 2014, in conformity with accounting principles generally accepted in the United States of America. </FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white"> &nbsp; </FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> We also audited the adjustments
described in Note 17 that were applied to restate the 2013 financial statements to correct an error. In our opinion, such adjustments
are appropriate and have been properly applied. We were not engage to audit, review or apply any procedures to the 2013 financial
statements of the Company other than with respect to the adjustments and, accordingly, we do not express an opinion or any other
form of assurance on the 2013 financial statements taken as a whole.&nbsp; </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I><U> /s/ KLJ &amp; Associates,
        LLP </U></I></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> KLJ &amp; Associates, LLP </P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white"> St.
    Louis Park, MN </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white"> March
    30, 2015 </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><BR CLEAR="ALL"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="balance"></A><B>OPTIMIZERx CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Consolidated Balance Sheet as of</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>December 31, 2014 and 2013&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">December&nbsp;31,</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">December&nbsp;31,</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">2013</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid">2014</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid">(restated)</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center">ASSETS</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">Current Assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 76%; font-size: 10pt; text-align: left; padding-left: 0.25in">Cash and cash equivalents</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">3,446,973</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">1,118,243</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0.25in">Accounts receivable</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,100,381</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,511,709</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Prepaid expenses</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">28,093</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">11,771</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt">Total Current Assets</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">5,575,447</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,641,723</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt">Property and equipment, net</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">12,813</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">15,057</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Other Assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0.25in">Patent rights, net</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">930,854</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">885,950</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0.25in">Web development costs, net</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">504,643</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">404,986</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Security deposit</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">5,049</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">5,049</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt">Total Other Assets</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">1,440,546</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">1,295,985</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt">TOTAL ASSETS</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">7,028,806</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">3,952,765</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center">LIABILITIES AND STOCKHOLDERS' EQUITY</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Current Liabilities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0.25in">Accounts payable - trade</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">200,372</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">188,739</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0.25in">Accounts payable - related party</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">570,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">570,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0.25in">Accrued expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">25,459</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">12,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 0.25in">Revenue share payable</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,502,761</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,287,552</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Deferred revenue</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">120,130</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">226,272</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Total Liabilities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,418,722</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,284,563</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Stockholders' Equity</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0.25in">Preferred stock, $.001 par value, 10,000,000 shares authorized,
    0 and 65 shares issued and outstanding at December 31, 2014 and 2013, respectively</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-0-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-0-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0.25in">Common stock, $.001 par value, 500,000,000 shares authorized,
    22,867,319 and 14,817,496 shares issued and outstanding at December 31, 2014 and 2013, respectively</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">22,867</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">14,817</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0.25in">Stock warrants</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,153,295</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">18,148,049</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 0.25in">Additional paid-in-capital</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">27,595,609</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">8,875,155</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0.25in">Stock Payable</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">963,063</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-0-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0.25in">Deferred stock compensation</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-0-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(270,462</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in">Accumulated deficit</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">(26,124,750</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">(25,099,357</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt">Total Stockholders' Equity</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">4,610,084</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">1,668,202</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">7,028,806</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">3,952,765</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">The accompanying notes are an integral part
of these financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="operations"></A><B>OPTIMIZERx CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Consolidated Statements of Operations for
the Years</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Ended December&nbsp;31, 2014 and 2013</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White">For the</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White">For the</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White">year ended</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White">year ended</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White">December&nbsp;31,</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White">December&nbsp;31,</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White">2013</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White">2014</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White">(restated)</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font-size: 10pt; text-align: left; padding-left: 9pt; background-color: White">NET REVENUE</TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right; background-color: White">6,502,962</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right; background-color: White">4,679,741</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; padding-left: 9pt; background-color: White">REVENUE SHARE EXPENSE</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">3,221,534</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">1,861,316</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; background-color: White">GROSS MARGIN</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">3,281,428</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">2,818,425</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; background-color: White">EXPENSES</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;&nbsp;&nbsp;&nbsp;Operating expenses</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; background-color: White">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">1,172,242</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">523,382</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation
    and amortization</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">264,340</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">193,791</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lawsuit
    settlement</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">400,000</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">-0-</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
    operating expenses</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">2,471,174</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">2,368,788</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt; background-color: White">Total Operating
    expenses</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">4,307,756</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">3,085,961</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; background-color: White">LOSS FROM
    OPERATIONS</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">(1,026,328</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">(267,536</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">OTHER INCOME</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 9pt; background-color: White">Interest income</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">935</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">246</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt; background-color: White">Interest
    expense</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">-0-</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">-0-</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; background-color: White">TOTAL OTHER
    INCOME</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">935</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">246</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 9pt; background-color: White">LOSS BEFORE PROVISION FOR INCOME
    TAXES</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">(1,025,393</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">)</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">(267,290</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White">PROVISION FOR INCOME TAXES</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">-0-</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">-0-</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; padding-left: 10pt; background-color: White">NET LOSS</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White">(1,025,393</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White">(267,290</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White">22,382,415</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White">14,388,017</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: FULLY
    DILUTED</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White">24,008,353</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White">21,196,096</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; background-color: White">NET LOSS PER SHARE: BASIC AND
    DILUTED (no separate per share amount shown because loss is antidilutive)</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White">(0.04</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White">(0.02</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">The accompanying notes are an integral part
of these financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="equity"></A><B>OPTIMIZERx CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Consolidated Statement of Stockholders&rsquo;
Equity for the Year</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Ended December&nbsp;31, 2013 (restated)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">Preferred</FONT><BR>
    <FONT STYLE="font-size: 8pt">Stock</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">Preferred
    Stock</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">Common Stock</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">Common Stock</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">Stock</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 8pt">Additional</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 8pt">Paid-in</FONT></P></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">Stock</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">Deferred
    Stock</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">Accumulated</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">Total</FONT><BR>
    <FONT STYLE="font-size: 8pt">Stockholders&rsquo;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"><FONT STYLE="font-size: 8pt">Shares</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"><FONT STYLE="font-size: 8pt">Amount</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"><FONT STYLE="font-size: 8pt">Shares</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"><FONT STYLE="font-size: 8pt">Amount</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"><FONT STYLE="font-size: 8pt">Warrants</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"><FONT STYLE="font-size: 8pt">Capital</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"><FONT STYLE="font-size: 8pt">Payable</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"><FONT STYLE="font-size: 8pt">Compensation</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"><FONT STYLE="font-size: 8pt">Deficit</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"><FONT STYLE="font-size: 8pt">Equity</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">Balance, January 1, 2013</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">65</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">-0-</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">14,232,496</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">14,232</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">20,058,051</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">6,164,666</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 6%; font: 10pt Times New Roman, Times, Serif; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">-0-</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">-0-</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">(24,832,067</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">1,404,882</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">Issuance of stock options:</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 9pt; background-color: White"><FONT STYLE="font-size: 8pt">to
    employees</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">7,720</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">7,720</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 9pt; background-color: White"><FONT STYLE="font-size: 8pt">for
    consulting</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">146,412</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">(59,134</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">87,278</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">Issuance of common stock:</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 9pt; background-color: White"><FONT STYLE="font-size: 8pt">for
    services</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">84,000</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">84</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">141,856</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">(36,520</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">105,420</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 9pt; background-color: White"><FONT STYLE="font-size: 8pt">for
    severance</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">500,000</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">500</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">504,500</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">(505,000</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">-0-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 9pt; background-color: White"><FONT STYLE="font-size: 8pt">for
    correction of prior issue</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">1,000</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">1</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">(1</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">-0-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">Reclassification for expired
    warrants</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">(1,910,002</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">1,910,002</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">-0-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">Expense consulting services</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">330,192</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">330,192</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">Net
    loss for the year</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">(267,290</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">(267,290</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"><FONT STYLE="font-size: 8pt">Balance, December 31,
    2013 (restated)</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">65</FONT></TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">-0-</FONT></TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">14,817,496</FONT></TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">14,817</FONT></TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">18,148,049</FONT></TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">8,875,155</FONT></TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">-0-</FONT></TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">(270,462</FONT></TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">(25,099,357</FONT></TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">1,668,202</FONT></TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;The accompanying
notes are an integral part of these financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OPTIMIZERx CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Consolidated Statement of Stockholders&rsquo;
Equity for the Year</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Ended December&nbsp;31, 2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 8pt">Preferred</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 8pt">Stock</FONT></P></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">Preferred
    Stock</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">Common Stock</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">Common Stock</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">Stock</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 8pt">Additional</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 8pt">Paid-in</FONT></P></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">Stock</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">Deferred
    Stock</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White"><FONT STYLE="font-size: 8pt">Accumulated</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 8pt">Total</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 8pt">Stockholders&rsquo;</FONT></P></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"><FONT STYLE="font-size: 8pt">Shares</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"><FONT STYLE="font-size: 8pt">Amount</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"><FONT STYLE="font-size: 8pt">Shares</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"><FONT STYLE="font-size: 8pt">Amount</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"><FONT STYLE="font-size: 8pt">Warrants</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"><FONT STYLE="font-size: 8pt">Capital</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"><FONT STYLE="font-size: 8pt">Payable</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"><FONT STYLE="font-size: 8pt">Compensation</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"><FONT STYLE="font-size: 8pt">Deficit</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"><FONT STYLE="font-size: 8pt">Equity</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">Balance, December&nbsp;31, 2013 (restated)</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">65</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">-0-</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">14,817,496</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">14,817</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">18,148,049</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">8,875,155</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 6%; font: 10pt Times New Roman, Times, Serif; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">-0-</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">(270,462</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">(25,099,357</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 6%; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">1,668,202</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">Issuance of stock options:</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 9pt; background-color: White"><FONT STYLE="font-size: 8pt">to
    employees</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">272,804</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">272,804</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 9pt; background-color: White"><FONT STYLE="font-size: 8pt">to
    consultants</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">16,935</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">(16,935</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">-0-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">Issuance of common stock:</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 9pt; background-color: White"><FONT STYLE="font-size: 8pt">for
    services</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">167,065</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">167</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">26,812</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">14,688</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">41,667</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 9pt; background-color: White"><FONT STYLE="font-size: 8pt">for
    cash</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">8,333,333</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">8,333</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">8,408,699</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">378,000</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">8,795,032</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 9pt; background-color: White"><FONT STYLE="font-size: 8pt">for warrant exercise</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">445,765</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">446</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">(694,133</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">693,687</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">-0-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">Issue warrants for equity
    raise</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">1,110,211</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">(1,110,211</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">-0-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">Issue stock rights to
    officers</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">570,375</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">570,375</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">Reclassify expired and
    redeemed warrants</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">(16,410,832</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">16,410,832</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">-0-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">Expense consulting services</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">287,397</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">287,397</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">Redeem shares for cash</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">(65</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">-0-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">(896,340</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">(896</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">(5,999,104</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">(6,000,000</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">Net
    loss for the year</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">(1,025,393</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">(1,025,393</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"><FONT STYLE="font-size: 8pt">Balance, December&nbsp;31,
    2014</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">-0-</FONT></TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">-0-</FONT></TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">22,867,319</FONT></TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">22,867</FONT></TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">2,153,295</FONT></TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">27,595,609</FONT></TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">963,063</FONT></TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">-0-</FONT></TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">(26,124,750</FONT></TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"><FONT STYLE="font-size: 8pt">4,610,084</FONT></TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;The accompanying
notes are an integral part of these financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="cashflow"></A><B>OPTIMIZERx CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Consolidated Statements of Cash Flows for
the Years</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Ended December&nbsp;31, 2014 and 2013</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White">For the</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White">For the</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White">year ended</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White">year ended</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White">December&nbsp;31,</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White">December&nbsp;31,</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White">2013</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White">2014</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White">(restated)</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; background-color: White">CASH FLOWS FROM OPERATING ACTIVITIES:</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font-size: 10pt; text-align: left; padding-left: 0.25in; background-color: White">Net loss for the
    period</TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right; background-color: White">(1,025,393</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">)</TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right; background-color: White">(267,290</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">Adjustments to reconcile net income (loss) to net cash
    provided by (used in) operating activities:</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0.25in; background-color: White">Depreciation and amortization</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">264,340</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">193,791</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0.25in; background-color: White">Loss on disposal of assets</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">3,295</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">-0-</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0.25in; background-color: White">Stock options issued for services</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">272,804</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">94,998</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 0.25in; background-color: White">Stock-based compensation</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">899,438</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">435,612</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">Changes in:</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0.25in; background-color: White">Accounts receivable</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">(588,672</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">)</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">(894,911</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0.25in; background-color: White">Prepaid expenses</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">(16,322</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">)</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">56,387</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0.25in; background-color: White">Accounts payable</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">11,633</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">134,046</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 0.25in; background-color: White">Revenue share payable</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">215,210</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">1,196,975</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0.25in; background-color: White">Accrued expenses</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">13,459</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">6,000</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in; background-color: White">Deferred
    revenue</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">(106,142</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">177,020</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 1.5pt; background-color: White">NET CASH
    PROVIDED BY (USED IN) OPERATING ACTIVITIES</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">(56,350</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">1,132,628</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; background-color: White">CASH FLOWS FROM INVESTING ACTIVITIES:</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0.25in; background-color: White">Purchases of property and equipment</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">(6,984</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">)</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">-0-</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 0.25in; background-color: White">Patent rights</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">(110,551</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">)</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">(150,588</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in; background-color: White">Web development
    costs</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">(292,417</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">(148,060</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 1.5pt; background-color: White">NET CASH
    USED IN INVESTING ACTIVITIES</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">(409,952</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">(298,648</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; background-color: White">CASH FLOWS FROM FINANCING ACTIVITIES:</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds
    from issuance of common stock</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">8,795,032</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">-0-</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Redemption
    of common and preferred stock</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">(6,000,000</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">-0-</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 1.5pt; background-color: White">NET CASH
    PROVIDED BY FINANCING ACTIVITIES</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">2,795,032</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">-0-</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; background-color: White">NET INCREASE (DECREASE) IN CASH
    AND CASH EQUIVALENTS</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">2,328,730</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">833,980</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 1.5pt; background-color: White">CASH AND
    CASH EQUIVALENTS - BEGINNING OF PERIOD</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">1,118,243</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">284,263</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 4pt; background-color: White">CASH AND CASH
    EQUIVALENTS - END OF PERIOD</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White">3,446,973</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White">1,118,243</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; background-color: White">SUPPLEMENTAL CASH FLOW INFORMATION:</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; padding-left: 0.25in; background-color: White">Cash paid
    for interest</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White">-0-</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White">-0-</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; padding-left: 0.25in; background-color: White">Cash paid
    for income taxes</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White">-0-</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White">-0-</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; background-color: White">SUPPLEMENTAL DISCLOSURE OF NONCASH
    INVESTING AND FINANCING ACTIVITIES:</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; padding-left: 0.25in; background-color: White">Common stock
    issued for future services</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White">-0-</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White">270,462</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;The accompanying
notes are an integral part of these financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="consolidated"></A><B>OPTIMIZERx
CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>NOTES TO THE CONSOLIDATED
FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>DECEMBER&nbsp;31,
2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">NOTE 1 &ndash; NATURE OF BUSINESS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">OptimizeRx Corporation, is a technology solutions
company targeting the health care industry. Our objective is to bring better access to better care through connecting patients,
physicians and pharmaceutical manufacturers through technology. Originally defined as a marketing and advertising company through
our consumer website, we have matured into a technology solutions provider as we launched our direct to physician solution, SampleMD.
SampleMD allows physicians to search, print and send available sample trial vouchers and/or co-pay coupons on behalf of their
patients. The SampleMD solution is integrated into the physician&rsquo;s ePrescribing or Electronic Medical Records applications,
but could also be a stand-alone desktop application. OptimizeRx solutions provide pharmaceutical manufacturers a direct to physician
channel for communicating and promoting their products. It provides health care providers a means to provide sampling and coupons
without having to physically store samples on site, and it provides better access and affordability to patients.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The company was originally formed as Optimizer
Systems, LLC in the State of Michigan on January 31, 2006. It incorporated in the State of Michigan on October 22, 2007 and changed
its name to OptimizeRx Corporation. On April 14, 2008, RFID, Ltd., a Colorado corporation, consummated a reverse merger by entering
into a share exchange agreement with the stockholders of OptimizeRx Corporation, pursuant to which the stockholders of OptimizeRx
Corporation exchanged all of the issued and outstanding capital stock of OptimizeRx Corporation for 1,256,958 shares of common
stock of RFID, Ltd., representing 100% of the outstanding capital stock of RFID, Ltd. As of April&nbsp;30, 2008, RFID&rsquo;s
officers and directors resigned their positions and RFID changed its business to OptimizeRx&rsquo;s business. On April&nbsp;15,
2008, RFID, Ltd.&rsquo;s corporate name was changed to OptimizeRx Corporation. On September&nbsp;4, 2008, a migratory merger was
completed, thereby changing the state of incorporation from Colorado to Nevada, resulting in the current corporate structure,
in which OptimizeRx Corporation, a Nevada corporation, is the parent corporation, and OptimizeRx Corporation, a Michigan corporation,
which is a wholly-owned subsidiary (together, &quot;OptimizeRx&quot; and &quot;the Company&quot;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">NOTE 2 &ndash; SUMMARY OF
SIGNIFICANT ACCOUNTING POLICIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Basis of Presentation</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The financial statements of the Company have
been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in
US dollars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Accounting Basis</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company uses the accrual basis of accounting
and accounting principles generally accepted in the United States of America (&ldquo;GAAP&rdquo; accounting). The Company has
adopted a December 31 fiscal year end.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt"><U>Principles
of Consolidation</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">The financial
statements reflect the consolidated results of OptimizeRx Corporation (a Nevada corporation) and its wholly owned subsidiary OptimizeRx
Corporation (a Michigan corporation). All material inter-company transactions have been eliminated in the consolidation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt"><U>Cash
and Cash Equivalents</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">For purposes
of the accompanying financial statements, the Company considers all highly liquid instruments with an initial maturity of three
months or less to be cash equivalents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>OPTIMIZERx CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>NOTES TO THE CONSOLIDATED
FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>DECEMBER&nbsp;31,
2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">NOTE 2 &ndash; SUMMARY OF
SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Fair Value of Financial Instruments</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">The fair
value of cash, accounts receivable, prepaid expenses, accounts payable, accounts payable &ndash; related party, accrued expenses
and deferred revenue approximates the carrying amount of these financial instruments due to their short-term nature.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fair value is defined as the price that would
be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at
the measurement date and in the principal or most advantageous market for that asset or liability. The fair value should be calculated
based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the
entity. In addition, the fair value of liabilities should include consideration of non-performance risk including our own credit
risk.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition to defining fair value, the disclosure
requirements around fair value establish a fair value hierarchy for valuation inputs which is expanded. The hierarchy prioritizes
the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each
fair value measurement is reported in one of the three levels which is determined by the lowest level input that is significant
to the fair value measurement in its entirety. These levels are:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 1 &ndash; inputs are based upon unadjusted
quoted prices for identical instruments traded in active markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 2 &ndash; inputs are based upon significant
observable inputs other than quoted prices included in Level 1, such as quoted prices for identical or similar instruments in
markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the
market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 3 &ndash; inputs are generally unobservable
and typically reflect management&rsquo;s estimates of assumptions that market participants would use in pricing the asset or liability.
The fair values are therefore determined using model-based techniques that include option pricing models, discounted cash flow
models, and similar techniques. The Company&rsquo;s stock options and warrants are valued using level 3 inputs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying value of the Company&rsquo;s
financial assets and liabilities which consist of cash, accounts receivable, prepaid expenses, patent rights, web development
costs, accounts payable, accounts payable &ndash; related party, accrued expenses and deferred revenue are valued using level
1 inputs. The Company believes that the recorded values approximate their fair value due to the short maturity of such instruments.
Unless otherwise noted, it is management&rsquo;s opinion that the Company is not exposed to significant interest, exchange or
credit risks arising from these financial instruments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Accounts Receivable and Allowance for Doubtful
Accounts</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable are reported at realizable
value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded.
The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors,
including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part
of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of
its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates.
Because the Company&rsquo;s customers are primarily large well capitalized companies, historically there has been very little
bad debt expense. Bad debt expense was $0 for each of the years ended December&nbsp;31, 2014 and 2013. The allowance for doubtful
accounts was $0 as of both December&nbsp;31, 2014 and 2013.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>OPTIMIZERx CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>NOTES TO THE CONSOLIDATED
FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>DECEMBER&nbsp;31,
2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">NOTE 2 &ndash; SUMMARY OF
SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Property and Equipment</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">The capital
assets are being depreciated over their estimated useful lives of three to seven years using the straight-line method of depreciation
for book purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>Revenue Recognition and Revenue Share Expense</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue is recognized when it is earned. Revenues
are generated from our SampleMD activities in which we deliver eCoupons and eVouchers through a distribution network of ePrescribers
and Electronic Health Record technology providers (channel partners), or from reselling services that complement our business
for other of our partners.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We recognize setup fees that are required
for integrating client offerings and campaigns into the SampleMD content delivery system and network upon completion of the setup
and launch of the client&rsquo;s campaign within the SampleMD system. As the eCoupons and or eVouchers are distributed through
the SampleMD platform and network of channel partners (a transaction), these transactions are recorded and revenue is recognized
at the time of distribution. Revenue for transactions can be realized based on a price per distribution or a price per redemption
depending on the client contract. Additionally, the company also recognizes revenue for providing program performance reporting
and maintenance, either by the company directly delivering reports or by providing access to its online reporting portal that
the client can utilize. These fees are charged monthly and recognized as recurring monthly revenue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The company on occasion has also resold products
and or services that are available through our channel partners, and that is complementary to our core businesses and client base.
In these instances net revenue is recognized based on the commission based revenue split that the company receives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Based on the volume of transactions that are
delivered through our channel partner network, we provide a revenue share to compensate the partner for their promotion of the
campaign. Revenue shares are a negotiated percentage of the transaction fees and can also be specific to special considerations
and campaigns. In addition, we pay revenue share to PDR/LDM as a result of a 2014 legal settlement in an amount equal to the greater
of 10% of eCoupon revenues generated or $0.37 per eCoupon distributed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>Income Taxes</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Income taxes are computed using the asset
and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on
the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted
tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence,
are not expected to be realized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>Use of Estimates</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">The preparation
of financial statements in conformity with generally accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported
amounts of revenues and expenses during the reporting period. Estimates and assumptions have been made in determining the depreciable
lives of such assets and the allowance for doubtful accounts receivable. Actual results could differ from these estimates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>Concentration of Credit Risks</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">The Company
maintains its cash and cash equivalents in bank deposit accounts, which, at times, may exceed federally insured limits. The Company
has not experienced any losses in such accounts; however, amounts in excess of the federally insured limit may be at risk if the
bank experiences financial difficulties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>OPTIMIZERx CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>NOTES TO THE CONSOLIDATED
FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>DECEMBER&nbsp;31,
2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">NOTE 2 &ndash; SUMMARY OF
SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Research and Development</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">The Company
expenses research and development expenses as incurred. Our research efforts are focused on understanding the market dynamics
that have the potential to affect the business in both the short and long term. Our primary goal is to help patients better afford
and access the medicines their doctor prescribes, as well as other healthcare products and services they need. Based on this,
the Company continually seeks better ways to meet this mission through improved technology, better user experiences and new ways
to engage industries to provide new support for patients needing their products, as well seeking new services and solutions to
offer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt"><U>Share-based
Payments</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company uses the fair value method to
account for stock-based compensation. The fair value of the equity instrument is charged directly to compensation expense and
additional paid-in capital over the period during which services are rendered. The fair value of each award is estimated on the
date of each grant. For restricted stock the fair market value is based on the market value of the stock granted on the date of
the grant. For options, it is estimated using the Black Scholes option pricing model that uses the assumptions noted in the following
table. Estimated volatilities are based on the historical volatility of the Company&rsquo;s stock over the same period as the
expected term of the options. The expected term of options granted represents the period of time that options granted are expected
to be outstanding. The Company uses historical data to estimate option exercise behavior and to determine this term. The risk
free rate used is based on the U.S. Treasury yield curve in effect at the time of the grant using a time period equal to the expected
option term. The Company has never paid dividends and does not expect to pay any dividends in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; padding: 0; text-indent: 0; background-color: White">2014</TD><TD STYLE="padding: 0; font-size: 10pt; text-indent: 0; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; padding: 0; text-indent: 0; background-color: White">2013</TD><TD STYLE="padding: 0; font-size: 10pt; text-indent: 0; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; font-size: 10pt; text-align: left; padding: 0; text-indent: 0; background-color: White">Expected dividend
    yield</TD><TD STYLE="width: 1%; font-size: 10pt; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right; padding: 0; text-indent: 0; background-color: White">0</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; padding: 0; text-indent: 0; background-color: White">%</TD><TD STYLE="width: 1%; font-size: 10pt; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD><TD STYLE="width: 11%; font-size: 10pt; text-align: right; padding: 0; text-indent: 0; background-color: White">0</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; padding: 0; text-indent: 0; background-color: White">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0; background-color: White">Risk free interest rate</TD><TD STYLE="font-size: 10pt; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; padding: 0; text-indent: 0; background-color: White"><FONT STYLE="font-size: 10pt">0.90%-1.44%</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; padding: 0; text-indent: 0; background-color: White"><FONT STYLE="font-size: 10pt">0.79%-1.42%</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0; background-color: White">Expected option term</TD><TD STYLE="font-size: 10pt; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; padding: 0; text-indent: 0; background-color: White"><FONT STYLE="font-size: 10pt">3.5
                                         years</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; padding: 0; text-indent: 0; background-color: White"><FONT STYLE="font-size: 10pt">5.0
                                         years </FONT></TD><TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0; background-color: White">Turnover/forfeiture rate</TD><TD STYLE="font-size: 10pt; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; padding: 0; text-indent: 0; background-color: White">0</TD><TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0; background-color: White">%</TD><TD STYLE="font-size: 10pt; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; padding: 0; text-indent: 0; background-color: White">0</TD><TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0; background-color: White">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0; background-color: White">Expected volatility</TD><TD STYLE="font-size: 10pt; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; padding: 0; text-indent: 0; background-color: White"><FONT STYLE="font-size: 10pt">117%
                                         - 138%</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; padding: 0; text-indent: 0; background-color: White"><FONT STYLE="font-size: 10pt">155%
                                         - 171%</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0; background-color: White">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 25.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">The Black-Scholes option valuation
model and other existing models were developed for use&nbsp;in estimating the fair value of traded options that have no vesting
restrictions and are fully transferable. These option valuation models require the input of, and are highly sensitive to, subjective
assumptions including the expected stock price volatility. OptimizerRx&rsquo;s stock options have characteristics significantly
different from those of traded options, and changes in the subjective input assumptions could materially affect the fair value
estimate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.25in 0 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>Loss
Per Common and Common Equivalent Share</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
computation of basic earnings per common share is computed using the weighted average number of common shares outstanding during
the year. The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during
the year plus common stock equivalents which would arise from the exercise of warrants outstanding using the treasury stock method
and the average market price per share during the year. Options, warrants and convertible preferred stock have not been included
in the diluted earnings per share calculation for either year since their effect is anti-dilutive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>OPTIMIZERx CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>NOTES TO THE CONSOLIDATED
FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>DECEMBER&nbsp;31,
2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">NOTE 2 &ndash; SUMMARY OF
SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Impairment of Long-Lived Assets</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">The Company
continually monitors events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be
recoverable. When such events or changes in circumstances are present, the Company assesses the recoverability of long-lived assets
by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If
the total of the future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss
based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower
of the carrying amount or the fair value less costs to sell.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>Recently Issued Accounting Guidance</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">The Company
does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company&rsquo;s
results of operations, financial position or cash flow.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">NOTE
3 &ndash; PREPAID EXPENSES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">Prepaid
expenses consisted of the following as of December&nbsp;31, 2014 and 2013:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White">2014</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White">2013</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font-size: 10pt; background-color: White">Insurance</TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right; background-color: White">18,093</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right; background-color: White">6,722</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; background-color: White">Rent</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">-0-</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">5,049</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">Legal</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">10,000</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">-0-</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; background-color: White">Total prepaid expenses</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White">28,093</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White">11,771</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">NOTE 4 &ndash; PROPERTY AND EQUIPMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company owned equipment recorded at cost
which consisted of the following as of December&nbsp;31, 2014 and 2013:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid">2014</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid">2013</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 76%; font-size: 10pt; text-align: left">Computer equipment</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">19,519</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">22,360</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt">Furniture and fixtures</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">11,088</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">11,088</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 10pt">Subtotal</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">30,607</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">33,448</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt">Accumulated depreciation</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">(17,794</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">(18,391</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; padding-left: 10pt">Property and equipment, net</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">12,813</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">15,057</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Depreciation expense was $5,933 and $5,628
for the years ended December&nbsp;31, 2014 and 2013, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OPTIMIZERx CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>DECEMBER&nbsp;31, 2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">NOTE 5 &ndash; WEB-BASED TECHNOLOGY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has capitalized costs in developing
their web-based technology, which consisted of the following as of December&nbsp;31, 2014 and 2013:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White">2014</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White">2013</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font-size: 10pt; text-align: left; background-color: White">OptimizeRx web-based technology</TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right; background-color: White">154,133</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right; background-color: White">154,133</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">SampleMD web-based technology</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">602,517</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">602,517</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White">SampleMD 2.0 web-based technology</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">440,477</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">148,060</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt; background-color: White">Subtotal, web-based technology</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">1,197,127</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">904,710</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">Accumulated amortization</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">(633,401</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">)</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">(440,641</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">Impairment</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">(59,083</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">(59,083</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; padding-left: 10pt; background-color: White">Web-based
    technology, net</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White">504,643</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White">404,986</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Amortization is recorded using the straight-line
method over a period of up to five years. During 2014, the Company launched its SampleMD 2.0 web-based technology. The OptimizeRx
web-based technology was fully impaired in 2010 and has no remaining carrying value. Amortization expense for the web-based technology
costs was $192,760 and $130,289 for the years ended December&nbsp;31, 2014 and 2013, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">NOTE 6 &ndash; PATENT AND
TRADEMARKS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April&nbsp;26, 2010, the Company acquired
the technical contributions and assignment of all exclusive rights to and for the SampleMD patent from an officer and shareholder
in exchange for 300,000 shares of common stock to be granted at the discretion of the seller in addition to 200,000 stock options,
which expire in April 2015, that were valued at $360,000. The shares were valued on the grant date at $570,000 and have been recorded
as a payable to the related party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has capitalized costs in purchasing
and defending the SampleMD patent, which consisted of the following as of December&nbsp;31, 2014 and 2013:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White">2014</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White">2013</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font-size: 10pt; text-align: left; background-color: White">Patent rights and intangible assets</TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right; background-color: White">930,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right; background-color: White">930,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">Patent defense costs</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">170,937</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">87,993</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">New patents and trademarks</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">90,202</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">62,595</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White">Accumulated amortization</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">(260,285</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">(194,638</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; padding-left: 10pt; background-color: White">Patent rights
    and intangible assets, net</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White">930,854</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White">885,950</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company began amortizing the patent, using
the straight-line method over the estimated useful life of 17 years, once it was put into service in July 2010. In 2013, the Company
began incurring costs related to defense of the patent. These costs have been capitalized and will be amortized using the straight-line
method over the remaining useful life of the original patent. Amortization expense was $65,647 and $57,874 for the years ended
December&nbsp;31, 2014 and 2013, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OPTIMIZERx CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>DECEMBER&nbsp;31, 2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">NOTE 7 &ndash; DEFERRED REVENUE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has several signed contracts with
customers for the distribution or redemption of coupons, or other services, which include payment in advance. The payments are
not recorded as revenue until the revenue is earned under its revenue recognition policy discussed in Note 1. Deferred revenue
was $120,130 and $226,272 as of December&nbsp;31, 2014 and 2013, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">NOTE 8 &ndash; RELATED PARTY
TRANSACTIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">During
the year ended December&nbsp;31, 2010, the Company acquired the technical contributions and assignment of all exclusive rights
to and for the SampleMD patent in process at the time from an officer and shareholder in exchange for 300,000 shares of common
stock to be granted at the discretion of the seller in addition to 200,000 stock options, which expire in April 2015, that were
valued at $360,000. The shares were valued on the grant date at $570,000 and have been recorded as a payable to the related party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">NOTE 9 &ndash; COMMON STOCK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">OptimizeRx Corporation has 500,000,000 shares
of $.001 par value common stock authorized as of December 31, 2014. There were 22,867,319 and 14,817,496 common shares issued
and outstanding at December&nbsp;31, 2014 and 2013, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June&nbsp;1, 2013, the Company entered
into a consulting agreement with North Coast Advisors, Inc. for various services. The Company agreed to issue 20,000 shares of
common stock as of the date of the contract. The Company also agreed to issue an additional 20,000 shares every six months in
alignment with the agreement renewal up to the two years of the agreement. The first 20,000 shares were valued at the Company&rsquo;s
common stock closing price as of the date of the contract, which was $1.945/share; and the second 20,000 shares were valued at
the Company&rsquo;s common stock closing price of $1.50/share on the date of issuance, and have been expensed. An additional 10,000
shares were issued in 2014 before the agreement was terminated by the Company. The 2014 shares were valued at $1.85, the closing
price of the Company&rsquo;s common stock on the date of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 10, 2013, the Company entered into
a capital markets advisory agreement with Taglich Brothers, Inc. for various services. The agreement covered a one year period
and the Company agreed to issue 44,000 shares of common stock to Taglich over the term of the agreement. The shares were valued
at $1.66, the closing price of the stock on the date of the agreement and were written off over the term of the agreement. The
shares were issued in June 2014 upon expiration of the contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September&nbsp;20, 2013, the Company entered
into a separation agreement that included post-employment consulting services with the former CEO of the Company. The Company
agreed to issue 500,000 shares of common stock, 250,000 shares immediately and 250,000 by January&nbsp;1, 2014. The shares have
been issued and the Company recognized the entire issuance in the December 31, 2013 shares outstanding. The shares were valued
at $505,000 and $174,808 of that amount remained as deferred stock compensation as of December&nbsp;31, 2013, but has been fully
amortized to expenses as of December 31, 2014.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In&nbsp;March 2014,&nbsp;the Company&nbsp;entered
into a securities purchase agreement, pursuant to which&nbsp;the Company&nbsp;sold 8,333,333 shares of&nbsp;the Company&rsquo;s
common stock for $1.20 per share, or gross proceeds of $10,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OPTIMIZERx CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>DECEMBER&nbsp;31, 2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">NOTE 9 &ndash; COMMON STOCK
(CONTINUED)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Placement agents in the offering received
commissions equal to approximately 9.7% of gross proceeds, for an aggregate commission of approximately $970,000, including reimbursements
for their reasonable out of pocket expenses. Placement agents also received warrants to purchase up to 804,139 shares of&nbsp;the
Company's common stock with an exercise price of $1.20 per share and a term of 5 years. The warrants were valued at $1,110,211,
have been recorded as equity issuance costs, and were registered on a registration statement dated May 28, 2014. In addition to
the warrants to placement agents, the Company also paid cash bonuses of $240,000 to three executive officers, agreed to issue
200,000 shares to three executive officers, and issued 150,000 shares to a consultant, in connection with the equity raise. The
stock was valued based on the fair market value on the grant date, which was $630,000 in total. These amounts have been recorded
as equity issuance costs, resulting in total equity issuance costs of $2.95 million. The 200,000 shares for the three executive
officers have not been issued, but are recorded as stock payable and can be requested by the respective officers at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&nbsp;used the net proceeds of
the offering to exercise the securities redemption option agreement, as amended, with Vicis Capital Master Fund that provided&nbsp;the
Company&nbsp;with an option to purchase all of the outstanding shares and derivative securities held by Vicis for total payment
of $6,000,000. The shares and derivative securities included the Series A Convertible Preferred Stock, Series B Convertible Preferred
Stock, Common Stock, and warrants to purchase shares of common stock held by Vicis in the Company. The balance of the net proceeds
was used for working capital purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In January 2014, an executive officer exercised
500,000 stock warrants using the cashless exercise feature included in the warrants. In exchange for the 500,000 warrants, 410,348
shares of common stock were issued. In October 2014, a consultant exercised 50,000 stock warrants using the cashless exercise
feature included in the warrants. In exchange for the 50,000 warrants, 35,417 shares of common stock were issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2014, the Company agreed to grant
337,500 shares of common stock, half of which vested immediately and half of which vested in August 2014, to two executive officers
as bonuses based on their efforts to recapitalize the company to secure approximately $3 million in working capital while reducing
potential fully diluted shares by approximately 7 million shares. Stock-based compensation related to these bonuses was $570,375
during the year ended December 31, 2014. These shares have not yet been issued and are recorded as stock payable, but can be requested
by the officers at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2014, the Company adopted a Director Compensation
plan for outside Directors. In connection with this plan, 19,565 shares were granted with a total value of $23,166. A total of
7,065 shares were issued in 2014 and 12,500 shares were included in stock payable at December 31, 2014 and issued in January 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="letter-spacing: -0.1pt">NOTE 10 &ndash;
PREFERRED STOCK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Series A Preferred</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December&nbsp;31, 2008,
35 preferred shares were issued for $3,500,000. Issuance costs totaled $515,000 resulting in net proceeds of $2,985,000. The 35
shares are convertible to 3,500,000 shares of common stock and bear a 10% cumulative dividend. In addition, there was a warrant
issued to purchase 6,000,000 shares of common stock at an exercise price of $2 for a period of seven years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>OPTIMIZERx CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>NOTES TO THE CONSOLIDATED
FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>DECEMBER&nbsp;31,
2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">NOTE 10 &ndash; PREFERRED
STOCK (CONTINUED)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The holders of the preferred stock are entitled
to semi-annual dividends payable on the stated value of the Series A preferred stock at a rate of 10% per annum, which shall be
cumulative, and accrue daily from the issuance date. The dividends may be paid in cash or shares of the Company's common stock
at management&rsquo;s discretion. If after the conversion eligibility date, the market price for the common stock for any ten
consecutive trading days in which the stock trades for over $2 per share and trading exceeds 100,000 shares per day, the preferred
shareholders can be required to convert their shares to common stock. Each share of Series A preferred stock shall also be convertible
at the option of the holder into that number of shares of common stock of the Company at the stated value of such share at a $1
conversion price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The holder could cause this conversion at
the time the shares are eligible for resale by the holder. The conversion price is subject to adjustment as hereinafter provided,
at any time, or from time to time upon the terms and in the manner hereinafter set forth in the shareholder agreement. There is
no conversion expiration date, however, the holder must provide 30 days notice for the registration of the conversion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May&nbsp;12, 2010, the Company&rsquo;s
Board declared and issued 236,598 common shares as payment for all cumulative and current semi-annual dividends. On November&nbsp;16,
2010, the Company&rsquo;s Board declared and issued 173,922 common shares for its semi-annual dividend payment. On March&nbsp;25,
2011, the Company&rsquo;s Board declared and issued 176,768 common shares for its semi-annual dividend payment. On September&nbsp;21,
2011, the Company's Board declared and issued 156,306 common shares for its semi-annual dividend payment. The Company has undeclared
dividends that were due in February and September 2012 totaling $350,000 and undeclared dividends of $350,000 that were due in
February and September 2013 for a total undeclared amount of $700,000 as of December&nbsp;31, 2013.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As described in greater detail in Note 10,
all of the Series A Preferred shares were redeemed in 2014.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Series B Preferred</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December&nbsp;31, 2010,
15 preferred shares were issued for $1,500,000. The 15 shares are convertible to 1,000,000 shares of common stock and bear a 10%
cumulative dividend. In addition, there was a warrant issued to purchase 3,000,000 shares of common stock at an exercise price
of $3 for a period of seven years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preferred stock was issued for $1,500,000
less associated issuance costs of $350,000 for net proceeds of $1,150,000. Additionally, 3,000,000 common stock warrants were
issued with the preferred stock. Based on the fair values of the preferred stock and common stock warrants on the issue date,
$341,100 was allocated to preferred stock and $1,158,900 was allocated to the common stock warrants. Equity issuance costs of
$350,000 were allocated to the preferred stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the quarter ended September&nbsp;30,
2011, 15 preferred shares were issued to an investor for $1,500,000. The 15 shares are convertible to 1,000,000 shares of common
stock and bear a 10% cumulative dividend. In addition, there was a warrant issued to purchase 1,000,000 shares of common stock
at an exercise price of $3 for a period of seven years. Based on the fair values of the preferred stock and common stock warrants
on the issue date, $855,460 was allocated to preferred stock and $644,540 was allocated to the common stock warrants. See Note
12.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OPTIMIZERx CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>DECEMBER&nbsp;31, 2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">NOTE 10 &ndash; PREFERRED
STOCK (CONTINUED)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">The holders of the preferred
stock are entitled to semi-annual dividends payable on the stated value of the Series B preferred stock at a rate of 10% per annum,
which shall be cumulative, and accrue daily from the issuance date. The dividends may be paid in cash or shares of the Company's
common stock at management&rsquo;s discretion. If after the conversion eligibility date, the market price for the common stock
for any ten consecutive trading days in which the stock trades for over $2 per share and trading exceeds 100,000 shares per day,
the preferred shareholders can be required to convert their shares to common stock. Each share of Series B preferred stock shall
also be convertible at the option of the holder into that number of shares of common stock of the Company at the stated value
of such share at a $1.50 conversion price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The holder could cause this conversion at
the time the shares are eligible for resale by the holder. The conversion price is subject to adjustment as hereinafter provided,
at any time, or from time to time upon the terms and in the manner hereinafter set forth in the shareholder agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March&nbsp;25, 2011, the Company&rsquo;s
Board declared and issued 75,758 common shares for its semi-annual dividend payment. On September&nbsp;21, 2011, the Company's
Board declared and issued 66,988 common shares for its semi-annual dividend payment. The Company has undeclared dividends that
were due in February and September 2012 totaling $150,000 and undeclared dividends of $150,000 that were due in February and September
2013 for a total undeclared amount of $300,000 as of December&nbsp;31, 2013.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As described in greater detail in Note 9,
all of the Series B Preferred shares were redeemed in 2014.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">NOTE 11 &ndash; STOCK OPTIONS
AND WARRANTS&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">The Company sponsors a stock-based incentive
compensation plan known as the 2013 Equity Compensation Plan (the &ldquo;Plan&rdquo;), which was established by the Board of Directors
of the Company and approved by the shareholders of the Company in June 2013. A total of 1,500,000 shares were initially reserved
for issuance under the plan, of which 552,500 options have been granted, 537,500 shares have been granted, and 410,000 remain
available for grant.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 0; text-align: justify">The plan allows the Company to grant
incentive stock options, non-qualified stock options, stock appreciation right, or restricted stock. The incentive stock options
are exercisable for up to ten years, at an option price per share not less than the fair market value on the date the option is
granted. The incentive stock options are limited to persons who are regular full-time employees of the Company at the date of
the grant of the option. Non-qualified options may be granted to any person, including, but not limited to, employees, independent
agents, consultants and attorneys, who the Company&rsquo;s Board or Compensation Committee believes have contributed, or will
contribute, to the success of the Company. Non-qualified options may be issued at option prices of less than fair market value
on the date of grant and are exercisable for up to ten years from date of grant. The option vesting schedule for options granted
is determined by the Compensation Committee of the Board of Directors at the time of the grant. The Plan provides for accelerated
vesting of unvested options if there is a change in control, as defined in the plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prior to establishment of the plan, the Board
granted options under terms similar to those described in the preceding paragraphs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The compensation cost that has been charged
against income related to options for the years ended December 31, 2014 and 2013, was $272,804 and $94,998, respectively. No income
tax benefit was recognized in the income statement and no compensation was capitalized in any of the years presented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OPTIMIZERx CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>DECEMBER&nbsp;31, 2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">NOTE 11 &ndash; STOCK OPTIONS
AND WARRANTS&nbsp;(continued)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company had the following option activity
during the years ended December&nbsp;31, 2014 and 2013:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White">Number
    of Options</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White">Weighted
    average exercise price</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font-size: 10pt; background-color: White">Outstanding, January 1, 2013</TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right; background-color: White">1,484,100</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right; background-color: White">0.98</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; background-color: White">Granted - 2013</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">2,175,000</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">1.00</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; background-color: White">Exercised - 2013</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">0</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">0</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">Expired &ndash; 2013</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">(2,479,100</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">(1.00</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 10pt; background-color: White">Balance, December 31, 2013</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">1,180,000</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">.97</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; background-color: White">Granted &ndash; 2014</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">387,500</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">1.73</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; background-color: White">Exercised &ndash; 2014</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">0</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">0</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">Expired &ndash; 2014</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">(260,000</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White">(0.39</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 4pt; padding-left: 10pt; background-color: White">Balance, December&nbsp;31, 2014</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White">1,307,500</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White">1.31</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">NOTE 12 &ndash;WARRANTS </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has issued warrants, primarily
in connection with capital raising activities. As also discussed in Note 9, in 2014 we issued 804,139 warrants, with an exercise
price of $1.20 per share, in connection with a $10 million equity raise, the proceeds of which were used to retire common stock,
preferred, stock, and previously existing warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company had the following warrants outstanding
as of December&nbsp;31, 2014:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White">Number
    of Warrants</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White">Exercise
    Price</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White">Expiration Date</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="width: 31%; font-size: 10pt; text-align: right; background-color: White">1,000,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="width: 31%; font-size: 10pt; text-align: right; background-color: White">2.25</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="width: 32%; font-size: 10pt; text-align: center; padding-left: 5.4pt; background-color: White">10/5/2017</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">50,000</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">0.89</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center; padding-left: 5.4pt; background-color: White">2/17/2016</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">804,139</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White">$</TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White">1.20</TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center; padding-left: 5.4pt; background-color: White">3/17/2019</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company had the following warrant activity
during the years ended December&nbsp;31, 2014 and 2013:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid">Number of Warrants</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid">Weighted average exercise price</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 76%; font-size: 10pt">Outstanding, January 1, 2013</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">12,277,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">2.25</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">Granted - 2013</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">Exercised - 2013</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">Expired &ndash; 2013</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">(527,000</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">(1.73</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 10pt">Balance, December 31, 2013</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">11,750,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2.27</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">Granted &ndash; 2014</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">804,139</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1.20</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">Exercised &ndash; 2014</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(550,000</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(0.35</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">Cancelled - 2014</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(10,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(2.40</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">Expired &ndash; 2014</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">(150,000</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">(1.45</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 4pt; padding-left: 10pt">Balance, December&nbsp;31, 2014</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">1,854,139</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">1.69</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>OPTIMIZERx CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>NOTES TO THE CONSOLIDATED
FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>DECEMBER&nbsp;31,
2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">NOTE 13 &ndash; OPERATING
LEASES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company signed the lease for its current
office space located in Rochester Michigan on December 1, 2011 at an approximate rent of $5,000 per month. The initial lease term
was for three years with an option to renew for an additional two years at approximately $5,200 per month. The lease was renewed
and now expires on November 30, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Minimum annual rent payments are as follows
for the remainder term of the lease:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 88%; font-size: 10pt">&nbsp;Year ended December 31, 2015</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">62,418</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;Year ended December 31, 2016</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">57,217</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt">Total lease commitment</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">119,635</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">NOTE 14 &ndash; MAJOR CUSTOMERS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">The Company
had the following major customers that individually accounted for 10% or more of revenue in any one of the years presented</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; background-color: White">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; background-color: White">2014</TD><TD STYLE="padding-bottom: 1.5pt; background-color: White">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; background-color: White">Percentage</TD><TD STYLE="padding-bottom: 1.5pt; background-color: White">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; background-color: White">2013</TD><TD STYLE="padding-bottom: 1.5pt; background-color: White">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; background-color: White">Percentage</TD><TD STYLE="padding-bottom: 1.5pt; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left; background-color: White">Company A</TD><TD STYLE="width: 1%; background-color: White">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; background-color: White">$</TD><TD STYLE="width: 9%; text-align: right; background-color: White">1,270,064</TD><TD STYLE="width: 1%; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="width: 1%; background-color: White">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; background-color: White">20</TD><TD STYLE="width: 1%; text-align: left; background-color: White">%</TD><TD STYLE="width: 1%; background-color: White">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; background-color: White">$</TD><TD STYLE="width: 9%; text-align: right; background-color: White">1,776,824</TD><TD STYLE="width: 1%; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="width: 1%; background-color: White">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; background-color: White">36</TD><TD STYLE="width: 1%; text-align: left; background-color: White">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; background-color: White">Company B</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">797,972</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">12</TD><TD STYLE="text-align: left; background-color: White">%</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">1,053,321</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">22</TD><TD STYLE="text-align: left; background-color: White">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; background-color: White">Company C</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">772,320</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">12</TD><TD STYLE="text-align: left; background-color: White">%</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">305,980</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">7</TD><TD STYLE="text-align: left; background-color: White">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; background-color: White">Company D</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">644,702</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">10</TD><TD STYLE="text-align: left; background-color: White">%</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">278,499</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">6</TD><TD STYLE="text-align: left; background-color: White">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: White">Company E</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">628,741</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">10</TD><TD STYLE="text-align: left; background-color: White">%</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">71,030</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">2</TD><TD STYLE="text-align: left; background-color: White">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; background-color: White; padding-bottom: 1.5pt">All other customers</TD><TD STYLE="background-color: White; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; background-color: White; border-bottom: Black 1.5pt solid">2,389,163</TD><TD STYLE="text-align: left; background-color: White; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="background-color: White; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: right; background-color: White; border-bottom: Black 1.5pt solid">36</TD><TD STYLE="text-align: left; background-color: White; padding-bottom: 1.5pt">%</TD><TD STYLE="background-color: White; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; background-color: White; border-bottom: Black 1.5pt solid">1,193,587</TD><TD STYLE="text-align: left; background-color: White; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="background-color: White; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: right; background-color: White; border-bottom: Black 1.5pt solid">25</TD><TD STYLE="text-align: left; background-color: White; padding-bottom: 1.5pt">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="background-color: White">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">&nbsp;</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">&nbsp;</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">&nbsp;</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="background-color: White">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White">&nbsp;</TD><TD STYLE="text-align: right; background-color: White">&nbsp;</TD><TD STYLE="text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="background-color: White; padding-bottom: 4pt">Total</TD><TD STYLE="background-color: White; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White; border-bottom: Black 4pt double">$</TD><TD STYLE="text-align: right; background-color: White; border-bottom: Black 4pt double">6,502,962</TD><TD STYLE="text-align: left; background-color: White; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="background-color: White; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="text-align: right; background-color: White; border-bottom: Black 4pt double">100</TD><TD STYLE="text-align: left; background-color: White; padding-bottom: 4pt">%</TD><TD STYLE="background-color: White; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White; border-bottom: Black 4pt double">&nbsp;</TD><TD STYLE="text-align: right; background-color: White; border-bottom: Black 4pt double">4,679,741</TD><TD STYLE="text-align: left; background-color: White; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="background-color: White; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: left; background-color: White; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="text-align: right; background-color: White; border-bottom: Black 4pt double">100</TD><TD STYLE="text-align: left; background-color: White; padding-bottom: 4pt">%</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">NOTE 15 &ndash; INCOME TAXES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2014, the Company had net
operating loss carry forwards of approximately $8.8 million that expire from 2027 through 2034 that are available to offset future
taxable income. The Company was formed in 2006 as a limited liability company and incorporated in 2007. Activity prior to incorporation
is not reflected in the Company&rsquo;s corporate tax returns. In the future, the cumulative net operating loss carry-forward
for income tax purposes may differ from the cumulative financial statement loss due to timing differences between book and tax
reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The provision for Federal income tax consists
of the following for the years ended December&nbsp;31, 2014 and 2012:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid">2014</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid">2013</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">Federal income tax benefit attributable to:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 76%; font-size: 10pt; text-align: left; padding-left: 10pt">Current operations</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">349,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">91,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt">Permanent and Timing Differences (net)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(160,000</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(294,000</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Valuation allowance</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">(189,000</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">203,000</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; padding-left: 20pt">Net provision for federal income tax</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">0</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">0</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OPTIMIZERx CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>DECEMBER&nbsp;31, 2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">NOTE 15 &ndash; INCOME TAXES (continued)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The cumulative tax effect at the expected
rate of 34% of significant items comprising our net deferred tax amount is as follows as of December&nbsp;31, 2013 and 2012:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid">2014</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid">2013</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">Deferred tax asset attributable to:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 76%; font-size: 10pt; text-align: left; padding-left: 10pt">Net operating loss carryover</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">2,982,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right">2,793,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Valuation allowance</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">(2,982,000</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">(2,793,000</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; padding-left: 20pt">Net deferred tax asset</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">0</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">0</TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">Under certain circumstances
issuance of common shares can result in an ownership change under Internal Revenue Code Section 382 which limits the Company&rsquo;s
ability to utilize carry forwards from prior to the ownership change. Any such ownership change resulting from stock issuances
and redemptions could limit the Company&rsquo;s ability to utilize any net operating loss carry forwards or credits generated
before this change in ownership. These limitations can limit both the timing of usage of these laws, as well as the loss of the
ability to use these net operating losses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">NOTE 16 &ndash; CONTINGENT
LIABILITIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Legal</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The company is currently involved in the following
legal proceedings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In September 2014, we initial litigation against
Shadron Stastney, the Company&rsquo;s previous CEO, in the U.S. District Court in the Eastern District of Michigan as a result
of a dispute related to his separation agreement. Mr. Stastney alleged damages related to the non-registration of shares that
he was granted as part of his separation agreement signed in September 2013. Under the terms of the contract we are not obligated
to register the shares and we deny any obligation to do so. We have requested declarative relief from the court and also requested
an injunction from the court preventing Mr. Stastney from continuing to pursue his claims. Mr. Stastney has filed a counterclaim
requesting damages of $450,000 related to the nonregistration of his shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In March 2015, we initiated litigation
against LDM Group, LLC and PDR Network, LLC in the United States District Court in the Eastern District of Missouri related to
the breach by LDM, and PDR as successor, of the settlement agreement signed February 28, 2014 related to previous litigation with
LDM. LDM has failed to live up to its obligations under the settlement agreement including, but not limited to, not allowing the
Company to distribute its eCoupon programs in the LDM network, not allowing the Company to distribute the LDM patient education
programs, and not providing other information required under the settlement agreement. The Company is seeking enforcement of the
settlement agreement and is seeking damages in an amount at least equal to the amounts paid to date to LDM under the settlement
agreement, which approximates $900,000, as well as damages for lost income and business value as a result of LDM&rsquo;s breach
of the agreement.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In March 2015, we also initiated litigation
against PDR Network, LLC in the United States District Court in the District of New Jersey as a result of PDR&rsquo;s breach of
the Master Services Agreement between the parties requiring PDR to exclusively use the Company&rsquo;s eCoupon solution. The Company
asserts that PDR&rsquo;s acquisition of LDM and the use of the LDM network to distribute coupons by PDR violates the agreement
between the parties and is seeking damages in an amount at least equal the amounts paid to date by the Company to LDM under the
settlement agreement, which approximates $900,000, as well as damages for lost income and business value as a result of PDR&rsquo;s
actions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 63; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OPTIMIZERx CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>DECEMBER&nbsp;31, 2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="letter-spacing: -0.1pt">NOTE 16 &ndash;
CONTINGENT LIABILITIES (continued)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In early 2014 the Company learned that
Mr. Milton Wilpon (&ldquo;Mr. Wilpon&rdquo;) of New Jersey claimed to have obtained a default judgment for approximately $929,000
in the New Jersey Superior Court, Essex County (the &ldquo;Judgment&rdquo;) against a predecessor of the Company and was seeking
to amend the Judgment to add the Company as a judgment debtor.&nbsp;&nbsp; The Judgment was entered in 2006 when the predecessor
of the Company was a dormant shell company and the Judgment allegedly related to a settlement agreement that was breached in 2001
(the &ldquo;Settlement Agreement&rdquo;).&nbsp; The Company appeared in the action and filed a motion to vacate the Judgment on
several grounds, including that it appeared that the Summons and Complaint were never properly served and that plaintiff had never
filed an arbitration as was required by the Settlement Agreement.&nbsp; In September 2014, the Court granted the Company&rsquo;s
motion and vacated the Judgment in its entirety and dismissed the action.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2014, the Company was served with
a copy of a Demand for Arbitration filed by Mr. Wilpon relating to his claims under the Settlement Agreement.&nbsp; On February
24, 2015, the Company filed an appearance with the AAA objecting to the arbitration on several grounds, including (1) that claims
arose in 2001 and are barred by the applicable statute of limitations; (2) plaintiff did not properly serve and file the demand
for arbitration and (3) plaintiff has not followed the proper procedure for the appointment of an arbitrator as provided by the
Settlement Agreement.&nbsp; &nbsp;The Company intends vigorously to oppose Mr. Wilpon&rsquo;s claims.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><U>Revenue-share contracts</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has contacts with various Electronic
Health Records systems and ePrescribe platforms, whereby we agree to share a portion of the revenue we generate for eCoupons distributed
through their networks. These contracts grant audit rights related to the payments to our partners, and in some cases would require
us to pay for the audit if the audit determined there was an underpayment and the underpayment meets certain thresholds, such
as 10%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 64; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OPTIMIZERx CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>DECEMBER&nbsp;31, 2014</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">NOTE 17 &ndash; RESTATEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt">The Company
discovered and recorded items requiring it to restate its 2013 financial results, as well as its 2014 quarterly results, to</FONT>
<FONT STYLE="font-size: 10pt">correct the accounting for certain transactions contained therein. The restatement relates to unrecorded
stock compensation related to investor relations and consulting services, unrecorded revenue share payables, and changes in revenue
recognition, all occurring during the year ended December 31, 2013. The revenue recognition relates to promotional programs started
in 2013 that were expected to be completed in 2013, but actually carried over into 2014.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following items were restated in the 2013
Annual Financial Statements</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-decoration: underline; text-align: center; padding-bottom: 1pt; padding-left: 5.4pt">Balance Sheet</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><U>Previously
                                         stated</U></FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><U>Adjustments</U></FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><U>Restated</U></FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 46%; text-align: justify; padding-left: 5.4pt">Accounts receivable</TD><TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1,566,964</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">(55,255</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1,511,709</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 5.4pt">Revenue share payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,193,661</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">93,891</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,287,552</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 5.4pt">Deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4,252</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">222,020</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">226,272</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 5.4pt">Additional paid in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">8,726,708</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">148,477</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">8,875,155</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 5.4pt">Deferred stock compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(233,942</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(36,520</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(270,462</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 5.4pt">Accumulated deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(24,616,220</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(483,137</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(25,099,357</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 5.4pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-decoration: underline; text-align: center; padding-left: 5.4pt">Statement of Operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 5.4pt">Revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4,957,016</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(277,275</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4,679,741</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 5.4pt">Revenue share expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,767,425</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">93,891</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,861,316</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 5.4pt">Operating expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,973,990</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">111,701</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3,085,691</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 5.4pt">Net income (loss)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">215,847</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(483,137</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(267,290</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 5.4pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-decoration: underline; text-align: center; padding-left: 5.4pt">Statement of Cash Flows</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 5.4pt">Net income (loss)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">215,847</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(483,137</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(267,290</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 5.4pt">Stock options issued for services</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">19,547</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">75,451</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">94,998</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 5.4pt">Stock-based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">399,092</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">36,520</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">435,612</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 5.4pt">Changes in accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(950,166</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">55,255</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(894,911</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 5.4pt">Changes in revenue share payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,103,084</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">93,891</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,196,975</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 5.4pt">Changes in deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(45,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">222,020</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">177,020</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 65; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">The following tables show
the effect of the restatement on the unaudited quarterly information previously filed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">Period Ended September 30,
2013 (unaudited):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-decoration: underline; text-align: center"><FONT STYLE="font-size: 10pt"><U>Balance Sheet</U></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Previously stated</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Adjustments</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Restated</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="width: 65%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Revenue share payable</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">782,902</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">28,376</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">811,278</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Deferred revenue</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">13,272</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">147,860</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">161,132</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Additional paid in capital</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; background-color: white"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white; text-align: right"><FONT STYLE="font-size: 10pt">8,449,271</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; background-color: white">&nbsp;</TD>
    <TD STYLE="vertical-align: top; background-color: white"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white; text-align: right"><FONT STYLE="font-size: 10pt">148,477</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; background-color: white">&nbsp;</TD>
    <TD STYLE="vertical-align: top; background-color: white"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white; text-align: right"><FONT STYLE="font-size: 10pt">8,597,748</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Deferred stock compensation</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white">&nbsp;</TD>
    <TD STYLE="vertical-align: top; background-color: white"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white; text-align: right"><FONT STYLE="font-size: 10pt">(233,077</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white"><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white">&nbsp;</TD>
    <TD STYLE="vertical-align: top; background-color: white"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white; text-align: right"><FONT STYLE="font-size: 10pt">(54,780</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white"><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white">&nbsp;</TD>
    <TD STYLE="vertical-align: top; background-color: white"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white; text-align: right"><FONT STYLE="font-size: 10pt">(287,857</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white"><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Accumulated deficit</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white">&nbsp;</TD>
    <TD STYLE="vertical-align: top; background-color: white"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white; text-align: right"><FONT STYLE="font-size: 10pt">(24,870,854</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white"><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white">&nbsp;</TD>
    <TD STYLE="vertical-align: top; background-color: white"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white; text-align: right"><FONT STYLE="font-size: 10pt">(270,207</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white"><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white">&nbsp;</TD>
    <TD STYLE="vertical-align: top; background-color: white"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white; text-align: right"><FONT STYLE="font-size: 10pt">(25,141,061</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white"><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-decoration: underline; text-align: center"><FONT STYLE="font-size: 10pt"><U>Statement of Operations</U></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Three Months ended September 30, 2013</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Revenue</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,373,029</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(147,860</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,225,169</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Revenue share expense</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">529,134</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">28,376</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">557,510</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Operating expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">982,504</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">93,971</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,076,475</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Net income (loss)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(141,527</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(270,207</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(411,734</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Nine Months ended September 30, 2013</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 10pt">Revenue</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">3,146,406</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(147,860</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">2,998,546</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 10pt">Revenue share expense</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,264,059</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">28,376</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,292,435</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 10pt">Operating expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">2,272,239</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">93,971</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">2,366,210</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-size: 10pt">Net income (loss)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(389,716</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(270,207</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(659,923</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-decoration: underline; text-align: center"><FONT STYLE="font-size: 10pt"><U>Statement of Cash Flows</U></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Net income (loss)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(389,716</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(270,207</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(659,923</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Stock-based compensation</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">310,823</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">93,971</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">404,794</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Changes in revenue share payable</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">649,825</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">28,376</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">678,201</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Changes in deferred revenue</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(35,980</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">147,860</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">111,880</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">Period Ended March 31, 2014
(unaudited):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-decoration: underline; text-align: center"><FONT STYLE="font-size: 10pt"><U>Balance Sheet</U></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Previously stated</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Adjustments</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Restated</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="width: 66%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Revenue share payable</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">797,725</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">167,880</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">965,605</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Deferred revenue</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">168,714</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">268,807</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">437,521</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Additional paid in capital</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; background-color: white"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white; text-align: right"><FONT STYLE="font-size: 10pt">27,155,730</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; background-color: white">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; background-color: white"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white; text-align: right"><FONT STYLE="font-size: 10pt">148,477</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; background-color: white">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; background-color: white"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white; text-align: right"><FONT STYLE="font-size: 10pt">27,304,207</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Deferred stock compensation</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; background-color: white"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white; text-align: right"><FONT STYLE="font-size: 10pt">(454,409</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white"><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; background-color: white"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white; text-align: right"><FONT STYLE="font-size: 10pt">(18,260</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white"><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; background-color: white"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white; text-align: right"><FONT STYLE="font-size: 10pt">(472,669</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white"><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">Accumulated deficit</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; background-color: white"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white; text-align: right"><FONT STYLE="font-size: 10pt">(25,269,535</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white"><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; background-color: white"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white; text-align: right"><FONT STYLE="font-size: 10pt">(591,917</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white"><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; background-color: white"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white; text-align: right"><FONT STYLE="font-size: 10pt">(25,861,452</FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: white"><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-decoration: underline; text-align: center"><FONT STYLE="font-size: 10pt"><U>Statement of Operations</U></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Three Months ended March 31, 2014</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Revenue</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,317,347</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(27,919)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,289,428</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Revenue share expense</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">498,810</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">62,601</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">561,411</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Operating expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,471,598</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">18,260</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,489,858</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Net income (loss)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(653,315</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(108,780</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(762,095</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-decoration: underline; text-align: center"><FONT STYLE="font-size: 10pt"><U>Statement of Cash Flows</U></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Net income (loss)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(653,315</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(108,780</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(762,095</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Stock-based compensation</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">361,957</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">18,260</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">380,217</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Changes in revenue share payable</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(395,935</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">62,601</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(333,334</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Changes in deferred revenue</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">164,462</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">27,919</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">192,381</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 66; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>P</B><FONT STYLE="letter-spacing: -0.1pt">eriod Ended June 30,
2014 (unaudited):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-decoration: underline; text-align: center"><FONT STYLE="font-size: 10pt"><U>Balance Sheet</U></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Previously stated</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Adjustments</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Restated</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="width: 66%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Revenue share payable</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">506,901</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">366,088</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">872,989</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Deferred revenue</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">42,908</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">258,270</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">301,178</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Additional paid in capital</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">27,304,112</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">84,677</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">27,388,789</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Accumulated deficit</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(25,322,216</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(738,674</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">26,060,890</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-decoration: underline; text-align: center"><FONT STYLE="font-size: 10pt"><U>Statement of Operations</U></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Three Months ended June 30, 2014</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Revenue</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,454,214</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(27,206</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,427,008</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Revenue share expense</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">540,048</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">190,092</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">730,140</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Operating expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">967,070</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(70,541</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">896,529</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Net income (loss)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(52,681</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(146,757</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(199,438</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Six Months ended June 30, 2014</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Revenue</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">2,771,560</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(55,124</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">2,716,436</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Revenue share expense</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,038,858</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">252,693</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,291,551</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Operating expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">2,439,028</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(52,281</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">2,386,747</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Net income (loss)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(705,996</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(255,537</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(961,533</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-decoration: underline; text-align: center"><FONT STYLE="font-size: 10pt"><U>Statement of Cash Flows</U></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Net income (loss)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(705,996</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(255,537</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(961,533</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Stock-based compensation</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">654,634</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(52,281</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">602,353</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Changes in revenue share payable</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(686,760</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">252,693</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(434,067</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Changes in deferred revenue</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">38,656</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">55,124</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">93,780</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">Period Ended September 30,
2014(unaudited):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-decoration: underline; text-align: center"><FONT STYLE="font-size: 10pt"><U>Balance Sheet</U></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Previously stated</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Adjustments</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Restated</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="width: 66%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Revenue share payable</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">853,410</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">421,019</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,274,429</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Deferred revenue</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">118,949</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">118,949</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Additional paid in capital</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">28,398,825</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">84,677</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">28,483,502</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Accumulated deficit</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(25,716,530</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(638,903</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(26,355,433</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-decoration: underline; text-align: center"><FONT STYLE="font-size: 10pt"><U>Statement of Operations</U></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Three Months ended September 30, 2014</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Revenue</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,620,215</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">199,206</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,819,421</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Revenue share expense</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">858,898</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">99,435</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">958,,333</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Operating expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,155,933</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-0-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,155,933</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Net income (loss)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(394,314</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">99,771</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(294,543</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Nine Months ended September 30, 2014</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Revenue</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">4,391,775</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">144,082</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">4,535,857</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Revenue share expense</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,897,757</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">352,127</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">2,249,884</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Operating expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">3,594,961</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(52,280</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">3,542,681</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Net income (loss)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(1,100,310</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(155,766</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(1,256,076</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-decoration: underline; text-align: center"><FONT STYLE="font-size: 10pt"><U>Statement of Cash Flows</U></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Net income (loss)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(1,100,310</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(155,766</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(1,256,076</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Stock-based compensation</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1,118,952</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(52,280</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(1,066,672</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Changes in revenue share payable</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(340,251</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">352,127</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">11,876</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Changes in deferred revenue</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(4,252</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(144,082</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">(148,334</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0"><FONT STYLE="letter-spacing: -0.1pt">NOTE 18 &ndash;
SUBSEQUENT EVENTS </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In January 2015, we issued 12,500 shares of
common stock to two outside directors as payment of their quarterly Director Fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In March 2015, we signed a capital markets
advisory agreement whereby we agreed to issue 90,000 shares of common stock in two increments as payment for the advisory services.
The first 45,000 shares were issued in March 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt">In accordance
with ASC 855-10, the Company has analyzed its operations subsequent to December&nbsp;31, 2014 through the date these financial
statements were issued and has determined that it does not have any material subsequent events to disclose in these financial
statements other than the events described above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>



<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <A NAME="a_1"></A><A NAME="a_002"></A><A NAME="a_004"></A><A NAME="a_005"></A><A NAME="a_006"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>OPTIMIZERx
CORPORATION</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> &nbsp;CONDENSED
CONSOLIDATED BALANCE SHEETS (UNAUDITED) </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> AS
OF JUNE 30, 2015 AND DECEMBER 31, 2014 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> &nbsp; </B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="background-color: White"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; background-color: White"> June 30,<BR>
    2015 </TD><TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; background-color: White"> December&nbsp;31,<BR>
    2014 </TD><TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> ASSETS </B></FONT></TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; background-color: White"> &nbsp; </TD><TD STYLE="background-color: White"> &nbsp; </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; background-color: White"> &nbsp; </TD><TD STYLE="background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="background-color: White"> Current Assets </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="background-color: White"> &nbsp; </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; padding-left: 18pt; background-color: White"> Cash and cash equivalents </TD><TD STYLE="width: 1%; background-color: White"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; background-color: White"> $ </TD><TD STYLE="width: 9%; text-align: right; background-color: White"> 3,645,878 </TD><TD STYLE="width: 1%; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="width: 1%; background-color: White"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; background-color: White"> $ </TD><TD STYLE="width: 9%; text-align: right; background-color: White"> 3,446,973 </TD><TD STYLE="width: 1%; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 18pt; background-color: White"> Accounts receivable </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> 1,918,419 </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> 2,100,381 </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 18pt; background-color: White"> Prepaid expenses </TD><TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; background-color: White"> 76,376 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; background-color: White"> 28,093 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; background-color: White"> Total Current Assets </TD><TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; background-color: White"> 5,640,673 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; background-color: White"> 5,575,447 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; background-color: White"> Property and equipment, net </TD><TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; background-color: White"> 10,674 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; background-color: White"> 12,813 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; background-color: White"> Other Assets </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 18pt; background-color: White"> Patent rights, net </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> 901,491 </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> 930,854 </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 18pt; background-color: White"> Web development costs, net </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> 424,075 </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> 504,643 </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 18pt; background-color: White"> Security deposit </TD><TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; background-color: White"> 5,049 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; background-color: White"> 5,049 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; background-color: White"> Total Other Assets </TD><TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; background-color: White"> 1,330,615 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; background-color: White"> 1,440,546 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt; background-color: White"> TOTAL ASSETS </TD><TD STYLE="padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; background-color: White"> $ </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; background-color: White"> 6,981,962 </TD><TD STYLE="padding-bottom: 4pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; background-color: White"> $ </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; background-color: White"> 7,028,806 </TD><TD STYLE="padding-bottom: 4pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="background-color: White"> &nbsp; </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> LIABILITIES
    AND STOCKHOLDERS' EQUITY </B></FONT></TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; background-color: White"> Current Liabilities </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 18pt; background-color: White"> Accounts payable - trade </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> $ </TD><TD STYLE="text-align: right; background-color: White"> 172,183 </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> $ </TD><TD STYLE="text-align: right; background-color: White"> 200,372 </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 18pt; background-color: White"> Accounts payable - related party </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> 570,000 </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> 570,000 </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 18pt; background-color: White"> Accrued expenses </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> 9,851 </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> 25,459 </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 18pt; background-color: White"> Revenue share payable </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> 1,190,995 </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> 1,502,761 </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 18pt; background-color: White"> Deferred revenue </TD><TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; background-color: White"> 336,213 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; background-color: White"> 120,130 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 18pt; background-color: White"> Total Liabilities </TD><TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; background-color: White"> 2,279,242 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; background-color: White"> 2,418,722 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; background-color: White"> Stockholders' Equity </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 36pt; text-indent: -18pt; background-color: White"> Common stock, $.001 par value,
    500,000,000 shares authorized, 22,949,819 and 22,867,319 shares issued and outstanding, respectively </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> 22,950 </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> 22,867 </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 36pt; text-indent: -18pt; background-color: White"> Preferred stock, $.001 par
    value, 10,000,000 shares authorized, no shares issued and outstanding </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> - </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> - </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 18pt; background-color: White"> Stock warrants </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> 2,153,295 </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> 2,153,295 </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 18pt; background-color: White"> Additional paid-in-capital </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> 27,806,253 </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> 27,595,609 </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 18pt; background-color: White"> Stock payable </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> 1,132,148 </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> 963,063 </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 18pt; background-color: White"> Deferred stock compensation </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> (18,750 </TD><TD STYLE="text-align: left; background-color: White"> ) </TD><TD STYLE="background-color: White"> &nbsp; </TD>
    <TD STYLE="text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="text-align: right; background-color: White"> - </TD><TD STYLE="text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 18pt; background-color: White"> Accumulated deficit </TD><TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; background-color: White"> (26,393,176 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; background-color: White"> ) </TD><TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; background-color: White"> (26,124,750 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; background-color: White"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; background-color: White"> Total Stockholders' Equity </TD><TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; background-color: White"> 4,702,720 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; background-color: White"> 4,610,084 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt; background-color: White"> TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY </TD><TD STYLE="padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; background-color: White"> $ </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; background-color: White"> 6,981,962 </TD><TD STYLE="padding-bottom: 4pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left; background-color: White"> $ </TD><TD STYLE="border-bottom: Black 4pt double; text-align: right; background-color: White"> 7,028,806 </TD><TD STYLE="padding-bottom: 4pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> The
accompanying notes are an integral part of these financial statements.<B>&nbsp;</B> </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <A NAME="a_2"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>OPTIMIZERx
CORPORATION</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> FOR
THE THREE AND SIX MONTHS ENDED JUNE 30, 2015 AND 2014 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; text-align: center; background-color: White"> For the Three Months Ended </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; text-align: center; background-color: White"> For the Six Months Ended </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"> June
    30 </TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"> June
    30 </TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"> 2015 </TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"> Restated<BR>
    2014 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"> 2015 </TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; background-color: White"> Restated<BR>
    2014 </TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt; background-color: White"> NET
    REVENUE </TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"> $ </TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right; background-color: White"> 1,705,457 </TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"> $ </TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right; background-color: White"> 1,426,808 </TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"> $ </TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right; background-color: White"> 3,193,010 </TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"> $ </TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right; background-color: White"> 2,716,236 </TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-indent: -10pt; padding-left: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-indent: -10pt; padding-left: 10pt; padding-bottom: 1.5pt; background-color: White"> REVENUE
    SHARE EXPENSE </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 1.5pt solid; background-color: White"> 882,327 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 1.5pt solid; background-color: White"> 730,140 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 1.5pt solid; background-color: White"> 1,638,768 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 1.5pt solid; background-color: White"> 1,291,551 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-indent: -10pt; padding-left: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt; background-color: White"> GROSS MARGIN </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> 823,130 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> 696,668 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> 1,554,242 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> 1,424,685 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-indent: -10pt; padding-left: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt; padding-bottom: 1.5pt; background-color: White"> OPERATING
    EXPENSES </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 1.5pt solid; background-color: White"> 980,659 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 1.5pt solid; background-color: White"> 896,529 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 1.5pt solid; background-color: White"> 1,823,269 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 1.5pt solid; background-color: White"> 2,386,747 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-indent: -10pt; padding-left: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt; padding-bottom: 1.5pt; background-color: White"> INCOME
    (LOSS) FROM OPERATIONS </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 1.5pt solid; background-color: White"> (157,529 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> ) </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 1.5pt solid; background-color: White"> (199,861 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> ) </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 1.5pt solid; background-color: White"> (269,027 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> ) </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 1.5pt solid; background-color: White"> (962,062 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-indent: -10pt; padding-left: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt; background-color: White"> OTHER INCOME
    (EXPENSE) </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt; padding-bottom: 1.5pt; background-color: White"> Interest
    income </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 1.5pt solid; background-color: White"> 304 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 1.5pt solid; background-color: White"> 223 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 1.5pt solid; background-color: White"> 601 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 1.5pt solid; background-color: White"> 329 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-indent: -10pt; padding-left: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt; padding-bottom: 1.5pt; background-color: White"> TOTAL
    OTHER INCOME (EXPENSE) </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 1.5pt solid; background-color: White"> 304 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 1.5pt solid; background-color: White"> 223 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 1.5pt solid; background-color: White"> 601 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 1.5pt solid; background-color: White"> 329 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-indent: -10pt; padding-left: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt; background-color: White"> INCOME (LOSS)
    BEFORE PROVISION </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt; background-color: White"> FOR INCOME
    TAXES </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> (157,225 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> ) </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> (199,638 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> ) </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> (268,426 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> ) </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> (961,733 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-indent: -10pt; padding-left: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt; padding-bottom: 1.5pt; background-color: White"> PROVISION
    FOR INCOME TAXES </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 1.5pt solid; background-color: White"> - </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 1.5pt solid; background-color: White"> - </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 1.5pt solid; background-color: White"> - </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 1.5pt solid; background-color: White"> - </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-indent: -10pt; padding-left: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt; padding-bottom: 4pt; background-color: White"> NET
    INCOME (LOSS) </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 4pt double; background-color: White"> $ </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 4pt double; background-color: White"> (157,225 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 3pt; background-color: White"> ) </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 4pt double; background-color: White"> $ </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 4pt double; background-color: White"> (199,638 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 3pt; background-color: White"> ) </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 4pt double; background-color: White"> $ </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 4pt double; background-color: White"> (268,426 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 3pt; background-color: White"> ) </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 4pt double; background-color: White"> $ </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 4pt double; background-color: White"> (961,733 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 3pt; background-color: White"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-indent: -10pt; padding-left: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-indent: -10pt; padding-left: 10pt; background-color: White"> WEIGHTED AVERAGE NUMBER OF
    SHARES OUTSTANDING </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-indent: -10pt; padding-left: 20pt; padding-bottom: 4pt; background-color: White"> BASIC </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 4pt double; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 4pt double; background-color: White"> 22,924,819 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 4pt double; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 4pt double; background-color: White"> 23,241,707 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 4pt double; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 4pt double; background-color: White"> 22,917,678 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 4pt double; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 4pt double; background-color: White"> 20,355,651 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-indent: -10pt; padding-left: 20pt; padding-bottom: 4pt; background-color: White"> DILUTED </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 4pt double; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: center; border-bottom: Black 4pt double; background-color: White"> &nbsp;N/A </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 4pt double; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: center; border-bottom: Black 4pt double; background-color: White"> N/A </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 4pt double; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: center; border-bottom: Black 4pt double; background-color: White"> &nbsp;N/A </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 4pt double; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: center; border-bottom: Black 4pt double; background-color: White"> &nbsp;N/A </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-indent: -10pt; padding-left: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-indent: -10pt; padding-left: 10pt; background-color: White"> NET INCOME (LOSS) PER SHARE </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-indent: -10pt; padding-left: 20pt; padding-bottom: 4pt; background-color: White"> BASIC </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 4pt double; background-color: White"> $ </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 4pt double; background-color: White"> (0.01 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 3pt; background-color: White"> ) </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 4pt double; background-color: White"> $ </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 4pt double; background-color: White"> (0.01 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 3pt; background-color: White"> ) </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 4pt double; background-color: White"> $ </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 4pt double; background-color: White"> (0.01 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 3pt; background-color: White"> ) </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 4pt double; background-color: White"> $ </TD><TD STYLE="font-size: 10pt; text-align: right; border-bottom: Black 4pt double; background-color: White"> (0.05 </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 3pt; background-color: White"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-indent: -10pt; padding-left: 20pt; padding-bottom: 4pt; background-color: White"> DILUTED </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 4pt double; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: center; border-bottom: Black 4pt double; background-color: White"> &nbsp;N/A </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 4pt double; background-color: White"> $ </TD><TD STYLE="font-size: 10pt; text-align: center; border-bottom: Black 4pt double; background-color: White"> N/A </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 4pt double; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: center; border-bottom: Black 4pt double; background-color: White"> &nbsp;N/A </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; border-bottom: Black 4pt double; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: center; border-bottom: Black 4pt double; background-color: White"> &nbsp;N/A </TD><TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; background-color: White"> &nbsp; </TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> The
accompanying notes are an integral part of these financial statements. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> &nbsp; </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <A NAME="a_3"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>OPTIMIZERx
CORPORATION</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> FOR
THE SIX MONTHS ENDED JUNE 30, 2015 AND 2014 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; border-bottom: Black 1.5pt solid; text-align: center; background-color: White"> For
    the six months Ended<BR>
    June 30 </TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; border-bottom: Black 1.5pt solid; text-align: center; background-color: White"> 2015 </TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; border-bottom: Black 1.5pt solid; text-align: center; background-color: White"> Restated<BR>
    2014 </TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; background-color: White"> CASH FLOWS FROM OPERATING ACTIVITIES: </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font-size: 10pt; text-align: left; padding-left: 18pt; background-color: White"> Net loss for the
    period </TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"> $ </TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right; background-color: White"> (268,426 </TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"> ) </TD><TD STYLE="width: 1%; font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"> $ </TD><TD STYLE="width: 9%; font-size: 10pt; text-align: right; background-color: White"> (961,733 </TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left; background-color: White"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 16.5pt; background-color: White"> Adjustments to reconcile net
    loss to net cash provided by (used in) operating activities: </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 33pt; background-color: White"> Depreciation and amortization </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> 159,337 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> 115,828 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 33pt; background-color: White"> Stock and options issued for
    services </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> 361,062 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> 627,354 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> Changes in: </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 18pt; background-color: White"> Accounts receivable </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> 181,962 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> 302,202 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 18pt; background-color: White"> Prepaid expenses </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> (48,283 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> ) </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> (30,198 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 18pt; background-color: White"> Accounts payable </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> (28,189 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> ) </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> 203,714 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 18pt; background-color: White"> Revenue share payable </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> (311,766 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> ) </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> (414,563 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 18pt; background-color: White"> Accrued expenses </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> (15,608 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> ) </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> (12,000 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; padding-left: 18pt; background-color: White"> Deferred
    revenue </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"> 216,083 </TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"> 19,651 </TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> NET CASH PROVIDED BY (USED
    IN) OPERATING ACTIVITIES </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"> 246,172 </TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"> (149,745 </TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; background-color: White"> CASH FLOWS FROM INVESTING ACTIVITIES: </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 18pt; background-color: White"> Purchase of property and equipment </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> - </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> (1.592 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 18pt; background-color: White"> Patent rights </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> (4,517 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> ) </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> (92.624 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; padding-left: 18pt; background-color: White"> Website
    site development costs </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"> (42,750 </TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"> ) </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"> (119,616 </TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> NET CASH USED IN INVESTING
    ACTIVITIES </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"> (47,267 </TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"> ) </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"> (213,832 </TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; background-color: White"> CASH FLOWS FROM FINANCING ACTIVITIES: </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Issuance
    of common stock </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> - </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> 10,000,000 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity
    issuance costs </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> - </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> (1,204,968 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase
    of common and preferred stock and warrants </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"> - </TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"> (6,000,000 </TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> NET CASH PROVIDED BY FINANCING
    ACTIVITIES </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"> - </TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"> 2,795,032 </TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> NET INCREASE IN CASH AND CASH EQUIVALENTS </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> 198,905 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> 2,431,455 </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; background-color: White"> CASH AND CASH EQUIVALENTS
    - BEGINNING OF PERIOD </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"> 3,446,973 </TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right; background-color: White"> 1,118,243 </TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; background-color: White"> CASH AND CASH EQUIVALENTS -
    END OF PERIOD </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"> 3,645,878 </TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"> 3,549,698 </TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; background-color: White"> SUPPLEMENTAL CASH FLOW INFORMATION: </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: right; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; padding-left: 18pt; background-color: White"> Cash paid
    for interest </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"> - </TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"> - </TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 4pt; padding-left: 18pt; background-color: White"> Cash paid
    for income taxes </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"> - </TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt; background-color: White"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left; background-color: White"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right; background-color: White"> - </TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: White"> &nbsp; </TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> The
accompanying notes are an integral part of these financial statements.<B>&nbsp;</B> </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> &nbsp; </B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"> <A NAME="a_4"></A><FONT STYLE="letter-spacing: -0.1pt"><B>OPTIMIZERx
CORPORATION</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"><B> NOTES TO THE CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) </B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"><B> JUNE 30, 2015 </B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: center"><B> &nbsp; </B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> NOTE 1 &ndash; NATURE OF BUSINESS AND BASIS OF
PRESENTATION </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> OptimizeRx Corporation is a technology solution
company focused on the health care industry. Its objective is to bring better access to better care by leveraging its proprietary
technology to provide on demand savings and support within physicians and patients web based platforms, including Electronic Health
Records and Patient Portals. Initially defined as a marketing and advertising company through its consumer website, OptimizeRx.com,
the Company has matured as a technology solutions provider through its direct to physician solution, SampleMD. SampleMD allows
physicians to automatically display and distribute sample vouchers and/or co-pay coupons electronically within the ePrescription
platform to pharmacies on behalf of their patients. The SampleMD solution is integrated into the ePrescribing or Electronic Medical
Records applications, but can also sit on a prescriber&rsquo;s desktop. </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> OptimizeRx solutions provide health care institutions
with an alternative option to the traditional hassles and issues associated with storing and managing physical drug samples and
pre-printed coupons and it provides better access and affordability to patients to improve affordability, adherence and outcomes.
In turn, OptimizeRx provides pharmaceutical manufacturers with both direct to consumer and direct to physician channels for more
efficiently communicating and promoting their products and savings. </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> The consolidated financial statements for the three
and six month periods ended June 30, 2015 and 2014 have been prepared by us without audit pursuant to the rules and regulations
of the Securities and Exchange Commission. In the opinion of management, all adjustments necessary to present fairly our financial
position, results of operations, and cash flows as of June 30, 2015 and 2014, and for the periods then ended, have been made.
Those adjustments consist of normal and recurring adjustments. The consolidated balance sheet as of December 31, 2014, has been
derived from the audited consolidated balance sheet as of that date. </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> Certain information and note disclosures normally
included in our annual financial statements prepared in accordance with generally accepted accounting principles have been condensed
or omitted. These consolidated financial statements should be read in conjunction with a reading of the financial statements and
notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014, as filed with the Securities
and Exchange Commission. </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> The results of operations for the three and six
month periods ended June 30, 2015, are not necessarily indicative of the results to be expected for the full year. Certain reclassifications
have been made in the prior period&rsquo;s consolidated financial statements to conform to the current period&rsquo;s presentation. </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt"> &nbsp; </FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt"> NOTE 2 &ndash; STOCKHOLDERS EQUITY </FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt"> &nbsp; </FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt"> In January
2015, we issued 12,500 shares of common stock to outside Directors in connection with our Director Compensation plan, which calls
for issuance of 6,250 shares per quarter for each Director. Those shares were recorded as stock payable at December 31, 2014.
In addition, we recorded an additional 12,500 shares, valued at $16,375 as stock payable at March 31, 2015 for shares to be issued
in April 2015 and 12,500 shares, valued at $13,375 were issued in June 2015 for the second quarter payment. </FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt"> &nbsp; </FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt"> In February
2015, we entered into a capital markets advisory agreement covering a one year period, which called for 90,000 shares of common
stock to be issued as compensation. These shares were valued at $112,500 and are being amortized to expense over the period of
service. 45,000 of these shares were issued in March 2015, with the balance to be issued in August 2015. The agreement was terminated
in July 2015, effective in August, and the remaining 45,000 shares will not be issued. The total expense to be recognized will
be $56,250 and is being amortized over the period the agreement is in effect. </FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt"> &nbsp; </FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="letter-spacing: -0.1pt"> &nbsp; </FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="letter-spacing: -0.1pt"><B> OPTIMIZERx
CORPORATION </B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"><B> NOTES TO THE CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) </B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"><B> JUNE 30, 2015 </B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: center"><FONT STYLE="letter-spacing: -0.1pt"><B> &nbsp; </B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt"> NOTE 2 &ndash; STOCKHOLDERS EQUITY
(CONTINUED) </FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt"> &nbsp; </FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> In&nbsp;March 2014,&nbsp;we&nbsp;entered into a
securities purchase agreement, pursuant to which&nbsp;we&nbsp;sold 8,333,333 shares of&nbsp;our common stock for $1.20 per share,
or gross proceeds of $10,000,000. </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> Placement agents in the offering received commissions
equal to approximately 9.7% of gross proceeds, for an aggregate commission of approximately $970,000, including reimbursements
for their reasonable out of pocket expenses. Placement agents also received warrants to purchase up to 804,139 shares of&nbsp;our
common stock with an exercise price of $1.20 per share and a term of 5 years. The warrants were valued at $1,110,211, have been
recorded as equity issuance costs, and were registered on a registration statement that went effective May 28, 2014. In addition
to the warrants to placement agents, we also paid cash bonuses of $240,000 to three executive officers, agreed to issue 200,000
shares to three executive officers, and issued 150,000 shares to a consultant, in connection with the equity raise. The stock
was valued based on the fair market value on the grant date, which was $630,000 in total. These amounts have been recorded as
equity issuance costs, resulting in total equity issuance costs of $2.95 million. The 200,000 shares for the three executive officers
have not been issued, but are recorded as stock payable and can be requested by the executive officers at any time. </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> We&nbsp;used the net proceeds of the offering to
exercise the securities redemption option agreement, as amended, with Vicis Capital Master Fund that provided&nbsp;us&nbsp;with
an option to purchase all of the outstanding shares and derivative securities held by Vicis for total payment of $6,000,000. The
shares and derivative securities included the Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Common
Stock, and warrants to purchase shares of common stock held by Vicis in the Company. The balance of the net proceeds were used
for working capital purposes. </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> In January 2014, an executive officer exercised
500,000 stock warrants using the cashless exercise feature included in the warrants. In exchange for the 500,000 warrants, 410,348
shares of common stock were issued. </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> In June 2015, we agreed to grant 197,605 fully
vested shares of our common stock to two executive officers as bonuses. These shares have not been issued, but are recorded as
stock payable and can be requested by the officers at any time. </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> In February 2014, we agreed to grant 337,500 shares
of our common stock, half of which vested immediately and half of which vested in August 2014, to two executive officers as bonuses
based on their efforts to recapitalize the company to secure approximately $3 million in working capital while reducing fully
diluted shares by approximately 7 million shares. These shares have not been issued, but are recorded as stock payable and can
be requested by the officers at any time. </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="letter-spacing: -0.1pt"><B> OPTIMIZERx
CORPORATION </B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"><B> NOTES TO THE CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) </B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"><B> JUNE 30, 2015 </B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: center"><FONT STYLE="letter-spacing: -0.1pt"><B> &nbsp; </B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt"> NOTE 3 &ndash; SHARE BASED PAYMENTS
&ndash; OPTIONS </FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt"> &nbsp; </FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> We use the fair value method to account for stock
based compensation. We recorded $110,039 and $170,611 in compensation expense in the periods ended June 30, 2015 and 2014, respectively,
related to options issued under our stock-based incentive compensation plan. This includes expense related to options issued in
prior years for which the requisite service period for those options includes the current year, options granted in the current
year and options repriced in the current year. The fair value of these instruments was calculated using the Black-Scholes option
pricing model. Information related to the assumptions used in this model is set forth in our Annual Report on Form 10-K for the
fiscal year ended December 31, 2014. </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt"> &nbsp; </FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt"> NOTE 4 &ndash; COMMITMENTS AND
CONTINGENCIES </FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt"> &nbsp; </FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt"><I> Litigation </I></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt"> &nbsp; </FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> The company is currently involved in the following
legal proceedings. </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> In September 2014, we initiated litigation against
Shadron Stastney, the Company&rsquo;s previous CEO, in the U.S. District Court in the Eastern District of Michigan as a result
of a dispute related to his separation agreement. Mr. Stastney alleged damages related to the non-registration of shares that
he was granted as part of his separation agreement signed in September 2013. Under the terms of the contract we are not obligated
to register the shares and we deny any obligation to do so. We have requested declarative relief from the court and also requested
an injunction from the court preventing Mr. Stastney from continuing to pursue his claims. Mr. Stastney has filed a counterclaim
requesting damages of $450,000 related to the nonregistration of his shares. The parties are currently in the discovery process. </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> In March 2015, we initiated litigation against
LDM Group, LLC and PDR Network, LLC in the U.S. District Court in the Eastern District of Missouri related to the breach by LDM,
and PDR as successor, of the settlement agreement signed February 28, 2014 related to previous litigation with LDM. LDM has failed
to live up to its obligations under the settlement agreement including, but not limited to, not allowing us to distribute our
eCoupon programs in the LDM network, not allowing us to distribute the LDM patient education programs, and not providing other
information required under the settlement agreement. We are seeking enforcement of the settlement agreement and we are seeking
damages in an amount at least equal to the amounts paid to date to LDM under the settlement agreement, which approximates $1.0
million, as well as damages for lost income and business value as a result of LDM&rsquo;s breach of the agreement. </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> In March 2015, we also initiated litigation against
PDR Network, LLC in the U.S. District Court in the District of New Jersey as a result of PDR&rsquo;s breach of the Master Services
Agreement between the parties requiring PDR to exclusively use our eCoupon solution. We assert that PDR&rsquo;s acquisition of
LDM and the use of the LDM network to distribute coupons by PDR violates the agreement between the parties and we are seeking
damages in an amount at least equal the amounts paid to date by us to LDM under the settlement agreement, which approximates $1.0
million, as well as damages for lost income and business value as a result of PDR&rsquo;s actions. </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> In May 2015, we filed an amended complaint in the
Missouri case to consolidate the two cases and withdrew the case against PDR Networks in the U.S. District Court in the District
of New Jersey, without prejudice. </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="color: Black"> In July, 2015,
the U.S. District Court for the Eastern District of Missouri dismissed the case, citing lack of Federal jurisdiction in the matter.
We are in the process of refiling the consolidated case against PDR Network and LDM group in State court in Missouri. </FONT></P>



<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"> &nbsp;&nbsp; </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: center"><FONT STYLE="letter-spacing: -0.1pt"><B> OPTIMIZERx
CORPORATION </B></FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: center"><B> NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS (UNAUDITED) </B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: center"><B> JUNE 30, 2015 </B></P>

<P STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 0; text-align: center"> &nbsp;<I>&nbsp;</I> </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"><FONT STYLE="letter-spacing: -0.1pt"> NOTE 5 &ndash;
RESTATEMENT </FONT></P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"> We restated our financial statements to correct
the way we accounted for certain items related to stock based compensation, revenue share expense, and revenue recognition. The
full impact of the restatement was reflected in the December 31, 2014 financial statements at the end of the year. The table below
reflects the impact on the 2014 period reflected in this report. </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The restated Consolidated Statement of
Operations and Consolidated Statement of Cash Flows for the three and six months ended June&nbsp;30, 2014, as applicable, is as
follows: </P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0; text-align: justify; text-indent: 0.5in"> &nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1.5pt solid; padding: 0pt; text-indent: 0pt"> Three months
    ended June 30, 2014 </TD><TD STYLE="padding: 0pt; text-align: center; text-indent: 0pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding: 0pt; text-indent: 0pt"> &nbsp; </TD><TD STYLE="padding: 0pt; text-align: center; text-indent: 0pt"> &nbsp; </TD><TD STYLE="padding: 0pt; text-align: center; text-indent: 0pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding: 0pt; text-indent: 0pt"> Previously </TD><TD STYLE="padding: 0pt; text-align: center; text-indent: 0pt"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center; text-indent: 0pt"> Financial Statement </TD><TD STYLE="padding: 0pt; text-align: center; text-indent: 0pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding: 0pt; text-align: center; text-indent: 0pt"> Line Item </TD><TD STYLE="padding: 0pt; text-align: center; text-indent: 0pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; padding: 0pt; text-indent: 0pt"> Corrected </TD><TD STYLE="padding: 0pt; text-align: center; text-indent: 0pt"> &nbsp; </TD><TD STYLE="padding: 0pt; text-align: center; text-indent: 0pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; padding: 0pt; text-indent: 0pt"> Stated </TD><TD STYLE="padding: 0pt; text-align: center; text-indent: 0pt"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; text-align: left; padding: 0pt; text-indent: 0pt"> Income statement </TD><TD STYLE="width: 1%; padding: 0pt; text-indent: 0pt"> &nbsp; </TD>
    <TD STYLE="width: 28%; padding: 0pt; text-indent: 0pt"> Revenue </TD><TD STYLE="width: 1%; padding: 0pt; text-indent: 0pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; padding: 0pt; text-indent: 0pt"> &nbsp; </TD><TD STYLE="width: 9%; text-align: right; padding: 0pt; text-indent: 0pt"> 1,426,808 </TD><TD STYLE="width: 1%; text-align: left; padding: 0pt; text-indent: 0pt"> &nbsp; </TD><TD STYLE="width: 1%; padding: 0pt; text-indent: 0pt"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left; padding: 0pt; text-indent: 0pt"> &nbsp; </TD><TD STYLE="width: 9%; text-align: right; padding: 0pt; text-indent: 0pt"> 1,454,214 </TD><TD STYLE="width: 1%; text-align: left; padding: 0pt; text-indent: 0pt"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> Income statement </TD><TD STYLE="padding: 0pt; text-indent: 0pt"> &nbsp; </TD>
    <TD STYLE="padding: 0pt; text-indent: 0pt"> Cost of Sales </TD><TD STYLE="padding: 0pt; text-indent: 0pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> $ </TD><TD STYLE="text-align: right; padding: 0pt; text-indent: 0pt"> 730,140 </TD><TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> &nbsp; </TD><TD STYLE="padding: 0pt; text-indent: 0pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> $ </TD><TD STYLE="text-align: right; padding: 0pt; text-indent: 0pt"> 540,048 </TD><TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> Income statement </TD><TD STYLE="padding: 0pt; text-indent: 0pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> Operating expenses </TD><TD STYLE="padding: 0pt; text-indent: 0pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> &nbsp; </TD><TD STYLE="text-align: right; padding: 0pt; text-indent: 0pt"> 896,529 </TD><TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> &nbsp; </TD><TD STYLE="padding: 0pt; text-indent: 0pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> &nbsp; </TD><TD STYLE="text-align: right; padding: 0pt; text-indent: 0pt"> 967,070 </TD><TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding: 0pt; text-indent: 0pt"> Income statement </TD><TD STYLE="padding: 0pt; text-indent: 0pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> Loss from operations </TD><TD STYLE="padding: 0pt; text-indent: 0pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> $ </TD><TD STYLE="text-align: right; padding: 0pt; text-indent: 0pt"> (199,861 </TD><TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> ) </TD><TD STYLE="padding: 0pt; text-indent: 0pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> $ </TD><TD STYLE="text-align: right; padding: 0pt; text-indent: 0pt"> (52,904 </TD><TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> Income statement </TD><TD STYLE="padding: 0pt; text-indent: 0pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> Loss before income taxes </TD><TD STYLE="padding: 0pt; text-indent: 0pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> $ </TD><TD STYLE="text-align: right; padding: 0pt; text-indent: 0pt"> (199,638 </TD><TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> ) </TD><TD STYLE="padding: 0pt; text-indent: 0pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> $ </TD><TD STYLE="text-align: right; padding: 0pt; text-indent: 0pt"> (52,681 </TD><TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> Income statement </TD><TD STYLE="padding: 0pt; text-indent: 0pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> Net loss </TD><TD STYLE="padding: 0pt; text-indent: 0pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> $ </TD><TD STYLE="text-align: right; padding: 0pt; text-indent: 0pt"> (199,638 </TD><TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> ) </TD><TD STYLE="padding: 0pt; text-indent: 0pt"> &nbsp; </TD>
    <TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> $ </TD><TD STYLE="text-align: right; padding: 0pt; text-indent: 0pt"> (52,681 </TD><TD STYLE="text-align: left; padding: 0pt; text-indent: 0pt"> ) </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman,serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="letter-spacing: -0.1pt"><B><I> &nbsp; </I></B> &nbsp; </FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1.5pt solid"> Six months ended June 30, 2014 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center"> Previously </TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center"> Financial Statement </TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center"> Line Item </TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"> Corrected </TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"> Stated </TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; text-align: left; text-indent: 0pt; padding-left: 0pt"> Income statement </TD><TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 28%; text-indent: 0pt; padding-left: 0pt"> Revenue </TD><TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; text-align: right"> 2,716,236 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; text-align: right"> 2,771,560 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: 0pt; padding-left: 0pt"> Income statement </TD><TD> &nbsp; </TD>
    <TD STYLE="text-indent: 0pt; padding-left: 0pt"> Cost of Sales </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> 1,291,551 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> 1,038,858 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: 0pt; padding-left: 0pt"> Income statement </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left; text-indent: 0pt; padding-left: 0pt"> Operating expenses </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 2,386,747 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 2,439,028 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: 0pt; padding-left: 0pt"> Income statement </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left; text-indent: 0pt; padding-left: 0pt"> Loss from operations </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> (962,062 </TD><TD STYLE="text-align: left"> ) </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> (706,326 </TD><TD STYLE="text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: 0pt; padding-left: 0pt"> Income statement </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left; text-indent: 0pt; padding-left: 0pt"> Loss before income taxes </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> (961,733 </TD><TD STYLE="text-align: left"> ) </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> (705,996 </TD><TD STYLE="text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: 0pt; padding-left: 0pt"> Income statement </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left; text-indent: 0pt; padding-left: 0pt"> Net loss </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> (961,733 </TD><TD STYLE="text-align: left"> ) </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> (705,996 </TD><TD STYLE="text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: 0pt; padding-left: 0pt"> Statement of cash flows </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left; text-indent: 0pt; padding-left: 0pt"> Net loss </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> (961,733 </TD><TD STYLE="text-align: left"> ) </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> (705,996 </TD><TD STYLE="text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: 0pt; padding-left: 0pt"> Statement of cash flows </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left; text-indent: 0pt; padding-left: 0pt"> Stock and options issued for services </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> 627,344 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> 654,634 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: 0pt; padding-left: 0pt"> Statement of cash flows </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left; text-indent: 0pt; padding-left: 0pt"> Increase in accounts payable </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> 203,714 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> 173,889 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: 0pt; padding-left: 0pt"> Statement of cash flows </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left; text-indent: 0pt; padding-left: 0pt"> Decrease in revenue share payable </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> (311,776 </TD><TD STYLE="text-align: left"> ) </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> (686,760 </TD><TD STYLE="text-align: left"> ) </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: 0pt; padding-left: 0pt"> Statement of cash flows </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left; text-indent: 0pt; padding-left: 0pt"> Increase in deferred revenue </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> 19,651 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> $ </TD><TD STYLE="text-align: right"> 38,656 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0"> &nbsp;<B>&nbsp;</B> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="changes"></A><B>CHANGES IN AND DISAGREEMENTS
WITH ACCOUNTANTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 25, 2014, Silberstein Ungar, PLLC
notified us that its principals joined the accounting firm of KLJ &amp; Associates, LLP. As a result of the transaction, on July
25, 2014, Silberstein Ungar, PLLC resigned as our independent registered public accounting firm and we engaged KLJ &amp; Associates,
LLP as our independent registered public accounting firm.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="available"></A><B>AVAILABLE INFORMATION</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">We file annual, quarterly and current
reports, proxy statements and other documents with the SEC. These filings contain important information which does not appear
in this prospectus. You may read and copy, at prescribed rates, any documents we have filed with the SEC at its Public Reference
Room located at 100 F Street, N.E., Washington, DC 20549. You may obtain information on the operation of the Public Reference
Room by calling the SEC at 1-800-SEC-0330. We also file these documents with the SEC electronically. You can access the electronic
versions of these filings on the SEC&rsquo;s website found at http://www.sec.gov.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">We have filed with the Securities and
Exchange Commission (&ldquo;SEC&rdquo;) a registration statement for the securities on Form S-1 under the Securities Act. This
prospectus, which forms part of the registration statement, does not contain all the information contained in the registration
statement. Whenever a reference is made in this prospectus to any of our contracts or other documents, the reference may not be
complete and, for a copy of the contract or document, you should refer to the exhibits that are part of the registration statement.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">You may inspect and copy the registration
statement at the public reference facilities maintained by the SEC at 100 F Street, N.E., Washington, D.C. 20549 upon payment
of certain prescribed fees. You may obtain information on the operation of the SEC&rsquo;s public reference facilities by calling
the SEC at 1-800-SEC-0330. You may also access the registration statement electronically through the SEC&rsquo;s Electronic Data
Gathering, Analysis and Retrieval, or EDGAR, system at the SEC&rsquo;s website located at http://www.sec.gov.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Until _______________, all dealers
that effect transactions in these securities whether or not participating in this offering may be required to deliver a prospectus.
This is in addition to the dealers&rsquo; obligation to deliver a prospectus when acting as underwriters and with respect to their
unsold allotments or subscriptions.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 75; Options: NewSection; Value: 42 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PART II </B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS
</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%; font-size: 10pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Item 13.</B></FONT></TD>
    <TD STYLE="font-size: 10pt; line-height: 115%; width: 92%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Other
    Expenses of Issuance and Distribution </B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -12pt; padding-left: 12pt; background-color: White">SEC
    Registration Fees</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; background-color: White">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; background-color: White">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right; background-color: White">127.50</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -12pt; padding-left: 12pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Accounting
    Fees and Expenses<SUP>*</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; background-color: White">5,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -12pt; padding-left: 12pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Legal
    Fees and Expenses<SUP>*</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; background-color: White">5,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-indent: -12pt; padding-left: 12pt; background-color: White"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Miscellaneous<SUP>*</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; background-color: White">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; background-color: White">5,000</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; background-color: White">&nbsp;</TD><TD STYLE="font-size: 1pt; background-color: White">&nbsp;</TD>
    <TD STYLE="font-size: 1pt; text-align: left; background-color: White">&nbsp;</TD><TD STYLE="font-size: 1pt; text-align: right; background-color: White">&nbsp;</TD><TD STYLE="font-size: 1pt; text-align: left; background-color: White">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -12pt; padding-left: 12pt; background-color: White">Total</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; background-color: White">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; background-color: White">15,127.50</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; background-color: White">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">* Estimates</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">We will bear our fees and expenses
incurred in connection with the registration of shares of common stock in connection with this offering. The Selling Shareholders
will bear all selling and other expenses that they incur in connection with their sale of shares of common stock pursuant to the
prospectus which is part of this registration statement.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%; font-size: 10pt; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Item&nbsp;14.</B></FONT></TD>
    <TD STYLE="font-size: 10pt; line-height: 115%; width: 92%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Indemnification
    of Directors and Officers. </B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">Our officers and directors are
indemnified as provided by the Nevada Revised Statutes and our bylaws.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">Under the governing Nevada statutes,
director immunity from liability to a company or its shareholders for monetary liabilities applies automatically unless it is
specifically limited by a company's articles of incorporation.&nbsp; Our articles of incorporation do not contain any limiting
language regarding director immunity from liability.&nbsp; Excepted from this immunity are:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 48px; line-height: 115%">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 48px; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.</FONT></TD>
    <TD STYLE="text-align: justify; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a willful failure
    to deal fairly with the company or its shareholders in connection with a matter in which the director has a material conflict
    of interest;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 48px; line-height: 115%">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 48px; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2.</FONT></TD>
    <TD STYLE="text-align: justify; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a violation of criminal
    law (unless the director had reasonable cause to believe that his or her conduct was lawful or no reasonable cause to believe
    that his or her conduct was unlawful);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 48px; line-height: 115%">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 48px; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3.</FONT></TD>
    <TD STYLE="text-align: justify; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a transaction from
    which the director derived an improper personal profit; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 48px; line-height: 115%">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 48px; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.</FONT></TD>
    <TD STYLE="text-align: justify; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">willful misconduct.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">Our bylaws provide that we will
indemnify our directors and officers to the fullest extent not prohibited by Nevada law; provided, however, that we may modify
the extent of such indemnification by individual contracts with our directors and officers; and, provided, further, that we shall
not be required to indemnify any director or officer in connection with any proceeding (or part thereof) initiated by such person
unless:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 48px; line-height: 115%">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 48px; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.</FONT></TD>
    <TD STYLE="text-align: justify; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">such indemnification
    is expressly required to be made by law;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 48px; line-height: 115%">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 48px; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2.</FONT></TD>
    <TD STYLE="text-align: justify; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the proceeding was
    authorized by our Board of Directors;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 48px; line-height: 115%">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 48px; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3.</FONT></TD>
    <TD STYLE="text-align: justify; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">such indemnification
    is provided by us, in our sole discretion, pursuant to the powers&nbsp; vested us under Nevada law; or;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 48px; line-height: 115%">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 48px; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.</FONT></TD>
    <TD STYLE="text-align: justify; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">such indemnification
    is required to be made pursuant to the bylaws.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Our bylaws provide that we will
advance to any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action,
suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that he is or was a director
or officer, of the company, or is or was serving at the request of the company as a director or executive officer of another company,
partnership, joint venture, trust or other enterprise, prior to the final disposition of the proceeding, promptly following request
therefore, all expenses incurred by any director or officer in connection with such proceeding upon receipt of an undertaking
by or on behalf of such person to repay said amounts if it should be determined ultimately that such person is not entitled to
be indemnified under our bylaws or otherwise.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Our bylaws provide that no advance shall be made
by us to an officer of the company, except by reason of the fact that such officer is or was a director of the company in which
event this paragraph shall not apply, in any action, suit or proceeding, whether civil, criminal, administrative or investigative,
if a determination is reasonably and promptly made: (a) by the board of directors by a majority vote of a quorum consisting of
directors who were not parties to the proceeding, or (b) if such quorum is not obtainable, or, even if obtainable, a quorum of
disinterested directors so directs, by independent legal counsel in a written opinion, that the facts known to the decision-making
party at the time such determination is made demonstrate clearly and convincingly that such person acted in bad faith or in a
manner that such person did not believe to be in or not opposed to the best interests of the company.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 76; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Item&nbsp;15.</B></FONT></TD>
    <TD STYLE="line-height: 115%; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Recent Sales
    of Unregistered Securities. </B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In January 2015, we issued 12,500 shares
of restricted common stock to our outside Directors as part of our director compensation package for services rendered in the
fourth quarter of 2014.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In March 2015, we signed a capital
markets advisory agreement whereby we agreed to issue 90,000 shares of common stock in two increments as payment for the advisory
services. The first 45,000 shares were issued in March 2015.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> On June 24, 2015, our Board of Directors
resolved to award our CEO, David Harrell, 79,042 restricted shares of our common stock in recognition of his contributions to
our company. We also resolved to award our Vice President of Sales, Terry Hamilton, 118,563 restricted shares of our common stock
in recognition of his contributions to our company. The awards are subject to the terms of our 2013 Incentive Plan and to their
respective Restricted Stock Award Agreements. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> On June 24, 2015, our Board of Directors
resolved to grant our CFO, Doug Baker, an option to acquire 100,000 shares of our common stock with an exercise price of $1.05
per share in recognition of his contributions to our company. The option will vest over a one year period and will expire in five
years. The grant is subject to the terms of our 2013 Incentive Plan and to the Stock Option Agreement in favor of Mr. Baker. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> On June 24, 2015, our Board of Directors
approved an amendment to Mr. Baker&rsquo;s May 19, 2014 option to acquire 100,000 shares of our common stock with an exercise
price of $1.72 per share (the &ldquo;Old Option&rdquo;). The amendment modifies the Old Option&rsquo;s exercise price to $1.05
per share. The amendment did not change the option&rsquo;s vesting schedule or any other terms. </P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="margin: 0; text-align: justify"> On September 24, 2015, we issued 6,011,106 shares of our common stock to WPP Luxembourg
Gamma Three Sarl, an accredited investor, at $0.7875 per share for total proceeds of $4,733,746, </P>



<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">These securities were issued pursuant
to Section 4(2) of the Securities Act and/or Rule 506 promulgated thereunder. The holders represented their intention to acquire
the securities for investment only and not with a view towards distribution. The investors were given adequate information about
us to make an informed investment decision. We did not engage in any general solicitation or advertising. We directed our transfer
agent to issue the stock certificates with the appropriate restrictive legend affixed to the restricted stock.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Item&nbsp;16.</B></FONT></TD>
    <TD STYLE="line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Exhibits </B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="vertical-align: top; width: 8%; border-bottom: black 1.5pt solid; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif"><B>Exhibit
    Number</B></FONT></TD>
    <TD STYLE="width: 2%; line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 90%; border-bottom: black 1.5pt solid; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif"><B>Description</B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">3.1</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Articles
    of Incorporation of OptimizeRx Corporation (the &ldquo;Company&rdquo;)<SUP>1</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">3.2</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Amended
    and Restated Bylaws of the Company<SUP>1</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">3.3</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Certificate
    of Designation, filed on September 5, 2008, with the Secretary of State of the State of Nevada by the Company<SUP>1</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">5.1</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Opinion
    of The Doney Law Firm, with consent to use</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">10.1</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Employment
    Agreement, dated August 1, 2008<SUP>2</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">10.2</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Employment
    Agreement, dated June 1, 2008<SUP>2</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">10.3</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Employment
    Agreement Addendum, dated March 18, 2010<SUP>2</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">10.4</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Employment
    Agreement Addendum, dated March 18, 2010<SUP>2</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">10.5</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Amendment
    to Employment Agreement, dated July 28, 2010<SUP>3</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">10.6</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Amendment
    to Employment Agreement, dated July 28, 2010<SUP>3</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">10.7</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Employment
    Agreement, dated January 14, 2013<SUP>4</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">10.8</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Securities
    Redemption Option Agreement, dated January 10, 2013<SUP>5</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">10.9</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Amendment
    to Employment Agreement, dated August 14, 2013<SUP>6</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">10.10</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Amendment
    to Employment Agreement, dated August 14, 2013<SUP>6</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">10.11</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Amendment
    to Employment Agreement, dated August 14, 2013<SUP>6</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">10.12</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Separation
    Agreement, dated September 20, 2013<SUP>7</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">10.13</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Amendment
    No. 1 to Securities Redemption Option Agreement<SUP>8</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">10.14</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Securities
    Purchase Agreement<SUP>9</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">10.15</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Registration
    Rights Agreement<SUP>9</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">10.16</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Warrant
    Agreement<SUP>10</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">10.17</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Warrant
    Agreement<SUP>10</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">10.18</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Employment
    Agreement, dated May 12, 2014<SUP>11</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">10.19</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Advisory
    Agreement, dated February 23, 2015</FONT><SUP>12</SUP></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"> 10.20 </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"> Stock Purchase Agreement,
    dated September 24, 2015<SUP>13</SUP> </TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><P STYLE="margin: 0"> 10.21 </P>


</TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"> Investor Rights Agreement,
    dated September 24, 2015<SUP>13</SUP> </TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><P STYLE="margin: 0"> 10.22 </P>


</TD>
    <TD STYLE="line-height: 107%"></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"> Indemnity Agreement, dated
    September 24, 2015<SUP>13</SUP> </TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">21.1</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">List
    of Subsidiaries<SUP>1</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">23.1</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Consent
    of KLJ &amp; Associates, LLP, an Independent Registered Public Accounting Firm</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 3.2pt; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">23.2</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0.8pt; text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Consent
    of Silberstein Ungar, PLLC, an Independent Registered Public Accounting Firm</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 77; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; width: 5%; vertical-align: top"><SUP>1</SUP></TD>
    <TD STYLE="text-align: justify; width: 95%">Incorporated by reference to the Form S-1, filed by the Company with the Securities
    and Exchange Commission on November 12, 2008.</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; vertical-align: top"><SUP>2</SUP></TD>
    <TD STYLE="text-align: justify">Incorporated by reference to the Form 10-K, filed by the Company with the Securities and Exchange
    Commission on March 31, 2010.</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; vertical-align: top"><SUP>3</SUP></TD>
    <TD STYLE="text-align: justify">Incorporated by reference to the Form 8-K, filed by the Company with the Securities and Exchange
    Commission on July 30, 2010.</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; vertical-align: top"><SUP>4</SUP></TD>
    <TD STYLE="text-align: justify">Incorporated by reference to the Form 8-K, filed by the Company with the Securities and Exchange
    Commission on January 18, 2013.</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; vertical-align: top"><SUP>5</SUP></TD>
    <TD STYLE="text-align: justify">Incorporated by reference to the Form 8-K, filed by the Company with the Securities and Exchange
    Commission on January 11, 2013.</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; vertical-align: top"><SUP>6</SUP></TD>
    <TD STYLE="text-align: justify">Incorporated by reference to the Form 8-K, filed by the Company with the Securities and Exchange
    Commission on August 15, 2013.</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; vertical-align: top"><SUP>7</SUP></TD>
    <TD STYLE="text-align: justify">Incorporated by reference to the Form 8-K, filed by the Company with the Securities and Exchange
    Commission on September 20, 2013.</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; vertical-align: top"><SUP>8</SUP></TD>
    <TD STYLE="text-align: justify">Incorporated by reference to the Form 8-K, filed by the Company with the Securities and Exchange
    Commission on January 2, 2014.</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; vertical-align: top"><SUP>9</SUP></TD>
    <TD STYLE="text-align: justify">Incorporated by reference to the Form 8-K, filed by the Company with the Securities and Exchange
    Commission on March 18, 2014.</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; vertical-align: top"><SUP>10</SUP></TD>
    <TD STYLE="text-align: justify">Incorporated by reference to the Form S-1/A, filed by the Company with the Securities and
    Exchange Commission on May 12, 2014.</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD STYLE="text-align: left; vertical-align: top"><SUP>11</SUP></TD>
    <TD>Incorporated by reference to the Form 8-K, filed by the Company with the Securities and Exchange Commission on May 14,
    2014.</TD></TR>

<TR>
    <TD STYLE="vertical-align: top; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><SUP> 12 </SUP></FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Incorporated
    by reference to the Form S-1/A, filed by the Company with the Securities and Exchange Commission on June 1, 2015. </FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><SUP> 13 </SUP></FONT></TD>
    <TD STYLE="line-height: 107%; font-size: 10pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Incorporated
    by reference to the Form 8-K, filed by the Company with the Securities and Exchange Commission on September 30, 2015. </FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%; line-height: 115%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<B>Item&nbsp;17.</B></FONT></TD>
    <TD STYLE="line-height: 115%; width: 92%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Undertakings. </B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The registrant hereby undertakes:</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 24.5pt"></TD><TD STYLE="width: 18pt">(a)</TD><TD STYLE="text-align: justify">To file, during any period
                                         in which offers or sales are being made, a post-effective amendment to this registration
                                         statement:</TD></TR></TABLE>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 42.5pt; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt">(i)
to include any prospectus required by Section&nbsp;10(a)(3) of the Securities Act;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt">(ii)&nbsp;to
reflect in the prospectus any facts or events arising after the effective date of this registration statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set
forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if
the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high
end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule
424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering
price set forth in the &ldquo;Calculation of Registration Fee&rdquo; table in the effective registration statement; and</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt">(iii)&nbsp;to
include any material information with respect to the plan of distribution not previously disclosed in the registration statement
or any material change to such information in the registration statement.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">(b) That, for
the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a
new registration statement relating to the securities offered therein and the offering of such securities at that time shall be
deemed to be the initial bona fide offering thereof.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">(c)&nbsp;To remove
from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination
of the offering.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"></P>

<!-- Field: Page; Sequence: 78; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">(d)&nbsp;That,
for the purpose of determining liability under the Act to any purchaser, each prospectus filed pursuant to Rule 424(b) as part
of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses
filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is
first used after effectiveness. Provided, however , that no statement made in a registration statement or prospectus that is part
of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement
or prospectus that is part of the registration statement will, as to purchaser with a time of contract of sale prior to such first
use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration
statement or made in any such document immediately prior to such date of first use.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">(e) Insofar as
indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling
persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion
of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of
1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other that the
payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful
defense of any action, suit of proceeding) is asserted by such director, officer or controlling person in connection with the
securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy
as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 79; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><A HREF="#toc" TITLE="Table of Contents" STYLE="font-style: italic">Table of Contents</A></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURES </B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> Pursuant to the requirements of
the Securities Act of 1933, as amended, the Registrant has duly caused this Registration Statement to be signed on its behalf
by the undersigned, thereunto duly authorized in the City of Rochester, State of Michigan on September 30, 2015. </P>



<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">OptimizeRx Corporation</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; line-height: 107%">&nbsp;</TD>
    <TD STYLE="width: 35%; text-align: justify; line-height: 107%">&nbsp;</TD>
    <TD STYLE="width: 60%; line-height: 107%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">/s/
    David Harrell</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD><P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">David Harrell</P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Chief Executive Officer, Principal Executive Officer
        and Director</P></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif"> September 30, 2015 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">OptimizeRx Corporation</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; line-height: 107%">&nbsp;</TD>
    <TD STYLE="width: 35%; text-align: justify; line-height: 107%">&nbsp;</TD>
    <TD STYLE="width: 60%; line-height: 107%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">/s/
    Doug Baker</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD><P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Doug Baker</P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Chief Financial Officer, Principal Financial Officer
        and Principal Accounting Officer</P></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif"> September 30, 2015 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>POWER OF ATTORNEY </B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the requirements of the
Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in
the capacities and on the dates indicated.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: black 1.5pt solid; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">/s/
    David Harrell</FONT></TD>
    <TD STYLE="width: 60%; line-height: 107%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">David Harrell</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Chief Executive Officer, Principal
    Executive Officer and Director</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif"> Date: </FONT></TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif"> September 30, 2015 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif"> By: </FONT></TD>
    <TD STYLE="width: 35%; border-bottom: black 1.5pt solid; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif"> /s/
    Lynn O&rsquo;Connor Vos </FONT></TD>
    <TD STYLE="width: 60%; line-height: 107%"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%"> &nbsp; </TD>
    <TD STYLE="line-height: 107%"><P STYLE="margin: 0"> Lynn O&rsquo;Connor Vos </P>


</TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif"> Title: </FONT></TD>
    <TD STYLE="line-height: 107%"> Director </TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif"> Date: </FONT></TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif"> September 30, 2015 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: black 1.5pt solid; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">/s/
    Terence J. Hamilton</FONT></TD>
    <TD STYLE="width: 60%; line-height: 107%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Terence J. Hamilton</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Vice President, Sales and Director</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif"> Date: </FONT></TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif"> September 30, 2015 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; line-height: 107%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">/s/
    Gus D. Halas</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Gus D. Halas&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Director</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif"> Date: </FONT></TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif"> September 30, 2015 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: black 1.5pt solid; line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">/s/
    Jack Pinney</FONT></TD>
    <TD STYLE="width: 60%; line-height: 107%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%">&nbsp;</TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Jack Pinney</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Director</FONT></TD>
    <TD STYLE="line-height: 107%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif"> Date: </FONT></TD>
    <TD STYLE="line-height: 107%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif"> September 30, 2015 </FONT></TD>
    <TD STYLE="line-height: 107%"> &nbsp; </TD></TR>
</TABLE>
<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>



<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">II-5</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-right: 0; margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>posam2015a15i_optimizerx.htm
<DESCRIPTION>OPINION OF THE DONEY LAW FIRM, WITH CONSENT TO USE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="img_002.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">September
29, 2015</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">OptimizeRx
Corp.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">400 Water
Street, Suite 200</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Rochester,
MI 48307</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Re:
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;OptimizeRx Corp. Post-Effective Registration Statement on Form S-1</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Ladies and
Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">I
have acted as counsel for OptimizeRx Corp., a Nevada corporation (the &ldquo;Company&rdquo;), in connection with the post-effective
amendment to the registration statement on Form S-1 (the &ldquo;Registration Statement&rdquo;) filed with the Securities and Exchange
Commission (the &ldquo;Commission&rdquo;) on September 29, 2015, and any amendments thereto, pursuant to the Securities Act of
1933, as amended (the &ldquo;Act&rdquo;). The Registration Statement relates to the resale registration of: (a) 804,139 shares
of common stock reserved for issuance and issuable upon the exercise of the warrants; and (b) 45,000 shares of the Company&rsquo;s
common stock, all of which are to be offered and sold by certain stockholders of the Company (the &ldquo;Selling Stockholders&rdquo;)
as set forth in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
rendering the opinion set forth below, I have reviewed: (a) the Registration Statement and the exhibits attached thereto; (b)
the Company's Articles of Incorporation; (c) the Company's Bylaws; (d) certain records of the Company's corporate proceedings
as reflected in its minute books; and (e) such statutes, records and other documents as we have deemed relevant. In my examination,
I have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, and conformity
with the originals of all documents submitted to us as copies thereof. In addition, I have made such other examinations of law
and fact, as I have deemed relevant in order to form a basis for the opinion hereinafter expressed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Based
upon the foregoing, I am of the opinion that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
                                         shares of common stock to be sold by the Selling Stockholders are legally and validly
                                         issued, fully paid and non-assessable.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2.</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
                                         shares of common stock underlying the warrants to be sold by the Selling Stockholders
                                         will be validly issued, fully paid and non-assessable and will be a binding obligation
                                         of the Company under the law of the State of Nevada when issued by the Company if the
                                         exercise price is received by the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">This
opinion is based on Nevada general corporate law, including the statutory provisions, all applicable provisions of the Nevada
constitution and reported judicial decisions interpreting those laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Very truly
yours,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>/s/ Scott
Doney</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Scott Doney,
Esq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>CONSENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">I
HEREBY CONSENT to the use of my opinion in connection with the Post-Effective Amendment to the Registration Statement on Form
S-1 Registration Statement and any amendments thereto filed with the Securities and Exchange Commission as counsel for the registrant,
OptimizeRx Corp.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Very truly
yours,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>/s/ Scott
Doney</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Scott Doney,
Esq</FONT></P>










<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">2</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>posam2015a123i_optimizerx.htm
<DESCRIPTION>CONSENT OF KLJ & ASSOCIATES, LLP, AN INDEPENDENT REGISTERED
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">&nbsp;<IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CONSENT OF INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">To the Board of Directors</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">OptimizeRx Corp.</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">As independent registered public accountants, we hereby
consent to the use of our audit report dated March 30, 2015, with respect to the financial statements of OptimizeRx Corp. in its
registration statement Form S-1/A. We also consent to the reference of our firm under the caption &ldquo;interest of named experts
and counsel&rdquo; in the registration statement.</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">/s/ KLJ &amp; Associates, LLP</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">Edina, Minnesota</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">September 30, 2015</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: green"><FONT STYLE="color: Black">5201 Eden Ave</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: green"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: Black">Suite
300</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: green"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: Black">Edina,
MN 55436</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: green"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: Black">630.277.2330</FONT></P>



<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>posam2015a123ii_optimizerx.htm
<DESCRIPTION>CONSENT OF SILBERSTEIN UNGAR, PLLC, AN INDEPENDENT REGISTERED
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #A2224B; text-align: right"><FONT STYLE="color: #000000"><B>Exhibit
23.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #A2224B">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #A2224B"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #000000">Silberstein
Ungar, PLLC CPAs and Business Advisors</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%"><FONT STYLE="color: #000000">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #A2224B"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; color: #A2224B"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #000000">Phone
(248) 331-5465</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #000000">Fax
(248) 281-0940</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #000000">20750
Civic Center Drive, Suite 418</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #000000">Southfield,
MI 48076</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; color: #A2224B"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #000000"></FONT><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif; color: #000000">September
29, 2015</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #000000"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #000000"><B>CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #000000">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #000000">Board
of Directors</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #000000">OptimizeRx
Corporation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #000000">Rochester,
MI</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #000000">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #000000">To
Whom It May Concern:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #000000">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #000000">Silberstein
Ungar, PLLC hereby consents to the use in the Form S-1/A (Post Effective Amendment No. 1 to Form S-1/A), Registration Statement
under the Securities Act of 1933, filed by OptimizeRx Corporation of our report dated March 20, 2014, relating to the consolidated
financial statements of OptimizeRx Corporation, a Nevada Corporation, as of and for the year ending December 31, 2013, and the
reference to us under the caption &ldquo;Interests of Named Experts&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #000000">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #000000">Sincerely,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #000000">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #000000"><U>/s/
Silberstein Ungar, PLLC</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #000000">Silberstein
Ungar, PLLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #000000">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #000000">&nbsp;</FONT></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>img_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_001.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !B 2\# 2(  A$! Q$!_\0
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MOVO_ /@I?^TWX+^//Q]M/@GK'A72?@7\-?V>?VBK?P7?:CX7TK7=2\4?M ?
M:#PY>>,?$J7UV)C+X4\+W?B&S\+QZ?&S6>J:C]M>57>U*KVKPTXCEFD,J4LM
M]K/ ?7EB/K<_JB7U]9:\(ZOU;G^OK$M/ZLJ3?L&L1S^R]XY)^(?#\,MEFDEC
ME2AC%@W0>&C]:;>"^OK$JE[9Q>#>'NE7]HE[9>PM[30_HVR/4?F*,CU'YBOQ
MJ_:C^,O[0GPZT;X=ZWX#_:>\5ZC\7OV@= \+K\!_V4_ OP=^$7B'Q!XH\57/
MA/2KO6[Z;7_$6B7=_H'PYT?49Y]>\;>./$,Z:3X8TAY;>&>6[-A8S^%^-?VD
M_P!L/X0_'7X._LW?M ?M6R^$_$4G[)U_\7?B5XZ^"O[+47Q6'B'XJ3?$JRT5
M=%T[PUHO@OQ=>Z'X2T/P_>OI\.LRZ;I\&KWUDEY.;6>^2SCX\)P/C\=1I5J&
M8Y8Y5J./Q$,/*.9K%RH97&*Q]>CA_P"S_:8JAAZ\XX/V^&<J-7%\]'#U*_L,
M3/#]6*XRP>#JU:=;+LQ4:53!47B%++7AE5S&4G@J-2O]><,-6KT8RQ:H8CEK
M4L+R5:].C[6@JW]!.1ZC\Q1D'H0?QK^?SQQ^V'\6/"6N?L[Z)9_MG^/YO OQ
M=^(7Q<T/QC\3_$_[&-UH7C/PXOP_^&,WBC1O#OAWX8S?"^SUO5]/U/5Y+5]0
M\3P>&=3MK>+S8#?VR13!/L?_ ()^_M'?$WX\^*OCI;W'Q%A_:%^ 'A&7P=%\
M*OVCQ\,9?A'/XG\6W8UVW^)7PZD\.O:Z5%KO_"O[O3])6X\16>A:/'#>ZK=Z
M)<QW=U8O.F68<%9IE^6ULUJUL++"T:?M7^[S##RE'Z]_9RA&>+P=&@L6\0IR
MA@)UUC:E"G5Q%.E.G3GR:8#C'+<PS&EEE*CB88FK+D2=3 5U&7U+Z_SN&%Q=
M6N\,J#C&6-C1>$A7J4Z$ZL:DX\WZ>T445\>?6!117">//'NB^ -(DU7593)-
M(6BT[38F'VK4+G;D10C)V1K]Z>=@(X4Y.YRJ-E6K4L/2J5ZU2-*E2BYSG-VC
M&*ZMZO71)).4I-1BG*23RKUZ.&HU,1B*D*5&E%SJ5)NT8Q7YMNRC%)RE)QC%
M.4DGU&JZOIFB6,^I:O?6VG6-LI>:ZNIDAB0#MN<C<[8PJ(&D<_*JL<9^6_&'
M[3EK;O)9>"=+74&&Y/[7U?S(;3(SA[:P1TN95Z%7N'MPPQ^[.:^<?'7C[Q%X
M^U!KW6;HBVBD)L-)@<K8:?&QPJ10L6\V7: 'N9]TCDGYE4!:X/EF/)PV,_[N
M1R<8!7()/7/%?F&<\:8NK4GA\K_V6@FU]8G&,L34Z7@I*4,/%K56C4JZ^].#
MNE^<YEQ?B<3*5++$\+ATY)8B<4\352;7-%24HT(NUTK3JV:YI0?NKTC6?BU\
M1M?=FOO%.H6T$F<VFFD:9;XQ]Q4LUBD=0./WDDA(Y;'4\2\EU>.9+JYN+AV)
M/F3S23.QS@_/([.2??(ZXZ5##'O8%N0H( YR<\ [3W.1D],8X)K;M;4MA0N.
MI]NN&]B1U_N]#UQ7RCJXG%2Y\3B<1B)M[UJU6J^E[<]244O\,8KR[>$I8G%2
MYL17K5I2=[U:M6H_NE.26_2*ZVLDV0VHN;=HVMKBX@<'(>WFDBD##[Q!B96[
M=<X[CM7HNB_$GXA:$T?V/Q-J,T48 6UU)UU*V(&1L*7:R.JD<9CDC89.&'6L
M.WTTMCCJ1QV[=^<YQWXSWSP-==(;'*$>F%X_+G\L]:[\,L71:GAZU>C+>]&K
M5I]M^2:B_G&2?9GJ8:EB*/O4*U:C)6LZ4YPMUU491B_G&77<][\*?M%0R216
MGC+2C8DD*=6TH236O. 'N+)R\\* Y+O#)<8_AC &1]):;JVG:S9PZAI5Y;W]
ME.,Q7-K*DT3@@9&Y"2KJ2 48"1&X9%YK\Z)]+90<ICGLI'IUQ]X\G_/%:'A;
MQ;K_ ($U 7VBSEK:1P;[3)F8Z??QCAEEBSB*?;\L=Q$%E'/S%<H?J\NXIQF%
ME"EF<7B:#?+]8C%+$TUMS245&->*^TN6%7?EE)V3^BP>>XG#M0QR>(I:)UHQ
M2Q%/:\I**4:Z5[R5H5++1R:2?Z-#H/\ /\N/RHKB/ _CG1_'6DKJ6ER&.:/;
M%J&GRL#=:?<D F*11]^-QEH+A1LF7E<2*Z#MQQ_G_"OT"A7HXFE3K4*D:M*I
M%3A.#O&47U[IK:46E*,DXR49)I?74JM.M3A5I3C4IU(J4)Q=TT^OEV::3333
M2::11116IH%%%% !1110 4444 %%%% !1110 4UL8.3C&#U]""#CZ\']?2LK
M6]<TCPWI.I:]KVI6.CZ)H]G/J&J:IJ5Q':6.GV5LF^>XN;B9A'%%$@8LS-R?
ME52S '\,OVE_^"L>JSWVH^%?V:M/M+;3+9Y;:;XH>)+$7,]Z8\QS3^%] N3Y
M$%IPQ@U'6$DDG0)/';6^<5\IQ5QKP_P;A(8G.\9[.=92^JX&A'ZQC\8X?%[#
M#1E%^SBVHSQ%:=##4W)1G6<VJ;^0XOXZX;X(P<,5GV-]E4KJ?U/ 8:*Q&8XU
MPTE]7PL9Q:I0;C&IB:\Z&%I.2C.M*;5)_;Y_8JU_X:^(_B%K_P"S5^TS\0?V
M;_"'Q-\4ZGX\\:?#BQ\+_#CQ]X L/&/B"9[CQ/XK\"V/Q%\/:Q)X"O?$5[(^
MIZQIVCW2>'[O5I9-1.E)<2NS^<>%OV'OV6/ 7BGX&^*XOC-=:AXR^#WQ:^)G
MQQ\5>)/&/CGPAKWB7XW?%#XK>%%\(>)_$OQ/O]2'FRS06"0KHMEHD6EV&BV]
MI9Z=86T%C;) ?Q]\/>!?VU_VN[MM9LV^*GQ"L)WPWB+7]>O-"\&QH6VA;2XN
MYK/3Y+=22 FD6MY$%4A>F*]OL_\ @DM^U%=P"XO=4^&.GW,B@FUN/%.M7TJ.
M>2KSP:8(]W\)*ESD<YS7RE'Z0'B3F].=;AK@+/L9@:U/V4\PJO#X2MF-!82M
M@J?UK%X;*L//,.7"UZU&DZ^.Q_)SJI&M.O"&)A^(T>/<TSMK%\,^#>=9IET:
MOM\)B,?C\PCA82^M4L9[7+\/%0R_"JIB:%*K467RG3J.'LW)T)3H3_H^T/5?
M#FH6Y3PY?Z'>6RGS"-#O-.N8 3MRY33I'C&=J@MU(P,G@5\T> OV1?!OP_\
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M"JLZZI*:Q"J1]GB.;VE.IR5Z4U.A4C3494%^87A[_@G5XN\#?&+Q_P#&_P
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M[\>^.]1D:?4/%?B?7_$=Q*S99FU._N+J)<\X6.)HXT'\,:J-HQS_ %U_LO\
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MMZO\.;CP!I/AKP)=_$'Q%\1=>O\ 0]&TFV\06'AR*%M/T.[\07-W=:C?VUW
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M_P#]#3\(_P %UC'X9M:OV7_!'?XZ2RJMSXY^$-BC8W2+9:Y<NF#V5+=2>,'
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MG:)ING:-HUA9:1H^CV5KIFDZ1I5K%I^FZ3IME$(;33].LK8)!:V=M$HCAA1
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MY;R;ZI:I;=.GWM?-$LLF[.2=HP<= >".I[>I]\=351V!#'D!5) )R.5ZGO\
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M0B/RCFOFO2/B5XR^"VD?&3PU8V6CQ?&#Q3^T9X.T/Q+JWP^TB+7_  3I47Q
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5%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !@ 9$# 2(  A$! Q$!_\0
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M-_PBVNXM+I.HM9"?W;_16P0?3(KI/A-JMQ'#J'AB_)%UILK!0?[N<$?@>?\
M@5):.QC%\D^7H_S/2J\@^&/_ "5#QG_UT;_T8:]?KR#X8_\ )4/&?_71O_1A
MJC<]?KY1UW_D8-2_Z^I?_0C7U=7RCKO_ ",&I?\ 7U+_ .A&HF<F+V1HV_A3
M5]0\+?VU:*;BTAD='B4DM'@ EL>G/;TJ#PQXCN?"^LIJ%M''(0-KI(N<J>H!
MZ@^XKV+X.<^"I ?^?M__ $%:XSXI^"ET:\&LZ?'ML;AL2QJ.(I/\#_.IMI=&
M3I-052)Z_P"'O$-CXETF._L7RIX>,_>C;N#6M7S7X!\52>%_$$<CN?L-P1'<
MIVQV;ZCK^=?2:LKHKJ0RL,@CN*N+NCJHU.>/F<W\0/\ D0]8_P"N']17S..M
M?3'Q _Y$/6/^N']17S..M3/<YL5\2/K+2_\ D$V?_7!/_015NJFE_P#()L_^
MN"?^@BK=:'<M@HHK*\0Z_9^&](EU&\)*K@(B_>D8] * ;25V:M> _&+_ )'@
M?]>D?\VKW>QNEOK"WNT1T6>-9 KCD C/->$?&+_D>!_UZ1_S:HGL88G^&7O@
MI_R,5_\ ]>O_ +,*]PKP_P""G_(Q7_\ UZ_^S"O<*<-AX;^&%%%%4;A1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X7K^HR7'CSQ+
MJZD%M*M&AMN>DK8A3'N&9C7I_@RV^Q:!#8A]ZVA\E3CT _KFO%=*N3=:5JEY
M*,O=ZS9!R?0N[G]0*]J\'R>=IERW_3RW\A2AM<YZ6JYN]Q_AJ)F2XO)>%\QT
MCSZ9Y/\ GTKF-0U<7^K7%X&_=)^[A^@[_P"?6NX@CLK_ $8P6DO^C2(T8:,X
M(Z@_CG->0:N9=&NYM.GXD@.,]F!Z,/J*1LNA/J&I=?FKTKP4V_P=IK>L9/\
MX\:\#U#4^OS5[M\/GW^ ](;UAS_X\:?4I[GS[\1;HIXQU9 >?M3_ ,ZXDDDY
M-=3\1?\ D>M7_P"OJ3^=<K26Q--WB%7=&_Y#FG_]?$?_ *$*I5=T;_D.:?\
M]?$?_H0IL<_A9]'_ !EN[BU\"LD$FQ9YUCD& =RX)Q^8%<;X<U8CQWX:UP$!
M=:LD6?'>3!C;\=RJ?QKJ_C;_ ,B3%_U]I_)J\OT:9AX8\&SC[]OJ4\:GV$B,
M/U-2SGJ;M]K'TS7D'PQ_Y*AXS_ZZ-_Z,->OUY!\,?^2H>,_^NC?^C#5G2>OU
M\HZ[_P C!J7_ %]2_P#H1KZ@U>'4+C3)HM+N8[:[88261=P7UX]<5Y))\%=4
MED:236;9G8EF)1LDFHDFSFQ$)3LHHZ?X.?\ (ER?]?;_ /H*UV6N:5#K>B7>
MG3@%)XRH/H>Q_ X-<KX&\&:SX1GEBEU6"?3Y<LT"H<[\8!!/3WKL;]+N2PF2
MPECBNBN(I)%W*I]2*:V-*:?L[-'R=/$]O<20N,/&Q5OJ#7T#\*_$/]L^%4M9
M7S=6!\IL]2G\)_+C\*Y&;X+:K//)-)K-JTDC%F/EMR3R:U_"WPVUSPOK,=];
M:U;>62%GC\ML2)GD?7TJ8IIG-1A4A*]M#J_B!_R(>L?]</\ V85\S#K7TGXW
M\.:OXFLDL+'4H;2S;F='0DR$'(Y':O/_ /A2.H_]!>U_[]M1)-LK$4YSEHC=
ML_C%H-O8V\+6E^6CC5"0J]0,?WJF_P"%T>'_ /GSO_\ OA/_ (JN<_X4CJ/_
M $%[7_OVU'_"D=1_Z"]K_P!^VHO(.:OV+FJ?$VY\3W=IHGAR&>S>ZF6-KER
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M!_,$44!VLXZ$Y4Y^E-FDKV]W<O>'_AQ!/I$-[J5[J,>H78\^X$,^P;FYY'J
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M[50J:[.X'_/4!_YBO2]1\(^.[2,PS)I_B&U485;N-96Q[%L,/SKF[CP[)O\
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M3M2F@NH85B:VMB^2$4UT'PZT[4#?^(/$5_92V7]K7(D@MYAAUC&<%AV)S^E
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1G]F?&3_GYO\ _O\ K10!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>img_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_002.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !9 E$# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBOC?\
M:M_;L^ ?[&=SX)M/C7>>,;6;X@0Z]/X='A7P?JGBI7C\.-I::F;YM.!%B5;6
M+/R!-_KP92G^J:OD7_A^1^P?_P!!;XO?^&B\3_X4U%O9,+H_8*BOQ]_X?D?L
M'_\ 06^+W_AHO$_^%'_#\C]@_P#Z"WQ>_P##1>)_\*?++L_Z^8KKN?L%17X^
M_P##\C]@_P#Z"WQ>_P##1>)_\*/^'Y'[!_\ T%OB]_X:+Q/_ (4<LNS_ *^8
M77<_8*BOQ]_X?D?L'_\ 06^+W_AHO$_^%'_#\C]@_P#Z"WQ>_P##1>)_\*.6
M79_U\PNNY^P5%?C[_P /R/V#_P#H+?%[_P -%XG_ ,*/^'Y'[!__ $%OB]_X
M:+Q/_A1RR[/^OF%UW/V"HK\??^'Y'[!__06^+W_AHO$_^%'_  _(_8/_ .@M
M\7O_  T7B?\ PHY9=G_7S"Z[G[!45^/O_#\C]@__ *"WQ>_\-%XG_P */^'Y
M'[!__06^+W_AHO$_^%'++L_Z^877<_8*BOQ]_P"'Y'[!_P#T%OB]_P"&B\3_
M .%'_#\C]@__ *"WQ>_\-%XG_P *.679_P!?,+KN?L%17X^_\/R/V#_^@M\7
MO_#1>)_\*/\ A^1^P?\ ]!;XO?\ AHO$_P#A1RR[/^OF%UW/V"HK\??^'Y'[
M!_\ T%OB]_X:+Q/_ (4?\/R/V#_^@M\7O_#1>)_\*.679_U\PNNY^P5%?C[_
M ,/R/V#_ /H+?%[_ ,-%XG_PH_X?D?L'_P#06^+W_AHO$_\ A1RR[/\ KYA=
M=S]@J*_'W_A^1^P?_P!!;XO?^&B\3_X4?\/R/V#_ /H+?%[_ ,-%XG_PHY9=
MG_7S"Z[G[!45^/O_  _(_8/_ .@M\7O_  T7B?\ PH_X?D?L'_\ 06^+W_AH
MO$_^%'++L_Z^877<_8*BOQ]_X?D?L'_]!;XO?^&B\3_X4?\ #\C]@_\ Z"WQ
M>_\ #1>)_P#"CEEV?]?,+KN?L%17X^_\/R/V#_\ H+?%[_PT7B?_  H_X?D?
ML'_]!;XO?^&B\3_X4<LNS_KYA==S]@J*_'W_ (?D?L'_ /06^+W_ (:+Q/\
MX4?\/R/V#_\ H+?%[_PT7B?_  HY9=G_ %\PNNY^P5%?C[_P_(_8/_Z"WQ>_
M\-%XG_PH_P"'Y'[!_P#T%OB]_P"&B\3_ .%'++L_Z^877<_8*BOQ]_X?D?L'
M_P#06^+W_AHO$_\ A1_P_(_8/_Z"WQ>_\-%XG_PHY9=G_7S"Z[G[!45^/O\
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MU/\ :)&ESZG9:O87EM?SZ:%"V$UU%++9J-MN\:\5^^7Q+_8"_8C^*_@#Q?\
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MX-_X)&_&'XE>,OB]^P+^U_H&L^+/^"=WQ"^)FKW&N>+O@MXJTMKV>^_9\O\
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M_P#!"3]ICQ!<:EXV_95N=1^*W[%/CO6@EK)\:_V.O&NKSZIIL>GR,1#>ZSX
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M+H]'E\+?&+Q!XX\#:3\+_$,/B&"2YT"?1O'E]J,/A?4(-;@B>329[;5)(M1
M LWF+*"ES^Q[^R-<V]Q;W?[+7[.,]K<03074%S\$?AE+;SV\T;1SPW$4OAAH
MY8)8F9)HY 8WC9E<%217Y/\ _!:KX'?#7X!_\$!_VQO@;\-/#MOI'PR^&'[/
M^EZ%X%\-W&V_MO#VCZ/\1/"=[H6GV)N$/EP>'Y/(CT3:HDTV&RLE@</;1R4
M?KYX5^,G[.?CGX5W7QS\%?$;X2>+O@M9:?K6KW7Q8\,^(O"NN?#J+2?#C7"Z
M_JA\8Z9<W.@MIVBM9W:ZG?)?-:V1M;@7$L9@EV?-EM_P4P_X)9WE];Z9;_MY
M_L(R:A=LB6MF?VE?@/'<7#R';&D,<GC%&D>5ODB106D<A$#,0*;_ ,$IM,TV
MT_X)<_\ !/G3K73K"VTY_P!B?]FS?I]O9V\-E(;[X.^$[B^,EI'&L#F]N+BX
MGO&>-C=3SSS7!DEFD9OP0_X-<OV9/V;?C+_P34^-4/Q>_9]^"/Q2BE_;A_:+
M\/R+\0_A3X$\9[M#@T/X9QV^CD^(M!U%AIEND\R6]B"+:W61UAC0$B@#^LCP
M[<^ _&&B:=XF\)3^$?%/AS6+<7>D>(/#LNC:WHFJ6I=HQ<Z=JNF-=6%];ET=
M!-;7$L9=&7=E2!Y5\8?CY^RW^SU-X7M_CU\7O@=\%9?&UW<6'@X?%;QIX(^'
MZ>*;^T>U2YL= E\5:AI46K7MNU[:>=:6+SW$:W$3O&$<-7\UO_!+[PMI_P"Q
M_P#\' O_  48_8'_ &3KC4+7]AFU_9X\$_'K7_A'9:Y?:S\/_@!\?]?E^%\S
M:'X.M[J[N[?PN_B6S\8^*;FY\/6C1/\ V>NG:9-&UIX,TZ&R^F/^#FS]EO4/
MVSOV._V9/V;O#4NDZ?X^^*W[<7@#PK\/=<U2T@G73O%TWP)_:*U71[(7$C1R
M65MXCU#2+3P[?W,4\0AMM1:XE$B6_ED _HI_L31#TTC2_P#P7VG_ ,9H_L/1
M?^@/I?\ X+[3_P"-5^-'_! ']N/4?VY?^";'P?U_QW=W!^/'P%>[_9G_ &@M
M,U0F/Q!:?$;X26]EI%MJVO6LJQW,.J>+O!TGAGQ1J9F@B US4]8LU!DL9@OU
M9_P4U_:0\8_LT?LB^.-:^$<<-]^T9\7=:\)_LW?LL:%(Q5]:_:.^/6M0?#[X
M92*HBE\RQ\(7VJ7?Q&\1!E"0^%/!>OW+LJ0$T >W_#+]I3]DOXQ>._$_PV^#
MGQQ^ ?Q0^)'@,W\GC'P7\-_B!X#\9>+?!S:/JHT74&\2:+X:U34=3T![#6O^
M)9/_ &G!:-#J*M:G%Q&Z+](5_(/_ ,&O7[/_ (<_9B_:'_X+8_ C0;^^\2+\
M%_VK?AI\)3XTUYUO/$WBE?!%I\7-+O-9U;4F07$TFM:S%J6NO;L_EP7&I3!5
MW%F/]?% !1110 4444 <-\2_B/X0^$7@+Q5\2O'NJIHWA+P=H]WK>M7YC>>5
M+6U3(@M+6(-->7]Y*8[2PLH%::[O)H;>)2\@KA_$G[0/@?PO_P )+<7MGXHO
M-'\"VFB7WQ$\0:3H;ZCH_P /[;7-.MM;AD\2R17 O6.G:!>6?B+78]#L=9ET
M+0+NUU?54M;*>*5O&/VT/AE\8_B'\.O'@^'MUX2UG3K3X/?$C3=,\ :OX9\0
M:QKNL>.?$'AW5-)LM6T&ZTKQ-H^GKK4&E74VC>&5U33KRUTO4-7O=6F=G6V:
MT\W^,OPV^)MQX5^)/@7X93^/+/X@_M(?#KPIX?\ &S:=X*MI?A=H_B;4/"-I
M\.?$7CZT\7^(9IT\%/IG@[28(=?\/W4OB#6-0MM*T(^'-'?Q%>76H7 !]B:I
M\7K&T\=6O@/1O!?CSQE<%=#?7/$GA33=$O/"?A)?$+2/IP\1ZKJ/B'2KB.0Z
M?&NLW$&DV&KSV^D7%G=O%F^M(YI-'^+%OK_C[4_!&D^!OB#=Z?I%]?Z5??$4
M:1I,/P[35]+LDN=1TR'5)]>BUN[N;.[=M%GEM/#T]DFMPW5@;O-I<R1?,OB#
MX4VND>+O"-[\&?#'Q6\-_%/2_B9\/++Q+XOO[_Q19>!]>^&WA4>'O#OC(^)D
MO-7N? ^N^'-5^&>AOI7AO2M-L?[?A\3Q>'K^UM-)O+2]U"'4\'?#^/1OC-\.
MO$/PA\)_%7P'HMY>_$;5/CS:>,=1\40>&-?M->TS6;_2Q/I7B36=7T?5/&S?
M$N^T_6].U?P8&@LM"D\3VUUJ2V-_96$H!]$>+/BA'H7C_P +?"[1-"F\1^-O
M%7AGQ3XU@LY-2M-$TO3O"GA#4/#FCZMJ=]J=TEQ-)/)K'BW0=/L=.TW3[^YE
M-Q<W5T;*SM'G?T'0[Z_U+2-.O]5T>X\/ZE=6L<M]HEW=6=[<:9<D8FM)+S3I
MI[&Z\IP0MQ:S/%*FUU(W;1X9\>O _P ./'B^'+'X@> O'.N3Z0NKZQX1\>_#
MF#Q);>,/ 6MK%;6LAT#Q/X%OK/QKX;U'58)TDC-FW]AZHNFM!K9D2WMK>:/]
MG_6/B;IO@SP#X+^+&C>.M2\73^'_ !?J\_C37;3P],MOH.E>,I-/\#:+\0-4
MT*]BLU^*.I^"-1T&^UJ#2=+FTV[U+3/$MS)>P7$*Q7 !N^,OB_JOA_XDV7PO
M\.?#[4_&GB&\^'6L?$E/LFOZ#H<+Z7HOB/1_#=QIEO)K=Q;0OJT]UK=G-:K<
MSV>G-$LPN-0MF1=W5_##XG^&?BUX9;Q-X974[06>KZOX:\0:!K]@VE>)?"7B
MOP_=M8:]X6\3:4\DW]GZUI-VNR9(I[JRN[:2UU/2[V_TJ^L;ZY\6\9'7?#?[
M46@^/AX+\9^(/#%M^SQXP\+OJ'A?0I=90^);[XC>#-7L-#)BECCM[V\T[2;^
MZCDO)+:QCC@_TF\@,D8?R74/AE\1](72?B]?>$-5@U;7OVO-%^.?C+X?^%+B
M'6-;\,> HOA5/\&;*"6STJ[>T\3>(8;*T\.>+/&MAH,VIQO=3:K'H_\ ;DFC
MV=S? 'Z#$A068A54$LQ(   R22>  .23P!3?,CWK'YB>8Z&1$WKO:-2H9U7.
MYD4N@+ %064$Y89_,)_A=XM\=QV$/B?X7^,)_#6M?\%"]:^(%[H/B6R;RY/A
M1<?#G6+*W\2:WIG]HRQIX.U+6VLWDT?4%8&>YCMM7T2*=+NVAU/CEX3^(&I>
M/VM?!OPMUCP]%\/?BU^SE?\ @37?!7@D:GJ?BSPAIVN>!$\;:O=?$*?4X;/P
M=X1\+^&8_$?A6_\ A_HEG#K&J6.EWEU=Q:II?B06\0!^E1= ZQEU#N&9$+ .
MRH5#LJYRP0N@8@$*67.-PRA= XB+H)&1G6,L-[(A57<)G<45G168#"EU!(+#
M/YK^+_A!XI-C^U'XXT;P!XC;XHS_ +3WPU\5_"[Q';0W$GB.7PKHUC\#++4+
M[P?=27A-GX:$-EX]MM<TZS-E8ZO;C7$U6QOX[L>?Y=XVU[0=9^*?QG\'?$?6
M$\,+'^TOX U'P_\ '"^TKXCR7'@32=$A^&>HI\-M,\?>&/"MU\/]*@URS@N=
M+ETW4OB%X9M](M/&VHVGC?0;S4R_]O 'Z\F1 ZQET$CJSHA8;V1"H=U7.YE4
MN@9@"%+J"06&?-?C#\2[;X1> -3\>7>C7GB"'3M4\)Z2-*L+FTL[JYN?%WB[
M0O!]BRW%ZR6T45M?:];7-TTC BTAG,2R2B.)_B[QC\.OB!JVC?'70)_!?BNY
M^.NO_&*[U_X,_%JR61M-T/PS/K.CW?PYUBP\:QR>1X2T'X=:);?V9XN\$SR6
M<_B!M*UJ*/1=?C\6B34/H[]K+0?$'B7X%^(-(\-:'JOB76G\4_">_BTG1+0W
MFHW%IH?Q:\#:[K$]O:AU,BV.D:9?ZA*@?>8;:18A)*4C< ZOPO\ &&WU3X@7
M7PJ\7>%=;\ >/#HEYXH\/6.KS:?J6A^./"^G7MGI^KZQX.\1Z3<7%EJ$N@7N
MI:5!XAT+4(]*\1:0NK:7>S:5)I=_;7\GL:E3D*5.P[2%(^4X!VD#[IP0<'!P
M0>A%?'7Q$\->*/C!XYTKQ?:^#?$/A[PO\(O ?Q>BT>\UVUBT_P 2?$#Q?\0O
M!Q\+P:-H/AY9WU:T\-:9IAO+N_O=<CTN?5_$,F@0:5I\UOIEW?CI?V=O#=G\
M'/@W\ /!L'PRU_2->\4>#?!MEX\ETK2;1VT#QCI_PWL[G7=;^)E_<:DE\UW<
MW^CMX?EU<G7+^ZUN?3K29OLSF[A /3O&?Q/A\,^-?!'PXTO19O$'C3QYIOBO
M7M*L&U&TT;3;/P[X)_L*+Q#JVHZG=K-)^XO/$^@6-II^G6&HW]U-J#7#006%
ME>WD'=^']0U+5-(L[[6-#N/#>IRB=;S1;J\LM0ELI8;B:  7VG2S6=U#<)$E
MU;31,K/;3Q>=%!/YD$?C'QX\%?#KQY;^&M(^(OP]\7^)[>QGU36?#GC'P+;^
M((_%/P^\06MM!;Q7NA^(?!-[9>.?"^J:K:7EQ%:ZAH4BV=TEE<66L2I#);PW
M/SKX5T+XU>'KK]FGQW\0-.^(OBW3_ WB+X_^'=2ENH;;7?B=;?#WQE)-;_!K
M5_B5HWADK!K?B*+P]HFC6/BV\TFSO+O3]6U&WOM5MXYSKMY; 'W/JGBK2-(U
M_P ,^&KW^TO[4\7/K$>C?9=%UB^T_=H6G?VIJ']JZQ96,^DZ"/LG_'DVMWNG
MC4[C_1-.-U= PC,^'_Q!\+_$WP;I7CSPG>37/AO65OWL[J]M+C3)P-,U&]TJ
M]%S9WJ0W%J8+W3[J-A/&A*QB0?(RL?A?X1^"/B9:P?L>2:UX*\;:+'X?^*O[
M5&K^.=/UC#R^&_#_ (P7XQ2^#O\ A*UMM2O;-[741KGAV+2XUGU&"&2YM%B,
M20,T7(^%_A1\2/"WPD^ OA:'X>ZEI.B?#KXM>.9OC/X7A\(V?B"'Q%::JOC^
M'P7XHA\,Z=KND/\ $;PSX=U?5?#>H7=E;75U((YK'6+32=6F\-2V=N ?J474
M(9,Y0*7RH+Y4#=E0@8MD<@*"6Z $D5XMH?Q^^'^M:3\2==D/B30=+^%?B>'P
MAXGD\3>&-7T*^?7+O1_#VN:?::1HEY;KKVJ2ZK:>*O#\6CV\.EI>:O?ZI:V&
MFVUU=2K&8/@!X8NO"GA#7-/EG\3-I]UXY\3ZOH=AXC\/1^$X-%TK5)[>Z_LG
MPKX<;5M8U+1_!\.HMJ-QHFGZU<6]_:"ZN+>#3['2(]+MU^5?B#\(?&GBN+XY
MO-X2\3WVA1_MD_![XN7'A^PE?2M2^(_PX\$^!_@S;:Z/#%S'?6+WS66K^'-1
MOH=/6]L9];NO"\NBV[[M1MFF /LS4/BC::/X)UKQMK/@_P =Z5'I-Y;:?;>&
M;C1;.X\6^(;[4I]-L]$L_#VE:=JM]!>W.NZGJUGI6G17%]9O'J#30ZD-/2WG
ME3H_!7BFY\8:''K5WX0\6^")GNKJV.@^-;32;+78UMI-BW4D&BZUKUB+6Z^_
M:L-0:5XQF2&(X!^/;3X<:%J.H?$6V\7^ ?B=?_ G6_'/@#7?A[X.AB\9PW_A
M[Q=HOAW6YO%OBFW\/:5J5GXQT'P5?ZHVA)8Z,L)MCXLM=1UN/0K:SOTU&;VW
M]FS0O&_ASP'K&E^+W\1+I<?C_P :3?#.P\9:E<ZQXRT;X53ZLTG@S1_$^IWU
MS>ZG<WME;FZ73H]8OK[6[#PZ^B:9KEU+J]E>X /H*BBB@ K^7;_@Z]_Y,J_8
MV_[2:_LR_P#J+?%VOZB:_E2_X.Q/%FCQ?LI?L=>";9-9UOQA#^WE\&OBS-X8
M\,>'/$'BK7(/AQ\.O#7Q%A\9^+[C3_#VFZE<6VCZ+<^(=$LWFG2-KN\U&"UL
M4N9A*D8!_5;7\BW_  5I^'GBKXJ_\'$O_!'OP'X*^,WQ!_9_\2Z[^SU^T@NG
M?%CX6V7@K4/''A<V7ASXGZA<KHUI\0_#'C+PA*NLVEK/H6H_VMX;U,)I>I7D
MEI'#?+;7$7]:>@Z]HWBG0]'\2^'=2M-8T#Q!I=AK6B:M82B>RU/2M4M8KW3[
M^TF7B6VN[6:*>&0<-'(IXS7\J/\ P4+\?>%],_X.9?\ @D9JMW=WPT3X;?!W
MXL^%OB%XAM]$UJ\\-^"?$7Q=\-_%'1OAQHWB?Q#::?-HVC:AXIU'4=+@L[:]
MO8I((]7TB[OEM;+4[2XE /U9_P"'<O[5G_29/]O_ /\ "0_8H_\ H5J_)W_@
MCU\/_%'PL_X+W_\ !;[P%XT^,/C[X^>)O#_PZ_8YBU3XM?%"S\&V'CGQ:U[\
M--!U.V?7+3X?>&O!_@^$Z-97MMX>T[^QO#>E1OI.DV$EW%+J#W=S/_6;7\HW
M_!,SXF^#]=_X.,?^"T>J:=>:DVB_%SPA\!--^&'B&ZT#7-/\-^/=0^!G@?PI
MX,^*-IX5\07VGP:1K<WAG7X;J$II]Y.=2L+&_P!7TS[7IEE<748!RG_!0_X6
M^)_C)_P<Y_L > O"'QO^*7[/&N:E_P $[?BE=6_Q0^#8\"GQWI46F^(_VA+V
MXL+ ?$;P9X^\*_8]7BA:PU+[9X9N[C[)+)]BGL[GR[F/]9H_^":?[0EC\8/V
M</B9J7_!37]KGXU>%_@K\9M-^)7BKX0?'*+X*#P)X\TRT\+^*/#T5K+)\'?A
M!\+-=76=%O?$%OK^B)K>HZYX:>_TY#>:,MZFGZGI_P".?[>_[5_P&^ G_!S5
M^R#\;/BCXPU31?A3\#?V&/'OPU^+/CC1O 'Q'\<Z)X'\?>-9_C;J/AKPEK#^
M O"7B>Y&M:A8>)_#MY):VUM.-/@UK3FU%[1KA5'ZT>(?^#@W_@E!H6A:QK5K
M^T3XL\3W.EZ;>7]MX;\,_LW?M.7GB+7KBV@>6'2-$MK[X/Z;82ZIJ,JK:60O
M]1TZP6>5'O;^RM5FN8@#]HJ*^>?V2?C1K'[1W[+O[/7[0'B#PK-X&UGXV?!O
MX=_%74/!=S#=P7?A.?Q[X6TSQ/\ \([>P7Q-W#?:.FII87T<Y,B7<$RG@"O<
M]:UK2?#FC:MXAU_4;/1]"T+3;[6=9U;4)X[6PTO2M,M9;W4-0O;F4K%;VEE:
M037%S/(RI%#&[L0JDT ?R_\ _!J[_P D%_X*0?\ :4_]I'_TP?#NOZB-0:P6
MPOFU1K5=,6SN6U%KXQ"R6P$+F[:\,^(1:BW$AN#,?*$6\R?)FOX@O^" ?_!3
M/]C/]BSX-?MQ>'_VEOB+XU^&_B/XH_M_?'3XT?#[P\WP!_:&\5ZMXK^&GBC1
M?!<'AWQ-I<7@CX5^)(&BU>XTO48+>QGN8=3C>T=KFS@A>&67]*/VD?VL?VW_
M /@KAX3US]DK_@G#^SU\;_V;/V=?BQIUQX4^.O\ P47_ &J/AYK_ ,%=/TWX
M4ZY&EIXITK]FCX3>*AI/Q)^(7B;Q?X?NKW1[7Q1=:9H%KI$<]U;,/#\]Y9>,
MM% /YR/A[X2\=/\ \&F/_!26]^'UMJI^&^K?\% -9\4^"H[%95M[SX):+\9?
MV>]+U/4+!44"?P[;ZOHEY]M: O;1/I.J/*46VN2/[]/V'_&/@WX@_L9?LG>-
M?AY=V-]X'\2_LX?!75?"T^FR1RV:Z-<?#KPZ;.UB,7RH]C&!8SP$+);7%O+;
M2I'+$Z+Q7PS_ ."?G[-'PO\ V$M,_P""=.D>#!?_ +-=M\&-7^".LZ!J$D7]
MI^*-!\4:;?VWC/Q%K-_;00H?&'BW6-7UCQ;JNM6EO;-'XHU*?4K"&T,=O'#_
M #V?L9_%;]J3_@WKN-=_8H_;@^'?Q?\ CO\ \$U-)\4ZUJ_[*/[>GPC\!^(_
MBC#\'/"OB74[[6I_AK^T%X)\%V.L>*?"6G0:C<W-[:W=II5S%I?B"_U.T\,)
MXH\)ZA8_\(> ?UUU_+1_P<&6%IXA_;B_X-]O#7AJ.2?XN3?\%%M+U[P\EDZ?
M;K?X?>'O$/PBU/XD7DB(&N8["".W\/W=S<X6VBM[*[>9@$+)^B'B'_@O%_P3
M,CT:RF^$WQOUW]J'QWKML7\(_!7]ESX4_$[XT?&/Q9J+1&2VT.T\&^'/"H/A
MO5+I@85_X3[4/"%A;2AUO[ZT$<A3PK]B[]C7]I?]IO\ ;MO/^"N/_!0[P+:?
M"'Q?X2\"ZE\*OV#OV/7U>Q\3:K^S5\+]?6_C\1?$7XK:UI;R:-=?';X@Z?JV
MJ6^I:;I,MS!X6TO7-0TK4)WN['0M-\+ 'OG_  4(_P"3^?\ @B1_V=Y^T?\
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MINGS-;>9]G,ME9PVTA@\W][Y)>,F+S/WFS;O^;-?D9_P_P!_^"3/_1TVH?\
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M7\E/_!%O_@L%_P $]?V5_P#@EY^Q]^S[\?OC7XJ^'7QA^&/P]UK0_'7@J_\
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MZ*^'/BGPQ^RI^S5_P4-^&%E-/\5/^";'[6/PJ^.=A<6[,C?\(#XB\4:!X?\
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MT30-=U74M4URVFT^TOHY<+Q?\:_BGX#T?4WN_$5G>^%=1^+7P=\.6E_INO\
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MX@MK"[T;2?"OQ<^&ECJ%_%XJ\(^,M/FM9+S5?%UIJ/CJZB6SOC<0GX1:<(4
MFE-%AGZ+45^5.@?M=>,K>Y^!?Q*UF]LH?AI%\/M8^"WQ<T2XGEAEL/VII_"U
MQXKM=*N+B3S3%<Z=K/PUOOAY;6]V5N9M;^)6F0;O/ECCG_2+X=:#J/AGP+X5
MT36+NZO]:L=%LO[<O+R_NM3GN-<N(Q=ZU+]MO9)KB6%M4GN_LJO(5@M?)MXE
M2&*-%&K?U_7]- =H!C@4444@$P#SZ?Y__5Z4N.GMTHHH *,8_G110 =****
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MO/*9]_YR_P##.'_!8;_I('\&O_#!Z'_\HJ/^&</^"PW_ $D#^#7_ (8/0_\
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M.TS_  _UC3K'28O"FJ_#VYNI;C4'\*W_ (>N+.VUBYFU^PDM/$##55]4\?>
MO"OQ.\(ZQX'\:Z4FL>'=<B@2\M/M%S9W$-Q9W<&H:;J6FZC8S6VH:3K&CZG:
M6>JZ-K&FW-KJ6DZI9VFHV%S;W=M#*GY3?\,X?\%AO^D@?P:_\,'H?_RBH_X9
MP_X+#?\ 20/X-?\ A@]#_P#E%1;^]'[W_D%_[K^Y?YGZ-Q?!&UO[2/1O''Q
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M->\.WFH:N?#NH_:/*L(=<UB"2SN8[^0#\TO^&</^"PW_ $D#^#7_ (8/0_\
MY14?\,X?\%AO^D@?P:_\,'H?_P HJ+?WE][_ ,@O_=?W+_,_1:^^ ?AF[\%_
M!KP1;^(O%^EVGP+U#PKJ?@C5["[T)]:DO/!WA'5/!.D/KLFH^'K_ $S4E?1-
M8O?MT::7:I<7C1W*B'RQ'7I_AK0+O0(-0COO%/B/Q9/J&H-?F]\2/HWG649M
M+2T33M/M]!T70M/MM/B^RFY6/[$]Q)=W5W//=2^:BQ?DU_PSA_P6&_Z2!_!K
M_P ,'H?_ ,HJ/^&</^"PW_20/X-?^&#T/_Y146_O1_'_ ""_]V7X?YGZ'>'O
M@+#X434;3P_\4OBGI>E:K\0/$GQ(OM(MKWP2MM-KWBSQ3?\ C'6K0WA\"G65
MT*YUK49V.EC5 &L@NGS32V;312Z>M_ OPAKG@KX;^");_P 16-M\*O$O@;Q?
MX3UW3KVP@\11^(/ DRR6E_?WDNESV5VWB"&34;#Q6BZ="NLV&M:S;?Z,+YF3
M\WO^&</^"PW_ $D#^#7_ (8/0_\ Y14?\,X?\%AO^D@?P:_\,'H?_P HJ+?W
MH_C_ )!?^[+\/\S](G_9]^$DN@ZEX9E\':=)HNK_ !;A^.>H63AFBN?B?!XS
ML/'Z>)Y ?OW/_"4:;:7S1/NA>.+[,R& [![/7X[?\,X?\%AO^D@?P:_\,'H?
M_P HJ/\ AG#_ (+#?]) _@U_X8/0_P#Y146_O1^]_P"07_NR^Y?YG[$T5^.W
M_#.'_!8;_I('\&O_  P>A_\ RBH_X9P_X+#?]) _@U_X8/0__E%1;^]'\?\
M(+_W9?A_F?L317X[?\,X?\%AO^D@?P:_\,'H?_RBH_X9P_X+#?\ 20/X-?\
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M;:IJEG965W:S3@'-^(_V;OA_XA\17WB:#5?B3X1OM2\.^'/"E]:?#[XG^-_
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3I;.[1CU>BB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !@ 9$# 2(  A$! Q$!_\0
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M-_PBVNXM+I.HM9"?W;_16P0?3(KI/A-JMQ'#J'AB_)%UILK!0?[N<$?@>?\
M@5):.QC%\D^7H_S/2J\@^&/_ "5#QG_UT;_T8:]?KR#X8_\ )4/&?_71O_1A
MJC<]?KY1UW_D8-2_Z^I?_0C7U=7RCKO_ ",&I?\ 7U+_ .A&HF<F+V1HV_A3
M5]0\+?VU:*;BTAD='B4DM'@ EL>G/;TJ#PQXCN?"^LIJ%M''(0-KI(N<J>H!
MZ@^XKV+X.<^"I ?^?M__ $%:XSXI^"ET:\&LZ?'ML;AL2QJ.(I/\#_.IMI=&
M3I-052)Z_P"'O$-CXETF._L7RIX>,_>C;N#6M7S7X!\52>%_$$<CN?L-P1'<
MIVQV;ZCK^=?2:LKHKJ0RL,@CN*N+NCJHU.>/F<W\0/\ D0]8_P"N']17S..M
M?3'Q _Y$/6/^N']17S..M3/<YL5\2/K+2_\ D$V?_7!/_015NJFE_P#()L_^
MN"?^@BK=:'<M@HHK*\0Z_9^&](EU&\)*K@(B_>D8] * ;25V:M> _&+_ )'@
M?]>D?\VKW>QNEOK"WNT1T6>-9 KCD C/->$?&+_D>!_UZ1_S:HGL88G^&7O@
MI_R,5_\ ]>O_ +,*]PKP_P""G_(Q7_\ UZ_^S"O<*<-AX;^&%%%%4;A1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X7K^HR7'CSQ+
MJZD%M*M&AMN>DK8A3'N&9C7I_@RV^Q:!#8A]ZVA\E3CT _KFO%=*N3=:5JEY
M*,O=ZS9!R?0N[G]0*]J\'R>=IERW_3RW\A2AM<YZ6JYN]Q_AJ)F2XO)>%\QT
MCSZ9Y/\ GTKF-0U<7^K7%X&_=)^[A^@[_P"?6NX@CLK_ $8P6DO^C2(T8:,X
M(Z@_CG->0:N9=&NYM.GXD@.,]F!Z,/J*1LNA/J&I=?FKTKP4V_P=IK>L9/\
MX\:\#U#4^OS5[M\/GW^ ](;UAS_X\:?4I[GS[\1;HIXQU9 >?M3_ ,ZXDDDY
M-=3\1?\ D>M7_P"OJ3^=<K26Q--WB%7=&_Y#FG_]?$?_ *$*I5=T;_D.:?\
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M $%[7_OVU'_"D=1_Z"]K_P!^VHO(.:OV+FJ?$VY\3W=IHGAR&>S>ZF6-KER
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M!_,$44!VLXZ$Y4Y^E-FDKV]W<O>'_AQ!/I$-[J5[J,>H78\^X$,^P;FYY'J
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M[50J:[.X'_/4!_YBO2]1\(^.[2,PS)I_B&U485;N-96Q[%L,/SKF[CP[)O\
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M3M2F@NH85B:VMB^2$4UT'PZT[4#?^(/$5_92V7]K7(D@MYAAUC&<%AV)S^E
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1G]F?&3_GYO\ _O\ K10!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>9
<FILENAME>oprx-20150630.xml
<DESCRIPTION>XBRL INSTANCE FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!-- Generated using Ez-XBRL version 7.3.0.6 [10/01/2015 12:12:15 AM] -->
<!-- Based on XBRL 2.1 -->
<!--XBRL Document Modified with Ez-Editor Version 1.3.0.2 on Thursday, October 01, 2015 12:17:34 AM -->
<xbrli:xbrl xmlns:oprx="http://OPRX/20150630" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2014-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2015-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2015-01-31" xmlns:us-types="http://fasb.org/us-types/2015-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr">
<link:schemaRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:type="simple" xlink:href="oprx-20150630.xsd"/>
<!-- Context Section  -->
<xbrli:context id="Context_As_Of_14_Apr_2008T00_00_00_TO_14_Apr_2008T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2008-04-14
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Apr_2008T00_00_00_TO_14_Apr_2008T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2008-04-01
</xbrli:startDate>
<xbrli:endDate>
2008-04-14
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Dec_2008T00_00_00_TO_31_Dec_2008T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2008-12-01
</xbrli:startDate>
<xbrli:endDate>
2008-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_26_Apr_2010T00_00_00_TO_26_Apr_2010T00_00_00_FiniteLivedIntangibleAssetsByMajorClassAxis_PatentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2010-04-26
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Apr_2010T00_00_00_TO_26_Apr_2010T00_00_00_FiniteLivedIntangibleAssetsByMajorClassAxis_PatentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-04-01
</xbrli:startDate>
<xbrli:endDate>
2010-04-26
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_May_2010T00_00_00_TO_12_May_2010T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-05-01
</xbrli:startDate>
<xbrli:endDate>
2010-05-12
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Nov_2010T00_00_00_TO_16_Nov_2010T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-11-01
</xbrli:startDate>
<xbrli:endDate>
2010-11-16
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2010T00_00_00_TO_31_Dec_2010T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2010-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Dec_2010T00_00_00_TO_31_Dec_2010T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2010-12-01
</xbrli:startDate>
<xbrli:endDate>
2010-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Mar_2011T00_00_00_TO_25_Mar_2011T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-03-01
</xbrli:startDate>
<xbrli:endDate>
2011-03-25
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Mar_2011T00_00_00_TO_25_Mar_2011T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-03-01
</xbrli:startDate>
<xbrli:endDate>
2011-03-25
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Sep_2011T00_00_00_TO_21_Sep_2011T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-09-01
</xbrli:startDate>
<xbrli:endDate>
2011-09-21
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Sep_2011T00_00_00_TO_21_Sep_2011T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-09-01
</xbrli:startDate>
<xbrli:endDate>
2011-09-21
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_30_Sep_2011T00_00_00_TO_30_Sep_2011T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2011-09-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Sep_2011T00_00_00_TO_30_Sep_2011T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-09-01
</xbrli:startDate>
<xbrli:endDate>
2011-09-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Sep_2011T00_00_00_TO_30_Sep_2011T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2011-09-01
</xbrli:startDate>
<xbrli:endDate>
2011-09-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_30_Sep_2012T00_00_00_TO_30_Sep_2012T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-09-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Feb_2012T00_00_00_TO_30_Sep_2012T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2012-02-01
</xbrli:startDate>
<xbrli:endDate>
2012-09-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2012T00_00_00_TO_31_Dec_2012T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2012T00_00_00_TO_31_Dec_2012T00_00_00_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2012T00_00_00_TO_31_Dec_2012T00_00_00_StatementEquityComponentsAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2012T00_00_00_TO_31_Dec_2012T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2012T00_00_00_TO_31_Dec_2012T00_00_00_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2012T00_00_00_TO_31_Dec_2012T00_00_00_StatementEquityComponentsAxis_RetainedEarningsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2012T00_00_00_TO_31_Dec_2012T00_00_00_StatementEquityComponentsAxis_PreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2012T00_00_00_TO_31_Dec_2012T00_00_00_StatementEquityComponentsAxis_StockPayableMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">oprx:StockPayableMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2012-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_01_Jun_2013T00_00_00_TO_01_Jun_2013T00_00_00_FinancialInstrumentAxis_ConsultingAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">oprx:ConsultingAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-06-01
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_10_Jun_2013T00_00_00_TO_10_Jun_2013T00_00_00_FinancialInstrumentAxis_CapitalMarketsAdvisoryAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">oprx:CapitalMarketsAdvisoryAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-06-10
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_20_Sep_2013T00_00_00_TO_20_Sep_2013T00_00_00_FinancialInstrumentAxis_SeparationAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">oprx:SeparationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-09-20
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_01_Jul_2013T00_00_00_TO_30_Sep_2013T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-07-01
</xbrli:startDate>
<xbrli:endDate>
2013-09-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_01_Jul_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-07-01
</xbrli:startDate>
<xbrli:endDate>
2013-09-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_01_Jul_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:RestatementAdjustmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-07-01
</xbrli:startDate>
<xbrli:endDate>
2013-09-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_9ME_01_Jan_2013T00_00_00_TO_30_Sep_2013T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-09-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_9ME_01_Jan_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-09-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_9ME_01_Jan_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:RestatementAdjustmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-09-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_30_Sep_2013T00_00_00_TO_30_Sep_2013T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-09-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_30_Sep_2013T00_00_00_TO_30_Sep_2013T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-09-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_30_Sep_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-09-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_30_Sep_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:RestatementAdjustmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-09-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Feb_2013T00_00_00_TO_30_Sep_2013T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-02-01
</xbrli:startDate>
<xbrli:endDate>
2013-09-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_RetainedEarningsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:RestatementAdjustmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_AwardTypeAxis_StockCompensationPlanMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_ConcentrationRiskByBenchmarkAxis_AllOtherCustomersMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">oprx:AllOtherCustomersMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyAMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">oprx:CompanyAMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyBMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">oprx:CompanyBMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyCMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">oprx:CompanyCMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyDMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">oprx:CompanyDMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyEMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">oprx:CompanyEMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2013-01-01
</xbrli:startDate>
<xbrli:endDate>
2013-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_RetainedEarningsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_PreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_StockPayableMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">oprx:StockPayableMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:RestatementAdjustmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_FiniteLivedIntangibleAssetsByMajorClassAxis_WebBasedTechnologyMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">oprx:WebBasedTechnologyMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_FiniteLivedIntangibleAssetsByMajorClassAxis_WebBasedTechnologyOneMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">oprx:WebBasedTechnologyOneMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_FiniteLivedIntangibleAssetsByMajorClassAxis_WebBasedTechnologyTwoMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">oprx:WebBasedTechnologyTwoMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2013-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_02_Jan_2014T00_00_00_TO_02_Jan_2014T00_00_00_FinancialInstrumentAxis_SeparationAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">oprx:SeparationAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-01-02
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Jan_2014T00_00_00_TO_31_Jan_2014T00_00_00_TitleOfIndividualAxis_OfficerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:OfficerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-01-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Jan_2014T00_00_00_TO_31_Jan_2014T00_00_00_TitleOfIndividualAxis_OfficerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:OfficerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-01-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_28_Feb_2014T00_00_00_TO_28_Feb_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-02-28
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_01_Jan_2014T00_00_00_TO_31_Mar_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_01_Jan_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_01_Jan_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:RestatementAdjustmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:RestatementAdjustmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_TitleOfIndividualAxis_PlacementAgentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">oprx:PlacementAgentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_TitleOfIndividualAxis_ThreeOfficerMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">oprx:ThreeOfficerMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_TitleOfIndividualAxis_ConsultantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">oprx:ConsultantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_FinancialInstrumentAxis_SecuritiesPurchaseAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">oprx:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_AgreementAxis_SecuritiesPurchaseAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="oprx:AgreementAxis">oprx:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_TitleOfIndividualAxis_PlacementAgentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">oprx:PlacementAgentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-03-01
</xbrli:startDate>
<xbrli:endDate>
2014-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_FinancialInstrumentAxis_SecuritiesPurchaseAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">oprx:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-03-01
</xbrli:startDate>
<xbrli:endDate>
2014-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_AgreementAxis_SecuritiesPurchaseAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="oprx:AgreementAxis">oprx:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-03-01
</xbrli:startDate>
<xbrli:endDate>
2014-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-04-01
</xbrli:startDate>
<xbrli:endDate>
2014-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-04-01
</xbrli:startDate>
<xbrli:endDate>
2014-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:RestatementAdjustmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-04-01
</xbrli:startDate>
<xbrli:endDate>
2014-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:RestatementAdjustmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_30_Jun_2014T00_00_00_TO_30_Jun_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_30_Jun_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_30_Jun_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:RestatementAdjustmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_01_Jul_2014T00_00_00_TO_30_Sep_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-07-01
</xbrli:startDate>
<xbrli:endDate>
2014-09-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_01_Jul_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-07-01
</xbrli:startDate>
<xbrli:endDate>
2014-09-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_01_Jul_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:RestatementAdjustmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-07-01
</xbrli:startDate>
<xbrli:endDate>
2014-09-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_9ME_01_Jan_2014T00_00_00_TO_30_Sep_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-09-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_9ME_01_Jan_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-09-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_9ME_01_Jan_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:RestatementAdjustmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-09-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-09-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-09-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">us-gaap:RestatementAdjustmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-09-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Oct_2014T00_00_00_TO_31_Oct_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-10-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_02_Oct_2014T00_00_00_TO_31_Oct_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-10-02
</xbrli:startDate>
<xbrli:endDate>
2014-10-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_RetainedEarningsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_PreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_StockPayableMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">oprx:StockPayableMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_AwardTypeAxis_StockCompensationPlanMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_ConcentrationRiskByBenchmarkAxis_AllOtherCustomersMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">oprx:AllOtherCustomersMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyAMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">oprx:CompanyAMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyBMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">oprx:CompanyBMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyCMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">oprx:CompanyCMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyDMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">oprx:CompanyDMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyEMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">oprx:CompanyEMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_TitleOfIndividualAxis_DirectorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantOneMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">oprx:WarrantOneMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantTwoMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">oprx:WarrantTwoMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantThreeMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">oprx:WarrantThreeMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_RangeAxis_MaximumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_RangeAxis_MinimumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2014-01-01
</xbrli:startDate>
<xbrli:endDate>
2014-12-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_RetainedEarningsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_PreferredStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_StockPayableMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">oprx:StockPayableMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_FinancialInstrumentAxis_ConsultingAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">oprx:ConsultingAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_AwardTypeAxis_StockCompensationPlanMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_FiniteLivedIntangibleAssetsByMajorClassAxis_WebBasedTechnologyMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">oprx:WebBasedTechnologyMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_FiniteLivedIntangibleAssetsByMajorClassAxis_WebBasedTechnologyOneMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">oprx:WebBasedTechnologyOneMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_FiniteLivedIntangibleAssetsByMajorClassAxis_WebBasedTechnologyTwoMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">oprx:WebBasedTechnologyTwoMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_TitleOfIndividualAxis_DirectorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantOneMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">oprx:WarrantOneMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantTwoMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">oprx:WarrantTwoMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantThreeMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">oprx:WarrantThreeMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_TitleOfIndividualAxis_VicisMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">oprx:VicisMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2014-12-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Jan_2015T00_00_00_TO_31_Jan_2015T00_00_00_TitleOfIndividualAxis_DirectorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2015-01-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Jan_2015T00_00_00_TO_31_Jan_2015T00_00_00_TitleOfIndividualAxis_DirectorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2015-01-01
</xbrli:startDate>
<xbrli:endDate>
2015-01-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Jan_2015T00_00_00_TO_31_Jan_2015T00_00_00_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_DirectorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2015-01-01
</xbrli:startDate>
<xbrli:endDate>
2015-01-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Feb_2015T00_00_00_TO_28_Feb_2015T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2015-02-01
</xbrli:startDate>
<xbrli:endDate>
2015-02-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Feb_2015T00_00_00_TO_28_Feb_2015T00_00_00_FinancialInstrumentAxis_CapitalMarketsAdvisoryAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">oprx:CapitalMarketsAdvisoryAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2015-02-01
</xbrli:startDate>
<xbrli:endDate>
2015-02-28
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Mar_2015T00_00_00_TO_31_Mar_2015T00_00_00_FinancialInstrumentAxis_CapitalMarketsAdvisoryAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">oprx:CapitalMarketsAdvisoryAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2015-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_31_Mar_2015T00_00_00_TO_31_Mar_2015T00_00_00_SubsequentEventTypeAxis_SubsequentEventMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2015-03-31
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Mar_2015T00_00_00_TO_31_Mar_2015T00_00_00_SubsequentEventTypeAxis_SubsequentEventMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2015-03-01
</xbrli:startDate>
<xbrli:endDate>
2015-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Mar_2015T00_00_00_TO_31_Mar_2015T00_00_00_SubsequentEventTypeAxis_SubsequentEventMember_PlanNameAxis_IncrementOneMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">oprx:IncrementOneMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2015-03-01
</xbrli:startDate>
<xbrli:endDate>
2015-03-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_01_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2015-04-01
</xbrli:startDate>
<xbrli:endDate>
2015-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_3ME_01_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00_TitleOfIndividualAxis_DirectorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2015-04-01
</xbrli:startDate>
<xbrli:endDate>
2015-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2015-01-01
</xbrli:startDate>
<xbrli:endDate>
2015-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00_TitleOfIndividualAxis_DirectorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2015-01-01
</xbrli:startDate>
<xbrli:endDate>
2015-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00_TitleOfIndividualAxis_TwoOfficersMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">oprx:TwoOfficersMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2015-01-01
</xbrli:startDate>
<xbrli:endDate>
2015-06-30
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2015-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00_TitleOfIndividualAxis_DirectorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>
2015-06-30
</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="Context_Custom_01_Jul_2015T00_00_00_TO_31_Jul_2015T00_00_00_SubsequentEventTypeAxis_SubsequentEventMember_FinancialInstrumentAxis_CapitalMarketsAdvisoryAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001448431</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">oprx:CapitalMarketsAdvisoryAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>
2015-07-01
</xbrli:startDate>
<xbrli:endDate>
2015-07-31
</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<!-- Unit Section  -->
<!--
I~1\FVPHexeD5678YReqi>IhkevEkirxw7=c444c555cT{h>J66EFFF:1G8E;184JH1<HFH1F7G58<G<G74J -->
<xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD_per_Share"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit>
<xbrli:unit id="pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit>
<!-- Element Section  --><dei:EntityRegistrantName contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00">OptimizeRx Corp</dei:EntityRegistrantName>
<dei:EntityCentralIndexKey contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00">0001448431</dei:EntityCentralIndexKey>
<dei:AmendmentFlag contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00">true</dei:AmendmentFlag>
<dei:DocumentType contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00">S-1</dei:DocumentType>
<dei:EntityFilerCategory contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00">Smaller Reporting Company</dei:EntityFilerCategory>
<dei:DocumentPeriodEndDate contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00">2015-06-30</dei:DocumentPeriodEndDate>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_31_Dec_2012T00_00_00_TO_31_Dec_2012T00_00_00" unitRef="USD" decimals="0">284263</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">1118243</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_30_Jun_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">3549698</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">3446973</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">3645878</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:AccountsReceivableNetCurrent contextRef="Context_As_Of_30_Sep_2013T00_00_00_TO_30_Sep_2013T00_00_00" unitRef="USD" decimals="0">811278</us-gaap:AccountsReceivableNetCurrent>
<us-gaap:AccountsReceivableNetCurrent contextRef="Context_As_Of_30_Sep_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">782902</us-gaap:AccountsReceivableNetCurrent>
<us-gaap:AccountsReceivableNetCurrent contextRef="Context_As_Of_30_Sep_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">28376</us-gaap:AccountsReceivableNetCurrent>
<us-gaap:AccountsReceivableNetCurrent contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">1511709</us-gaap:AccountsReceivableNetCurrent>
<us-gaap:AccountsReceivableNetCurrent contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">1566964</us-gaap:AccountsReceivableNetCurrent>
<us-gaap:AccountsReceivableNetCurrent contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-55255</us-gaap:AccountsReceivableNetCurrent>
<us-gaap:AccountsReceivableNetCurrent contextRef="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00" unitRef="USD" decimals="0">965605</us-gaap:AccountsReceivableNetCurrent>
<us-gaap:AccountsReceivableNetCurrent contextRef="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">797725</us-gaap:AccountsReceivableNetCurrent>
<us-gaap:AccountsReceivableNetCurrent contextRef="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">167880</us-gaap:AccountsReceivableNetCurrent>
<us-gaap:AccountsReceivableNetCurrent contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">2100381</us-gaap:AccountsReceivableNetCurrent>
<us-gaap:AccountsReceivableNetCurrent contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">1918419</us-gaap:AccountsReceivableNetCurrent>
<us-gaap:PrepaidExpenseCurrent contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">11771</us-gaap:PrepaidExpenseCurrent>
<us-gaap:PrepaidExpenseCurrent contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">28093</us-gaap:PrepaidExpenseCurrent>
<us-gaap:PrepaidExpenseCurrent contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">76376</us-gaap:PrepaidExpenseCurrent>
<us-gaap:AssetsCurrent contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">2641723</us-gaap:AssetsCurrent>
<us-gaap:AssetsCurrent contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">5575447</us-gaap:AssetsCurrent>
<us-gaap:AssetsCurrent contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">5640673</us-gaap:AssetsCurrent>
<us-gaap:PropertyPlantAndEquipmentNet contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">15057</us-gaap:PropertyPlantAndEquipmentNet>
<us-gaap:PropertyPlantAndEquipmentNet contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">12813</us-gaap:PropertyPlantAndEquipmentNet>
<us-gaap:PropertyPlantAndEquipmentNet contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">10674</us-gaap:PropertyPlantAndEquipmentNet>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">885950</us-gaap:FiniteLivedIntangibleAssetsNet>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">930854</us-gaap:FiniteLivedIntangibleAssetsNet>
<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">901491</us-gaap:FiniteLivedIntangibleAssetsNet>
<us-gaap:CapitalizedComputerSoftwareNet contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">404986</us-gaap:CapitalizedComputerSoftwareNet>
<us-gaap:CapitalizedComputerSoftwareNet contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">504643</us-gaap:CapitalizedComputerSoftwareNet>
<us-gaap:CapitalizedComputerSoftwareNet contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">424075</us-gaap:CapitalizedComputerSoftwareNet>
<us-gaap:SecurityDeposit contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">5049</us-gaap:SecurityDeposit>
<us-gaap:SecurityDeposit contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">5049</us-gaap:SecurityDeposit>
<us-gaap:SecurityDeposit contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">5049</us-gaap:SecurityDeposit>
<us-gaap:OtherAssets contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">1295985</us-gaap:OtherAssets>
<us-gaap:OtherAssets contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">1440546</us-gaap:OtherAssets>
<us-gaap:OtherAssets contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">1330615</us-gaap:OtherAssets>
<us-gaap:Assets contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">3952765</us-gaap:Assets>
<us-gaap:Assets contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">7028806</us-gaap:Assets>
<us-gaap:Assets contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">6981962</us-gaap:Assets>
<us-gaap:AccountsPayableTradeCurrent contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">188739</us-gaap:AccountsPayableTradeCurrent>
<us-gaap:AccountsPayableTradeCurrent contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">200372</us-gaap:AccountsPayableTradeCurrent>
<us-gaap:AccountsPayableTradeCurrent contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">172183</us-gaap:AccountsPayableTradeCurrent>
<us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">570000</us-gaap:AccountsPayableRelatedPartiesCurrent>
<us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">570000</us-gaap:AccountsPayableRelatedPartiesCurrent>
<us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">570000</us-gaap:AccountsPayableRelatedPartiesCurrent>
<us-gaap:AccruedLiabilitiesCurrent contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">12000</us-gaap:AccruedLiabilitiesCurrent>
<us-gaap:AccruedLiabilitiesCurrent contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">25459</us-gaap:AccruedLiabilitiesCurrent>
<us-gaap:AccruedLiabilitiesCurrent contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">9851</us-gaap:AccruedLiabilitiesCurrent>
<oprx:RevenueSharePayableCurrent contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">1287552</oprx:RevenueSharePayableCurrent>
<oprx:RevenueSharePayableCurrent contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">1193661</oprx:RevenueSharePayableCurrent>
<oprx:RevenueSharePayableCurrent contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">93891</oprx:RevenueSharePayableCurrent>
<oprx:RevenueSharePayableCurrent contextRef="Context_As_Of_30_Jun_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">872989</oprx:RevenueSharePayableCurrent>
<oprx:RevenueSharePayableCurrent contextRef="Context_As_Of_30_Jun_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">506901</oprx:RevenueSharePayableCurrent>
<oprx:RevenueSharePayableCurrent contextRef="Context_As_Of_30_Jun_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">366088</oprx:RevenueSharePayableCurrent>
<oprx:RevenueSharePayableCurrent contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">1274429</oprx:RevenueSharePayableCurrent>
<oprx:RevenueSharePayableCurrent contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">853410</oprx:RevenueSharePayableCurrent>
<oprx:RevenueSharePayableCurrent contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">421019</oprx:RevenueSharePayableCurrent>
<oprx:RevenueSharePayableCurrent contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">1502761</oprx:RevenueSharePayableCurrent>
<oprx:RevenueSharePayableCurrent contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">1190995</oprx:RevenueSharePayableCurrent>
<us-gaap:DeferredRevenueCurrent contextRef="Context_As_Of_30_Sep_2013T00_00_00_TO_30_Sep_2013T00_00_00" unitRef="USD" decimals="0">161132</us-gaap:DeferredRevenueCurrent>
<us-gaap:DeferredRevenueCurrent contextRef="Context_As_Of_30_Sep_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">13272</us-gaap:DeferredRevenueCurrent>
<us-gaap:DeferredRevenueCurrent contextRef="Context_As_Of_30_Sep_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">147860</us-gaap:DeferredRevenueCurrent>
<us-gaap:DeferredRevenueCurrent contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">226272</us-gaap:DeferredRevenueCurrent>
<us-gaap:DeferredRevenueCurrent contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">4252</us-gaap:DeferredRevenueCurrent>
<us-gaap:DeferredRevenueCurrent contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">222020</us-gaap:DeferredRevenueCurrent>
<us-gaap:DeferredRevenueCurrent contextRef="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00" unitRef="USD" decimals="0">437521</us-gaap:DeferredRevenueCurrent>
<us-gaap:DeferredRevenueCurrent contextRef="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">168714</us-gaap:DeferredRevenueCurrent>
<us-gaap:DeferredRevenueCurrent contextRef="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">268807</us-gaap:DeferredRevenueCurrent>
<us-gaap:DeferredRevenueCurrent contextRef="Context_As_Of_30_Jun_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">301178</us-gaap:DeferredRevenueCurrent>
<us-gaap:DeferredRevenueCurrent contextRef="Context_As_Of_30_Jun_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">42908</us-gaap:DeferredRevenueCurrent>
<us-gaap:DeferredRevenueCurrent contextRef="Context_As_Of_30_Jun_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">258270</us-gaap:DeferredRevenueCurrent>
<us-gaap:DeferredRevenueCurrent contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">118949</us-gaap:DeferredRevenueCurrent>
<us-gaap:DeferredRevenueCurrent contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:DeferredRevenueCurrent contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">118949</us-gaap:DeferredRevenueCurrent>
<us-gaap:DeferredRevenueCurrent contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">120130</us-gaap:DeferredRevenueCurrent>
<us-gaap:DeferredRevenueCurrent contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">336213</us-gaap:DeferredRevenueCurrent>
<us-gaap:LiabilitiesCurrent contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">2284563</us-gaap:LiabilitiesCurrent>
<us-gaap:LiabilitiesCurrent contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">2418722</us-gaap:LiabilitiesCurrent>
<us-gaap:LiabilitiesCurrent contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">2279242</us-gaap:LiabilitiesCurrent>
<us-gaap:CommonStockValue contextRef="Context_As_Of_20_Sep_2013T00_00_00_TO_20_Sep_2013T00_00_00_FinancialInstrumentAxis_SeparationAgreementMember" unitRef="USD" decimals="0">505000</us-gaap:CommonStockValue>
<us-gaap:CommonStockValue contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">14817</us-gaap:CommonStockValue>
<us-gaap:CommonStockValue contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">22867</us-gaap:CommonStockValue>
<us-gaap:CommonStockValue contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_TitleOfIndividualAxis_DirectorMember" unitRef="USD" decimals="0">23166</us-gaap:CommonStockValue>
<us-gaap:CommonStockValue contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">22950</us-gaap:CommonStockValue>
<us-gaap:PreferredStockValue contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:PreferredStockValue contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:PreferredStockValue contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:WarrantsAndRightsOutstanding contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">18148049</us-gaap:WarrantsAndRightsOutstanding>
<us-gaap:WarrantsAndRightsOutstanding contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">2153295</us-gaap:WarrantsAndRightsOutstanding>
<us-gaap:WarrantsAndRightsOutstanding contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">2153295</us-gaap:WarrantsAndRightsOutstanding>
<us-gaap:AdditionalPaidInCapital contextRef="Context_As_Of_30_Sep_2013T00_00_00_TO_30_Sep_2013T00_00_00" unitRef="USD" decimals="0">8597748</us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="Context_As_Of_30_Sep_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">8449271</us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="Context_As_Of_30_Sep_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">148477</us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">8875155</us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">8726708</us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">148477</us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00" unitRef="USD" decimals="0">27304207</us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">27155730</us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">148477</us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="Context_As_Of_30_Jun_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">27388789</us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="Context_As_Of_30_Jun_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">27304112</us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="Context_As_Of_30_Jun_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">84677</us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">28483502</us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">28398825</us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">84677</us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">27595609</us-gaap:AdditionalPaidInCapital>
<us-gaap:AdditionalPaidInCapital contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">27806253</us-gaap:AdditionalPaidInCapital>
<oprx:StockPayable contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">0</oprx:StockPayable>
<oprx:StockPayable contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">963063</oprx:StockPayable>
<oprx:StockPayable contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">1132148</oprx:StockPayable>
<us-gaap:DeferredCompensationEquity contextRef="Context_As_Of_20_Sep_2013T00_00_00_TO_20_Sep_2013T00_00_00_FinancialInstrumentAxis_SeparationAgreementMember" unitRef="USD" decimals="0">174808</us-gaap:DeferredCompensationEquity>
<us-gaap:DeferredCompensationEquity contextRef="Context_As_Of_30_Sep_2013T00_00_00_TO_30_Sep_2013T00_00_00" unitRef="USD" decimals="0">-287857</us-gaap:DeferredCompensationEquity>
<us-gaap:DeferredCompensationEquity contextRef="Context_As_Of_30_Sep_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-233077</us-gaap:DeferredCompensationEquity>
<us-gaap:DeferredCompensationEquity contextRef="Context_As_Of_30_Sep_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-54780</us-gaap:DeferredCompensationEquity>
<us-gaap:DeferredCompensationEquity contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">270462</us-gaap:DeferredCompensationEquity>
<us-gaap:DeferredCompensationEquity contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-233942</us-gaap:DeferredCompensationEquity>
<us-gaap:DeferredCompensationEquity contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-36520</us-gaap:DeferredCompensationEquity>
<us-gaap:DeferredCompensationEquity contextRef="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00" unitRef="USD" decimals="0">-472669</us-gaap:DeferredCompensationEquity>
<us-gaap:DeferredCompensationEquity contextRef="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-454409</us-gaap:DeferredCompensationEquity>
<us-gaap:DeferredCompensationEquity contextRef="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-18260</us-gaap:DeferredCompensationEquity>
<us-gaap:DeferredCompensationEquity contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:DeferredCompensationEquity contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">18750</us-gaap:DeferredCompensationEquity>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of_30_Sep_2013T00_00_00_TO_30_Sep_2013T00_00_00" unitRef="USD" decimals="0">-25141061</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of_30_Sep_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-24870854</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of_30_Sep_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-270207</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">-25099357</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-24616220</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-483137</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00" unitRef="USD" decimals="0">-25861452</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-25269535</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-591917</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of_30_Jun_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-26060890</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of_30_Jun_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-25322216</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of_30_Jun_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-738674</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">-26355433</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-25716530</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-638903</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">-26124750</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-26393176</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2012T00_00_00_TO_31_Dec_2012T00_00_00" unitRef="USD" decimals="0">1404882</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2012T00_00_00_TO_31_Dec_2012T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">14232</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2012T00_00_00_TO_31_Dec_2012T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="USD" decimals="0">20058051</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2012T00_00_00_TO_31_Dec_2012T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">6164666</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2012T00_00_00_TO_31_Dec_2012T00_00_00_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="0">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2012T00_00_00_TO_31_Dec_2012T00_00_00_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD" decimals="0">-24832067</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2012T00_00_00_TO_31_Dec_2012T00_00_00_StatementEquityComponentsAxis_PreferredStockMember" unitRef="USD" decimals="0">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2012T00_00_00_TO_31_Dec_2012T00_00_00_StatementEquityComponentsAxis_StockPayableMember" unitRef="USD" decimals="0">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">1668202</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">14817</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="USD" decimals="0">18148049</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">8875155</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="0">-270462</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD" decimals="0">-25099357</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_PreferredStockMember" unitRef="USD" decimals="0">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_StockPayableMember" unitRef="USD" decimals="0">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">4610084</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">22867</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="USD" decimals="0">2153295</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">27595609</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="0">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD" decimals="0">-26124750</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_PreferredStockMember" unitRef="USD" decimals="0">0</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_StockPayableMember" unitRef="USD" decimals="0">963063</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">4702720</us-gaap:StockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">3952765</us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">7028806</us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">6981962</us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockSharesAuthorized contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesAuthorized contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesAuthorized contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesIssued contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="shares" decimals="INF">65</us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesIssued contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="shares" xsi:nil="true"/>
<us-gaap:PreferredStockSharesIssued contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" xsi:nil="true"/>
<us-gaap:PreferredStockSharesOutstanding contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="shares" decimals="INF">65</us-gaap:PreferredStockSharesOutstanding>
<us-gaap:PreferredStockSharesOutstanding contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="shares" xsi:nil="true"/>
<us-gaap:PreferredStockSharesOutstanding contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" xsi:nil="true"/>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="Context_As_Of_01_Jun_2013T00_00_00_TO_01_Jun_2013T00_00_00_FinancialInstrumentAxis_ConsultingAgreementMember" unitRef="USD_per_Share" decimals="3">1.945</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="Context_As_Of_10_Jun_2013T00_00_00_TO_10_Jun_2013T00_00_00_FinancialInstrumentAxis_CapitalMarketsAdvisoryAgreementMember" unitRef="USD_per_Share" decimals="2">1.66</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockSharesAuthorized contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="shares" decimals="INF">500000000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesAuthorized contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="shares" decimals="INF">500000000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesAuthorized contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" decimals="INF">500000000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of_01_Jun_2013T00_00_00_TO_01_Jun_2013T00_00_00_FinancialInstrumentAxis_ConsultingAgreementMember" unitRef="shares" decimals="INF">20000</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of_10_Jun_2013T00_00_00_TO_10_Jun_2013T00_00_00_FinancialInstrumentAxis_CapitalMarketsAdvisoryAgreementMember" unitRef="shares" decimals="INF">44000</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of_20_Sep_2013T00_00_00_TO_20_Sep_2013T00_00_00_FinancialInstrumentAxis_SeparationAgreementMember" unitRef="shares" decimals="INF">250000</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="shares" decimals="INF">14817496</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of_02_Jan_2014T00_00_00_TO_02_Jan_2014T00_00_00_FinancialInstrumentAxis_SeparationAgreementMember" unitRef="shares" decimals="INF">250000</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of_31_Oct_2014T00_00_00_TO_31_Oct_2014T00_00_00" unitRef="shares" decimals="INF">35417</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="shares" decimals="INF">22867319</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_TitleOfIndividualAxis_DirectorMember" unitRef="shares" decimals="INF">12500</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesIssued contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" decimals="INF">22949819</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesOutstanding contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="shares" decimals="INF">14817496</us-gaap:CommonStockSharesOutstanding>
<us-gaap:CommonStockSharesOutstanding contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="shares" decimals="INF">22867319</us-gaap:CommonStockSharesOutstanding>
<us-gaap:CommonStockSharesOutstanding contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" decimals="INF">22949819</us-gaap:CommonStockSharesOutstanding>
<us-gaap:Revenues contextRef="Context_3ME_01_Jul_2013T00_00_00_TO_30_Sep_2013T00_00_00" unitRef="USD" decimals="0">1225169</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_3ME_01_Jul_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">1373029</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_3ME_01_Jul_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-147860</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_9ME_01_Jan_2013T00_00_00_TO_30_Sep_2013T00_00_00" unitRef="USD" decimals="0">2998546</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_9ME_01_Jan_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">3146406</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_9ME_01_Jan_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-147860</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">4679741</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">4957016</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-277275</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_ConcentrationRiskByBenchmarkAxis_AllOtherCustomersMember" unitRef="USD" decimals="0">1193587</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyAMember" unitRef="USD" decimals="0">1776824</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyBMember" unitRef="USD" decimals="0">1053321</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyCMember" unitRef="USD" decimals="0">305980</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyDMember" unitRef="USD" decimals="0">278499</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyEMember" unitRef="USD" decimals="0">71030</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_3ME_01_Jan_2014T00_00_00_TO_31_Mar_2014T00_00_00" unitRef="USD" decimals="0">1289428</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_3ME_01_Jan_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">1317347</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_3ME_01_Jan_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-27919</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">1426808</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">1454214</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-27206</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">2716236</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">2771560</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-55124</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_3ME_01_Jul_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">1819421</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_3ME_01_Jul_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">1620215</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_3ME_01_Jul_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">199206</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_9ME_01_Jan_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">4535857</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_9ME_01_Jan_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">4391775</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_9ME_01_Jan_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">144082</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">6502962</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_ConcentrationRiskByBenchmarkAxis_AllOtherCustomersMember" unitRef="USD" decimals="0">2389163</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyAMember" unitRef="USD" decimals="0">1270064</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyBMember" unitRef="USD" decimals="0">797972</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyCMember" unitRef="USD" decimals="0">772320</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyDMember" unitRef="USD" decimals="0">644702</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyEMember" unitRef="USD" decimals="0">628741</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_3ME_01_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">1705457</us-gaap:Revenues>
<us-gaap:Revenues contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">3193010</us-gaap:Revenues>
<oprx:RevenueShareExpense contextRef="Context_3ME_01_Jul_2013T00_00_00_TO_30_Sep_2013T00_00_00" unitRef="USD" decimals="0">557510</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_3ME_01_Jul_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">529134</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_3ME_01_Jul_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">28376</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_9ME_01_Jan_2013T00_00_00_TO_30_Sep_2013T00_00_00" unitRef="USD" decimals="0">1292435</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_9ME_01_Jan_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">1264059</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_9ME_01_Jan_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">28376</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">1861316</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">1767425</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">93891</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_3ME_01_Jan_2014T00_00_00_TO_31_Mar_2014T00_00_00" unitRef="USD" decimals="0">561411</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_3ME_01_Jan_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">498810</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_3ME_01_Jan_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">62601</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">730140</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">540048</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">190092</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">1291551</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">1038858</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">252693</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_3ME_01_Jul_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">958333</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_3ME_01_Jul_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">858898</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_3ME_01_Jul_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">99435</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_9ME_01_Jan_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">2249884</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_9ME_01_Jan_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">1897757</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_9ME_01_Jan_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">352127</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">3221534</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_3ME_01_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">882327</oprx:RevenueShareExpense>
<oprx:RevenueShareExpense contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">1638768</oprx:RevenueShareExpense>
<us-gaap:GrossProfit contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">2818425</us-gaap:GrossProfit>
<us-gaap:GrossProfit contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">696668</us-gaap:GrossProfit>
<us-gaap:GrossProfit contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">1424685</us-gaap:GrossProfit>
<us-gaap:GrossProfit contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">3281428</us-gaap:GrossProfit>
<us-gaap:GrossProfit contextRef="Context_3ME_01_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">823130</us-gaap:GrossProfit>
<us-gaap:GrossProfit contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">1554242</us-gaap:GrossProfit>
<us-gaap:AllocatedShareBasedCompensationExpense contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">523382</us-gaap:AllocatedShareBasedCompensationExpense>
<us-gaap:AllocatedShareBasedCompensationExpense contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">1172242</us-gaap:AllocatedShareBasedCompensationExpense>
<us-gaap:DepreciationAndAmortization contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">193791</us-gaap:DepreciationAndAmortization>
<us-gaap:DepreciationAndAmortization contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">115828</us-gaap:DepreciationAndAmortization>
<us-gaap:DepreciationAndAmortization contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">264340</us-gaap:DepreciationAndAmortization>
<us-gaap:DepreciationAndAmortization contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">159337</us-gaap:DepreciationAndAmortization>
<us-gaap:LitigationSettlementExpense contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:LitigationSettlementExpense contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">400000</us-gaap:LitigationSettlementExpense>
<us-gaap:OtherCostAndExpenseOperating contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">2368788</us-gaap:OtherCostAndExpenseOperating>
<us-gaap:OtherCostAndExpenseOperating contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">2471174</us-gaap:OtherCostAndExpenseOperating>
<us-gaap:OperatingExpenses contextRef="Context_3ME_01_Jul_2013T00_00_00_TO_30_Sep_2013T00_00_00" unitRef="USD" decimals="0">1076475</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_3ME_01_Jul_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">982504</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_3ME_01_Jul_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">93971</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_9ME_01_Jan_2013T00_00_00_TO_30_Sep_2013T00_00_00" unitRef="USD" decimals="0">2366210</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_9ME_01_Jan_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">2272239</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_9ME_01_Jan_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">93971</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">3085961</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">2973990</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">111701</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_3ME_01_Jan_2014T00_00_00_TO_31_Mar_2014T00_00_00" unitRef="USD" decimals="0">1489858</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_3ME_01_Jan_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">1471598</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_3ME_01_Jan_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">18260</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">896529</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">967070</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-70541</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">2386747</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">2439028</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-52281</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_3ME_01_Jul_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">1155933</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_3ME_01_Jul_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">1155933</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_3ME_01_Jul_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" xsi:nil="true"/>
<us-gaap:OperatingExpenses contextRef="Context_9ME_01_Jan_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">3542681</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_9ME_01_Jan_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">3594961</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_9ME_01_Jan_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-52280</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">4307756</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_3ME_01_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">980659</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">1823269</us-gaap:OperatingExpenses>
<us-gaap:OperatingIncomeLoss contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">-267536</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-199861</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-52904</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-962062</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-706326</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">-1026328</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="Context_3ME_01_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-157529</us-gaap:OperatingIncomeLoss>
<us-gaap:OperatingIncomeLoss contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-269027</us-gaap:OperatingIncomeLoss>
<us-gaap:InterestAndOtherIncome contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">246</us-gaap:InterestAndOtherIncome>
<us-gaap:InterestAndOtherIncome contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">223</us-gaap:InterestAndOtherIncome>
<us-gaap:InterestAndOtherIncome contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">329</us-gaap:InterestAndOtherIncome>
<us-gaap:InterestAndOtherIncome contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">935</us-gaap:InterestAndOtherIncome>
<us-gaap:InterestAndOtherIncome contextRef="Context_3ME_01_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">304</us-gaap:InterestAndOtherIncome>
<us-gaap:InterestAndOtherIncome contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">601</us-gaap:InterestAndOtherIncome>
<us-gaap:InterestExpense contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">0</us-gaap:InterestExpense>
<us-gaap:InterestExpense contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">0</us-gaap:InterestExpense>
<us-gaap:NonoperatingIncomeExpense contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">246</us-gaap:NonoperatingIncomeExpense>
<us-gaap:NonoperatingIncomeExpense contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">223</us-gaap:NonoperatingIncomeExpense>
<us-gaap:NonoperatingIncomeExpense contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">329</us-gaap:NonoperatingIncomeExpense>
<us-gaap:NonoperatingIncomeExpense contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">935</us-gaap:NonoperatingIncomeExpense>
<us-gaap:NonoperatingIncomeExpense contextRef="Context_3ME_01_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">304</us-gaap:NonoperatingIncomeExpense>
<us-gaap:NonoperatingIncomeExpense contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">601</us-gaap:NonoperatingIncomeExpense>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">-267290</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-199638</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-52681</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-961733</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-705996</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">-1025393</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="Context_3ME_01_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-157225</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-268426</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
<us-gaap:IncomeTaxExpenseBenefit contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:IncomeTaxExpenseBenefit contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:IncomeTaxExpenseBenefit contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:IncomeTaxExpenseBenefit contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxExpenseBenefit>
<us-gaap:IncomeTaxExpenseBenefit contextRef="Context_3ME_01_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:IncomeTaxExpenseBenefit contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:NetIncomeLoss contextRef="Context_3ME_01_Jul_2013T00_00_00_TO_30_Sep_2013T00_00_00" unitRef="USD" decimals="0">-411734</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_3ME_01_Jul_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-141527</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_3ME_01_Jul_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-270207</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_9ME_01_Jan_2013T00_00_00_TO_30_Sep_2013T00_00_00" unitRef="USD" decimals="0">-659923</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_9ME_01_Jan_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-389716</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_9ME_01_Jan_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-270207</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">-267290</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD" decimals="0">-267290</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">215847</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-483137</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_3ME_01_Jan_2014T00_00_00_TO_31_Mar_2014T00_00_00" unitRef="USD" decimals="0">-762095</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_3ME_01_Jan_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-653315</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_3ME_01_Jan_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-108780</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-199638</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-52681</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-146757</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-961733</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-705996</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-255537</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_3ME_01_Jul_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">-294543</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_3ME_01_Jul_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-394314</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_3ME_01_Jul_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">99771</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_9ME_01_Jan_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">-1256076</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_9ME_01_Jan_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-1100310</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_9ME_01_Jan_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-155766</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">-1025393</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="USD" decimals="0">-1025393</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_3ME_01_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-157225</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-268426</us-gaap:NetIncomeLoss>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="shares" decimals="0">14388017</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="shares" decimals="0">23241707</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="shares" decimals="0">20355651</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="shares" decimals="0">22382415</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="Context_3ME_01_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" decimals="0">22924819</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" decimals="0">22917678</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="shares" decimals="0">21196096</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="shares" xsi:nil="true"/>
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="shares" xsi:nil="true"/>
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="shares" decimals="0">24008353</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="Context_3ME_01_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" xsi:nil="true"/>
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="shares" xsi:nil="true"/>
<us-gaap:EarningsPerShareBasicAndDiluted contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD_per_Share" decimals="2">-0.02</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD_per_Share" decimals="2">-0.04</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:EarningsPerShareBasic contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD_per_Share" decimals="2">-0.01</us-gaap:EarningsPerShareBasic>
<us-gaap:EarningsPerShareBasic contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD_per_Share" decimals="2">-0.05</us-gaap:EarningsPerShareBasic>
<us-gaap:EarningsPerShareBasic contextRef="Context_3ME_01_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD_per_Share" decimals="2">-0.01</us-gaap:EarningsPerShareBasic>
<us-gaap:EarningsPerShareBasic contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD_per_Share" decimals="2">-0.01</us-gaap:EarningsPerShareBasic>
<us-gaap:EarningsPerShareDiluted contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD_per_Share" xsi:nil="true"/>
<us-gaap:EarningsPerShareDiluted contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD_per_Share" xsi:nil="true"/>
<us-gaap:EarningsPerShareDiluted contextRef="Context_3ME_01_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD_per_Share" xsi:nil="true"/>
<us-gaap:EarningsPerShareDiluted contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD_per_Share" xsi:nil="true"/>
<us-gaap:SharesOutstanding contextRef="Context_As_Of_31_Dec_2012T00_00_00_TO_31_Dec_2012T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">14232496</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of_31_Dec_2012T00_00_00_TO_31_Dec_2012T00_00_00_StatementEquityComponentsAxis_PreferredStockMember" unitRef="shares" decimals="INF">65</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">14817496</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_PreferredStockMember" unitRef="shares" decimals="INF">65</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">22867319</us-gaap:SharesOutstanding>
<us-gaap:SharesOutstanding contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_PreferredStockMember" unitRef="shares" decimals="INF">0</us-gaap:SharesOutstanding>
<us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">7720</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
<us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">7720</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
<us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">272804</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
<us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">272804</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
<oprx:StockIssuedDuringPeriodValueConsultants contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">87278</oprx:StockIssuedDuringPeriodValueConsultants>
<oprx:StockIssuedDuringPeriodValueConsultants contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">146412</oprx:StockIssuedDuringPeriodValueConsultants>
<oprx:StockIssuedDuringPeriodValueConsultants contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="0">-59134</oprx:StockIssuedDuringPeriodValueConsultants>
<oprx:StockIssuedDuringPeriodValueConsultants contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">0</oprx:StockIssuedDuringPeriodValueConsultants>
<oprx:StockIssuedDuringPeriodValueConsultants contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">16935</oprx:StockIssuedDuringPeriodValueConsultants>
<oprx:StockIssuedDuringPeriodValueConsultants contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="0">-16935</oprx:StockIssuedDuringPeriodValueConsultants>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">105420</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">84</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">141856</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="0">-36520</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="Context_Custom_01_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_FinancialInstrumentAxis_SecuritiesPurchaseAgreementMember" unitRef="USD" decimals="0">10000000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">41667</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">167</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">26812</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_StockPayableMember" unitRef="USD" decimals="0">14688</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">84000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">167065</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="Context_Custom_01_Mar_2015T00_00_00_TO_31_Mar_2015T00_00_00_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="shares" decimals="INF">90000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="Context_Custom_01_Mar_2015T00_00_00_TO_31_Mar_2015T00_00_00_SubsequentEventTypeAxis_SubsequentEventMember_PlanNameAxis_IncrementOneMember" unitRef="shares" decimals="INF">45000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">0</us-gaap:StockIssuedDuringPeriodValueOther>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">500</us-gaap:StockIssuedDuringPeriodValueOther>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">504500</us-gaap:StockIssuedDuringPeriodValueOther>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="0">-505000</us-gaap:StockIssuedDuringPeriodValueOther>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="Context_3ME_01_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00_TitleOfIndividualAxis_DirectorMember" unitRef="USD" decimals="0">16375</us-gaap:StockIssuedDuringPeriodValueOther>
<us-gaap:StockIssuedDuringPeriodValueOther contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00_TitleOfIndividualAxis_DirectorMember" unitRef="USD" decimals="0">13375</us-gaap:StockIssuedDuringPeriodValueOther>
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">500000</us-gaap:StockIssuedDuringPeriodSharesOther>
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="Context_Custom_01_Jan_2014T00_00_00_TO_31_Jan_2014T00_00_00_TitleOfIndividualAxis_OfficerMember" unitRef="shares" decimals="INF">410348</us-gaap:StockIssuedDuringPeriodSharesOther>
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="Context_3ME_01_Apr_2015T00_00_00_TO_30_Jun_2015T00_00_00_TitleOfIndividualAxis_DirectorMember" unitRef="shares" decimals="INF">12500</us-gaap:StockIssuedDuringPeriodSharesOther>
<us-gaap:StockIssuedDuringPeriodSharesOther contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00_TitleOfIndividualAxis_DirectorMember" unitRef="shares" decimals="INF">12500</us-gaap:StockIssuedDuringPeriodSharesOther>
<oprx:StockIssuedDuringPeriodOfCommonStockValueForPriorIssue contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">0</oprx:StockIssuedDuringPeriodOfCommonStockValueForPriorIssue>
<oprx:StockIssuedDuringPeriodOfCommonStockValueForPriorIssue contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">1</oprx:StockIssuedDuringPeriodOfCommonStockValueForPriorIssue>
<oprx:StockIssuedDuringPeriodOfCommonStockValueForPriorIssue contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-1</oprx:StockIssuedDuringPeriodOfCommonStockValueForPriorIssue>
<oprx:StockIssuedDuringPeriodOfCommonStockShareForPriorIssue contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">1000</oprx:StockIssuedDuringPeriodOfCommonStockShareForPriorIssue>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Context_Custom_01_Dec_2008T00_00_00_TO_31_Dec_2008T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="USD" decimals="0">3500000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Context_Custom_01_Dec_2010T00_00_00_TO_31_Dec_2010T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="USD" decimals="0">1500000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Context_Custom_01_Sep_2011T00_00_00_TO_30_Sep_2011T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">644540</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Context_Custom_01_Feb_2012T00_00_00_TO_30_Sep_2012T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="USD" decimals="0">350000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Context_Custom_01_Feb_2013T00_00_00_TO_30_Sep_2013T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="USD" decimals="0">350000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">300000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">8795032</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="USD" decimals="0">1500000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">8333</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">8408699</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_StockPayableMember" unitRef="USD" decimals="0">378000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_01_Dec_2008T00_00_00_TO_31_Dec_2008T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="shares" decimals="INF">35</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_01_Apr_2010T00_00_00_TO_26_Apr_2010T00_00_00_FiniteLivedIntangibleAssetsByMajorClassAxis_PatentsMember" unitRef="shares" decimals="INF">300000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_01_May_2010T00_00_00_TO_12_May_2010T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="shares" decimals="INF">236598</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_01_Nov_2010T00_00_00_TO_16_Nov_2010T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="shares" decimals="INF">173922</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_01_Dec_2010T00_00_00_TO_31_Dec_2010T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="shares" decimals="0">15</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_01_Mar_2011T00_00_00_TO_25_Mar_2011T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="shares" decimals="INF">176768</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_01_Mar_2011T00_00_00_TO_25_Mar_2011T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">75758</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_01_Sep_2011T00_00_00_TO_21_Sep_2011T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="shares" decimals="INF">156306</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_01_Sep_2011T00_00_00_TO_21_Sep_2011T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">66988</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_01_Sep_2011T00_00_00_TO_30_Sep_2011T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="shares" decimals="0">15</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_Custom_01_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_FinancialInstrumentAxis_SecuritiesPurchaseAgreementMember" unitRef="shares" decimals="INF">8333333</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">8333333</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_AwardTypeAxis_StockCompensationPlanMember" unitRef="shares" decimals="INF">1500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">446</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="USD" decimals="0">-694133</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">693687</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="shares" decimals="INF">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">445765</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="USD" decimals="0">1110211</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-1110211</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
<oprx:StockIssuedDuringPeriodOfIssueStockRightsToOfficers contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">570375</oprx:StockIssuedDuringPeriodOfIssueStockRightsToOfficers>
<oprx:StockIssuedDuringPeriodOfIssueStockRightsToOfficers contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_StockPayableMember" unitRef="USD" decimals="0">570375</oprx:StockIssuedDuringPeriodOfIssueStockRightsToOfficers>
<oprx:ReclassificationForExpiredWarrants contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">0</oprx:ReclassificationForExpiredWarrants>
<oprx:ReclassificationForExpiredWarrants contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="USD" decimals="0">-1910002</oprx:ReclassificationForExpiredWarrants>
<oprx:ReclassificationForExpiredWarrants contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1910002</oprx:ReclassificationForExpiredWarrants>
<oprx:AdjustmentsToAdditionalPaidInCapitalExpiredAndRedeemedWarrants contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">0</oprx:AdjustmentsToAdditionalPaidInCapitalExpiredAndRedeemedWarrants>
<oprx:AdjustmentsToAdditionalPaidInCapitalExpiredAndRedeemedWarrants contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="USD" decimals="0">-16410832</oprx:AdjustmentsToAdditionalPaidInCapitalExpiredAndRedeemedWarrants>
<oprx:AdjustmentsToAdditionalPaidInCapitalExpiredAndRedeemedWarrants contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">16410832</oprx:AdjustmentsToAdditionalPaidInCapitalExpiredAndRedeemedWarrants>
<us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">330192</us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense>
<us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="0">330192</us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense>
<us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">287397</us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense>
<us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_DeferredCompensationShareBasedPaymentsMember" unitRef="USD" decimals="0">287397</us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense>
<us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">-6000000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
<us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">-896</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
<us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-5999104</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
<us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_PreferredStockMember" unitRef="USD" decimals="0">0</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
<us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="Context_Custom_01_Feb_2015T00_00_00_TO_28_Feb_2015T00_00_00_FinancialInstrumentAxis_CapitalMarketsAdvisoryAgreementMember" unitRef="USD" decimals="0">112500</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
<us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="Context_Custom_01_Jul_2015T00_00_00_TO_31_Jul_2015T00_00_00_SubsequentEventTypeAxis_SubsequentEventMember_FinancialInstrumentAxis_CapitalMarketsAdvisoryAgreementMember" unitRef="USD" decimals="0">56250</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
<us-gaap:StockRedeemedOrCalledDuringPeriodShares contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">-896340</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
<us-gaap:StockRedeemedOrCalledDuringPeriodShares contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_PreferredStockMember" unitRef="shares" decimals="INF">-65</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
<us-gaap:StockRedeemedOrCalledDuringPeriodShares contextRef="Context_Custom_01_Jan_2015T00_00_00_TO_31_Jan_2015T00_00_00_TitleOfIndividualAxis_DirectorMember" unitRef="shares" decimals="0">6250</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
<us-gaap:StockRedeemedOrCalledDuringPeriodShares contextRef="Context_Custom_01_Feb_2015T00_00_00_TO_28_Feb_2015T00_00_00_FinancialInstrumentAxis_CapitalMarketsAdvisoryAgreementMember" unitRef="shares" decimals="INF">90000</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
<us-gaap:GainLossOnDispositionOfAssets1 contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">0</us-gaap:GainLossOnDispositionOfAssets1>
<us-gaap:GainLossOnDispositionOfAssets1 contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">-3295</us-gaap:GainLossOnDispositionOfAssets1>
<oprx:StockOptionsIssuedForServices contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">-94998</oprx:StockOptionsIssuedForServices>
<oprx:StockOptionsIssuedForServices contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-19547</oprx:StockOptionsIssuedForServices>
<oprx:StockOptionsIssuedForServices contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-75451</oprx:StockOptionsIssuedForServices>
<oprx:StockOptionsIssuedForServices contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-627354</oprx:StockOptionsIssuedForServices>
<oprx:StockOptionsIssuedForServices contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-654634</oprx:StockOptionsIssuedForServices>
<oprx:StockOptionsIssuedForServices contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">-272804</oprx:StockOptionsIssuedForServices>
<oprx:StockOptionsIssuedForServices contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-361062</oprx:StockOptionsIssuedForServices>
<us-gaap:ShareBasedCompensation contextRef="Context_9ME_01_Jan_2013T00_00_00_TO_30_Sep_2013T00_00_00" unitRef="USD" decimals="0">404794</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_9ME_01_Jan_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">310823</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_9ME_01_Jan_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">93971</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">435612</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">399092</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">36520</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_3ME_01_Jan_2014T00_00_00_TO_31_Mar_2014T00_00_00" unitRef="USD" decimals="0">380217</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_3ME_01_Jan_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">361957</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_3ME_01_Jan_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">18260</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">170611</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">654634</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-52281</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_9ME_01_Jan_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">-1066672</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_9ME_01_Jan_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">1118952</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_9ME_01_Jan_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-52280</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">899438</us-gaap:ShareBasedCompensation>
<us-gaap:ShareBasedCompensation contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">110039</us-gaap:ShareBasedCompensation>
<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">894911</us-gaap:IncreaseDecreaseInAccountsReceivable>
<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-950166</us-gaap:IncreaseDecreaseInAccountsReceivable>
<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">55255</us-gaap:IncreaseDecreaseInAccountsReceivable>
<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-302202</us-gaap:IncreaseDecreaseInAccountsReceivable>
<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">173889</us-gaap:IncreaseDecreaseInAccountsReceivable>
<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">588672</us-gaap:IncreaseDecreaseInAccountsReceivable>
<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-181962</us-gaap:IncreaseDecreaseInAccountsReceivable>
<us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">-56387</us-gaap:IncreaseDecreaseInPrepaidExpense>
<us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">30198</us-gaap:IncreaseDecreaseInPrepaidExpense>
<us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">16322</us-gaap:IncreaseDecreaseInPrepaidExpense>
<us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">48283</us-gaap:IncreaseDecreaseInPrepaidExpense>
<us-gaap:IncreaseDecreaseInAccountsPayable contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">134046</us-gaap:IncreaseDecreaseInAccountsPayable>
<us-gaap:IncreaseDecreaseInAccountsPayable contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">203714</us-gaap:IncreaseDecreaseInAccountsPayable>
<us-gaap:IncreaseDecreaseInAccountsPayable contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">11633</us-gaap:IncreaseDecreaseInAccountsPayable>
<us-gaap:IncreaseDecreaseInAccountsPayable contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-28189</us-gaap:IncreaseDecreaseInAccountsPayable>
<oprx:RevenueSharePayable contextRef="Context_9ME_01_Jan_2013T00_00_00_TO_30_Sep_2013T00_00_00" unitRef="USD" decimals="0">-678201</oprx:RevenueSharePayable>
<oprx:RevenueSharePayable contextRef="Context_9ME_01_Jan_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-649825</oprx:RevenueSharePayable>
<oprx:RevenueSharePayable contextRef="Context_9ME_01_Jan_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-28376</oprx:RevenueSharePayable>
<oprx:RevenueSharePayable contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">-1196975</oprx:RevenueSharePayable>
<oprx:RevenueSharePayable contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-1103084</oprx:RevenueSharePayable>
<oprx:RevenueSharePayable contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-93891</oprx:RevenueSharePayable>
<oprx:RevenueSharePayable contextRef="Context_3ME_01_Jan_2014T00_00_00_TO_31_Mar_2014T00_00_00" unitRef="USD" decimals="0">333334</oprx:RevenueSharePayable>
<oprx:RevenueSharePayable contextRef="Context_3ME_01_Jan_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">395935</oprx:RevenueSharePayable>
<oprx:RevenueSharePayable contextRef="Context_3ME_01_Jan_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-62601</oprx:RevenueSharePayable>
<oprx:RevenueSharePayable contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">414563</oprx:RevenueSharePayable>
<oprx:RevenueSharePayable contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">686760</oprx:RevenueSharePayable>
<oprx:RevenueSharePayable contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-252693</oprx:RevenueSharePayable>
<oprx:RevenueSharePayable contextRef="Context_9ME_01_Jan_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">-11876</oprx:RevenueSharePayable>
<oprx:RevenueSharePayable contextRef="Context_9ME_01_Jan_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">340251</oprx:RevenueSharePayable>
<oprx:RevenueSharePayable contextRef="Context_9ME_01_Jan_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-352127</oprx:RevenueSharePayable>
<oprx:RevenueSharePayable contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">-215210</oprx:RevenueSharePayable>
<oprx:RevenueSharePayable contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">311766</oprx:RevenueSharePayable>
<us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">6000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
<us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-12000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
<us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">13459</us-gaap:IncreaseDecreaseInAccruedLiabilities>
<us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-15608</us-gaap:IncreaseDecreaseInAccruedLiabilities>
<us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="Context_9ME_01_Jan_2013T00_00_00_TO_30_Sep_2013T00_00_00" unitRef="USD" decimals="0">111880</us-gaap:IncreaseDecreaseInDeferredRevenue>
<us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="Context_9ME_01_Jan_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-35980</us-gaap:IncreaseDecreaseInDeferredRevenue>
<us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="Context_9ME_01_Jan_2013T00_00_00_TO_30_Sep_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">147860</us-gaap:IncreaseDecreaseInDeferredRevenue>
<us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">177020</us-gaap:IncreaseDecreaseInDeferredRevenue>
<us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-45000</us-gaap:IncreaseDecreaseInDeferredRevenue>
<us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">222020</us-gaap:IncreaseDecreaseInDeferredRevenue>
<us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="Context_3ME_01_Jan_2014T00_00_00_TO_31_Mar_2014T00_00_00" unitRef="USD" decimals="0">192381</us-gaap:IncreaseDecreaseInDeferredRevenue>
<us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="Context_3ME_01_Jan_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">164462</us-gaap:IncreaseDecreaseInDeferredRevenue>
<us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="Context_3ME_01_Jan_2014T00_00_00_TO_31_Mar_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">27919</us-gaap:IncreaseDecreaseInDeferredRevenue>
<us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">19651</us-gaap:IncreaseDecreaseInDeferredRevenue>
<us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">38656</us-gaap:IncreaseDecreaseInDeferredRevenue>
<us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">55124</us-gaap:IncreaseDecreaseInDeferredRevenue>
<us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="Context_9ME_01_Jan_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">-148334</us-gaap:IncreaseDecreaseInDeferredRevenue>
<us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="Context_9ME_01_Jan_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-4252</us-gaap:IncreaseDecreaseInDeferredRevenue>
<us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="Context_9ME_01_Jan_2014T00_00_00_TO_30_Sep_2014T00_00_00_CreationDateAxis_RestatementAdjustmentMember" unitRef="USD" decimals="0">-144082</us-gaap:IncreaseDecreaseInDeferredRevenue>
<us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">-106142</us-gaap:IncreaseDecreaseInDeferredRevenue>
<us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">216083</us-gaap:IncreaseDecreaseInDeferredRevenue>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">1132628</us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-149745</us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">-56350</us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">246172</us-gaap:NetCashProvidedByUsedInOperatingActivities>
<oprx:PurchasesOfPropertyAndEquipment contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">0</oprx:PurchasesOfPropertyAndEquipment>
<oprx:PurchasesOfPropertyAndEquipment contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">1592</oprx:PurchasesOfPropertyAndEquipment>
<oprx:PurchasesOfPropertyAndEquipment contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">6984</oprx:PurchasesOfPropertyAndEquipment>
<oprx:PurchasesOfPropertyAndEquipment contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" xsi:nil="true"/>
<oprx:PatentRights contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">150588</oprx:PatentRights>
<oprx:PatentRights contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">92624</oprx:PatentRights>
<oprx:PatentRights contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">110551</oprx:PatentRights>
<oprx:PatentRights contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">4517</oprx:PatentRights>
<oprx:WebsiteDevelopmentCosts contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">148060</oprx:WebsiteDevelopmentCosts>
<oprx:WebsiteDevelopmentCosts contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">119616</oprx:WebsiteDevelopmentCosts>
<oprx:WebsiteDevelopmentCosts contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">292417</oprx:WebsiteDevelopmentCosts>
<oprx:WebsiteDevelopmentCosts contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">42750</oprx:WebsiteDevelopmentCosts>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">-298648</us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-213832</us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">-409952</us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">-47267</us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">10000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">8795032</us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" xsi:nil="true"/>
<oprx:StockIssueDuringPeriodValueIssuedForCash contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-1204968</oprx:StockIssueDuringPeriodValueIssuedForCash>
<oprx:StockIssueDuringPeriodValueIssuedForCash contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-6000000</us-gaap:ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants>
<us-gaap:ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:PaymentsForRepurchaseOfEquity contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">0</us-gaap:PaymentsForRepurchaseOfEquity>
<us-gaap:PaymentsForRepurchaseOfEquity contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">6000000</us-gaap:PaymentsForRepurchaseOfEquity>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">2795032</us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">2795032</us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">833980</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">2431455</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">2328730</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">198905</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<us-gaap:InterestPaid contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">0</us-gaap:InterestPaid>
<us-gaap:InterestPaid contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:InterestPaid contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">0</us-gaap:InterestPaid>
<us-gaap:InterestPaid contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:IncomeTaxesPaid contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxesPaid>
<us-gaap:IncomeTaxesPaid contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:IncomeTaxesPaid contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxesPaid>
<us-gaap:IncomeTaxesPaid contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" xsi:nil="true"/>
<us-gaap:StockIssued1 contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">270462</us-gaap:StockIssued1>
<us-gaap:StockIssued1 contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">0</us-gaap:StockIssued1>
<us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;NOTE 1 &amp;#8211; NATURE OF BUSINESS&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;OptimizeRx Corporation, is a technology solutions company targeting the health care industry. Our objective is to bring better access to better care through connecting patients, physicians and pharmaceutical manufacturers through technology. Originally defined as a marketing and advertising company through our consumer website, we have matured into a technology solutions provider as we launched our direct to physician solution, SampleMD. SampleMD allows physicians to search, print and send available sample trial vouchers and/or co-pay coupons on behalf of their patients. The SampleMD solution is integrated into the physician&amp;#8217;s ePrescribing or Electronic Medical Records applications, but could also be a stand-alone desktop application. OptimizeRx solutions provide pharmaceutical manufacturers a direct to physician channel for communicating and promoting their products. It provides health care providers a means to provide sampling and coupons without having to physically store samples on site, and it provides better access and affordability to patients.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The company was originally formed as Optimizer Systems, LLC in the State of Michigan on January 31, 2006. It incorporated in the State of Michigan on October 22, 2007 and changed its name to OptimizeRx Corporation. On April 14, 2008, RFID, Ltd., a Colorado corporation, consummated a reverse merger by entering into a share exchange agreement with the stockholders of OptimizeRx Corporation, pursuant to which the stockholders of OptimizeRx Corporation exchanged all of the issued and outstanding capital stock of OptimizeRx Corporation for 1,256,958 shares of common stock of RFID, Ltd., representing 100% of the outstanding capital stock of RFID, Ltd. As of April&amp;#160;30, 2008, RFID&amp;#8217;s officers and directors resigned their positions and RFID changed its business to OptimizeRx&amp;#8217;s business. On April&amp;#160;15, 2008, RFID, Ltd.&amp;#8217;s corporate name was changed to OptimizeRx Corporation. On September&amp;#160;4, 2008, a migratory merger was completed, thereby changing the state of incorporation from Colorado to Nevada, resulting in the current corporate structure, in which OptimizeRx Corporation, a Nevada corporation, is the parent corporation, and OptimizeRx Corporation, a Michigan corporation, which is a wholly-owned subsidiary (together, "OptimizeRx" and "the Company").&lt;/p&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
<us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;NOTE 1 &amp;#8211; NATURE OF BUSINESS AND BASIS OF PRESENTATION&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;OptimizeRx Corporation is a technology solution company focused on the health care industry. Its objective is to bring better access to better care by leveraging its proprietary technology to provide on demand savings and support within physicians and patients web based platforms, including Electronic Health Records and Patient Portals. Initially defined as a marketing and advertising company through its consumer website, OptimizeRx.com, the Company has matured as a technology solutions provider through its direct to physician solution, SampleMD. SampleMD allows physicians to automatically display and distribute sample vouchers and/or co-pay coupons electronically within the ePrescription platform to pharmacies on behalf of their patients. The SampleMD solution is integrated into the ePrescribing or Electronic Medical Records applications, but can also sit on a prescriber&amp;#8217;s desktop.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;OptimizeRx solutions provide health care institutions with an alternative option to the traditional hassles and issues associated with storing and managing physical drug samples and pre-printed coupons and it provides better access and affordability to patients to improve affordability, adherence and outcomes. In turn, OptimizeRx provides pharmaceutical manufacturers with both direct to consumer and direct to physician channels for more efficiently communicating and promoting their products and savings.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The consolidated financial statements for the three and six month periods ended June 30, 2015 and 2014 have been prepared by us without audit pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of management, all adjustments necessary to present fairly our financial position, results of operations, and cash flows as of June 30, 2015 and 2014, and for the periods then ended, have been made. Those adjustments consist of normal and recurring adjustments. The consolidated balance sheet as of December 31, 2014, has been derived from the audited consolidated balance sheet as of that date.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Certain information and note disclosures normally included in our annual financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted. These consolidated financial statements should be read in conjunction with a reading of the financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014, as filed with the Securities and Exchange Commission.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The results of operations for the three and six month periods ended June 30, 2015, are not necessarily indicative of the results to be expected for the full year. Certain reclassifications have been made in the prior period&amp;#8217;s consolidated financial statements to conform to the current period&amp;#8217;s presentation.&lt;/p&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
<us-gaap:SignificantAccountingPoliciesTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;NOTE 2 &amp;#8211; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;u&gt;Basis of Presentation&lt;/u&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;u&gt;Accounting Basis&lt;/u&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company uses the accrual basis of accounting and accounting principles generally accepted in the United States of America (&amp;#8220;GAAP&amp;#8221; accounting). The Company has adopted a December 31 fiscal year end.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&lt;u&gt;Principles of Consolidation&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;The financial statements reflect the consolidated results of OptimizeRx Corporation (a Nevada corporation) and its wholly owned subsidiary OptimizeRx Corporation (a Michigan corporation). All material inter-company transactions have been eliminated in the consolidation.&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&lt;u&gt;Cash and Cash Equivalents&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;For purposes of the accompanying financial statements, the Company considers all highly liquid instruments with an initial maturity of three months or less to be cash equivalents.&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;u&gt;Fair Value of Financial Instruments&lt;/u&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;The fair value of cash, accounts receivable, prepaid expenses, accounts payable, accounts payable &amp;#8211; related party, accrued expenses and deferred revenue approximates the carrying amount of these financial instruments due to their short-term nature.&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Fair value is defined as the price that would be received upon sale of an asset
 or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date and in the principal or most advantageous market for that asset or liability. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the entity. In addition, the fair value of liabilities should include consideration of non-performance risk including our own credit risk.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;In addition to defining fair value, the disclosure requirements around fair value establish a fair value hierarchy for valuation inputs which is expanded. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of the three levels which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Level 1 &amp;#8211; inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Level 2 &amp;#8211; inputs are based upon significant observable inputs other than quoted prices included in Level 1, such as quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Level 3 &amp;#8211; inputs are generally unobservable and typically reflect management&amp;#8217;s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques that include option pricing models, discounted cash flow models, and similar techniques. The Company&amp;#8217;s stock options and warrants are valued using level 3 inputs.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The carrying value of the Company&amp;#8217;s financial assets and liabilities which consist of cash, accounts receivable, prepaid expenses, patent rights, web development costs, accounts payable, accounts payable &amp;#8211; related party, accrued expenses and deferred revenue are valued using level 1 inputs. The Company believes that the recorded values approximate their fair value due to the short maturity of such instruments. Unless otherwise noted, it is management&amp;#8217;s opinion that the Company is not exposed to significant interest, exchange or credit risks arising from these financial instruments.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;u&gt;Accounts Receivable and Allowance for Doubtful Accounts&lt;/u&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact
 the collectability of these receivables or reserve estimates. Because the Company&amp;#8217;s customers are primarily large well capitalized companies, historically there has been very little bad debt expense. Bad debt expense was $0 for each of the years ended December&amp;#160;31, 2014 and 2013. The allowance for doubtful accounts was $0 as of both December&amp;#160;31, 2014 and 2013.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;u&gt;Property and Equipment&lt;/u&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;The capital assets are being depreciated over their estimated useful lives of three to seven years using the straight-line method of depreciation for book purposes.&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;u&gt;Revenue Recognition and Revenue Share Expense&lt;/u&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Revenue is recognized when it is earned. Revenues are generated from our SampleMD activities in which we deliver eCoupons and eVouchers through a distribution network of ePrescribers and Electronic Health Record technology providers (channel partners), or from reselling services that complement our business for other of our partners.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;We recognize setup fees that are required for integrating client offerings and campaigns into the SampleMD content delivery system and network upon completion of the setup and launch of the client&amp;#8217;s campaign within the SampleMD system. As the eCoupons and or eVouchers are distributed through the SampleMD platform and network of channel partners (a transaction), these transactions are recorded and revenue is recognized at the time of distribution. Revenue for transactions can be realized based on a price per distribution or a price per redemption depending on the client contract. Additionally, the company also recognizes revenue for providing program performance reporting and maintenance, either by the company directly delivering reports or by providing access to its online reporting portal that the client can utilize. These fees are charged monthly and recognized as recurring monthly revenue.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The company on occasion has also resold products and or services that are available through our channel partners, and that is complementary to our core businesses and client base. In these instances net revenue is recognized based on the commission based revenue split that the company receives.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Based on the volume of transactions that are delivered through our channel partner network, we provide a revenue share to compensate the partner for their promotion of the campaign. Revenue shares are a negotiated percentage of the transaction fees and can also be specific to special considerations and campaigns. In addition, we pay revenue share to PDR/LDM as a result of a 2014 legal settlement in an amount equal to the greater of 10% of eCoupon revenues generated or $0.37 per eCoupon distributed.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;u&gt;Income Taxes&lt;/u&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal;
 -webkit-text-stroke-width: 0px;"&gt;Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;u&gt;Use of Estimates&lt;/u&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates and assumptions have been made in determining the depreciable lives of such assets and the allowance for doubtful accounts receivable. Actual results could differ from these estimates.&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;u&gt;Concentration of Credit Risks&lt;/u&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;The Company maintains its cash and cash equivalents in bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts; however, amounts in excess of the federally insured limit may be at risk if the bank experiences financial difficulties.&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;u&gt;Research and Development&lt;/u&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;The Company expenses research and development expenses as incurred. Our research efforts are focused on understanding the market dynamics that have the potential to affect the business in both the short and long term. Our primary goal is to help patients better afford and access the medicines their doctor prescribes, as well as other healthcare products and services they need. Based on this, the Company continually seeks better ways to meet this mission through improved technology, better user experiences and new ways to engage industries to provide new support for patients needing their products, as well seeking new services and solutions to offer.&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&lt;u&gt;Share-based Payments&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company uses the fair value method to account for stock-based compensation. The fair value of the equity instrument is charged directly to compensation expense and additional paid-in capital over the period during which services are rendered. The fair value of each award is estimated on the date of each grant. For restricted stock the fair market value is based on the market value of the stock granted on the date of the grant. For options, it is estimated using the Black Scholes option pricing model that uses the assumptions noted in the following table. Estimated volatilities are based on the historical volatility of the Company&amp;#8217;s stock over the same period as the expected term of the options. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The Company uses historical data to estimate option exercise behavior and to determine this term. The risk free rate used is based on the U.S. Treasury yield curve in effect at the time of the grant using a time period equal to the expected option term. The Company has never paid dividends and does not expect to pay any dividends in the future.&lt;/p&gt;&lt;p style="font:
 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: center; text-indent: 0px; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;2014&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: center; text-indent: 0px; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;2013&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: center; text-indent: 0px; font-size: 10pt; background-color: white;" colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: center; text-indent: 0px; font-size: 10pt; background-color: white;" colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="padding: 0px; width: 758px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;Expected dividend yield&lt;/td&gt;&lt;td style="padding: 0px; width: 10px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; width: 10px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; width: 114px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;0&lt;/td&gt;&lt;td style="padding: 0px; width: 11.33px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;%&lt;/td&gt;&lt;td style="padding: 0px; width: 10px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; width: 10px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; width: 104.66px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;0&lt;/td&gt;&lt;td style="padding: 0px; width: 11.33px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;Risk free interest rate&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;0.90%-1.44%&lt;/font&gt;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;0.79%-1.42%&lt;/font&gt;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;Expected option term&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;3.5 years&lt;/font&gt;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;5.0 years&lt;/font&gt;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;Turnover/forfeiture rate&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;0&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;%&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;0&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px;
 font-size: 10pt; background-color: white;"&gt;Expected volatility&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;117% - 138%&lt;/font&gt;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;155% - 171%&lt;/font&gt;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 25.9pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Black-Scholes option valuation model and other existing models were developed for use&amp;#160;in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. These option valuation models require the input of, and are highly sensitive to, subjective assumptions including the expected stock price volatility. OptimizerRx&amp;#8217;s stock options have characteristics significantly different from those of traded options, and changes in the subjective input assumptions could materially affect the fair value estimate.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0.25in 0px 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"&gt;&lt;u&gt;Loss Per Common and Common Equivalent Share&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"&gt;The computation of basic earnings per common share is computed using the weighted average number of common shares outstanding during the year. The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the year plus common stock equivalents which would arise from the exercise of warrants outstanding using the treasury stock method and the average market price per share during the year. Options, warrants and convertible preferred stock have not been included in the diluted earnings per share calculation for either year since their effect is anti-dilutive.&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;u&gt;Impairment of Long-Lived Assets&lt;/u&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;The Company continually monitors events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, the Company assesses the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell.&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;u&gt;Recently Issued Accounting Guidance&lt;/u&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company&amp;#8217;s results of operations, financial position or cash flow.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
<us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00">&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;NOTE 3 &amp;#8211; SHARE BASED PAYMENTS &amp;#8211; OPTIONS&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;"&gt;We use the fair value method to account for stock based compensation. We recorded $110,039 and $170,611 in compensation expense in the periods ended June 30, 2015 and 2014, respectively, related to options issued under our stock-based incentive compensation plan. This includes expense related to options issued in prior years for which the requisite service period for those options includes the current year, options granted in the current year and options repriced in the current year. The fair value of these instruments was calculated using the Black-Scholes option pricing model. Information related to the assumptions used in this model is set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014.&lt;/p&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
<oprx:PrepaidExpensesTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;NOTE 3 &amp;#8211; PREPAID EXPENSES&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;Prepaid expenses consisted of the following as of December&amp;#160;31, 2014 and 2013:&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;&lt;table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;2014&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;2013&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="width: 1191px; font-size: 10pt; background-color: white;"&gt;Insurance&lt;/td&gt;&lt;td style="width: 16px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px; font-size: 10pt; text-align: left; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="width: 142px; font-size: 10pt; text-align: right; background-color: white;"&gt;18,093&lt;/td&gt;&lt;td style="width: 16px; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px; font-size: 10pt; text-align: left; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="width: 141px; font-size: 10pt; text-align: right; background-color: white;"&gt;6,722&lt;/td&gt;&lt;td style="width: 15px; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;Rent&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;-0-&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;5,049&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;Legal&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right; background-color: white;"&gt;10,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right; background-color: white;"&gt;-0-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; text-align: left; padding-bottom: 4pt; background-color: white;"&gt;Total prepaid expenses&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 4pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right; background-color: white;"&gt;28,093&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 4pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right; background-color: white;"&gt;11,771&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color:
 white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;</oprx:PrepaidExpensesTextBlock>
<us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;NOTE 4 &amp;#8211; PROPERTY AND EQUIPMENT&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company owned equipment recorded at cost which consisted of the following as of December&amp;#160;31, 2014 and 2013:&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;table style="width: 1250.4px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;2014&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;2013&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="width: 950.4px; text-align: left; font-size: 10pt;"&gt;Computer equipment&lt;/td&gt;&lt;td style="width: 12.8px; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 12.8px; text-align: left; font-size: 10pt;"&gt;$&lt;/td&gt;&lt;td style="width: 112.8px; text-align: right; font-size: 10pt;"&gt;19,519&lt;/td&gt;&lt;td style="width: 12.8px; text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 12.8px; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 12px; text-align: left; font-size: 10pt;"&gt;$&lt;/td&gt;&lt;td style="width: 112px; text-align: right; font-size: 10pt;"&gt;22,360&lt;/td&gt;&lt;td style="width: 12px; text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"&gt;Furniture and fixtures&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"&gt;11,088&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"&gt;11,088&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="padding-left: 10pt; font-size: 10pt;"&gt;Subtotal&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt;"&gt;30,607&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt;"&gt;33,448&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"&gt;(17,794&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"&gt;(18,391&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; padding-bottom: 4pt; padding-left: 10pt; font-size: 10pt;"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"&gt;12,813&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"&gt;15,057&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform:
 none;
 text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Depreciation expense was $5,933 and $5,628 for the years ended December&amp;#160;31, 2014 and 2013, respectively.&lt;/p&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
<oprx:WebBasedTechnologyTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;NOTE 5 &amp;#8211; WEB-BASED TECHNOLOGY&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company has capitalized costs in developing their web-based technology, which consisted of the following as of December&amp;#160;31, 2014 and 2013:&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;2014&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;2013&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="width: 1191px; text-align: left; font-size: 10pt; background-color: white;"&gt;OptimizeRx web-based technology&lt;/td&gt;&lt;td style="width: 16px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px; text-align: left; font-size: 10pt; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="width: 142px; text-align: right; font-size: 10pt; background-color: white;"&gt;154,133&lt;/td&gt;&lt;td style="width: 16px; text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px; text-align: left; font-size: 10pt; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="width: 141px; text-align: right; font-size: 10pt; background-color: white;"&gt;154,133&lt;/td&gt;&lt;td style="width: 15px; text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;SampleMD web-based technology&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; background-color: white;"&gt;602,517&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; background-color: white;"&gt;602,517&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;SampleMD 2.0 web-based technology&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;440,477&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;148,060&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; padding-left: 10pt; font-size: 10pt; background-color: white;"&gt;Subtotal, web-based technology&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; background-color: white;"&gt;1,197,127&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; background-color: white;"&gt;904,710&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;Accumulated amortization&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; background-color: white;"&gt;(633,401&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; background-color: white;"&gt;(440,641&lt;/td&gt;&lt;td style="text-align: left;
 font-size: 10pt; background-color: white;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;Impairment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;(59,083&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;(59,083&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; padding-bottom: 4pt; padding-left: 10pt; font-size: 10pt; background-color: white;"&gt;Web-based technology, net&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;504,643&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 4pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;404,986&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 4pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;div style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Amortization is recorded using the straight-line method over a period of up to five years. During 2014, the Company launched its SampleMD 2.0 web-based technology. The OptimizeRx web-based technology was fully impaired in 2010 and has no remaining carrying value. Amortization expense for the web-based technology costs was $192,760 and $130,289 for the years ended December&amp;#160;31, 2014 and 2013, respectively.&lt;/div&gt;&lt;/div&gt;</oprx:WebBasedTechnologyTextBlock>
<us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;NOTE 6 &amp;#8211; PATENT AND TRADEMARKS&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;On April&amp;#160;26, 2010, the Company acquired the technical contributions and assignment of all exclusive rights to and for the SampleMD patent from an officer and shareholder in exchange for 300,000 shares of common stock to be granted at the discretion of the seller in addition to 200,000 stock options, which expire in April 2015, that were valued at $360,000. The shares were valued on the grant date at $570,000 and have been recorded as a payable to the related party.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company has capitalized costs in purchasing and defending the SampleMD patent, which consisted of the following as of December&amp;#160;31, 2014 and 2013:&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;2014&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;2013&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="width: 1191px; text-align: left; font-size: 10pt; background-color: white;"&gt;Patent rights and intangible assets&lt;/td&gt;&lt;td style="width: 16px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px; text-align: left; font-size: 10pt; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="width: 142px; text-align: right; font-size: 10pt; background-color: white;"&gt;930,000&lt;/td&gt;&lt;td style="width: 16px; text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px; text-align: left; font-size: 10pt; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="width: 141px; text-align: right; font-size: 10pt; background-color: white;"&gt;930,000&lt;/td&gt;&lt;td style="width: 15px; text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;Patent defense costs&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; background-color: white;"&gt;170,937&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; background-color: white;"&gt;87,993&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;New patents and trademarks&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; background-color: white;"&gt;90,202&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; background-color: white;"&gt;62,595&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;Accumulated amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;(260,285&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td
 style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;(194,638&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; padding-bottom: 4pt; padding-left: 10pt; font-size: 10pt; background-color: white;"&gt;Patent rights and intangible assets, net&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;930,854&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 4pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;885,950&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 4pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;div style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company began amortizing the patent, using the straight-line method over the estimated useful life of 17 years, once it was put into service in July 2010. In 2013, the Company began incurring costs related to defense of the patent. These costs have been capitalized and will be amortized using the straight-line method over the remaining useful life of the original patent. Amortization expense was $65,647 and $57,874 for the years ended December&amp;#160;31, 2014 and 2013, respectively.&lt;/div&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
<us-gaap:DeferredRevenueDisclosureTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;NOTE 7 &amp;#8211; DEFERRED REVENUE&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company has several signed contracts with customers for the distribution or redemption of coupons, or other services, which include payment in advance. The payments are not recorded as revenue until the revenue is earned under its revenue recognition policy discussed in Note 1. Deferred revenue was $120,130 and $226,272 as of December&amp;#160;31, 2014 and 2013, respectively.&lt;/p&gt;</us-gaap:DeferredRevenueDisclosureTextBlock>
<us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;NOTE 8 &amp;#8211; RELATED PARTY TRANSACTIONS&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;During the year ended December&amp;#160;31, 2010, the Company acquired the technical contributions and assignment of all exclusive rights to and for the SampleMD patent in process at the time from an officer and shareholder in exchange for 300,000 shares of common stock to be granted at the discretion of the seller in addition to 200,000 stock options, which expire in April 2015, that were valued at $360,000. The shares were valued on the grant date at $570,000 and have been recorded as a payable to the related party.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
<us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;NOTE 9 &amp;#8211; COMMON STOCK&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;OptimizeRx Corporation has 500,000,000 shares of $.001 par value common stock authorized as of December 31, 2014. There were 22,867,319 and 14,817,496 common shares issued and outstanding at December&amp;#160;31, 2014 and 2013, respectively.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;On June&amp;#160;1, 2013, the Company entered into a consulting agreement with North Coast Advisors, Inc. for various services. The Company agreed to issue 20,000 shares of common stock as of the date of the contract. The Company also agreed to issue an additional 20,000 shares every six months in alignment with the agreement renewal up to the two years of the agreement. The first 20,000 shares were valued at the Company&amp;#8217;s common stock closing price as of the date of the contract, which was $1.945/share; and the second 20,000 shares were valued at the Company&amp;#8217;s common stock closing price of $1.50/share on the date of issuance, and have been expensed. An additional 10,000 shares were issued in 2014 before the agreement was terminated by the Company. The 2014 shares were valued at $1.85, the closing price of the Company&amp;#8217;s common stock on the date of issuance.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;On June 10, 2013, the Company entered into a capital markets advisory agreement with Taglich Brothers, Inc. for various services. The agreement covered a one year period and the Company agreed to issue 44,000 shares of common stock to Taglich over the term of the agreement. The shares were valued at $1.66, the closing price of the stock on the date of the agreement and were written off over the term of the agreement. The shares were issued in June 2014 upon expiration of the contract.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;On September&amp;#160;20, 2013, the Company entered into a separation agreement that included post-employment consulting services with the former CEO of the Company. The Company agreed to issue 500,000 shares of common stock, 250,000 shares immediately and 250,000 by January&amp;#160;1, 2014. The shares have been issued and the Company recognized the entire issuance in the December 31, 2013 shares outstanding. The shares were valued at $505,000 and $174,808 of that amount remained as deferred stock compensation as of December&amp;#160;31, 2013, but has been fully amortized to expenses as of December 31, 2014.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;In&amp;#160;March 2014,&amp;#160;the Company&amp;#160;entered into a securities purchase agreement, pursuant to which&amp;#160;the Company&amp;#160;sold 8,333,333 shares of&amp;#160;the Company&amp;#8217;s common stock for $1.20 per share, or gross proceeds of $10,000,000.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;div style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Placement agents in the offering received commissions equal to approximately 9.7% of gross proceeds, for an aggregate commission of approximately $970,000, including reimbursements for their reasonable out of pocket expenses. Placement agents also received warrants to purchase up to 804,139 shares of&amp;#160;the Company's common stock with an exercise price of $1.20 per share and a term of 5 years. The warrants were valued at $1,110,211, have been recorded as equity issuance costs, and were registered on a registration statement dated May 28, 2014. In addition to the warrants to placement agents, the Company also paid cash bonuses of $240,000 to three executive officers, agreed to issue 200,000 shares to
 three executive officers, and issued 150,000 shares to a consultant, in connection with the equity raise. The stock was valued based on the fair market value on the grant date, which was $630,000 in total. These amounts have been recorded as equity issuance costs, resulting in total equity issuance costs of $2.95 million. The 200,000 shares for the three executive officers have not been issued, but are recorded as stock payable and can be requested by the respective officers at any time.&lt;/div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company&amp;#160;used the net proceeds of the offering to exercise the securities redemption option agreement, as amended, with Vicis Capital Master Fund that provided&amp;#160;the Company&amp;#160;with an option to purchase all of the outstanding shares and derivative securities held by Vicis for total payment of $6,000,000. The shares and derivative securities included the Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Common Stock, and warrants to purchase shares of common stock held by Vicis in the Company. The balance of the net proceeds was used for working capital purposes.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;In January 2014, an executive officer exercised 500,000 stock warrants using the cashless exercise feature included in the warrants. In exchange for the 500,000 warrants, 410,348 shares of common stock were issued. In October 2014, a consultant exercised 50,000 stock warrants using the cashless exercise feature included in the warrants. In exchange for the 50,000 warrants, 35,417 shares of common stock were issued.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;In February 2014, the Company agreed to grant 337,500 shares of common stock, half of which vested immediately and half of which vested in August 2014, to two executive officers as bonuses based on their efforts to recapitalize the company to secure approximately $3 million in working capital while reducing potential fully diluted shares by approximately 7 million shares. Stock-based compensation related to these bonuses was $570,375 during the year ended December 31, 2014. These shares have not yet been issued and are recorded as stock payable, but can be requested by the officers at any time.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;div style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;In 2014, the Company adopted a Director Compensation plan for outside Directors. In connection with this plan, 19,565 shares were granted with a total value of $23,166. A total of 7,065 shares were issued in 2014 and 12,500 shares were included in stock payable at December 31, 2014 and issued in January 2015.&lt;/div&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
<us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;NOTE 2 &amp;#8211; STOCKHOLDERS EQUITY&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;In January 2015, we issued 12,500 shares of common stock to outside Directors in connection with our Director Compensation plan, which calls for issuance of 6,250 shares per quarter for each Director. Those shares were recorded as stock payable at December 31, 2014. In addition, we recorded an additional 12,500 shares, valued at $16,375 as stock payable at March 31, 2015 for shares to be issued in April 2015 and 12,500 shares, valued at $13,375 were issued in June 2015 for the second quarter payment.&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;In February 2015, we entered into a capital markets advisory agreement covering a one year period, which called for 90,000 shares of common stock to be issued as compensation. These shares were valued at $112,500 and are being amortized to expense over the period of service. 45,000 of these shares were issued in March 2015, with the balance to be issued in August 2015. The agreement was terminated in July 2015, effective in August, and the remaining 45,000 shares will not be issued. The total expense to be recognized will be $56,250 and is being amortized over the period the agreement is in effect.&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;In&amp;#160;March 2014,&amp;#160;we&amp;#160;entered into a securities purchase agreement, pursuant to which&amp;#160;we&amp;#160;sold 8,333,333 shares of&amp;#160;our common stock for $1.20 per share, or gross proceeds of $10,000,000.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Placement agents in the offering received commissions equal to approximately 9.7% of gross proceeds, for an aggregate commission of approximately $970,000, including reimbursements for their reasonable out of pocket expenses. Placement agents also received warrants to purchase up to 804,139 shares of&amp;#160;our common stock with an exercise price of $1.20 per share and a term of 5 years. The warrants were valued at $1,110,211, have been recorded as equity issuance costs, and were registered on a registration statement that went effective May 28, 2014. In addition to the warrants to placement agents, we also paid cash bonuses of $240,000 to three executive officers, agreed to issue 200,000 shares to three executive officers, and issued 150,000 shares to a consultant, in connection with the equity raise. The stock was valued based on the fair market value on the grant date, which was $630,000 in total. These amounts have been recorded as equity issuance costs, resulting in total equity issuance costs of $2.95 million. The 200,000 shares for the three executive officers have not been issued, but are recorded as stock payable and can be requested by the executive officers at any time.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;We&amp;#160;used the net proceeds of the offering to exercise the securities redemption option agreement, as amended, with Vicis Capital Master Fund that provided&amp;#160;us&amp;#160;with an option to purchase all of the outstanding shares and derivative securities held by Vicis for total payment of $6,000,000. The shares and derivative securities included the Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Common Stock, and warrants to purchase shares of common stock held by Vicis in the Company. The balance of the net proceeds were used for working capital purposes.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal;
 -webkit-text-stroke-width:
 0px;"&gt;In January 2014, an executive officer exercised 500,000 stock warrants using the cashless exercise feature included in the warrants. In exchange for the 500,000 warrants, 410,348 shares of common stock were issued.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;In June 2015, we agreed to grant 197,605 fully vested shares of our common stock to two executive officers as bonuses. These shares have not been issued, but are recorded as stock payable and can be requested by the officers at any time.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;In February 2014, we agreed to grant 337,500 shares of our common stock, half of which vested immediately and half of which vested in August 2014, to two executive officers as bonuses based on their efforts to recapitalize the company to secure approximately $3 million in working capital while reducing fully diluted shares by approximately 7 million shares. These shares have not been issued, but are recorded as stock payable and can be requested by the officers at any time.&lt;/p&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
<us-gaap:PreferredStockTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;NOTE 10 &amp;#8211; PREFERRED STOCK&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&lt;u&gt;Series A Preferred&lt;/u&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;During the year ended December&amp;#160;31, 2008, 35 preferred shares were issued for $3,500,000. Issuance costs totaled $515,000 resulting in net proceeds of $2,985,000. The 35 shares are convertible to 3,500,000 shares of common stock and bear a 10% cumulative dividend. In addition, there was a warrant issued to purchase 6,000,000 shares of common stock at an exercise price of $2 for a period of seven years.&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;The holders of the preferred stock are entitled to semi-annual dividends payable on the stated value of the Series A preferred stock at a rate of 10% per annum, which shall be cumulative, and accrue daily from the issuance date. The dividends may be paid in cash or shares of the Company's common stock at management&amp;#8217;s discretion. If after the conversion eligibility date, the market price for the common stock for any ten consecutive trading days in which the stock trades for over $2 per share and trading exceeds 100,000 shares per day, the preferred shareholders can be required to convert their shares to common stock. Each share of Series A preferred stock shall also be convertible at the option of the holder into that number of shares of common stock of the Company at the stated value of such share at a $1 conversion price.&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;The holder could cause this conversion at the time the shares are eligible for resale by the holder. The conversion price is subject to adjustment as hereinafter provided, at any time, or from time to time upon the terms and in the manner hereinafter set forth in the shareholder agreement. There is no conversion expiration date, however, the holder must provide 30 days notice for the registration of the conversion.&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;On May&amp;#160;12, 2010, the Company&amp;#8217;s Board declared and issued 236,598 common shares as payment for all cumulative and current semi-annual dividends. On November&amp;#160;16, 2010, the Company&amp;#8217;s Board declared and issued 173,922 common shares for its semi-annual dividend payment. On March&amp;#160;25, 2011, the Company&amp;#8217;s Board declared and issued 176,768 common shares for its semi-annual dividend payment. On September&amp;#160;21, 2011, the Company's Board declared and issued 156,306 common shares for its semi-annual dividend payment. The Company has undeclared dividends that were due in February and September 2012 totaling $350,000 and undeclared dividends of $350,000 that were due in February and September 2013 for a total undeclared amount of $700,000 as of December&amp;#160;31, 2013.&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;
 margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;As described in greater detail in Note 10, all of the Series A Preferred shares were redeemed in 2014.&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&lt;u&gt;Series B Preferred&lt;/u&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;During the year ended December&amp;#160;31, 2010, 15 preferred shares were issued for $1,500,000. The 15 shares are convertible to 1,000,000 shares of common stock and bear a 10% cumulative dividend. In addition, there was a warrant issued to purchase 3,000,000 shares of common stock at an exercise price of $3 for a period of seven years.&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;The preferred stock was issued for $1,500,000 less associated issuance costs of $350,000 for net proceeds of $1,150,000. Additionally, 3,000,000 common stock warrants were issued with the preferred stock. Based on the fair values of the preferred stock and common stock warrants on the issue date, $341,100 was allocated to preferred stock and $1,158,900 was allocated to the common stock warrants. Equity issuance costs of $350,000 were allocated to the preferred stock.&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: center; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;During the quarter ended September&amp;#160;30, 2011, 15 preferred shares were issued to an investor for $1,500,000. The 15 shares are convertible to 1,000,000 shares of common stock and bear a 10% cumulative dividend. In addition, there was a warrant issued to purchase 1,000,000 shares of common stock at an exercise price of $3 for a period of seven years. Based on the fair values of the preferred stock and common stock warrants on the issue date, $855,460 was allocated to preferred stock and $644,540 was allocated to the common stock warrants. See Note 12.&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;The holders of the preferred stock are entitled to semi-annual dividends payable on the stated value of the Series B preferred stock at a rate of 10% per annum, which shall be cumulative, and accrue daily from the issuance date. The dividends may be paid in cash or shares of the Company's common stock at management&amp;#8217;s discretion. If after the conversion eligibility date, the market price for the common stock for any ten consecutive trading days in which the stock trades for over $2 per share and trading exceeds 100,000 shares per day, the preferred shareholders can be required to convert their shares to common stock. Each share of Series B preferred stock shall also be convertible at the option of the holder into that number of shares of common stock of the Company at the stated value of such share at a $1.50 conversion price.&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto;
 text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;The holder could cause this conversion at the time the shares are eligible for resale by the holder. The conversion price is subject to adjustment as hereinafter provided, at any time, or from time to time upon the terms and in the manner hereinafter set forth in the shareholder agreement.&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;On March&amp;#160;25, 2011, the Company&amp;#8217;s Board declared and issued 75,758 common shares for its semi-annual dividend payment. On September&amp;#160;21, 2011, the Company's Board declared and issued 66,988 common shares for its semi-annual dividend payment. The Company has undeclared dividends that were due in February and September 2012 totaling $150,000 and undeclared dividends of $150,000 that were due in February and September 2013 for a total undeclared amount of $300,000 as of December&amp;#160;31, 2013.&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;As described in greater detail in Note 9, all of the Series B Preferred shares were redeemed in 2014.&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;</us-gaap:PreferredStockTextBlock>
<us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;NOTE 11 &amp;#8211; STOCK OPTIONS AND WARRANTS&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 8pt 0px 0px; text-align: justify;"&gt;The Company sponsors a stock-based incentive compensation plan known as the 2013 Equity Compensation Plan (the &amp;#8220;Plan&amp;#8221;), which was established by the Board of Directors of the Company and approved by the shareholders of the Company in June 2013. A total of 1,500,000 shares were initially reserved for issuance under the plan, of which 552,500 options have been granted, 537,500 shares have been granted, and 410,000 remain available for grant.&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 8pt 0px 0px; text-align: justify;"&gt;The plan allows the Company to grant incentive stock options, non-qualified stock options, stock appreciation right, or restricted stock. The incentive stock options are exercisable for up to ten years, at an option price per share not less than the fair market value on the date the option is granted. The incentive stock options are limited to persons who are regular full-time employees of the Company at the date of the grant of the option. Non-qualified options may be granted to any person, including, but not limited to, employees, independent agents, consultants and attorneys, who the Company&amp;#8217;s Board or Compensation Committee believes have contributed, or will contribute, to the success of the Company. Non-qualified options may be issued at option prices of less than fair market value on the date of grant and are exercisable for up to ten years from date of grant. The option vesting schedule for options granted is determined by the Compensation Committee of the Board of Directors at the time of the grant. The Plan provides for accelerated vesting of unvested options if there is a change in control, as defined in the plan.&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;Prior to establishment of the plan, the Board granted options under terms similar to those described in the preceding paragraphs.&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;The compensation cost that has been charged against income related to options for the years ended December 31, 2014 and 2013, was $272,804 and $94,998, respectively. No income tax benefit was recognized in the income statement and no compensation was capitalized in any of the years presented.&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;The Company had the following option activity during the years ended December&amp;#160;31, 2014 and 2013:&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;&lt;table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size:
 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;Number of Options&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;Weighted average exercise price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="width: 1191px; font-size: 10pt; background-color: white;"&gt;Outstanding, January 1, 2013&lt;/td&gt;&lt;td style="width: 16px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 142px; font-size: 10pt; text-align: right; background-color: white;"&gt;1,484,100&lt;/td&gt;&lt;td style="width: 16px; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px; font-size: 10pt; text-align: left; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="width: 141px; font-size: 10pt; text-align: right; background-color: white;"&gt;0.98&lt;/td&gt;&lt;td style="width: 15px; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;Granted - 2013&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;2,175,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;1.00&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;Exercised - 2013&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;0&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;0&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;Expired &amp;#8211; 2013&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right; background-color: white;"&gt;(2,479,100&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: white;"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right; background-color: white;"&gt;(1.00&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: white;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="font-size: 10pt; padding-left: 10pt; background-color: white;"&gt;Balance, December 31, 2013&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;1,180,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;.97&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;Granted &amp;#8211; 2014&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;387,500&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;1.73&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;Exercised &amp;#8211; 2014&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;0&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;0&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;Expired &amp;#8211; 2014&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td
 style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right; background-color: white;"&gt;(260,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: white;"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right; background-color: white;"&gt;(0.39&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: white;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="font-size: 10pt; padding-bottom: 4pt; padding-left: 10pt; background-color: white;"&gt;Balance, December&amp;#160;31, 2014&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 4pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right; background-color: white;"&gt;1,307,500&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 4pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right; background-color: white;"&gt;1.31&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
<oprx:WarrantsTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;NOTE 12 &amp;#8211;WARRANTS&lt;/font&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company has issued warrants, primarily in connection with capital raising activities. As also discussed in Note 9, in 2014 we issued 804,139 warrants, with an exercise price of $1.20 per share, in connection with a $10 million equity raise, the proceeds of which were used to retire common stock, preferred, stock, and previously existing warrants.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company had the following warrants outstanding as of December&amp;#160;31, 2014:&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;Number of Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;Expiration Date&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center; font-size: 10pt; background-color: white;" colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; background-color: white;" colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="width: 10.66px; text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 322.66px; text-align: right; font-size: 10pt; background-color: white;"&gt;1,000,000&lt;/td&gt;&lt;td style="width: 10.66px; text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10.66px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10.66px; text-align: left; font-size: 10pt; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="width: 322px; text-align: right; font-size: 10pt; background-color: white;"&gt;2.25&lt;/td&gt;&lt;td style="width: 10px; text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 324.8px; text-align: center; padding-left: 5.4pt; font-size: 10pt; background-color: white;"&gt;10/5/2017&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; background-color: white;"&gt;50,000&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; background-color: white;"&gt;0.89&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; padding-left: 5.4pt; font-size: 10pt; background-color: white;"&gt;2/17/2016&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; background-color: white;"&gt;804,139&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; background-color: white;"&gt;1.20&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; padding-left: 5.4pt; font-size: 10pt; background-color: white;"&gt;3/17/2019&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company had the following warrant activity during the years ended December&amp;#160;31, 2014 and 2013:&lt;/p&gt;&lt;p style="font:
 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;Number of Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;Weighted average exercise price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="width: 790px; font-size: 10pt;"&gt;Outstanding, January 1, 2013&lt;/td&gt;&lt;td style="width: 10.66px; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10.66px; text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 94px; text-align: right; font-size: 10pt;"&gt;12,277,000&lt;/td&gt;&lt;td style="width: 10.66px; text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10px; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10px; text-align: left; font-size: 10pt;"&gt;$&lt;/td&gt;&lt;td style="width: 93.33px; text-align: right; font-size: 10pt;"&gt;2.25&lt;/td&gt;&lt;td style="width: 10px; text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt;"&gt;Granted - 2013&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt;"&gt;0&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt;"&gt;0&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt;"&gt;Exercised - 2013&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt;"&gt;0&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt;"&gt;0&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;Expired &amp;#8211; 2013&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"&gt;(527,000&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"&gt;(1.73&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="padding-left: 10pt; font-size: 10pt;"&gt;Balance, December 31, 2013&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt;"&gt;11,750,000&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt;"&gt;2.27&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt;"&gt;Granted &amp;#8211; 2014&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt;"&gt;804,139&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt;"&gt;1.20&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt;"&gt;Exercised &amp;#8211; 2014&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt;"&gt;(550,000&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt;"&gt;(0.35&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt;"&gt;Cancelled - 2014&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt;"&gt;(10,000,000&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt;"&gt;(2.40&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;Expired &amp;#8211; 2014&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"&gt;(150,000&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt;
 border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"&gt;(1.45&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="padding-bottom: 4pt; padding-left: 10pt; font-size: 10pt;"&gt;Balance, December&amp;#160;31, 2014&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"&gt;1,854,139&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"&gt;1.69&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</oprx:WarrantsTextBlock>
<us-gaap:LeasesOfLesseeDisclosureTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;NOTE 13 &amp;#8211; OPERATING LEASES&lt;/font&gt;&lt;/p&gt;&lt;p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: justify;"&gt;The Company signed the lease for its current office space located in Rochester Michigan on December 1, 2011 at an approximate rent of $5,000 per month. The initial lease term was for three years with an option to renew for an additional two years at approximately $5,200 per month. The lease was renewed and now expires on November 30, 2016.&lt;/p&gt;&lt;p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: justify;"&gt;Minimum annual rent payments are as follows for the remainder term of the lease:&lt;/p&gt;&lt;p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;&lt;table style="width: 1039.33px; border-collapse: collapse;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="width: 914.666687011719px; font-size: 10pt;"&gt;&amp;#160;Year ended December 31, 2015&lt;/td&gt;&lt;td style="width: 10.6666669845581px; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10.6666669845581px; font-size: 10pt; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="width: 93.3333358764648px; font-size: 10pt; text-align: right;"&gt;62,418&lt;/td&gt;&lt;td style="width: 10px; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;Year ended December 31, 2016&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;"&gt;57,217&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="color: #000000; font-family: 'times new roman', times, serif; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-size: 10pt; text-align: left; padding-bottom: 4pt;"&gt;Total lease commitment&lt;/td&gt;&lt;td style="color: #000000; font-family: 'times new roman', times, serif; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-size: 10pt; padding-bottom: 4pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="color: #000000; font-family: 'times new roman', times, serif; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="color: #000000; font-family: 'times new roman', times, serif; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right;"&gt;119,635&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LeasesOfLesseeDisclosureTextBlock>
<oprx:MajorCustomerTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;NOTE 14 &amp;#8211; MAJOR CUSTOMERS&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;The Company had the following major customers that individually accounted for 10% or more of revenue in any one of the years presented&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&lt;/p&gt;&lt;table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;2014&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;Percentage&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;2013&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;Percentage&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="width: 815px; text-align: left; background-color: white;"&gt;Company A&lt;/td&gt;&lt;td style="width: 16px; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px; text-align: left; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="width: 142px; text-align: right; background-color: white;"&gt;1,270,064&lt;/td&gt;&lt;td style="width: 16px; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 142px; text-align: right; background-color: white;"&gt;20&lt;/td&gt;&lt;td style="width: 16px; text-align: left; background-color: white;"&gt;%&lt;/td&gt;&lt;td style="width: 15px; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px; text-align: left; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="width: 141px; text-align: right; background-color: white;"&gt;1,776,824&lt;/td&gt;&lt;td style="width: 15px; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 141px; text-align: right; background-color: white;"&gt;36&lt;/td&gt;&lt;td style="width: 15px; text-align: left; background-color: white;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; background-color: white;"&gt;Company B&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;797,972&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;12&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;%&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;1,053,321&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;22&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; background-color: white;"&gt;Company C&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;772,320&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;12&lt;/td&gt;&lt;td
 style="text-align: left; background-color: white;"&gt;%&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;305,980&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;7&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; background-color: white;"&gt;Company D&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;644,702&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;10&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;%&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;278,499&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;6&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="background-color: white;"&gt;Company E&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;628,741&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;10&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;%&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;71,030&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;2&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; background-color: white;"&gt;All other customers&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;2,389,163&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;36&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; background-color: white;"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;1,193,587&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;25&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; background-color: white;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="padding-bottom: 4pt; background-color: white;"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 4pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;6,502,962&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 4pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 4pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;100&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 4pt; background-color: white;"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 4pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt;
 border-bottom-style: double; background-color: white;"&gt;4,679,741&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 4pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 4pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;100&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 4pt; background-color: white;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;</oprx:MajorCustomerTextBlock>
<us-gaap:IncomeTaxDisclosureTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;NOTE 15 &amp;#8211; INCOME TAXES&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;As of December 31, 2014, the Company had net operating loss carry forwards of approximately $8.8 million that expire from 2027 through 2034 that are available to offset future taxable income. The Company was formed in 2006 as a limited liability company and incorporated in 2007. Activity prior to incorporation is not reflected in the Company&amp;#8217;s corporate tax returns. In the future, the cumulative net operating loss carry-forward for income tax purposes may differ from the cumulative financial statement loss due to timing differences between book and tax reporting.&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;The provision for Federal income tax consists of the following for the years ended December&amp;#160;31, 2014 and 2012:&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;&lt;table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;2014&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;2013&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-size: 10pt;"&gt;Federal income tax benefit attributable to:&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right;" colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right;" colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="width: 776.666687011719px; font-size: 10pt; text-align: left; padding-left: 10pt;"&gt;Current operations&lt;/td&gt;&lt;td style="width: 10.6666669845581px; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10.6666669845581px; font-size: 10pt; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="width: 94px; font-size: 10pt; text-align: right;"&gt;349,000&lt;/td&gt;&lt;td style="width: 10.6666669845581px; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10px; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10px; font-size: 10pt; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="width: 93.3333358764648px; font-size: 10pt; text-align: right;"&gt;91,000&lt;/td&gt;&lt;td style="width: 10px; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt;"&gt;Permanent and Timing Differences (net)&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right;"&gt;(160,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right;"&gt;(294,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt;"&gt;Valuation allowance&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;"&gt;(189,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;"&gt;203,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; text-align: left; padding-bottom: 4pt; padding-left: 20pt;"&gt;Net
 provision for federal income tax&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 4pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right;"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 4pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right;"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;The cumulative tax effect at the expected rate of 34% of significant items comprising our net deferred tax amount is as follows as of December&amp;#160;31, 2013 and 2012:&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;2014&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;2013&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-size: 10pt;"&gt;Deferred tax asset attributable to:&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right;" colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right;" colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="width: 776.666687011719px; font-size: 10pt; text-align: left; padding-left: 10pt;"&gt;Net operating loss carryover&lt;/td&gt;&lt;td style="width: 10.6666669845581px; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10.6666669845581px; font-size: 10pt; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="width: 94px; font-size: 10pt; text-align: right;"&gt;2,982,000&lt;/td&gt;&lt;td style="width: 10.6666669845581px; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10px; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10px; font-size: 10pt; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="width: 93.3333358764648px; font-size: 10pt; text-align: right;"&gt;2,793,000&lt;/td&gt;&lt;td style="width: 10px; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt;"&gt;Valuation allowance&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;"&gt;(2,982,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;"&gt;(2,793,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; text-align: left; padding-bottom: 4pt; padding-left: 20pt;"&gt;Net deferred tax asset&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 4pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right;"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 4pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right;"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal;
 letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;Under certain circumstances issuance of common shares can result in an ownership change under Internal Revenue Code Section 382 which limits the Company&amp;#8217;s ability to utilize carry forwards from prior to the ownership change. Any such ownership change resulting from stock issuances and redemptions could limit the Company&amp;#8217;s ability to utilize any net operating loss carry forwards or credits generated before this change in ownership. These limitations can limit both the timing of usage of these laws, as well as the loss of the ability to use these net operating losses.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
<us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;NOTE 16 &amp;#8211; CONTINGENT LIABILITIES&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&lt;u&gt;Legal&lt;/u&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;The company is currently involved in the following legal proceedings.&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;In September 2014, we initial litigation against Shadron Stastney, the Company&amp;#8217;s previous CEO, in the U.S. District Court in the Eastern District of Michigan as a result of a dispute related to his separation agreement. Mr. Stastney alleged damages related to the non-registration of shares that he was granted as part of his separation agreement signed in September 2013. Under the terms of the contract we are not obligated to register the shares and we deny any obligation to do so. We have requested declarative relief from the court and also requested an injunction from the court preventing Mr. Stastney from continuing to pursue his claims. Mr. Stastney has filed a counterclaim requesting damages of $450,000 related to the nonregistration of his shares.&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;In March 2015, we initiated litigation against LDM Group, LLC and PDR Network, LLC in the United States District Court in the Eastern District of Missouri related to the breach by LDM, and PDR as successor, of the settlement agreement signed February 28, 2014 related to previous litigation with LDM. LDM has failed to live up to its obligations under the settlement agreement including, but not limited to, not allowing the Company to distribute its eCoupon programs in the LDM network, not allowing the Company to distribute the LDM patient education programs, and not providing other information required under the settlement agreement. The Company is seeking enforcement of the settlement agreement and is seeking damages in an amount at least equal to the amounts paid to date to LDM under the settlement agreement, which approximates $900,000, as well as damages for lost income and business value as a result of LDM&amp;#8217;s breach of the agreement.&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;In March 2015, we also initiated litigation against PDR Network, LLC in the United States District Court in the District of New Jersey as a result of PDR&amp;#8217;s breach of the Master Services Agreement between the parties requiring PDR to exclusively use the Company&amp;#8217;s eCoupon solution. The
 Company asserts that PDR&amp;#8217;s acquisition of LDM and the use of the LDM network to distribute coupons by PDR violates the agreement between the parties and is seeking damages in an amount at least equal the amounts paid to date by the Company to LDM under the settlement agreement, which approximates $900,000, as well as damages for lost income and business value as a result of PDR&amp;#8217;s actions.&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;In early 2014 the Company learned that Mr. Milton Wilpon (&amp;#8220;Mr. Wilpon&amp;#8221;) of New Jersey claimed to have obtained a default judgment for approximately $929,000 in the New Jersey Superior Court, Essex County (the &amp;#8220;Judgment&amp;#8221;) against a predecessor of the Company and was seeking to amend the Judgment to add the Company as a judgment debtor.&amp;#160;&amp;#160; The Judgment was entered in 2006 when the predecessor of the Company was a dormant shell company and the Judgment allegedly related to a settlement agreement that was breached in 2001 (the &amp;#8220;Settlement Agreement&amp;#8221;).&amp;#160; The Company appeared in the action and filed a motion to vacate the Judgment on several grounds, including that it appeared that the Summons and Complaint were never properly served and that plaintiff had never filed an arbitration as was required by the Settlement Agreement.&amp;#160; In September 2014, the Court granted the Company&amp;#8217;s motion and vacated the Judgment in its entirety and dismissed the action.&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;In December 2014, the Company was served with a copy of a Demand for Arbitration filed by Mr. Wilpon relating to his claims under the Settlement Agreement.&amp;#160; On February 24, 2015, the Company filed an appearance with the AAA objecting to the arbitration on several grounds, including (1) that claims arose in 2001 and are barred by the applicable statute of limitations; (2) plaintiff did not properly serve and file the demand for arbitration and (3) plaintiff has not followed the proper procedure for the appointment of an arbitrator as provided by the Settlement Agreement.&amp;#160; &amp;#160;The Company intends vigorously to oppose Mr. Wilpon&amp;#8217;s claims.&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&lt;u&gt;Revenue-share contracts&lt;/u&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;The Company has contacts with various Electronic Health Records systems and ePrescribe platforms, whereby we agree to share a portion of the revenue we generate for eCoupons distributed through their networks. These contracts grant audit rights related to the payments to our partners, and in some cases would require us to pay for the audit if the audit determined there was an underpayment and the underpayment meets certain thresholds, such as 10%.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
<us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00">&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;NOTE 4 &amp;#8211; COMMITMENTS AND CONTINGENCIES&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&lt;i&gt;Litigation&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;"&gt;The company is currently involved in the following legal proceedings.&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;"&gt;In September 2014, we initiated litigation against Shadron Stastney, the Company&amp;#8217;s previous CEO, in the U.S. District Court in the Eastern District of Michigan as a result of a dispute related to his separation agreement. Mr. Stastney alleged damages related to the non-registration of shares that he was granted as part of his separation agreement signed in September 2013. Under the terms of the contract we are not obligated to register the shares and we deny any obligation to do so. We have requested declarative relief from the court and also requested an injunction from the court preventing Mr. Stastney from continuing to pursue his claims. Mr. Stastney has filed a counterclaim requesting damages of $450,000 related to the nonregistration of his shares. The parties are currently in the discovery process.&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;"&gt;In March 2015, we initiated litigation against LDM Group, LLC and PDR Network, LLC in the U.S. District Court in the Eastern District of Missouri related to the breach by LDM, and PDR as successor, of the settlement agreement signed February 28, 2014 related to previous litigation with LDM. LDM has failed to live up to its obligations under the settlement agreement including, but not limited to, not allowing us to distribute our eCoupon programs in the LDM network, not allowing us to distribute the LDM patient education programs, and not providing other information required under the settlement agreement. We are seeking enforcement of the settlement agreement and we are seeking damages in an amount at least equal to the amounts paid to date to LDM under the settlement agreement, which approximates $1.0 million, as well as damages for lost income and business value as a result of LDM&amp;#8217;s breach of the agreement.&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;"&gt;In March 2015, we also initiated litigation against PDR Network, LLC in the U.S. District Court in the District of New Jersey as a result of PDR&amp;#8217;s breach of the Master Services Agreement between the parties requiring PDR to exclusively use our eCoupon solution. We assert that PDR&amp;#8217;s acquisition of LDM and the use of the LDM network to distribute coupons by PDR violates the agreement between the parties and we are seeking damages in an amount at least equal the amounts paid to date by us to LDM under the settlement agreement, which approximates $1.0 million, as well as damages for lost income and business
 value as a
 result of PDR&amp;#8217;s actions.&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;"&gt;In May 2015, we filed an amended complaint in the Missouri case to consolidate the two cases and withdrew the case against PDR Networks in the U.S. District Court in the District of New Jersey, without prejudice.&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&lt;font style="color: black;"&gt;In July, 2015, the U.S. District Court for the Eastern District of Missouri dismissed the case, citing lack of Federal jurisdiction in the matter. We are in the process of refiling the consolidated case against PDR Network and LDM group in State court in Missouri.&lt;/font&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
<us-gaap:AccountingChangesAndErrorCorrectionsTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;NOTE 17 &amp;#8211; RESTATEMENT&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;The Company discovered and recorded items requiring it to restate its 2013 financial results, as well as its 2014 quarterly results, to&lt;/font&gt;&amp;#160;&lt;font style="font-size: 10pt;"&gt;correct the accounting for certain transactions contained therein. The restatement relates to unrecorded stock compensation related to investor relations and consulting services, unrecorded revenue share payables, and changes in revenue recognition, all occurring during the year ended December 31, 2013. The revenue recognition relates to promotional programs started in 2013 that were expected to be completed in 2013, but actually carried over into 2014.&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;The following items were restated in the 2013 Annual Financial Statements&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&lt;/p&gt;&lt;table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-decoration: underline; text-align: center; padding-bottom: 1pt; padding-left: 5.4pt;"&gt;Balance Sheet&lt;/td&gt;&lt;td style="padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid; text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Previously stated&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid; text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Adjustments&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid; text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Restated&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="width: 713.8125px; text-align: justify; padding-left: 5.4pt;"&gt;Accounts receivable&lt;/td&gt;&lt;td style="width: 79px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="width: 173px; text-align: right;"&gt;1,566,964&lt;/td&gt;&lt;td style="width: 16px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 79px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="width: 172px; text-align: right;"&gt;(55,255&lt;/td&gt;&lt;td style="width: 15px; text-align: left;"&gt;)&lt;/td&gt;&lt;td style="width: 78px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="width: 172px; text-align: right;"&gt;1,511,709&lt;/td&gt;&lt;td style="width: 15px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Revenue share payable&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;1,193,661&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;93,891&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;1,287,552&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Deferred revenue&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;4,252&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;222,020&lt;/td&gt;&lt;td
 style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;226,272&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Additional paid in capital&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;8,726,708&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;148,477&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;8,875,155&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Deferred stock compensation&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(233,942&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(36,520&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(270,462&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Accumulated deficit&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(24,616,220&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(483,137&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(25,099,357&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-decoration: underline; text-align: center; padding-left: 5.4pt;"&gt;Statement of Operations&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Revenue&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;4,957,016&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(277,275&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;4,679,741&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Revenue share expense&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;1,767,425&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;93,891&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;1,861,316&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Operating expenses&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;2,973,990&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;111,701&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;3,085,691&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Net income (loss)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;215,847&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(483,137&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(267,290&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-decoration: underline; text-align: center; padding-left: 5.4pt;"&gt;Statement of Cash Flows&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Net income (loss)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;215,847&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(483,137&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(267,290&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Stock options issued for services&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td
 style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;19,547&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;75,451&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;94,998&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Stock-based compensation&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;399,092&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;36,520&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;435,612&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Changes in accounts receivable&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(950,166&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;55,255&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(894,911&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Changes in revenue share payable&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;1,103,084&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;93,891&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;1,196,975&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Changes in deferred revenue&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(45,000&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;222,020&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;177,020&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&lt;br /&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;The following tables show the effect of the restatement on the unaudited quarterly information previously filed.&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;Period Ended September 30, 2013 (unaudited):&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-decoration: underline; text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Balance Sheet&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;Previously stated&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;Adjustments&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;Restated&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="width: 1019px; text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 142px; text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 141px; text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 125px; text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size:
 10pt;"&gt;Revenue share payable&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;782,902&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;28,376&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;811,278&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Deferred revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;13,272&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;147,860&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;161,132&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Additional paid in capital&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;8,449,271&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: top; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;148,477&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: top; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;8,597,748&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Deferred stock compensation&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: top; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;(233,077&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: top; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;(54,780&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: top; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;(287,857&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Accumulated deficit&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: top; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;(24,870,854&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: top; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;(270,207&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: top; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;(25,141,061&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-decoration: underline; text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Statement of Operations&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;Three Months ended September 30, 2013&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,373,029&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(147,860&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td
 style="text-align:
 right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,225,169&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue share expense&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;529,134&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;28,376&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;557,510&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Operating expenses&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;982,504&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;93,971&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,076,475&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Net income (loss)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(141,527&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(270,207&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(411,734&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;Nine Months ended September 30, 2013&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;Revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;3,146,406&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(147,860&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;2,998,546&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;Revenue share expense&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,264,059&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;28,376&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,292,435&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;Operating expenses&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;2,272,239&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;93,971&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;2,366,210&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;Net income (loss)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(389,716&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(270,207&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(659,923&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-decoration: underline; text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Statement of Cash Flows&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Net income (loss)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(389,716&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(270,207&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(659,923&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Stock-based compensation&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size:
 10pt;"&gt;310,823&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;93,971&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;404,794&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Changes in revenue share payable&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;649,825&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;28,376&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;678,201&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Changes in deferred revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(35,980&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;147,860&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;111,880&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;Period Ended March 31, 2014 (unaudited):&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-decoration: underline; text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Balance Sheet&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;Previously stated&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;Adjustments&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;Restated&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="width: 1035px; text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 126px; text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 141px; text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 125px; text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue share payable&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;797,725&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;167,880&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;965,605&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Deferred revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;168,714&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;268,807&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;437,521&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Additional paid in capital&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;27,155,730&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; background-color: white;"&gt;&lt;font
 style="font-size: 10pt;"&gt;148,477&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;27,304,207&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Deferred stock compensation&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;(454,409&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;(18,260&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;(472,669&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Accumulated deficit&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;(25,269,535&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;(591,917&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;(25,861,452&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-decoration: underline; text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Statement of Operations&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;Three Months ended March 31, 2014&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,317,347&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(27,919)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,289,428&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue share expense&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;498,810&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;62,601&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;561,411&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Operating expenses&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,471,598&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;18,260&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,489,858&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Net income (loss)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(653,315&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(108,780&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font
 style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(762,095&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-decoration: underline; text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Statement of Cash Flows&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Net income (loss)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(653,315&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(108,780&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(762,095&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Stock-based compensation&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;361,957&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;18,260&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;380,217&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Changes in revenue share payable&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(395,935&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;62,601&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(333,334&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Changes in deferred revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;164,462&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;27,919&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;192,381&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"&gt;&lt;b&gt;P&lt;/b&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;eriod Ended June 30, 2014 (unaudited):&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-decoration: underline; text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Balance Sheet&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;Previously stated&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;Adjustments&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;Restated&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="width: 1035px; text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width:
 126px; text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 141px; text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 125px; text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue share payable&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;506,901&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;366,088&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;872,989&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Deferred revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;42,908&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;258,270&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;301,178&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Additional paid in capital&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;27,304,112&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;84,677&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;27,388,789&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Accumulated deficit&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(25,322,216&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(738,674&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;26,060,890&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-decoration: underline; text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Statement of Operations&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;Three Months ended June 30, 2014&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,454,214&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(27,206&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,427,008&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue share expense&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;540,048&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;190,092&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;730,140&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Operating expenses&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;967,070&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(70,541&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;896,529&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Net income (loss)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(52,681&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(146,757&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size:
 10pt;"&gt;(199,438&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;Six Months ended June 30, 2014&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;2,771,560&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(55,124&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;2,716,436&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue share expense&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,038,858&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;252,693&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,291,551&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Operating expenses&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;2,439,028&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(52,281&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;2,386,747&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Net income (loss)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(705,996&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(255,537&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(961,533&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-decoration: underline; text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Statement of Cash Flows&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Net income (loss)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(705,996&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(255,537&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(961,533&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Stock-based compensation&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;654,634&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(52,281&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;602,353&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Changes in revenue share payable&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(686,760&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;252,693&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(434,067&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Changes in deferred revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;38,656&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font
 style="font-size: 10pt;"&gt;55,124&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;93,780&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;Period Ended September 30, 2014(unaudited):&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-decoration: underline; text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Balance Sheet&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;Previously stated&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;Adjustments&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;Restated&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="width: 1035px; text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 126px; text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 141px; text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 125px; text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue share payable&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;853,410&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;421,019&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,274,429&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Deferred revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;-0-&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;118,949&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;118,949&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Additional paid in capital&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;28,398,825&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;84,677&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;28,483,502&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Accumulated deficit&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(25,716,530&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(638,903&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(26,355,433&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td
 style="text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-decoration: underline; text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Statement of Operations&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;Three Months ended September 30, 2014&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,620,215&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;199,206&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,819,421&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue share expense&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;858,898&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;99,435&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;958,,333&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Operating expenses&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,155,933&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;-0-&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,155,933&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Net income (loss)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(394,314&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;99,771&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(294,543&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;Nine Months ended September 30, 2014&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;4,391,775&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;144,082&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;4,535,857&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue share expense&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,897,757&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;352,127&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;2,249,884&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Operating expenses&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;3,594,961&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(52,280&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;3,542,681&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Net income (loss)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(1,100,310&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td
 style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(155,766&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(1,256,076&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-decoration: underline; text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Statement of Cash Flows&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Net income (loss)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(1,100,310&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(155,766&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(1,256,076&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Stock-based compensation&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,118,952&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(52,280&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(1,066,672&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Changes in revenue share payable&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(340,251&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;352,127&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;11,876&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Changes in deferred revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(4,252&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(144,082&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(148,334&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;</us-gaap:AccountingChangesAndErrorCorrectionsTextBlock>
<us-gaap:AccountingChangesAndErrorCorrectionsTextBlock contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00">&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;NOTE 5 &amp;#8211; RESTATEMENT&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;"&gt;We restated our financial statements to correct the way we accounted for certain items related to stock based compensation, revenue share expense, and revenue recognition. The full impact of the restatement was reflected in the December 31, 2014 financial statements at the end of the year. The table below reflects the impact on the 2014 period reflected in this report.&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;"&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;The restated Consolidated Statement of Operations and Consolidated Statement of Cash Flows for the three and six months ended June&amp;#160;30, 2014, as applicable, is as follows:&lt;/p&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;&lt;table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding: 0pt; text-indent: 0pt;" colspan="3"&gt;Three months ended June 30, 2014&lt;/td&gt;&lt;td style="padding: 0pt; text-align: center; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; padding: 0pt; text-indent: 0pt;" colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: center; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: center; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; padding: 0pt; text-indent: 0pt;" colspan="2"&gt;Previously&lt;/td&gt;&lt;td style="padding: 0pt; text-align: center; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding: 0pt; text-align: center; text-indent: 0pt;"&gt;Financial Statement&lt;/td&gt;&lt;td style="padding: 0pt; text-align: center; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding: 0pt; text-align: center; text-indent: 0pt;"&gt;Line Item&lt;/td&gt;&lt;td style="padding: 0pt; text-align: center; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding: 0pt; text-indent: 0pt;" colspan="2"&gt;Corrected&lt;/td&gt;&lt;td style="padding: 0pt; text-align: center; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: center; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding: 0pt; text-indent: 0pt;" colspan="2"&gt;Stated&lt;/td&gt;&lt;td style="padding: 0pt; text-align: center; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="width: 543px; text-align: left; padding: 0pt; text-indent: 0pt;"&gt;Income statement&lt;/td&gt;&lt;td style="width: 18px; padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 543px; padding: 0pt; text-indent: 0pt;"&gt;Revenue&lt;/td&gt;&lt;td style="width: 18px; padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 18px; text-align: left; padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 175px; text-align: right; padding: 0pt; text-indent: 0pt;"&gt;1,426,808&lt;/td&gt;&lt;td style="width: 18px; text-align: left; padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 177px; text-align: right; padding: 0pt; text-indent: 0pt;"&gt;1,454,214&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;Income statement&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;Cost of Sales&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; padding: 0pt; text-indent: 0pt;"&gt;730,140&lt;/td&gt;&lt;td style="text-align: left;
 padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td
 style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; padding: 0pt; text-indent: 0pt;"&gt;540,048&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;Income statement&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;Operating expenses&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; padding: 0pt; text-indent: 0pt;"&gt;896,529&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; padding: 0pt; text-indent: 0pt;"&gt;967,070&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding: 0pt; text-indent: 0pt;"&gt;Income statement&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;Loss from operations&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; padding: 0pt; text-indent: 0pt;"&gt;(199,861&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;)&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; padding: 0pt; text-indent: 0pt;"&gt;(52,904&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;Income statement&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;Loss before income taxes&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; padding: 0pt; text-indent: 0pt;"&gt;(199,638&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;)&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; padding: 0pt; text-indent: 0pt;"&gt;(52,681&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;Income statement&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;Net loss&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; padding: 0pt; text-indent: 0pt;"&gt;(199,638&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;)&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; padding: 0pt; text-indent: 0pt;"&gt;(52,681&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin-top: 0px; text-align: center; margin-bottom: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="3"&gt;Six months ended June 30, 2014&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center;" colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center;" colspan="2"&gt;Previously&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;"&gt;Financial Statement&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;"&gt;Line Item&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;Corrected&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;Stated&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="width: 543px; text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Income statement&lt;/td&gt;&lt;td style="width: 18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 543px; text-indent: 0pt; padding-left: 0pt;"&gt;Revenue&lt;/td&gt;&lt;td style="width: 18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 18px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 175px; text-align: right;"&gt;2,716,236&lt;/td&gt;&lt;td style="width: 18px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 177px; text-align: right;"&gt;2,771,560&lt;/td&gt;&lt;td style="width: 19px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Income statement&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt;"&gt;Cost of Sales&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:
 left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;1,291,551&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:
 left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;1,038,858&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Income statement&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Operating expenses&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;2,386,747&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;2,439,028&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; text-indent: 0pt; padding-left: 0pt;"&gt;Income statement&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Loss from operations&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(962,062&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(706,326&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Income statement&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Loss before income taxes&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(961,733&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(705,996&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Income statement&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Net loss&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(961,733&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(705,996&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Statement of cash flows&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Net loss&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(961,733&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(705,996&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Statement of cash flows&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Stock and options issued for services&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;627,344&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;654,634&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Statement of cash flows&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Increase in accounts payable&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;203,714&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;173,889&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Statement of cash flows&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Decrease in revenue share payable&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(311,776&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(686,760&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Statement of cash flows&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Increase in deferred revenue&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;19,651&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;38,656&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;</us-gaap:AccountingChangesAndErrorCorrectionsTextBlock>
<us-gaap:SubsequentEventsTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;NOTE 18 &amp;#8211; SUBSEQUENT EVENTS&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;In January 2015, we issued 12,500 shares of common stock to two outside directors as payment of their quarterly Director Fees.&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;In March 2015, we signed a capital markets advisory agreement whereby we agreed to issue 90,000 shares of common stock in two increments as payment for the advisory services. The first 45,000 shares were issued in March 2015.&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;In accordance with ASC 855-10, the Company has analyzed its operations subsequent to December&amp;#160;31, 2014 through the date these financial statements were issued and has determined that it does not have any material subsequent events to disclose in these financial statements other than the events described above.&lt;/font&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
<oprx:BasisOfAccountingPolicyTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;u&gt;Basis of Presentation&lt;/u&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars.&lt;/p&gt;&lt;/div&gt;</oprx:BasisOfAccountingPolicyTextBlock>
<us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;u&gt;Accounting Basis&lt;/u&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company uses the accrual basis of accounting and accounting principles generally accepted in the United States of America (&amp;#8220;GAAP&amp;#8221; accounting). The Company has adopted a December 31 fiscal year end.&lt;/p&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
<us-gaap:ConsolidationPolicyTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&lt;u&gt;Principles of Consolidation&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;The financial statements reflect the consolidated results of OptimizeRx Corporation (a Nevada corporation) and its wholly owned subsidiary OptimizeRx Corporation (a Michigan corporation). All material inter-company transactions have been eliminated in the consolidation.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
<us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&lt;u&gt;Cash and Cash Equivalents&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;For purposes of the accompanying financial statements, the Company considers all highly liquid instruments with an initial maturity of three months or less to be cash equivalents.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
<us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;u&gt;Fair Value of Financial Instruments&lt;/u&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;The fair value of cash, accounts receivable, prepaid expenses, accounts payable, accounts payable &amp;#8211; related party, accrued expenses and deferred revenue approximates the carrying amount of these financial instruments due to their short-term nature.&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Fair value is defined as the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date and in the principal or most advantageous market for that asset or liability. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the entity. In addition, the fair value of liabilities should include consideration of non-performance risk including our own credit risk.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;In addition to defining fair value, the disclosure requirements around fair value establish a fair value hierarchy for valuation inputs which is expanded. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of the three levels which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Level 1 &amp;#8211; inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Level 2 &amp;#8211; inputs are based upon significant observable inputs other than quoted prices included in Level 1, such as quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Level 3 &amp;#8211; inputs are generally unobservable and typically reflect management&amp;#8217;s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques that include option pricing models, discounted cash flow models, and similar techniques. The Company&amp;#8217;s stock options and warrants are valued using level 3 inputs.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The carrying value of the Company&amp;#8217;s financial assets and liabilities which consist of cash, accounts receivable, prepaid expenses, patent rights, web development costs, accounts payable, accounts payable &amp;#8211; related party, accrued expenses and deferred revenue are valued using level 1 inputs. The Company believes that the recorded values approximate their fair value due to the short maturity of such instruments. Unless otherwise noted, it is management&amp;#8217;s opinion that the Company is not exposed to significant interest, exchange or credit risks arising from these
 financial instruments.&lt;/p&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
<us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;u&gt;Accounts Receivable and Allowance for Doubtful Accounts&lt;/u&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Because the Company&amp;#8217;s customers are primarily large well capitalized companies, historically there has been very little bad debt expense. Bad debt expense was $0 for each of the years ended December&amp;#160;31, 2014 and 2013. The allowance for doubtful accounts was $0 as of both December&amp;#160;31, 2014 and 2013.&lt;/p&gt;&lt;/div&gt;</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
<us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;u&gt;Property and Equipment&lt;/u&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;The capital assets are being depreciated over their estimated useful lives of three to seven years using the straight-line method of depreciation for book purposes.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
<us-gaap:RevenueRecognitionPolicyTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;u&gt;Revenue Recognition and Revenue Share Expense&lt;/u&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Revenue is recognized when it is earned. Revenues are generated from our SampleMD activities in which we deliver eCoupons and eVouchers through a distribution network of ePrescribers and Electronic Health Record technology providers (channel partners), or from reselling services that complement our business for other of our partners.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;We recognize setup fees that are required for integrating client offerings and campaigns into the SampleMD content delivery system and network upon completion of the setup and launch of the client&amp;#8217;s campaign within the SampleMD system. As the eCoupons and or eVouchers are distributed through the SampleMD platform and network of channel partners (a transaction), these transactions are recorded and revenue is recognized at the time of distribution. Revenue for transactions can be realized based on a price per distribution or a price per redemption depending on the client contract. Additionally, the company also recognizes revenue for providing program performance reporting and maintenance, either by the company directly delivering reports or by providing access to its online reporting portal that the client can utilize. These fees are charged monthly and recognized as recurring monthly revenue.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The company on occasion has also resold products and or services that are available through our channel partners, and that is complementary to our core businesses and client base. In these instances net revenue is recognized based on the commission based revenue split that the company receives.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Based on the volume of transactions that are delivered through our channel partner network, we provide a revenue share to compensate the partner for their promotion of the campaign. Revenue shares are a negotiated percentage of the transaction fees and can also be specific to special considerations and campaigns. In addition, we pay revenue share to PDR/LDM as a result of a 2014 legal settlement in an amount equal to the greater of 10% of eCoupon revenues generated or $0.37 per eCoupon distributed.&lt;/p&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
<us-gaap:IncomeTaxPolicyTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;u&gt;Income Taxes&lt;/u&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.&lt;/p&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
<us-gaap:UseOfEstimates contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;u&gt;Use of Estimates&lt;/u&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates and assumptions have been made in determining the depreciable lives of such assets and the allowance for doubtful accounts receivable. Actual results could differ from these estimates.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
<us-gaap:ConcentrationRiskCreditRisk contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;u&gt;Concentration of Credit Risks&lt;/u&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;The Company maintains its cash and cash equivalents in bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts; however, amounts in excess of the federally insured limit may be at risk if the bank experiences financial difficulties.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
<us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;u&gt;Research and Development&lt;/u&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;The Company expenses research and development expenses as incurred. Our research efforts are focused on understanding the market dynamics that have the potential to affect the business in both the short and long term. Our primary goal is to help patients better afford and access the medicines their doctor prescribes, as well as other healthcare products and services they need. Based on this, the Company continually seeks better ways to meet this mission through improved technology, better user experiences and new ways to engage industries to provide new support for patients needing their products, as well seeking new services and solutions to offer.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
<us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&lt;u&gt;Share-based Payments&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Company uses the fair value method to account for stock-based compensation. The fair value of the equity instrument is charged directly to compensation expense and additional paid-in capital over the period during which services are rendered. The fair value of each award is estimated on the date of each grant. For restricted stock the fair market value is based on the market value of the stock granted on the date of the grant. For options, it is estimated using the Black Scholes option pricing model that uses the assumptions noted in the following table. Estimated volatilities are based on the historical volatility of the Company&amp;#8217;s stock over the same period as the expected term of the options. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The Company uses historical data to estimate option exercise behavior and to determine this term. The risk free rate used is based on the U.S. Treasury yield curve in effect at the time of the grant using a time period equal to the expected option term. The Company has never paid dividends and does not expect to pay any dividends in the future.&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: center; text-indent: 0px; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;2014&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: center; text-indent: 0px; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;2013&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: center; text-indent: 0px; font-size: 10pt; background-color: white;" colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: center; text-indent: 0px; font-size: 10pt; background-color: white;" colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="padding: 0px; width: 758px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;Expected dividend yield&lt;/td&gt;&lt;td style="padding: 0px; width: 10px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; width: 10px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; width: 114px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;0&lt;/td&gt;&lt;td style="padding: 0px; width: 11.33px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;%&lt;/td&gt;&lt;td style="padding: 0px; width: 10px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; width: 10px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; width: 104.66px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;0&lt;/td&gt;&lt;td style="padding: 0px; width: 11.33px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;Risk free interest rate&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;0.90%-1.44%&lt;/font&gt;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;0.79%-1.42%&lt;/font&gt;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;Expected option term&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&lt;font
 style="font-size: 10pt;"&gt;3.5 years&lt;/font&gt;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;5.0 years&lt;/font&gt;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;Turnover/forfeiture rate&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;0&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;%&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;0&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;Expected volatility&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;117% - 138%&lt;/font&gt;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;155% - 171%&lt;/font&gt;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 25.9pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The Black-Scholes option valuation model and other existing models were developed for use&amp;#160;in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. These option valuation models require the input of, and are highly sensitive to, subjective assumptions including the expected stock price volatility. OptimizerRx&amp;#8217;s stock options have characteristics significantly different from those of traded options, and changes in the subjective input assumptions could materially affect the fair value estimate.&lt;/p&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
<us-gaap:EarningsPerSharePolicyTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"&gt;&lt;u&gt;Loss Per Common and Common Equivalent Share&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"&gt;The computation of basic earnings per common share is computed using the weighted average number of common shares outstanding during the year. The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the year plus common stock equivalents which would arise from the exercise of warrants outstanding using the treasury stock method and the average market price per share during the year. Options, warrants and convertible preferred stock have not been included in the diluted earnings per share calculation for either year since their effect is anti-dilutive.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
<us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;u&gt;Impairment of Long-Lived Assets&lt;/u&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;The Company continually monitors events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, the Company assesses the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;u&gt;Recently Issued Accounting Guidance&lt;/u&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company&amp;#8217;s results of operations, financial position or cash flow.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
<us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: center; text-indent: 0px; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;2014&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: center; text-indent: 0px; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;2013&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: center; text-indent: 0px; font-size: 10pt; background-color: white;" colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: center; text-indent: 0px; font-size: 10pt; background-color: white;" colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="padding: 0px; width: 758px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;Expected dividend yield&lt;/td&gt;&lt;td style="padding: 0px; width: 10px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; width: 10px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; width: 114px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;0&lt;/td&gt;&lt;td style="padding: 0px; width: 11.33px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;%&lt;/td&gt;&lt;td style="padding: 0px; width: 10px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; width: 10px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; width: 104.66px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;0&lt;/td&gt;&lt;td style="padding: 0px; width: 11.33px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;Risk free interest rate&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;0.90%-1.44%&lt;/font&gt;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;0.79%-1.42%&lt;/font&gt;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;Expected option term&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;3.5 years&lt;/font&gt;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;5.0 years&lt;/font&gt;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;Turnover/forfeiture rate&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;0&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;%&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;0&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="padding: 0px; text-align: left;
 text-indent: 0px; font-size: 10pt; background-color: white;"&gt;Expected volatility&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;117% - 138%&lt;/font&gt;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;155% - 171%&lt;/font&gt;&lt;/td&gt;&lt;td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
<oprx:PrepaidExpensesTableTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;&lt;table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;2014&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;2013&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="width: 1191px; font-size: 10pt; background-color: white;"&gt;Insurance&lt;/td&gt;&lt;td style="width: 16px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px; font-size: 10pt; text-align: left; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="width: 142px; font-size: 10pt; text-align: right; background-color: white;"&gt;18,093&lt;/td&gt;&lt;td style="width: 16px; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px; font-size: 10pt; text-align: left; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="width: 141px; font-size: 10pt; text-align: right; background-color: white;"&gt;6,722&lt;/td&gt;&lt;td style="width: 15px; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;Rent&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;-0-&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;5,049&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;Legal&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right; background-color: white;"&gt;10,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right; background-color: white;"&gt;-0-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; text-align: left; padding-bottom: 4pt; background-color: white;"&gt;Total prepaid expenses&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 4pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right; background-color: white;"&gt;28,093&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 4pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right; background-color: white;"&gt;11,771&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</oprx:PrepaidExpensesTableTextBlock>
<us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;/p&gt;&lt;table style="width: 1250.4px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;2014&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;2013&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="width: 950.4px; text-align: left; font-size: 10pt;"&gt;Computer equipment&lt;/td&gt;&lt;td style="width: 12.8px; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 12.8px; text-align: left; font-size: 10pt;"&gt;$&lt;/td&gt;&lt;td style="width: 112.8px; text-align: right; font-size: 10pt;"&gt;19,519&lt;/td&gt;&lt;td style="width: 12.8px; text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 12.8px; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 12px; text-align: left; font-size: 10pt;"&gt;$&lt;/td&gt;&lt;td style="width: 112px; text-align: right; font-size: 10pt;"&gt;22,360&lt;/td&gt;&lt;td style="width: 12px; text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"&gt;Furniture and fixtures&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"&gt;11,088&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"&gt;11,088&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="padding-left: 10pt; font-size: 10pt;"&gt;Subtotal&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt;"&gt;30,607&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt;"&gt;33,448&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"&gt;(17,794&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;"&gt;(18,391&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; padding-bottom: 4pt; padding-left: 10pt; font-size: 10pt;"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"&gt;12,813&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;"&gt;15,057&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
<oprx:ScheduleOfCapitalizedCostsInDevelopingWebBasedTechnologyTableTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;/p&gt;&lt;table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;2014&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;2013&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="width: 1191px; text-align: left; font-size: 10pt; background-color: white;"&gt;OptimizeRx web-based technology&lt;/td&gt;&lt;td style="width: 16px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px; text-align: left; font-size: 10pt; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="width: 142px; text-align: right; font-size: 10pt; background-color: white;"&gt;154,133&lt;/td&gt;&lt;td style="width: 16px; text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px; text-align: left; font-size: 10pt; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="width: 141px; text-align: right; font-size: 10pt; background-color: white;"&gt;154,133&lt;/td&gt;&lt;td style="width: 15px; text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;SampleMD web-based technology&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; background-color: white;"&gt;602,517&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; background-color: white;"&gt;602,517&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;SampleMD 2.0 web-based technology&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;440,477&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;148,060&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; padding-left: 10pt; font-size: 10pt; background-color: white;"&gt;Subtotal, web-based technology&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; background-color: white;"&gt;1,197,127&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; background-color: white;"&gt;904,710&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;Accumulated amortization&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; background-color: white;"&gt;(633,401&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; background-color: white;"&gt;(440,641&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;Impairment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;(59,083&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt;
 border-bottom-style: solid; background-color: white;"&gt;(59,083&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; padding-bottom: 4pt; padding-left: 10pt; font-size: 10pt; background-color: white;"&gt;Web-based technology, net&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;504,643&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 4pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;404,986&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 4pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</oprx:ScheduleOfCapitalizedCostsInDevelopingWebBasedTechnologyTableTextBlock>
<us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;div&gt;&lt;table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;2014&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;2013&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="width: 1191px; text-align: left; font-size: 10pt; background-color: white;"&gt;Patent rights and intangible assets&lt;/td&gt;&lt;td style="width: 16px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px; text-align: left; font-size: 10pt; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="width: 142px; text-align: right; font-size: 10pt; background-color: white;"&gt;930,000&lt;/td&gt;&lt;td style="width: 16px; text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px; text-align: left; font-size: 10pt; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="width: 141px; text-align: right; font-size: 10pt; background-color: white;"&gt;930,000&lt;/td&gt;&lt;td style="width: 15px; text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;Patent defense costs&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; background-color: white;"&gt;170,937&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; background-color: white;"&gt;87,993&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;New patents and trademarks&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; background-color: white;"&gt;90,202&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; background-color: white;"&gt;62,595&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;Accumulated amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;(260,285&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;(194,638&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; padding-bottom: 4pt; padding-left: 10pt; font-size: 10pt; background-color: white;"&gt;Patent rights and intangible assets, net&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;930,854&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 4pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;885,950&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 4pt; font-size: 10pt; background-color: white;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
<us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;Number of Options&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;Weighted average exercise price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="width: 790px; font-size: 10pt; background-color: white;"&gt;Outstanding, January 1, 2013&lt;/td&gt;&lt;td style="width: 10.6666669845581px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10.6666669845581px; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 94px; font-size: 10pt; text-align: right; background-color: white;"&gt;1,484,100&lt;/td&gt;&lt;td style="width: 10.6666669845581px; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10px; font-size: 10pt; text-align: left; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="width: 93.3333358764648px; font-size: 10pt; text-align: right; background-color: white;"&gt;0.98&lt;/td&gt;&lt;td style="width: 10px; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;Granted - 2013&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;2,175,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;1.00&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;Exercised - 2013&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;0&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;0&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;Expired &amp;#8211; 2013&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right; background-color: white;"&gt;(2,479,100&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: white;"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right; background-color: white;"&gt;(1.00&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: white;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="font-size: 10pt; padding-left: 10pt; background-color: white;"&gt;Balance, December 31, 2013&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;1,180,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;.97&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;Granted &amp;#8211; 2014&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;387,500&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;1.73&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;Exercised &amp;#8211; 2014&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;0&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color:
 white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;0&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;Expired &amp;#8211; 2014&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right; background-color: white;"&gt;(260,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: white;"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right; background-color: white;"&gt;(0.39&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: white;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="font-size: 10pt; padding-bottom: 4pt; padding-left: 10pt; background-color: white;"&gt;Balance, December&amp;#160;31, 2014&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 4pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right; background-color: white;"&gt;1,307,500&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 4pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right; background-color: white;"&gt;1.31&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
<us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;Number of Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;Expiration Date&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-size: 10pt; text-align: center; background-color: white;" colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; background-color: white;" colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="width: 10.6666669845581px; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 322.666656494141px; font-size: 10pt; text-align: right; background-color: white;"&gt;1,000,000&lt;/td&gt;&lt;td style="width: 10.6666669845581px; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10.6666669845581px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10.6666669845581px; font-size: 10pt; text-align: left; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="width: 322px; font-size: 10pt; text-align: right; background-color: white;"&gt;2.25&lt;/td&gt;&lt;td style="width: 10px; font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10px; font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 324.802093505859px; font-size: 10pt; text-align: center; padding-left: 5.4pt; background-color: white;"&gt;10/5/2017&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;50,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;0.89&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; padding-left: 5.4pt; background-color: white;"&gt;2/17/2016&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;804,139&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right; background-color: white;"&gt;1.20&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; padding-left: 5.4pt; background-color: white;"&gt;3/17/2019&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
<oprx:ScheduleOfShare-BasedCompensationWarrantActivityTableTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;Number of Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;Weighted average exercise price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="width: 790px; font-size: 10pt;"&gt;Outstanding, January 1, 2013&lt;/td&gt;&lt;td style="width: 10.6666669845581px; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10.6666669845581px; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 94px; font-size: 10pt; text-align: right;"&gt;12,277,000&lt;/td&gt;&lt;td style="width: 10.6666669845581px; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10px; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10px; font-size: 10pt; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="width: 93.3333358764648px; font-size: 10pt; text-align: right;"&gt;2.25&lt;/td&gt;&lt;td style="width: 10px; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt;"&gt;Granted - 2013&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right;"&gt;0&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right;"&gt;0&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt;"&gt;Exercised - 2013&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right;"&gt;0&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right;"&gt;0&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;Expired &amp;#8211; 2013&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;"&gt;(527,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;"&gt;(1.73&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; padding-left: 10pt;"&gt;Balance, December 31, 2013&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right;"&gt;11,750,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right;"&gt;2.27&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt;"&gt;Granted &amp;#8211; 2014&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right;"&gt;804,139&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right;"&gt;1.20&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt;"&gt;Exercised &amp;#8211; 2014&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right;"&gt;(550,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right;"&gt;(0.35&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt;"&gt;Cancelled - 2014&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right;"&gt;(10,000,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right;"&gt;(2.40&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;Expired &amp;#8211; 2014&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;"&gt;(150,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;"&gt;(1.45&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color:
 white;"&gt;&lt;td style="font-size: 10pt; padding-bottom: 4pt; padding-left: 10pt;"&gt;Balance, December&amp;#160;31, 2014&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 4pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right;"&gt;1,854,139&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 4pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right;"&gt;1.69&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</oprx:ScheduleOfShare-BasedCompensationWarrantActivityTableTextBlock>
<us-gaap:ScheduleOfRentExpenseTableTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;&lt;table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="width: 1379px; font-size: 10pt;"&gt;&amp;#160;Year ended December 31, 2015&lt;/td&gt;&lt;td style="width: 16px; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px; font-size: 10pt; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="width: 141px; font-size: 10pt; text-align: right;"&gt;62,418&lt;/td&gt;&lt;td style="width: 15px; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;Year ended December 31, 2016&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;"&gt;57,217&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; text-align: left; padding-bottom: 4pt;"&gt;Total lease commitment&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 4pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right;"&gt;119,635&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&amp;#160;&lt;/p&gt;</us-gaap:ScheduleOfRentExpenseTableTextBlock>
<oprx:ScheduleOfMajorCustomersIndividualRevenueTableTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;2014&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;Percentage&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;2013&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2"&gt;Percentage&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="width: 815px; text-align: left; background-color: white;"&gt;Company A&lt;/td&gt;&lt;td style="width: 16px; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px; text-align: left; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="width: 142px; text-align: right; background-color: white;"&gt;1,270,064&lt;/td&gt;&lt;td style="width: 16px; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 142px; text-align: right; background-color: white;"&gt;20&lt;/td&gt;&lt;td style="width: 16px; text-align: left; background-color: white;"&gt;%&lt;/td&gt;&lt;td style="width: 15px; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px; text-align: left; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="width: 141px; text-align: right; background-color: white;"&gt;1,776,824&lt;/td&gt;&lt;td style="width: 15px; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px; text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 141px; text-align: right; background-color: white;"&gt;36&lt;/td&gt;&lt;td style="width: 15px; text-align: left; background-color: white;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; background-color: white;"&gt;Company B&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;797,972&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;12&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;%&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;1,053,321&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;22&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; background-color: white;"&gt;Company C&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;772,320&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;12&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;%&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;305,980&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;7&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; background-color: white;"&gt;Company D&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;644,702&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;10&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;%&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;278,499&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;6&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="background-color: white;"&gt;Company E&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;628,741&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;10&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;%&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color:
 white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;71,030&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;2&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; background-color: white;"&gt;All other customers&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;2,389,163&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;36&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; background-color: white;"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;1,193,587&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;"&gt;25&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt; background-color: white;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="padding-bottom: 4pt; background-color: white;"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 4pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;6,502,962&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 4pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 4pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;100&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 4pt; background-color: white;"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 4pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;4,679,741&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 4pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 4pt; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;"&gt;100&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 4pt; background-color: white;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;</oprx:ScheduleOfMajorCustomersIndividualRevenueTableTextBlock>
<us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;2014&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;2013&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-size: 10pt;"&gt;Federal income tax benefit attributable to:&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right;" colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right;" colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="width: 776.666687011719px; font-size: 10pt; text-align: left; padding-left: 10pt;"&gt;Current operations&lt;/td&gt;&lt;td style="width: 10.6666669845581px; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10.6666669845581px; font-size: 10pt; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="width: 94px; font-size: 10pt; text-align: right;"&gt;349,000&lt;/td&gt;&lt;td style="width: 10.6666669845581px; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10px; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10px; font-size: 10pt; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="width: 93.3333358764648px; font-size: 10pt; text-align: right;"&gt;91,000&lt;/td&gt;&lt;td style="width: 10px; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt;"&gt;Permanent and Timing Differences (net)&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right;"&gt;(160,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right;"&gt;(294,000&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt;"&gt;Valuation allowance&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;"&gt;(189,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;"&gt;203,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; text-align: left; padding-bottom: 4pt; padding-left: 20pt;"&gt;Net provision for federal income tax&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 4pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right;"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 4pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right;"&gt;0&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
<us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;2014&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;2013&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-size: 10pt;"&gt;Deferred tax asset attributable to:&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right;" colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right;" colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="width: 776.666687011719px; font-size: 10pt; text-align: left; padding-left: 10pt;"&gt;Net operating loss carryover&lt;/td&gt;&lt;td style="width: 10.6666669845581px; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10.6666669845581px; font-size: 10pt; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="width: 94px; font-size: 10pt; text-align: right;"&gt;2,982,000&lt;/td&gt;&lt;td style="width: 10.6666669845581px; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10px; font-size: 10pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10px; font-size: 10pt; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="width: 93.3333358764648px; font-size: 10pt; text-align: right;"&gt;2,793,000&lt;/td&gt;&lt;td style="width: 10px; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt;"&gt;Valuation allowance&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;"&gt;(2,982,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;"&gt;(2,793,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="font-size: 10pt; text-align: left; padding-bottom: 4pt; padding-left: 20pt;"&gt;Net deferred tax asset&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 4pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right;"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 4pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right;"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-size: 10pt; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
<us-gaap:RestatementToPriorYearIncomeTextBlock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;The following items were restated in the 2013 Annual Financial Statements&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;/p&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: center; padding-bottom: 1pt; padding-left: 5.4pt; text-decoration: underline;"&gt;Balance Sheet&lt;/td&gt;&lt;td style="padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Previously stated&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Adjustments&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Restated&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="width: 713.81px; text-align: justify; padding-left: 5.4pt;"&gt;Accounts receivable&lt;/td&gt;&lt;td style="width: 79px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="width: 173px; text-align: right;"&gt;1,566,964&lt;/td&gt;&lt;td style="width: 16px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 79px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="width: 172px; text-align: right;"&gt;(55,255&lt;/td&gt;&lt;td style="width: 15px; text-align: left;"&gt;)&lt;/td&gt;&lt;td style="width: 78px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px; text-align: left;"&gt;$&lt;/td&gt;&lt;td style="width: 172px; text-align: right;"&gt;1,511,709&lt;/td&gt;&lt;td style="width: 15px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Revenue share payable&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;1,193,661&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;93,891&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;1,287,552&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Deferred revenue&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;4,252&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;222,020&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;226,272&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Additional paid in capital&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;8,726,708&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;148,477&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;8,875,155&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Deferred stock compensation&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(233,942&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(36,520&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(270,462&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Accumulated deficit&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(24,616,220&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(483,137&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(25,099,357&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: center; padding-left: 5.4pt; text-decoration: underline;"&gt;Statement of Operations&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align:
 left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Revenue&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;4,957,016&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(277,275&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;4,679,741&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Revenue share expense&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;1,767,425&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;93,891&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;1,861,316&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Operating expenses&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;2,973,990&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;111,701&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;3,085,691&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Net income (loss)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;215,847&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(483,137&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(267,290&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: center; padding-left: 5.4pt; text-decoration: underline;"&gt;Statement of Cash Flows&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Net income (loss)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;215,847&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(483,137&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(267,290&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Stock options issued for services&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;19,547&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;75,451&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;94,998&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Stock-based compensation&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;399,092&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;36,520&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;435,612&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Changes in accounts receivable&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(950,166&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;55,255&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(894,911&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Changes in revenue share payable&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;1,103,084&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;93,891&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;1,196,975&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding-left: 5.4pt;"&gt;Changes in deferred revenue&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(45,000&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;222,020&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;177,020&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align:
 justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;Period Ended September 30, 2013 (unaudited):&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center; text-decoration: underline;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Balance Sheet&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;Previously stated&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;Adjustments&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;Restated&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="width: 1019px; text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 142px; text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 141px; text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 125px; text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue share payable&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;782,902&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;28,376&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;811,278&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Deferred revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;13,272&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;147,860&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;161,132&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align: justify; vertical-align: top;"&gt;&lt;font style="font-size: 10pt;"&gt;Additional paid in capital&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;8,449,271&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: top; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;148,477&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: top; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;8,597,748&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align: justify; vertical-align: top;"&gt;&lt;font style="font-size: 10pt;"&gt;Deferred stock compensation&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: top; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;(233,077&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: top; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;(54,780&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: top; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;(287,857&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color:
 white;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td
 style="text-align: justify; vertical-align: top;"&gt;&lt;font style="font-size: 10pt;"&gt;Accumulated deficit&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: top; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;(24,870,854&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: top; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;(270,207&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: top; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;(25,141,061&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: center; text-decoration: underline;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Statement of Operations&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;Three Months ended September 30, 2013&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,373,029&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(147,860&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,225,169&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue share expense&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;529,134&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;28,376&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;557,510&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Operating expenses&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;982,504&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;93,971&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,076,475&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Net income (loss)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(141,527&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(270,207&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(411,734&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;Nine Months ended September 30, 2013&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;Revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;3,146,406&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(147,860&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;2,998,546&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;Revenue share expense&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,264,059&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;28,376&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size:
 10pt;"&gt;1,292,435&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr
 style="vertical-align: bottom; background-color: white;"&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;Operating expenses&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;2,272,239&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;93,971&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;2,366,210&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;Net income (loss)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(389,716&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(270,207&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(659,923&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: center; text-decoration: underline;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Statement of Cash Flows&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Net income (loss)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(389,716&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(270,207&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(659,923&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Stock-based compensation&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;310,823&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;93,971&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;404,794&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Changes in revenue share payable&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;649,825&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;28,376&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;678,201&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Changes in deferred revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(35,980&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;147,860&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;111,880&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;Period Ended March 31, 2014 (unaudited):&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;Three Months ended March 31, 2014&lt;/div&gt;&lt;table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center; text-decoration: underline;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Balance Sheet&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;Previously stated&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;Adjustments&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td
 style="text-align: center; border-bottom-color: black;
 border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;Restated&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="width: 1035px; text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 126px; text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 141px; text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 125px; text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue share payable&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;797,725&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;167,880&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;965,605&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Deferred revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;168,714&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;268,807&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;437,521&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align: justify; vertical-align: top;"&gt;&lt;font style="font-size: 10pt;"&gt;Additional paid in capital&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;27,155,730&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;148,477&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;27,304,207&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align: justify; vertical-align: top;"&gt;&lt;font style="font-size: 10pt;"&gt;Deferred stock compensation&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;(454,409&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;(18,260&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;(472,669&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="text-align: justify; vertical-align: top;"&gt;&lt;font style="font-size: 10pt;"&gt;Accumulated deficit&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;(25,269,535&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;(591,917&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;(25,861,452&lt;/font&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; background-color: white;"&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: center; text-decoration: underline;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Statement of Operations&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align:
 bottom; background-color:
 white;"&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,317,347&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(27,919)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,289,428&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue share expense&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;498,810&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;62,601&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;561,411&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Operating expenses&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,471,598&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;18,260&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,489,858&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Net income (loss)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(653,315&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(108,780&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(762,095&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: center; text-decoration: underline;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Statement of Cash Flows&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Net income (loss)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(653,315&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(108,780&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(762,095&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Stock-based compensation&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;361,957&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;18,260&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;380,217&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Changes in revenue share payable&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(395,935&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;62,601&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(333,334&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Changes in deferred revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;164,462&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;27,919&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;192,381&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px;
 white-space: normal; widows:
 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;P&lt;/b&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;eriod Ended June 30, 2014 (unaudited):&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center; text-decoration: underline;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Balance Sheet&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;Previously stated&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;Adjustments&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;Restated&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="width: 1035px; text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 126px; text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 141px; text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 125px; text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue share payable&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;506,901&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;366,088&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;872,989&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Deferred revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;42,908&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;258,270&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;301,178&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Additional paid in capital&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;27,304,112&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;84,677&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;27,388,789&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Accumulated deficit&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(25,322,216&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(738,674&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;26,060,890&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: center; text-decoration: underline;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Statement of Operations&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;Three Months ended June 30, 2014&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,454,214&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td
 style="text-align: right;"&gt;&lt;font
 style="font-size: 10pt;"&gt;(27,206&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,427,008&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue share expense&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;540,048&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;190,092&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;730,140&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Operating expenses&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;967,070&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(70,541&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;896,529&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Net income (loss)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(52,681&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(146,757&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(199,438&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;Six Months ended June 30, 2014&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;2,771,560&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(55,124&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;2,716,436&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue share expense&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,038,858&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;252,693&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,291,551&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Operating expenses&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;2,439,028&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(52,281&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;2,386,747&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Net income (loss)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(705,996&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(255,537&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(961,533&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: center; text-decoration: underline;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Statement of Cash Flows&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Net income (loss)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size:
 10pt;"&gt;(705,996&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size:
 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(255,537&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(961,533&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Stock-based compensation&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;654,634&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(52,281&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;602,353&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Changes in revenue share payable&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(686,760&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;252,693&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(434,067&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Changes in deferred revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;38,656&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;55,124&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;93,780&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&amp;#160;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;Period Ended September 30, 2014(unaudited):&lt;/font&gt;&lt;/p&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center; text-decoration: underline;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Balance Sheet&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;Previously stated&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;Adjustments&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;&lt;font style="font-size: 10pt;"&gt;Restated&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="width: 1035px; text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 126px; text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 16px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 141px; text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 125px; text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 15px;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue share payable&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;853,410&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;421,019&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,274,429&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Deferred revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;-0-&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;118,949&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;118,949&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom;
 background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font
 style="font-size: 10pt;"&gt;Additional paid in capital&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;28,398,825&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;84,677&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;28,483,502&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Accumulated deficit&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(25,716,530&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(638,903&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(26,355,433&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: center; text-decoration: underline;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Statement of Operations&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;Three Months ended September 30, 2014&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,620,215&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;199,206&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,819,421&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue share expense&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;858,898&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;99,435&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;958,,333&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Operating expenses&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,155,933&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;-0-&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,155,933&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Net income (loss)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(394,314&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;99,771&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(294,543&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: center;"&gt;&lt;font style="font-size: 10pt;"&gt;Nine Months ended September 30, 2014&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;4,391,775&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;144,082&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size:
 10pt;"&gt;4,535,857&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom;
 background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Revenue share expense&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,897,757&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;352,127&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;2,249,884&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Operating expenses&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;3,594,961&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(52,280&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;3,542,681&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Net income (loss)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(1,100,310&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(155,766&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(1,256,076&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: center; text-decoration: underline;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;u&gt;Statement of Cash Flows&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Net income (loss)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(1,100,310&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(155,766&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(1,256,076&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Stock-based compensation&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;1,118,952&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(52,280&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(1,066,672&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Changes in revenue share payable&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(340,251&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;352,127&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;11,876&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify;"&gt;&lt;font style="font-size: 10pt;"&gt;Changes in deferred revenue&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(4,252&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(144,082&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right;"&gt;&lt;font style="font-size: 10pt;"&gt;(148,334&lt;/font&gt;&lt;/td&gt;&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:RestatementToPriorYearIncomeTextBlock>
<us-gaap:RestatementToPriorYearIncomeTextBlock contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00">&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify; text-indent: 0.5in;"&gt;&lt;/p&gt;&lt;table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding: 0pt; text-indent: 0pt;" colspan="3"&gt;Three months ended June 30, 2014&lt;/td&gt;&lt;td style="padding: 0pt; text-align: center; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; padding: 0pt; text-indent: 0pt;" colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: center; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: center; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; padding: 0pt; text-indent: 0pt;" colspan="2"&gt;Previously&lt;/td&gt;&lt;td style="padding: 0pt; text-align: center; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding: 0pt; text-align: center; text-indent: 0pt;"&gt;Financial Statement&lt;/td&gt;&lt;td style="padding: 0pt; text-align: center; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding: 0pt; text-align: center; text-indent: 0pt;"&gt;Line Item&lt;/td&gt;&lt;td style="padding: 0pt; text-align: center; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding: 0pt; text-indent: 0pt;" colspan="2"&gt;Corrected&lt;/td&gt;&lt;td style="padding: 0pt; text-align: center; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-align: center; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding: 0pt; text-indent: 0pt;" colspan="2"&gt;Stated&lt;/td&gt;&lt;td style="padding: 0pt; text-align: center; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="width: 543px; text-align: left; padding: 0pt; text-indent: 0pt;"&gt;Income statement&lt;/td&gt;&lt;td style="width: 18px; padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 543px; padding: 0pt; text-indent: 0pt;"&gt;Revenue&lt;/td&gt;&lt;td style="width: 18px; padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 18px; text-align: left; padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 175px; text-align: right; padding: 0pt; text-indent: 0pt;"&gt;1,426,808&lt;/td&gt;&lt;td style="width: 18px; text-align: left; padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 177px; text-align: right; padding: 0pt; text-indent: 0pt;"&gt;1,454,214&lt;/td&gt;&lt;td style="width: 19px; text-align: left; padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;Income statement&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;Cost of Sales&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; padding: 0pt; text-indent: 0pt;"&gt;730,140&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; padding: 0pt; text-indent: 0pt;"&gt;540,048&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;Income statement&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;Operating expenses&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; padding: 0pt; text-indent: 0pt;"&gt;896,529&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right; padding: 0pt; text-indent: 0pt;"&gt;967,070&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; padding: 0pt; text-indent: 0pt;"&gt;Income statement&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;Loss from operations&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; padding: 0pt; text-indent: 0pt;"&gt;(199,861&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;)&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; padding: 0pt; text-indent: 0pt;"&gt;(52,904&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;Income statement&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;Loss before income taxes&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; padding: 0pt; text-indent: 0pt;"&gt;(199,638&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;)&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; padding: 0pt; text-indent: 0pt;"&gt;(52,681&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; padding: 0pt; text-indent:
 0pt;"&gt;Income statement&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td
 style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;Net loss&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; padding: 0pt; text-indent: 0pt;"&gt;(199,638&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;)&lt;/td&gt;&lt;td style="padding: 0pt; text-indent: 0pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; padding: 0pt; text-indent: 0pt;"&gt;(52,681&lt;/td&gt;&lt;td style="text-align: left; padding: 0pt; text-indent: 0pt;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin-top: 0px; text-align: center; margin-bottom: 0px;"&gt;&lt;font style="letter-spacing: -0.1pt;"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="3"&gt;Six months ended June 30, 2014&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center;" colspan="2"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center;" colspan="2"&gt;Previously&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;"&gt;Financial Statement&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;"&gt;Line Item&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;Corrected&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"&gt;Stated&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="width: 543px; text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Income statement&lt;/td&gt;&lt;td style="width: 18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 543px; text-indent: 0pt; padding-left: 0pt;"&gt;Revenue&lt;/td&gt;&lt;td style="width: 18px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 18px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 175px; text-align: right;"&gt;2,716,236&lt;/td&gt;&lt;td style="width: 18px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 19px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 177px; text-align: right;"&gt;2,771,560&lt;/td&gt;&lt;td style="width: 19px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Income statement&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-indent: 0pt; padding-left: 0pt;"&gt;Cost of Sales&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;1,291,551&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;1,038,858&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Income statement&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Operating expenses&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;2,386,747&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right;"&gt;2,439,028&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: justify; text-indent: 0pt; padding-left: 0pt;"&gt;Income statement&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Loss from operations&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(962,062&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(706,326&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Income statement&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Loss before income taxes&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(961,733&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(705,996&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Income statement&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Net loss&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(961,733&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(705,996&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Statement of cash flows&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Net loss&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(961,733&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(705,996&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom;
 background-color: white;"&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Statement of cash flows&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Stock and
 options issued for services&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;627,344&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;654,634&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Statement of cash flows&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Increase in accounts payable&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;203,714&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;173,889&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: white;"&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Statement of cash flows&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Decrease in revenue share payable&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(311,776&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;(686,760&lt;/td&gt;&lt;td style="text-align: left;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: #cceeff;"&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Statement of cash flows&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt;"&gt;Increase in deferred revenue&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;19,651&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left;"&gt;$&lt;/td&gt;&lt;td style="text-align: right;"&gt;38,656&lt;/td&gt;&lt;td style="text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; margin-top: 0px; margin-bottom: 0px;"&gt;&amp;#160;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:RestatementToPriorYearIncomeTextBlock>
<us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued contextRef="Context_Custom_01_Apr_2008T00_00_00_TO_14_Apr_2008T00_00_00" unitRef="shares" decimals="0">1256958</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
<us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="Context_As_Of_14_Apr_2008T00_00_00_TO_14_Apr_2008T00_00_00" unitRef="pure" decimals="2">1.00</us-gaap:EquityMethodInvestmentOwnershipPercentage>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="pure" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="pure" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="pure" decimals="4">0.0079</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="pure" decimals="4">0.0090</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="pure" decimals="4">0.0142</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="pure" decimals="4">0.0144</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">P3Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="pure" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="pure" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="pure" decimals="2">1.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="pure" decimals="2">1.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="pure" decimals="2">1.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="pure" decimals="2">1.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">0</us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:ProvisionForDoubtfulAccounts contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">0</us-gaap:ProvisionForDoubtfulAccounts>
<us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
<us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_RangeAxis_MaximumMember">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_RangeAxis_MinimumMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
<us-gaap:RevenueRecognitionNewAccountingPronouncementMaterialEffectDescription contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">Legal settlement in an amount equal to the greater of 10% of eCoupon revenues generated or $0.37 per eCoupon distributed.</us-gaap:RevenueRecognitionNewAccountingPronouncementMaterialEffectDescription>
<us-gaap:PrepaidInsurance contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">6722</us-gaap:PrepaidInsurance>
<us-gaap:PrepaidInsurance contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">18093</us-gaap:PrepaidInsurance>
<us-gaap:PrepaidRent contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">5049</us-gaap:PrepaidRent>
<us-gaap:PrepaidRent contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">0</us-gaap:PrepaidRent>
<oprx:PrepaidLegalFees contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">0</oprx:PrepaidLegalFees>
<oprx:PrepaidLegalFees contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">10000</oprx:PrepaidLegalFees>
<us-gaap:PropertyPlantAndEquipmentGross contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">33448</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember" unitRef="USD" decimals="0">22360</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember" unitRef="USD" decimals="0">11088</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">30607</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember" unitRef="USD" decimals="0">19519</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PropertyPlantAndEquipmentGross contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember" unitRef="USD" decimals="0">11088</us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">18391</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">17794</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
<us-gaap:Depreciation contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">5628</us-gaap:Depreciation>
<us-gaap:Depreciation contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">5933</us-gaap:Depreciation>
<us-gaap:CapitalizedComputerSoftwareGross contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">904710</us-gaap:CapitalizedComputerSoftwareGross>
<us-gaap:CapitalizedComputerSoftwareGross contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_FiniteLivedIntangibleAssetsByMajorClassAxis_WebBasedTechnologyMember" unitRef="USD" decimals="0">154133</us-gaap:CapitalizedComputerSoftwareGross>
<us-gaap:CapitalizedComputerSoftwareGross contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_FiniteLivedIntangibleAssetsByMajorClassAxis_WebBasedTechnologyOneMember" unitRef="USD" decimals="0">602517</us-gaap:CapitalizedComputerSoftwareGross>
<us-gaap:CapitalizedComputerSoftwareGross contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_FiniteLivedIntangibleAssetsByMajorClassAxis_WebBasedTechnologyTwoMember" unitRef="USD" decimals="0">148060</us-gaap:CapitalizedComputerSoftwareGross>
<us-gaap:CapitalizedComputerSoftwareGross contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">1197127</us-gaap:CapitalizedComputerSoftwareGross>
<us-gaap:CapitalizedComputerSoftwareGross contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_FiniteLivedIntangibleAssetsByMajorClassAxis_WebBasedTechnologyMember" unitRef="USD" decimals="0">154133</us-gaap:CapitalizedComputerSoftwareGross>
<us-gaap:CapitalizedComputerSoftwareGross contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_FiniteLivedIntangibleAssetsByMajorClassAxis_WebBasedTechnologyOneMember" unitRef="USD" decimals="0">602517</us-gaap:CapitalizedComputerSoftwareGross>
<us-gaap:CapitalizedComputerSoftwareGross contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_FiniteLivedIntangibleAssetsByMajorClassAxis_WebBasedTechnologyTwoMember" unitRef="USD" decimals="0">440477</us-gaap:CapitalizedComputerSoftwareGross>
<us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">440641</us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization>
<us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">633401</us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization>
<oprx:CapitalizedComputerSoftwareImpairment contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">-59083</oprx:CapitalizedComputerSoftwareImpairment>
<oprx:CapitalizedComputerSoftwareImpairment contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">-59083</oprx:CapitalizedComputerSoftwareImpairment>
<oprx:CapitalizedComputerSoftwareAmortizationPeriodDescription contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">Over a period of up to five years.</oprx:CapitalizedComputerSoftwareAmortizationPeriodDescription>
<us-gaap:CapitalizedComputerSoftwareAmortization contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">130289</us-gaap:CapitalizedComputerSoftwareAmortization>
<us-gaap:CapitalizedComputerSoftwareAmortization contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">192760</us-gaap:CapitalizedComputerSoftwareAmortization>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">930000</us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">930000</us-gaap:FiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedPatentsGross contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">87993</us-gaap:FiniteLivedPatentsGross>
<us-gaap:FiniteLivedPatentsGross contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">170937</us-gaap:FiniteLivedPatentsGross>
<us-gaap:OtherFiniteLivedIntangibleAssetsGross contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">62595</us-gaap:OtherFiniteLivedIntangibleAssetsGross>
<us-gaap:OtherFiniteLivedIntangibleAssetsGross contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">90202</us-gaap:OtherFiniteLivedIntangibleAssetsGross>
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">194638</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">260285</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<oprx:OptionsGrantedToAcquireExclusivePatentRightsShares contextRef="Context_Custom_01_Apr_2010T00_00_00_TO_26_Apr_2010T00_00_00_FiniteLivedIntangibleAssetsByMajorClassAxis_PatentsMember" unitRef="shares" decimals="INF">200000</oprx:OptionsGrantedToAcquireExclusivePatentRightsShares>
<oprx:OptionsGrantedToAcquireExclusivePatentRightsValue contextRef="Context_As_Of_26_Apr_2010T00_00_00_TO_26_Apr_2010T00_00_00_FiniteLivedIntangibleAssetsByMajorClassAxis_PatentsMember" unitRef="USD" decimals="0">360000</oprx:OptionsGrantedToAcquireExclusivePatentRightsValue>
<us-gaap:SaleOfStockTransactionDate contextRef="Context_Custom_01_Apr_2010T00_00_00_TO_26_Apr_2010T00_00_00_FiniteLivedIntangibleAssetsByMajorClassAxis_PatentsMember">2015-04-30</us-gaap:SaleOfStockTransactionDate>
<us-gaap:FiniteLivedIntangibleAssetsAmortizationMethod contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">Straight-line method.</us-gaap:FiniteLivedIntangibleAssetsAmortizationMethod>
<us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">57874</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths>
<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">65647</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths>
<us-gaap:SharesIssued contextRef="Context_As_Of_01_Jun_2013T00_00_00_TO_01_Jun_2013T00_00_00_FinancialInstrumentAxis_ConsultingAgreementMember" unitRef="shares" decimals="INF">20000</us-gaap:SharesIssued>
<us-gaap:SharesIssued contextRef="Context_As_Of_31_Jan_2014T00_00_00_TO_31_Jan_2014T00_00_00_TitleOfIndividualAxis_OfficerMember" unitRef="shares" decimals="INF">410348</us-gaap:SharesIssued>
<us-gaap:SharesIssued contextRef="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_TitleOfIndividualAxis_ThreeOfficerMember" unitRef="shares" decimals="INF">200000</us-gaap:SharesIssued>
<us-gaap:SharesIssued contextRef="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_TitleOfIndividualAxis_ConsultantMember" unitRef="shares" decimals="INF">150000</us-gaap:SharesIssued>
<us-gaap:SharesIssued contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_FinancialInstrumentAxis_ConsultingAgreementMember" unitRef="shares" decimals="INF">10000</us-gaap:SharesIssued>
<us-gaap:SharesIssued contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_TitleOfIndividualAxis_DirectorMember" unitRef="shares" decimals="INF">7065</us-gaap:SharesIssued>
<us-gaap:SharesIssued contextRef="Context_As_Of_31_Jan_2015T00_00_00_TO_31_Jan_2015T00_00_00_TitleOfIndividualAxis_DirectorMember" unitRef="shares" decimals="INF">12500</us-gaap:SharesIssued>
<us-gaap:SharesIssued contextRef="Context_As_Of_31_Mar_2015T00_00_00_TO_31_Mar_2015T00_00_00_FinancialInstrumentAxis_CapitalMarketsAdvisoryAgreementMember" unitRef="shares" decimals="INF">45000</us-gaap:SharesIssued>
<us-gaap:SharesIssuedPricePerShare contextRef="Context_As_Of_01_Jun_2013T00_00_00_TO_01_Jun_2013T00_00_00_FinancialInstrumentAxis_ConsultingAgreementMember" unitRef="USD_per_Share" decimals="2">1.50</us-gaap:SharesIssuedPricePerShare>
<us-gaap:SharesIssuedPricePerShare contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_FinancialInstrumentAxis_ConsultingAgreementMember" unitRef="USD_per_Share" decimals="2">1.85</us-gaap:SharesIssuedPricePerShare>
<oprx:WarrantExercisePricePeriod contextRef="Context_Custom_01_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_TitleOfIndividualAxis_PlacementAgentsMember">P5Y</oprx:WarrantExercisePricePeriod>
<oprx:WarrantExercisePricePeriod contextRef="Context_Custom_01_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_FinancialInstrumentAxis_SecuritiesPurchaseAgreementMember">P5Y</oprx:WarrantExercisePricePeriod>
<us-gaap:SaleOfStockPricePerShare contextRef="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_FinancialInstrumentAxis_SecuritiesPurchaseAgreementMember" unitRef="USD_per_Share" decimals="2">1.20</us-gaap:SaleOfStockPricePerShare>
<us-gaap:SaleOfStockPricePerShare contextRef="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_AgreementAxis_SecuritiesPurchaseAgreementMember" unitRef="USD_per_Share" decimals="2">1.20</us-gaap:SaleOfStockPricePerShare>
<oprx:CommissionsPercentage contextRef="Context_Custom_01_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_TitleOfIndividualAxis_PlacementAgentsMember" unitRef="pure" decimals="3">0.097</oprx:CommissionsPercentage>
<us-gaap:AccruedSalesCommissionCurrent contextRef="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_TitleOfIndividualAxis_PlacementAgentsMember" unitRef="USD" decimals="0">970000</us-gaap:AccruedSalesCommissionCurrent>
<oprx:PurchaseOfWarrants contextRef="Context_Custom_01_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_TitleOfIndividualAxis_PlacementAgentsMember" unitRef="shares" decimals="INF">804139</oprx:PurchaseOfWarrants>
<us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants contextRef="Context_Custom_01_Sep_2011T00_00_00_TO_30_Sep_2011T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">855460</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
<us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants contextRef="Context_Custom_01_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_TitleOfIndividualAxis_PlacementAgentsMember" unitRef="USD" decimals="0">1110211</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
<us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">341100</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
<us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_TitleOfIndividualAxis_ThreeOfficerMember" unitRef="USD" decimals="0">240000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
<us-gaap:PaymentsOfStockIssuanceCosts contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">630000</us-gaap:PaymentsOfStockIssuanceCosts>
<us-gaap:PaymentsOfStockIssuanceCosts contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">630000</us-gaap:PaymentsOfStockIssuanceCosts>
<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">337500</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross contextRef="Context_Custom_01_Feb_2015T00_00_00_TO_28_Feb_2015T00_00_00" unitRef="USD" decimals="0">337500</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00_TitleOfIndividualAxis_TwoOfficersMember" unitRef="USD" decimals="0">197605</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
<us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="shares" decimals="INF">570375</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
<oprx:AdditionalWorkingCapital contextRef="Context_As_Of_28_Feb_2014T00_00_00_TO_28_Feb_2014T00_00_00" unitRef="USD" decimals="-6">3000000</oprx:AdditionalWorkingCapital>
<oprx:AdditionalWorkingCapital contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="-6">3000000</oprx:AdditionalWorkingCapital>
<oprx:FullyDilutedShares contextRef="Context_As_Of_28_Feb_2014T00_00_00_TO_28_Feb_2014T00_00_00" unitRef="shares" decimals="-6">7000000</oprx:FullyDilutedShares>
<oprx:FullyDilutedShares contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="shares" decimals="-6">7000000</oprx:FullyDilutedShares>
<us-gaap:DebtIssuanceCosts contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="-4">2950000</us-gaap:DebtIssuanceCosts>
<us-gaap:DebtIssuanceCosts contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="0">2950000</us-gaap:DebtIssuanceCosts>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="shares" decimals="INF">2175000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="shares" decimals="INF">387500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_AwardTypeAxis_StockCompensationPlanMember" unitRef="shares" decimals="INF">552500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_TitleOfIndividualAxis_DirectorMember" unitRef="shares" decimals="INF">19565</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<oprx:WarrantsExercised contextRef="Context_Custom_01_Jan_2014T00_00_00_TO_31_Jan_2014T00_00_00_TitleOfIndividualAxis_OfficerMember" unitRef="shares" decimals="INF">500000</oprx:WarrantsExercised>
<oprx:WarrantsExercised contextRef="Context_Custom_02_Oct_2014T00_00_00_TO_31_Oct_2014T00_00_00" unitRef="shares" decimals="INF">50000</oprx:WarrantsExercised>
<oprx:WarrantsExercised contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="shares" decimals="INF">500000</oprx:WarrantsExercised>
<oprx:DebtRedemptionLongtermDebtAmount contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_TitleOfIndividualAxis_VicisMember" unitRef="USD" decimals="0">6000000</oprx:DebtRedemptionLongtermDebtAmount>
<oprx:DebtRedemptionLongtermDebtAmount contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00_TitleOfIndividualAxis_DirectorMember" unitRef="USD" decimals="0">6000000</oprx:DebtRedemptionLongtermDebtAmount>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="Context_Custom_01_Dec_2008T00_00_00_TO_31_Dec_2008T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="USD" decimals="0">515000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="USD" decimals="0">350000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">350000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
<us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock contextRef="Context_Custom_01_Dec_2008T00_00_00_TO_31_Dec_2008T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="USD" decimals="0">2985000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
<us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="USD" decimals="0">1150000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
<us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD" decimals="0">1158900</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
<us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="Context_Custom_01_Dec_2008T00_00_00_TO_31_Dec_2008T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="shares" decimals="INF">3500000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
<us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="Context_Custom_01_Dec_2010T00_00_00_TO_31_Dec_2010T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="shares" decimals="INF">1000000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
<us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="Context_Custom_01_Sep_2011T00_00_00_TO_30_Sep_2011T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="shares" decimals="INF">1000000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
<us-gaap:PreferredStockDividendRatePercentage contextRef="Context_Custom_01_Dec_2008T00_00_00_TO_31_Dec_2008T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="pure" decimals="2">0.10</us-gaap:PreferredStockDividendRatePercentage>
<us-gaap:PreferredStockDividendRatePercentage contextRef="Context_Custom_01_Dec_2010T00_00_00_TO_31_Dec_2010T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="pure" decimals="2">0.10</us-gaap:PreferredStockDividendRatePercentage>
<us-gaap:PreferredStockDividendRatePercentage contextRef="Context_Custom_01_Sep_2011T00_00_00_TO_30_Sep_2011T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="pure" decimals="2">0.10</us-gaap:PreferredStockDividendRatePercentage>
<us-gaap:PreferredStockDividendRatePercentage contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="pure" decimals="2">0.10</us-gaap:PreferredStockDividendRatePercentage>
<us-gaap:PreferredStockDividendRatePercentage contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="pure" decimals="2">0.10</us-gaap:PreferredStockDividendRatePercentage>
<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="Context_As_Of_31_Dec_2010T00_00_00_TO_31_Dec_2010T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="shares" decimals="INF">3000000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="Context_As_Of_30_Sep_2011T00_00_00_TO_30_Sep_2011T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="shares" decimals="INF">1000000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="shares" decimals="INF">6000000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
<us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares" decimals="INF">3000000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_Custom_01_Dec_2008T00_00_00_TO_31_Dec_2008T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="USD_per_Share" decimals="0">2</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_Custom_01_Dec_2010T00_00_00_TO_31_Dec_2010T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="USD_per_Share" decimals="0">3</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_Custom_01_Sep_2011T00_00_00_TO_30_Sep_2011T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="USD_per_Share" decimals="0">3</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="USD_per_Share" decimals="0">2</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="USD_per_Share" decimals="0">2</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantOneMember" unitRef="USD_per_Share" decimals="2">2.25</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantTwoMember" unitRef="USD_per_Share" decimals="2">0.89</invest:InvestmentWarrantsExercisePrice>
<invest:InvestmentWarrantsExercisePrice contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantThreeMember" unitRef="USD_per_Share" decimals="2">1.20</invest:InvestmentWarrantsExercisePrice>
<us-gaap:TreasuryStockNumberOfSharesHeld contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="shares" decimals="INF">100000</us-gaap:TreasuryStockNumberOfSharesHeld>
<us-gaap:TreasuryStockNumberOfSharesHeld contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="shares" decimals="INF">100000</us-gaap:TreasuryStockNumberOfSharesHeld>
<us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="USD_per_Share" decimals="0">1</us-gaap:DebtInstrumentConvertibleConversionPrice1>
<us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementClassOfStockAxis_SeriesBPreferredStockMember" unitRef="USD_per_Share" decimals="2">1.50</us-gaap:DebtInstrumentConvertibleConversionPrice1>
<us-gaap:TemporaryEquityAccretionOfDividends contextRef="Context_Custom_01_Sep_2011T00_00_00_TO_21_Sep_2011T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="USD" decimals="0">350000</us-gaap:TemporaryEquityAccretionOfDividends>
<us-gaap:PreferredStockRedemptionAmount contextRef="Context_As_Of_30_Sep_2012T00_00_00_TO_30_Sep_2012T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="USD" decimals="0">350000</us-gaap:PreferredStockRedemptionAmount>
<us-gaap:PreferredStockRedemptionAmount contextRef="Context_As_Of_30_Sep_2013T00_00_00_TO_30_Sep_2013T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="USD" decimals="0">350000</us-gaap:PreferredStockRedemptionAmount>
<us-gaap:PreferredStockRedemptionAmount contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementClassOfStockAxis_SeriesAPreferredStockMember" unitRef="USD" decimals="0">700000</us-gaap:PreferredStockRedemptionAmount>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="Context_As_Of_31_Dec_2012T00_00_00_TO_31_Dec_2012T00_00_00" unitRef="shares" decimals="INF">1484100</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="shares" decimals="INF">1180000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="shares" decimals="INF">1307500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_AwardTypeAxis_StockCompensationPlanMember" unitRef="shares" decimals="INF">410000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="shares" decimals="INF">-2479100</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="shares" decimals="INF">-260000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="Context_As_Of_31_Dec_2012T00_00_00_TO_31_Dec_2012T00_00_00" unitRef="USD_per_Share" decimals="2">0.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD_per_Share" decimals="2">0.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD_per_Share" decimals="2">1.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD_per_Share" decimals="0">1</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD_per_Share" decimals="2">1.73</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD_per_Share" decimals="0">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD_per_Share" decimals="0">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD_per_Share" decimals="2">-1.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD_per_Share" decimals="2">-0.39</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_AwardTypeAxis_StockCompensationPlanMember" unitRef="shares" decimals="INF">537500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_AwardTypeAxis_StockCompensationPlanMember" unitRef="USD" decimals="0">94998</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_AwardTypeAxis_StockCompensationPlanMember" unitRef="USD" decimals="0">272804</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="Context_As_Of_31_Dec_2012T00_00_00_TO_31_Dec_2012T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="shares" decimals="INF">12277000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="shares" decimals="INF">11750000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="shares" decimals="INF">1854139</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantOneMember" unitRef="shares" decimals="INF">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantTwoMember" unitRef="shares" decimals="INF">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantThreeMember" unitRef="shares" decimals="INF">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
<oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantOneMember">2017-05-10</oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate>
<oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantTwoMember">2016-02-17</oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate>
<oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantThreeMember">2017-03-17</oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="shares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="shares" decimals="INF">804139</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="shares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="shares" decimals="INF">-550000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="shares" xsi:nil="true"/>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="shares" decimals="INF">-10000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="shares" decimals="INF">-527000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="shares" decimals="INF">-150000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations>
<oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage contextRef="Context_As_Of_31_Dec_2012T00_00_00_TO_31_Dec_2012T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="USD_per_Share" decimals="2">2.25</oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage>
<oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="USD_per_Share" decimals="2">2.27</oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage>
<oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="USD_per_Share" decimals="2">1.69</oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage>
<oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="USD_per_Share" decimals="0">0</oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted>
<oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="USD_per_Share" decimals="2">1.20</oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted>
<oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExercise contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="USD_per_Share" decimals="0">0</oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExercise>
<oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExercise contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="USD_per_Share" decimals="2">0.35</oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExercise>
<oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExpiration contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="USD_per_Share" decimals="2">-1.73</oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExpiration>
<oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExpiration contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="USD_per_Share" decimals="2">-2.40</oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExpiration>
<oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageCancellation contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="USD_per_Share" xsi:nil="true"/>
<oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageCancellation contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="USD_per_Share" decimals="2">-1.45</oprx:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageCancellation>
<us-gaap:SaleOfStockConsiderationReceivedPerTransaction contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_StatementEquityComponentsAxis_WarrantMember" unitRef="USD" decimals="-6">10000000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
<us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">62418</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
<us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">57217</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
<us-gaap:OperatingLeasesFutureMinimumPaymentsDue contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">119635</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
<us-gaap:ConcentrationRiskPercentage1 contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="pure" decimals="2">1.00</us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_ConcentrationRiskByBenchmarkAxis_AllOtherCustomersMember" unitRef="pure" decimals="2">0.25</us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyAMember" unitRef="pure" decimals="2">0.36</us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyBMember" unitRef="pure" decimals="2">0.22</us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyCMember" unitRef="pure" decimals="2">0.07</us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyDMember" unitRef="pure" decimals="2">0.06</us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyEMember" unitRef="pure" decimals="2">0.02</us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="pure" decimals="2">1.00</us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_ConcentrationRiskByBenchmarkAxis_AllOtherCustomersMember" unitRef="pure" decimals="2">0.36</us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyAMember" unitRef="pure" decimals="2">0.20</us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyBMember" unitRef="pure" decimals="2">0.12</us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyCMember" unitRef="pure" decimals="2">0.12</us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyDMember" unitRef="pure" decimals="2">0.10</us-gaap:ConcentrationRiskPercentage1>
<us-gaap:ConcentrationRiskPercentage1 contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00_ConcentrationRiskByBenchmarkAxis_CompanyEMember" unitRef="pure" decimals="2">0.10</us-gaap:ConcentrationRiskPercentage1>
<oprx:ConcentrationRiskPercentageTotal contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="pure" decimals="2">0.10</oprx:ConcentrationRiskPercentageTotal>
<us-gaap:CurrentFederalTaxExpenseBenefit contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">91000</us-gaap:CurrentFederalTaxExpenseBenefit>
<us-gaap:CurrentFederalTaxExpenseBenefit contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">349000</us-gaap:CurrentFederalTaxExpenseBenefit>
<oprx:FederalIncomeTaxExpensesBenefitPermanentAndTimingDifferences contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">294000</oprx:FederalIncomeTaxExpensesBenefitPermanentAndTimingDifferences>
<oprx:FederalIncomeTaxExpensesBenefitPermanentAndTimingDifferences contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">160000</oprx:FederalIncomeTaxExpensesBenefitPermanentAndTimingDifferences>
<oprx:FederalIncomeTaxExpensesBenefitValueAllowance contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">-203000</oprx:FederalIncomeTaxExpensesBenefitValueAllowance>
<oprx:FederalIncomeTaxExpensesBenefitValueAllowance contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">189000</oprx:FederalIncomeTaxExpensesBenefitValueAllowance>
<us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations contextRef="Context_FYE_01_Jan_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">0</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
<us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">0</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
<us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">2793000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
<us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">2982000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
<us-gaap:DeferredTaxAssetsValuationAllowance contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">2793000</us-gaap:DeferredTaxAssetsValuationAllowance>
<us-gaap:DeferredTaxAssetsValuationAllowance contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">2982000</us-gaap:DeferredTaxAssetsValuationAllowance>
<us-gaap:DeferredTaxAssetsNet contextRef="Context_As_Of_31_Dec_2013T00_00_00_TO_31_Dec_2013T00_00_00" unitRef="USD" decimals="0">0</us-gaap:DeferredTaxAssetsNet>
<us-gaap:DeferredTaxAssetsNet contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">0</us-gaap:DeferredTaxAssetsNet>
<us-gaap:OperatingLossCarryforwards contextRef="Context_As_Of_31_Dec_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="-5">8800000</us-gaap:OperatingLossCarryforwards>
<us-gaap:OperatingLossCarryforwardsLimitationsOnUse contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00">Expire from 2027 through 2034 that are available to offset future taxable income.</us-gaap:OperatingLossCarryforwardsLimitationsOnUse>
<us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="pure" decimals="2">0.34</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
<us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount contextRef="Context_As_Of_30_Sep_2014T00_00_00_TO_30_Sep_2014T00_00_00" unitRef="USD" decimals="0">450000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount>
<us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent contextRef="Context_As_Of_30_Jun_2015T00_00_00_TO_30_Jun_2015T00_00_00" unitRef="USD" decimals="-5">1000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="Context_As_Of_31_Mar_2015T00_00_00_TO_31_Mar_2015T00_00_00_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="USD" decimals="0">900000</us-gaap:BusinessCombinationContingentConsiderationLiability>
<us-gaap:LossContingencyDamagesSoughtValue contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="USD" decimals="0">929000</us-gaap:LossContingencyDamagesSoughtValue>
<oprx:ContigentLiabilitiesRelatedToAuditFeesInPercentage contextRef="Context_FYE_01_Jan_2014T00_00_00_TO_31_Dec_2014T00_00_00" unitRef="pure" decimals="2">0.10</oprx:ContigentLiabilitiesRelatedToAuditFeesInPercentage>
<us-gaap:CostOfGoodsSold contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">730140</us-gaap:CostOfGoodsSold>
<us-gaap:CostOfGoodsSold contextRef="Context_3ME_01_Apr_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">540048</us-gaap:CostOfGoodsSold>
<us-gaap:CostOfGoodsSold contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">1291551</us-gaap:CostOfGoodsSold>
<us-gaap:CostOfGoodsSold contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">1038858</us-gaap:CostOfGoodsSold>
<oprx:IncreaseDecreaseInRevenueSharePayable contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00" unitRef="USD" decimals="0">-311776</oprx:IncreaseDecreaseInRevenueSharePayable>
<oprx:IncreaseDecreaseInRevenueSharePayable contextRef="Context_6ME_01_Jan_2014T00_00_00_TO_30_Jun_2014T00_00_00_CreationDateAxis_ScenarioPreviouslyReportedMember" unitRef="USD" decimals="0">-686760</oprx:IncreaseDecreaseInRevenueSharePayable>
<us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="Context_Custom_01_Jan_2015T00_00_00_TO_31_Jan_2015T00_00_00_SubsequentEventTypeAxis_SubsequentEventMember_TitleOfIndividualAxis_DirectorMember" unitRef="shares" decimals="INF">12500</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
<oprx:StockIssuedDuringPeroidSharesCacelled contextRef="Context_Custom_01_Jul_2015T00_00_00_TO_31_Jul_2015T00_00_00_SubsequentEventTypeAxis_SubsequentEventMember_FinancialInstrumentAxis_CapitalMarketsAdvisoryAgreementMember" unitRef="USD" decimals="0">45000</oprx:StockIssuedDuringPeroidSharesCacelled>
<us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="Context_Custom_01_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_AgreementAxis_SecuritiesPurchaseAgreementMember" unitRef="shares" decimals="INF">8333333</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
<us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="Context_Custom_01_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_AgreementAxis_SecuritiesPurchaseAgreementMember" unitRef="USD" decimals="0">10000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
<us-gaap:SharePrice contextRef="Context_As_Of_31_Mar_2014T00_00_00_TO_31_Mar_2014T00_00_00_TitleOfIndividualAxis_PlacementAgentsMember" unitRef="USD_per_Share" decimals="2">1.20</us-gaap:SharePrice>
<dei:AmendmentDescription contextRef="Context_6ME_01_Jan_2015T00_00_00_TO_30_Jun_2015T00_00_00">On May 4, 2015, we filed with the Securities and Exchange Commission a registration statement on Form S-1 (File No. 333-203820), which was amended by a pre-effective amendment filed on June 1, 2015, to register the offer and sale of 849,139 shares of our common stock, $0.001 par value per share, of which 804,139 shares of common stock are issuable upon the exercise of warrants.
The Registration Statement was declared effective by the Commission on June 16, 2015.
This Post-Effective Amendment No. 1 to the Form S-1/A is being filed to include a revised audit opinion from our independent auditor, KLJ &amp;amp; Associates, LLP. All securities offered hereby are being offered on a delayed or continuous basis. We are not registering any additional securities under this Post-Effective Amendment. All filing fees payable in connection with the registration of these securities were previously paid by us in connection with the filing of the Form S-1.</dei:AmendmentDescription>

<!-- Footnote Section -->
<link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
</link:footnoteLink>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>oprx-20150630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Modified with Ez-Editor Version 1.3.0.2 on Thursday, October 01, 2015 12:17:34 AM -->
<schema targetNamespace="http://OPRX/20150630" elementFormDefault="qualified" xmlns:oprx="http://OPRX/20150630" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:us-gaap="http://fasb.org/us-gaap/2015-01-31" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2014-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2015-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:us-types="http://fasb.org/us-types/2015-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric">
<annotation><appinfo>
<link:roleType roleURI="http://OPRX/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
<link:definition>001 - Document - Document and Entity Information</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/CondensedConsolidatedBalanceSheetUnaudited" id="CondensedConsolidatedBalanceSheetUnaudited">
<link:definition>002 - Statement - Condensed Consolidated Balance Sheet (Unaudited)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/CondensedConsolidatedBalanceSheetParentheticalUnaudited" id="CondensedConsolidatedBalanceSheetParentheticalUnaudited">
<link:definition>003 - Statement - Condensed Consolidated Balance Sheet (Parenthetical) (Unaudited)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/CondensedConsolidatedStatementsOfOperationsUnaudited" id="CondensedConsolidatedStatementsOfOperationsUnaudited">
<link:definition>004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/CondensedConsolidatedStatementOfStockholdersEquity" id="CondensedConsolidatedStatementOfStockholdersEquity">
<link:definition>005 - Statement - Condensed Consolidated Statement of Stockholders' Equity</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" id="CondensedConsolidatedStatementsOfCashFlowsUnaudited">
<link:definition>006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/NatureOfBusinessAndBasisOfPresentation" id="NatureOfBusinessAndBasisOfPresentation">
<link:definition>007 - Disclosure - Nature of Business and Basis of Presentation</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/StockholdersEquity" id="StockholdersEquity">
<link:definition>008 - Disclosure - Stockholders Equity</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/ShareBasedPaymentsOptions" id="ShareBasedPaymentsOptions">
<link:definition>009 - Disclosure - Share Based Payments   Options</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
<link:definition>010 - Disclosure - Commitments and Contingencies</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/Restatement" id="Restatement">
<link:definition>011 - Disclosure - Restatement</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
<link:definition>012 - Disclosure - Summary of Significant Accounting Policies</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/PrepaidExpenses" id="PrepaidExpenses">
<link:definition>013 - Disclosure - Prepaid Expenses</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/PropertyAndEquipment" id="PropertyAndEquipment">
<link:definition>014 - Disclosure - Property and Equipment</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/WebBasedTechnology" id="WebBasedTechnology">
<link:definition>015 - Disclosure - Web Based Technology</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/PatentAndTrademarks" id="PatentAndTrademarks">
<link:definition>016 - Disclosure - Patent and Trademarks</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/DeferredRevenue" id="DeferredRevenue">
<link:definition>017 - Disclosure - Deferred Revenue</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
<link:definition>018 - Disclosure - Related Party Transactions</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/CommonStock" id="CommonStock">
<link:definition>019 - Disclosure - Common Stock</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/PreferredStock" id="PreferredStock">
<link:definition>020 - Disclosure - Preferred Stock</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/StockOptionsAndWarrants" id="StockOptionsAndWarrants">
<link:definition>021 - Disclosure - Stock Options and Warrants</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/Warrants" id="Warrants">
<link:definition>022 - Disclosure - Warrants</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/OperatingLeases" id="OperatingLeases">
<link:definition>023 - Disclosure - Operating Leases</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/MajorCustomers" id="MajorCustomers">
<link:definition>024 - Disclosure - Major Customers</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/IncomeTaxes" id="IncomeTaxes">
<link:definition>025 - Disclosure - Income Taxes</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/SubsequentEvents" id="SubsequentEvents">
<link:definition>026 - Disclosure - Subsequent Events</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/SummaryofSignificantAccountingPoliciesPolicies" id="SummaryofSignificantAccountingPoliciesPolicies">
<link:definition>027 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/RestatementTables" id="RestatementTables">
<link:definition>028 - Disclosure - Restatement (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/SummaryofSignificantAccountingPoliciesTables" id="SummaryofSignificantAccountingPoliciesTables">
<link:definition>029 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/PrepaidExpensesTables" id="PrepaidExpensesTables">
<link:definition>030 - Disclosure - Prepaid Expenses (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/PropertyandEquipmentTables" id="PropertyandEquipmentTables">
<link:definition>031 - Disclosure - Property and Equipment (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/WebBasedTechnologyTables" id="WebBasedTechnologyTables">
<link:definition>032 - Disclosure - Web Based Technology (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/PatentandTrademarksTables" id="PatentandTrademarksTables">
<link:definition>033 - Disclosure - Patent and Trademarks (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/StockOptionsAndWarrantsTables" id="StockOptionsAndWarrantsTables">
<link:definition>034 - Disclosure - Stock Options and Warrants (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/WarrantsTables" id="WarrantsTables">
<link:definition>035 - Disclosure - Warrants (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/OperatingLeasesTables" id="OperatingLeasesTables">
<link:definition>036 - Disclosure - Operating Leases (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/MajorCustomersTables" id="MajorCustomersTables">
<link:definition>037 - Disclosure - Major Customers (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/IncomeTaxesTables" id="IncomeTaxesTables">
<link:definition>038 - Disclosure - Income Taxes (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/NatureOfBusinessAndBasisOfPresentationDetails" id="NatureOfBusinessAndBasisOfPresentationDetails">
<link:definition>039 - Disclosure - Nature of Business and Basis of Presentation (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/StockholdersEquityDetails" id="StockholdersEquityDetails">
<link:definition>040 - Disclosure - Stockholders Equity (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/ShareBasedPaymentsOptionsDetails" id="ShareBasedPaymentsOptionsDetails">
<link:definition>041 - Disclosure - Share Based Payments   Options (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/CommitmentsAndContingenciesDetails" id="CommitmentsAndContingenciesDetails">
<link:definition>042 - Disclosure - Commitments and Contingencies (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/RestatementDetails" id="RestatementDetails">
<link:definition>043 - Disclosure - Restatement (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/SummaryofSignificantAccountingPoliciesDetails" id="SummaryofSignificantAccountingPoliciesDetails">
<link:definition>044 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/SummaryOfSignificantAccountingPoliciesDetailsTextual" id="SummaryOfSignificantAccountingPoliciesDetailsTextual">
<link:definition>045 - Disclosure - Summary of Significant Accounting Policies (Details Textual)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/PrepaidExpensesDetails" id="PrepaidExpensesDetails">
<link:definition>046 - Disclosure - Prepaid Expenses (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/PropertyandEquipmentDetails" id="PropertyandEquipmentDetails">
<link:definition>047 - Disclosure - Property and Equipment (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/PropertyAndEquipmentDetailsTextual" id="PropertyAndEquipmentDetailsTextual">
<link:definition>048 - Disclosure - Property and Equipment (Details Textual)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/WebBasedTechnologyDetails" id="WebBasedTechnologyDetails">
<link:definition>049 - Disclosure - Web Based Technology (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/WebBasedTechnologyDetailsTextuals" id="WebBasedTechnologyDetailsTextuals">
<link:definition>050 - Disclosure - Web Based Technology (Details Textuals)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/PatentandTrademarksDetails" id="PatentandTrademarksDetails">
<link:definition>051 - Disclosure - Patent and Trademarks (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/PatentAndTrademarksDetailsTextuals" id="PatentAndTrademarksDetailsTextuals">
<link:definition>052 - Disclosure - Patent and Trademarks (Details Textuals)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/DeferredRevenueDetails" id="DeferredRevenueDetails">
<link:definition>053 - Disclosure - Deferred Revenue (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/RelatedPartyTransactionsDetails" id="RelatedPartyTransactionsDetails">
<link:definition>054 - Disclosure - Related Party Transactions (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/CommonStockDetails" id="CommonStockDetails">
<link:definition>055 - Disclosure - Common Stock (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/PreferredStockdetails" id="PreferredStockdetails">
<link:definition>056 - Disclosure - Preferred Stock (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/StockOptionsAndWarrantsDetails" id="StockOptionsAndWarrantsDetails">
<link:definition>057 - Disclosure - Stock Options and Warrants (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/StockOptionsAndWarrantsDetailTextuals" id="StockOptionsAndWarrantsDetailTextuals">
<link:definition>058 - Disclosure - Stock Options and Warrants (Detail Textuals)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/WarrantsDetails" id="WarrantsDetails">
<link:definition>059 - Disclosure - Warrants (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/WarrantsDetails1" id="WarrantsDetails1">
<link:definition>060 - Disclosure - Warrants (Details 1)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/WarrantsDetailsTextuals" id="WarrantsDetailsTextuals">
<link:definition>061 - Disclosure - Warrants (Details Textuals)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/OperatingLeasesDetails" id="OperatingLeasesDetails">
<link:definition>062 - Disclosure - Operating Leases (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/MajorCustomersDetails" id="MajorCustomersDetails">
<link:definition>063 - Disclosure - Major Customers (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/MajorCustomersDetailTextuals" id="MajorCustomersDetailTextuals">
<link:definition>064 - Disclosure - Major Customers (Detail Textuals)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/IncomeTaxesDetails" id="IncomeTaxesDetails">
<link:definition>065 - Disclosure - Income Taxes (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/IncomeTaxesDetails1" id="IncomeTaxesDetails1">
<link:definition>066 - Disclosure - Income Taxes (Details 1)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/IncomeTaxesDetailTextuals" id="IncomeTaxesDetailTextuals">
<link:definition>067 - Disclosure - Income Taxes (Detail Textuals)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://OPRX/role/SubsequentEventsDetails" id="SubsequentEventsDetails">
<link:definition>068 - Disclosure - Subsequent Events (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="oprx-20150630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="oprx-20150630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="oprx-20150630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="oprx-20150630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
</appinfo></annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<import namespace="http://fasb.org/us-gaap/2015-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/country/2013-01-31" schemaLocation="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/currency/2014-01-31" schemaLocation="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/exch/2015-01-31" schemaLocation="http://xbrl.sec.gov/exch/2015/exch-2015-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd"/>
<import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
<import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<import namespace="http://fasb.org/us-types/2015-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2015/elts/us-types-2015-01-31.xsd"/>
<element name="DocumentAndEntityInformationAbstract" id="oprx_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="RevenueSharePayableCurrent" id="oprx_RevenueSharePayableCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StockPayable" id="oprx_StockPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="RevenueShareExpense" id="oprx_RevenueShareExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StockPayableMember" id="oprx_StockPayableMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StockIssuedDuringPeriodValueConsultants" id="oprx_StockIssuedDuringPeriodValueConsultants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StockIssuedDuringPeriodOfCommonStockValueForPriorIssue" id="oprx_StockIssuedDuringPeriodOfCommonStockValueForPriorIssue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StockIssuedDuringPeriodOfCommonStockShareForPriorIssue" id="oprx_StockIssuedDuringPeriodOfCommonStockShareForPriorIssue" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StockIssuedDuringPeriodOfIssueStockRightsToOfficers" id="oprx_StockIssuedDuringPeriodOfIssueStockRightsToOfficers" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ReclassificationForExpiredWarrants" id="oprx_ReclassificationForExpiredWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AdjustmentsToAdditionalPaidInCapitalExpiredAndRedeemedWarrants" id="oprx_AdjustmentsToAdditionalPaidInCapitalExpiredAndRedeemedWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StockOptionsIssuedForServices" id="oprx_StockOptionsIssuedForServices" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="RevenueSharePayable" id="oprx_RevenueSharePayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PurchasesOfPropertyAndEquipment" id="oprx_PurchasesOfPropertyAndEquipment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PatentRights" id="oprx_PatentRights" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WebsiteDevelopmentCosts" id="oprx_WebsiteDevelopmentCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StockIssueDuringPeriodValueIssuedForCash" id="oprx_StockIssueDuringPeriodValueIssuedForCash" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PrepaidExpensesAbstract" id="oprx_PrepaidExpensesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PrepaidExpensesTextBlock" id="oprx_PrepaidExpensesTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WebBasedTechnologyAbstract" id="oprx_WebBasedTechnologyAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WebBasedTechnologyTextBlock" id="oprx_WebBasedTechnologyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantsDisclouresAbstract" id="oprx_WarrantsDisclouresAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantsTextBlock" id="oprx_WarrantsTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="MajorCustomerAbstract" id="oprx_MajorCustomerAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="MajorCustomerTextBlock" id="oprx_MajorCustomerTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="BasisOfAccountingPolicyTextBlock" id="oprx_BasisOfAccountingPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PrepaidExpensesTableTextBlock" id="oprx_PrepaidExpensesTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ScheduleOfCapitalizedCostsInDevelopingWebBasedTechnologyTableTextBlock" id="oprx_ScheduleOfCapitalizedCostsInDevelopingWebBasedTechnologyTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ScheduleOfShare-BasedCompensationWarrantActivityTableTextBlock" id="oprx_ScheduleOfShare-BasedCompensationWarrantActivityTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ScheduleOfMajorCustomersIndividualRevenueTableTextBlock" id="oprx_ScheduleOfMajorCustomersIndividualRevenueTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="NatureOfBusinessDetailsTextualAbstract" id="oprx_NatureOfBusinessDetailsTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PlacementAgentsMember" id="oprx_PlacementAgentsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ThreeOfficerMember" id="oprx_ThreeOfficerMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ConsultantMember" id="oprx_ConsultantMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="VicisMember" id="oprx_VicisMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="TwoOfficersMember" id="oprx_TwoOfficersMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AgreementAxis" id="oprx_AgreementAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem"/>
<element name="AgreementDomain" id="oprx_AgreementDomain" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SecuritiesPurchaseAgreementMember" id="oprx_SecuritiesPurchaseAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CapitalMarketsAdvisoryAgreementMember" id="oprx_CapitalMarketsAdvisoryAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StockholdersEquityTextualAbstract" id="oprx_StockholdersEquityTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="StockIssuedDuringPeroidSharesCacelled" id="oprx_StockIssuedDuringPeroidSharesCacelled" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantExercisePricePeriod" id="oprx_WarrantExercisePricePeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="DebtRedemptionLongtermDebtAmount" id="oprx_DebtRedemptionLongtermDebtAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CommissionsPercentage" id="oprx_CommissionsPercentage" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PurchaseOfWarrants" id="oprx_PurchaseOfWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AdditionalWorkingCapital" id="oprx_AdditionalWorkingCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FullyDilutedShares" id="oprx_FullyDilutedShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantsExercised" id="oprx_WarrantsExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ShareBasedPaymentsOptionsTextulaAbstract" id="oprx_ShareBasedPaymentsOptionsTextulaAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ContigentLiabilitiesRelatedToAuditFeesInPercentage" id="oprx_ContigentLiabilitiesRelatedToAuditFeesInPercentage" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IncreaseDecreaseInRevenueSharePayable" id="oprx_IncreaseDecreaseInRevenueSharePayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract" id="oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PrepaidLegalFees" id="oprx_PrepaidLegalFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PropertyPlantAndEquipmentTextualAbstract" id="oprx_PropertyPlantAndEquipmentTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WebBasedTechnologyMember" id="oprx_WebBasedTechnologyMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WebBasedTechnologyOneMember" id="oprx_WebBasedTechnologyOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WebBasedTechnologyTwoMember" id="oprx_WebBasedTechnologyTwoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CapitalizedComputerSoftwareImpairment" id="oprx_CapitalizedComputerSoftwareImpairment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CapitalizedComputerSoftwareAmortizationPeriodDescription" id="oprx_CapitalizedComputerSoftwareAmortizationPeriodDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="OptionsGrantedToAcquireExclusivePatentRightsShares" id="oprx_OptionsGrantedToAcquireExclusivePatentRightsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="OptionsGrantedToAcquireExclusivePatentRightsValue" id="oprx_OptionsGrantedToAcquireExclusivePatentRightsValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ConsultingAgreementMember" id="oprx_ConsultingAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="SeparationAgreementMember" id="oprx_SeparationAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="PurchaseAgreementMember" id="oprx_PurchaseAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="VicisCapitalAgreementMember" id="oprx_VicisCapitalAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantOneMember" id="oprx_WarrantOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantTwoMember" id="oprx_WarrantTwoMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="WarrantThreeMember" id="oprx_WarrantThreeMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate" id="oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate" type="xbrli:dateItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract" id="oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage" id="oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted" id="oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExercise" id="oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExercise" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExpiration" id="oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExpiration" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageCancellation" id="oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageCancellation" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CompanyAMember" id="oprx_CompanyAMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CompanyBMember" id="oprx_CompanyBMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CompanyCMember" id="oprx_CompanyCMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CompanyDMember" id="oprx_CompanyDMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="CompanyEMember" id="oprx_CompanyEMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="AllOtherCustomersMember" id="oprx_AllOtherCustomersMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="ConcentrationRiskPercentageTotal" id="oprx_ConcentrationRiskPercentageTotal" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FederalIncomeTaxExpensesBenefitPermanentAndTimingDifferences" id="oprx_FederalIncomeTaxExpensesBenefitPermanentAndTimingDifferences" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="FederalIncomeTaxExpensesBenefitValueAllowance" id="oprx_FederalIncomeTaxExpensesBenefitValueAllowance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
<element name="IncrementOneMember" id="oprx_IncrementOneMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>oprx-20150630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Modified with Ez-Editor Version 1.3.0.2 on Thursday, October 01, 2015 12:17:34 AM -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#CondensedConsolidatedBalanceSheetUnaudited" roleURI="http://OPRX/role/CondensedConsolidatedBalanceSheetUnaudited"/>
<calculationLink xlink:type="extended" xlink:role="http://OPRX/role/CondensedConsolidatedBalanceSheetUnaudited">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent" order="20" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_PrepaidExpenseCurrent" order="30" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaap_OtherAssets"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssets" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet" order="10" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssets" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet" order="20" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaap_SecurityDeposit"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssets" xlink:to="loc_us-gaap_SecurityDeposit" order="30" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_AssetsCurrent" order="10" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet" order="20" use="optional" weight="1"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_OtherAssets" order="30" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent" order="10" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrent"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrent" order="20" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent" order="30" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_RevenueSharePayableCurrent" xlink:label="loc_oprx_RevenueSharePayableCurrent"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_oprx_RevenueSharePayableCurrent" order="40" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_DeferredRevenueCurrent" order="50" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_CommonStockValue" order="10" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_PreferredStockValue" order="20" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding" order="30" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_AdditionalPaidInCapital" order="40" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockPayable" xlink:label="loc_oprx_StockPayable"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_oprx_StockPayable" order="50" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationEquity" xlink:label="loc_us-gaap_DeferredCompensationEquity"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_DeferredCompensationEquity" order="60" use="optional" weight="-1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit" order="70" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_LiabilitiesCurrent" order="10" use="optional" weight="1"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_StockholdersEquity" order="20" use="optional" weight="1"/></calculationLink>





<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#CondensedConsolidatedStatementsOfOperationsUnaudited" roleURI="http://OPRX/role/CondensedConsolidatedStatementsOfOperationsUnaudited"/>
<calculationLink xlink:type="extended" xlink:role="http://OPRX/role/CondensedConsolidatedStatementsOfOperationsUnaudited">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit" xlink:to="loc_us-gaap_Revenues" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_RevenueShareExpense" xlink:label="loc_oprx_RevenueShareExpense"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit" xlink:to="loc_oprx_RevenueShareExpense" order="20" use="optional" weight="-1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense" order="10" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_DepreciationAndAmortization" order="20" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LitigationSettlementExpense" xlink:label="loc_us-gaap_LitigationSettlementExpense"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_LitigationSettlementExpense" order="30" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherCostAndExpenseOperating" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating" order="40" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="loc_us-gaap_GrossProfit" order="10" use="optional" weight="1"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="loc_us-gaap_OperatingExpenses" order="20" use="optional" weight="-1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="loc_us-gaap_InterestAndOtherIncome"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_us-gaap_InterestAndOtherIncome" order="10" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_us-gaap_InterestExpense" order="20" use="optional" weight="-1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="loc_us-gaap_OperatingIncomeLoss" order="10" use="optional" weight="1"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="loc_us-gaap_NonoperatingIncomeExpense" order="20" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="10" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit" order="20" use="optional" weight="-1"/></calculationLink>





<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#CondensedConsolidatedStatementsOfCashFlowsUnaudited" roleURI="http://OPRX/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"/>
<calculationLink xlink:type="extended" xlink:role="http://OPRX/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_NetIncomeLoss" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_DepreciationAndAmortization" order="20" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockOptionsIssuedForServices" xlink:label="loc_oprx_StockOptionsIssuedForServices"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_oprx_StockOptionsIssuedForServices" order="30" use="optional" weight="-1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1" order="40" use="optional" weight="-1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_ShareBasedCompensation" order="50" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" order="60" use="optional" weight="-1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" order="70" use="optional" weight="-1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable" order="80" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_RevenueSharePayable" xlink:label="loc_oprx_RevenueSharePayable"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_oprx_RevenueSharePayable" order="90" use="optional" weight="-1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" order="100" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" order="110" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities"/><loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PurchasesOfPropertyAndEquipment" xlink:label="loc_oprx_PurchasesOfPropertyAndEquipment"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="loc_oprx_PurchasesOfPropertyAndEquipment" order="10" use="optional" weight="-1"/><loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PatentRights" xlink:label="loc_oprx_PatentRights"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="loc_oprx_PatentRights" order="20" use="optional" weight="-1"/><loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WebsiteDevelopmentCosts" xlink:label="loc_oprx_WebsiteDevelopmentCosts"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="loc_oprx_WebsiteDevelopmentCosts" order="30" use="optional" weight="-1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" order="10" use="optional" weight="1"/><loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsForRepurchaseOfEquity" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfEquity"/><calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfEquity" order="20" use="optional" weight="-1"/></calculationLink>


<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#PrepaidExpensesDetails" roleURI="http://OPRX/role/PrepaidExpensesDetails"/>
<calculationLink xlink:type="extended" xlink:role="http://OPRX/role/PrepaidExpensesDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidInsurance" xlink:label="loc_us-gaap_PrepaidInsurance"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="loc_us-gaap_PrepaidInsurance" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidRent" xlink:label="loc_us-gaap_PrepaidRent"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="loc_us-gaap_PrepaidRent" order="20" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PrepaidLegalFees" xlink:label="loc_oprx_PrepaidLegalFees"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="loc_oprx_PrepaidLegalFees" order="30" use="optional" weight="1"/>
</calculationLink>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#PropertyandEquipmentDetails" roleURI="http://OPRX/role/PropertyandEquipmentDetails"/>
<calculationLink xlink:type="extended" xlink:role="http://OPRX/role/PropertyandEquipmentDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="20" use="optional" weight="-1"/>
</calculationLink>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#WebBasedTechnologyDetails" roleURI="http://OPRX/role/WebBasedTechnologyDetails"/>
<calculationLink xlink:type="extended" xlink:role="http://OPRX/role/WebBasedTechnologyDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareNet" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareNet" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" order="20" use="optional" weight="-1"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CapitalizedComputerSoftwareImpairment" xlink:label="loc_oprx_CapitalizedComputerSoftwareImpairment"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareNet" xlink:to="loc_oprx_CapitalizedComputerSoftwareImpairment" order="30" use="optional" weight="1"/>
</calculationLink>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#PatentandTrademarksDetails" roleURI="http://OPRX/role/PatentandTrademarksDetails"/>
<calculationLink xlink:type="extended" xlink:role="http://OPRX/role/PatentandTrademarksDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedPatentsGross" xlink:label="loc_us-gaap_FiniteLivedPatentsGross"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaap_FiniteLivedPatentsGross" order="20" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_OtherFiniteLivedIntangibleAssetsGross"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaap_OtherFiniteLivedIntangibleAssetsGross" order="30" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="40" use="optional" weight="-1"/>
</calculationLink>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#OperatingLeasesDetails" roleURI="http://OPRX/role/OperatingLeasesDetails"/>
<calculationLink xlink:type="extended" xlink:role="http://OPRX/role/OperatingLeasesDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="20" use="optional" weight="1"/>
</calculationLink>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#IncomeTaxesDetails" roleURI="http://OPRX/role/IncomeTaxesDetails"/>
<calculationLink xlink:type="extended" xlink:role="http://OPRX/role/IncomeTaxesDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_FederalIncomeTaxExpensesBenefitPermanentAndTimingDifferences" xlink:label="loc_oprx_FederalIncomeTaxExpensesBenefitPermanentAndTimingDifferences"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="loc_oprx_FederalIncomeTaxExpensesBenefitPermanentAndTimingDifferences" order="20" use="optional" weight="-1"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_FederalIncomeTaxExpensesBenefitValueAllowance" xlink:label="loc_oprx_FederalIncomeTaxExpensesBenefitValueAllowance"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="loc_oprx_FederalIncomeTaxExpensesBenefitValueAllowance" order="30" use="optional" weight="-1"/>
</calculationLink>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#IncomeTaxesDetails1" roleURI="http://OPRX/role/IncomeTaxesDetails1"/>
<calculationLink xlink:type="extended" xlink:role="http://OPRX/role/IncomeTaxesDetails1">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="10" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance" order="20" use="optional" weight="-1"/>
</calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>oprx-20150630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Modified with Ez-Editor Version 1.3.0.2 on Thursday, October 01, 2015 12:17:34 AM -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#CondensedConsolidatedStatementOfStockholdersEquity" roleURI="http://OPRX/role/CondensedConsolidatedStatementOfStockholdersEquity"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#StockholdersEquityDetails" roleURI="http://OPRX/role/StockholdersEquityDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#CommitmentsAndContingenciesDetails" roleURI="http://OPRX/role/CommitmentsAndContingenciesDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#RestatementDetails" roleURI="http://OPRX/role/RestatementDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#SummaryOfSignificantAccountingPoliciesDetailsTextual" roleURI="http://OPRX/role/SummaryOfSignificantAccountingPoliciesDetailsTextual"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#PropertyandEquipmentDetails" roleURI="http://OPRX/role/PropertyandEquipmentDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#WebBasedTechnologyDetails" roleURI="http://OPRX/role/WebBasedTechnologyDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#PatentAndTrademarksDetailsTextuals" roleURI="http://OPRX/role/PatentAndTrademarksDetailsTextuals"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#RelatedPartyTransactionsDetails" roleURI="http://OPRX/role/RelatedPartyTransactionsDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#CommonStockDetails" roleURI="http://OPRX/role/CommonStockDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#PreferredStockdetails" roleURI="http://OPRX/role/PreferredStockdetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#StockOptionsAndWarrantsDetailTextuals" roleURI="http://OPRX/role/StockOptionsAndWarrantsDetailTextuals"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#WarrantsDetails" roleURI="http://OPRX/role/WarrantsDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#WarrantsDetails1" roleURI="http://OPRX/role/WarrantsDetails1"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#WarrantsDetailsTextuals" roleURI="http://OPRX/role/WarrantsDetailsTextuals"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#MajorCustomersDetails" roleURI="http://OPRX/role/MajorCustomersDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#SubsequentEventsDetails" roleURI="http://OPRX/role/SubsequentEventsDetails"/>
<definitionLink xlink:type="extended" xlink:role="http://OPRX/role/CondensedConsolidatedStatementOfStockholdersEquity">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2" xlink:to="loc_us-gaap_EquityComponentDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2" xlink:to="loc_us-gaap_EquityComponentDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaap_PreferredStockMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_PreferredStockMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_CommonStockMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_WarrantMember_6" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_7" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockPayableMember" xlink:label="loc_oprx_StockPayableMember_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_oprx_StockPayableMember_8" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_9" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_RetainedEarningsMember_10" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockholdersEquity_11" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_SharesOutstanding_12" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_13" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockIssuedDuringPeriodValueConsultants" xlink:label="loc_oprx_StockIssuedDuringPeriodValueConsultants_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_oprx_StockIssuedDuringPeriodValueConsultants_14" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_15" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_16"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_16" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther_17"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueOther_17" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther_18"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesOther_18" order="80" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockIssuedDuringPeriodOfCommonStockValueForPriorIssue" xlink:label="loc_oprx_StockIssuedDuringPeriodOfCommonStockValueForPriorIssue_19"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_oprx_StockIssuedDuringPeriodOfCommonStockValueForPriorIssue_19" order="90" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockIssuedDuringPeriodOfCommonStockShareForPriorIssue" xlink:label="loc_oprx_StockIssuedDuringPeriodOfCommonStockShareForPriorIssue_20"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_oprx_StockIssuedDuringPeriodOfCommonStockShareForPriorIssue_20" order="100" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_21"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_21" order="110" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_22"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_22" order="120" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_23"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_23" order="130" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_24"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_24" order="140" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_25"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_25" order="150" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockIssuedDuringPeriodOfIssueStockRightsToOfficers" xlink:label="loc_oprx_StockIssuedDuringPeriodOfIssueStockRightsToOfficers_26"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_oprx_StockIssuedDuringPeriodOfIssueStockRightsToOfficers_26" order="160" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ReclassificationForExpiredWarrants" xlink:label="loc_oprx_ReclassificationForExpiredWarrants_27"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_oprx_ReclassificationForExpiredWarrants_27" order="170" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_AdjustmentsToAdditionalPaidInCapitalExpiredAndRedeemedWarrants" xlink:label="loc_oprx_AdjustmentsToAdditionalPaidInCapitalExpiredAndRedeemedWarrants_28"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_oprx_AdjustmentsToAdditionalPaidInCapitalExpiredAndRedeemedWarrants_28" order="180" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense_29"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense_29" order="190" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="loc_us-gaap_StockRedeemedOrCalledDuringPeriodValue_30"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockRedeemedOrCalledDuringPeriodValue_30" order="200" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="loc_us-gaap_StockRedeemedOrCalledDuringPeriodShares_31"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockRedeemedOrCalledDuringPeriodShares_31" order="210" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_32"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_NetIncomeLoss_32" order="220" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://OPRX/role/StockholdersEquityDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_1" xlink:to="loc_us-gaap_TitleOfIndividualAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TitleOfIndividualAxis_2" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TitleOfIndividualAxis_2" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PlacementAgentsMember" xlink:label="loc_oprx_PlacementAgentsMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_oprx_PlacementAgentsMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ThreeOfficerMember" xlink:label="loc_oprx_ThreeOfficerMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_oprx_ThreeOfficerMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ConsultantMember" xlink:label="loc_oprx_ConsultantMember_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_oprx_ConsultantMember_6" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_VicisMember" xlink:label="loc_oprx_VicisMember_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_oprx_VicisMember_7" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OfficerMember" xlink:label="loc_us-gaap_OfficerMember_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_us-gaap_OfficerMember_8" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DirectorMember" xlink:label="loc_us-gaap_DirectorMember_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_us-gaap_DirectorMember_9" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_TwoOfficersMember" xlink:label="loc_oprx_TwoOfficersMember_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_oprx_TwoOfficersMember_10" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_AgreementAxis" xlink:label="loc_oprx_AgreementAxis_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_1" xlink:to="loc_oprx_AgreementAxis_11" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_AgreementDomain" xlink:label="loc_oprx_AgreementDomain_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_oprx_AgreementAxis_11" xlink:to="loc_oprx_AgreementDomain_12" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_AgreementDomain" xlink:label="loc_oprx_AgreementDomain_12_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_oprx_AgreementAxis_11" xlink:to="loc_oprx_AgreementDomain_12_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_SecuritiesPurchaseAgreementMember" xlink:label="loc_oprx_SecuritiesPurchaseAgreementMember_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_AgreementDomain_12" xlink:to="loc_oprx_SecuritiesPurchaseAgreementMember_13" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_14" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_14" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_15" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_15_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_14" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_15_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_16"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_15" xlink:to="loc_us-gaap_SubsequentEventMember_16" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_17"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_1" xlink:to="loc_us-gaap_FinancialInstrumentAxis_17" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_18"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_17" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_18" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_18_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_17" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_18_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CapitalMarketsAdvisoryAgreementMember" xlink:label="loc_oprx_CapitalMarketsAdvisoryAgreementMember_19"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_18" xlink:to="loc_oprx_CapitalMarketsAdvisoryAgreementMember_19" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockholdersEquityTextualAbstract" xlink:label="loc_oprx_StockholdersEquityTextualAbstract_20"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_oprx_StockholdersEquityTextualAbstract_20" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="loc_us-gaap_StockRedeemedOrCalledDuringPeriodShares_21"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_20" xlink:to="loc_us-gaap_StockRedeemedOrCalledDuringPeriodShares_21" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_22"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_20" xlink:to="loc_us-gaap_SharesIssued_22" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockIssuedDuringPeroidSharesCacelled" xlink:label="loc_oprx_StockIssuedDuringPeroidSharesCacelled_23"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_20" xlink:to="loc_oprx_StockIssuedDuringPeroidSharesCacelled_23" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_24"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_20" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_24" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_25"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_20" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_25" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantExercisePricePeriod" xlink:label="loc_oprx_WarrantExercisePricePeriod_26"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_20" xlink:to="loc_oprx_WarrantExercisePricePeriod_26" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_27"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_20" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_27" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_DebtRedemptionLongtermDebtAmount" xlink:label="loc_oprx_DebtRedemptionLongtermDebtAmount_28"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_20" xlink:to="loc_oprx_DebtRedemptionLongtermDebtAmount_28" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CommissionsPercentage" xlink:label="loc_oprx_CommissionsPercentage_29"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_20" xlink:to="loc_oprx_CommissionsPercentage_29" order="80" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_30"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_20" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_30" order="90" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PurchaseOfWarrants" xlink:label="loc_oprx_PurchaseOfWarrants_31"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_20" xlink:to="loc_oprx_PurchaseOfWarrants_31" order="100" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_32"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_20" xlink:to="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_32" order="110" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_33"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_20" xlink:to="loc_us-gaap_SharePrice_33" order="120" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_34"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_20" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_34" order="130" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="loc_us-gaap_StockRedeemedOrCalledDuringPeriodValue_35"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_20" xlink:to="loc_us-gaap_StockRedeemedOrCalledDuringPeriodValue_35" order="140" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther_36"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_20" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesOther_36" order="150" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther_37"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_20" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueOther_37" order="160" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_38"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_20" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_38" order="170" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_39"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_20" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_39" order="180" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_40"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_20" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_40" order="190" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_AdditionalWorkingCapital" xlink:label="loc_oprx_AdditionalWorkingCapital_41"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_20" xlink:to="loc_oprx_AdditionalWorkingCapital_41" order="200" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_FullyDilutedShares" xlink:label="loc_oprx_FullyDilutedShares_42"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_20" xlink:to="loc_oprx_FullyDilutedShares_42" order="210" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtIssuanceCosts" xlink:label="loc_us-gaap_DebtIssuanceCosts_43"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_20" xlink:to="loc_us-gaap_DebtIssuanceCosts_43" order="220" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantsExercised" xlink:label="loc_oprx_WarrantsExercised_44"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_20" xlink:to="loc_oprx_WarrantsExercised_44" order="230" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://OPRX/role/CommitmentsAndContingenciesDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_0" xlink:to="loc_us-gaap_LossContingenciesTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3" xlink:to="loc_us-gaap_SubsequentEventMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_6" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_8" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ContigentLiabilitiesRelatedToAuditFeesInPercentage" xlink:label="loc_oprx_ContigentLiabilitiesRelatedToAuditFeesInPercentage_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0" xlink:to="loc_oprx_ContigentLiabilitiesRelatedToAuditFeesInPercentage_9" order="50" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://OPRX/role/RestatementDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreationDateAxis" xlink:label="loc_us-gaap_CreationDateAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_CreationDateAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="loc_us-gaap_DefaultFinancialStatementsDateMember_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreationDateAxis_2" xlink:to="loc_us-gaap_DefaultFinancialStatementsDateMember_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="loc_us-gaap_DefaultFinancialStatementsDateMember_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreationDateAxis_2" xlink:to="loc_us-gaap_DefaultFinancialStatementsDateMember_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioPreviouslyReportedMember" xlink:label="loc_us-gaap_ScenarioPreviouslyReportedMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefaultFinancialStatementsDateMember_3" xlink:to="loc_us-gaap_ScenarioPreviouslyReportedMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestatementAdjustmentMember" xlink:label="loc_us-gaap_RestatementAdjustmentMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefaultFinancialStatementsDateMember_3" xlink:to="loc_us-gaap_RestatementAdjustmentMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_StatementOfFinancialPositionAbstract_6" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_7" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_RevenueSharePayableCurrent" xlink:label="loc_oprx_RevenueSharePayableCurrent_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6" xlink:to="loc_oprx_RevenueSharePayableCurrent_8" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6" xlink:to="loc_us-gaap_DeferredRevenueCurrent_9" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6" xlink:to="loc_us-gaap_AdditionalPaidInCapital_10" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationEquity" xlink:label="loc_us-gaap_DeferredCompensationEquity_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6" xlink:to="loc_us-gaap_DeferredCompensationEquity_11" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_12" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_IncomeStatementAbstract_13" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_13" xlink:to="loc_us-gaap_Revenues_14" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaap_CostOfGoodsSold_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_13" xlink:to="loc_us-gaap_CostOfGoodsSold_15" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_16"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_13" xlink:to="loc_us-gaap_OperatingExpenses_16" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_17"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_13" xlink:to="loc_us-gaap_OperatingIncomeLoss_17" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_18"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_13" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_18" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_RevenueShareExpense" xlink:label="loc_oprx_RevenueShareExpense_19"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_13" xlink:to="loc_oprx_RevenueShareExpense_19" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_20"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_13" xlink:to="loc_us-gaap_NetIncomeLoss_20" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_21"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_StatementOfCashFlowsAbstract_21" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockOptionsIssuedForServices" xlink:label="loc_oprx_StockOptionsIssuedForServices_22"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_21" xlink:to="loc_oprx_StockOptionsIssuedForServices_22" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_23"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_21" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_23" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_IncreaseDecreaseInRevenueSharePayable" xlink:label="loc_oprx_IncreaseDecreaseInRevenueSharePayable_24"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_21" xlink:to="loc_oprx_IncreaseDecreaseInRevenueSharePayable_24" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_25"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_21" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_25" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_26"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_21" xlink:to="loc_us-gaap_ShareBasedCompensation_26" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_RevenueSharePayable" xlink:label="loc_oprx_RevenueSharePayable_27"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_21" xlink:to="loc_oprx_RevenueSharePayable_27" order="50" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://OPRX/role/SummaryOfSignificantAccountingPoliciesDetailsTextual">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_RangeAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_2" xlink:to="loc_us-gaap_RangeMember_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_2" xlink:to="loc_us-gaap_RangeMember_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_3" xlink:to="loc_us-gaap_MaximumMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_3" xlink:to="loc_us-gaap_MinimumMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract" xlink:label="loc_oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract_6" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract_6" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_7" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract_6" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_8" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract_6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_9" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenueRecognitionNewAccountingPronouncementMaterialEffectDescription" xlink:label="loc_us-gaap_RevenueRecognitionNewAccountingPronouncementMaterialEffectDescription_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract_6" xlink:to="loc_us-gaap_RevenueRecognitionNewAccountingPronouncementMaterialEffectDescription_10" order="30" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://OPRX/role/PropertyandEquipmentDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" xlink:to="loc_us-gaap_ComputerEquipmentMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_6" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8" order="30" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://OPRX/role/WebBasedTechnologyDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WebBasedTechnologyMember" xlink:label="loc_oprx_WebBasedTechnologyMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3" xlink:to="loc_oprx_WebBasedTechnologyMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WebBasedTechnologyOneMember" xlink:label="loc_oprx_WebBasedTechnologyOneMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3" xlink:to="loc_oprx_WebBasedTechnologyOneMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WebBasedTechnologyTwoMember" xlink:label="loc_oprx_WebBasedTechnologyTwoMember_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3" xlink:to="loc_oprx_WebBasedTechnologyTwoMember_6" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_7" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_8" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CapitalizedComputerSoftwareImpairment" xlink:label="loc_oprx_CapitalizedComputerSoftwareImpairment_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0" xlink:to="loc_oprx_CapitalizedComputerSoftwareImpairment_9" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_10" order="40" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://OPRX/role/PatentAndTrademarksDetailsTextuals">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaap_PatentsMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3" xlink:to="loc_us-gaap_PatentsMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_OptionsGrantedToAcquireExclusivePatentRightsShares" xlink:label="loc_oprx_OptionsGrantedToAcquireExclusivePatentRightsShares_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0" xlink:to="loc_oprx_OptionsGrantedToAcquireExclusivePatentRightsShares_6" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_OptionsGrantedToAcquireExclusivePatentRightsValue" xlink:label="loc_oprx_OptionsGrantedToAcquireExclusivePatentRightsValue_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0" xlink:to="loc_oprx_OptionsGrantedToAcquireExclusivePatentRightsValue_7" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_8" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockTransactionDate" xlink:label="loc_us-gaap_SaleOfStockTransactionDate_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0" xlink:to="loc_us-gaap_SaleOfStockTransactionDate_9" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationMethod" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationMethod_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationMethod_10" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_11" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths_12" order="80" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://OPRX/role/RelatedPartyTransactionsDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaap_PatentsMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3" xlink:to="loc_us-gaap_PatentsMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_OptionsGrantedToAcquireExclusivePatentRightsShares" xlink:label="loc_oprx_OptionsGrantedToAcquireExclusivePatentRightsShares_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_oprx_OptionsGrantedToAcquireExclusivePatentRightsShares_6" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockTransactionDate" xlink:label="loc_us-gaap_SaleOfStockTransactionDate_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_us-gaap_SaleOfStockTransactionDate_7" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_OptionsGrantedToAcquireExclusivePatentRightsValue" xlink:label="loc_oprx_OptionsGrantedToAcquireExclusivePatentRightsValue_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_oprx_OptionsGrantedToAcquireExclusivePatentRightsValue_8" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_9" order="50" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://OPRX/role/CommonStockDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_TitleOfIndividualAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TitleOfIndividualAxis_2" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TitleOfIndividualAxis_2" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PlacementAgentsMember" xlink:label="loc_oprx_PlacementAgentsMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_oprx_PlacementAgentsMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ThreeOfficerMember" xlink:label="loc_oprx_ThreeOfficerMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_oprx_ThreeOfficerMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ConsultantMember" xlink:label="loc_oprx_ConsultantMember_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_oprx_ConsultantMember_6" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_VicisMember" xlink:label="loc_oprx_VicisMember_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_oprx_VicisMember_7" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OfficerMember" xlink:label="loc_us-gaap_OfficerMember_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_us-gaap_OfficerMember_8" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DirectorMember" xlink:label="loc_us-gaap_DirectorMember_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_us-gaap_DirectorMember_9" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_FinancialInstrumentAxis_10" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_10" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_11" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_11_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_10" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_11_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ConsultingAgreementMember" xlink:label="loc_oprx_ConsultingAgreementMember_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_11" xlink:to="loc_oprx_ConsultingAgreementMember_12" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CapitalMarketsAdvisoryAgreementMember" xlink:label="loc_oprx_CapitalMarketsAdvisoryAgreementMember_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_11" xlink:to="loc_oprx_CapitalMarketsAdvisoryAgreementMember_13" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_SeparationAgreementMember" xlink:label="loc_oprx_SeparationAgreementMember_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_11" xlink:to="loc_oprx_SeparationAgreementMember_14" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PurchaseAgreementMember" xlink:label="loc_oprx_PurchaseAgreementMember_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_11" xlink:to="loc_oprx_PurchaseAgreementMember_15" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_SecuritiesPurchaseAgreementMember" xlink:label="loc_oprx_SecuritiesPurchaseAgreementMember_16"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_11" xlink:to="loc_oprx_SecuritiesPurchaseAgreementMember_16" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_VicisCapitalAgreementMember" xlink:label="loc_oprx_VicisCapitalAgreementMember_17"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_11" xlink:to="loc_oprx_VicisCapitalAgreementMember_17" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_18"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_18" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_19"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_19" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_20"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_CommonStockSharesIssued_20" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_21"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_21" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_22"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_SharesIssued_22" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_23"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_23" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_24"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_CommonStockValue_24" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationEquity" xlink:label="loc_us-gaap_DeferredCompensationEquity_25"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_DeferredCompensationEquity_25" order="80" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_26"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_26" order="90" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantExercisePricePeriod" xlink:label="loc_oprx_WarrantExercisePricePeriod_27"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_oprx_WarrantExercisePricePeriod_27" order="100" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_28"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_28" order="110" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_29"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_29" order="120" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CommissionsPercentage" xlink:label="loc_oprx_CommissionsPercentage_30"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_oprx_CommissionsPercentage_30" order="130" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_31"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_31" order="140" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PurchaseOfWarrants" xlink:label="loc_oprx_PurchaseOfWarrants_32"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_oprx_PurchaseOfWarrants_32" order="150" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_33"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_33" order="160" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_34"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_34" order="170" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_35"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_35" order="180" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_36"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_36" order="190" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_37"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_37" order="200" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_AdditionalWorkingCapital" xlink:label="loc_oprx_AdditionalWorkingCapital_38"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_oprx_AdditionalWorkingCapital_38" order="210" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_FullyDilutedShares" xlink:label="loc_oprx_FullyDilutedShares_39"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_oprx_FullyDilutedShares_39" order="220" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtIssuanceCosts" xlink:label="loc_us-gaap_DebtIssuanceCosts_40"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_DebtIssuanceCosts_40" order="230" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_41"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_41" order="240" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantsExercised" xlink:label="loc_oprx_WarrantsExercised_42"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_oprx_WarrantsExercised_42" order="250" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_DebtRedemptionLongtermDebtAmount" xlink:label="loc_oprx_DebtRedemptionLongtermDebtAmount_43"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_oprx_DebtRedemptionLongtermDebtAmount_43" order="260" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://OPRX/role/PreferredStockdetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2" xlink:to="loc_us-gaap_ClassOfStockDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2" xlink:to="loc_us-gaap_ClassOfStockDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6" xlink:to="loc_us-gaap_EquityComponentDomain_7" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_7_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6" xlink:to="loc_us-gaap_EquityComponentDomain_7_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7" xlink:to="loc_us-gaap_CommonStockMember_8" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_9" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_10" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_11" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_12" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_13" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_14" order="60" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_15" order="70" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_16"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_16" order="80" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentWarrantsExercisePrice" xlink:label="loc_invest_InvestmentWarrantsExercisePrice_17"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_invest_InvestmentWarrantsExercisePrice_17" order="90" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TreasuryStockNumberOfSharesHeld" xlink:label="loc_us-gaap_TreasuryStockNumberOfSharesHeld_18"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_TreasuryStockNumberOfSharesHeld_18" order="100" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_19"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_19" order="110" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_20"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_20" order="120" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TemporaryEquityAccretionOfDividends" xlink:label="loc_us-gaap_TemporaryEquityAccretionOfDividends_21"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_TemporaryEquityAccretionOfDividends_21" order="130" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockRedemptionAmount" xlink:label="loc_us-gaap_PreferredStockRedemptionAmount_22"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_PreferredStockRedemptionAmount_22" order="140" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://OPRX/role/StockOptionsAndWarrantsDetailTextuals">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockCompensationPlanMember" xlink:label="loc_us-gaap_StockCompensationPlanMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" xlink:to="loc_us-gaap_StockCompensationPlanMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_7" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_9" order="50" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://OPRX/role/WarrantsDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2" xlink:to="loc_us-gaap_EquityComponentDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2" xlink:to="loc_us-gaap_EquityComponentDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantOneMember" xlink:label="loc_oprx_WarrantOneMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_oprx_WarrantOneMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantTwoMember" xlink:label="loc_oprx_WarrantTwoMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_oprx_WarrantTwoMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantThreeMember" xlink:label="loc_oprx_WarrantThreeMember_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_oprx_WarrantThreeMember_6" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_7" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentWarrantsExercisePrice" xlink:label="loc_invest_InvestmentWarrantsExercisePrice_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_invest_InvestmentWarrantsExercisePrice_8" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate" xlink:label="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate_9" order="30" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://OPRX/role/WarrantsDetails1">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2" xlink:to="loc_us-gaap_EquityComponentDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2" xlink:to="loc_us-gaap_EquityComponentDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_WarrantMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_6" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_7" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_8" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_9" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_10" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract" xlink:label="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract_11" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage" xlink:label="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract_11" xlink:to="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage_12" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted" xlink:label="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract_11" xlink:to="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted_13" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExercise" xlink:label="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExercise_14"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract_11" xlink:to="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExercise_14" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExpiration" xlink:label="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExpiration_15"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract_11" xlink:to="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExpiration_15" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageCancellation" xlink:label="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageCancellation_16"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract_11" xlink:to="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageCancellation_16" order="40" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://OPRX/role/WarrantsDetailsTextuals">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2" xlink:to="loc_us-gaap_EquityComponentDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2" xlink:to="loc_us-gaap_EquityComponentDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_WarrantMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted" xlink:label="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted_6" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_7" order="30" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://OPRX/role/MajorCustomersDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaap_ProductInformationLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductInformationLineItems_0" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_1" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CompanyAMember" xlink:label="loc_oprx_CompanyAMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3" xlink:to="loc_oprx_CompanyAMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CompanyBMember" xlink:label="loc_oprx_CompanyBMember_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3" xlink:to="loc_oprx_CompanyBMember_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CompanyCMember" xlink:label="loc_oprx_CompanyCMember_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3" xlink:to="loc_oprx_CompanyCMember_6" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CompanyDMember" xlink:label="loc_oprx_CompanyDMember_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3" xlink:to="loc_oprx_CompanyDMember_7" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CompanyEMember" xlink:label="loc_oprx_CompanyEMember_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3" xlink:to="loc_oprx_CompanyEMember_8" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_AllOtherCustomersMember" xlink:label="loc_oprx_AllOtherCustomersMember_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3" xlink:to="loc_oprx_AllOtherCustomersMember_9" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_0" xlink:to="loc_us-gaap_Revenues_10" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_0" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_11" order="20" use="optional"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://OPRX/role/SubsequentEventsDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_0" xlink:to="loc_us-gaap_SubsequentEventTable_1" order="0" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_4"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3" xlink:to="loc_us-gaap_SubsequentEventMember_4" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_5"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1" xlink:to="loc_us-gaap_TitleOfIndividualAxis_5" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_6"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TitleOfIndividualAxis_5" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_6" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_6_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TitleOfIndividualAxis_5" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_6_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DirectorMember" xlink:label="loc_us-gaap_DirectorMember_7"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_6" xlink:to="loc_us-gaap_DirectorMember_7" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_8"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1" xlink:to="loc_us-gaap_PlanNameAxis_8" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_9"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_8" xlink:to="loc_us-gaap_PlanNameDomain_9" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_9_Default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_8" xlink:to="loc_us-gaap_PlanNameDomain_9_Default" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_IncrementOneMember" xlink:label="loc_oprx_IncrementOneMember_10"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_9" xlink:to="loc_oprx_IncrementOneMember_10" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_11"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_11" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_12"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_12" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_13"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_13" order="30" use="optional"/>
</definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>oprx-20150630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Modified with Ez-Editor Version 1.3.0.2 on Thursday, October 01, 2015 12:17:34 AM -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
<labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_DocumentAndEntityInformationAbstract" xlink:label="loc_G8H693H3H85K_oprx_DocumentAndEntityInformationAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_DocumentAndEntityInformationAbstract" xml:lang="en-US">Document and Entity Information</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_DocumentAndEntityInformationAbstract" xlink:to="lab_I0J815J5J07M_oprx_DocumentAndEntityInformationAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_K77FGGG1H9F295KI3IGI_dei_EntityRegistrantName"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_dei_EntityRegistrantName" xml:lang="en-US">Entity Registrant Name</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_dei_EntityRegistrantName" xlink:to="lab_M99HIII3J1H417MK5KIK_dei_EntityRegistrantName"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_G8H693H3H85K_dei_EntityCentralIndexKey"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_dei_EntityCentralIndexKey" xml:lang="en-US">Entity Central Index Key</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_dei_EntityCentralIndexKey" xlink:to="lab_I0J815J5J07M_dei_EntityCentralIndexKey"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_K77FGGG1H9F295KI3IGI_dei_AmendmentFlag"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_dei_AmendmentFlag" xml:lang="en-US">Amendment Flag</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_dei_AmendmentFlag" xlink:to="lab_M99HIII3J1H417MK5KIK_dei_AmendmentFlag"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_G8H693H3H85K_dei_AmendmentDescription"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_dei_AmendmentDescription" xml:lang="en-US">Amendment Description</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_dei_AmendmentDescription" xlink:to="lab_I0J815J5J07M_dei_AmendmentDescription"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_K77FGGG1H9F295KI3IGI_dei_DocumentType"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_dei_DocumentType" xml:lang="en-US">Document Type</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_dei_DocumentType" xlink:to="lab_M99HIII3J1H417MK5KIK_dei_DocumentType"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_G8H693H3H85K_dei_EntityFilerCategory"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_dei_EntityFilerCategory" xml:lang="en-US">Entity Filer Category</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_dei_EntityFilerCategory" xlink:to="lab_I0J815J5J07M_dei_EntityFilerCategory"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_K77FGGG1H9F295KI3IGI_dei_DocumentPeriodEndDate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_dei_DocumentPeriodEndDate" xml:lang="en-US">Document Period End Date</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_dei_DocumentPeriodEndDate" xlink:to="lab_M99HIII3J1H417MK5KIK_dei_DocumentPeriodEndDate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_StatementOfFinancialPositionAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_StatementOfFinancialPositionAbstract" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_StatementOfFinancialPositionAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_AssetsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_AssetsAbstract" xml:lang="en-US">AssetsAbstract</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_AssetsAbstract" xml:lang="en-US">ASSETS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_AssetsAbstract" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_AssetsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_AssetsCurrentAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_AssetsCurrentAbstract" xml:lang="en-US">AssetsCurrentAbstract</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_AssetsCurrentAbstract" xml:lang="en-US">Current Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_AssetsCurrentAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_AssetsCurrentAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash and cash equivalents</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">CASH AND CASH EQUIVALENTS - END OF PERIOD</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_G8H693H3H85K_us-gaap_AccountsReceivableNetCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_AccountsReceivableNetCurrent" xml:lang="en-US">Accounts Receivable, Net, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_AccountsReceivableNetCurrent" xml:lang="en-US">Accounts receivable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_I0J815J5J07M_us-gaap_AccountsReceivableNetCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_PrepaidExpenseCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_PrepaidExpenseCurrent" xml:lang="en-US">Prepaid Expense, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_PrepaidExpenseCurrent" xml:lang="en-US">Total prepaid expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_PrepaidExpenseCurrent" xml:lang="en-US">Prepaid expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_PrepaidExpenseCurrent" xml:lang="en-US">Total prepaid expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_PrepaidExpenseCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_G8H693H3H85K_us-gaap_AssetsCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_AssetsCurrent" xml:lang="en-US">AssetsCurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_I0J815J5J07M_us-gaap_AssetsCurrent" xml:lang="en-US">Total Current Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_AssetsCurrent" xlink:to="lab_I0J815J5J07M_us-gaap_AssetsCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_PropertyPlantAndEquipmentNet"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property, Plant and Equipment, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property and equipment, net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property and equipment, net</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_PropertyPlantAndEquipmentNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssetsAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_OtherAssetsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_OtherAssetsAbstract" xml:lang="en-US">OtherAssetsAbstract</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_OtherAssetsAbstract" xml:lang="en-US">Other Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_OtherAssetsAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_OtherAssetsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_FiniteLivedIntangibleAssetsNet"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_FiniteLivedIntangibleAssetsNet" xml:lang="en-US">Finite-Lived Intangible Assets, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_FiniteLivedIntangibleAssetsNet" xml:lang="en-US">Patent rights and intangible assets, net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_FiniteLivedIntangibleAssetsNet" xml:lang="en-US">Patent rights, net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_FiniteLivedIntangibleAssetsNet" xml:lang="en-US">Patent rights and intangible assets, net</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_FiniteLivedIntangibleAssetsNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet" xlink:label="loc_G8H693H3H85K_us-gaap_CapitalizedComputerSoftwareNet"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_CapitalizedComputerSoftwareNet" xml:lang="en-US">Capitalized Computer Software, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_CapitalizedComputerSoftwareNet" xml:lang="en-US">Web development costs, net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_I0J815J5J07M_us-gaap_CapitalizedComputerSoftwareNet" xml:lang="en-US">Web-based technology,, net</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_CapitalizedComputerSoftwareNet" xlink:to="lab_I0J815J5J07M_us-gaap_CapitalizedComputerSoftwareNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SecurityDeposit" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_SecurityDeposit"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_SecurityDeposit" xml:lang="en-US">SecurityDeposit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_SecurityDeposit" xml:lang="en-US">Security deposit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_SecurityDeposit" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_SecurityDeposit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssets" xlink:label="loc_G8H693H3H85K_us-gaap_OtherAssets"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_OtherAssets" xml:lang="en-US">OtherAssets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_I0J815J5J07M_us-gaap_OtherAssets" xml:lang="en-US">Total Other Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_OtherAssets" xlink:to="lab_I0J815J5J07M_us-gaap_OtherAssets"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_Assets"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_Assets" xml:lang="en-US">Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_Assets" xml:lang="en-US">TOTAL ASSETS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_Assets" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_Assets"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">LiabilitiesAndStockholdersEquityAbstract</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_LiabilitiesCurrentAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US">LiabilitiesCurrentAbstract</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US">Current Liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_LiabilitiesCurrentAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_G8H693H3H85K_us-gaap_AccountsPayableTradeCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_AccountsPayableTradeCurrent" xml:lang="en-US">AccountsPayableTradeCurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_AccountsPayableTradeCurrent" xml:lang="en-US">Accounts payable - trade</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_I0J815J5J07M_us-gaap_AccountsPayableTradeCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_AccountsPayableRelatedPartiesCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_AccountsPayableRelatedPartiesCurrent" xml:lang="en-US">Accounts Payable, Related Parties, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_AccountsPayableRelatedPartiesCurrent" xml:lang="en-US">Accounts payable - related party</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_AccountsPayableRelatedPartiesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_G8H693H3H85K_us-gaap_AccruedLiabilitiesCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_AccruedLiabilitiesCurrent" xml:lang="en-US">Accrued Liabilities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_AccruedLiabilitiesCurrent" xml:lang="en-US">Accrued expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_I0J815J5J07M_us-gaap_AccruedLiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_RevenueSharePayableCurrent" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_RevenueSharePayableCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_RevenueSharePayableCurrent" xml:lang="en-US">Revenue Share Payable Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_RevenueSharePayableCurrent" xml:lang="en-US">Revenue share payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_RevenueSharePayableCurrent" xml:lang="en-US">Aggregate carrying value as of the balance sheet date of the liabilities for revenue share payable within one year (or the normal operating cycle, if longer).</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_RevenueSharePayableCurrent" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_RevenueSharePayableCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_G8H693H3H85K_us-gaap_DeferredRevenueCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_DeferredRevenueCurrent" xml:lang="en-US">Deferred Revenue, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_DeferredRevenueCurrent" xml:lang="en-US">Deferred revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_DeferredRevenueCurrent" xlink:to="lab_I0J815J5J07M_us-gaap_DeferredRevenueCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_LiabilitiesCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Liabilities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Total Liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_LiabilitiesCurrent" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_LiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_StockholdersEquityAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_StockholdersEquityAbstract" xml:lang="en-US">StockholdersEquityAbstract</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_StockholdersEquityAbstract" xml:lang="en-US">Stockholders' Equity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_StockholdersEquityAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_StockholdersEquityAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_CommonStockValue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_CommonStockValue" xml:lang="en-US">Common Stock, Value, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_CommonStockValue" xml:lang="en-US">Common stock value, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_CommonStockValue" xml:lang="en-US">Common stock value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_CommonStockValue" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_CommonStockValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_G8H693H3H85K_us-gaap_PreferredStockValue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_PreferredStockValue" xml:lang="en-US">Preferred Stock, Value, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_PreferredStockValue" xml:lang="en-US">Preferred stock value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_PreferredStockValue" xlink:to="lab_I0J815J5J07M_us-gaap_PreferredStockValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_WarrantsAndRightsOutstanding"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_WarrantsAndRightsOutstanding" xml:lang="en-US">WarrantsAndRightsOutstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_WarrantsAndRightsOutstanding" xml:lang="en-US">Stock warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_WarrantsAndRightsOutstanding" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_WarrantsAndRightsOutstanding"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_G8H693H3H85K_us-gaap_AdditionalPaidInCapital"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_AdditionalPaidInCapital" xml:lang="en-US">AdditionalPaidInCapital</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_AdditionalPaidInCapital" xml:lang="en-US">Additional paid-in-capital</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_AdditionalPaidInCapital" xlink:to="lab_I0J815J5J07M_us-gaap_AdditionalPaidInCapital"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockPayable" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_StockPayable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_StockPayable" xml:lang="en-US">Stock Payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_StockPayable" xml:lang="en-US">Stock Payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_StockPayable" xml:lang="en-US">Stock payable.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_StockPayable" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_StockPayable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationEquity" xlink:label="loc_G8H693H3H85K_us-gaap_DeferredCompensationEquity"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_DeferredCompensationEquity" xml:lang="en-US">Deferred Compensation Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_DeferredCompensationEquity" xml:lang="en-US">Deferred stock compensation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_I0J815J5J07M_us-gaap_DeferredCompensationEquity" xml:lang="en-US">Deferred stock compensation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_DeferredCompensationEquity" xlink:to="lab_I0J815J5J07M_us-gaap_DeferredCompensationEquity"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_RetainedEarningsAccumulatedDeficit"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">RetainedEarningsAccumulatedDeficit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Accumulated deficit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Accumulated deficit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_RetainedEarningsAccumulatedDeficit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_G8H693H3H85K_us-gaap_StockholdersEquity"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_StockholdersEquity" xml:lang="en-US">Stockholders' Equity Attributable to Parent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_I0J815J5J07M_us-gaap_StockholdersEquity" xml:lang="en-US">Total Stockholders' Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_I0J815J5J07M_us-gaap_StockholdersEquity" xml:lang="en-US">Beginning balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_I0J815J5J07M_us-gaap_StockholdersEquity" xml:lang="en-US">Ending balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_StockholdersEquity" xlink:to="lab_I0J815J5J07M_us-gaap_StockholdersEquity"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_LiabilitiesAndStockholdersEquity"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Liabilities and Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_LiabilitiesAndStockholdersEquity"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_G8H693H3H85K_us-gaap_CommonStockParOrStatedValuePerShare"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">CommonStockParOrStatedValuePerShare</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">Common stock par value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_I0J815J5J07M_us-gaap_CommonStockParOrStatedValuePerShare"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_CommonStockSharesAuthorized"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">CommonStockSharesAuthorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common stock, shares authorized</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_CommonStockSharesAuthorized"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_G8H693H3H85K_us-gaap_CommonStockSharesIssued"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common Stock, Shares, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common stock, shares issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_CommonStockSharesIssued" xlink:to="lab_I0J815J5J07M_us-gaap_CommonStockSharesIssued"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_CommonStockSharesOutstanding"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Common stock, shares outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_CommonStockSharesOutstanding"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_G8H693H3H85K_us-gaap_PreferredStockParOrStatedValuePerShare"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US">PreferredStockParOrStatedValuePerShare</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US">Preferred Stock, par value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_I0J815J5J07M_us-gaap_PreferredStockParOrStatedValuePerShare"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_PreferredStockSharesAuthorized"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US">PreferredStockSharesAuthorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US">Preferred stock, shares authorized</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_PreferredStockSharesAuthorized"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_G8H693H3H85K_us-gaap_PreferredStockSharesIssued"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_PreferredStockSharesIssued" xml:lang="en-US">PreferredStockSharesIssued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_PreferredStockSharesIssued" xml:lang="en-US">Preferred stock, shares issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_PreferredStockSharesIssued" xlink:to="lab_I0J815J5J07M_us-gaap_PreferredStockSharesIssued"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_PreferredStockSharesOutstanding"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">Preferred stock, shares outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_PreferredStockSharesOutstanding"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_IncomeStatementAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_IncomeStatementAbstract" xml:lang="en-US">Income Statement [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_IncomeStatementAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_IncomeStatementAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Revenues" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_Revenues"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_Revenues" xml:lang="en-US">Revenues</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_Revenues" xml:lang="en-US">Total</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_Revenues" xml:lang="en-US">NET REVENUE</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_Revenues" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_Revenues"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_RevenueShareExpense" xlink:label="loc_G8H693H3H85K_oprx_RevenueShareExpense"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_RevenueShareExpense" xml:lang="en-US">Revenue Share Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_RevenueShareExpense" xml:lang="en-US">REVENUE SHARE EXPENSE</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_oprx_RevenueShareExpense" xml:lang="en-US">Revenue share expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_RevenueShareExpense" xml:lang="en-US">Revenue share expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_I0J815J5J07M_oprx_RevenueShareExpense" xml:lang="en-US">REVENUE SHARE EXPENSE</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_RevenueShareExpense" xlink:to="lab_I0J815J5J07M_oprx_RevenueShareExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_GrossProfit"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_GrossProfit" xml:lang="en-US">GrossProfit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_GrossProfit" xml:lang="en-US">GROSS MARGIN</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_GrossProfit" xml:lang="en-US">GROSS MARGIN</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_GrossProfit" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_GrossProfit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_OperatingExpensesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_OperatingExpensesAbstract" xml:lang="en-US">Operating Expenses [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_OperatingExpensesAbstract" xml:lang="en-US">EXPENSES</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_OperatingExpensesAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_OperatingExpensesAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_OperatingCostsAndExpensesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_OperatingCostsAndExpensesAbstract" xml:lang="en-US">Operating Costs and Expenses [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_OperatingCostsAndExpensesAbstract" xml:lang="en-US">Operating expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_OperatingCostsAndExpensesAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_G8H693H3H85K_us-gaap_AllocatedShareBasedCompensationExpense"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_AllocatedShareBasedCompensationExpense" xml:lang="en-US">Allocated Share-based Compensation Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_AllocatedShareBasedCompensationExpense" xml:lang="en-US">Stock-based compensation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_I0J815J5J07M_us-gaap_AllocatedShareBasedCompensationExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_DepreciationAndAmortization"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_DepreciationAndAmortization" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_DepreciationAndAmortization" xml:lang="en-US">Depreciation and amortization</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_DepreciationAndAmortization" xml:lang="en-US">Depreciation and amortization</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_DepreciationAndAmortization" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_DepreciationAndAmortization"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LitigationSettlementExpense" xlink:label="loc_G8H693H3H85K_us-gaap_LitigationSettlementExpense"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_LitigationSettlementExpense" xml:lang="en-US">Litigation Settlement, Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_LitigationSettlementExpense" xml:lang="en-US">Lawsuit settlement</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_LitigationSettlementExpense" xlink:to="lab_I0J815J5J07M_us-gaap_LitigationSettlementExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherCostAndExpenseOperating" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_OtherCostAndExpenseOperating"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_OtherCostAndExpenseOperating" xml:lang="en-US">Other Cost and Expense, Operating</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_OtherCostAndExpenseOperating" xml:lang="en-US">Other operating expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_OtherCostAndExpenseOperating" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_OtherCostAndExpenseOperating"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_G8H693H3H85K_us-gaap_OperatingExpenses"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_OperatingExpenses" xml:lang="en-US">Operating Expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_OperatingExpenses" xml:lang="en-US">Operating expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_OperatingExpenses" xml:lang="en-US">OPERATING EXPENSES</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_I0J815J5J07M_us-gaap_OperatingExpenses" xml:lang="en-US">Total Operating expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_I0J815J5J07M_us-gaap_OperatingExpenses" xml:lang="en-US">OPERATING EXPENSES</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_OperatingExpenses" xlink:to="lab_I0J815J5J07M_us-gaap_OperatingExpenses"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_OperatingIncomeLoss"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_OperatingIncomeLoss" xml:lang="en-US">Operating Income (Loss)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_OperatingIncomeLoss" xml:lang="en-US">LOSS FROM OPERATIONS</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_OperatingIncomeLoss" xml:lang="en-US">Income (Loss) from operations</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_OperatingIncomeLoss" xml:lang="en-US">Loss from operations</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_OperatingIncomeLoss" xml:lang="en-US">INCOME (LOSS) FROM OPERATIONS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_OperatingIncomeLoss" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_OperatingIncomeLoss"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xml:lang="en-US">OTHER INCOME (EXPENSE)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_InterestAndOtherIncome"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_InterestAndOtherIncome" xml:lang="en-US">Interest and Other Income</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_InterestAndOtherIncome" xml:lang="en-US">Interest income</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_InterestAndOtherIncome" xml:lang="en-US">Interest income</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_InterestAndOtherIncome" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_InterestAndOtherIncome"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_G8H693H3H85K_us-gaap_InterestExpense"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_InterestExpense" xml:lang="en-US">Interest Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_InterestExpense" xml:lang="en-US">Interest expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_InterestExpense" xlink:to="lab_I0J815J5J07M_us-gaap_InterestExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_NonoperatingIncomeExpense"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_NonoperatingIncomeExpense" xml:lang="en-US">Nonoperating Income (Expense)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_NonoperatingIncomeExpense" xml:lang="en-US">TOTAL OTHER INCOME</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_NonoperatingIncomeExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_G8H693H3H85K_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xml:lang="en-US">LOSS BEFORE PROVISION FOR INCOME TAXES</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_I0J815J5J07M_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xml:lang="en-US">Loss before income taxes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_I0J815J5J07M_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xml:lang="en-US">INCOME LOSS BEFORE PROVISION FOR INCOME TAXES</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_I0J815J5J07M_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_IncomeTaxExpenseBenefit"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US">Income Tax Expense (Benefit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US">PROVISION FOR INCOME TAXES</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_IncomeTaxExpenseBenefit"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_G8H693H3H85K_us-gaap_NetIncomeLoss"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_NetIncomeLoss" xml:lang="en-US">Net Income (Loss) Attributable to Parent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_NetIncomeLoss" xml:lang="en-US">Net loss for the period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_NetIncomeLoss" xml:lang="en-US">Net income (loss)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_I0J815J5J07M_us-gaap_NetIncomeLoss" xml:lang="en-US">Net loss for the year</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_NetIncomeLoss" xml:lang="en-US">Net loss</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_I0J815J5J07M_us-gaap_NetIncomeLoss" xml:lang="en-US">NET INCOME (LOSS)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_NetIncomeLoss" xlink:to="lab_I0J815J5J07M_us-gaap_NetIncomeLoss"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xml:lang="en-US">WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_G8H693H3H85K_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xml:lang="en-US">WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: FULLY DILUTED</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_I0J815J5J07M_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_EarningsPerShareBasicAndDiluted"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US">Earnings Per Share, Basic and Diluted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US">NET INCOME (LOSS) PER SHARE: BASIC AND DILUTED (no separate per share amount shown because loss is antidilutive)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_EarningsPerShareBasicAndDiluted"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_EarningsPerShareAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_EarningsPerShareAbstract" xml:lang="en-US">Earnings Per Share [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_EarningsPerShareAbstract" xml:lang="en-US">NET INCOME (LOSS) PER SHARE</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_EarningsPerShareAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_EarningsPerShareAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_EarningsPerShareBasic"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_EarningsPerShareBasic" xml:lang="en-US">Earnings Per Share, Basic</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_EarningsPerShareBasic" xml:lang="en-US">BASIC</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_EarningsPerShareBasic" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_EarningsPerShareBasic"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_G8H693H3H85K_us-gaap_EarningsPerShareDiluted"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_EarningsPerShareDiluted" xml:lang="en-US">Earnings Per Share, Diluted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_EarningsPerShareDiluted" xml:lang="en-US">DILUTED</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_EarningsPerShareDiluted" xlink:to="lab_I0J815J5J07M_us-gaap_EarningsPerShareDiluted"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_StatementOfStockholdersEquityAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StatementOfStockholdersEquityAbstract" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_StatementOfStockholdersEquityAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_G8H693H3H85K_us-gaap_StatementTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_StatementTable" xml:lang="en-US">Statement [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_StatementTable" xlink:to="lab_I0J815J5J07M_us-gaap_StatementTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_StatementEquityComponentsAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StatementEquityComponentsAxis" xml:lang="en-US">Equity Components [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_StatementEquityComponentsAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_G8H693H3H85K_us-gaap_EquityComponentDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_EquityComponentDomain" xml:lang="en-US">Equity Component [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_EquityComponentDomain" xlink:to="lab_I0J815J5J07M_us-gaap_EquityComponentDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_PreferredStockMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_PreferredStockMember" xml:lang="en-US">Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_PreferredStockMember" xml:lang="en-US">Preferred Stock Shares [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_PreferredStockMember" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_PreferredStockMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_G8H693H3H85K_us-gaap_CommonStockMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_CommonStockMember" xml:lang="en-US">Common Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_CommonStockMember" xml:lang="en-US">Common Stock Shares [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_CommonStockMember" xlink:to="lab_I0J815J5J07M_us-gaap_CommonStockMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_WarrantMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_WarrantMember" xml:lang="en-US">Warrant [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_WarrantMember" xml:lang="en-US">Stock Warrant [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_WarrantMember" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_WarrantMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_G8H693H3H85K_us-gaap_AdditionalPaidInCapitalMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_AdditionalPaidInCapitalMember" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_AdditionalPaidInCapitalMember" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_I0J815J5J07M_us-gaap_AdditionalPaidInCapitalMember"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockPayableMember" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_StockPayableMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_StockPayableMember" xml:lang="en-US">Stock Payable [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_StockPayableMember" xml:lang="en-US">Stock Payable [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_StockPayableMember" xml:lang="en-US">Stock payable.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_StockPayableMember" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_StockPayableMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:label="loc_G8H693H3H85K_us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_DeferredCompensationShareBasedPaymentsMember" xml:lang="en-US">Deferred Compensation, Share-based Payments [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_DeferredCompensationShareBasedPaymentsMember" xml:lang="en-US">Deferred Stock Compensation [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:to="lab_I0J815J5J07M_us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_RetainedEarningsMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_RetainedEarningsMember" xml:lang="en-US">Retained Earnings [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_RetainedEarningsMember" xml:lang="en-US">Accumulated Deficit [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_RetainedEarningsMember" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_RetainedEarningsMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_G8H693H3H85K_us-gaap_StatementLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_StatementLineItems" xml:lang="en-US">Statement [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_StatementLineItems" xlink:to="lab_I0J815J5J07M_us-gaap_StatementLineItems"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_SharesOutstanding"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_SharesOutstanding" xml:lang="en-US">Shares, Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_SharesOutstanding" xml:lang="en-US">Beginning balance, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_SharesOutstanding" xml:lang="en-US">Ending balance, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_SharesOutstanding" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_SharesOutstanding"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:label="loc_G8H693H3H85K_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xml:lang="en-US">Stock Issued During Period, Value, Employee Benefit Plan</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xml:lang="en-US">Issuance of stock options: to employees</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:to="lab_I0J815J5J07M_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockIssuedDuringPeriodValueConsultants" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_StockIssuedDuringPeriodValueConsultants"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_StockIssuedDuringPeriodValueConsultants" xml:lang="en-US">Stock Issued During Period Value Consultants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_StockIssuedDuringPeriodValueConsultants" xml:lang="en-US">Issuance of stock options: to consultants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_StockIssuedDuringPeriodValueConsultants" xml:lang="en-US">Value of shares issued during the period to consultants.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_StockIssuedDuringPeriodValueConsultants" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_StockIssuedDuringPeriodValueConsultants"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_G8H693H3H85K_us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xml:lang="en-US">Stock Issued During Period, Value, Issued for Services</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xml:lang="en-US">Stock issued for services</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xml:lang="en-US">Issuance of common stock: for services</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_I0J815J5J07M_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xml:lang="en-US">Gross proceeds</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="lab_I0J815J5J07M_us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xml:lang="en-US">Stock issued for services, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xml:lang="en-US">Issuance of common stock: for services, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/disclosureGuidance" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xml:lang="en-US">Stock issued for advisory services</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_G8H693H3H85K_us-gaap_StockIssuedDuringPeriodValueOther"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_StockIssuedDuringPeriodValueOther" xml:lang="en-US">Stock Issued During Period, Value, Other</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_StockIssuedDuringPeriodValueOther" xml:lang="en-US">Issuance of common stock: for severance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_StockIssuedDuringPeriodValueOther" xml:lang="en-US">Additional shares issued, value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="lab_I0J815J5J07M_us-gaap_StockIssuedDuringPeriodValueOther"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_StockIssuedDuringPeriodSharesOther"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodSharesOther" xml:lang="en-US">Stock Issued During Period, Shares, Other</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodSharesOther" xml:lang="en-US">Issuance of common stock: for severance, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodSharesOther" xml:lang="en-US">Additional shares issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodSharesOther"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockIssuedDuringPeriodOfCommonStockValueForPriorIssue" xlink:label="loc_G8H693H3H85K_oprx_StockIssuedDuringPeriodOfCommonStockValueForPriorIssue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_StockIssuedDuringPeriodOfCommonStockValueForPriorIssue" xml:lang="en-US">Stock Issued During Period Of Common Stock Value For Prior Issue</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_StockIssuedDuringPeriodOfCommonStockValueForPriorIssue" xml:lang="en-US">Issuance of common stock: for correction of prior issue</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_StockIssuedDuringPeriodOfCommonStockValueForPriorIssue" xml:lang="en-US">Stock issued during period of common stock value for prior issue.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_StockIssuedDuringPeriodOfCommonStockValueForPriorIssue" xlink:to="lab_I0J815J5J07M_oprx_StockIssuedDuringPeriodOfCommonStockValueForPriorIssue"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockIssuedDuringPeriodOfCommonStockShareForPriorIssue" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_StockIssuedDuringPeriodOfCommonStockShareForPriorIssue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_StockIssuedDuringPeriodOfCommonStockShareForPriorIssue" xml:lang="en-US">Stock Issued During Period Of Common Stock Share For Prior Issue</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_StockIssuedDuringPeriodOfCommonStockShareForPriorIssue" xml:lang="en-US">Issuance of common stock: for correction of prior issue, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_StockIssuedDuringPeriodOfCommonStockShareForPriorIssue" xml:lang="en-US">Stock issued during period of common stock shares for prior issue.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_StockIssuedDuringPeriodOfCommonStockShareForPriorIssue" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_StockIssuedDuringPeriodOfCommonStockShareForPriorIssue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_G8H693H3H85K_us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Issuance of common stock: for cash</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Stock issued, Values</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_I0J815J5J07M_us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Stock issued, Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Issuance of common stock: for cash shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Sales of common stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/disclosureGuidance" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Shares initially reserved for issuance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_G8H693H3H85K_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xml:lang="en-US">Issuance of common stock: for warrant exercise</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_I0J815J5J07M_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US">Issuance of common stock: for warrant exercise, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US">Exercised</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_G8H693H3H85K_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xml:lang="en-US">Issue warrants for equity raise</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xml:lang="en-US">Warrant issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_I0J815J5J07M_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockIssuedDuringPeriodOfIssueStockRightsToOfficers" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_StockIssuedDuringPeriodOfIssueStockRightsToOfficers"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_StockIssuedDuringPeriodOfIssueStockRightsToOfficers" xml:lang="en-US">Stock Issued During Period Of Issue Stock Rights To Officers</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_StockIssuedDuringPeriodOfIssueStockRightsToOfficers" xml:lang="en-US">Issue stock rights to officers</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_StockIssuedDuringPeriodOfIssueStockRightsToOfficers" xml:lang="en-US">Stock issued during period of issue stock rights to officers.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_StockIssuedDuringPeriodOfIssueStockRightsToOfficers" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_StockIssuedDuringPeriodOfIssueStockRightsToOfficers"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ReclassificationForExpiredWarrants" xlink:label="loc_G8H693H3H85K_oprx_ReclassificationForExpiredWarrants"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_ReclassificationForExpiredWarrants" xml:lang="en-US">Reclassification For Expired Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_ReclassificationForExpiredWarrants" xml:lang="en-US">Reclassification for expired warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_ReclassificationForExpiredWarrants" xml:lang="en-US">Reclassification for expired warrants.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_ReclassificationForExpiredWarrants" xlink:to="lab_I0J815J5J07M_oprx_ReclassificationForExpiredWarrants"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_AdjustmentsToAdditionalPaidInCapitalExpiredAndRedeemedWarrants" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_AdjustmentsToAdditionalPaidInCapitalExpiredAndRedeemedWarrants"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_AdjustmentsToAdditionalPaidInCapitalExpiredAndRedeemedWarrants" xml:lang="en-US">Adjustments To Additional Paid In Capital Expired And Redeemed Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_AdjustmentsToAdditionalPaidInCapitalExpiredAndRedeemedWarrants" xml:lang="en-US">Reclassify expired and redeemed warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_AdjustmentsToAdditionalPaidInCapitalExpiredAndRedeemedWarrants" xml:lang="en-US">Adjustments to additional paid in capital expired and redeemed warrants.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_AdjustmentsToAdditionalPaidInCapitalExpiredAndRedeemedWarrants" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_AdjustmentsToAdditionalPaidInCapitalExpiredAndRedeemedWarrants"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense" xlink:label="loc_G8H693H3H85K_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Compensation Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense" xml:lang="en-US">Expense consulting services</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense" xlink:to="lab_I0J815J5J07M_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_StockRedeemedOrCalledDuringPeriodValue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockRedeemedOrCalledDuringPeriodValue" xml:lang="en-US">Stock Redeemed or Called During Period, Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockRedeemedOrCalledDuringPeriodValue" xml:lang="en-US">Redeem shares for cash</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockRedeemedOrCalledDuringPeriodValue" xml:lang="en-US">Called for issuance of shares, values</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_StockRedeemedOrCalledDuringPeriodValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="loc_G8H693H3H85K_us-gaap_StockRedeemedOrCalledDuringPeriodShares"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_StockRedeemedOrCalledDuringPeriodShares" xml:lang="en-US">Stock Redeemed or Called During Period, Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_StockRedeemedOrCalledDuringPeriodShares" xml:lang="en-US">Redeem shares for cash, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_StockRedeemedOrCalledDuringPeriodShares" xml:lang="en-US">Called for issuance of shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:to="lab_I0J815J5J07M_us-gaap_StockRedeemedOrCalledDuringPeriodShares"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_StatementOfCashFlowsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StatementOfCashFlowsAbstract" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_StatementOfCashFlowsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">NetCashProvidedByUsedInOperatingActivitiesAbstract</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockOptionsIssuedForServices" xlink:label="loc_G8H693H3H85K_oprx_StockOptionsIssuedForServices"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_StockOptionsIssuedForServices" xml:lang="en-US">Stock options issued for services</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_oprx_StockOptionsIssuedForServices" xml:lang="en-US">Stock options issued for services</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_I0J815J5J07M_oprx_StockOptionsIssuedForServices" xml:lang="en-US">Stock and options issued for services</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_StockOptionsIssuedForServices" xlink:to="lab_I0J815J5J07M_oprx_StockOptionsIssuedForServices"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_GainLossOnDispositionOfAssets1"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_GainLossOnDispositionOfAssets1" xml:lang="en-US">Gain (Loss) on Disposition of Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_GainLossOnDispositionOfAssets1" xml:lang="en-US">Loss on disposal of assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_GainLossOnDispositionOfAssets1" xml:lang="en-US">Loss on disposal of assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_GainLossOnDispositionOfAssets1" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_GainLossOnDispositionOfAssets1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_G8H693H3H85K_us-gaap_ShareBasedCompensation"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensation" xml:lang="en-US">Share-based Compensation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensation" xml:lang="en-US">Stock-based compensation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensation" xml:lang="en-US">Share Based Compensation Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensation" xml:lang="en-US">Stock-based compensation expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ShareBasedCompensation" xlink:to="lab_I0J815J5J07M_us-gaap_ShareBasedCompensation"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xml:lang="en-US">IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xml:lang="en-US">Changes in:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_G8H693H3H85K_us-gaap_IncreaseDecreaseInAccountsReceivable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_IncreaseDecreaseInAccountsReceivable" xml:lang="en-US">IncreaseDecreaseInAccountsReceivable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_IncreaseDecreaseInAccountsReceivable" xml:lang="en-US">Change in accounts receivable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_IncreaseDecreaseInAccountsReceivable" xml:lang="en-US">Accounts receivable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_IncreaseDecreaseInAccountsReceivable" xml:lang="en-US">Increase in accounts payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_I0J815J5J07M_us-gaap_IncreaseDecreaseInAccountsReceivable" xml:lang="en-US">Accounts receivable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_I0J815J5J07M_us-gaap_IncreaseDecreaseInAccountsReceivable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_IncreaseDecreaseInPrepaidExpense"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_IncreaseDecreaseInPrepaidExpense" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_IncreaseDecreaseInPrepaidExpense" xml:lang="en-US">Prepaid expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_IncreaseDecreaseInPrepaidExpense"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_G8H693H3H85K_us-gaap_IncreaseDecreaseInAccountsPayable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_IncreaseDecreaseInAccountsPayable" xml:lang="en-US">IncreaseDecreaseInAccountsPayable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_IncreaseDecreaseInAccountsPayable" xml:lang="en-US">Accounts payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_I0J815J5J07M_us-gaap_IncreaseDecreaseInAccountsPayable"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_RevenueSharePayable" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_RevenueSharePayable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_RevenueSharePayable" xml:lang="en-US">Revenue share payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_RevenueSharePayable" xml:lang="en-US">Increase in revenue share payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_RevenueSharePayable" xml:lang="en-US">Revenue share payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_RevenueSharePayable" xml:lang="en-US">Revenue share payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_RevenueSharePayable" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_RevenueSharePayable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_G8H693H3H85K_us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_IncreaseDecreaseInAccruedLiabilities" xml:lang="en-US">IncreaseDecreaseInAccruedLiabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_IncreaseDecreaseInAccruedLiabilities" xml:lang="en-US">Accrued expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_I0J815J5J07M_us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_IncreaseDecreaseInDeferredRevenue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_IncreaseDecreaseInDeferredRevenue" xml:lang="en-US">IncreaseDecreaseInDeferredRevenue</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_IncreaseDecreaseInDeferredRevenue" xml:lang="en-US">Changes in deferred revenue</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_IncreaseDecreaseInDeferredRevenue" xml:lang="en-US">Deferred revenue</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_IncreaseDecreaseInDeferredRevenue" xml:lang="en-US">Increase in deferred revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_IncreaseDecreaseInDeferredRevenue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_G8H693H3H85K_us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">NetCashProvidedByUsedInOperatingActivities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_I0J815J5J07M_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_I0J815J5J07M_us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xml:lang="en-US">NetCashProvidedByUsedInInvestingActivitiesAbstract</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PurchasesOfPropertyAndEquipment" xlink:label="loc_G8H693H3H85K_oprx_PurchasesOfPropertyAndEquipment"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_PurchasesOfPropertyAndEquipment" xml:lang="en-US">PurchasesOfPropertyAndEquipment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_I0J815J5J07M_oprx_PurchasesOfPropertyAndEquipment" xml:lang="en-US">Purchases of property and equipment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_PurchasesOfPropertyAndEquipment" xlink:to="lab_I0J815J5J07M_oprx_PurchasesOfPropertyAndEquipment"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PatentRights" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_PatentRights"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_PatentRights" xml:lang="en-US">PatentRights</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_PatentRights" xml:lang="en-US">Patent rights</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_PatentRights" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_PatentRights"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WebsiteDevelopmentCosts" xlink:label="loc_G8H693H3H85K_oprx_WebsiteDevelopmentCosts"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_WebsiteDevelopmentCosts" xml:lang="en-US">WebsiteDevelopmentCosts</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_I0J815J5J07M_oprx_WebsiteDevelopmentCosts" xml:lang="en-US">Website site development costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_WebsiteDevelopmentCosts" xlink:to="lab_I0J815J5J07M_oprx_WebsiteDevelopmentCosts"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_NetCashProvidedByUsedInInvestingActivities" xml:lang="en-US">NetCashProvidedByUsedInInvestingActivities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_NetCashProvidedByUsedInInvestingActivities" xml:lang="en-US">NET CASH USED IN INVESTING ACTIVITIES</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xml:lang="en-US">NetCashProvidedByUsedInFinancingActivitiesAbstract</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ProceedsFromIssuanceOfCommonStock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ProceedsFromIssuanceOfCommonStock" xml:lang="en-US">Proceeds from Issuance of Common Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ProceedsFromIssuanceOfCommonStock" xml:lang="en-US">Share of common stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ProceedsFromIssuanceOfCommonStock" xml:lang="en-US">Proceeds from issuance of common stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ProceedsFromIssuanceOfCommonStock" xml:lang="en-US">Proceeds from issuance of common stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ProceedsFromIssuanceOfCommonStock"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockIssueDuringPeriodValueIssuedForCash" xlink:label="loc_G8H693H3H85K_oprx_StockIssueDuringPeriodValueIssuedForCash"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_StockIssueDuringPeriodValueIssuedForCash" xml:lang="en-US">Stock Issue During Period Value Issued For Cash</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_oprx_StockIssueDuringPeriodValueIssuedForCash" xml:lang="en-US">Equity issuance costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_StockIssueDuringPeriodValueIssuedForCash" xml:lang="en-US">Value of shares issued as consideration for cash for development stage entities.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_StockIssueDuringPeriodValueIssuedForCash" xlink:to="lab_I0J815J5J07M_oprx_StockIssueDuringPeriodValueIssuedForCash"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants" xml:lang="en-US">Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants" xml:lang="en-US">Purchase of common and preferred stock and warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsForRepurchaseOfEquity" xlink:label="loc_G8H693H3H85K_us-gaap_PaymentsForRepurchaseOfEquity"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_PaymentsForRepurchaseOfEquity" xml:lang="en-US">Payments for Repurchase of Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_PaymentsForRepurchaseOfEquity" xml:lang="en-US">Redemption of common and preferred stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_I0J815J5J07M_us-gaap_PaymentsForRepurchaseOfEquity" xml:lang="en-US">Redemption of common and preferred stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_PaymentsForRepurchaseOfEquity" xlink:to="lab_I0J815J5J07M_us-gaap_PaymentsForRepurchaseOfEquity"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US">NET CASH PROVIDED BY FINANCING ACTIVITIES</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_G8H693H3H85K_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xml:lang="en-US">NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xml:lang="en-US">NET INCREASE IN CASH AND CASH EQUIVALENTS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="lab_I0J815J5J07M_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_SupplementalCashFlowInformationAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_SupplementalCashFlowInformationAbstract" xml:lang="en-US">SupplementalCashFlowInformationAbstract</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_SupplementalCashFlowInformationAbstract" xml:lang="en-US">SUPPLEMENTAL CASH FLOW INFORMATION:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_SupplementalCashFlowInformationAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_G8H693H3H85K_us-gaap_InterestPaid"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_InterestPaid" xml:lang="en-US">InterestPaid</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_InterestPaid" xml:lang="en-US">Cash paid for interest</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_InterestPaid" xlink:to="lab_I0J815J5J07M_us-gaap_InterestPaid"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_IncomeTaxesPaid"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_IncomeTaxesPaid" xml:lang="en-US">IncomeTaxesPaid</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_IncomeTaxesPaid" xml:lang="en-US">Cash paid for income taxes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_IncomeTaxesPaid" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_IncomeTaxesPaid"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xml:lang="en-US">SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssued1" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_StockIssued1"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssued1" xml:lang="en-US">Stock Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssued1" xml:lang="en-US">Common stock issued for future services</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_StockIssued1" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssued1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xml:lang="en-US">Nature of Business and Basis of Presentation [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xml:lang="en-US">NATURE OF BUSINESS AND BASIS OF PRESENTATION</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_EquityAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_EquityAbstract" xml:lang="en-US">Equity [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_EquityAbstract" xml:lang="en-US">Stockholders Equity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_EquityAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_EquityAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xml:lang="en-US">COMMON STOCK</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xml:lang="en-US">STOCKHOLDERS EQUITY</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xml:lang="en-US">Share Based Payments - Options and Stock Options and Warrants [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xml:lang="en-US">Shareholders' Equity and Share-based Payments [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xml:lang="en-US">SHARE BASED PAYMENTS - OPTIONS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US">CONTINGENT LIABILITIES</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xml:lang="en-US">Restatement [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock" xml:lang="en-US">Accounting Changes and Error Corrections [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock" xml:lang="en-US">RESTATEMENT</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_AccountingPoliciesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_AccountingPoliciesAbstract" xml:lang="en-US">Summary of Significant Accounting Policies [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_AccountingPoliciesAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_SignificantAccountingPoliciesTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_SignificantAccountingPoliciesTextBlock" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_SignificantAccountingPoliciesTextBlock" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_SignificantAccountingPoliciesTextBlock"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PrepaidExpensesAbstract" xlink:label="loc_G8H693H3H85K_oprx_PrepaidExpensesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_PrepaidExpensesAbstract" xml:lang="en-US">Prepaid Expenses [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_PrepaidExpensesAbstract" xlink:to="lab_I0J815J5J07M_oprx_PrepaidExpensesAbstract"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PrepaidExpensesTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_PrepaidExpensesTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_PrepaidExpensesTextBlock" xml:lang="en-US">Prepaid Expenses [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_PrepaidExpensesTextBlock" xml:lang="en-US">PREPAID EXPENSES</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_PrepaidExpensesTextBlock" xml:lang="en-US">The entire disclosure for prepaid expenses.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_PrepaidExpensesTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_PrepaidExpensesTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_PropertyPlantAndEquipmentAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_PropertyPlantAndEquipmentAbstract" xml:lang="en-US">Property and Equipment [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_PropertyPlantAndEquipmentAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xml:lang="en-US">PROPERTY AND EQUIPMENT</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WebBasedTechnologyAbstract" xlink:label="loc_G8H693H3H85K_oprx_WebBasedTechnologyAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_WebBasedTechnologyAbstract" xml:lang="en-US">Web Based Technology [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_WebBasedTechnologyAbstract" xlink:to="lab_I0J815J5J07M_oprx_WebBasedTechnologyAbstract"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WebBasedTechnologyTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_WebBasedTechnologyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_WebBasedTechnologyTextBlock" xml:lang="en-US">Web Based Technology [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_WebBasedTechnologyTextBlock" xml:lang="en-US">WEB-BASED TECHNOLOGY</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_WebBasedTechnologyTextBlock" xml:lang="en-US">The entire disclosure for web based technology.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_WebBasedTechnologyTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_WebBasedTechnologyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xml:lang="en-US">Patent and Trademarks [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_IntangibleAssetsDisclosureTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_IntangibleAssetsDisclosureTextBlock" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_IntangibleAssetsDisclosureTextBlock" xml:lang="en-US">PATENT AND TRADEMARKS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_IntangibleAssetsDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenueRecognitionAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_RevenueRecognitionAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_RevenueRecognitionAbstract" xml:lang="en-US">Revenue Recognition [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_RevenueRecognitionAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_RevenueRecognitionAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredRevenueDisclosureTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_DeferredRevenueDisclosureTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_DeferredRevenueDisclosureTextBlock" xml:lang="en-US">Deferred Revenue Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_DeferredRevenueDisclosureTextBlock" xml:lang="en-US">DEFERRED REVENUE</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_DeferredRevenueDisclosureTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_DeferredRevenueDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_RelatedPartyTransactionsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_RelatedPartyTransactionsAbstract" xml:lang="en-US">Related Party Transactions [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_RelatedPartyTransactionsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xml:lang="en-US">RELATED PARTY TRANSACTIONS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockTextBlock" xlink:label="loc_G8H693H3H85K_us-gaap_PreferredStockTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_PreferredStockTextBlock" xml:lang="en-US">Preferred Stock [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_PreferredStockTextBlock" xml:lang="en-US">PREFERRED STOCK</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_PreferredStockTextBlock" xlink:to="lab_I0J815J5J07M_us-gaap_PreferredStockTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xml:lang="en-US">STOCK OPTIONS AND WARRANTS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantsDisclouresAbstract" xlink:label="loc_G8H693H3H85K_oprx_WarrantsDisclouresAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_WarrantsDisclouresAbstract" xml:lang="en-US">Warrants [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_WarrantsDisclouresAbstract" xlink:to="lab_I0J815J5J07M_oprx_WarrantsDisclouresAbstract"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantsTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_WarrantsTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_WarrantsTextBlock" xml:lang="en-US">Warrants [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_WarrantsTextBlock" xml:lang="en-US">WARRANTS</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_WarrantsTextBlock" xml:lang="en-US">Warrants text.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_WarrantsTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_WarrantsTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_LeasesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_LeasesAbstract" xml:lang="en-US">Operating Leases [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_LeasesAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_LeasesAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_LeasesOfLesseeDisclosureTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_LeasesOfLesseeDisclosureTextBlock" xml:lang="en-US">Leases of Lessee Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_LeasesOfLesseeDisclosureTextBlock" xml:lang="en-US">OPERATING LEASES</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_LeasesOfLesseeDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_MajorCustomerAbstract" xlink:label="loc_G8H693H3H85K_oprx_MajorCustomerAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_MajorCustomerAbstract" xml:lang="en-US">Major Customer [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_MajorCustomerAbstract" xlink:to="lab_I0J815J5J07M_oprx_MajorCustomerAbstract"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_MajorCustomerTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_MajorCustomerTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_MajorCustomerTextBlock" xml:lang="en-US">Major Customer [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_MajorCustomerTextBlock" xml:lang="en-US">MAJOR CUSTOMERS</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_MajorCustomerTextBlock" xml:lang="en-US">Major customer text block.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_MajorCustomerTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_MajorCustomerTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_IncomeTaxDisclosureAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_IncomeTaxDisclosureAbstract" xml:lang="en-US">Income Taxes [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_IncomeTaxDisclosureAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_IncomeTaxDisclosureTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_IncomeTaxDisclosureTextBlock" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_IncomeTaxDisclosureTextBlock" xml:lang="en-US">INCOME TAXES</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_IncomeTaxDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_SubsequentEventsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_SubsequentEventsAbstract" xml:lang="en-US">Subsequent Events [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_SubsequentEventsAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_SubsequentEventsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_SubsequentEventsTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_SubsequentEventsTextBlock" xml:lang="en-US">SUBSEQUENT EVENTS</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_SubsequentEventsTextBlock" xml:lang="en-US">SUBSEQUENT EVENTS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_SubsequentEventsTextBlock"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_BasisOfAccountingPolicyTextBlock" xlink:label="loc_G8H693H3H85K_oprx_BasisOfAccountingPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_BasisOfAccountingPolicyTextBlock" xml:lang="en-US">Basis Of Accounting [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_BasisOfAccountingPolicyTextBlock" xml:lang="en-US">Basis of Presentation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_BasisOfAccountingPolicyTextBlock" xml:lang="en-US">Disclosure of accounting policy for basis of presentation.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_BasisOfAccountingPolicyTextBlock" xlink:to="lab_I0J815J5J07M_oprx_BasisOfAccountingPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xml:lang="en-US">Accounting Basis</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_G8H693H3H85K_us-gaap_ConsolidationPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ConsolidationPolicyTextBlock" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_ConsolidationPolicyTextBlock" xml:lang="en-US">Principles of Consolidation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_I0J815J5J07M_us-gaap_ConsolidationPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xml:lang="en-US">Cash and Cash Equivalents</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_G8H693H3H85K_us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_FairValueOfFinancialInstrumentsPolicy" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_FairValueOfFinancialInstrumentsPolicy" xml:lang="en-US">Fair Value of Financial Instruments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_I0J815J5J07M_us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xml:lang="en-US">Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xml:lang="en-US">Accounts Receivable and Allowance for Doubtful Accounts</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_G8H693H3H85K_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xml:lang="en-US">Property and Equipment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_I0J815J5J07M_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_RevenueRecognitionPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_RevenueRecognitionPolicyTextBlock" xml:lang="en-US">Revenue Recognition, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_RevenueRecognitionPolicyTextBlock" xml:lang="en-US">Revenue Recognition and Revenue Share Expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_RevenueRecognitionPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_G8H693H3H85K_us-gaap_IncomeTaxPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_IncomeTaxPolicyTextBlock" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_IncomeTaxPolicyTextBlock" xml:lang="en-US">Income Taxes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_I0J815J5J07M_us-gaap_IncomeTaxPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_UseOfEstimates"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_UseOfEstimates" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_UseOfEstimates" xml:lang="en-US">Use of Estimates</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_UseOfEstimates" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_UseOfEstimates"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_G8H693H3H85K_us-gaap_ConcentrationRiskCreditRisk"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ConcentrationRiskCreditRisk" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_ConcentrationRiskCreditRisk" xml:lang="en-US">Concentration of Credit Risks</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_I0J815J5J07M_us-gaap_ConcentrationRiskCreditRisk"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ResearchAndDevelopmentExpensePolicy"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ResearchAndDevelopmentExpensePolicy" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ResearchAndDevelopmentExpensePolicy" xml:lang="en-US">Research and Development</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ResearchAndDevelopmentExpensePolicy"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_G8H693H3H85K_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xml:lang="en-US">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xml:lang="en-US">Share-based Payments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_EarningsPerSharePolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_EarningsPerSharePolicyTextBlock" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_EarningsPerSharePolicyTextBlock" xml:lang="en-US">Loss Per Common and Common Equivalent Share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_EarningsPerSharePolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_G8H693H3H85K_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xml:lang="en-US">Impairment of Long-Lived Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_I0J815J5J07M_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US">Recently Issued Accounting Guidance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestatementToPriorYearIncomeTextBlock" xlink:label="loc_G8H693H3H85K_us-gaap_RestatementToPriorYearIncomeTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_RestatementToPriorYearIncomeTextBlock" xml:lang="en-US">Restatement to Prior Year Income [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_RestatementToPriorYearIncomeTextBlock" xml:lang="en-US">Schedule of restatement</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_RestatementToPriorYearIncomeTextBlock" xlink:to="lab_I0J815J5J07M_us-gaap_RestatementToPriorYearIncomeTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xml:lang="en-US">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xml:lang="en-US">Summary of hare based compensation fair value assumption methodology</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PrepaidExpensesTableTextBlock" xlink:label="loc_G8H693H3H85K_oprx_PrepaidExpensesTableTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_PrepaidExpensesTableTextBlock" xml:lang="en-US">Prepaid Expenses [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_oprx_PrepaidExpensesTableTextBlock" xml:lang="en-US">Schedule of prepaid expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_PrepaidExpensesTableTextBlock" xml:lang="en-US">Tabular disclosure of prepaid expenses.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_PrepaidExpensesTableTextBlock" xlink:to="lab_I0J815J5J07M_oprx_PrepaidExpensesTableTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_PropertyPlantAndEquipmentTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_PropertyPlantAndEquipmentTextBlock" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_PropertyPlantAndEquipmentTextBlock" xml:lang="en-US">Schedule of property and equipment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_PropertyPlantAndEquipmentTextBlock"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ScheduleOfCapitalizedCostsInDevelopingWebBasedTechnologyTableTextBlock" xlink:label="loc_G8H693H3H85K_oprx_ScheduleOfCapitalizedCostsInDevelopingWebBasedTechnologyTableTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_ScheduleOfCapitalizedCostsInDevelopingWebBasedTechnologyTableTextBlock" xml:lang="en-US">Schedule Of Capitalized Costs In Developing Web Based Technology [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_ScheduleOfCapitalizedCostsInDevelopingWebBasedTechnologyTableTextBlock" xml:lang="en-US">Schedule of capitalized costs in developing web-based technology</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_ScheduleOfCapitalizedCostsInDevelopingWebBasedTechnologyTableTextBlock" xml:lang="en-US">Tabular disclosure of capitalized costs in developing web-based technology.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_ScheduleOfCapitalizedCostsInDevelopingWebBasedTechnologyTableTextBlock" xlink:to="lab_I0J815J5J07M_oprx_ScheduleOfCapitalizedCostsInDevelopingWebBasedTechnologyTableTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xml:lang="en-US">Schedule of Patent and Trademarks</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_G8H693H3H85K_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xml:lang="en-US">Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xml:lang="en-US">Schedule of share based option activity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_I0J815J5J07M_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xml:lang="en-US">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xml:lang="en-US">Schedule of warrants outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ScheduleOfShare-BasedCompensationWarrantActivityTableTextBlock" xlink:label="loc_G8H693H3H85K_oprx_ScheduleOfShare-BasedCompensationWarrantActivityTableTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_ScheduleOfShare-BasedCompensationWarrantActivityTableTextBlock" xml:lang="en-US">Schedule Of Share-Based Compensation Warrant Activity [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_ScheduleOfShare-BasedCompensationWarrantActivityTableTextBlock" xml:lang="en-US">Schedule of warrant activity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_ScheduleOfShare-BasedCompensationWarrantActivityTableTextBlock" xml:lang="en-US">Tabular schedule of share-based compensation warrant activity.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_ScheduleOfShare-BasedCompensationWarrantActivityTableTextBlock" xlink:to="lab_I0J815J5J07M_oprx_ScheduleOfShare-BasedCompensationWarrantActivityTableTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfRentExpenseTableTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ScheduleOfRentExpenseTableTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ScheduleOfRentExpenseTableTextBlock" xml:lang="en-US">Schedule of Rent Expense [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ScheduleOfRentExpenseTableTextBlock" xml:lang="en-US">Schedule of Rent Expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ScheduleOfRentExpenseTableTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ScheduleOfRentExpenseTableTextBlock"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ScheduleOfMajorCustomersIndividualRevenueTableTextBlock" xlink:label="loc_G8H693H3H85K_oprx_ScheduleOfMajorCustomersIndividualRevenueTableTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_ScheduleOfMajorCustomersIndividualRevenueTableTextBlock" xml:lang="en-US">Schedule Of Major Customers Individual Revenue [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_ScheduleOfMajorCustomersIndividualRevenueTableTextBlock" xml:lang="en-US">Schedule of major customers individual revenue</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_ScheduleOfMajorCustomersIndividualRevenueTableTextBlock" xml:lang="en-US">Tabbular schedule of major customers individual revenue.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_ScheduleOfMajorCustomersIndividualRevenueTableTextBlock" xlink:to="lab_I0J815J5J07M_oprx_ScheduleOfMajorCustomersIndividualRevenueTableTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xml:lang="en-US">Federal income tax benifit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_G8H693H3H85K_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xml:lang="en-US">Deferred tax assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_I0J815J5J07M_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_NatureOfBusinessDetailsTextualAbstract" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_NatureOfBusinessDetailsTextualAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_NatureOfBusinessDetailsTextualAbstract" xml:lang="en-US">Nature Of Business Details Textual [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_NatureOfBusinessDetailsTextualAbstract" xml:lang="en-US">Nature of Business Details (Textual)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_NatureOfBusinessDetailsTextualAbstract" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_NatureOfBusinessDetailsTextualAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_G8H693H3H85K_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xml:lang="en-US">Shares issued by RFID, Ltd. pursuant to a share exchange agreement</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_I0J815J5J07M_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_EquityMethodInvestmentOwnershipPercentage" xml:lang="en-US">Equity Method Investment, Ownership Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_EquityMethodInvestmentOwnershipPercentage" xml:lang="en-US">Percentage of stock of owned by RFID</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="loc_G8H693H3H85K_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xml:lang="en-US">Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="lab_I0J815J5J07M_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_TitleOfIndividualAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_TitleOfIndividualAxis" xml:lang="en-US">Title of Individual [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_TitleOfIndividualAxis" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_TitleOfIndividualAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_G8H693H3H85K_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xml:lang="en-US">Relationship to Entity [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_I0J815J5J07M_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PlacementAgentsMember" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_PlacementAgentsMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_PlacementAgentsMember" xml:lang="en-US">Placement Agents [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_PlacementAgentsMember" xml:lang="en-US">Placement agents [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_PlacementAgentsMember" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_PlacementAgentsMember"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ThreeOfficerMember" xlink:label="loc_G8H693H3H85K_oprx_ThreeOfficerMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_ThreeOfficerMember" xml:lang="en-US">Three Officers [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_ThreeOfficerMember" xml:lang="en-US">Three executive officers [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_oprx_ThreeOfficerMember" xml:lang="en-US">Three officers [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_ThreeOfficerMember" xlink:to="lab_I0J815J5J07M_oprx_ThreeOfficerMember"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ConsultantMember" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_ConsultantMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_ConsultantMember" xml:lang="en-US">Consultant [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_ConsultantMember" xml:lang="en-US">Consultant [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_ConsultantMember" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_ConsultantMember"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_VicisMember" xlink:label="loc_G8H693H3H85K_oprx_VicisMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_VicisMember" xml:lang="en-US">Vicis [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_VicisMember" xml:lang="en-US">Vicis Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_oprx_VicisMember" xml:lang="en-US">Vicis Capital Master Fund [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_VicisMember" xlink:to="lab_I0J815J5J07M_oprx_VicisMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OfficerMember" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_OfficerMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_OfficerMember" xml:lang="en-US">Officer [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_OfficerMember" xml:lang="en-US">Officer [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_OfficerMember" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_OfficerMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DirectorMember" xlink:label="loc_G8H693H3H85K_us-gaap_DirectorMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_DirectorMember" xml:lang="en-US">Director [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_DirectorMember" xml:lang="en-US">Outside director [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_DirectorMember" xml:lang="en-US">Director [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_DirectorMember" xlink:to="lab_I0J815J5J07M_us-gaap_DirectorMember"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_TwoOfficersMember" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_TwoOfficersMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_TwoOfficersMember" xml:lang="en-US">Two Officers [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_TwoOfficersMember" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_TwoOfficersMember"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_AgreementAxis" xlink:label="loc_G8H693H3H85K_oprx_AgreementAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_AgreementAxis" xml:lang="en-US">Agreement [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_AgreementAxis" xlink:to="lab_I0J815J5J07M_oprx_AgreementAxis"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_AgreementDomain" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_AgreementDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_AgreementDomain" xml:lang="en-US">Agreement [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_AgreementDomain" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_AgreementDomain"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_SecuritiesPurchaseAgreementMember" xlink:label="loc_G8H693H3H85K_oprx_SecuritiesPurchaseAgreementMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_SecuritiesPurchaseAgreementMember" xml:lang="en-US">Securities Purchase Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_SecuritiesPurchaseAgreementMember" xml:lang="en-US">Securities Purchase Agreement [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_SecuritiesPurchaseAgreementMember" xlink:to="lab_I0J815J5J07M_oprx_SecuritiesPurchaseAgreementMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_SubsequentEventTypeAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_SubsequentEventTypeAxis" xml:lang="en-US">Subsequent Event Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_SubsequentEventTypeAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_G8H693H3H85K_us-gaap_SubsequentEventTypeDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_SubsequentEventTypeDomain" xml:lang="en-US">Subsequent Event Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_I0J815J5J07M_us-gaap_SubsequentEventTypeDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_SubsequentEventMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_SubsequentEventMember" xml:lang="en-US">Subsequent Event [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_SubsequentEventMember" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_SubsequentEventMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_G8H693H3H85K_us-gaap_FinancialInstrumentAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_FinancialInstrumentAxis" xml:lang="en-US">Financial Instrument [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_FinancialInstrumentAxis" xlink:to="lab_I0J815J5J07M_us-gaap_FinancialInstrumentAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xml:lang="en-US">Financial Instruments [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CapitalMarketsAdvisoryAgreementMember" xlink:label="loc_G8H693H3H85K_oprx_CapitalMarketsAdvisoryAgreementMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_CapitalMarketsAdvisoryAgreementMember" xml:lang="en-US">Capital Markets Advisory Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_oprx_CapitalMarketsAdvisoryAgreementMember" xml:lang="en-US">Capital Markets Advisory Agreement [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_CapitalMarketsAdvisoryAgreementMember" xlink:to="lab_I0J815J5J07M_oprx_CapitalMarketsAdvisoryAgreementMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ClassOfStockLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ClassOfStockLineItems" xml:lang="en-US">Class of Stock [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ClassOfStockLineItems" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ClassOfStockLineItems"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockholdersEquityTextualAbstract" xlink:label="loc_G8H693H3H85K_oprx_StockholdersEquityTextualAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_StockholdersEquityTextualAbstract" xml:lang="en-US">Stockholders Equity Textual [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_StockholdersEquityTextualAbstract" xml:lang="en-US">Stockholders Equity (Textual)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_StockholdersEquityTextualAbstract" xlink:to="lab_I0J815J5J07M_oprx_StockholdersEquityTextualAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_SharesIssued"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_SharesIssued" xml:lang="en-US">Shares, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_SharesIssued" xml:lang="en-US">Sale of comman stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_SharesIssued" xml:lang="en-US">Additional shares issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_SharesIssued" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_SharesIssued"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockIssuedDuringPeroidSharesCacelled" xlink:label="loc_G8H693H3H85K_oprx_StockIssuedDuringPeroidSharesCacelled"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_StockIssuedDuringPeroidSharesCacelled" xml:lang="en-US">Stock Issued During Peroid Shares Cacelled</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_oprx_StockIssuedDuringPeroidSharesCacelled" xml:lang="en-US">Number of shares not be issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_StockIssuedDuringPeroidSharesCacelled" xml:lang="en-US">Represnts number of shares terminated or cancelled.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_StockIssuedDuringPeroidSharesCacelled" xlink:to="lab_I0J815J5J07M_oprx_StockIssuedDuringPeroidSharesCacelled"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xml:lang="en-US">Sale of comman stock shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_G8H693H3H85K_us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xml:lang="en-US">Sale of common stock value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_I0J815J5J07M_us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantExercisePricePeriod" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_WarrantExercisePricePeriod"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_WarrantExercisePricePeriod" xml:lang="en-US">Warrant Exercise Price Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_WarrantExercisePricePeriod" xml:lang="en-US">Warrant exercise price period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_WarrantExercisePricePeriod" xml:lang="en-US">Warrant exercise price period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_WarrantExercisePricePeriod" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_WarrantExercisePricePeriod"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_G8H693H3H85K_us-gaap_SaleOfStockPricePerShare"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_SaleOfStockPricePerShare" xml:lang="en-US">Sale of Stock, Price Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_SaleOfStockPricePerShare" xml:lang="en-US">Sale of stock price per share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_I0J815J5J07M_us-gaap_SaleOfStockPricePerShare"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_DebtRedemptionLongtermDebtAmount" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_DebtRedemptionLongtermDebtAmount"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_DebtRedemptionLongtermDebtAmount" xml:lang="en-US">Debt redemption, amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_DebtRedemptionLongtermDebtAmount" xml:lang="en-US">Debt redemption, amount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_DebtRedemptionLongtermDebtAmount" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_DebtRedemptionLongtermDebtAmount"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CommissionsPercentage" xlink:label="loc_G8H693H3H85K_oprx_CommissionsPercentage"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_CommissionsPercentage" xml:lang="en-US">Commissions Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_CommissionsPercentage" xml:lang="en-US">Commissions percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_CommissionsPercentage" xml:lang="en-US">commissions percentage.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_CommissionsPercentage" xlink:to="lab_I0J815J5J07M_oprx_CommissionsPercentage"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_AccruedSalesCommissionCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_AccruedSalesCommissionCurrent" xml:lang="en-US">Accrued Sales Commission, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_AccruedSalesCommissionCurrent" xml:lang="en-US">Commissions</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_AccruedSalesCommissionCurrent" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_AccruedSalesCommissionCurrent"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PurchaseOfWarrants" xlink:label="loc_G8H693H3H85K_oprx_PurchaseOfWarrants"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_PurchaseOfWarrants" xml:lang="en-US">Purchase Of Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_PurchaseOfWarrants" xml:lang="en-US">Purchase of warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_PurchaseOfWarrants" xml:lang="en-US">Purchase of warrants.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_PurchaseOfWarrants" xlink:to="lab_I0J815J5J07M_oprx_PurchaseOfWarrants"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xml:lang="en-US">Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xml:lang="en-US">Warrants, value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_G8H693H3H85K_us-gaap_SharePrice"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_SharePrice" xml:lang="en-US">Share Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_SharePrice" xml:lang="en-US">Exercise price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_SharePrice" xlink:to="lab_I0J815J5J07M_us-gaap_SharePrice"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_EmployeeRelatedLiabilitiesCurrent" xml:lang="en-US">Employee-related Liabilities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_EmployeeRelatedLiabilitiesCurrent" xml:lang="en-US">Employee Bonus</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_G8H693H3H85K_us-gaap_PaymentsOfStockIssuanceCosts"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_PaymentsOfStockIssuanceCosts" xml:lang="en-US">Payments of Stock Issuance Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_PaymentsOfStockIssuanceCosts" xml:lang="en-US">Common stock issued for equity issuance costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_I0J815J5J07M_us-gaap_PaymentsOfStockIssuanceCosts"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xml:lang="en-US">Stock Issued During Period, Value, Share-based Compensation, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xml:lang="en-US">Employee bonus, Share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:label="loc_G8H693H3H85K_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xml:lang="en-US">Stock Issued During Period, Shares, Share-based Compensation, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xml:lang="en-US">Employee bonus, Value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:to="lab_I0J815J5J07M_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_AdditionalWorkingCapital" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_AdditionalWorkingCapital"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_AdditionalWorkingCapital" xml:lang="en-US">Additional Working Capital</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_AdditionalWorkingCapital" xml:lang="en-US">Additional working capital</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_AdditionalWorkingCapital" xml:lang="en-US">Additional working capital.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_AdditionalWorkingCapital" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_AdditionalWorkingCapital"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_FullyDilutedShares" xlink:label="loc_G8H693H3H85K_oprx_FullyDilutedShares"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_FullyDilutedShares" xml:lang="en-US">Fully Diluted Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_FullyDilutedShares" xml:lang="en-US">Fully diluted shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_FullyDilutedShares" xml:lang="en-US">fully diluted shares.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_FullyDilutedShares" xlink:to="lab_I0J815J5J07M_oprx_FullyDilutedShares"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtIssuanceCosts" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_DebtIssuanceCosts"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_DebtIssuanceCosts" xml:lang="en-US">Debt Issuance Cost</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_DebtIssuanceCosts" xml:lang="en-US">Equity issuance cost</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_DebtIssuanceCosts" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_DebtIssuanceCosts"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantsExercised" xlink:label="loc_G8H693H3H85K_oprx_WarrantsExercised"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_WarrantsExercised" xml:lang="en-US">Warrants Exercised</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_oprx_WarrantsExercised" xml:lang="en-US">Warrants exercised, number of shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_WarrantsExercised" xml:lang="en-US">Warrants exercised</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_WarrantsExercised" xlink:to="lab_I0J815J5J07M_oprx_WarrantsExercised"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedPaymentsOptionsTextulaAbstract" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_ShareBasedPaymentsOptionsTextulaAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_ShareBasedPaymentsOptionsTextulaAbstract" xml:lang="en-US">Share based payments options [Textual]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_ShareBasedPaymentsOptionsTextulaAbstract" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_ShareBasedPaymentsOptionsTextulaAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_G8H693H3H85K_us-gaap_LossContingenciesTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_LossContingenciesTable" xml:lang="en-US">Loss Contingencies [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_LossContingenciesTable" xlink:to="lab_I0J815J5J07M_us-gaap_LossContingenciesTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_LossContingenciesLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_LossContingenciesLineItems" xml:lang="en-US">Loss Contingencies [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_LossContingenciesLineItems" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_LossContingenciesLineItems"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount" xlink:label="loc_G8H693H3H85K_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Reported Claims, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount" xml:lang="en-US">Claims pertaining to damages to nonregistration of shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount" xlink:to="lab_I0J815J5J07M_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xml:lang="en-US">Damage related to LDM' s breach of the agreement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_G8H693H3H85K_us-gaap_BusinessCombinationContingentConsiderationLiability"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_BusinessCombinationContingentConsiderationLiability" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_BusinessCombinationContingentConsiderationLiability" xml:lang="en-US">Damage related to PDR's actions</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_I0J815J5J07M_us-gaap_BusinessCombinationContingentConsiderationLiability"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_LossContingencyDamagesSoughtValue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_LossContingencyDamagesSoughtValue" xml:lang="en-US">Loss Contingency, Damages Sought, Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_LossContingencyDamagesSoughtValue" xml:lang="en-US">Loss pertaining to Mr. Milton Wilpon for Litigation settlement</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_LossContingencyDamagesSoughtValue"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ContigentLiabilitiesRelatedToAuditFeesInPercentage" xlink:label="loc_G8H693H3H85K_oprx_ContigentLiabilitiesRelatedToAuditFeesInPercentage"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_ContigentLiabilitiesRelatedToAuditFeesInPercentage" xml:lang="en-US">Contigent Liabilities Related To Audit Fees In Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_ContigentLiabilitiesRelatedToAuditFeesInPercentage" xml:lang="en-US">Contingent Liabilities related to audit fees in percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_ContigentLiabilitiesRelatedToAuditFeesInPercentage" xml:lang="en-US">Contigent liabilities related to audit fees in percentage.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_ContigentLiabilitiesRelatedToAuditFeesInPercentage" xlink:to="lab_I0J815J5J07M_oprx_ContigentLiabilitiesRelatedToAuditFeesInPercentage"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ScheduleOfStockByClassTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ScheduleOfStockByClassTable" xml:lang="en-US">Schedule of Stock by Class [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ScheduleOfStockByClassTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreationDateAxis" xlink:label="loc_G8H693H3H85K_us-gaap_CreationDateAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_CreationDateAxis" xml:lang="en-US">Report Date [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_CreationDateAxis" xlink:to="lab_I0J815J5J07M_us-gaap_CreationDateAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_DefaultFinancialStatementsDateMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_DefaultFinancialStatementsDateMember" xml:lang="en-US">Financial Statement Filing Date [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_DefaultFinancialStatementsDateMember" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_DefaultFinancialStatementsDateMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioPreviouslyReportedMember" xlink:label="loc_G8H693H3H85K_us-gaap_ScenarioPreviouslyReportedMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ScenarioPreviouslyReportedMember" xml:lang="en-US">Previously Stated</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_ScenarioPreviouslyReportedMember" xml:lang="en-US">Previously stated [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ScenarioPreviouslyReportedMember" xlink:to="lab_I0J815J5J07M_us-gaap_ScenarioPreviouslyReportedMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestatementAdjustmentMember" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_RestatementAdjustmentMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_RestatementAdjustmentMember" xml:lang="en-US">Correction</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_RestatementAdjustmentMember" xml:lang="en-US">Adjustments [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_RestatementAdjustmentMember" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_RestatementAdjustmentMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_G8H693H3H85K_us-gaap_CostOfGoodsSold"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_CostOfGoodsSold" xml:lang="en-US">Cost of Goods Sold</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_CostOfGoodsSold" xml:lang="en-US">Cost of Sales</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_CostOfGoodsSold" xlink:to="lab_I0J815J5J07M_us-gaap_CostOfGoodsSold"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_IncreaseDecreaseInRevenueSharePayable" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_IncreaseDecreaseInRevenueSharePayable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_IncreaseDecreaseInRevenueSharePayable" xml:lang="en-US">Increase Decrease In Revenue Share Payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_IncreaseDecreaseInRevenueSharePayable" xml:lang="en-US">Decrease in revenue share payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_IncreaseDecreaseInRevenueSharePayable" xml:lang="en-US">Fair value of stock option as payment for services rendered .</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_IncreaseDecreaseInRevenueSharePayable" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_IncreaseDecreaseInRevenueSharePayable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xml:lang="en-US">Expected dividend yield</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_G8H693H3H85K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xml:lang="en-US">Risk free interest rate minimum</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xml:lang="en-US">Risk free interest rate maximum</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_G8H693H3H85K_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xml:lang="en-US">Expected option term</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_I0J815J5J07M_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US">Turnover/forfeiture rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_G8H693H3H85K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xml:lang="en-US">Expected volatility minimum</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xml:lang="en-US">Expected volatility maximum</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_G8H693H3H85K_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xml:lang="en-US">Property, Plant and Equipment [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_I0J815J5J07M_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_RangeAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_RangeAxis" xml:lang="en-US">Range [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_RangeAxis" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_RangeAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_G8H693H3H85K_us-gaap_RangeMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_RangeMember" xml:lang="en-US">Range [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_RangeMember" xlink:to="lab_I0J815J5J07M_us-gaap_RangeMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_MaximumMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_MaximumMember" xml:lang="en-US">Maximum [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_MaximumMember" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_MaximumMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_G8H693H3H85K_us-gaap_MinimumMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_MinimumMember" xml:lang="en-US">Minimum [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_MinimumMember" xlink:to="lab_I0J815J5J07M_us-gaap_MinimumMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_PropertyPlantAndEquipmentLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_PropertyPlantAndEquipmentLineItems" xml:lang="en-US">Property, Plant and Equipment [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_PropertyPlantAndEquipmentLineItems"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract" xlink:label="loc_G8H693H3H85K_oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract" xml:lang="en-US">Summary Of Significant Accounting Policies Details Textual [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract" xml:lang="en-US">Summary of Significant Accounting Policies Details (Textual)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract" xlink:to="lab_I0J815J5J07M_oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ProvisionForDoubtfulAccounts"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ProvisionForDoubtfulAccounts" xml:lang="en-US">Provision for Doubtful Accounts</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ProvisionForDoubtfulAccounts" xml:lang="en-US">Bad debt expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ProvisionForDoubtfulAccounts"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_G8H693H3H85K_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xml:lang="en-US">Allowance for Doubtful Accounts Receivable, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xml:lang="en-US">Allowance for doubtful accounts</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_I0J815J5J07M_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_PropertyPlantAndEquipmentUsefulLife" xml:lang="en-US">Property, Plant and Equipment, Useful Life</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_PropertyPlantAndEquipmentUsefulLife" xml:lang="en-US">Property and Equipment, Estimated useful lives</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenueRecognitionNewAccountingPronouncementMaterialEffectDescription" xlink:label="loc_G8H693H3H85K_us-gaap_RevenueRecognitionNewAccountingPronouncementMaterialEffectDescription"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_RevenueRecognitionNewAccountingPronouncementMaterialEffectDescription" xml:lang="en-US">Revenue Recognition, New Accounting Pronouncement, Material Effect, Description</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_RevenueRecognitionNewAccountingPronouncementMaterialEffectDescription" xml:lang="en-US">Revenue recognition and revenue shares, Description</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_RevenueRecognitionNewAccountingPronouncementMaterialEffectDescription" xlink:to="lab_I0J815J5J07M_us-gaap_RevenueRecognitionNewAccountingPronouncementMaterialEffectDescription"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidInsurance" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_PrepaidInsurance"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_PrepaidInsurance" xml:lang="en-US">Prepaid Insurance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_PrepaidInsurance" xml:lang="en-US">Insurance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_PrepaidInsurance" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_PrepaidInsurance"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidRent" xlink:label="loc_G8H693H3H85K_us-gaap_PrepaidRent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_PrepaidRent" xml:lang="en-US">Prepaid Rent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_PrepaidRent" xml:lang="en-US">Rent</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_PrepaidRent" xlink:to="lab_I0J815J5J07M_us-gaap_PrepaidRent"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PrepaidLegalFees" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_PrepaidLegalFees"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_PrepaidLegalFees" xml:lang="en-US">Prepaid Legal Fees</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_PrepaidLegalFees" xml:lang="en-US">Legal</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_PrepaidLegalFees" xml:lang="en-US">Amount of asset related to consideration paid in advance for legal fees that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_PrepaidLegalFees" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_PrepaidLegalFees"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_G8H693H3H85K_us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_I0J815J5J07M_us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_PropertyPlantAndEquipmentTypeDomain" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_G8H693H3H85K_us-gaap_ComputerEquipmentMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ComputerEquipmentMember" xml:lang="en-US">Computer Equipment [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_ComputerEquipmentMember" xml:lang="en-US">Computer equipment [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ComputerEquipmentMember" xlink:to="lab_I0J815J5J07M_us-gaap_ComputerEquipmentMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_FurnitureAndFixturesMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_FurnitureAndFixturesMember" xml:lang="en-US">Furniture and Fixtures [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_FurnitureAndFixturesMember" xml:lang="en-US">Furniture and fixtures [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_FurnitureAndFixturesMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_G8H693H3H85K_us-gaap_PropertyPlantAndEquipmentGross"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_PropertyPlantAndEquipmentGross" xml:lang="en-US">Property, Plant and Equipment, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_PropertyPlantAndEquipmentGross" xml:lang="en-US">Property and equipment, Subtotal</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_I0J815J5J07M_us-gaap_PropertyPlantAndEquipmentGross"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US">Accumulated depreciation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US">Accumulated depreciation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US">Accumulated depreciation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PropertyPlantAndEquipmentTextualAbstract" xlink:label="loc_G8H693H3H85K_oprx_PropertyPlantAndEquipmentTextualAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_PropertyPlantAndEquipmentTextualAbstract" xml:lang="en-US">Property Plant And Equipment Textual [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_PropertyPlantAndEquipmentTextualAbstract" xml:lang="en-US">Property and Equipment (Textual)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_PropertyPlantAndEquipmentTextualAbstract" xlink:to="lab_I0J815J5J07M_oprx_PropertyPlantAndEquipmentTextualAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_Depreciation"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_Depreciation" xml:lang="en-US">Depreciation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_Depreciation" xml:lang="en-US">Depreciation expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_Depreciation" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_Depreciation"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_G8H693H3H85K_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_I0J815J5J07M_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_G8H693H3H85K_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_I0J815J5J07M_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WebBasedTechnologyMember" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_WebBasedTechnologyMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_WebBasedTechnologyMember" xml:lang="en-US">Web Based Technology [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_WebBasedTechnologyMember" xml:lang="en-US">OptimizeRx web-based technology [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_WebBasedTechnologyMember" xml:lang="en-US">Web based Collection of computer programs and related data that provide instructions to a computer.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_WebBasedTechnologyMember" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_WebBasedTechnologyMember"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WebBasedTechnologyOneMember" xlink:label="loc_G8H693H3H85K_oprx_WebBasedTechnologyOneMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_WebBasedTechnologyOneMember" xml:lang="en-US">Web Based Technology One [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_WebBasedTechnologyOneMember" xml:lang="en-US">SampleMD web-based technology [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_WebBasedTechnologyOneMember" xml:lang="en-US">Sample web based Collection of computer programs and related data that provide instructions to a computer.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_WebBasedTechnologyOneMember" xlink:to="lab_I0J815J5J07M_oprx_WebBasedTechnologyOneMember"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WebBasedTechnologyTwoMember" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_WebBasedTechnologyTwoMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_WebBasedTechnologyTwoMember" xml:lang="en-US">Web Based Technology Two [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_WebBasedTechnologyTwoMember" xml:lang="en-US">SampleMD 2.0 web-based technology [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_WebBasedTechnologyTwoMember" xml:lang="en-US">sample 2.0 web based Collection of computer programs and related data that provide instructions to a computer.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_WebBasedTechnologyTwoMember" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_WebBasedTechnologyTwoMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_G8H693H3H85K_us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_FiniteLivedIntangibleAssetsLineItems" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_I0J815J5J07M_us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_CapitalizedComputerSoftwareGross"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_CapitalizedComputerSoftwareGross" xml:lang="en-US">Capitalized Computer Software, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_CapitalizedComputerSoftwareGross" xml:lang="en-US">Web-based technology, Subtotal</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_CapitalizedComputerSoftwareGross" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_CapitalizedComputerSoftwareGross"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:label="loc_G8H693H3H85K_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xml:lang="en-US">Capitalized Computer Software, Accumulated Amortization</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xml:lang="en-US">Accumulated amortization</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_I0J815J5J07M_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xml:lang="en-US">Accumulated amortization</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:to="lab_I0J815J5J07M_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CapitalizedComputerSoftwareImpairment" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_CapitalizedComputerSoftwareImpairment"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_CapitalizedComputerSoftwareImpairment" xml:lang="en-US">Capitalized Computer Software, Impairment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_CapitalizedComputerSoftwareImpairment" xml:lang="en-US">Impairment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_CapitalizedComputerSoftwareImpairment" xml:lang="en-US">Amount of write-down of capitalized computer software recognized in the income statement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_CapitalizedComputerSoftwareImpairment" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_CapitalizedComputerSoftwareImpairment"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNetAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_CapitalizedComputerSoftwareNetAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_CapitalizedComputerSoftwareNetAbstract" xml:lang="en-US">Web-Based Technology [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_CapitalizedComputerSoftwareNetAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_CapitalizedComputerSoftwareNetAbstract"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CapitalizedComputerSoftwareAmortizationPeriodDescription" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_CapitalizedComputerSoftwareAmortizationPeriodDescription"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_CapitalizedComputerSoftwareAmortizationPeriodDescription" xml:lang="en-US">Capitalized Computer Software Amortization Period, Description</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_CapitalizedComputerSoftwareAmortizationPeriodDescription" xml:lang="en-US">Web-based technology amortization period, Description</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_CapitalizedComputerSoftwareAmortizationPeriodDescription" xml:lang="en-US">Description of capitalized computer software amortization period.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_CapitalizedComputerSoftwareAmortizationPeriodDescription" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_CapitalizedComputerSoftwareAmortizationPeriodDescription"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization" xlink:label="loc_G8H693H3H85K_us-gaap_CapitalizedComputerSoftwareAmortization"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_CapitalizedComputerSoftwareAmortization" xml:lang="en-US">Capitalized Computer Software, Amortization</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_CapitalizedComputerSoftwareAmortization" xml:lang="en-US">Web-based technology, amortization expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_CapitalizedComputerSoftwareAmortization" xlink:to="lab_I0J815J5J07M_us-gaap_CapitalizedComputerSoftwareAmortization"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_FiniteLivedIntangibleAssetsGross"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_FiniteLivedIntangibleAssetsGross" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_FiniteLivedIntangibleAssetsGross" xml:lang="en-US">Patent rights and intangible assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_FiniteLivedIntangibleAssetsGross"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedPatentsGross" xlink:label="loc_G8H693H3H85K_us-gaap_FiniteLivedPatentsGross"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_FiniteLivedPatentsGross" xml:lang="en-US">Finite-Lived Patents, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_FiniteLivedPatentsGross" xml:lang="en-US">Patent defense costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_FiniteLivedPatentsGross" xlink:to="lab_I0J815J5J07M_us-gaap_FiniteLivedPatentsGross"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_OtherFiniteLivedIntangibleAssetsGross"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_OtherFiniteLivedIntangibleAssetsGross" xml:lang="en-US">Other Finite-Lived Intangible Assets, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_OtherFiniteLivedIntangibleAssetsGross" xml:lang="en-US">New patents and trademarks</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_OtherFiniteLivedIntangibleAssetsGross"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_G8H693H3H85K_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xml:lang="en-US">Accumulated amortization</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_I0J815J5J07M_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xml:lang="en-US">Accumulated amortization</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_I0J815J5J07M_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_PatentsMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_PatentsMember" xml:lang="en-US">Patents [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_PatentsMember" xml:lang="en-US">SampleMD Patent Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_PatentsMember" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_PatentsMember"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_OptionsGrantedToAcquireExclusivePatentRightsShares" xlink:label="loc_G8H693H3H85K_oprx_OptionsGrantedToAcquireExclusivePatentRightsShares"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_OptionsGrantedToAcquireExclusivePatentRightsShares" xml:lang="en-US">Options Granted To Acquire Exclusive Patent Rights Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_OptionsGrantedToAcquireExclusivePatentRightsShares" xml:lang="en-US">Stock options</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_OptionsGrantedToAcquireExclusivePatentRightsShares" xml:lang="en-US">Options granted to acquire exclusive patent rights shares.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_OptionsGrantedToAcquireExclusivePatentRightsShares" xlink:to="lab_I0J815J5J07M_oprx_OptionsGrantedToAcquireExclusivePatentRightsShares"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_OptionsGrantedToAcquireExclusivePatentRightsValue" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_OptionsGrantedToAcquireExclusivePatentRightsValue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_OptionsGrantedToAcquireExclusivePatentRightsValue" xml:lang="en-US">Options Granted To Acquire Exclusive Patent Rights Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_OptionsGrantedToAcquireExclusivePatentRightsValue" xml:lang="en-US">Shares values</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_OptionsGrantedToAcquireExclusivePatentRightsValue" xml:lang="en-US">Options granted to acquire exclusive patent rights value.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_OptionsGrantedToAcquireExclusivePatentRightsValue" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_OptionsGrantedToAcquireExclusivePatentRightsValue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockTransactionDate" xlink:label="loc_G8H693H3H85K_us-gaap_SaleOfStockTransactionDate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_SaleOfStockTransactionDate" xml:lang="en-US">Sale of Stock, Transaction Date</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_SaleOfStockTransactionDate" xml:lang="en-US">Expire date</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_SaleOfStockTransactionDate" xlink:to="lab_I0J815J5J07M_us-gaap_SaleOfStockTransactionDate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationMethod" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_FiniteLivedIntangibleAssetsAmortizationMethod"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_FiniteLivedIntangibleAssetsAmortizationMethod" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Method</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_FiniteLivedIntangibleAssetsAmortizationMethod" xml:lang="en-US">Amortizing patent</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_FiniteLivedIntangibleAssetsAmortizationMethod" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_FiniteLivedIntangibleAssetsAmortizationMethod"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_G8H693H3H85K_us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xml:lang="en-US">Useful life</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_I0J815J5J07M_us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" xml:lang="en-US">Amortization expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_G8H693H3H85K_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_I0J815J5J07M_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_RelatedPartyTransactionLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_RelatedPartyTransactionLineItems" xml:lang="en-US">Related Party Transaction [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_RelatedPartyTransactionLineItems"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ConsultingAgreementMember" xlink:label="loc_G8H693H3H85K_oprx_ConsultingAgreementMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_ConsultingAgreementMember" xml:lang="en-US">Consulting Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_ConsultingAgreementMember" xml:lang="en-US">Consulting Agreement [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_ConsultingAgreementMember" xlink:to="lab_I0J815J5J07M_oprx_ConsultingAgreementMember"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_SeparationAgreementMember" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_SeparationAgreementMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_SeparationAgreementMember" xml:lang="en-US">Separation Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_SeparationAgreementMember" xml:lang="en-US">Separation Agreement [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_SeparationAgreementMember" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_SeparationAgreementMember"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PurchaseAgreementMember" xlink:label="loc_G8H693H3H85K_oprx_PurchaseAgreementMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_PurchaseAgreementMember" xml:lang="en-US">Purchase Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_PurchaseAgreementMember" xml:lang="en-US">Purchase Agreement [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_PurchaseAgreementMember" xlink:to="lab_I0J815J5J07M_oprx_PurchaseAgreementMember"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_VicisCapitalAgreementMember" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_VicisCapitalAgreementMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_VicisCapitalAgreementMember" xml:lang="en-US">Vicis Capital Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_VicisCapitalAgreementMember" xml:lang="en-US">Vicis Capital Agreement [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_VicisCapitalAgreementMember" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_VicisCapitalAgreementMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_G8H693H3H85K_us-gaap_SharesIssuedPricePerShare"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_SharesIssuedPricePerShare" xml:lang="en-US">Shares Issued, Price Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_SharesIssuedPricePerShare" xml:lang="en-US">Shares Issued, per share value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_I0J815J5J07M_us-gaap_SharesIssuedPricePerShare"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US">Granted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US">Options granted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US">Shares granted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_G8H693H3H85K_us-gaap_StatementClassOfStockAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_StatementClassOfStockAxis" xml:lang="en-US">Class of Stock [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_StatementClassOfStockAxis" xlink:to="lab_I0J815J5J07M_us-gaap_StatementClassOfStockAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ClassOfStockDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ClassOfStockDomain" xml:lang="en-US">Class of Stock [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ClassOfStockDomain" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ClassOfStockDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_G8H693H3H85K_us-gaap_SeriesAPreferredStockMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_SeriesAPreferredStockMember" xml:lang="en-US">Series A Preferred Stock [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_SeriesAPreferredStockMember" xlink:to="lab_I0J815J5J07M_us-gaap_SeriesAPreferredStockMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_SeriesBPreferredStockMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_SeriesBPreferredStockMember" xml:lang="en-US">Series B Preferred Stock [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_SeriesBPreferredStockMember" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_SeriesBPreferredStockMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_G8H693H3H85K_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xml:lang="en-US">Issuance costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_I0J815J5J07M_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xml:lang="en-US">Proceeds from Issuance of Convertible Preferred Stock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xml:lang="en-US">Net proceeds of shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_G8H693H3H85K_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xml:lang="en-US">Preferred shares issued, values</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_I0J815J5J07M_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xml:lang="en-US">Preferred Shares issued, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="loc_G8H693H3H85K_us-gaap_PreferredStockDividendRatePercentage"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_PreferredStockDividendRatePercentage" xml:lang="en-US">Preferred Stock, Dividend Rate, Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_PreferredStockDividendRatePercentage" xml:lang="en-US">Percentage of cumulative dividend</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_PreferredStockDividendRatePercentage" xml:lang="en-US">Percentage of semi-annual dividends payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_PreferredStockDividendRatePercentage" xlink:to="lab_I0J815J5J07M_us-gaap_PreferredStockDividendRatePercentage"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US">Warrants issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentWarrantsExercisePrice" xlink:label="loc_G8H693H3H85K_invest_InvestmentWarrantsExercisePrice"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_invest_InvestmentWarrantsExercisePrice" xml:lang="en-US">Investment Warrants, Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_invest_InvestmentWarrantsExercisePrice" xml:lang="en-US">Exercise price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_invest_InvestmentWarrantsExercisePrice" xlink:to="lab_I0J815J5J07M_invest_InvestmentWarrantsExercisePrice"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TreasuryStockNumberOfSharesHeld" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_TreasuryStockNumberOfSharesHeld"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_TreasuryStockNumberOfSharesHeld" xml:lang="en-US">Treasury Stock, Number of Shares Held</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_TreasuryStockNumberOfSharesHeld" xml:lang="en-US">Treasury stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_TreasuryStockNumberOfSharesHeld" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_TreasuryStockNumberOfSharesHeld"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_G8H693H3H85K_us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_DebtInstrumentConvertibleConversionPrice1" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_DebtInstrumentConvertibleConversionPrice1" xml:lang="en-US">Conversion price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_I0J815J5J07M_us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TemporaryEquityAccretionOfDividends" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_TemporaryEquityAccretionOfDividends"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_TemporaryEquityAccretionOfDividends" xml:lang="en-US">Undeclared dividends</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_TemporaryEquityAccretionOfDividends" xml:lang="en-US">Undeclared dividends</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_TemporaryEquityAccretionOfDividends" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_TemporaryEquityAccretionOfDividends"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockRedemptionAmount" xlink:label="loc_G8H693H3H85K_us-gaap_PreferredStockRedemptionAmount"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_PreferredStockRedemptionAmount" xml:lang="en-US">Preferred Stock, Redemption Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_PreferredStockRedemptionAmount" xml:lang="en-US">Total Undeclared dividends</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_PreferredStockRedemptionAmount" xlink:to="lab_I0J815J5J07M_us-gaap_PreferredStockRedemptionAmount"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xml:lang="en-US">Number of shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_G8H693H3H85K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US">Available for grant, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US">Begining balnce , shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US">Ending balance, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xml:lang="en-US">Expired</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_G8H693H3H85K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xml:lang="en-US">Weighted average exercise price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US">Begining balance, weighted average exercise price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US">Ending balance, weighted average exercise price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_G8H693H3H85K_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Granted, weighted average exercise price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Exercised, weighted average exercise price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_G8H693H3H85K_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Expired, weighted average exercise price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_G8H693H3H85K_us-gaap_AwardTypeAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_AwardTypeAxis" xml:lang="en-US">Award Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_AwardTypeAxis" xlink:to="lab_I0J815J5J07M_us-gaap_AwardTypeAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xml:lang="en-US">Equity Award [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockCompensationPlanMember" xlink:label="loc_G8H693H3H85K_us-gaap_StockCompensationPlanMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_StockCompensationPlanMember" xml:lang="en-US">Stock Compensation Plan [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_StockCompensationPlanMember" xml:lang="en-US">2013 Equity Compensation Plan</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_StockCompensationPlanMember" xlink:to="lab_I0J815J5J07M_us-gaap_StockCompensationPlanMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_G8H693H3H85K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xml:lang="en-US">Shares granted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xml:lang="en-US">Compensation cost</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantOneMember" xlink:label="loc_G8H693H3H85K_oprx_WarrantOneMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_WarrantOneMember" xml:lang="en-US">Warrant One [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_WarrantOneMember" xml:lang="en-US">Warrant one [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_WarrantOneMember" xml:lang="en-US">Warrant one member.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_WarrantOneMember" xlink:to="lab_I0J815J5J07M_oprx_WarrantOneMember"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantTwoMember" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_WarrantTwoMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_WarrantTwoMember" xml:lang="en-US">Warrant Two [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_WarrantTwoMember" xml:lang="en-US">Warrant two [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_WarrantTwoMember" xml:lang="en-US">Warrant two.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_WarrantTwoMember" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_WarrantTwoMember"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantThreeMember" xlink:label="loc_G8H693H3H85K_oprx_WarrantThreeMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_WarrantThreeMember" xml:lang="en-US">Warrant Three [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_WarrantThreeMember" xml:lang="en-US">Warrant three [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_WarrantThreeMember" xml:lang="en-US">Warrant three.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_WarrantThreeMember" xlink:to="lab_I0J815J5J07M_oprx_WarrantThreeMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xml:lang="en-US">Number of Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xml:lang="en-US">Begining balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xml:lang="en-US">Ending balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate" xlink:label="loc_G8H693H3H85K_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instrument Expiration Date</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate" xml:lang="en-US">Expiration Date</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate" xml:lang="en-US">Share based compensation arrangement by share based payment award non option equity instrument expiration date.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate" xlink:to="lab_I0J815J5J07M_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_G8H693H3H85K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xml:lang="en-US">Granted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xml:lang="en-US">Granted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xml:lang="en-US">Exercised</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:label="loc_G8H693H3H85K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xml:lang="en-US">Cancellation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:to="lab_I0J815J5J07M_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xml:lang="en-US">Expired</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract" xlink:label="loc_G8H693H3H85K_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instrument Weighted Average Outstanding Roll Forward [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract" xlink:to="lab_I0J815J5J07M_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instrument Outstanding Weighted Average</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage" xml:lang="en-US">Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage" xml:lang="en-US">Begining balance, weighted average</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage" xml:lang="en-US">Ending balance, weighted average</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage" xml:lang="en-US">Share based compensation arrangement by share based payment award non option equity instrument outstanding weighted average.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted" xlink:label="loc_G8H693H3H85K_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instrument Weighted Average, Granted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted" xml:lang="en-US">Granted, weighted average</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted" xml:lang="en-US">Granted, weighted average</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted" xml:lang="en-US">Share based compensation arrangement by share based payment award non option equity instrument weighted average, grantedPayment Award Non Option Equity Instrument Weighted Average, Granted.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted" xlink:to="lab_I0J815J5J07M_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExercise" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExercise"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExercise" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instrument Weighted Average, Exercise</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExercise" xml:lang="en-US">Exercise, weighted average</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExercise" xml:lang="en-US">Share based compensation arrangement by share based payment award non option equity instrument weighted average, exercise.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExercise" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExercise"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExpiration" xlink:label="loc_G8H693H3H85K_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExpiration"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExpiration" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instrument Weighted Average, Expiration</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExpiration" xml:lang="en-US">Expired, weighted average</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExpiration" xml:lang="en-US">Share based compensation arrangement by share based payment award non option equity instrument weighted average, expiration.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExpiration" xlink:to="lab_I0J815J5J07M_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExpiration"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageCancellation" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageCancellation"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageCancellation" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instrument Weighted Average, Cancellation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageCancellation" xml:lang="en-US">Cancellation, weighted average</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageCancellation" xml:lang="en-US">Share based compensation arrangement by share based payment award non option equity instrument weighted average, cancellation.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageCancellation" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageCancellation"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_G8H693H3H85K_us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xml:lang="en-US">Sale of Stock, Consideration Received Per Transaction</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xml:lang="en-US">Proceed from warrant issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:to="lab_I0J815J5J07M_us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Next Twelve Months</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xml:lang="en-US">Year ended December 31, 2015</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_G8H693H3H85K_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Two Years</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xml:lang="en-US">Year ended December 31, 2016</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="lab_I0J815J5J07M_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xml:lang="en-US">Operating Leases, Future Minimum Payments Due</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xml:lang="en-US">Total lease commitment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_G8H693H3H85K_us-gaap_ScheduleOfProductInformationTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ScheduleOfProductInformationTable" xml:lang="en-US">Schedule of Product Information [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ScheduleOfProductInformationTable" xlink:to="lab_I0J815J5J07M_us-gaap_ScheduleOfProductInformationTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ConcentrationRiskByBenchmarkAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ConcentrationRiskByBenchmarkAxis" xml:lang="en-US">Concentration Risk Benchmark [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ConcentrationRiskByBenchmarkAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_G8H693H3H85K_us-gaap_ConcentrationRiskBenchmarkDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ConcentrationRiskBenchmarkDomain" xml:lang="en-US">Concentration Risk Benchmark [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_I0J815J5J07M_us-gaap_ConcentrationRiskBenchmarkDomain"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CompanyAMember" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_CompanyAMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_CompanyAMember" xml:lang="en-US">Company A [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_CompanyAMember" xml:lang="en-US">Company A [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_CompanyAMember" xml:lang="en-US">Company A.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_CompanyAMember" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_CompanyAMember"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CompanyBMember" xlink:label="loc_G8H693H3H85K_oprx_CompanyBMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_CompanyBMember" xml:lang="en-US">Company B [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_CompanyBMember" xml:lang="en-US">Company B [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_CompanyBMember" xml:lang="en-US">Company B.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_CompanyBMember" xlink:to="lab_I0J815J5J07M_oprx_CompanyBMember"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CompanyCMember" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_CompanyCMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_CompanyCMember" xml:lang="en-US">Company C [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_CompanyCMember" xml:lang="en-US">Company C [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_CompanyCMember" xml:lang="en-US">Company C.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_CompanyCMember" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_CompanyCMember"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CompanyDMember" xlink:label="loc_G8H693H3H85K_oprx_CompanyDMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_CompanyDMember" xml:lang="en-US">Company D [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_CompanyDMember" xml:lang="en-US">Company D [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_CompanyDMember" xml:lang="en-US">Company D.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_CompanyDMember" xlink:to="lab_I0J815J5J07M_oprx_CompanyDMember"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CompanyEMember" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_CompanyEMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_CompanyEMember" xml:lang="en-US">Company E [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_CompanyEMember" xml:lang="en-US">Company E [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_CompanyEMember" xml:lang="en-US">Company E.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_CompanyEMember" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_CompanyEMember"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_AllOtherCustomersMember" xlink:label="loc_G8H693H3H85K_oprx_AllOtherCustomersMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_AllOtherCustomersMember" xml:lang="en-US">All Other Customers [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_AllOtherCustomersMember" xml:lang="en-US">All other customers [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_AllOtherCustomersMember" xml:lang="en-US">All other customers.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_AllOtherCustomersMember" xlink:to="lab_I0J815J5J07M_oprx_AllOtherCustomersMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ProductInformationLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ProductInformationLineItems" xml:lang="en-US">Product Information [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ProductInformationLineItems" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ProductInformationLineItems"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_G8H693H3H85K_us-gaap_ConcentrationRiskPercentage1"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_ConcentrationRiskPercentage1" xml:lang="en-US">Revenue percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_ConcentrationRiskPercentage1" xml:lang="en-US">Revenues Percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_I0J815J5J07M_us-gaap_ConcentrationRiskPercentage1"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ConcentrationRiskPercentageTotal" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_ConcentrationRiskPercentageTotal"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_ConcentrationRiskPercentageTotal" xml:lang="en-US">Concentration Risk Percentage Total</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_ConcentrationRiskPercentageTotal" xml:lang="en-US">Total revenue percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_ConcentrationRiskPercentageTotal" xml:lang="en-US">Concentration risk percentage total.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_ConcentrationRiskPercentageTotal" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_ConcentrationRiskPercentageTotal"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_G8H693H3H85K_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xml:lang="en-US">Federal Income Tax Expense (Benefit), Continuing Operations [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xml:lang="en-US">Federal income tax benefit attributable to:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_I0J815J5J07M_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_CurrentFederalTaxExpenseBenefit"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_CurrentFederalTaxExpenseBenefit" xml:lang="en-US">Current Federal Tax Expense (Benefit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_CurrentFederalTaxExpenseBenefit" xml:lang="en-US">Current operations</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_CurrentFederalTaxExpenseBenefit"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_FederalIncomeTaxExpensesBenefitPermanentAndTimingDifferences" xlink:label="loc_G8H693H3H85K_oprx_FederalIncomeTaxExpensesBenefitPermanentAndTimingDifferences"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_oprx_FederalIncomeTaxExpensesBenefitPermanentAndTimingDifferences" xml:lang="en-US">Federal Income Tax Expenses Benefit Permanent And Timing Differences</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_oprx_FederalIncomeTaxExpensesBenefitPermanentAndTimingDifferences" xml:lang="en-US">Permanent and Timing Differences (net)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_I0J815J5J07M_oprx_FederalIncomeTaxExpensesBenefitPermanentAndTimingDifferences" xml:lang="en-US">Federal income tax expenses benefit permanent and timing differences.</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_I0J815J5J07M_oprx_FederalIncomeTaxExpensesBenefitPermanentAndTimingDifferences" xml:lang="en-US">Permanent and Timing Differences (net)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_oprx_FederalIncomeTaxExpensesBenefitPermanentAndTimingDifferences" xlink:to="lab_I0J815J5J07M_oprx_FederalIncomeTaxExpensesBenefitPermanentAndTimingDifferences"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_FederalIncomeTaxExpensesBenefitValueAllowance" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_FederalIncomeTaxExpensesBenefitValueAllowance"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_FederalIncomeTaxExpensesBenefitValueAllowance" xml:lang="en-US">Federal Income Tax Expenses Benefit Value Allowance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_FederalIncomeTaxExpensesBenefitValueAllowance" xml:lang="en-US">Valuation allowance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_FederalIncomeTaxExpensesBenefitValueAllowance" xml:lang="en-US">Federal income tax expenses benefit value allowance.</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_FederalIncomeTaxExpensesBenefitValueAllowance" xml:lang="en-US">Valuation allowance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_FederalIncomeTaxExpensesBenefitValueAllowance" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_FederalIncomeTaxExpensesBenefitValueAllowance"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_G8H693H3H85K_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xml:lang="en-US">Federal Income Tax Expense (Benefit), Continuing Operations</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_I0J815J5J07M_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xml:lang="en-US">Net provision for federal income tax</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="lab_I0J815J5J07M_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xml:lang="en-US">Deferred tax asset attributable to:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_G8H693H3H85K_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xml:lang="en-US">Net operating loss carryover</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_I0J815J5J07M_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_DeferredTaxAssetsValuationAllowance"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_DeferredTaxAssetsValuationAllowance" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_DeferredTaxAssetsValuationAllowance" xml:lang="en-US">Valuation allowance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_DeferredTaxAssetsValuationAllowance" xml:lang="en-US">Valuation allowance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_DeferredTaxAssetsValuationAllowance"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_G8H693H3H85K_us-gaap_DeferredTaxAssetsNet"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_DeferredTaxAssetsNet" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_I0J815J5J07M_us-gaap_DeferredTaxAssetsNet" xml:lang="en-US">Net deferred tax asset</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_I0J815J5J07M_us-gaap_DeferredTaxAssetsNet"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_OperatingLossCarryforwards"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_OperatingLossCarryforwards" xml:lang="en-US">Operating Loss Carryforwards</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_OperatingLossCarryforwards" xml:lang="en-US">Operating loss carryforwards</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_OperatingLossCarryforwards" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_OperatingLossCarryforwards"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:label="loc_G8H693H3H85K_us-gaap_OperatingLossCarryforwardsLimitationsOnUse"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xml:lang="en-US">Operating Loss Carryforwards, Limitations on Use</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_I0J815J5J07M_us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xml:lang="en-US">Operating loss expire description</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:to="lab_I0J815J5J07M_us-gaap_OperatingLossCarryforwardsLimitationsOnUse"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xml:lang="en-US">Effective rate of tax expected</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_G8H693H3H85K_us-gaap_SubsequentEventTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_SubsequentEventTable" xml:lang="en-US">Subsequent Event [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_SubsequentEventTable" xlink:to="lab_I0J815J5J07M_us-gaap_SubsequentEventTable"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_PlanNameAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_PlanNameAxis" xml:lang="en-US">Plan Name [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_PlanNameAxis" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_PlanNameAxis"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_G8H693H3H85K_us-gaap_PlanNameDomain"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_PlanNameDomain" xml:lang="en-US">Plan Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_PlanNameDomain" xlink:to="lab_I0J815J5J07M_us-gaap_PlanNameDomain"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_IncrementOneMember" xlink:label="loc_K77FGGG1H9F295KI3IGI_oprx_IncrementOneMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_IncrementOneMember" xml:lang="en-US">Increment One [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_M99HIII3J1H417MK5KIK_oprx_IncrementOneMember" xml:lang="en-US">Increment.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_oprx_IncrementOneMember" xlink:to="lab_M99HIII3J1H417MK5KIK_oprx_IncrementOneMember"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_G8H693H3H85K_us-gaap_SubsequentEventLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_I0J815J5J07M_us-gaap_SubsequentEventLineItems" xml:lang="en-US">Subsequent Event [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_G8H693H3H85K_us-gaap_SubsequentEventLineItems" xlink:to="lab_I0J815J5J07M_us-gaap_SubsequentEventLineItems"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_K77FGGG1H9F295KI3IGI_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xml:lang="en-US">Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xml:lang="en-US">Common stock Issued shares as director fees</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_K77FGGG1H9F295KI3IGI_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_M99HIII3J1H417MK5KIK_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
</labelLink></linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>oprx-20150630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Modified with Ez-Editor Version 1.3.0.2 on Thursday, October 01, 2015 12:17:34 AM -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#DocumentAndEntityInformation" roleURI="http://OPRX/role/DocumentAndEntityInformation"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#CondensedConsolidatedBalanceSheetUnaudited" roleURI="http://OPRX/role/CondensedConsolidatedBalanceSheetUnaudited"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#CondensedConsolidatedBalanceSheetParentheticalUnaudited" roleURI="http://OPRX/role/CondensedConsolidatedBalanceSheetParentheticalUnaudited"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#CondensedConsolidatedStatementsOfOperationsUnaudited" roleURI="http://OPRX/role/CondensedConsolidatedStatementsOfOperationsUnaudited"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#CondensedConsolidatedStatementOfStockholdersEquity" roleURI="http://OPRX/role/CondensedConsolidatedStatementOfStockholdersEquity"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#CondensedConsolidatedStatementsOfCashFlowsUnaudited" roleURI="http://OPRX/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#NatureOfBusinessAndBasisOfPresentation" roleURI="http://OPRX/role/NatureOfBusinessAndBasisOfPresentation"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#StockholdersEquity" roleURI="http://OPRX/role/StockholdersEquity"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#ShareBasedPaymentsOptions" roleURI="http://OPRX/role/ShareBasedPaymentsOptions"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#CommitmentsAndContingencies" roleURI="http://OPRX/role/CommitmentsAndContingencies"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#Restatement" roleURI="http://OPRX/role/Restatement"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#SummaryOfSignificantAccountingPolicies" roleURI="http://OPRX/role/SummaryOfSignificantAccountingPolicies"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#PrepaidExpenses" roleURI="http://OPRX/role/PrepaidExpenses"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#PropertyAndEquipment" roleURI="http://OPRX/role/PropertyAndEquipment"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#WebBasedTechnology" roleURI="http://OPRX/role/WebBasedTechnology"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#PatentAndTrademarks" roleURI="http://OPRX/role/PatentAndTrademarks"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#DeferredRevenue" roleURI="http://OPRX/role/DeferredRevenue"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#RelatedPartyTransactions" roleURI="http://OPRX/role/RelatedPartyTransactions"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#CommonStock" roleURI="http://OPRX/role/CommonStock"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#PreferredStock" roleURI="http://OPRX/role/PreferredStock"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#StockOptionsAndWarrants" roleURI="http://OPRX/role/StockOptionsAndWarrants"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#Warrants" roleURI="http://OPRX/role/Warrants"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#OperatingLeases" roleURI="http://OPRX/role/OperatingLeases"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#MajorCustomers" roleURI="http://OPRX/role/MajorCustomers"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#IncomeTaxes" roleURI="http://OPRX/role/IncomeTaxes"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#SubsequentEvents" roleURI="http://OPRX/role/SubsequentEvents"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://OPRX/role/SummaryofSignificantAccountingPoliciesPolicies"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#RestatementTables" roleURI="http://OPRX/role/RestatementTables"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#SummaryofSignificantAccountingPoliciesTables" roleURI="http://OPRX/role/SummaryofSignificantAccountingPoliciesTables"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#PrepaidExpensesTables" roleURI="http://OPRX/role/PrepaidExpensesTables"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#PropertyandEquipmentTables" roleURI="http://OPRX/role/PropertyandEquipmentTables"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#WebBasedTechnologyTables" roleURI="http://OPRX/role/WebBasedTechnologyTables"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#PatentandTrademarksTables" roleURI="http://OPRX/role/PatentandTrademarksTables"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#StockOptionsAndWarrantsTables" roleURI="http://OPRX/role/StockOptionsAndWarrantsTables"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#WarrantsTables" roleURI="http://OPRX/role/WarrantsTables"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#OperatingLeasesTables" roleURI="http://OPRX/role/OperatingLeasesTables"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#MajorCustomersTables" roleURI="http://OPRX/role/MajorCustomersTables"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#IncomeTaxesTables" roleURI="http://OPRX/role/IncomeTaxesTables"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#NatureOfBusinessAndBasisOfPresentationDetails" roleURI="http://OPRX/role/NatureOfBusinessAndBasisOfPresentationDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#StockholdersEquityDetails" roleURI="http://OPRX/role/StockholdersEquityDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#ShareBasedPaymentsOptionsDetails" roleURI="http://OPRX/role/ShareBasedPaymentsOptionsDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#CommitmentsAndContingenciesDetails" roleURI="http://OPRX/role/CommitmentsAndContingenciesDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#RestatementDetails" roleURI="http://OPRX/role/RestatementDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#SummaryofSignificantAccountingPoliciesDetails" roleURI="http://OPRX/role/SummaryofSignificantAccountingPoliciesDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#SummaryOfSignificantAccountingPoliciesDetailsTextual" roleURI="http://OPRX/role/SummaryOfSignificantAccountingPoliciesDetailsTextual"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#PrepaidExpensesDetails" roleURI="http://OPRX/role/PrepaidExpensesDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#PropertyandEquipmentDetails" roleURI="http://OPRX/role/PropertyandEquipmentDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#PropertyAndEquipmentDetailsTextual" roleURI="http://OPRX/role/PropertyAndEquipmentDetailsTextual"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#WebBasedTechnologyDetails" roleURI="http://OPRX/role/WebBasedTechnologyDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#WebBasedTechnologyDetailsTextuals" roleURI="http://OPRX/role/WebBasedTechnologyDetailsTextuals"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#PatentandTrademarksDetails" roleURI="http://OPRX/role/PatentandTrademarksDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#PatentAndTrademarksDetailsTextuals" roleURI="http://OPRX/role/PatentAndTrademarksDetailsTextuals"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#DeferredRevenueDetails" roleURI="http://OPRX/role/DeferredRevenueDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#RelatedPartyTransactionsDetails" roleURI="http://OPRX/role/RelatedPartyTransactionsDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#CommonStockDetails" roleURI="http://OPRX/role/CommonStockDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#PreferredStockdetails" roleURI="http://OPRX/role/PreferredStockdetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#StockOptionsAndWarrantsDetails" roleURI="http://OPRX/role/StockOptionsAndWarrantsDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#StockOptionsAndWarrantsDetailTextuals" roleURI="http://OPRX/role/StockOptionsAndWarrantsDetailTextuals"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#WarrantsDetails" roleURI="http://OPRX/role/WarrantsDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#WarrantsDetails1" roleURI="http://OPRX/role/WarrantsDetails1"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#WarrantsDetailsTextuals" roleURI="http://OPRX/role/WarrantsDetailsTextuals"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#OperatingLeasesDetails" roleURI="http://OPRX/role/OperatingLeasesDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#MajorCustomersDetails" roleURI="http://OPRX/role/MajorCustomersDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#MajorCustomersDetailTextuals" roleURI="http://OPRX/role/MajorCustomersDetailTextuals"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#IncomeTaxesDetails" roleURI="http://OPRX/role/IncomeTaxesDetails"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#IncomeTaxesDetails1" roleURI="http://OPRX/role/IncomeTaxesDetails1"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#IncomeTaxesDetailTextuals" roleURI="http://OPRX/role/IncomeTaxesDetailTextuals"/>
<roleRef xlink:type="simple" xlink:href="oprx-20150630.xsd#SubsequentEventsDetails" roleURI="http://OPRX/role/SubsequentEventsDetails"/>
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/> <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/DocumentAndEntityInformation">
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_DocumentAndEntityInformationAbstract" xlink:label="loc_oprx_DocumentAndEntityInformationAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityRegistrantName_1" order="0" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityCentralIndexKey_2" order="10" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_AmendmentFlag_3" order="20" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_dei_AmendmentDescription_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_AmendmentDescription_4" order="30" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentType_5" order="40" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_EntityFilerCategory_6" order="50" use="optional"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_DocumentAndEntityInformationAbstract_0" xlink:to="loc_dei_DocumentPeriodEndDate_7" order="60" use="optional"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/CondensedConsolidatedBalanceSheetUnaudited">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_AssetsAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_AssetsCurrentAbstract_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_5" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2" xlink:to="loc_us-gaap_AssetsCurrent_6" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssetsAbstract" xlink:label="loc_us-gaap_OtherAssetsAbstract_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_OtherAssetsAbstract_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_8" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaap_SecurityDeposit_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_8" xlink:to="loc_us-gaap_SecurityDeposit_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaap_OtherAssets_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_8" xlink:to="loc_us-gaap_OtherAssets_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_Assets_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_14" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_15" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_16" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_15" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_17" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_15" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_18" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_RevenueSharePayableCurrent" xlink:label="loc_oprx_RevenueSharePayableCurrent_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_15" xlink:to="loc_oprx_RevenueSharePayableCurrent_19" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_15" xlink:to="loc_us-gaap_DeferredRevenueCurrent_20" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_21"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_15" xlink:to="loc_us-gaap_LiabilitiesCurrent_21" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_22"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_14" xlink:to="loc_us-gaap_StockholdersEquityAbstract_22" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_23"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_22" xlink:to="loc_us-gaap_CommonStockValue_23" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_24"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_22" xlink:to="loc_us-gaap_PreferredStockValue_24" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_25"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_22" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_25" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_26"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_22" xlink:to="loc_us-gaap_AdditionalPaidInCapital_26" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockPayable" xlink:label="loc_oprx_StockPayable_27"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_22" xlink:to="loc_oprx_StockPayable_27" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationEquity" xlink:label="loc_us-gaap_DeferredCompensationEquity_28"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_22" xlink:to="loc_us-gaap_DeferredCompensationEquity_28" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_29"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_22" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_29" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_30"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_22" xlink:to="loc_us-gaap_StockholdersEquity_30" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_31"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_14" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_31" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/CondensedConsolidatedBalanceSheetParentheticalUnaudited">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesIssued_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_PreferredStockSharesIssued_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/CondensedConsolidatedStatementsOfOperationsUnaudited">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_Revenues_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_RevenueShareExpense" xlink:label="loc_oprx_RevenueShareExpense_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_oprx_RevenueShareExpense_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_GrossProfit_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_OperatingExpensesAbstract_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_5" xlink:to="loc_us-gaap_DepreciationAndAmortization_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LitigationSettlementExpense" xlink:label="loc_us-gaap_LitigationSettlementExpense_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_5" xlink:to="loc_us-gaap_LitigationSettlementExpense_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherCostAndExpenseOperating" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_5" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_9" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_5" xlink:to="loc_us-gaap_OperatingExpenses_10" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4" xlink:to="loc_us-gaap_OperatingIncomeLoss_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="loc_us-gaap_InterestAndOtherIncome_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_12" xlink:to="loc_us-gaap_InterestAndOtherIncome_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_12" xlink:to="loc_us-gaap_InterestExpense_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_12" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_16" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_17" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_NetIncomeLoss_18" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_19" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_20" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_21"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_21" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_22"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_EarningsPerShareAbstract_22" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_23"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_22" xlink:to="loc_us-gaap_EarningsPerShareBasic_23" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_24"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_22" xlink:to="loc_us-gaap_EarningsPerShareDiluted_24" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/CondensedConsolidatedStatementOfStockholdersEquity">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2" xlink:to="loc_us-gaap_EquityComponentDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaap_PreferredStockMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_PreferredStockMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_CommonStockMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_WarrantMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockPayableMember" xlink:label="loc_oprx_StockPayableMember_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_oprx_StockPayableMember_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_RetainedEarningsMember_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_us-gaap_StockholdersEquity_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_us-gaap_SharesOutstanding_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockIssuedDuringPeriodValueConsultants" xlink:label="loc_oprx_StockIssuedDuringPeriodValueConsultants_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_oprx_StockIssuedDuringPeriodValueConsultants_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_16" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_17" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueOther_18" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesOther_19" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockIssuedDuringPeriodOfCommonStockValueForPriorIssue" xlink:label="loc_oprx_StockIssuedDuringPeriodOfCommonStockValueForPriorIssue_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_oprx_StockIssuedDuringPeriodOfCommonStockValueForPriorIssue_20" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockIssuedDuringPeriodOfCommonStockShareForPriorIssue" xlink:label="loc_oprx_StockIssuedDuringPeriodOfCommonStockShareForPriorIssue_21"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_oprx_StockIssuedDuringPeriodOfCommonStockShareForPriorIssue_21" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_22"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_22" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_23"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_23" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_24"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_24" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_25"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_25" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_26"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_26" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockIssuedDuringPeriodOfIssueStockRightsToOfficers" xlink:label="loc_oprx_StockIssuedDuringPeriodOfIssueStockRightsToOfficers_27"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_oprx_StockIssuedDuringPeriodOfIssueStockRightsToOfficers_27" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ReclassificationForExpiredWarrants" xlink:label="loc_oprx_ReclassificationForExpiredWarrants_28"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_oprx_ReclassificationForExpiredWarrants_28" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_AdjustmentsToAdditionalPaidInCapitalExpiredAndRedeemedWarrants" xlink:label="loc_oprx_AdjustmentsToAdditionalPaidInCapitalExpiredAndRedeemedWarrants_29"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_oprx_AdjustmentsToAdditionalPaidInCapitalExpiredAndRedeemedWarrants_29" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense_30"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense_30" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="loc_us-gaap_StockRedeemedOrCalledDuringPeriodValue_31"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_us-gaap_StockRedeemedOrCalledDuringPeriodValue_31" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="loc_us-gaap_StockRedeemedOrCalledDuringPeriodShares_32"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_us-gaap_StockRedeemedOrCalledDuringPeriodShares_32" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_33"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_us-gaap_NetIncomeLoss_33" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_34"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_us-gaap_StockholdersEquity_34" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_35"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_us-gaap_SharesOutstanding_35" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_NetIncomeLoss_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_us-gaap_DepreciationAndAmortization_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockOptionsIssuedForServices" xlink:label="loc_oprx_StockOptionsIssuedForServices_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_oprx_StockOptionsIssuedForServices_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3" xlink:to="loc_us-gaap_ShareBasedCompensation_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_8" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_RevenueSharePayable" xlink:label="loc_oprx_RevenueSharePayable_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_8" xlink:to="loc_oprx_RevenueSharePayable_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_13" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_8" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_14" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PurchasesOfPropertyAndEquipment" xlink:label="loc_oprx_PurchasesOfPropertyAndEquipment_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16" xlink:to="loc_oprx_PurchasesOfPropertyAndEquipment_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PatentRights" xlink:label="loc_oprx_PatentRights_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16" xlink:to="loc_oprx_PatentRights_18" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WebsiteDevelopmentCosts" xlink:label="loc_oprx_WebsiteDevelopmentCosts_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16" xlink:to="loc_oprx_WebsiteDevelopmentCosts_19" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_16" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_20" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_21"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_21" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_22"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_21" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_22" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockIssueDuringPeriodValueIssuedForCash" xlink:label="loc_oprx_StockIssueDuringPeriodValueIssuedForCash_23"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_21" xlink:to="loc_oprx_StockIssueDuringPeriodValueIssuedForCash_23" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants_24"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_21" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants_24" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsForRepurchaseOfEquity" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfEquity_25"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_21" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfEquity_25" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_21" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_27"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_27" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_28"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_28" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_29"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_29" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_30"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_30" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaap_InterestPaid_31"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_30" xlink:to="loc_us-gaap_InterestPaid_31" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid_32"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_30" xlink:to="loc_us-gaap_IncomeTaxesPaid_32" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_33"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_33" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssued1" xlink:label="loc_us-gaap_StockIssued1_34"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_33" xlink:to="loc_us-gaap_StockIssued1_34" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/NatureOfBusinessAndBasisOfPresentation">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/StockholdersEquity">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/ShareBasedPaymentsOptions">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/CommitmentsAndContingencies">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/Restatement">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsTextBlock" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_0" xlink:to="loc_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/SummaryOfSignificantAccountingPolicies">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/PrepaidExpenses">
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PrepaidExpensesAbstract" xlink:label="loc_oprx_PrepaidExpensesAbstract_0"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PrepaidExpensesTextBlock" xlink:label="loc_oprx_PrepaidExpensesTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_PrepaidExpensesAbstract_0" xlink:to="loc_oprx_PrepaidExpensesTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/PropertyAndEquipment">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/WebBasedTechnology">
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WebBasedTechnologyAbstract" xlink:label="loc_oprx_WebBasedTechnologyAbstract_0"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WebBasedTechnologyTextBlock" xlink:label="loc_oprx_WebBasedTechnologyTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_WebBasedTechnologyAbstract_0" xlink:to="loc_oprx_WebBasedTechnologyTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/PatentAndTrademarks">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/DeferredRevenue">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenueRecognitionAbstract" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredRevenueDisclosureTextBlock" xlink:label="loc_us-gaap_DeferredRevenueDisclosureTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_0" xlink:to="loc_us-gaap_DeferredRevenueDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/RelatedPartyTransactions">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/CommonStock">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/PreferredStock">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockTextBlock" xlink:label="loc_us-gaap_PreferredStockTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_PreferredStockTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/StockOptionsAndWarrants">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/Warrants">
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantsDisclouresAbstract" xlink:label="loc_oprx_WarrantsDisclouresAbstract_0"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantsTextBlock" xlink:label="loc_oprx_WarrantsTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_WarrantsDisclouresAbstract_0" xlink:to="loc_oprx_WarrantsTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/OperatingLeases">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:label="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/MajorCustomers">
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_MajorCustomerAbstract" xlink:label="loc_oprx_MajorCustomerAbstract_0"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_MajorCustomerTextBlock" xlink:label="loc_oprx_MajorCustomerTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_MajorCustomerAbstract_0" xlink:to="loc_oprx_MajorCustomerTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/IncomeTaxes">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/SubsequentEvents">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_0" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/SummaryofSignificantAccountingPoliciesPolicies">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_BasisOfAccountingPolicyTextBlock" xlink:label="loc_oprx_BasisOfAccountingPolicyTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_oprx_BasisOfAccountingPolicyTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_UseOfEstimates_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_12" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_13" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_14" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_15" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_16" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/RestatementTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestatementToPriorYearIncomeTextBlock" xlink:label="loc_us-gaap_RestatementToPriorYearIncomeTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_0" xlink:to="loc_us-gaap_RestatementToPriorYearIncomeTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/SummaryofSignificantAccountingPoliciesTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/PrepaidExpensesTables">
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PrepaidExpensesAbstract" xlink:label="loc_oprx_PrepaidExpensesAbstract_0"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PrepaidExpensesTableTextBlock" xlink:label="loc_oprx_PrepaidExpensesTableTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_PrepaidExpensesAbstract_0" xlink:to="loc_oprx_PrepaidExpensesTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/PropertyandEquipmentTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/WebBasedTechnologyTables">
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WebBasedTechnologyAbstract" xlink:label="loc_oprx_WebBasedTechnologyAbstract_0"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ScheduleOfCapitalizedCostsInDevelopingWebBasedTechnologyTableTextBlock" xlink:label="loc_oprx_ScheduleOfCapitalizedCostsInDevelopingWebBasedTechnologyTableTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_WebBasedTechnologyAbstract_0" xlink:to="loc_oprx_ScheduleOfCapitalizedCostsInDevelopingWebBasedTechnologyTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/PatentandTrademarksTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/StockOptionsAndWarrantsTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/WarrantsTables">
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantsDisclouresAbstract" xlink:label="loc_oprx_WarrantsDisclouresAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_WarrantsDisclouresAbstract_0" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ScheduleOfShare-BasedCompensationWarrantActivityTableTextBlock" xlink:label="loc_oprx_ScheduleOfShare-BasedCompensationWarrantActivityTableTextBlock_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_WarrantsDisclouresAbstract_0" xlink:to="loc_oprx_ScheduleOfShare-BasedCompensationWarrantActivityTableTextBlock_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/OperatingLeasesTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfRentExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRentExpenseTableTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_ScheduleOfRentExpenseTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/MajorCustomersTables">
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_MajorCustomerAbstract" xlink:label="loc_oprx_MajorCustomerAbstract_0"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ScheduleOfMajorCustomersIndividualRevenueTableTextBlock" xlink:label="loc_oprx_ScheduleOfMajorCustomersIndividualRevenueTableTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_MajorCustomerAbstract_0" xlink:to="loc_oprx_ScheduleOfMajorCustomersIndividualRevenueTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/IncomeTaxesTables">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/NatureOfBusinessAndBasisOfPresentationDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_NatureOfBusinessDetailsTextualAbstract" xlink:label="loc_oprx_NatureOfBusinessDetailsTextualAbstract_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_oprx_NatureOfBusinessDetailsTextualAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_NatureOfBusinessDetailsTextualAbstract_1" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_NatureOfBusinessDetailsTextualAbstract_1" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/StockholdersEquityDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_1" xlink:to="loc_us-gaap_TitleOfIndividualAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualAxis_2" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PlacementAgentsMember" xlink:label="loc_oprx_PlacementAgentsMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_oprx_PlacementAgentsMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ThreeOfficerMember" xlink:label="loc_oprx_ThreeOfficerMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_oprx_ThreeOfficerMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ConsultantMember" xlink:label="loc_oprx_ConsultantMember_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_oprx_ConsultantMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_VicisMember" xlink:label="loc_oprx_VicisMember_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_oprx_VicisMember_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OfficerMember" xlink:label="loc_us-gaap_OfficerMember_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_us-gaap_OfficerMember_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DirectorMember" xlink:label="loc_us-gaap_DirectorMember_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_us-gaap_DirectorMember_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_TwoOfficersMember" xlink:label="loc_oprx_TwoOfficersMember_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_oprx_TwoOfficersMember_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_AgreementAxis" xlink:label="loc_oprx_AgreementAxis_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_1" xlink:to="loc_oprx_AgreementAxis_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_AgreementDomain" xlink:label="loc_oprx_AgreementDomain_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_AgreementAxis_11" xlink:to="loc_oprx_AgreementDomain_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_SecuritiesPurchaseAgreementMember" xlink:label="loc_oprx_SecuritiesPurchaseAgreementMember_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_AgreementDomain_12" xlink:to="loc_oprx_SecuritiesPurchaseAgreementMember_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_14" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_15" xlink:to="loc_us-gaap_SubsequentEventMember_16" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_1" xlink:to="loc_us-gaap_FinancialInstrumentAxis_17" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_17" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CapitalMarketsAdvisoryAgreementMember" xlink:label="loc_oprx_CapitalMarketsAdvisoryAgreementMember_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_18" xlink:to="loc_oprx_CapitalMarketsAdvisoryAgreementMember_19" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_1" xlink:to="loc_us-gaap_ClassOfStockLineItems_20" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockholdersEquityTextualAbstract" xlink:label="loc_oprx_StockholdersEquityTextualAbstract_21"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_20" xlink:to="loc_oprx_StockholdersEquityTextualAbstract_21" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="loc_us-gaap_StockRedeemedOrCalledDuringPeriodShares_22"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_21" xlink:to="loc_us-gaap_StockRedeemedOrCalledDuringPeriodShares_22" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_23"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_21" xlink:to="loc_us-gaap_SharesIssued_23" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockIssuedDuringPeroidSharesCacelled" xlink:label="loc_oprx_StockIssuedDuringPeroidSharesCacelled_24"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_21" xlink:to="loc_oprx_StockIssuedDuringPeroidSharesCacelled_24" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_25"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_21" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_25" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_26"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_21" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_26" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantExercisePricePeriod" xlink:label="loc_oprx_WarrantExercisePricePeriod_27"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_21" xlink:to="loc_oprx_WarrantExercisePricePeriod_27" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_28"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_21" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_28" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_DebtRedemptionLongtermDebtAmount" xlink:label="loc_oprx_DebtRedemptionLongtermDebtAmount_29"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_21" xlink:to="loc_oprx_DebtRedemptionLongtermDebtAmount_29" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CommissionsPercentage" xlink:label="loc_oprx_CommissionsPercentage_30"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_21" xlink:to="loc_oprx_CommissionsPercentage_30" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_31"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_21" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_31" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PurchaseOfWarrants" xlink:label="loc_oprx_PurchaseOfWarrants_32"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_21" xlink:to="loc_oprx_PurchaseOfWarrants_32" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_33"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_21" xlink:to="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_33" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_34"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_21" xlink:to="loc_us-gaap_SharePrice_34" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_35"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_21" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_35" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="loc_us-gaap_StockRedeemedOrCalledDuringPeriodValue_36"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_21" xlink:to="loc_us-gaap_StockRedeemedOrCalledDuringPeriodValue_36" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther_37"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_21" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesOther_37" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther_38"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_21" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueOther_38" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_39"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_21" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_39" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_40"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_21" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_40" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_41"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_21" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_41" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_AdditionalWorkingCapital" xlink:label="loc_oprx_AdditionalWorkingCapital_42"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_21" xlink:to="loc_oprx_AdditionalWorkingCapital_42" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_FullyDilutedShares" xlink:label="loc_oprx_FullyDilutedShares_43"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_21" xlink:to="loc_oprx_FullyDilutedShares_43" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtIssuanceCosts" xlink:label="loc_us-gaap_DebtIssuanceCosts_44"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_21" xlink:to="loc_us-gaap_DebtIssuanceCosts_44" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantsExercised" xlink:label="loc_oprx_WarrantsExercised_45"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_StockholdersEquityTextualAbstract_21" xlink:to="loc_oprx_WarrantsExercised_45" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/ShareBasedPaymentsOptionsDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedPaymentsOptionsTextulaAbstract" xlink:label="loc_oprx_ShareBasedPaymentsOptionsTextulaAbstract_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_oprx_ShareBasedPaymentsOptionsTextulaAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_ShareBasedPaymentsOptionsTextulaAbstract_1" xlink:to="loc_us-gaap_ShareBasedCompensation_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/CommitmentsAndContingenciesDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_LossContingenciesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3" xlink:to="loc_us-gaap_SubsequentEventMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_1" xlink:to="loc_us-gaap_LossContingenciesLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_9" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ContigentLiabilitiesRelatedToAuditFeesInPercentage" xlink:label="loc_oprx_ContigentLiabilitiesRelatedToAuditFeesInPercentage_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5" xlink:to="loc_oprx_ContigentLiabilitiesRelatedToAuditFeesInPercentage_10" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/RestatementDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreationDateAxis" xlink:label="loc_us-gaap_CreationDateAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_CreationDateAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="loc_us-gaap_DefaultFinancialStatementsDateMember_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreationDateAxis_2" xlink:to="loc_us-gaap_DefaultFinancialStatementsDateMember_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioPreviouslyReportedMember" xlink:label="loc_us-gaap_ScenarioPreviouslyReportedMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefaultFinancialStatementsDateMember_3" xlink:to="loc_us-gaap_ScenarioPreviouslyReportedMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestatementAdjustmentMember" xlink:label="loc_us-gaap_RestatementAdjustmentMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefaultFinancialStatementsDateMember_3" xlink:to="loc_us-gaap_RestatementAdjustmentMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_ClassOfStockLineItems_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6" xlink:to="loc_us-gaap_StatementOfFinancialPositionAbstract_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_RevenueSharePayableCurrent" xlink:label="loc_oprx_RevenueSharePayableCurrent_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7" xlink:to="loc_oprx_RevenueSharePayableCurrent_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7" xlink:to="loc_us-gaap_DeferredRevenueCurrent_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7" xlink:to="loc_us-gaap_AdditionalPaidInCapital_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationEquity" xlink:label="loc_us-gaap_DeferredCompensationEquity_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7" xlink:to="loc_us-gaap_DeferredCompensationEquity_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_13" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6" xlink:to="loc_us-gaap_IncomeStatementAbstract_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_14" xlink:to="loc_us-gaap_Revenues_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaap_CostOfGoodsSold_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_14" xlink:to="loc_us-gaap_CostOfGoodsSold_16" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_14" xlink:to="loc_us-gaap_OperatingExpenses_17" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_14" xlink:to="loc_us-gaap_OperatingIncomeLoss_18" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_14" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_19" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_RevenueShareExpense" xlink:label="loc_oprx_RevenueShareExpense_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_14" xlink:to="loc_oprx_RevenueShareExpense_20" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_21"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_14" xlink:to="loc_us-gaap_NetIncomeLoss_21" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_22"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_6" xlink:to="loc_us-gaap_StatementOfCashFlowsAbstract_22" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_23"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_22" xlink:to="loc_us-gaap_NetIncomeLoss_23" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_StockOptionsIssuedForServices" xlink:label="loc_oprx_StockOptionsIssuedForServices_24"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_22" xlink:to="loc_oprx_StockOptionsIssuedForServices_24" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_25"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_22" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_25" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_IncreaseDecreaseInRevenueSharePayable" xlink:label="loc_oprx_IncreaseDecreaseInRevenueSharePayable_26"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_22" xlink:to="loc_oprx_IncreaseDecreaseInRevenueSharePayable_26" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_27"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_22" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_27" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_28"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_22" xlink:to="loc_us-gaap_ShareBasedCompensation_28" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_RevenueSharePayable" xlink:label="loc_oprx_RevenueSharePayable_29"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_22" xlink:to="loc_oprx_RevenueSharePayable_29" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/SummaryofSignificantAccountingPoliciesDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_5" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_6" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_7" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_8" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/SummaryOfSignificantAccountingPoliciesDetailsTextual">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_RangeAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_2" xlink:to="loc_us-gaap_RangeMember_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_3" xlink:to="loc_us-gaap_MaximumMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_3" xlink:to="loc_us-gaap_MinimumMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract" xlink:label="loc_oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6" xlink:to="loc_oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract_7" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract_7" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract_7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenueRecognitionNewAccountingPronouncementMaterialEffectDescription" xlink:label="loc_us-gaap_RevenueRecognitionNewAccountingPronouncementMaterialEffectDescription_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract_7" xlink:to="loc_us-gaap_RevenueRecognitionNewAccountingPronouncementMaterialEffectDescription_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/PrepaidExpensesDetails">
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PrepaidExpensesAbstract" xlink:label="loc_oprx_PrepaidExpensesAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidInsurance" xlink:label="loc_us-gaap_PrepaidInsurance_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_PrepaidExpensesAbstract_0" xlink:to="loc_us-gaap_PrepaidInsurance_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidRent" xlink:label="loc_us-gaap_PrepaidRent_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_PrepaidExpensesAbstract_0" xlink:to="loc_us-gaap_PrepaidRent_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PrepaidLegalFees" xlink:label="loc_oprx_PrepaidLegalFees_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_PrepaidExpensesAbstract_0" xlink:to="loc_oprx_PrepaidLegalFees_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_PrepaidExpensesAbstract_0" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/PropertyandEquipmentDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" xlink:to="loc_us-gaap_ComputerEquipmentMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/PropertyAndEquipmentDetailsTextual">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PropertyPlantAndEquipmentTextualAbstract" xlink:label="loc_oprx_PropertyPlantAndEquipmentTextualAbstract_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_oprx_PropertyPlantAndEquipmentTextualAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_PropertyPlantAndEquipmentTextualAbstract_1" xlink:to="loc_us-gaap_Depreciation_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/WebBasedTechnologyDetails">
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WebBasedTechnologyAbstract" xlink:label="loc_oprx_WebBasedTechnologyAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_WebBasedTechnologyAbstract_0" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WebBasedTechnologyMember" xlink:label="loc_oprx_WebBasedTechnologyMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3" xlink:to="loc_oprx_WebBasedTechnologyMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WebBasedTechnologyOneMember" xlink:label="loc_oprx_WebBasedTechnologyOneMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3" xlink:to="loc_oprx_WebBasedTechnologyOneMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WebBasedTechnologyTwoMember" xlink:label="loc_oprx_WebBasedTechnologyTwoMember_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3" xlink:to="loc_oprx_WebBasedTechnologyTwoMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CapitalizedComputerSoftwareImpairment" xlink:label="loc_oprx_CapitalizedComputerSoftwareImpairment_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7" xlink:to="loc_oprx_CapitalizedComputerSoftwareImpairment_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/WebBasedTechnologyDetailsTextuals">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNetAbstract" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNetAbstract_0"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CapitalizedComputerSoftwareAmortizationPeriodDescription" xlink:label="loc_oprx_CapitalizedComputerSoftwareAmortizationPeriodDescription_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareNetAbstract_0" xlink:to="loc_oprx_CapitalizedComputerSoftwareAmortizationPeriodDescription_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareNetAbstract_0" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/PatentandTrademarksDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedPatentsGross" xlink:label="loc_us-gaap_FiniteLivedPatentsGross_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0" xlink:to="loc_us-gaap_FiniteLivedPatentsGross_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_OtherFiniteLivedIntangibleAssetsGross_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0" xlink:to="loc_us-gaap_OtherFiniteLivedIntangibleAssetsGross_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/PatentAndTrademarksDetailsTextuals">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaap_PatentsMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3" xlink:to="loc_us-gaap_PatentsMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_OptionsGrantedToAcquireExclusivePatentRightsShares" xlink:label="loc_oprx_OptionsGrantedToAcquireExclusivePatentRightsShares_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5" xlink:to="loc_oprx_OptionsGrantedToAcquireExclusivePatentRightsShares_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_OptionsGrantedToAcquireExclusivePatentRightsValue" xlink:label="loc_oprx_OptionsGrantedToAcquireExclusivePatentRightsValue_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5" xlink:to="loc_oprx_OptionsGrantedToAcquireExclusivePatentRightsValue_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_9" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockTransactionDate" xlink:label="loc_us-gaap_SaleOfStockTransactionDate_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5" xlink:to="loc_us-gaap_SaleOfStockTransactionDate_10" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationMethod" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationMethod_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationMethod_11" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_12" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths_13" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/DeferredRevenueDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenueRecognitionAbstract" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_0" xlink:to="loc_us-gaap_DeferredRevenueCurrent_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/RelatedPartyTransactionsDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaap_PatentsMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3" xlink:to="loc_us-gaap_PatentsMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_OptionsGrantedToAcquireExclusivePatentRightsShares" xlink:label="loc_oprx_OptionsGrantedToAcquireExclusivePatentRightsShares_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5" xlink:to="loc_oprx_OptionsGrantedToAcquireExclusivePatentRightsShares_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockTransactionDate" xlink:label="loc_us-gaap_SaleOfStockTransactionDate_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5" xlink:to="loc_us-gaap_SaleOfStockTransactionDate_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_OptionsGrantedToAcquireExclusivePatentRightsValue" xlink:label="loc_oprx_OptionsGrantedToAcquireExclusivePatentRightsValue_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5" xlink:to="loc_oprx_OptionsGrantedToAcquireExclusivePatentRightsValue_9" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_10" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/CommonStockDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_TitleOfIndividualAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualAxis_2" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PlacementAgentsMember" xlink:label="loc_oprx_PlacementAgentsMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_oprx_PlacementAgentsMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ThreeOfficerMember" xlink:label="loc_oprx_ThreeOfficerMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_oprx_ThreeOfficerMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ConsultantMember" xlink:label="loc_oprx_ConsultantMember_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_oprx_ConsultantMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_VicisMember" xlink:label="loc_oprx_VicisMember_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_oprx_VicisMember_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OfficerMember" xlink:label="loc_us-gaap_OfficerMember_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_us-gaap_OfficerMember_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DirectorMember" xlink:label="loc_us-gaap_DirectorMember_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_3" xlink:to="loc_us-gaap_DirectorMember_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_FinancialInstrumentAxis_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_10" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ConsultingAgreementMember" xlink:label="loc_oprx_ConsultingAgreementMember_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_11" xlink:to="loc_oprx_ConsultingAgreementMember_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CapitalMarketsAdvisoryAgreementMember" xlink:label="loc_oprx_CapitalMarketsAdvisoryAgreementMember_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_11" xlink:to="loc_oprx_CapitalMarketsAdvisoryAgreementMember_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_SeparationAgreementMember" xlink:label="loc_oprx_SeparationAgreementMember_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_11" xlink:to="loc_oprx_SeparationAgreementMember_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PurchaseAgreementMember" xlink:label="loc_oprx_PurchaseAgreementMember_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_11" xlink:to="loc_oprx_PurchaseAgreementMember_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_SecuritiesPurchaseAgreementMember" xlink:label="loc_oprx_SecuritiesPurchaseAgreementMember_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_11" xlink:to="loc_oprx_SecuritiesPurchaseAgreementMember_16" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_VicisCapitalAgreementMember" xlink:label="loc_oprx_VicisCapitalAgreementMember_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_11" xlink:to="loc_oprx_VicisCapitalAgreementMember_17" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_ClassOfStockLineItems_18" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_19" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_20" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_21"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_us-gaap_CommonStockSharesIssued_21" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_22"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_22" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_23"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_us-gaap_SharesIssued_23" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_24"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_24" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_25"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_us-gaap_CommonStockValue_25" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredCompensationEquity" xlink:label="loc_us-gaap_DeferredCompensationEquity_26"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_us-gaap_DeferredCompensationEquity_26" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_27"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_27" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantExercisePricePeriod" xlink:label="loc_oprx_WarrantExercisePricePeriod_28"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_oprx_WarrantExercisePricePeriod_28" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_29"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_29" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_30"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_30" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CommissionsPercentage" xlink:label="loc_oprx_CommissionsPercentage_31"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_oprx_CommissionsPercentage_31" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_32"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_32" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_PurchaseOfWarrants" xlink:label="loc_oprx_PurchaseOfWarrants_33"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_oprx_PurchaseOfWarrants_33" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_34"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_34" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_35"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_35" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_36"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_36" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_37"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_37" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_38"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_38" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_AdditionalWorkingCapital" xlink:label="loc_oprx_AdditionalWorkingCapital_39"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_oprx_AdditionalWorkingCapital_39" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_FullyDilutedShares" xlink:label="loc_oprx_FullyDilutedShares_40"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_oprx_FullyDilutedShares_40" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtIssuanceCosts" xlink:label="loc_us-gaap_DebtIssuanceCosts_41"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_us-gaap_DebtIssuanceCosts_41" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_42"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_42" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantsExercised" xlink:label="loc_oprx_WarrantsExercised_43"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_oprx_WarrantsExercised_43" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_DebtRedemptionLongtermDebtAmount" xlink:label="loc_oprx_DebtRedemptionLongtermDebtAmount_44"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_18" xlink:to="loc_oprx_DebtRedemptionLongtermDebtAmount_44" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/PreferredStockdetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2" xlink:to="loc_us-gaap_ClassOfStockDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6" xlink:to="loc_us-gaap_EquityComponentDomain_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7" xlink:to="loc_us-gaap_CommonStockMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_ClassOfStockLineItems_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_14" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_15" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_16" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_17" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentWarrantsExercisePrice" xlink:label="loc_invest_InvestmentWarrantsExercisePrice_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9" xlink:to="loc_invest_InvestmentWarrantsExercisePrice_18" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TreasuryStockNumberOfSharesHeld" xlink:label="loc_us-gaap_TreasuryStockNumberOfSharesHeld_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9" xlink:to="loc_us-gaap_TreasuryStockNumberOfSharesHeld_19" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_20"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_20" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_21"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9" xlink:to="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_21" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TemporaryEquityAccretionOfDividends" xlink:label="loc_us-gaap_TemporaryEquityAccretionOfDividends_22"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9" xlink:to="loc_us-gaap_TemporaryEquityAccretionOfDividends_22" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PreferredStockRedemptionAmount" xlink:label="loc_us-gaap_PreferredStockRedemptionAmount_23"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9" xlink:to="loc_us-gaap_PreferredStockRedemptionAmount_23" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/StockOptionsAndWarrantsDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_5" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/StockOptionsAndWarrantsDetailTextuals">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockCompensationPlanMember" xlink:label="loc_us-gaap_StockCompensationPlanMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3" xlink:to="loc_us-gaap_StockCompensationPlanMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/disclosureGuidance"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_10" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/WarrantsDetails">
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantsDisclouresAbstract" xlink:label="loc_oprx_WarrantsDisclouresAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_WarrantsDisclouresAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2" xlink:to="loc_us-gaap_EquityComponentDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantOneMember" xlink:label="loc_oprx_WarrantOneMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_oprx_WarrantOneMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantTwoMember" xlink:label="loc_oprx_WarrantTwoMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_oprx_WarrantTwoMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantThreeMember" xlink:label="loc_oprx_WarrantThreeMember_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_oprx_WarrantThreeMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentWarrantsExercisePrice" xlink:label="loc_invest_InvestmentWarrantsExercisePrice_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_invest_InvestmentWarrantsExercisePrice_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate" xlink:label="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/WarrantsDetails1">
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantsDisclouresAbstract" xlink:label="loc_oprx_WarrantsDisclouresAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_WarrantsDisclouresAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2" xlink:to="loc_us-gaap_EquityComponentDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_WarrantMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract" xlink:label="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage" xlink:label="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract_13" xlink:to="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted" xlink:label="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted_15"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract_13" xlink:to="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted_15" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExercise" xlink:label="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExercise_16"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract_13" xlink:to="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExercise_16" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExpiration" xlink:label="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExpiration_17"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract_13" xlink:to="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExpiration_17" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageCancellation" xlink:label="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageCancellation_18"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract_13" xlink:to="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageCancellation_18" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage" xlink:label="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage_19"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract_13" xlink:to="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage_19" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/WarrantsDetailsTextuals">
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_WarrantsDisclouresAbstract" xlink:label="loc_oprx_WarrantsDisclouresAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_WarrantsDisclouresAbstract_0" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2" xlink:to="loc_us-gaap_EquityComponentDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3" xlink:to="loc_us-gaap_WarrantMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_ClassOfStockLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted" xlink:label="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_5" xlink:to="loc_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_5" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/OperatingLeasesDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/MajorCustomersDetails">
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_MajorCustomerAbstract" xlink:label="loc_oprx_MajorCustomerAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_MajorCustomerAbstract_0" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_1" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CompanyAMember" xlink:label="loc_oprx_CompanyAMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3" xlink:to="loc_oprx_CompanyAMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CompanyBMember" xlink:label="loc_oprx_CompanyBMember_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3" xlink:to="loc_oprx_CompanyBMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CompanyCMember" xlink:label="loc_oprx_CompanyCMember_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3" xlink:to="loc_oprx_CompanyCMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CompanyDMember" xlink:label="loc_oprx_CompanyDMember_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3" xlink:to="loc_oprx_CompanyDMember_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_CompanyEMember" xlink:label="loc_oprx_CompanyEMember_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3" xlink:to="loc_oprx_CompanyEMember_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_AllOtherCustomersMember" xlink:label="loc_oprx_AllOtherCustomersMember_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3" xlink:to="loc_oprx_AllOtherCustomersMember_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaap_ProductInformationLineItems_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_1" xlink:to="loc_us-gaap_ProductInformationLineItems_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_10" xlink:to="loc_us-gaap_Revenues_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_10" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/MajorCustomersDetailTextuals">
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_MajorCustomerAbstract" xlink:label="loc_oprx_MajorCustomerAbstract_0"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_ConcentrationRiskPercentageTotal" xlink:label="loc_oprx_ConcentrationRiskPercentageTotal_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_oprx_MajorCustomerAbstract_0" xlink:to="loc_oprx_ConcentrationRiskPercentageTotal_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/IncomeTaxesDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_1" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_FederalIncomeTaxExpensesBenefitPermanentAndTimingDifferences" xlink:label="loc_oprx_FederalIncomeTaxExpensesBenefitPermanentAndTimingDifferences_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_1" xlink:to="loc_oprx_FederalIncomeTaxExpensesBenefitPermanentAndTimingDifferences_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_FederalIncomeTaxExpensesBenefitValueAllowance" xlink:label="loc_oprx_FederalIncomeTaxExpensesBenefitValueAllowance_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_1" xlink:to="loc_oprx_FederalIncomeTaxExpensesBenefitValueAllowance_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_1" xlink:to="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_5" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/IncomeTaxesDetails1">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/IncomeTaxesDetailTextuals">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_OperatingLossCarryforwards_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLimitationsOnUse_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLimitationsOnUse_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://OPRX/role/SubsequentEventsDetails">
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_0"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_0" xlink:to="loc_us-gaap_SubsequentEventTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_4"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3" xlink:to="loc_us-gaap_SubsequentEventMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_5"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1" xlink:to="loc_us-gaap_TitleOfIndividualAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_6"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualAxis_5" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DirectorMember" xlink:label="loc_us-gaap_DirectorMember_7"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_6" xlink:to="loc_us-gaap_DirectorMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_8"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1" xlink:to="loc_us-gaap_PlanNameAxis_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_9"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_8" xlink:to="loc_us-gaap_PlanNameDomain_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="oprx-20150630.xsd#oprx_IncrementOneMember" xlink:label="loc_oprx_IncrementOneMember_10"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_9" xlink:to="loc_oprx_IncrementOneMember_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_11"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1" xlink:to="loc_us-gaap_SubsequentEventLineItems_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_12"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_11" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_13"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_11" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/disclosureGuidance"/>
<loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_14"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_11" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
</presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847889948896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Nature of Business and Basis of Presentation (Details)<br></strong></div></th>
<th class="th">
<div>Apr. 14, 2008 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_NatureOfBusinessDetailsTextualAbstract', window );"><strong>Nature of Business Details (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued by RFID, Ltd. pursuant to a share exchange agreement</a></td>
<td class="nump">1,256,958<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of stock of owned by RFID</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_NatureOfBusinessDetailsTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_NatureOfBusinessDetailsTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)(4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 323<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph (a)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6382943&amp;loc=d3e33918-111571<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847763122752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 26, 2010</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrent', window );">Accounts Payable, Related Parties, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 570,000<span></span>
</td>
<td class="nump">$ 570,000<span></span>
</td>
<td class="nump">$ 570,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_OptionsGrantedToAcquireExclusivePatentRightsShares', window );">Stock options</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockTransactionDate', window );">Expire date</a></td>
<td class="text">Apr. 30,  2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_OptionsGrantedToAcquireExclusivePatentRightsValue', window );">Shares values</a></td>
<td class="nump">$ 360,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_OptionsGrantedToAcquireExclusivePatentRightsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Options granted to acquire exclusive patent rights shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_OptionsGrantedToAcquireExclusivePatentRightsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_OptionsGrantedToAcquireExclusivePatentRightsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Options granted to acquire exclusive patent rights value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_OptionsGrantedToAcquireExclusivePatentRightsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(k)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockTransactionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the subsidiary or equity investee issued or sold stock, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockTransactionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847763660800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Details Textual) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_PropertyPlantAndEquipmentTextualAbstract', window );"><strong>Property and Equipment (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 5,933<span></span>
</td>
<td class="nump">$ 5,628<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_PropertyPlantAndEquipmentTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_PropertyPlantAndEquipmentTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001213900-15-007386-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-15-007386-xbrl.zip
M4$L#!!0````(`)J"/D=T4REW@^D``%([#@`1`!P`;W!R>"TR,#$U,#8S,"YX
M;6Q55`D``R-$#%8C1`Q6=7@+``$$)0X```0Y`0``[%UM<^,VDOZ^5?L?M/Z\
ML@GPW3<S6_);XMEQ[+*]N6S=7;EH$;:9D4F%+QXK5W6__0"*DD@1E$41)$$*
MJ:DDPQ>QG^X'C4:C`7SZQ_OK9/"&_,#QW,\'X%`Z&"!W[-F.^_SYX%_W%T/C
MX!]?_OJ73W\;#@<_(1?Y5HCL013@^X/S/X>_G=Q^6[P^T`_E0^E0&_P7D(XD
M<`0EH`X`/"9_U,'HZG\&P^'BITZL`/\,?B?^`7@(5O?B*V?>.'I%;CBXPJ(\
M.?C9'T[X0KYX;CNAYP]^3;X)XF]"\E/W+Y$?V-;L[X/K<>@](G\@@;\/EE+H
MQ[*"I4@^]/[H3YQC\N\!UH`;''M3__WSP4L83H^/CJYO;G^+Y9<T&6MD_L3$
M<;\OG_CQX\<A>?O0\Y_QDY)\1&X_8EB+Q\E=VUF^D'Y8.YK?7#Z:^^D?<OPL
M,$WS*+Z[?#1P:`_B'P5'OUU]NQN_H%=KZ+A!:+GCC"S.!MG7GW<"3X%`W_3&
M_(G%"Z[GNM$K_7D[](_"V10=X8>&^"GD.^/E>Q^_E'TA5EQ(U:HZUVJX>'3L
M16[HS[+/!FA\^.R]'24WB9'EH02&,EB^%OD^;@)%[R5WR8M*]D4;.?1W\`W*
MX^A]_$)_GMR)V9=]P7'?4!#27YG?HZ!Q+6<<T-^);Y%70/:5P!G37\`W:(^'
M4[_@>7R'\D(4#)\M:[I\Y\D*'F,;)C<HT/$=0H:`^DY\A_+2^V0#?W_[EFI4
M4>@7/FH>X;L'Q&609G@<Q`WL%CT-XF9Y;/ECWYN@S8WW:.I[4^2'#I8SY2;B
M'R#2?SX(G-?I9'GMQ4=/GP^(1QHNG-#A>V`?'"W<YZGGAN@]'-RA<4B\8,:I
MC9.;COWY('GP810\7#\]`.5A-/4?,"KC7I(>YG_NKZG7#U8_B/VP$\Y6?W=L
M<@5[97\0JR.+?F']T\M_'GR1L%]2%$.1P:>C]9?)#Q[1OX"5Y7AVZHNQ?PKQ
M!2+C4%*&0%F]O;J[N+)Z_RBCD\U*.HV"T'M]D$!'M82UX(=GN(-.Z4D"J_?3
M]Y="VVLOI!6[NLM*L6=HG%>L3+M^%^(ODQ#@=&(%P?737>B-OX_>G>#A#LN`
M@M$-;B0(.V,[OG.%7G&/WXPY$FVB9R+>XH*-/_D^G3AC)YS+,K`=?'\>5R6>
M[;@0U,&7Y2/%Z#X=43^4LD9*IETY`V!)SN`79,">,W./!;6DS0$I0QGJ]0O'
M=4+TS7E#]J6+/<*S\SA!HR!`87`RN[)^]_Q8[3&);K",;AAT@S8E@*V(E$%8
M!W723AE(Q'=`K7ZG+(C`'1&R/F1.A1(^),\=]OW.E37+<P=`RG71[[30[Q`*
MJ&4YH^*NIT[._.*]43BC4:X+SK3#F7AD688S^`50@Y^9QRK+,':-,M3K'U'F
MI->4H:)K($99BU79QRB"`)P1(.\S2HUO\IRI(S:)XU>0C6M5RG71S[3!&=S)
MR*4X$[\`U6YPAMH25V^=_Q%A79UZKU//):.(^$W\UU?/[2/'ROJE\A+0%+J2
M(J?9/>7W'9I2^$V[+GQB2S[1+,L9<PAK[4?9<4;X1.$3>>%W,K:4Z/2F7A=#
MB^;'EK']9:G.L:4@`&<$8.(STIQIJ$]DQQG1)XH^L05^K_>)L(#>4`P3&AXF
M9/I$6'^?>($>!0%X(L":S\`4*)=OS7&FKCD:6)"B7UWGJK9KK6'5-)%17DF]
MC0`XZ'\[:O/_M'P?"]8K>V<P"5LO;3VR;8=4(%N3&\NQ+]U3:^J$UJ17MM^(
M47!AR86S),(@E[&J+:*SNQ?+1_%BGQMK1M[L2*'=EM0H`UDP9<F46Q1:CHOL
M<\MW'?>Y7YR@@Q/67UJ_TP.MS;9O:9C=%<O'6L%>T7J<H%[8G2S1.LZCZKK)
M)?#P-7*):>6,R:G7+QS7<L>.-;G$,OCQJMUDZ.<&T23$+G#T[*-8B=VP>0&@
MQ-J%L&HWNCR4M$PNA:W1@40W.O5ZH=&3V-CROR/<2.PW)_#\6;\(L`W$9L@`
M:LBM)NNNEBG4+!FHUXO(@)^T_#@F[A4!"F$U871S"&LPNGQU/G?ND[S)98K)
MN4J-KJ6<L9+T4BEGN:Z4<UFM/ISZ*.85^?J\!8V1:^%/X[CRS?&B8#*[15//
M#Y'=C8:T#B@U+?$!L@;F)OI$E%L4+"+5D?U[%(3=<;;%'-D`:J_H82;TL"C1
M60>]<[E%6]QH57CGIKUS;X@BO'./Z;%>C-0Q_YP?8-11L5->2:)@IX54,D_V
M%]UMK=UM=^PN>L^N6#M7ERG</"]N/A\^E:O+K"U\NOCWANAZ.<7(:?!4/2BM
M:7>!LEH5RS_$\H\]('?/:"I(TAA)1%&S((>H@FZR"GI?R"/*IALOF]X7:HDZ
M:T$7D5/MTA0FMT0125A!C]7UT0_+M^]G4[0JZT_WY3<3R^T&-S)`4LZC&)$@
MQD:_X;G8[X;S\MA;)_A^,CM![OCEU?+GV<319'(=OB!_/E6`_([$)!_A2DJ#
M"]`)SE3B#&F(ECL;]8HJ65""(2P8<M)'AIP(AK!CR&D?&7(J&,*.(6=]9,B9
M8`@[AISWD2'G>\B0]?7M'2L^6:OI:F@3``:U)**DJXZ:/@[M+\HMA,U%]<2>
MV5H40P@NB-H&/K:$ZPY31*G"/EN_TP,"#K>$ZX[EQ99P/32Y*#-J<NDFQW87
M54,]MO:-[^%OA3-2&Q..7)OXPRD!=S);E@81[QB%R%_>ZX;QMX"62?S0,`HN
MK''A(L+1;QCY"-^_<-[)_W4DS"]%AV*8>\6("P=K`7USWI!]Z6(AGAT<"XV"
M`(7!R>S*^MWSXT3Z/#V('N/1\3T:O[C>Q'N>=8,7)3`F@6$14D&-K:EQ[79D
MH,""'4NP@B!;$^3^A[<_!%F"[3I!)+@HU5"R>X[3KHL=AQLRNA(7:\`:O0+5
MZ/3K3CA!UT^7KNV\.79D36*37S\].6/D=\/,5`BKT#&#I1G;UM&@5]L`">,V
M:-RU.BNE;)U5C@]LZZR@L=@5*DL'VG5^ZZP4LG$2--@W&CFSRVBNQ5Q9/L<J
M8D`]N1;JE=6J2%TWND*V3T01N>X>TV,9KN:)T`7_O-Z%R?6.]+=6DG"W#<X4
M<FUWX3U[;&WZX.YF8HWGNGE&G:D"+!CDQ6D:*B!AZ(?[%Q^A/@SE8ROGT0@3
M+PY[[$R-_R8#KV/9*_,69];'D>^$#@IN(G_\8@6H9QGV#^#M%0F6V+MM^OF6
M+&DL_;?V*O<NPK.VPK-\%D/F(XNQ"SE$A]"<B^@5<40GLD\,2?+GHRF-'LL3
MQ#E-C^:UJI35JE;GP;!;:U7D4YN>ONH-440"ML?TT#;-;G;/.Y>>%.1#J\([
M<U]<P"M1A'?N,3V6AV3FB=`%_[R>V-+J/4ET:R4)=]ML<0&_=A?>LRO67I3A
M11.JK9/C8SEUA/D.1B_;P=1SQFI9K0K/V72@VANB"%?;8WJ8F\<Q7?/.I<-_
M/K0JO#/W:01>B2*\<X_IL1PIY8G0!?^\/L`PZQU.;JTDX6Z;32/P:W?A/3MF
M;?!P/0ZIY2JYZSR[0B#56BH(.ZJE7$>,]93>JN+CCGA-L?6</)/3:K+?35>T
M6CJ\:>0\GX^U*HXA:6;CX?TAS$FO"4-%)PC#G#"]/1Z'-<'*2\#!`3T])'?/
M:"I(TAA)Q+%/@AR%Y!#G1`GR[$P><;!4XP=+[0NUQ$E4@BXEZ-+IG``?1U?M
M"U7$65>"(]+#Z(?EV\M#46+MI;MT<L9(-\B1`9)*]A0C$L381`S\XABCG6_T
M?NL$WT]F)\@=O[Q:_CRI.)I,KL,7Y,\G[I#?D=#D(UR)'RE`)SA3B3.D(5KN
M;-0KJF1!"8:P8,A)'QER(AC"CB&G?63(J6`(.X:<]9$A9X(A[!ARWD>&G`N&
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M<">SI?6)FJ(0^<M[W;#\%M`R^1X:1L&%-2Y<1#CH#2,?X?L7SCOYOXY$]Z7H
M4`QSKQB!>THG1-^<-V1?NEB(9P>'0*,@0&%P,KNR?O?\.'<_SPJBQWA0?(_&
M+ZXW\9YGW>!%"8R+\I\"I((:6U.C,P6E+-A1:Z5I3PG2F8I2%@2IM=246X*(
MA0A]MJY85R#,O6[NSCAU7I8)=-S<HNJ_1R:G=]>_8M@=20`4]-6Q;5,P>F#4
MI$A?73<JY;J(P1A;5R7%^W6>$B+,V^Y:7[7LZHP<(UBMSMB%$7?18X#^B$A/
M]X;_M9KAR5Y/*H[[P)\"Q*FI(!KT#402S&7(W`OTF&<N-/+7N5I8E%<L+*M8
M.(0&%XHMGM]/RB`M_SO"@;#]Y@2>/^O77/\V$)MIF9P0:!E#8IU0NY3\=<&?
MYOFS'G+*]0XHMB=#J?B"=^,S#QTXM_>J]Q`&;]G@^0Y"+MM!R#6';C5QY($4
M:/QBO<X?N73'?NQ+NS-5T-IX(ZVXI(/*JV^OR"K/#VH?36E,E1Z^1FZG!AE*
M6:UJM9QO7E:KO4@C<#B8YX0.VM5Y<0ZJ>XVL=(J$#ZV*1L9)QHQK.MS_\*Z?
MGIQQ9\XLV#1IEP.S5XQ(!N=4VW?`\:Z/:+-*8IS!**$DX4?KR%?48]W4!%@T
MH4^`Y:Z7&XOV.K?9WDB5TZQJWM?K97V]7F$<^[?A</`OUPD'=[AU8GT-!L/A
MXOI?_W+Y?^"_+WZ]^1F]HS-5TXU_WZ(_G"^7+]_1V_EWQW__H7\>*XHR5E5U
M?/^_+U^^:MKYQ<7%,?C)./\/8"A??P:??K[X&5SH/ZG&IY\^_:0K7Y,/S"6)
MR*=)\_K7W=G!E^3B*[*"R$=?L`D4"/1C?&\A^>+6XN_D??JO/4S)[E5DVX3E
M[\:."7U)/?P+IH%O8:^TXZ=S[Y.+9\CU7C'9*#^;F)1(%6SZW<Q/'&6EWXQ\
M_MLY56[[8<HO3J.4"K._1VY]]&N$2.>3N!%E./;)1L[Q>=PX;M&S@YLD]LXD
MDS1(V'F+GJJ,]ZZGH?/J_(ENWP>GGC_]=%3T/2+DZMXI(CO_8Q]AH_=_HADC
M8=+^M/!;"T%&6%<VT=?%Q'IF)`!V>&C^Z<RO+SYYYHUCATC<,:,OW@T3K.G?
MSNKZPID@_Q3[JF?L:EE]]M6:X%\=W**IYY,%U8/DG(:TXC,?7M?!3>PMS^=>
ME)%4JX`DJY/,MX@@RZ6A5O`R<FWR'U(=^F9-$"D,#4\MWY]A5+]:DX@NW'J5
M)2RHLEQ=/QB0MAK_"/'"`QN-':S%X/,!D=Q0H"9_.BHE6#U(Y`(D\G9(```&
M5%J%LN2&4L`993LHLJJ8FFEP894MMN?="$51-%/GPRI;M.2-4#1%-?0J5AF-
MQUZ$'[E%8X0??YR@7U!X&OD^Z3PW(KA#4TH3H5S?B,```*8!;)*G8;D?3GT4
M[YE`/.5\\#1&KH7=YXV/WAPO"B:SN<]'=C(2VH14-Z`IP8X@O47!8JG`R/X=
MCS]3P[W-OEO6M>8P,G/4*@"Z9'(I.&,:`E733$WI"-1=>3A45:BJ38),R@%R
M?5/N^D:Y34W5)#[E9NT.35V'74&Z*PV!IAN&U$);JQ@B02!)L@&:[*S8!$3`
M!(8"=G#DF,-3R['/W\E.2:C)K@?H>DK15#G8"%J5$X9DRG4*RHH#NI:)03X4
M=+Z+08,FAYH"=)C294:":J)5-+*JZJJBZ"Q%8V5655,D3=]&:X5;(.&FWTPT
M*:EZFH#%XC`5NZ+M`32`W)S8S%P^9H527NP-&YHT1!/#4$TU%1QLEHBQ[!6Y
M8LJ2H2K-RLZ*,"9&:8)=9$]F[)P_YSMEDXWT[KRG\(?EHX8XHTB*:6CI?,\F
MB1C+7K5OD10MFPRM7W96G%&@(NGJ+K+?H7'D.^'L#`^-`J<1DF!%IR+@-0&J
MRE:=!,QE8Q9A;"O;=?B"_+F':"2>@*9J&BGVI;Y?1:RJ\8*B2*JBL1*+63P@
MRY(&/M96<_:3317JFKH>N>XH3$6KZ1(T#$FK)@PK6VFF`4P-;A0F&<`G&Y/?
M^Y;=Z/#<,'29DD^@B,-2ZJIC=4F2=<I<0SU2,VNY.@2&7%7J6S2Q0G)HB1\Z
MJ,EAO:I+^)]"\:ERU8*C:A?=,@YFW7EU''Z$[&^.]>A,G(;)!."Z['19V`E<
MU>6HBFHV(3"S8:"A@BWEC<LU;]$;<B,4U_<E%&J4#X:NJMBE?R!+<^*RGI<$
MIJQI@&N`NTX#F;)AUHZ,5:6/H4/3,#F2EC'15$DS)9ZLP8YGN`%)AE$_M*2`
M)`<M=_T#EZ8K"FR`:5N+RYAIABHK0.(:WZY,4R"00.VF8Y:I4"4\`&^NS5<=
M!P%3,DUU*W&7:YV2`]N2IQNLX`,:`')JK$F7I#%968<E,M1Y!K=S98JB&YI4
M+S!F\^50J]T([06^"E1YQK9S)2B$$JR=8&RJ[A195R'@1E;6+DPS=*!PC&YG
MBFF&(>EU.V=&ZR<D`-)U[BW+RMR'F1+/X'9FF&I`O68GQFPX!0PS/7_9LJS5
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M(N2;;*PRRYALV+49)D?R,B<;;DX`0*X1[DHV0]&:X!J;'#,T%$-6I08LT5;-
M#C1DTS!@[6%"*_GH1KC&;!RFJZ:J2<WYM:K#+]V0-*C*6\D;5_;$^8&DI*>)
M"'A1BI;^[N["5%U!K,D228U7EXA=V94,@6(4B+0^UT"6?2(WB!OF_#1M/I/,
M``^O:7.S>?DKHV26%1A"'-"HE)G]EH5FW-<,H2Q+>A=@[KX-EZ*G]S^J$R"S
M23M=4C1*15;+,M?`/5/I`LR=N2=K*JT`K1Z`;!('0T6'FD:I&&A9:-;D4U1%
MD;H`<V?R`0/2RFMK;5U,9[%V[648Q6*&KI96WRT*+<=%]KGENX[['(S&X^@U
MBE=YXA\@AR<T$[RH0`&2ELKY?RQ8*S"8=RF*H6>W!>H,\)W;.8X6,HG>)A&S
MBG@P8R73E%7^8;!GK`8TF(X2.@-\9\8JA@SDUDS-*$Z"JJ$!);UP@E,8S!FK
M0LU49;6#P'<?1)K`!"TQEM4LS1"'@YIDF"VYFO8F;S!C90@AT#H(?&?&ZK*1
MV92RE3BHXEP/9JRLJHHL<P^#/6-UH*ER:TVUA9FAH29CW]22J5E-*6#&`JAD
M!HZMN)J*8U_2\$P9Z#M[S'CJXL6;V,@/2J0/*A[;!!1),8Q41)87HQ$A'^X6
M+6#^LR1GX+F(U$'&1UJN:IBW*@6!,O>0DCK/;6:W)4DUI/2^1WPB*I@YW0(A
M'L\I6KJDGD^`M(16O,/#B160/<EFY,U@"[P2[TC77=>6B2092NG%'7QBRU;Z
M]\%:Z5EO#O!4782@:0:4ZO;?6V1OV'9)F559?$+:ODO*+Q3A$]'N75*N\)Q/
M@,RZI.'Z##J?>'?JF'*)<CZQ<=<Q54;$6<=4<:2J:$"2#*5U(9EV3&OK<?F$
M5&*LM+Z<CD]`N_=+^0);/A%V9JQ4&>E.75(NY\4G-NZZI,J(2G9)BX+G.D`Q
M.^9&EZ`.M]9\:A..D6NW,\;+':[QD5#,`;`^D*,I`+4=XE$&0-8MW%C^M1^W
M.CO>-^$&^;&GKX5(#U/D/\0_GP8D8\]S*$G9(SFW$+$F4&7)Q3.HG0G7%*CX
M=C"*PA?/)T=[L:==$'\AC>+REPMRAN'\GR(HZX(QAE"*9%Q!V(U2#4&X#(*H
M01*E.\%B<1@*O1-MMMXX9UMQJE&@I#BU[J*SHUT+=G5A(7X3%JYUEYPM9$HE
M.7;HU"2P^'[6U-3K12O[\$\&T23$&MBXLJ^P&P2'II(^G/)C1.P4`"2Z`JC7
M"Q60)"TL_SO"HRO[S0D\?[:#,B!11L&.:O7KHOY8M"4X=46AS<*I/?[<'4YK
MD:<JY8*>#6*QE)Y%T-FX]$SC38;2?Q@F-=9/%6"%'^#,!Z?E,;;2%17@593Z
M\3:VJT"13=4&C,IXH$V*)Q23'B"P$UJ"#U\M2MDY]7J'+7,]#JFN/'?]8Y%E
M52G8;+@.+K'H?.+Y3AF8'`E==D/BHE9"^%,W+*9=*82F0M+0U81N8W2_A4<J
M&.!7%K^A1L!8_*9Y4R!^<M8`_9AT^>I\'EE-*#0I?<`:A"I(;PJQ^'1MXC`_
M0TV7)=@N@-TW<E@[**VT[&8BNT6)3$MS`9JFH2I:@^(PYH+\_^Q=;6_;N++^
M*\(>W#U?ZB[?16YQ+I"^'01HFZ+MWL7]5"@V'>NL(_E*<MKLK[^D9#MR_":+
M0TGI;A?8-HI>GF<X',X,R2%F@J%^"?2G"V__]PCV<V>^F0A5R'"'<*!/C5(\
M1-A%%]P).!1^"$G(.\6>)D;:1142?(KS/U[>O]3)>'9K0M5J*=A\?E7,=/;*
MT$AO==9D_9`]=IO+<%`\[#J;*+F_:%3=+A22L"'"?]D$/N*4DFZ[<$/XKYH8
M<\25[-(>-D;_NM'Z1\F4BU?B#?V;!NA#C*B+Z.G6,.I8CP,3J1B1'<(!=U%Q
M2)F+&70GX#`4*0S@75\L]I7V.+?0!69$;!4<]0X'6A489P2[#"GN!!Q4@3@Y
MU^*8%I]?F1X+0KN$`UYX/L3<R>%W)]"^:@['3H[1=LSM>CBIQ&:`<'%TSH4#
M?H@R002[^/ON!%J?9Z&4FU50Q[7X/%5@W`0<W&6H/1<.=-A*E0D[7%3!G4#[
MHTT8D@3,YW5<^BXX(ELKQ[W#\1-$$RH5%G10/,X)HDF(D(`+H@'A-PFB0V7^
M&Y82G1%#AR&A!"Z&!D3?)(86S&X9&B+Z)C&T(-(M@;KMZ;O6/`X19TX#X[:W
MZ7K(-E84X0.:61Z1L;I03I.]^6[W9NY??@<Z&\9YR/'Z)),]"+RC`_8F.%&8
MLD'Q:>M<$$EMT3(P)J`S9Y@HPFS=U-[@04<D1##$U:`(#45S0.?9L!28XC[A
M06M.*$)&(+M"?_-PRKK>'JPG2%J<"\QPG^C`)VRE]#+V=I\T%T0@#RT#DT,/
MC>/%/,BYKY0Z9PAM#E8;!I_VN32$%`&D`IIQ-TX.YAQ2KWO.P&-$I>20JM-?
M1KXLW4^]>?J.:5G%):5]HH,^#9U+J3S8G![R]TKY#%P<]880ZQ5`!K`]I_>Q
M5&%HTS`#(M16<R@GF$!2`4W_4V)KK'G(?<#DXZ0D%%1XH.DY+*@,Q0D#MT[=
M_3M+\_QCEDX/5+`'C9>)Q)+53]"N??T<4*`NM5!"".F,"=9;8X0)Z2XHX$XI
M\=92+I#6<^V*A.+Z:C>0UG/M@)R;]B,G05W,Y^G8[@,O.V=9LW#K&,.NTEB<
M4%J?^FV&RPL31Q7%."1;DC^?RFN]R,PKJ]V5R>3BUG@'\9_ECQTD%!4-56W:
MZ0@8%\RPM@IS2:1WS*!Z0@2C#'4L9V>KHB@-S\;\+B[BFZHRJBZ*>56TTJ-E
M.5)/QPV*:V'E1_44CH"I8ZY6?*1Y842\^O750MLYY@-[$6$=)BID*&N=ZQ@<
M0-BNW8N%QA*S%K#7%U<W=;&'$H6"U==L[6#P#Q`X3E62<,0&QJC]-(X*,2@7
MV&V75`A27PO1`T#HM<W$.%%4#8S2</0'U,)3)+D2_0*$UA\54J5@NT1_T\C8
MC&0(MGU@-U@QJ<IYD!X!@N^S"8VS.S1*K15($@';&4#37U()3F"-?<]SRDJ$
M*.Q7XI`'!B/.8,T/[$ZN\CSCL%>`T.,7HPH16//3YVXO0J2?\0MF_Q?F-K'1
M*T#H\6N0E,Y0H",YG#;NOJ.&4&XW#ON,`3O7$,H5@_;Z^YM++DV,3W_?-?5'
M41ARX=$C<$SM*HD$A_7!8%//=KY;G`WP,AFGM_I=FG<01X^("#G=U\8/*-J`
M!/6U1U@IN;?;=PL2V)J9_J_VYAO=6('ZJ2,E"*IO*.T))+3H0R1,UP2G!6I_
M1Q@1@W*?1PVI]XY&;H1YN#\2AM005Y#&#".R+]S:#_+28,AT.>]2SL%4=W4P
M<56O1+@?1$N8H`:9$.H))JCQHG6U!(4)VL\5Y9TTNNOVU?I8Y;'170_/JV>=
MF\/L;-40VD6W9_[\?%B.2M@,UH<T2;<M9V=RVS*-!W&T!^O/0'H`Z\],>@#K
MSUAZ5P-(D^E=#2`-9R.P#[[3VRR]M:#B9&D>6#E7:9*_U-,TT]5]7Z+O.G\?
M)VD6%_<UP[S]ENI`T_>ZF*7F-W>ZRJ9T%`D3M64&.V,W)*&"1^Z"RK^%VGNF
M82L3_!=M!>C,"`XI_5NHO6=RN%+B+]\,X)DG3M7?R@V>*2.$_^6%"IW9DXP,
MI?^;UZW\Y)<ZT9UL#MSQ6'<PM(7IZ@D>F0X_!X;KJ`T$PU^VQ6.CG=^YO#0:
M*(P/NF@VOP&ST6'$L*UD7PN-Z]_W"PS:5\(,\_HL2*]4'$JR(X)@6(#N:1@)
MXXEN)?ZZ`P:M*52JL'Z04*]4AJ`I?G--'0+[^GDMR\JKL?MZT\2Z,RM9%U&<
MZ,F;*$N,U]2D6'.O;(#7L&(N63\*`ZCV3%),8<T\R)Z+42@(4KP78-`&4G!*
M\5"HM#]_#\E0PO1<OWGC#H%YSKWVRL3AH$81<AB3XC<+VR$PWYG,7JFT][DX
MY\"##\B&B1%1C#,83>EYH\2(*D:QCY"TVR)\80AC%T&W38PPX0*%/F*?[A4%
M8X0HAAG@>]PH@3D/!4R+>)XGZ1"9AT`.DH[?J1.PL1%Z^N$@L-]U?#,SW?;B
M3F?1C?ZPM,UQ-2T+;.57R\)TC61B&NIEE,=CZ!1$7GYE9[\XE1+AVEA]%D98
M<@[APUYRA!*&0S0,<@XN[WYRB'(N.!X$.0>+NI\<H=*T'1\$.0<K=H"<(DS6
M#Y<=C%J"D+,G84A_Y%['\^6Z*F']^4[L)<%8"52/T,Y$"4T0P&8>F6>#0`A@
M^#PC!+=>#"%).1VHDK3JY)TJ"33"M?_[46?K8J;Q^"*9K"!ZF.SYNM#9U_);
M==T@QEE$S^M'^YU`!DOBW$CG*`D&1\)#+ODH='P">CO`;CG-HX"Y%\!NT5GO
M$AX,X&,=$$Z+SS!OQP#!:2D0(#@M]"(A3X":C8H7^=>K:<U0DP,&O';]>$+(
M_'B;)I^+=/S'3BYHUY6Y_/"VK*=OPNBZQWO47>F)V,=,3W66&7?C'&Z">V7E
MO!"C57-)'/IN+F=B@VPNYW1KB^8B1(J0UG,!0R36KKE04U+VI9=YOM23U\O,
M_-)8Z3B=_$\T7^HWMXMY>J_7ZTP_SJ,.CA((P_K9X6?"ZYO9B::\F$QB.R$3
MS3]&\>0R>14MXB*:-SM3?:A2<9S"(2&1]7CFB7'SUN(`<BG/43KVG"&=+^?&
M*G2QOU>&)%P?[M005"\DO+4H9H)A\O0E\'HU'KVJ'4CS<$S-Q^B^W)O3:&56
M[:#X_@3BOI5D\`3\Z;10FX,<G[``X%2ZI4":6/GJ\MLT^ZRSNWC<195_C#AK
MZGCLP.N7ET.XL&?L:C@0/RT9N`QE6-8+D_XX,H&S!%3P@72=5\N\2&^ME':7
MLA]:XOXV3J)D'$?SRR0OLF6Y9*Q<#J?'!D01Z_SC,AO/C%`N;C*MFYXI@-"C
MXZP&HSFNM7JQ$.&3I`5J*/&/*02',$Y(3'Y$D92`C#V,KN>Z6?!3/P\.6@Y5
MCFMPGL2!Y)QD36S@`4Y>I=%'&M;8#+257>Y3'#MC)3\P5M:N?UY>Y_K_EE8D
M=^9_7^X7JZ7CV]>;RD,U&B%_$'%\M<FJ#]%M=<ME,LY*W;I*=HW*`7$Q[E=<
MI4TJBY=V6DOD))KNH8-Z"KRI%SA,LNT]`H[8$^<.F`!$C3HOI"S.7?+P]4M<
MS/75]#*9Q'?Q9!G-*QG$F1X7:=;()Z;AZ>$-DN.YJR@`.%)PCJMIRR%8KP,C
M#V\6R]:(`-!^&)$/N6Q[KN]MWJOIU`R!NZU[:)S%B++3+CPL6]^]]9!+2IJ8
M:%BJOCLM)-5CZ>VK::TKE3W>^%L?S6^R\MY.G"@'?$.@!YN2^='%T=X5&W4H
MF[('#4I5#AF$<DQSX-74?_F@OY6_.15Y5IR1W"^+^O6-+%[-HSR_FI9?7Z6M
MLUCG%R?64NT[\.Z,?/6&D!\)8'1`&U!S";P\6P)X$!)8;6['CT?%W>NM)`!J
M<`5CG/4ML+?Z>L_:WHW`]JWM!>XTPQ!`@W)W/Y0`VH\?O?47VI^!`9T"E*'B
MB#:<[.F9R`\V4/0ZYREIO?[5TV7=WH^6#$FAU(\@A#.G-6DHO>A\%6\/ST,^
M$#/0IM-W_F2P2A%M^\A$[+G^-C9L]+OX3ALE+Z+D)C9M?9'GNLA?WK^/_I-F
MI7"JS1=&7/MRV8?D<$Y&T)\LWD?WN[+`9,]U3_I`J."J::[0GQP^I'=[Y"#V
M7/<D!QQ214Y[!+[ET%W\N+_.4?_6835+O1T_$K[GNC=-$*'HOT?`R0$Z+C@@
MMY"'O'^Q[4T_D'W7?:D/%Q2=7G#[=.30D?H(H1HL.^M%;'#9JZ=C?SM:>'QH
MV1TM__0DC/X7VCTQ_A??HFSRL'K,?KF^XL0N'&MN/GTYYF5D5_[N:E$>;O7F
MN\[&<>ZE)E"[U6)[T?5/#30'PUC#W2A/4QB_1UD6-2O5*Q3#3?-13U,8[?-4
M0E$A&VY0:"N;RH1T8A$:E'XX&^,`&,(/?(SQL/$*\Y-B>2B=G7])#RCCJL-6
MW^AT)#@;7?_4P(P?QA@1C']D8;@L=@&1SO&%(>6U\K>?;%U*\][5*L,.YM]X
MB,I%J&T1]LX.=FH"3!R?]-@&H[&Y7#K>;]/LS?=%;&+0E7)TL!%]O2+I-):N
M8<-Y;EC9I5?DJ3)UV$W>EG@3`[9Z]B*9?-(3FR\X1RA`I4'<<`Z)+J"V"X:1
MI.2O)B*76BO`$EO[`?OV\US8VVY*&K_'Q>QAD7G]IM4YQ/[-/Z4(J]H\FBOB
MP;'O:L?5$Q>D:ZTY&5(5_L#LNU(CGX*LG-&5N;K*7D7S^9[T3`=G2XF]M4I.
M(NN)"V@Z=235XWSJ$^7M$"]SI8QC^KCRTQ.5P]G+.?O2^YT5W-L[X8C<<_W0
MG.&ZL:/L#VWD,+F+\S2[/ZM@T;[M<=V+8G4ZY$[QA=WKYQ5?\"<X+HS@O,JM
MRM;V;3L/9)RM`:4[FT!.TQFH!-HM6AGMY-R[$\#.-NG=OK-[W75#K9UB.D_M
M?9'NWG:>4<SF/('\.XH3>Y;C5?(ZSA=I7@[G5]-JP2[NM";+<2B@H%V=5TH4
M/P?X0Y9X-?55)8L[K38Z4DRIK1+1A[!TB!C\1&#%63AXCI_:GA0<<L:Q9WJP
M!]@+$E+.!@896NL$9X+Z)@EKP=8%\#ML%]>SB*G`2)"FD#=CXB8#4\^,[(6[
M?03XZ;VMQ]=,(1:J>GB[%T='2($5GF(D"1TLM[;F55$58D^L0(=R1KG8JGO:
M)U)HW5(*J>%R:ZM;C^M50[*BQX:_/:O`CP.5B-0/3>\5*;1N">,?#I=;6]W"
MD@A?N@7J#>(0">S+PO;L!*Y]P(%R:QUR<$*DKR93QVFMAOJF+JWQ#H4(?0T=
MYV(%5B^,L51\N.2<],N7\8(M0*(4H[*3#NX8*6&,$'U\[N)1I&5E:'.#D4CY
M]V5R,1ZGRZ3(/^FQCN_LHL@.SC!33-6'AR:H>F$!G3]0'&$AGB3QMOV><\)Y
M#XQALUL4$5(_\WZP-*!'HY!*J7I76-<E[5)N^0L]M9YK7@Q+K`0H#:,3BRB>
M=+8`<<0%K>\<.X7(&3VH%;"+_F2'X$'[`!:4'-4=KY)W5'TFB:10X->=9+4'
MI(/C_RA#K-&HOX+DCA]4[PFB(6:=XH=5?:/[1[7'L_A=[;Z)RYN-P37\JST@
M=SI9ZC(L.`87=#YD)$)I[MYL0]F!X!T>^*P?4Y+P01%J'84;.QH*0"JP[@$V
M#HX*(47==\1G0G2*)!L4H];*HZA4D!T;=C[#_H$4=-]S&(H_G($\##ZM%4<0
M`3HB@+HW##,3EO2(#GJ"P@2[`@V*3_OABA.A(-L&>"8"2]#1M.>Y!Q.G$.[/
M<^MTNH%R@DGH;=QU7I:%#3Y_G=0QY*`8A^*$8A\-1[*EGKR+H^MX7M::\^\Z
MBJWUT4TP@7"`S3)CT@\+V&B;,GXJ6O7?%,ZY5B[0T5S?N2S6>SM7O<E_'&XG
MDN51;7H$J7O\T,$6Y>K),6Z]%HB%4G1+%C8I&H:(#!L_M'H^.F+Y23!NJY[$
MSI=V2Q8TFX`5H?+H$H7>\4-/]0K&CL\N#I!Q:_4,%3[JI(!SA5U?J03O5CE[
MSFE0*?C1&;0!$FZ_8@:3H[-MGKT8YZ0(DY0.FP#XR$YXMY:SQ\0*9@S);MG"
MIEXP$IAU2P`T-B78A*9'Y[./X/^@BU=1/ON8I7?Q1$]>WO^6V_.;KA8Z,_J1
MW%R,B_BNHYP-QI0(4HNRFX,#I`2<PF$J9+QG2K#]A0M:+\8P@$9R[4!,X/IR
MP/,8E3G1]>$9^=74/&9N+.XODHDM^K&P=K2[2JXG@#@!AG59N2(=8`95?:$V
M,_?=R?E\Y?Z>Q[\F\?Q?/Q794O_TRP.6\M2]JB!Q!]:<(R[792?JGVZ.!U3A
ME!E;F!,<X$5HB&_FUB#$X[JDDN/P&)K?]74>%\:IN-/SM-3=5VG>B1XQB3;3
MUP=0M$():\Y,"(Z%!Y2PE3H589MF]B=+5U4D(6_0X">&Z\ODSH0T';NP(Z*D
M8*==V#W@`"G!NK`$4TE/NT=^*<&ZL`RIK3V5`V@EUPE*%A(1NC(RMX^UGN1O
ML_36%E>)DK&^FM8*]75:%^PD&G?HL&,`>ES:M@,&L%M=0\51O:]WW@1PWN[#
MV1P[!3$W=8-L%^EF'0=38JL$6P-@/IB`B/=X>V\7M:Q^TN8WU9F;R?%3`8!K
MD#7KCTT1=\H=MJ56-<B-HGS2BU5(>C6MBI)V:]./(8&$[!KJ[ZA.4^`'1MY5
M0=!NW='3:;H]L`#)P&X[>SPX]4()-AX;!"6/AL?",G;/_F5[RETTMWVH&L`>
MSU-T4&>"TJT%8>>@`V4%VR\8Q:Q>4Z$W6K!]@]KC,(;76JXU6I14"*"Q+@VV
MS,1R]OR%3@>2^H?/`N2J]$?,S)G"<-1,>&&`VERC->FM_A)]UWD/RK'U[7-A
M>561<Z4"J26`4@'5E=H!EAW4?"<AVEI26/^Z`RJXACH$Z"J[B9+XSW+%C,&0
MI_-X4IW&E$Q,E)<;DQU5M=\W=?\W)S_DK^-\/$_S9::_&.POYV"9G/_^>5Z\
MF,1W/]\4+^P_%T%>W,_UOWZ:FC?^&F"T*'Y)TLP0#?Y9Q+?&^TOTM\`$K%'R
MSV=!>>59D)N19OHBN(VRFSCY-4"+[R\""V<4S>,;<\$N!8JG]R\,Y'F:_1K\
MHPJ,5C<5)IS-I^8;OP9)FNC5U3B9:(N@?-E<%\86CO)%9%U1>Y]%]"+XEF:3
MAZOEK=]F<:'+:[IV7SQ)O^6&SHO`\AKE1::+\>SAAM$W??U';+#83YO?IG_H
MD7FHF%5O_<F*Y\/5ES<!#GZ.;A<O_B$)-B_[</'EMT]O@JNWP<O?/E]^>//Y
MLY7A+XOA2O,YCY.!R+,2)!;HQ="%-A@5M#7+;^,_]:?OP:LT6Z19:3&>!7$>
M1`;S>)88=C?W@3$NR[*ZN:%[NXB2^Z`P@M$V:1\4,QW,=#0O9L$XRG1@6!K9
M9/?/@ZME%J37_]$VTM/VG44:7-MD87!=D@^B\5CGU>7J0OF"8I:ERYLR<YC8
M9\W]"X/+FJUGP6)VG\?&EADH43(Q/T:&[5@;=&/3GJ8)E]-H7!B[EN6;%ST0
M,9BRV#1H-)_?&X,[C1,]"2)+]K8\_,1^R[XVFMSIK(AS^_.&\>IMJ6%EH.7+
M6P/X6S45^,S\(YA%AN5M9#\^,5(PK`[(<%'%Q)G]LGEN'BV3\<P\8]\\*8^@
ML2+9,-T\^2SX;%1\KM^_?K[Y5V"H&#VHR\4\F^LH&\^,M(RTBY*1&0X,K;LH
MGI>[,_/R\:#(S*@0W*5+\_VLE.@OJ64W6D0VG[5<6+AI8IIG%LVG03JUK1UG
MF_9X'GPQK;_!L@9JV]I\6-\8?5K+PJK)!N3&YH4O\D#;T6J<Q==6VN;S;^9&
M`EF:Q./@O9Z4[?I)CTVW,``7B_GJK&"C"]=+NU9E.3?$YKG5(2/PO#`D3"<U
MO<XT</Y'D2[J3QD%>%#YG18YKD[1WL89SR*CIG/3":W@;F_-H#Z.-HID7GR;
MKKN)%5R63I9C*[C+8OW5?*O[K)6C5$J]:L\UOK+9UN]>M\^WN)BE1A1&_\H/
MK=&52IX7:;9N[K(I*W6US\<U!-L=LNP"4\-H4FT<O"]?NF[SOZWKWP.2+Y%9
M<[(VN-^,>4P?S+5%7UGK=1?.@L_WN7%HC73>O7MES$QI9$HGUYJJ]_%X%AL?
MV6J]<6"7478?4/PL(`B)LO_%)LZI!KW22!U^^FI<I-?F<X243X=5]YO9,T]M
M-S+M%=UJVT?VCZ?&Z"3!A;'%\P"S\@WR6?#I[>5K@[N8/#>]T=QM&BV:I,&X
M/@Q7P\QMB2\*,FT&I=P,,=H,O5EP?1]H&]';/K\:;<J#N0+]O8(61.L3O$H3
M4=++;3`Q2^>E@3$L#SD`BV5FYX]*6V=:>WS.TQL`UB[/5X.&&1)L!%-*SABK
MTDR7HVMU]ECUZB/OM.85/R-</%-<5D1+".-R)O?A\;I8,[VHXB#[(8S0?ZVQ
M'`7P\(;@HOQ$V7(/?9FB>A-NC63I=!J/5P/I:K!(S4\&A.FBAOQJ#%@=RE7=
M9E^RI4O72^-VK-RB!V%L?6=]RX-B/<##_/_;^]/FQI%C813^WA'S'_#.,[ZW
M)P+28"6(\1*A[E;[M$\O>EH:S_6G#H@L2O"`!(U%:OG7OYFU8"%!$B!!$B#+
M<8ZM)L%"5FZ5E>LRAY5^G/$\XUJ4,O'Z]1Q\2^8)K;W(7Y9Q,YQ5/I[V(<@8
MYT^Z<(CG#K"OBGN/"/`L?9>P&V,A;;DH4F*#[LM%`J#Z3)Z\L8<4C=,@81Q/
M%QBE4<125L6F<+(=/;%5?(;Q[BHN]_C"9:E#0Q6-%:^T,OL!$&SU8IG**/V&
M@4`MZF>0G>#E(GQ&9HA3,!W'/FJEUTD(QC0@2%5^S)?_D;[N1X3E+5.)/_Z\
M</C^PF_:N;>@;:_`P3T.C1U+NWD<SN-8K>5J4*X^OU/>7-U^N,5/;[Y>WUY_
MOKNZ^_#E\R[FB_0^=`9;G6''%6?\*J]#9A%.PE$:XT5YML;K\`'.T"V\#G`T
M!6A@>?1PPH,8+D=PM)($-70!JL)U#.`8DRF]7M.[%SO1XW2.59G4Z((C:-%C
MP:]1Z#I0[CW<SCSP$J1:C$?6*$BI75*X!?\/VV=V"895;M@JR@V\""Z_L.L9
MV!2[N#5\E@&TX-;(*74)/Z"GN#B,X+X99^X.;Z7#*'-V%%_4CI?#2Q,0FX3?
M=,=^#(A\X;87\()_GR:9IV.#CX-DV*9K<=+A;H5W@D[WRTC%0*?.`I^TZ2+9
MS1D":*2N$"`>PN0I<[Z:,-JX#<@](SM=Y<]#54FUOI5:7W:ME94U;#?A#]"[
M*65<V,',HUH[9-+&90+V/Z8W)D`N*)T8/5G4@8572O@SCD/0"2A&="UT>0F-
M!^AG"EVXQ)1QE#YD_C#FHB,7U$]*<I?:#NXQ_-N?XB])^2&X(8P?6>JEN`5C
MF)7J;@6TZ*RH;?-7KW5)TOW>A_!?N4;-E'A^":WT6,;T3CU%]R#!>RM"'[PT
M\&$JA8-/:A*I25IW`XH;)@CF1%PHE:PC!.-?JA\>(\)D*O:_`T?/0![F-%D)
M#G;8VUB!6R-1F.-&M^F3&+5F$9M[0F:H!/"^/T8S,,U=ZA[88DG)&8;OBU*A
M.R+RD`;L!!:^I5LR2B.6UXA/7`MG')8<@,*BSI0/S+0(Y_X,U1S\DNHINBV5
M.LV\K-T%DA^U#K5"0X5[M)2)YT<@K1@RRG$C/$O"44*!"EF).#42J-\2L_(G
MU)SRZ`/5R&$/"Q0+=,+?,X93M8"]J3<F:.>$,2E!CB0$2PQ?PCF:(0V]-E2[
MY,\R,ZE$\WLOP`QV)7XD).&PO@-<H`N*.W(13#1#*11@9,+9,6;>(P2:4H]J
M]0VK)H]>HN#74HU)-=8BKM[";<N#>X0_0V#9)1<E8!;"Q62<.<1BOBC(,[O_
ML7`$RC:<U"E@L%+]93H+G@7+!"T-9&QJ$SR0&4@]KH@VRYP&$-@`#FH,@?2-
M?&H!Y4(,4C+&P31CO':$4Q_P-Z92&=?1Q?$C#<3>@W8D'@4)?O/O=#:BFV8V
M'OV*WFN8JJQ<2.`G9AYCM*86<'+%<,)Z'^$UYSU>R'3MXG\S=34!W,(C+\2+
M^`E0H3A`]B=^(*S&FKI;,KU4$.W:.95'];:V#7`UV/,@/YG5X%.M,J8&_1,1
MHB=>2IU@"OD^AUL"R8_[21HPZ;E4A`Z#4SN`FY8_$2Z'A?-?1&1`M\`B#,2%
MN-,F'<(N+\*]4@SO5"PW+P0<CAH5N05^I%B9)5>9BKV!-Z!GJ"_9E;V6(L0$
M_EH@8Q&H"^U2GR>%2(A1BH3<_O;IT]77?V'0X_;#WS]_>/_A[=7G.^7J[=LO
MOWV^^_#Y[\K-EX\?WGZX9LF8^*:,TSJ<T]&EV$@#`BT<'WW!=J>$(<4_WGAP
M]T)]7U1P%(VI1&C#,[KRN.)':1X.67(F[&*8\^/TMQF]PM+3B&6C3`'K(X\Y
M(6F^(*4N>]MOM\HX#`(OZGZ67I?4D\S3VUK+Y":/0A6.5#!;*1BA1-*877Q1
M*41XR[T76KR@):CH5RJ-"NVR28^\%J:0H?WY[U=7-]D_84_Y2WYF_KEBZ-<;
MATQ]%>_6BS?O0ZBA$4V#[+\6DD92-W$M5-U-+F<@/Z5KY(+6D_38(SU6VF,1
MF00TV+D82"AX6%9D'KVNR@3]F8>!8YZWJ2SE;:Y>K2H5%'3H58`17$S:!M`Q
MY!Q=9'DX2"IOM.A:(0&\85;,4!\5&>_RT/PFE:T4[D,H6]H[#.6/_E'H0B%5
M[>&H\1X]N2DHL)ADUUVT":G&0M.S2@^7DP1I")B5LX'N`YWX"(HT\(&>8YH&
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MK]`4H!))OV=H(!%]!BP,D9J+/O@9/`HV2%"Z96%2[S.+7F.-!!5+'^[WM!>J
MQZZ14^)AW)?6T.)=DMT(LT`WN@.`LC2--DZPO`)^[#V0,(W%JBRB[B4,:&J]
M"-"82ZV@?_(<FI$7C-*`YZOQBA=8()W.V?V0KE@%-T->&M-P/")55%HNOUZE
M:0(+"\=S,L)@M@C`8_$L0OH!'AN/>7)ALJ0V@\+<8[X+GK63&8#L:DPS`6<7
M<Q+1C"@,BT1^_$>A[@4S?."BK8Q`"_H)_5;&,J1BVB/*"KR-;$\U$[W<9"S.
M6#Y/V`/5!%>.2&2L17`0CXL2@6/K[@,?;[#%CQ]]$(-H]$A[&=#/>-W;;)Y2
M+Q,O%`:+P,/4'J8@\E_1U!J`\[_<%."_X[5#>$?""K8@SG4&%>'O.#DE+^3G
MOZ*%=*`DF(HK[Y<&%L-[(#^U?83&8PKG4KGV8)G"TT4MZ:/1Q(82TGR]699R
M5((PV^N8H#E"CX+[%_I<$#X#_MB##%BF[N#A.$^U$0IJ%1@SZKA#]04<\2+R
M&/G;87N_=ET\I$[ILT[Y2+FW7''-!8\6FU(!I79+.F-9\/#O_Z0AO1^@+<0R
M`'W<%ZW[*=KT6`\EL@MH4A\33!GSESR]?YXV:O!T44^7CA'Z<(B)W:C39PL<
M7TSTY@($N$WAH(!;PCKA@'_$_M0/O*@D)[ZP[;G!+%)CF=2P`I=I.";!!8,]
M/Y%I);/_GY2_B9U6Z,`L[JQH-Z\[,!$\K,Q%NSZ,HO">=QR"\Z[P$_XLW#(\
M^DX,,R7P&E;4G27ETLN[<,6B31\7C7JPOZ42D$I@[TK`7*4$\@24=%9@;I2T
MY&7.J^M%H#8O>BOW`P0\346:2MNWWL5+-P.;EII,L!2V8(^FM$]"44$4U`(S
M2?D=EY<KBS?3GP!'X(4!?72D4'27?<E2^IG2RM<MI=F4L,+[4PE]`[]^%H-;
M<`=T,P+F@!.)$49J!*D1]EVK*YS2F4<H6<'&N9>:GU[(R47W$3MK"Y6CC5SR
M<SHF5(GHG%"5]E@9YV,:8=DX.93COEHH=2&4I7RZ>Q+X\#57*ZQ`!_.&N5%"
MXF(<@#OS"S??W,G/7/REZ"DUH`IFT:7RVXQ&4*D=]NS'U"C"@EZ?7K)7:&51
MK)Q!*&#W8VI4`3;"F/60*QI)/A\ZH.9M"=$<RIU[J+Y81QI1M[LJEB'UF-1C
M!TQICK'1#E<U5,2OL`<1=5FC??XN3.\3,,D5\;B,U39&^=6R4J=Z,_,@@JJ)
M"&SYO_0K[HN=$7HN>((<[(XV%O00JKS0>5%8E&/1?X"I5A'(H<6%7.L&/&.0
M*7'JS61/5R1`LV;37C3V_XM+HX9&SRAH0/%"_KXG'RC,<O<"M'Q%;`H;7Y9V
M7W#=>LHLI4G5\!`V?`FC4GNP,N#%ZI-"<]-+Y7]\V@T'+\G\W:(&'0XZ6#PB
M_O0^C6+F-<43+?)IAQKLQ383':H">O2)8YUOCEF\(>V((_"&3;DVD*4BEB20
MRKII8)@.;8-8I,+G34*Q.ZH?T`;8A5)9GX?W:.<=ZA.8O/#>0(('IMX+-N4!
M-/[P:@4AV,%3)$6(Z,$K#,FO))?*&S+R\*:QRL`9@62&4YKP1*MSX'>T!C?`
MAOE@D,`=GK><I5S#DJE\!/4QHQ6[\$<D[VWQ1"),FTJ2`!TM:&[<)\(``9@6
M/J&]5W_2*`$(LB2G'&;EQPL%\87&MKPR7K0`,1G+>R6UMT1/\2[628/V(JJS
MM-21S4]R>:9O?:;?1*@P$M8=$+-)Z7U`'ME[3Z\2[;7%;0\=Q005^!B;<_.V
M;>$3=0CCK28_JD')HIX)_">1?(KQ0SK<`@YGKLO8U8J=$I&'M[X+.!XP%I@\
MPM$(/\O>([J(WX?A'UE6JTR`ZNH%H_=20O7*5VY(8L_.AYF?65_B\UO:L?^:
M'=M2'35&]->RH0XH1J/J&;N4,6\&:(D9&N_\P:*7.A&]PC#E*.\TF\^ES?K'
M/Z-?&!41Z*>WA1:1Y)^BJZQH;NOEK6>1U'!5`730L0)98U<Q'V!5@U^ET$8W
M'P;S6LR904L<H(]_5M%`I?"CE<JL8K16:7R,>FE8]WUJV>,6L\$"J`59$`Y[
MSJ11MF;GK;)S4H"G)ZR_DUQ(8<M).E<FA!2"LSRMBO4A$MV1D:]'`>UV'4XF
M=-Y)S!L9PM4)T)-E0!7:+--N.YBTR<3V18GII!C678P+)0U5\PD5/#>1&A(4
M,.J6IH.YQ.<,AO)=CT-0[!>==WJF;Z1#1.BMN:@X\%Z6Z0[<>=ZP>IR/+2NN
MEC6>+NX`O>,+:@&+#PM)KC^K_&);*B]DN.9>$.ZBJ%"CW-&+/$HMJ8)FRQ0J
M2W`M+LY#W<QO4TI@Y5F^8(B7M22L4/P.&("PD!\:;X2-:>');)P1D+P1O!"P
M.Q:M@8,7E5_MF3>!-L+.=A-G>T2`F5YEQ?,A,-E4*66D4O>3G[401DY$?S11
M%>)3O<E3U<2K6)==VGN=LAO^E"U"O0CW+X47YMWGT9T1SJBYFK]Q3ANZYUYV
ML6%`*B`+,2IRV:CH("6!!2*<WD(+I(*7S,<EJ!@7.FZ*9S@RI,*7"O]`T[Q0
MSD<C#YLH,N\I$\\X#,;ECM*8^U(R8Y#'\\F%I3&,"\J/1=5%MFAN_O#>N6QR
M(]Y`N27$8W=<QE!1B=Z\,6M2SOR8Z'"NUI"E1-M1UB62?RY^$\\#/RF(=.;N
MI/4-TNJ20KA/E+TI\NA3&*3L-"^=V9F<\0.L8(54R)FP/^C44]'?W\O9G=YI
M:3/'*=YK><@Z^S5O,LDZR6-G^=SV$@95;E[P26]4!\!['^!Q%HLG$;8B\![R
M_/)":0\[&ZF-.,N&@Q9K6^C?-"A2J$Y9,"L7(A6X5^]E>9<W[[[^\O'=)S8"
MA;6:8#5(U.$=D`>LCB;HN1>9Z0@3*]X#>Q</>V:\/H#)E+!+F<YFU7&;4;PS
M+EQ<`8<_:9>F0RTF\5S!BI1*I4-*I=?Z(_-E?9CAO`KESOM.9+"[A,<?7M4L
M-*((3!"!S'('!9DF6890GK%83(IZX<YLS-MA<Y36/:7FF4A^]KI5N59>.>&Q
M9,V,?;QL$VH`B4K)<M/N\C4)7X,+B*S-RO?QGH6\4J>X;][I-\"AIA[M18P+
M1C0-E-W%GT$A7Q5RM/.XI)]-F<D[&.?5T1D^"HC`\TXMW$PSZY+@*O2F)Y+%
ML][(K.&$N-9*_2KU:\OZ];>8VC+7(M=`ZMB]1R=9I]:L-+FRK1@;98";1RW;
MK(DK=V@6DRI1CTR]/PHY)4PM+N:Y>Z!^1R(75*1#35G*Q1H-RWXQYADS:Z<L
MK%HZLS9IB$,DN8Y9D6C^([I5FH%TF?/LTEZ6F\2+`T>L)@*TJ'ZS8"^O^LGV
MF-1(1,ES=^"@&"4I/:)8Y[<1+1!@1UHQSS3/ZY%Q8*G;]ZC;WX8SO*[FJN8M
MRX#^BAG04M'O7=&+%$/JS(?_C]F\4]%D;K&-&.JI>V_V!RHGG*FUF%2J4D7+
M$(ZYA>3[B*#Q2<;\7(`W4`,7NS<N)ONC]U-8EBS;$H,P+TH04H\DO)II/_[*
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M:Z!&5#I!6%;"<[8LF3V@:YY/9<>;26%L.CXHAJ33:+S`(F['7YHSFV,'=X#?
MTP4$(BA6LG'#&.9#*U\>7K(1Z"GA6AQO-&&4EZ/?>"]574(E(=H8P%%J+$63
MR?$`838Y:]"!!?F<$EFDDZ9&+;<5I0E@<+V@_0A%02O-4>"Y.UD&43%LBMI8
M5/30(R7+=:)]#R_0,\73ZT4&O:@)X]X:EKZ:JTJ:]X4GJ*AG*X-):X6\9R\:
MEZOF1$B`>Y7H8P_8>^`29V_BF0TZGCK)69>"#'_\;,ZZ/I8B#*4O1?(=_3U=
M>_F]+$B:O9;W0A!UR\7*`6$;O`D\6.YV]!C2@JZ*-@W,7,C'KA1<5[0J6A0)
M3D+T/M%UF8?I.GO=4X@CH`LAE=(N\ZJN_$%1<+:NT8,@:.Q-,ZKR9IEY2*+0
M#(9C@Y%UZ0G1-T)@-B)\;E1<Y!I<"I/]*$X6?X([6PB&E$H-EZ2HL'/:U:98
M%\E)0;Z3:(05Z/<$+#8<'$F=?6$>E6*V";/$\`WT'CO!2A",#?$N=@N,]=OE
M+3P<T2#3B_+BDV",\:4GZGXDS`9<R&W,6(LSC\>^X7@IA>DS'/`]Y+"5+OAX
M8V?M2<<^#2J->:.`D.37_Q%U!V-:`4LC%`\*IDOS)KTK%/D/KZ0JK^&.I$(K
M$,=_I&NF>VF:&2)VV",%>`+WC^#EU\TTJ,#(/:U@O<"R5&\>`U;$7R6\;,*`
M,@(KF2_\UQ\U]N\Y'AOLWQDV(H$*8%+:0DMP`5R%DG":VQS)6#S)ERER3@DU
MC&;^?PFS+6!+H'H?:&O,"\Y2E.R5=$K&W7SAPM"3.D`P0C(\"CCN\1A:_$YP
MX:6]_#L*T:\*G?.R9F/()4#NV5]_-.@F,>.HT_B4!-Q(0//8^/PEB:2>V#^;
MU66)GF!`HOS8LECQBO\S&A&P=S>+*5=ECCU<Q&]`)LGN&[P6-K,P<9E57A.]
MF;UV%&Y;?GNKJ-D:'MU:!(AV/=L=(JTI($4CNE7<_$DRR"[P6)>#P=GQR(XJ
MLXCXFD=0._OXFCDV1,L\ZN$X]@ET.`3L!$)+;+WHDE_\->/]2U?[TX5^:5E_
M6O:W]P=SDEL.Q"V.2[G%Z#JW',K8W*-Y67#)2E'HG"B8ES9KV]1Q09"\<GQ>
ML2^U7O!*7\W-NS2:88P14!M-B)_0J5;2WCRP*-2]1AWO:BT)?6*$[I"5]\.K
M;>V\/)-"LG'GCFY==_ZD7"BZ.>SZC4=R2P>XQ;8IMSAZU[FEH#E_H?DDXE^=
M2ZTT[$L7]]GIE)S.88TNU@F4W8G4Q8N%U,6\^P%+7J3]LFB]`/GNQTF6U8CY
M\K2W`RVYX&T1TICDM,!,.-['G^=*+F2LLAF38;$DF195S$+EB;!7B;S/K'4.
MK=5(`S%G>T(BEBO)&M95[R$KDJ9`L'FOX43-UGL$742+%V:Q3X==)B$.!;S_
M-V&S+XL9F^7Q"%FB'LNH9`T&<\OA4OD"/YN"6HB^?E\S:HON&O-TL2U%A%@>
ME2;18ML_WBLC$;7%85R!1+8G-@0G2_$K[(3MO;@?5K:,"9,1&P-8*&`ICQNF
M697[Z4FA:)>&#=#2/T]3WA8/*EGU<#A<;X&ARI>7RR0^AG&LW(!>?!M.I[SG
M-O_S.BOS9=VW*>5D]40W"2HZ2*9)5CE_[\7^B/;U]K$3,/8_&S'*LI9LO//C
M0E^E9X(V+::QPUT72]/RZ3K%7\?%G/9BSPOT1;(L[P5PQGY`7[46H%)Z^AI0
M-L.@S(,TSM:G!U6Q;IWW*Z?G!LY5(UFWBSS7'MZ3C8XLOBE'5B)RY]D+>/U+
MUH>#@RTF<6:->]EVEY#V11Q_^<!*/`?#&?4Z8%[V/!(]FM@+N:&1L,8AQ;'`
MK#-5!<;9NT=>,$J#?-8#;]=+$0>[&XG9>;P(@`XY2OP+NB(<P;)H<"<-((_'
M-KOM81?*B#7OGR@?P]G#Q4<?RW&O:%><A5-+HG9_Y>S%&FK0NCZ.8E.P1Y+0
M9+E%/_*C43H5?8/Y$`;4Q8`-N"PDA4FIA89+6&Q^$5#B\I9'V+>#Z3_:;?A)
M7*1^Q\$6M#L(?W\8K7X]JQVG55[EHO#2=+5L_:PP;1F<^Y=2UZ;G1Y(\\O*T
MY<FOQ=9-SWX0%#91:"N;S@K3D;.;&BMXRJ<E8P]6WMTUI&6.DT)=5.$QU.0!
M*[?W9F6X\D:`[%K&(%L</)=UB<>A=[GD84N6\N%=[KNR]!91M;=<_LG>>\G%
MEQ?0`0[8U%3LZ+4P^!!_!'MCAD'ERY9>15%`9]RR.4E!T*\3K4M]K3I[)>R]
M#N9M6D:LW><''-0X%E-4D;W_GOICU&#RB#O8$;=4E(H*:\P==K0E(*>6SZA5
MZG88SN#O$6\LB)U1T'KWRE.@Z>Q-H4.KJIY%ISY:JRSZ<:N%SE2T#Q>?%I(I
M_G7J[9>Q_X1__^67-+YX\+SYK[<Y1#F[W82!/_))?`=H?1/`[>-O/[SZ2_8+
MO%4\A@'VG+FF]?M7LS']D/9<$0T8LM^RN3/?DZ]D\M<?W[*_OPT^77_3]&__
M\&;?#$VW[S3M&_N_NR_?3.W;/]*%SW_\6XG+%QER*9K!V846G)4*4I_@!N@A
M@Y8^9=?/_,-5C(N#22X>%QX.HSF<L,"F7IJ$90D"LR.J#+]42]`F(:B0FPT2
ML$)N-M7F5FB&QK+T^<O=M6*6AL;?_L_5UVOES=7M]3OEYNI?GZX_W]V6'OAR
M<_?AR^?;.D>&9('NLT`S(Z#S%.TY^2K/=C&$3(QOKM?B1:EJ\?)[88#63[JN
MJ9KITLO@3[JCJ0-=9VV#*QJYE(:.BV',<`80Q=3HD&1;#$FV5#P5YRPZA-.M
M"E.V17"*G\>T*QH=U5'L2N/3GJ,86BI!,@\\VJ3&%P$S0*>`;O4K?-HX)8SX
MX%5$#W,VLDLD'(YP/A/1:T9TSF#MV,,L^E=X9:'K.UU37>HXPE%5?(A%//ES
MV,3$'U4_N*(+#Y_KPQKPL-G5PF>XW#AF,?I::AR#TT'HQ##Z50%OBVUD6(N2
M&6^R1L.V\`?V[\<&=X]T?#D0[FJ&+@;E*[T!HJ7T'A8'97#QOUE/^PG<F.$1
MBH?R$&]%#-@NA``+=D]#*P8MH'`>??_U!MMC^V,^GG2#F?/^7T4SQRJ;.?HW
M`+7\>1TSIW9+#:D_U^C/>HIQ1WOGYNOUS=6'=\KU_W=S_?GV>GN[IK\T[S"%
MJQPMQS!Q^DO<TQ9HKNGSQJQT,%:<,-=DN0&:1V_IXNC)F4*<0<)^,7\]0S;I
M,%.LU@%-FF;9`V>U!-1WBS4C<R\[9K6>L+NT(`>4-QW*6Q&U_9XB-XF&*\?N
MD[2QT=4B5B0YCMJV:D_DV%\Y2]:ZPM6;)Y%_P#$,61"C"BUB^<%><OO7K[Z<
M-+_V?3]M?(UE;'P/KRE8^R)]J&KN:DYJ=5,-D&COE435J[=/HFHN;DJB@>H8
MQF'V=/":VV8D_BJ&2M32V7L]!-IA]YUYXT*[Z!3\YX!S6]4L]_`[V-^QVXI5
M]1&G+A_=<-N'378`GCPXV+5,`TW5M(U5U!N-S`-(L&2FSC/3NH/JT)QT,&-F
M&>#%K5J;NX;0+,SY@K-P>]G8_,9]L)BUDL%PJ&A`]FF.'QK8.N)@K+]V51*M
M"YI5<D\7N$?75<?1]\\]/[S:K4J?IP,N_#!+$EP;\"[F!-Y$F*"8O-P$F$<X
M&V-$G4ZU>^?'HR#$\9O[")0+\`.9`+LF`98&IJV%P/27F^NO=_]2KCZ_4Z[_
M[V\?;C`7;T4TJC,8[5(JO&S@L,M$L?!Y1N@((:8E\KPQ6AP4)SR-JKV`ZWX)
M)`(.?6?JMO,>*H.EAJU=6C)<NE6XM&$;HTT7MKK+5?'ZLF>Q_5OM7F*<$H>[
M!R:/<WWG>W9+"J1D(%?"^99U/HCR\V9CK,:X'%9%:YJ&L?@R->'<'*^J6I!?
M1RI7U%W5UE=[PK<#L_G^=UZF920V0:%AJ.9@M8]U&Q`/+C>;O5SKQ/Q]&LU8
M+UPTJ2;^=_Q[M7]KCVJS&J=[49I;0+>"B_8&GJZKVG#8`''].1\EH8]/Z#TW
M\;Y`4`7F*B&[3>]I@X/:OM#V.*U%KJ!+F9HZT)P#`-0CE)BJ935AZFYP[V["
M=C4:I5->5S7&:=,CGY9*21U[;!W[6G=4QUU]M]R-[C]+`A^?P$/5=%>'9-HE
M\/'4CU4,"FX\8T7<AIKVV?58569D]1VY5O#JF`R[,;ZWX:*X%S:M!Y1NJ,,U
MWIF:Y&_+HI>4;9&RMJK934S`%HC1G^;LG8J"=#&T]\,KAC;XWXZ&]]X5[-FL
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M`-\"P`'Y]*Z9+MCKT;(GV=B9D0::H=KZ+O'C[M612[P?Y4C?.LQ54YB-2ZV9
M0!_#A#Q<9/0P/'QHN"U+4RUGEV#&*5U()#?M!K=N#55M38KMH;GI\+'[=6'Z
M#7J7Y\BITHK:;(ZKNNNHNB'MJ$-CWM4LU=&;2'@W1+F1'=4,Y&(FH#<-`:+_
MKL\$/$O&>3W`-%&M2=96LQ>L3LP[3WRC93>P&N#[AU<[8GS?:>8[V0CYO$EI
M<9Z0Q?G:=E5MN$N:W594WCD+6#*19**6]>=.KJ+:N<;KM_1[92+$SBG(G926
MS;V'MHQ='">U=4,?3K#[!U;KZ<RM>XDD^W22?2Q@'W<XZ`C[R&3J-A.KQOY3
MY]#6F7S"JX)#`.>B9=V1\EEL\$L/Q?0"A["(27UTTK8GQLR%$R6=X_"U"4Z[
MH[G6E\J[-,(EV"2]XKCOP$MGHT><RI;$RL9P#ILDMR&A@V9_3U(<$<_&A[.9
M;_!NC28I8JKD+(3=33TV0[T\-_U2*>%!I)2+Y/'*-[)L2YIUKKN&Z@PT/H#0
MU%1CZ+:9>5[(X5YHF+<FA[S8,^_#+/%F#SYH$C;^O'^M\GHM9(B)1BGG@W('
MO:N[Z\]WM'_>W=>K=]>?KK[^;ZWY;IU1=STX);J'M,ZP[Y>9<C6/_"!'G3&@
M6DLKZW5O])^4:E[\D&I*O!A2Q1+Y]RD;QXEZSHMQ.#GMQ@<GAQ<$H'%'`9PX
M<'A0BY#.,:<M8+@2S4Z)N9?@SR9`"'@`?C[Q1X2-)8WS,9NH^V')1U!Z3(N;
M&NU?SIZA6>VC<#H%5<]&S,+;[DDV]]1C`]C'H"0!6WP$.ST)21"PQ='XH]_`
M+PVQ-EV*#T<5V?5PE`!*\"<4A73`+&(-WO%,X`MZ_-!7_F0.Z#KLO..`%I_A
MT]LIE,H8\$!_93OL[>R4`P3>$S(K-#F,\93V7FAR.9^.*H:ESKTH6:QMZIX8
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MIN89L\]P:*NNO4L);[\R-7L=_94IF3N&S._)@S<3UQ`1$1>!\#HIFO@M`:Q,
MZ7TFC<DD#93`GQ`,D>L.RTY4E7`V(HJ?T'3&>9K@T1LBNI_\$4U>^4<:O-",
MGTOEPXSG*29+</JS41K1I$\6VA>))K"6<&#R8#W;`DUU$5[-0O9*,4D`#8%G
M/P@P08?CH69V*DMU$0F?"UO'+T/0:?X,!ZIS:"J30&F&Y\!6!Y;#&PL[ZM"Q
M]I[?V2!WLYCJ^0X0'45D_)4\D5E*]IOI*;6<H%NC]$ZGE-[Y[OK]]=>OU^^4
MK]?_O/[\VS5E`YG9*;.S#I^=%8/2B``OF)Y)$[1FL),1IKG[R:,R@CV'4P+:
M3NB^L1]GJ9V@3D&UC<ET+E(F1V$ZIZF0\$T(CT?B1,FR(^'`"-(Q'@<O-!N4
M9E8^>7`8L2Q(_CE<!R,"&TM*>8T1TW!*.DO\@&M[]HD/^MB+<`=@SF'"9I(_
MC2L\S%CRYAQN^*,7FNB9QC$K&?@<)@3NY(K0H]D/6::_H:FZR3/]#6.@&HY1
M/]]L95?Y7-MO5M]%9?^5';`WF,AYASP'Q,+L4YG?W^T#8%@Z`+Y>?[RZ`_U_
M<_7U[E^8XO_Y]NKMW8<OGV62_P$(4FNZ>/>PW4OFYR5APFS>9#4?K[X`DY*C
M$$ZJ6%0#($UEV4'+90?5PK9\!VIPSA6/QUM$#2--C"-9DA<\W>7AV%G]0`]'
MMW0XOOWRZ=.7S\KMW9>W_]LK!2V/P[,\#@N%RF_#:!Y&S)N$MRN;:>R%$^&G
M2TW342DRA5L^(;PT>0PCY@@KW3(4<;F@>CLB3&4;ACH<.*JINU0QZY8ZU!W5
M<@?9JNRU?ARGW+<6IDF<>*S<!A3[KK.QNL<979)#Z:'8HO;T'^F,Y)ACW+C@
M?J8%#_3^CG8=K0U+@X2R]$-$"+4$J0OC<QC!?[\-O3A1KL9/?ARB]_O#;'1)
M[;4G+_+#-,[\%,PHRNQ/7(MZLZG\`!SKC#LFK]2B0Z.)_RU<*@LK!W&XM+R7
MVWM>L/`R]-.\*+'_78$7)H^TBH[2/=\JOBW??42`A6`9UJ:!&K3/(?==<]"R
MAQEL$S\"))5?NV`[%DB0'=G.G^,R'M#60DJ`'3HB&[`BS%?F:[ET+?L7^N8_
MLWQ*:@O#L^/6P4(]K%_:&GN=L'D%B$@/=$JI"^8N#Q&,+Y6K$JWT9>BXQF4]
M*2SX.;`;6:`1[AKX>.K/J)U\_U+<"2,*_7'UK@'^H<W$8FEOM3"R8M.=5_"=
MT552O6^KWE%B:JAU%A9$G/Q!T"G,%/C+HI*_\QX"U")O(NIUWJS@\]^/,'*(
M\@32P'T4O,6-4$"K#@/+VG#3%U!EL4D4]16Z=Z6$#P9K)+Q2C,LJAD93J;D8
M^4!^ZLEH#%&NRRCMJ$Y"3S_S.GA%UT5VW.U)(GK-_(B)^PK%<2\O7,U4R"V9
M)PNW%J..0HD)7+L8O^8B0IUD/#`U5N9AG%R0Z3P(7[B"R$Q+H4-R<PNQ!:+T
M]OK+PJ&[WHZTUWH)81]VZ7M_.B5C'\0[>&%W,OXUV`O_\&:I%[TL6LM6289S
M^Z5P#2QBB8?(_LL]K;!MGTN]-V/I(/CQXDW4S.#/;Y1KM9FMV9D+\2?=@;NJ
M-F1X@V^]:9A2LQ7S-]CM=RPB<MR``VC!^N+D6Q^"`S:X3Q-Z":<;9YW"\G02
M(`6WY>*5]VPID-(,VA?*/LQRI'WR(K`2:->\_,,E`QX_7-)FHQ1.=9_$HJ%*
MX117\3,4X`29G=ZR-JP>A\%8&:JF:>+_Y\IIS<^J;A5H=8'A8FAH2+%5:$+`
M0Q3&,0NRD#%SA.F9>TP*F\RPW"/2;@)8D]G##S2]A!]I8`P3&J"$$Y#X3S0#
M9CJ%@X]&%LE_4L`=BMH<V/8[3:F$4\2]=/Z$[%MF:)4R/KIP'D`$']`8S]>B
M4<G2(C^Y+)ZF<LN#`>%/[T%H"4N!X:%*'[-LO#B<T=`:G+6XV!PDC239&7:I
M+.V0>IBR;3U[$8;S:!@TTQ7,-334<)*DNT'>_]\%*:<FD(<W`!*-?%BLZ%8I
MRCZ+SV8W#5LT"T4[(8-JZ=ZCZJ`;#!V.XNI8(Z'!O=Q$H0FE:G[;`0I@KZB(
MA3,]_F]N^H&QDC!<C:G?Y9/WHAA#83A]*$==DR*<B+T%1"]$K!'K<\\'1O+B
M1^4^G*4Q]_H;%K/:Z)J@I!%UHQ1]ZB*ZC!M8\CB6+,$D_.'5NE]C#0TS\71[
MX8>YE]3#PP$$`/XY(S2LFANT'*^1!R3EMAPC-^"<TX?U1>67SHD'[,FNYSR:
ML10]+KGX!JSW`Y4_G"TE$H*9]1<WHS9LC%OF8KGJ)QGZ+UU;F?I!`/L5KK42
MBD1FP"KT,M@P)ZU@2C,STXM("5Z&,Q$-1ZJ,0%3N\:'_I"0N^/KRP$K^'C2&
M@95002]E"\N#45JA>\D&S;&7QOP:.`.9+IIKI0.37J"XZN=N>F&+%G-"Y^6[
MMDKS1*8T"TAE6N>?/JRAO.6>OD\>:FWE?4IOJ!X%X,F'IS?8KN(XXB\LGG*8
M#22@+X0^N=2S]H.1_^11(2QLXY$$5$P9@%0[4!4C4E=1J0PR^[5X[UV]9N9E
MH"E(\`A\=@6[F='*3506-Y&X]-XR7P!_ZLWZI]ZRLYG_BQZ#52?^"F=E>:O<
M-BIY,NZ]@.I3CL@2:Z!BITR#.`+^_8.UVV8$A5?/0[10I%!*/;:_V[1PA+%K
M-#=,RP=XIJ_&N?^-VS9<4O(:(S3>`LP%S'3<A'A)2A/LN`1S*1$_IG9C*140
MOQ4O$D^IB@5VK6D-5TEBP=U.5_PR2D)T2O%M%4RXTG8.M9N%S9BV:NE.G;U(
M5I;2OT?I?T_NHX+X5X?MV)7$-!W57N-[?_2""7[*+BU/S%I?],!7/S13KM*'
ME.904"A"FG)1<9-`KS2_&19O4W"5(A-`.#NTX4*1547RT!K;$2W4'*'X+K@4
M3'&_05`6#V(`-<#[QC@=T3ABB&G//GS!7.-C/TAQ$QPM8`R4%W>RM=D3E\S6
MX%,R2J[Y0A%H0B]W8J_T!HAYQ*9C*^.UF>'E;+>X',K`.]@+299"&FNO8>RF
MMNH>MOKR)250^B3WI;8JM-48;C`T'>&=#ZR<P,G[MBA;<S##Z7F,5QFX%V6/
ML2-[V:4#]CS^1E5T5[4'=BDT)^H0V.6)7V^X%P<])J:J#P:7<$%AW\!GCJHM
MK+&0YD234(VB@F5/%>R,!>=(LBSS13^67S+M[!KET[5K`-HK'!A\*A8.V.7"
M`>W;/]*%SW<L'#C)O(A&%0-&J6*`E@K\SY>/[ZZ_WBK7__>W#W?_:BV5_:QQ
MO8?2@//0[4V07+Z\VBIHS,R);ZPQ5=&^6CH%JOSZ81JM.4VR\1I>$#`W5^8\
MAQ<.5,/.`,"8SG\`4/30X8/$@]^)E=%0"^-R[L<:GWB%VB^%7B@:\M^7LVV+
M:%%+<:,!M2VK7L>B[/Q=-H4_CXW<%P^RO(!N^3@KO\VD;UN1(F=G]V:>PBQ0
MQQV(ZPKBI(Z2.JI+2%ZX8C,EU3Q9ER;;TB*-Q6S;HA;BGF2W1B6MN/S%I1OH
MPIUQ*;C,)5I<&>\)!:DB-RQ/E,W'7O(DP$O%8LELS",>KTJ8S9)[;#6/L@IO
M^I+FR=P']F*>\D*I0*%#$RQ,)A,>1,P64;,DO[PC$H=8`(H]EE@X,_,XXCMY
M()5C@(%82!`4K9E^LMG9P&SU)20N8JZ<E<RB#`SL_>K!\Y9;J1SWE9_W3/:0
MEE=<=',V'MIU1\Z\.P]F:,<G?QZXDIEV6V7:+<GR:>37\?XC&*W,3)0=L^V>
MR?Z3[&2*W0FEV%7%WUH*\IR'2I?'7WU<_4[ZDTB7QC)_KA/Y<WB@[C>![CR$
M3RHJ^L`/K]9@"[X\\;2YLZ:]E),]I):*@`Z[?"SDD^FNHPXTFZ=1\52PG$V7
M+G9ULL)6)3VU:!5+6UB*SL'S,BO$9SD=<U%BSB8E<]M$S"[HBI;2L#*[G/YZ
M?=+5C@,L%D6+\OG$`^2^_+HY-W%IFA`7$SK62`@)_0P;$'DHF*5/GPEV)<X_
M7"6P../DXG'AX3":@[T$XNFE25C6''`]BY(JC5"M.38)?X6^V"#Y*_1%4=5M
ME_*E:Z6<KYNO8HA&[4:QIT_Q;M"WJAWGGB.7)T;:KDINI9&2D3;%/S*G3*;*
M*<E22;SN$J]9DWYMB(5?RCQSH54DOM!(M*G:PKGWH1PLH(Y`@I.U=):24@HS
M++I+?S)4=VCG7D(SRT!'DV94<.N!&9:]=&675C!T[G&7'O#+GQ0^^AEM03!A
M?"#=>"$/,6'=EFF#>^Z0$-LLN@8S5^;*%R<KXGD&BV>6<HR>P'AC@;SS$!IY
MF)TL:?NG#U')\)M+-KXP*O>B0\V#]7-)P-1`3*;^A3>;81J#T"-Q=KGB`5L:
M%Q_G%3:E(,;2&Q(,J_.>GJBIYG3\R"R=BF@OZ!F6BI?K,!:Z\$:C*,6&H,`Q
M;(()OBD+V&+$F&G2'-*IAR,=65`=X]885\\SI,N]#1=;`0&DP(C>`PU,E?J"
MY9--0*=.%&^2\*1`IK1IO@8!`OCW?H`Q91;+Q@=XO)LI2>$67DIVHI=10L/L
ML;C1`W/1^-38>Z&A&(:KO%LJ?L]#T31'$=1O.9="+$"^LQ-(+ZMU?!C65A?9
M(A\*$Q<OTFQ\32B.*>Y3R%,&BGNZ5*X]1M>(4GTE;S#*TS2(^_()R)MAA_-B
M3]9L5@W-;(!'@(DP\1Y/FNJSJDQPL>HB_\9I!BWEUI_T(F$I[<[D^.J?CMOH
MR)04ZLPIA',5`W3/I31'P(^+8E:<5I448NAX0%'5&C`%"A^"S2U<>FQA=@HL
MRBQF9\?I_;_)B.:H>F,$B^5@850_(OZ,:7*14J`6'8,TXY0=.A2DD/TO;1<M
M6DZS$#\/!0+[S&"QXL(QJ/X)'=S`GRF.W"KWJ:9W#L!LZ4C)NU*S$^4Q?,;Y
M"6I1&T[1*\QWH)@:.R]F85(\<$I9;7F#:_Z>,]%M'9:3U<:YU&[=I9IHXOW)
M*_:M-BH&`):,R3>A%V%>T"CP(M[P@5_##7.@VNYP8>21%V>I1M16!(NI<-FG
M\8X4;"J\P549[Y?*%YP-^[3@`]$'V\.I.Z;J&L8"G+3D,HDKH<AJ!94OO)2H
MT/#<II#HVT$R4)W!(L9J0U+5?EVO@.;_70N#/5!-;7%053T8BLW5L<<W3OWE
M;\CO-/GPPW%**Z.R:"1"D>T!P3:82PK-_I],.Q]T6+DN^FS$0PW>87(W#\N"
M*ZS,.Y_CL@Z_:VSJ;GXF1T^'U-H/KZ1AW74:U:30%4X6B$>1?\\R!,">]-#J
M')/$\X-\)#CH^$+NZW)@8Z'4?8Q6:=8)Y4PDM,.TEL9A;R5T,9KX1D83^T.\
MYB._]3K11#V/)J+UIZ\+`NH;8W%["@*:6P<!A75XSD'`#G.V/$QZJX_N*L)W
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MYQT?\>G/,/"+'M'1TD#"/V;A\PQ-P(3V?`;#D4?Y2].F;O#1U_B(X"5#PW[Q
ML^R?^I]_+K:R)B!0]X$?/^:MJ)AMCI9F-O%JT;>(#FOLF/64_ZKD3%UXOC"Q
MR2S-.M07.TGP288^3DT-7M#50:(GGD&2.</12N:#3^APK:PCF6VSJ3/,E5IL
MP\W',*J*7>Z%5O$$;LYBLQOX7!?%>P(CP!/^%_KDF1SF_18W*C@8B7V.2_R8
M=<;+!8[[T!GCJ+BU"YR7X$_\S(.??<E#*"``!#.8Z#Q>1"5UF`%7)9$_2O)\
M(H1DQ8N8<X\%O3/^8H,,$A'CYCXY$1]@CKT\_(%]Z&A"%5PZ-S2SQU!-,=3@
MQX+K-P,9^%-?Q+Y!PO'CY\>0-[Q[2.'.2GOK75`7(9G.@_"%+$6AA(MSS$-D
M>8=]T?QZS@)/GTOH%W#P@)<8J4J3(5XX.(7)$ZP5'\5+!K2:PX1/CLF<4,[.
M1A[D0P682]-+0/'-R`M.0W@,-[A2%F?^8:=K'R0/54O@DR>A:-#*@RM&2O4,
M]J'&.4_YAZK(%8C3T0A)6L;>!K2(.5U)B5/H(CE_K.<-.@8$R2'&=FU@3>8=
M+OV4<1*'`--4:!_S$1PO*5]#@"W(Z./5BXW=RD^3%>CD"*DXH8K.\R)G,7CH
ML<B=W,R;Y`&&`Q*QX!@'$WZ7SGA72P&E/^$I+CX>UKR',ILZ`7HKH#WBQV1"
M8><N;M0Z\GCHWNU/NF)Z0:&;R*=S#'+35(PRR"V^7`D(+2+DE=N&-#05@_K'
M@XEJ59R;6G+Q\%R`$:&9`W,O\F"M^>.Y%`+TCS&DZ':=0G>/"S=73#QGT1",
MQ]![%ARAT0/:*0]PLXJI"1Y.T8@,1+:D$&610L1,C7*)4WF./=XK53:9R7`,
M=:BQCW]R+=5UAW3"TIQ-Q@JH%25>FGC?`:@9'-]L^&=A!"=7$/S!?-H6KDL[
MH11VB3_-FU;3WZ)ARC46`W^.5UEJ:DOF[2;S2O72>0I)NG22+N6X.QL<-0G1
M[4)O57RL%NI?FC!:KEU=U.Q+8>U<Q?]Z'@S087(W3I!/J.N`TXD#H-L#9S5O
M+\O`*H0V(W,%DNYQ3D-T`>P3>/,8<"O^*F%WTQ@.942"@"_\UQ\U]N\Y5LBP
M?V>HB`0>:.;OR`L$=N_#)`FGN8Y+QL5))R7>O/=&?SQ$(=QR+CC74^:H)$(R
M7K?@#Z_XDAS4"P8%O.C2;O=-_#U5]6V<`NS5XCWW`;QZ\3O!.QRXTG=<5N,P
M\,=K`$?R`IUF?_W18%&W+*/Z"[,X5^YE!8KV2)USI\WO5$_B-0&$Q7L@"Y5A
M1Z+4+TE46YHK7O%_1B-")I,J01<HU%T]5\]UX?V2CXQ4LVES/"=L):;$&P?-
MWU>#P]:O7F2W@$Q:?)]E;'PA#=5L>*.N6D,+R[0[MT%[K^2J7KWA;G[:3*5J
M)F]*)>W2'1YF2_O2",57['#P_YT[02_6B_S^SZOV^7YG)C%4W:&#+3JUBW/`
MO'YY#*3O[XQN1L3K;*2KE,H*U=TIZ"7&NRB*]0_';:Y)U]C`'*2SF'/93$[W
M=#G;Q[WK``QZ<+#K,/UK0[4<=ZTA7_?&V!!C/TL^Z@G8M?AHK2US(!8ZH&4C
M=H10UCHDWW@!IN:J2P%::?<L.!;TH29O(T?`_*7KG+`%5,L]L&#J6))!BN\P
MA[0RH%-[.`>\ZY=.@T.B(Y*Y!S>!E,Z.75\EQGLFE$=Q&#20TY8O>C^\DE>]
M?;@,!NL-=.DPD%RTF8NT2],]-@L=P6$@=F2UXT583@;<7DJLH\B(M9+5QF%Z
M'Y!NBLB.4-?SA)C:^@M7)0&/83F="R>M3MSH)`-=FGI'>*>@:'^A&:_B7Z>:
MHMS'9BPU&J?F+7]V[.>#K8'">?3]U]]YH_=]=/H9^T\"?$1#_48S1O$.DW65
M"19ZR<R+^I`QWB\,P9L9=G,B^:)`U$D&I^GF*YFW@GLV,5PU]VQ*^*[@H^6:
MA,X@;5T&_4%1MMB=4<SAX1*B8F8OH`#[G[/Z^AF6[&%Y'4[JX?5U2N3Y,9:/
M\'(2G\27RE7,^FICZ_(T9HUTLGYMO/F:\IQU2!AJEJJ;;N'-]`W5XR?T2T/+
MNVVH5:!A$VU-`54>T-[HK"L/PDE$P_%\=A%OO(,-!=*8E3MBL_6HW"A=S;N'
MJ^(3+(*!3Y_\,(T!1>2[SYH69*,DNLZ(4GI/1WH7:[SR(2IY*OJF=J76JG*N
M-I$OBAEZC?M&Q56:Z5Z:IJROJE5?5<4JR\[^;A0I"5-R9Z_2KC?70[VG^\01
MP3OEYHA%29(PA?@,:\CP#NYH._A"MU84=?FF$R''PW"!1$E?2@^UR\%@T7QB
M3K%]E9N9AE'Q3N[[:_;2;+[@IG<>89O9*_?^@EWWM+%R#RC6"KF,2\/>O*M#
MDVF?-#(-ZW*XZG92#I39E]7>ZO4"H/UB_P*WJL4DQWVE5!R`+CMSF;U>(QQ@
M"WO%2;L2OC.VM<OAZHAWWW'=HJ0:O^@.2NK@8"=\'V25.V5/EH$Z)JSHUCY9
M7+<HK"87UD7&W!SQE2YDZ74_C-=]GZW5*$EXJR@9/Y(.^4,W/&O9]=EU#^<!
MW/_GCM$]=Q8[3H$#1X?C5OHPZ`]V:A*VRH.U/T=5PY5=JZ9?BEF_AFHX3LON
MPE;<35LM4A.VC=X]URP>5#7PV*8;KQN50:5ZV8:->]J[%K9XZ]Y0RM4>+!(;
M!^;2K1M,G2-E)#8.P:=-;*3&_9?V:)"N<G+MP1QMTY^Z)_!>V\9ZVV@9=4UH
ML[K045+X4!1>VW.A7?+N6]<4BPLK`6JA-5%WSPA=5YV=PYRG=W3"Q61UMY^N
MGIYK[R);=QWH+I%V#_F='N/N&)?K$..VT-BFNV1Z;;>C=.LW?>@P+K1+<[47
M:$M$')15WZ)]$`3B)GT2#,H&F$L>Y>@P+JW6$='A6_1J%I9WK(/=L1H?$?(6
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MP,#R4SJ-G8V.CXC(@Q4-7O@L8MIU!=&"S^'[0"_B%[!0\ASRWR`H.1S!"T)@
M+$/`WLRFQ\.2F%A&1\0_*X3>S6+<Y^?PB8<>-+K1P;IN+2?$.K52OD]HOY^`
M'Z?I%%A@EF*S(N3=.6\.IG@142AO8OZVX%%D\*F'ZBEB[`NLGDG7NJSLT\!:
M.P.E\Q3KU1G.[:4M;Y&8Z>K6Y0#^,W1`R3FZ6R/U[U^@A!;R]T7@LD;.'7W;
M8.`.+=L>5D[;W"9U<\.2RUE^#?(.X3_VT!E8`VM8<S@H77Q@J):^>0IH=6UO
M-;Q'CY^L\!/49Y#%TL)=7[5RN>.TC.XL=`6^M!W56"K&;NRDZPJ'MM&^=.OC
M:N=NI<=L3;J.EI47<F9RATEFU&)C0#]!$V(E-_6;/!PE76DFNT8Y6@U48[]I
M<AP"'*4G]@8;1=*Q^W0LG+NZ[JJ#I7R$2K=EWNUYHT,RZ^?\R?MW&+V%RTLX
M)=%>_96R8_C1.X8W<[I:):?KIZM_?/FJO/WM]N[+I^NOM7RN)T;Q;A"S*S[A
M$R-N5V5WC2NR`6G7MUV8XAF@C/@A$,.W7J(`0OPG?YQZ0?"B>*,17*O0\XU.
M/EW[$^!0F881;2D>D2<R2]%UK>#Z@"OA\V-^YWE$8BR0'DNV.C&VDAJC=Z1=
MX7C&91EB:S=%$2XF>^"TT0MDZ^X>&6-<>&/<KGAU-::.V0MD3V/N]K1L58.+
MHS:GWB8-5.*V'FYO2(1P>`^-^X5(#-?FWL:EP!*WW>3>O?>N'NIV=9.1M?`*
M"_]J8_20=H!IJ\WPBG8RNS5FUJU5C9DWM,TV'$W5!JL/BEV@;HJ48V*XP?+;
MH7I-7=\N</]IXZIVFZC=1LYJ,*^^'?,ZSD`=&IN9=QNHFR+EF!ANPKQ;H=I<
MG5&P"]R+S'NX9N6U#H8WJS,+6N\,O(<&S&N7=%Q'=1WC@!#V'V=Z:^A:K;5/
M`$NJ9INJ::P>SBMYJ\(\V!MO';*O?"VU^O:$R>@X!K!^DZ)/R?H5:O6'5U*Q
M+AMAFJVZ0\E;C>2QHUJU;5/UW0G3<&!9JJ-)4[613FU-39RR1C6<H6JY34IH
M)6>M]@1TUDZMI4&O3YEFQE!U+'DADQJT=?L*;ONF-$D;'3H=5:`-3-)MHH-7
M0:"$R2,I9,ZM1,0!`K$<OX<>4KTE/QT:3$,UAZZJ#UIH$MR#H/Q>X>\".=>$
M;]K!P^HC3HKRD6FOJ[IKJO:PB2=$BG)GR;EFX,Y^1/E(U[*S,`6/`F3W())H
MDVB3:-OC#:ZR\=_:W],&!+4/\LWK'<:DVUQ&O&6B6ALG_X[`#51;,U1WT,1]
ML!<Z'8CX>W_-D>BH[]02>C,6ZE_%3D1J#TCVI5;23>"TU('C-G3#2P&6`KRR
MY:ZL%.U2I6AK1<"\@W)UIY%B&^4/LQ%\=^=]/U`'9<EF1V8SUF?$+O49^?#Y
M[9=/U\K=U?_'&SN??"%YAZG4N)OIJ=*H?[)U%6,7CL5&FI9*&W,4>X',2**$
M<Q)Y"?8"`;4;*R,OBEZPU<>S%XWI.@N-HX>70P5(&=#>T]@MA+6&5B9`3GB-
MX6"SZC!]>(1_F!9[A'8+?O+\@/8=2$+LK!W#NR=I`HI>2;SO]`N?'@*L%;4`
MDW?`GK+.VX:F#;#OL`?DF_K8E"3PO7L_\),7["U(?X$MJW&E:!Y&HF,W_,ZY
M5*Y&B?^$C\XC'QL6AX7G<#L^\&68*!&9!&3$?UE`6::JG#\#GL3Z"#W\!#8R
MBR^5#^P7;&,,X:-TF@;P@B>R$M\7'-^L`SG%`EUVGL)+8A"7J?>BC/W)!*A)
M\;RP[L2?>;,1]@Z/$P`)^RNRU<<I13=(&+Z0K4!F(UCQGB3/A,S`=@S_H"AC
MVX`](6RK6GJ?F&AW6)"E^NVM^D7U!2KSR8]1J:!(OR=P/P/I+(@VV+2Q'R>Q
MZ)>4MV02O=19!Z5R4^2<^$*I4]F%/XQ5_=5/C!TZ3/RV^[]7[W=9*%;AM!FE
MMV["<\RV.MLV@F^Y=?C:AIY[;)/12I\<B</=N[4TPV&3T%A=IJ\X8N[)C$Q\
ML+Z3)/+OTX0;W[_6)D$KI./];!>QO,6RA_[=4;:QK[`IEP?'&6P<WK&FN7MA
MAB(K.!"3DMBE!FR:E6CHZ3@/J\D`#]-RUXY)W1W@)EAI!;5=F8WBZO4PVZO9
M*/4%[8:`33=#44-[_X[=Y]\5[O.O9R1I?[IU>UQ9E\ZO896UE*X)TDG@PG"M
M?>"B`_R]8#^M8OM_>D'*?',>7H]Q/.^A[%$Y#FBUB`[7'W.[#02J+[F2PGNB
ML*&9>R1PE\_=4FI#62L9F5;Z3)(?7BVX^"9+]Z_MV;C):)XNCIDYXLB4^CQ;
M.3"ZQ3-=$K6O1#V[)*53\JF?*HWZ&08KQ*C1(TG@OCI"AR0-<)'O<Q9FIV'T
M<**8UI_P?W`NMS^!,Q]NN["C:4Q#^Q&<M7#G#=.(AM''!*Z^$6%Q:V\*=D""
M\?O"3&*OE`6Q%#DS9>2L,_QRN!E&,N0F0VXRY-9!'/8PY/:N=`3%F-`F0VT]
MVD:_0FV?5^0.A@#Q60?=#-4=&C+LMI^PFZ$Z[GI?X*E%WF1DHK]^Z]>;=8&,
M3?2?QIM44KLT[I!.VA256/"*H$DJ'=:G[["61#U!HLHH1!_\D[V*0OSPZASC
M$+\!Q)$R@@/;\V?*R(]&Z31./)HUY\=QBG]AI&`43J=@SL>/7D3P;CU3X'_3
M(&'#S97P>4:B^-&?*R-`R@-14KKN!_22S;Q`^<I'H;\-QT2Y)2-Z-S"'!J)C
M],CJ%>.5Y82BB#$)E32!/_]+%BLQ:=U?5KB(ZRQ"=*E<S5Z4.(6W+0'+MD++
MBW"=.,&Z>K'[F(9"P&P@TSE-X@5<I,&8P=P$9"R_K%%3"M2`ER$Z'LB,L"+-
M>S+!F?+)HQ\+F/T"TFE1:$P82!X'$JC"0`3%^TCAY(6.0,TT]A[$,'K\G?<,
M8N7%RC,)`OQ??)H"Q^NOBKN)"?_5\EY(7"B-_,LO==H7%-L<`!X!7JS/C*]F
M8^QE``N3V<@GL6Q\L(TZX@(/\APE'==0C0-:GVF+A$&I1<+;+Y_O/GS^^_7G
M.^7CAZLW'SY^N/O`FR54![S.B/#=(//A8IFG2MJN"O#ZGCDI_O&1//!6@ZFD
M5W?I15-3>+L(M#=8%5,`_Y@]A<%3WODAK\H.D+*8\SDB!"][\9FT2.@?<?MU
M)SM'"GV8P05IGK#N-*PSS3.:^WZ"+4S`#/<?>&CE`:YL<:+</GKC"/Y]FWAQ
M,B,OZLI+R3PB3WZ8QLK;ZR^JD.+?+F\O%;"OD\@?)?"S-$K$5]>P(-S?\F_A
M.O`)[FL`P8PUFN&70&R$HXS]>)XF>)L*Z*4%+@MX7XG)W(L$Q!&A_5<NE4_1
M908P!HG(`_QB[$WA7A(75T`P@$P7$7E`(-@ZF`;'+J*T@0X\@HUP'H"P^"OX
M$]Y(@5KU?II%QQ19"=?FI<(NQ/2Z1*)I=@/"RT;D`0J`%MBP!UOAA/<!TH(!
MR@#D/^70X<41G@<.?*&W/_X#VAPH5,:A$H>7RN]$>?2>$&W_24F,JXW)**`@
MTT\#GTP*?6TH?7!A+XC#PH^`(O[LW^F,7:T7GD?"$WJ=*B.>/C:B%ZT4OP2H
MYFD4PT6=WC0#SY_&"[1ZQ"1"/\`WXN)XP:?/"5!H*QU.1\#=3Y9-*]8J:+I(
M4DHLBCAY>G14-\G3H_,4DG3I)%W@5/_D12/L^Z;;A1.==6E;.M,_OOND_#T*
MT[FJ?/SXENK[FW=?E<\D`;C_8!^*\WM&6[W=8F^SN-%!'L?PC+^HF>\CX@&<
M]R\(A)J]&M1^G(Y&!'X4J>)4C(&0`3M1E\[6]^0^2KWH13&&O!E3X469)5+8
M^[.?/.([+^GNZ3GCT8,&G@_P+$SGM"L=MH7*#M*8>YI70N//1D&*=Q)5N4\3
M>FZ+[GA)J-)_>^(:4^P`B`<TQ=8]VC3X4@(HG0.<<,T!4P-,`XY<A'8F"%-S
M/?&[.6P"H23C=,2P(%9GF,?E:"G=F'INZ50U?X9\SI[&0]?'D/9Z+)2[!E*C
MB/R!*Q)<:\2>7D=3VC8P_YDXX)GSGQ<8@"46$&`T!6`"2Y6S$_L233*?4G),
MNP*&=/?K@59Y<*#08C%6?G(U:D^4W-4"'"PU#,(X$76&"/5]&H-6B6/ER0O`
MKEFP6@&*DH7,F5^XO3/\2;7:3;4JZ=)1NDA#L>,46C9(Z(5RK56RBPE2-#T^
M`V'_0:(8K_YE?0QO6*.//U$S!J[LT9./@=FK['P2#5OQ*;S\^]2+@&<C'E<(
M-QPYY#N8`C%8$L&+"&-6NDG$01^'08K[IZ?G#Z^R\Q-3QZ*$.Q\6(?9&\-;8
M%Y=:/.9H`UEX%[Z3[Z1@,RQ8!B/Z[ACM+P0;K*2`8K5T'E7N=YLS>M4!#6]?
M,%ZZ<5XO8YL:@?)\[JB6D>=`YRDDZ=))NL#Y3+P(3BIZ=2XJ8U#@$5ZPZ?&#
MOME/?I#`:?.['^"I]5HH2$/[,W[+/LX^U/_\\\(13-VWW%^/CNCP'G/!J(-W
M3"8>:MY_I^,'JNQ18R^TO'<-VN](G/.%A6_3.:$I6=004)5K.#>_XS]FR8OR
M&A\N@/H/_HH2H,+P\-!A,";,^R#.T+>%EO;H_Q<''^S#@Y78F2N6I9^.Q^4?
MXMF2;6U,[I,PNBQHK.PO>GO.5L)WT?+/0M?]YT=Q&*^&\YF^;XQ<@%Z21SP,
MBVWY2^#RD`@@N.`U\:HOYY01<'5F+65@Z4M(OLU_GME.181?+NPYP]1\#DR7
M1W[9L4NA%K&`:2CB&D_>R.,NCFP[:$V1)]H#B!4`Q&KNF6$;P%ZLXC7T`US@
M-L6T0V;;(##`JD@!@A$87`^=(\!D@";0/$\T#,)_S1[U)Q,^RP$?YK`"X-&]
M+R(/:)=X<>Y)X:9/%:J*Z*D(TS%BH\TK0E&K+$R.+`2686N!^H!FZG&"#8#R
M8.P!-N+4!PD:%R@@[9Z.:F])EX[21=JC':<0Z-5L-L_R7!YVSE--3\,%&(.>
MO[#\@W=D2@\D.'FO"OJ=*7W0ZKDQQ,Y4;BODD>["_7:3]O\R*\0W+)4[48J0
MYF<-/=1H'CT%&1^ZNKH",^O?F`?/@*`JO0#T^O/RM?XS.^0XW%X4QB0[]&ER
M`!R0]UY4.,\`C,`?\08O7I*RID*%C/$_*Z^-GPO'YMC/P@^%$S8[\^FBXQSE
MI2,5/GMM_EPZ@]GT()8RQL\PMC)+&QOCJ",QW`-@#>&'(BI1.+#Q13&/B-0_
MJ_,_2V$0.*(!L<J3_Q`"CN.`^CG".0X54I8M9S;8B*5$2.713>4AU7OG*222
M@7E%T`7-^,G2JV*9'MQU"A95**IU)!U2CIUNB#:,ZU_CD+@HG/DCY7^(%\`W
M7\DHQ`*G^"6F;>OPD"`W$8E'D7]/\*Q(<-<QNI'A?@>J_9E[O%$M,S;Q%#J"
MC;G64?-'O*X,'A754O04X2[\N.!9'V>C]^"'?B3<[[$HGLI8D-W>@$ACN)+2
M$M>EC,2Y]T++E.B!D4;4!8^U6"J?KZ?$Z,X>>3B=[IE6B_'KI9+2W\#O\\..
MOL>?%/XQ)IA[Z#,G#]YUJ>M@QNP3_NX\JE#\<$H(0"7*^6##)'X,`[0>:.4;
M+*-K?ZHLTFI6?-5RV=;@4[%LRRZ7;6G?_I$N?%ZG;*M+4M[Q0JQ-.I0KS]WK
MM:R%<JU/GS[<?;K^?'>K7'U^EY=OO=VE:DO2O5-T;Z%82U*T6Q2%9WU:SY5E
M"%!J^AE=)9'[3^33$MN>DZ]#Q7I=HFK_:=AR[Y0N$>=D16Y=@=Z*Q#E9HB=+
M]$ZL1(_F!V2IA^C"*QP]+#@`EW_LO_O"SII8GC/RG)'G3*-S9E\E8TW/$UDI
MME#9Q=RXA;1M]`(W+Q!;6N;@=6&_L[-RFWJPY_)/CU@3IE]J"LA<`#OO<%U8
MEY1F_U6D/-%Z1:[V:XY6GV$=+#4J'@]Y61$J7UI+U,52HFW4^YIR(G;4'4/#
M__"JH./A'^U6$TG%<0#%(75Z9TE#=?I+KM'SO$>LP8`_1UG:/E?/V74"\R-0
M*8Q`YG#,@:@:`%W&<R>H'@)C?QP!>-17@C^I.!KBK8\%E;X@3*D'YM]@_X^(
ME/^N,9G,Z^MZ5MAB;+$T?$`HBG^DP4LQ5[I*6$5:U%I'1+D6!I6"JHQ\UH<:
M7HC/ON<CQ_\-S\<@U=2*XIH`C`I8.[O\^J)TBWHI\<<1`34F.K@4U--XI0*B
MJ@JM&TS7GE.O-5;#<^<N_%/`?KDBGMI&)M;5B+I[X?&WM$DX_OXZBL+H;1A%
MK.EZO#X12_;/[E$>0`O]LYU20M;7Z]N[J[MKS,@ZP\[*W2#D*8_8D`?CBBF<
MQ9QJ$3;CQ:P139O&0"C-FLX]#7["8IHQ/6?0UTWG=D_\F0=G!9Q\[)Y;'NS`
M'[,4N*]'"2WKR1Y+PK+0EUAKXQ9&[(CAQ:GB'*+'>9:.C*3B=VR6-IZG./NL
MRXK8#_4)L"@`]1NDLPP/;#H'WBH(K,:]W5FXP)\]P0KP4E;B)6J'\0SG(SYB
M[M)1BXN*/'*69C[W7K!0BOO:V<`->L,0C^'O'F;4,Z.B-U\)1QC^I'Z2-!*&
MPPOQ(H5=@K*2-C%?7>QV:;WBKL$B897"+%^'!17H:21JO('@K/H;L\2SD?'P
MTWN6%@0"ES_*XAI`@!1`?J&#1WSX%ID-BZ%"RAFK[!.I53JE5:3>[SB%[DHY
M=TQY4RGE&BY+S*-"?#6;H0/U?::\;X46C"6!NTE@*8*=IU")+@FO?<Y,&(;8
M7]B:FPDBAK7:`V<U!I8QM0KO%;C@@QB!;P)O'@,*Q5\E)&:,<>&-<;OBU=68
MVH#?'\$X"P(.QE]_U-B_^<A&_'>&O3:'NU)@QFA[41/M5Q820DXL4W-$V^Q4
M3`M>GO1J7V;#.]]X`:VVOWTD:R:\5JVYOPF_F^;[%G>]YV'#34#A!*A_D<G*
M>V]XV@[V#:#'W4)A;\G`K$N?[=$DJ;U7:E]1392;*Y+.ITGGK^1XPKRO2>,<
M@P[<R8>Z8:]TP:T\;[C7'7TS(^(_T6G$JQ`A7N9F+MO-S"!(/%@$K<Y(:/%C
MQUS\=6%XLZ[:@X'J#JQ=8*B_DR/LWEBS^]>VK1JVO7&1)=;((?AYXY:'6VQY
MS0MWW#(07-=51W-W@>'@DMI,++]6N?26]EN3)$VIL!+ONFNJ@X'>\$5K(#SL
M!@#ZH=M;Z'75&#JJ;1MM;:`;G/Z.3`AM]<7=R4?&L@7:M#4,'QIXPS!4S="6
M?O;#J]YL8*`:SHEQ^!5\+N(@F%>*H^J]N9_P<;+'P_90=0#?CC;L*[_KUE"U
M'*>OX`_5H6.K^AKKK9?\GFGTY6#GD1'^VC!-U;6:ZI=E`_G`8)L#U:Y0ZQV'
MVG`TU1KLBNQN\#1<D]-IR@+U8S+Q1_ZR<_;0Z+74@0['9?\8PQJ:JFXV5=M'
M!]NP5<UU5=/>%?)NL/2^CL&&/RQ@>!^OE%OIWE;VRO];1.:61"/+7\!TZB]S
MPM:+3Y<B<BM=W$HWSHFO'?'+N+:C:OJ@(WRRC3GLJ(;3]*YW;*L'C$S'51VK
M-;=IIYB:^]<Q]W06'YO%==49.*IEM.8.D/[U9N@?#G35;$_#=(/3N?F"[5$8
ME[=LQC3W\:JN8ZJNV_3:VAU&H=''WO*YJ6I#6QVT)ZC=X///).N?\#H(X_C8
M!Z>AV^K0ZJUONK=.&CA"C<:Z17IHY'5-;J6O'IJW7ORHO`_"9^FAD5LY'3F1
MIH\T?<[5]+FEJ0/AG!5!^W&<$C:I411`-T7VIA2HYK=`5[7[R^..K5IV;Z^P
MKJ6Z;FM92QWB^(M[+^9=QSJ2,F.ZKJJYO<V(W"ISIC/06Z:M#O032X=\FW>D
M\&H4GQSX$'5M3=4'37W`QS[[-Q2!=)S-7P]1H>M-CZ-N6BYOEQNN=*R(0T,/
M\.IJJ8XS2]^#3+H[4-W&8>#^Z/1QM^HY7ELVCH?IF3Y?5<C1%RYWG#;!+_#X
M+[01AOB7[%;2I6XE]Y'R2P4=3[ZW#,?'23;:+#>"HL*'0[1"UM":3"9DE.3C
MS//N=^&,C_>F,\'A-,A;]A4GO<SS1ANT]?8Y]F\[9?994`62L*="V!O`>3A6
MKFE_R'S$H:FQ!I'*ZTSR?_Y5DOZD2%]+IF6_LKWV*]L]M%Y)]O7]<Y9;D^W2
M1.?2WFMW([I\XZ9"R`1`G]E??S3J(ZBZ6]B>,7+"^%SLQR4QN2TF2QVO]H+&
M/?>UTC7=;=+'M&I;Q1Y,A_B-M:YW40?AW6J/>CM[M+=L+'6(WRQW4]O7'@_I
MP]V@/'YX55(?J^(7*W5)'3=D'<WU4SV5M8HZ=5[A#`W5U8S=]]./[1I#U70&
MY[+;H:ZKAC/<8;L=$LK"OBJ[99V"-.IFUOCI#-A3MQQU.-#.9KL#7=7-7:A;
MDL9EX!;E,@GGNTZUV="U:R.^ME,5F\V*K5506XRP"H!E!FD!IJ%J62YH!KV/
M2&^^+N7;TZ1DL5>;I&-_Z3A4;==1'6N#;;4?C!_^&-C4S*XSK'S"+$?;]FG[
MU1UUX/A94OQ0%+<MU1ENL(\EP4^(X-C;>FAW6\2/<`E9T792LN0A6-)2AXX&
M7&EUFBLET5LE.E#<T+JMAR3%6Z6XK>J6KFJ#O?H8VCU\#N*/WLWUN(\J?0E6
M:V!UI,/'%FE(ZYJSUDA(ZB0U)%B=X=UM^?/N,2)$^01?/<9\;OIR7JQDS1,'
MJYM1XZ^G%BQ63<=4-</=ISQU:<.OZP>,=S8T#X:8RI8L\&%S;C#0AA_LP@V=
MEMN*+L7'IET;3&T;KJJ;&YPKIR/#YY6`9=N.:NN[9+AT4R17M%,^!7ETAX9J
M:V<CCZZINIOR2DYGM[JJ.0/5XHTG3DDBJ[L?GH)`OD:_I&UL<$;WS.IK!3&U
MO/3GB!@+>]/7LJEV1DPGO3"?_9ETPIP[6&US9FWN.S4_BZGJ%A@-VMG<6D[2
MS]+*Y14;KJJVM0LG'%LL3]2-HJO&P%(U^VR<H>?E2`'RNH9JF5VZN-4&_H2]
M)0;6JZF&>39B=U[^$D,U!P/5Z)0'LS;P)^P2,8>NZNAUM/]Y&6C2);(*,0/;
M55VCSJU_9\3('+U^.@PZ"M:)Y.@MC.>2.7KG`):,%4G#J!N(D8;1.1I&=4!>
M.W*IMR0NM?`R=4T=UJ+Q2=S:S\M'86F6ZKB[).QT4RYKC=#IK7P67C&P7)#.
M73R[O=KN>3GN!\X0[(Y=E%'GI;-RUL\I".9KTU;=3?TGSM!F/+>^=;JN#FNQ
M00T1EJ.+.CJZJ$P[.9NB.T2KE-3:8TD^>='H43%UFO5GR9$DITOV!1&N)JP<
M22)'DI3`.^'!#W(DB1Q)TDU,GL!($G-I,$371Y(8`SF2I.XZ<B1)=UU/)SZ0
M!/LJGX\W6!\X.SI7>K5==V"K`ZU+6=SMR.3I3B09#%5'/YMR>`.V.ZR5)G$2
MV[5,1[6-UJ(SR\#)D20GVC#4<%3=ME7'W&M[\GUA_0RIF?>96A'3.J/!)+TG
MYB;1-#5KW_V;NW,@]&8XR6FSW6O+ME1+VU`)N'_<=*QI^(D371^JQJ94"$GS
MTZ*YY1CJ8%.CR2,374XI.3>N-&S01*YJ;^H1(+71:='==G75U>6LDK,B.@C[
M<*"KEKUAG&Z73J&#.*M[5B`IP>I,[$..*SD-)NDH6)ULE%DQKJ2<+RO9\L3!
MZF8X^=1::.JJJ3NJ:9U-8/6UX<"EQ&VAYJD?^]558^BJEK%A'GI_1?%$VV9:
M[E`=[M3>K5?;'1CJ8*=BU%[MUL8;LGYZM;<GW$\3".;HJNWNHD?[M>$:\:,3
MVJUJP3$YM$_OF#SAGE(#VP3SM4[.:IWE3@@QNC94G0[V!]B0ZG0(U#A@:6CN
M07A&^IC[Z7GH*%@GXF.6[3;/$"QI&DG3J!N(Z:II='3$G+1A5`?DTVRW66RV
M.=!5USX;3_]Y.3#,H:8:FY*M>GA&GTVSS=>F:ZMNK3E*YW4RG5=HX+5I@N5V
M.B-290//RK-I8*G68$.*Y.DP-8NYG\MN===0S6%+T3W9EE.VY>P"A3@.^M.?
M4=*GV_0!6MSC'S>4/O=5VG5=3\UB)]5_I#,BQJ?+1JH]9(2Z1%\0ZFK"RD:J
MLI%J";P3;E<I&ZG*1JK=Q*1LI$H.W604)VO)5JKUUY&M5+OK!#SM5JJV-E#=
M\_%IXZAZ;7@VF=-#QU#=X2[NSF[*Y,FV4K6`7MK9L*=A#U7#.9_`N*:KNG-Z
M>?W;=EOM$>EXOT1=/YM`V=!2!YMZ?9[.;I&^0TS'.[VSLG'/L1Z1#7O\F(:A
M&G*<>T4:I3D$$3Y(^D:O$&/`%6"@J4/W(*FWLO2FE7-"@G4`=I+MG4Z#23H*
M5E_:.Y6"^)(K3QRL;EKMI]?="5N_&^<S)0B[.QF:O)94,`)@1MO)R=EID3W1
M+E"VI:F:=3:N:=V%[;IGX^USP-S1K5T\\=V4R1-N`^4.0(V>3_#DM:.IME4G
M4'U>Y^G0':BV<7INZQ/NB&`;ZJ!64<YY<?)KW1JH3JVJ\#-`#*;0%5#CNJIE
MUK&^=D:-=%CWTX_14;`ZZ?2[];]+E]_Y@M5-B^?47'Z&ZF"?VO-I?/+:ME7=
MD`'W"D;0!V"^U'&&]E)D3]3EIZN:.=RQ$W&O-FS@S<PUSV6[NFJXH*!MV?V]
M1T0S0)&ZJK;3%(U>;1C=)89TEU0P@CD<J,Y.\W*Z*;TG[/IS-%MU71D5KDCD
MM57;E+Z_)<2X`SBBS3HVR<Z(D9Z_?KHS.@K6B:2JRB[Q9PB6-(RD8=0-Q$C#
MZ!P-HSH@GWR7^(%MJ8-:_8>EH^.$)7V@&:II[^*5[:;\GD\_^0$ZJFK%`<^+
ML\\LWO#:,BU5&QS$ENF\R)]L0WFL.K=W"?5V;;<;1D76#OKW9;]K7^&:-6=6
MU3B+94-YV5!>4DA2Z+P[B=\4^\??DGE"IO<DRI)190_YDZ7\@A17$U;VD)<]
MY$O@G7"G;ME#7O:0[R8F90]Y<OCNZK*#?/UU9`?Y[GK]3KN#_-`V54L_FR(?
MR]!5[8PF2*J&8ZG6"388.-D>\A?:Q=EPISY47>M\A''G[793%,^A@?Q0-=VA
M.C3J3%4_"68]LP;R0]4:FJJM[=(RK*/2>>(-Y+$XV39E=LIRVHX)QXUVD`S+
M?B'&&*BF;:O6J6:?]BQ97X)US$,F3X^1#'668)U(G9<<27"&8'6R.UG%2(+E
MO!#)FB<.5C<O@Z?6I$Q7!X:F&OK9N&6PDVB]N02GL5UUJ+NJ99Q>CZ/3[CTV
MM(?JT#V;)D>TO>_9Z"`7B*N:M;PG_9+)$^X[IJNZ;:ON3D3KU8;/*8S:`FV[
M*9`GW#'#="W5K'4/K+/<Z2`&CE+'V<7<Z]5N7QO`!K8E`Q%=N+)+L+IV8C3V
MO7WV9]+U=NY@==.6.377&Y@OK@YG]=E<>W7+4K7AV<P4!+O$M-5AK8%.O93$
M$W6]Z>K0=6H.XCH)1C5M0]6-L]FNH1J6JPZ'N]@QW93+$W:_F:H-%SUW<#X7
M6]H-3V9E5C""57=^9+^D]X1]=;JJ:YIJUJJ2ZP\[5V?^-4>.;:O.0+;^K>`:
MPQZHFG,0U$CG7C]]%1T%ZT220F7S_S,$2YI'TCSJ#&JD<726QE$=D$]^``#H
M!:QXM\_&92Z='BNE71L,U(%3AQ-.5-K/9UR`:6F@W.4@C#./4^BZ.JQUO/?+
MCC^'&0"O+1#@@^CJ?J&E?@;`V2%FJ)JU1CVU>;J7!Q",_:<*E/%/__)+&E\\
M>-[\UZO1"+0$1AFY)%_-QM=1%$9O0Y#E$:T@O@-<O`G`.O_;#Z_^LM4/P:"?
M(4:_DLE??WS+_OXV^'3]3=.__<.;?3,TW;[3M&_L_^Z^?#.U;_](%S[_\6^X
MA?6MP0NX.WJS[RYU]J:?3E;W3>?MM6OVZU_@VG5=P3]_N;M6;(6QX=#085-?
MKV_OKNZN/UU_OEOF[)HMX+M$Y_Y3=8%?+VU_5NES["%Q3E8(?R=@9[$VSDJ8
M1LK$GWFSD>\%2BQ<_K&2A*!YJ3I6DD>B/'LORC-1/*:ZX8>`!F4$)J0'YAL@
M81K#FJPU%OPR1H>,LNR041=N;#P[156\66;[P?^.PH<9[8-WJ=S!NR=I$"C^
M%-!(0Q$(#H>?1B>>/7SW)`!0"6V9AP^\(R.>JZRS7.7J77IL=P1>SU=^(5[$
M7LL&#MR3('P6Z\?T$0$*>Q-=?,YF5RR`X2-@\S!*+OLJ`_WG>*F@>D6N'YL>
MYVO>V?&)+ETB7SVZW#T63@ZPQ>EP`?J/%0V$J%Y?_6`>5*;'"6K3A+9\P9_%
M_G=E&A;J3\"J)[G0BAH4.#O@-?-YX(]07ZL**%T/UPMPW5_[*MO]E^3&BE<.
M^#G*@)]RGHBRC^DC'%S<T?+LJJ0XB<3D>@:5P)+PE^O.JEPO%2]:V-[RRS=X
MA];AJOZ^C+JOV>,..HZ<?.;1X7;0Q#%>(3\'DI5:>WR?76^R(_88G-`EE'S$
M$M8/@(NNB,1Q=2L3,^YCY1.<3EL%=0'?M_FXK,ZIM(I8W_\9C0B93*JT'<>1
M;9F+)E]`)LEFS."*'UC>7KQ110F"#/%==5:NP2+E#=19M%AI?&`HV9K;8;G!
M6YP5(ZEJO4=7+6.@#K5A1S;C[H$,[F'(X.Q&!MM2C35V\3XW<XCD@CTHF)8(
M6&>9MV%,W1VW7L`+,?<(T'9H^ZE!-+O6@@[<U71+JP_F#Z]VE:F\"NNT4&E;
MFJI9JW5LM^1YC0'1#XG>#LH5%=>=@W.K(I):*P_=@6KS\7@'A?=$\>D.'%5S
M&FC0[A_CF6OX=.3^8QC'RB0*ITI8'IO0.4A;/Y=>8P?M(6_$T!Z</Y\+^FQ#
M=;75-GL[V).G^=92?4\F841$J6'B?>_JF;X?R1Z8;9N<YR39HB])9R6[Y_?N
M[:#$TF$L&>XF=%*..X:^0\MQ.0V_/\DJ7<ID:I2^<I&$\R+8"Z$7_A!3HNRY
MQEGL^.R]^,.O$``_H_Y]Q;?5&>XR5>9$4V664F%NJ[+@:B?"9*S+WURQBQWB
MJSODM[0(V'&V6C];96?`.IBDLFH/6R2AM$BW0^ZT=F[)?OERSSJH8<I(WZ3Z
M(-BKEP!R4"W1;M['DIDKS.`+_'Z;.V(Q:V"[Y([:,#7)\&@G@Z.M#`VZCJ$Z
M^D`US,&!@'&W0$-UTD%;&1("#8ZNVH/5T9)=@#F<IZ4]46JB%.N\<'T.0W,5
M_,.K`N:;W-QYQHOA`KWM!G?S3?QV^"UHYE`=V@V<,]V)VQ^'3[<#H49D?EL@
MMH\`<ZUE#@>J8SG'Y.*6=F*9KJH976'F9M'H/G%SK7CS3ES06).]=@>&J@V,
MAN]9]B(?&&Q'&ZBFL=IRJ@>V5+MK&+5."/7@S*JK#A_PV2MFM577/3*S=MZ2
MW0Z$E5%!R9J]8<W]Z-%2M?H(J]4G60MTR:.21X^O/KO#H;0),^W<$,Y9\P<_
MCE/>*2@FT9,_.OKI/S`<U;0:Y-SM];[5''S;4@=F:^!+E;O),HF(%Z/Y*OI>
MQ:4>P\=C!$,S56=-^+?C?*P[ICH<-B@5.+ZSH+=<_([D7+RZ7?81CV93Q]FW
MNQ[-!P=[@*Z[-0$':?6VK((K>T0?48>YZN"X\8==H#>'`'U3F:NC@`_;2?@V
MO8_)?U+@HVO@B61#U^#W_RIV#;;*78/U;Z`IRY_7Z1K<W_9SG+QQXD7+(GG\
M/,YB?['&29>T=;`^+/4.OOWMS>WU__WM^O.=<OU/^.];RHO;=!#N+\V[2N`2
M1ZX;CB@IU#D*?9@IH%%3+WK!E%1;Q3;!_.:O&ZJM:<S<C*DQ$4ZGX4QA[8&3
M4$F>0R5,D]@?$V7LHZH/(]J^$6Q388`D@+9(^0^\`#`;O"CO^'/*>T+B1HUU
M)5=(N944*LCM)R\:/>92&\-#(+4>V/QS/_$"7.@/@EVRQT]^'(*`>P\1X4VW
M'TE$[EE/</R0MOVF8J^XFJJMEGILC`U2[Z-ESWMPY^(NNL!F+Q1^0]X(W(_B
M1+'LXOK/),KTC5_<DE0-'66\)H9<K6H82=H^DO8#\ZI&8V\V(@!S\JA<W;Y5
MAK9]H6LJ50-OP^G<F[THC]CB>>8%+_]%(0>5D>>^*'%V!40-)-K^%_I$B_[_
MR6,4I@^/=&'L18U_Q*1Z+$!1J6!$`P$8$]C*U$<-F3QZ"<"AC$-DJ#"![Y^P
M:?4+H`D>HHOE8!%Z-47HQGX\"D+FSECS]A"^0SWHL0$#_/=C$H\B_QXAN@^?
MR.4*@<AOU2LOQWB##N?1]U_?>+$??YGDU^^;,/!'+_NX10M/0%%<MRA<V]QU
M>E$'5,O-LGPUJ&VK%+KM2M8$3N@\;4H./#!OX&`#R/(9IND:I2>Q2+'([(,J
M:9HLZ)(G'.I!9LH\(G,O8F;#HB9Z(#/0,`%<-^`;,L?.]5XF)?!+,%_\><"&
MU^'JO\W\K+L]?>75%%`]\JCVH,YV1E+VMM]N074$@1<MWE]RUU@M^2RZPE8\
M*R5Z:UY<JE/=2;ASPBB45.<EUZW@\JX@QFE,V#`>$,LH!>3<"^59D%,J?)5B
M6R'?FR3YM7`F&MJ?_WYU=9/]$_:4O^1G=E,I62[CD"F0XE`BT%7Q",#&<4-8
MV;M2$323[Z)&R.=NP#$B]<#Q]4"3E@%4,]SD#(O34HKT7%`?&RY&DAZ[T&.E
M:<''?5&],2I.N8'#/@V8[?%E#GB%2^77[T#`:!ZR>XORVE,^DR=O[.&4-?'I
MSU1CX07G^3%$Y10^XW4#[Q+^V$</Z^K5/OFC1_\!K@S%]2Z5JR#(+R4^UI%>
MC+ANHJ3R6'2M8!:1`-XP\PHJ<51DO%7WCFJMM4X'E725%S]>S<;X/]?_2?TG
M+T`$2Z75'R')E!8=ZD3G/N$?!6I*E74X:KP/(V6>@B*(278#0B.%2C[:0E7Z
MK.QT0:GWQP3C,:!#0+<\@D(*?*`G*@:`,>6^$KPO@=[Q<60C=1HG:>0G+^RU
MA4$^`!*<9-01<D]87@G)N:.A7JFC+XH*YKWG1__T@I1\F61-*C[DNV"_E`KF
M6+<C)(]"Z8-LD[<1*9!(7ICV;^0@%9X$%5!"U3SS-8++"P@:G;%'72>@!T1%
MK;J4(+O\22D90\R*G7M1\J*R2QS)UZ/GQV+"%T[YB\+O_I3>S*AAXD41U6;>
M%%_%%5W)K5K45&-8`X/.-*`</X818B^:*C/46"L=JMWD,3I.KR-<MBG4VQFD
M=48PW^>"YJ-G?T+#"A[CZGGDCPB+,3R':3#&TY()'SR3SC&2"L<==77,X#<Q
M2?!HI?)(OV5((!%]`DYL[]X/\#Q&-^=,H9UK@I+U#R](GM'T9_%>*I0^W#N]
MPH3D*?'BE$5L6?2$WE1F`F"\I@)=`8XI-HKPQD_P8^^!A&DL5F6Q75@N`SD#
MC4=W<Z2`</*-C[Q@E#)=P<9)AW3/Z937F-`5J^!FJ$M9L`51BGJ"FD%+KU=I
M#&=AX7A.1O[$'W&-H<#&*:08MAJ/?3;-.EE2FF)1']B;[P*0$Z1CDAE4[,H&
MSP*+7LQ)A/Q*/<^1'__!GT9@<30W7`"5$>A`/Z'?KHII=T;"I%KJLUHJ\#8-
M5Z)>HI>%C,49R_,X)N@#4$Q@?F>9'#0YO2@1."SX/O#Q1EC\^-$',8A&CR]4
M*^!G3"C\V3REW@]_](B:$>P!#[L>,@61_PKD.80[AO]?;@CPW_DS*JQXYPC`
M9@CB7&=0$?Z>\#`Q?P'[51HS5P=3<>7]TMA->(]I*-2&X1J/*9Q+Y=J#90I/
M%[5D-OR=K0YT%Q>Q$H397@OQY?L7^EP0/@/^V(,,6!YYCFFJ#FHGC^UG00^5
MP)A1AQ*J+^`(IFKC[.VPO54CDCLC'E*G]%FG?*3<JY>L?RYX*%M,0*G=DLY8
M$UCX]W_2D-X.T!)BL\%]W!<6Q90L>D#"6`1P$["/1,::/"<E3^^=IXT:/%W4
MTZ5CA#Y<2/0I<SPW&2EG<P$"W*9P4,`=89UP8*FU/_4#+RK)B3_+<CF9"0Y0
MHLW+I$:EQOPT')/@@L&>G\@)&3W._/^D_$WLM$*'8'%G1;MYW8&)X,$/J%T?
M1E%XCW$*=MX5?L*?A5N&QVK'TWNP(F;H7`S8P3A)`0!Z=1>N3;3IXZ)1[Z_.
M#>\,/TLET'\E8*Y2`GF&03HK,#=*6O(R1V&%KT0`$=`'EV7:_D:LYOPY1NN9
M>[OP*M_RK7?QTLW`1HW$FC85[-$TQF6*"J*@%IA)RN^XK/5#]F;Z$^`(O#"@
MAPY^F=639E\B2H32RM<MY5&4L,+RR$63"?SULQ=%S%D!<-/-")@#3B1&&*D1
MI$;8<WY2YI+./$+)"C;.?=3\]$).+KJ/V%E+O49QTM@A/_?H99?6_,98WG$/
M$@W"$,[IM7`4QLFAW/;50JD+H2PE3-V3P(>ON5I!W,$VT6<YSK14'@7@KOS"
MS3=W\3,'?RD:20VH@EETJ?PVHQ%):H<]^S$UBLA8Q=QN/UZEE<.Y/Z.FD8!0
MP.ZS9'#`1ABS@IBBD423+T"CJ_#`B)8Y4W,H=^ZA^O(I@FA_1QK)^.%5=2QC
M8[I8K7AG,4#Z->.F^`YO55>S\1=$"T\XB_/OKP+0WNBP?!]&[\+T/@%S3#PE
MXZB=R#*-E9Q<5"@SFE&+6E!-$8_+V&ICE%\MJV&JZ3*?'RB'B,"6_TN_XM[3
M&:&:W!/D8+>JL:"'4+YJP07*;4!6B)(I0Q%Z`5R'8ZXG`YY[QM0N]3^RIRMR
M4C'M8S;VHK&/-354IZ(O$W26>"%_WY,/%&998`':JB*:!+OP2[LO.%L]99;2
M/%=X:.+1HEZU$-@H`UY,R<=:8(0+GKI4_@>.O3"BUUK^;M2Z"!4<3;!X1/SI
M?1K%S,^)9U#D$V1Q/V;Y*`EY``N<'E;B(.:;8S9J.$+E+_`&6]]$EHKHCT!J
M1!Y2,&`QH1A.\UAD)]/D&H$KP%Q``SMY]9+/`W*T>I+>XB<OK/`HXX&I!Y_`
M2[(\PT4RL)!WD1`A(@>O'"2_0EPJ;\C(PYO!*H-D!'(93FG"#RU8@-]%/N;\
M@"`3,"#@SLT+0RG/L&0B'P%]S"C%+NCP<V0R2M(G$F':4)($Z!A!\^`^$08#
MP+3P"9CRL?*31M%/D"$YW3!-6DQ`6E/CA<P!?YB,X;V2TENBIGB71Z]7]V`$
MU%IZT\G;YD%:/*!O(N2;Y.4F`&L"&Z3\)_6I+2>S)#MR^`H*45[)R"//UKWG
M+8EZ=7&10A\L04T[)G`Q`M,7]7OX1'VM>&'(SU30AZ@2`O])Y$EB:`XM=SQ%
MN=IAMQ:FSB,/+U076,.K3$GR"&<8_"Q[#QXLJ&SNP_"/+`&S66IC73DO&^_T
MS`?5$C[,_/[5>_2>6ZE\<RHH!3)052`^OZ5M]Z[922?50F-$?RU;MH!BM$.>
M'\F,7]A!6F=H[?('BXY8%'8V-B&-E%LXW@/RZ1V+?S!O"UABS-YZ1M<G*@30
M$V]#C.(POP;Y9YB.'M$\$I7D'OHUD\B_3RFIP;8'=/R!^H!@!2^MUH[8CZ_1
M9HO"F3]2_@<N!6!J?*6V.7-X`E$>,*DA?&()UZ_1/S`CS'0%Z..?5;3I*/QH
MV#$S4O3&8(X(-,<"WK4/MGB/2@O-6]1&+,X$<.$W8DWI#)7.T#VB['>2"REL
M.4GGRH200OR19PZQ_M#\LD;+-$>!SUH_30AFXS`!&@$%X.B=94D^))=B>K9A
M7B(3VQ<E?HD3,J6_$T))H[%,1D3Z'3W0*6#4\^JEL_R^P6`H7X\X!+3@@5^_
M,Q#8&R^5*W;M*RD.O,IDN@-WGFD-VDHB[TJ1K3:'&RF2N+0#=``OJ`6L^RKD
M<?ZL\KM@J;*+X9J[#?B=OD*-<E\F\BBU:`J:+5.H+(>SN#B/YC)'1RE'DZ>Q
M@BE3UI*P0O$[8`#"HEIH1)$9RWR<%8A`R1O!"P&[_.J-]TR5WX;9]=L+XC#?
M39SM$0%F>I45`(?`9%.EE'1)_36B6GCJ(2>BOY2H"O&IWN396.)5K$\97'0Y
MN^%/V2+TXGW_4G@A%A>SBA?:M61&S<;\C?B_H"HR1[+8,"`5D(48%>E:5'20
MDL`"<!L?LYJ:X"5S"@DJ4IJF4<2B;^P9C@RI\*7"WW?TB\L(ROEHY,4HUM3=
MR,0S#@/,6PG'Z2C)=&/9C$$>]YX\/Z!>4Z$=T6Y95'XL<"P2(G/S!\MDDY#]
M!./8PA+BX2DN8ZBHJ#N/:4P,K3#''WIHJS5D*9<4>YKY,=T@^SSKK3T/_*0@
MTIE_D";P2ZM+"N$^4?:FR*-/89"RT[QT9F=RQ@^P@A52(6?"_J`=`OD5!4[P
M<BMYD#=D=+C7\JAL]FO>T<^GQ_`T+-I>PJ#*S0O>TH_J`'CO`SS.PLTDPAG(
MWD.>0EVH7F%G([419TS3W)-2^0;]FT81"@48"V;E@FO_F;;'7][ES;NOOWQ\
M]TFA(116Y<_*;*B/."`/6%!+T-DMDJ\1)E:=!O8N'O;,>'T`DREAES)=^Q.]
M,S*;4;PS+EQ<`8<_:9>F0RTF\5S!BJSAD][@'RHZD]A$KCOON_0A'=Z'Q,>A
MW66C\J2+J%D%2SYID-G+H);2)$L]R5/ABMDV+]R5BPDA8Q)M>$K-4USRP8:K
MDGB\<B9=R888^WC%)=3L$"5X2:G72/ER@J_!!40Z8.7[>+\Q7@)2W#=>"X!<
M<"&`"\Z(7CYAP8CF%[(;\#.HP:M"\F\>0`-+B.O^<=ZD-2NZS?!10`2>,FKA
M/IC9=`17H?<KD86,L;\1#\$6+I,;M=HJ15549K_%Y,OD.LNCE"IL_RH,4(Y,
MD2%=JK&]!\!8*\.LL+2R69&/_J\9;AY56;,NA]Q75TR)0V&=>G\4,@R8[EG,
M4O9`QXU$)I](C9FR`/P:-9;D?5JYR5>Y*78%K%XZ,Z2H]UZD*(Y9B5_^([I5
MFHURF?/LTE[R')6I-^;S:)A6%ZN)&"#JN"R>R&LVLCTF-=(2\DP.T,:C)*7G
M`.LG-:+IW>S<*&0)%K(\&H4:R\IQH7<<6MR,I;[Z\1]O:9XB_B5UZ`%T:`G_
MM/D;RQ-%`DB%NG^%*M*ZJ#\8_C^F#MR1:&VUV+P(]<&]-_L#E4`8^\EB(I]*
M%1I#..9SD>\C;)D_(6.N?^$-U%K#WFN+*='H0!-F$LMP&]->TS@.E@4NF9;A
MK_RS\A@^@^J+U$P9PB/XQCAK!;7BQ10VL,"\A/<B8$_3G>5O+Z:NHRKR1Z";
M_*:Z9XV&*6<VQ`1KOJ]FXW=Y^CJ/H<MLXV,G/##B4)DHD$<JJ(,IJ,RNB8JT
M*%9ZY,49M*X4+X%@Z7Q)H_PG9#*AX2N\D$W"4<KO;"E>AD4^;K&,<_PR\Z;^
MB%MXU#2B/K\0P[`^<W(5[+XL%P&U)*99YN49U.X+<76PI1A4+/'T17D(L>2!
M!L\>23#'@A:?ZMI[BAI\`290\!Z_-,Q&^]2,L?2,I=_Z:%[164%SD8^!88.8
M);-ZH@#WD69DC%C6:R$X48A,D!=@3<1;P<'J+S?,`V,RI6HU)N2/#-)G[X5N
M8TI(0G^GB-"!\+OZ4[Q=DV(ZB"I^#=2(2MJ7!86?LV7)[`$]H\#3*7H$"?U0
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MOA291?3W=.WE][((4/9:7LLLZ@Z+Z<GBY'T3>+#<[>@QI`4>%676[##.^^(7
MG!>TJE&4#$U"]#_0=9F/X3I[W5,8>$G1<UW:95[ED3\H"E#6%6H+@L;>-*,J
M;W67>WX+S1PX-AA9EYX0==\"LQ'AHS7B(M?@4IC)1'&R^!/<V8+/N51XM"1%
MA9W3KA3%*BE."O*=1".L(+TG8`_YF.4T&[,F6MSYSTY^9N?@&^@-:X+IYNB"
MYUVH%ACKM\M;>#BBOOP7Y<4GP1C=^$_4`468A;60N)6Q%F<>CWW#\5**068X
MX'O(82M=/?$NR=H+PFF(OOLQ+_05TX_8.M3J\%X4EB,E'A1,E^8M-J4BWS[U
M@8JL0!O_D:Z9[J5I9HC888_-!J958.2>5K/A>/+`F\>`%?%7"2^;,*",P`+E
M"__U1XW]FX\(QW]GV-@T,KUB+CI?IL@Y)=0L38%;GKI.R5Y)IZI9VEUX(<<*
MFLHDJ@<$(R3#HX#C'@^AQ>\$%U[:R[_CP_/H"(`U&T,N`7+/_OJC03>)AGBG
M\2D)N)&`YK'Q61A*+_7$_MBL+DOT!`,2Y<>6Q8I7_)_1B("UNUE,N2IS[.$B
M?@,R27;?X+6PF(6!RVSRFNC-[+6C<-ORVUM%S=;PZ-8B0+1GT>X0:4T!*1K1
MK>+F3Y)!=H''NAP,SHY'=E291<37/(+:V<?7S*TA&EY1_\:Q3Z##(6`G$%IB
MZT6'_.*O&>]?NMJ?+O1+R_K3LK>]/YB3W'(@;G%<RBU&U[GE4,;F'LW+@D-6
MBL(Q1.&'5VN%P;RT66^8CHN"Y);C*T[[4NL%K_35X+Q+HQG&&`&UT83X"9U*
M(RW.`XM"W8O4\2[7DM`G1N@3L//R/`K)Q)T[N'7=^9-RH>CFL.LW'LDM'>`6
MVZ;<XNA=YY:"WOR%YI.(?W4N'\>P+UW<9Z=3<CJ'-;I8)U!V)Q(7+Q82%_,2
M<Y:Z2%L!T5Q\\MV/DRRG$7/1:0$]S1/GM>=I3'):8!X<[^G-,R47\E79A+BP
M6))*"Q9FH?)$V*M$UF?6%8360:2!F)([(1'+E&2]N*KWD!7)4B#8M,9PHF;K
M/8(NHH4!L]BGH^J2$$=ZW?^;L,EUQ7S-<JOT+$V/Y5.RWFFYY7"I8#+\%-1"
M]/7[FD$Y=->8I8NU_Q%B>52:(XD=S7A#@D34EH9Q!1+9GM@(BRS!K[`3MO?B
M?EC9*J9+1FR(5Z$XI#PLE.94;BS\WZ(FH%A2<.U%6+4;WY"(KM2O/B>GIR:J
MSM>&&*I\>;G>X&,8QPJ0')-;I[PS+__S.JOD9#UZ*=?),H1N$E3TF4N3K#CZ
MWHO]$>W^BV)-NR2-&&59XR;>'VZA#\PS0?,0\\'ATH@55/G0BN*OXV)R>+%]
M`#KU6+KT`CAC/Z"O6@M0*<][#2B;85#F01IGZU.=7RQ-YEV-J0K&`4,D:QR0
M)ZW#>[(9:L4WY<A*1!(Z>P$O),E:&G"PQ4BZK+TGV^X2TKZ(DR2?W(9'2CBC
MUW=,<9Y'HJ<,>R$_LQ/6@Z$X'Y-UTJG`.'NW&"`O.K/SIIX4<;"[D1@BQ;/I
MZ>R0Q+^@*\(1TJRV;</)4NJRA8W'(JR>^1*]\^-Y&'O!E\G'</;P$5X[OJ(]
M(^3)='Q%QMIR9=1"64$J75`R*8Q."P>&/"/V5_!<K+(%A>?C<"$%.[T()9+;
MI2,_&J53T=B3=TE'-0C8`),W*4SK*[2-P7+DBX`2ES=NP:X(3/70=J!/XCKP
M.W:>I[T7^/O#:/7K674QK50JEPV7Y@5EZV?%5<O@W+^4>L\\/Y+DD9=8+4\?
M+#:@>?:#H+")0M_'=%:8T)G=-UC13CZQ$YLD\O:+(2W5FQ1J>PJ/H1(-6$&V
M-RO#E?<,8Y<+!MGB**6LC3..<<HE#QM>E,_-<E>+I;>(RK/E$D;VWDLNOKP(
M;$S5,*'58XNCO/!'L#=V)E>^;.E5%`5TSB(;*!($S0Z3;4Z(X@GSF3Q?9=V<
M;J)P!G^.2&'\7[].E]YK.]XR8\1Z\'W`(5]C):>0\O?4'Z.ND(?)P0Z3I1)&
M5`UC[N"A+<0XM7Q&K5)WM*)`T2X5:*)ZY9F?;&X;UU95-;*BLQ>M;!6M:=5"
MAQW:3X@WSL]4;#-%TE01%)4(*)X1Z%U0\%\FU6Z7*[3@64^X^,U+_@ROZ;_"
M(NR^Z)@3E`Q92"H+2<^Y#E$6DO:<@+*0]#S8K']5C=UZX5F@7!:2%J"3=8(E
M>&0AJ60064@J"TF/?P:?6>JC+"25W"(+23M98"`+2;LL"K*,5/)*75Z19:2R
MC/3T1:$[U862T&="Z*-9>3^\DH6D?6?C6D>W+"25W')6A:3+*4@MIQ%AAE(X
MC[[_>H.#+_TQGQX3WR$4^T@VRC*,%I.!FB6Z+"&>)_;0V'@I=^;)BWP/"5;Z
ME-6)Y!^N2K\)_!FY>%QX.(SFC]XL_E7QTB1<E>*S*1.I(E5G0Q+.BN2ES7E7
M9;Z]M/U9)3^N3VFR!T[V`IG/M"Y/H75UNK0@!Y2GA.2)(FV_IRH<?NPLEHUI
M2(M8D>0X:E+1GLBQO\M&%EAT]>9'_`><`IKEGE>A12P_V(OEM7[U99-F[?M^
MVO@:R]CX'F[QK7V1/E0U=S4GM;JI!DBT]TJBZM7;)U$U%S<ET4!U#.,P>SJX
M1[1A.)WPN:RU=/9>#X%VV'UGWKC0+CH%_SG@W%8URSW\#O9W[+9B57TD#UYP
M=,-M'S;9`7CRX&#7,@TT5=,V^K@W&ID'D&#)3)UGIG4'U:$YZ6#&S#+`BUNU
M-L=T:9GZG/D(LT'HV\O&YC?N@\6LE0PV#M/[@.S3'#\TL'7$P5A_[:HD6A<T
MJ^2>+G"/KJN.HW>$>RHC*'_Y97-HHUBB?1-AY7CR@MWNDJO9&+N9S3%FLH]`
MB*RZKMN/8$-@PK"U2TN&)K8*330,Z&XRCNHN5^7(/D2Y[%[B"1*'NP<!CF,J
M\SV[)052.HPJX7S+.B!&M#D@/1\V^D6-RV&59[2IRY@O4Q/.S;[AJ@7YT5^=
M4>&JMK[:Z[0=F,WWO_,R+2.Q"0H-0S4'J_T9VX!X<+G9?*-<)^;OTVC&LH*Q
MR]S$_XY_K[Y+[E%M5N-T+TIS"^A6<-'>P`-[7AL.&R"N/^>C)/3Q";WG<H8+
M!+6<#+8`V6UZ3[LMUO8[M,=I+7(%*W?2U('F'`"@'J'$5"VK"5-W@WMW$[:K
MT2B=8D]F[']!YA$9^30%5.K88^O8U[JC.N[JN^5N=/]9$OCX!!ZJIKO:_=DN
M@8^G?JRB`W[C&2L\J-2TSZ['JC(CJ^_(M1S%QV38C;[T#1?%O;!I/:!T0QVN
M\<[4)'];%KVD;(N4M57-7C0!&]21;(YU9*4AMZ-',DX#\F7RUIO[8$'#[L9O
ML1WWA]D[-E`*J/P[N:=E)G=D]#B#73Z\[*V&Y.1#)WN-E_2@D*-+(9*VBN'V
M7I9PK(!`SZHW)#G.J7JCCM6P;@=B(N#7[PKHI`LV,R/)CKB-?OP#5'GLNL6Z
M51ZUC)VU"2.VI>IFS3*/77?5K3*/`]!HB=WW2J-6=M4!;ULS@&\!X(!\>M=,
M%^SU:-F3;.S,2`/-4&U]%Q]U]^I")-Z/<J1O[4JK*<S&I=9,H(]A0A[.^WH8
M'CXTW):EJ9;31"Y.^4(BN6DWN'5KJ&IKTG@.S4V'CP^L"P5LT+L\#J]**VJS
M.:[JKJ/JAK2C#HUY5[-41V\BX=T0Y49V5#.0B]D&WC0$B/Z[/MO@+!GG]0!3
M4;0FD>%F+U@=_#]/?*-E-[`.A^]])[+M9"'DHVZEO7E"]N9KVU6UX2Z!_*VH
MO'.>D62BUIGHAU>]9Z-CNHIJYS.MW]+O%5>7%M*<.BDOFVN)MXQ='"=]9D-?
M';#[!U;K*5.M>XDD^W22?2Q@'W<XZ`C[U,@':S'#JUA*GZ_X899XLP<?'KR*
M8Y+$5[/QW\-P_.P'P2$2Q/J:`M71@O%>>KL[FWXCLZ$Z10Z9#;5A!S=>`K1C
MAVU,<_S]3+LK'E7O*U$H,Z(JG,SF^NYV,B/J^!E1=6ETGAE17".,R01[*X%.
MC=>H@+/T3^N.IKJF#.`=&N]#1W77-+?KJJ3N,7[W&:XF<RJO[.R&F\^83+WH
M#RFQ"Z%?U=!6]SJ7`KNGS$5#M5V[=P+;?FE_RU%X&:KI8;S/&(`2&C:1!AGP
MDURTR$6Z:ZD#<P^M?LXNWE?#\R'#?R<0O\';_M#>I6^+#/^=,?L,A[;JVKOD
MA6]#V)I!O]9Z)0B]W,^.TBN&7BZWR-@BAED=`JV>TWJ;P`^POCB<Q5>CQ'_R
MD_VUS*@,@VJF>VF:,A(JIWH>-_3V.9W>DT@))PH7AZ/?0B1M!&U^I[./T=<`
MHN(]$(5\)]'(CXDRC_PU8RY['C%UW"WF>W])DQ@."MRWJH""3KWH1=%596UH
M.5/&EP/Z'W=HV?9PB]&C#2)P==ZU;*JT]';7:F=FJ&H-+56O$9D[ZF[U-N?$
MUUV]X6XVQE)=$^P$^(\]=`;6P*ILPMZ8@-JEN]HST>K^CC^#:^UO_PYV%VK8
MB_6*8O^'7/M"L#.3&*KNV&OC[\?8Q3E@7K\\!M(/.%]T+8#7W,J14EFINCL%
MO<1X%T6Q_N&XS=WJ^OO<CT`Z&?1#0]?_W%!.Y;C6HX)=A^E?&ZKEN&MM_#U-
M;6U08RWYJ/M\M-:6.1`+'6%R>C'<N1;6-U[@S49$5=Z1$:&^.'.3V^(L3V%=
MU8?KLX&E_;,?S%^ZJS-H^V\!U7(/+)@ZJV/49\D@YM!1;2F81W`3.`T.B8Y(
MYA[<!%(Z.W9][1C&?WAU!CCOH\N@@:3*JU[WKWJ8.+W.0)<.`\E%F[E(NS17
MC[D^78?!QJ3I9EZ$G/S<G;"#KK6.(B.;TT&[*"([0EW/$V)JZR]<]1);#V#M
MG0LGK<[BZ"0#79J++3LK$Y>KTG&WS:==D9V+OWL,`]ALC%/PDI?/84)^]R+T
MN\1?HJ^TYD,FY?8B*;=S^9-Y;JO@J)WM"IG<VA9QA/M&N3EB+JLD3.%^3C6Y
M\LY+%JG1Q!K>6E'4Y9M..)T.PP42);51<B2/=2?2G$W#H*^W!Y9K\=9++5PR
M-*U>\Z4CIWCW.W5_8_HW$+<5>AJ7QNJ.!H?)^#YP?KYI6)=#S=!<T];LH>UN
MW)M0,F7GBWVY^=*J:[_8O\`E8\U,\/WZY#L8=K)ELD9]86^AH&.XVFEZ<KC>
M7E*-7W0')76Q2_0!';X=E-6AAI-GSXB!CBNL^J5Q1HIQ>V$UN;`N,F9]9V4S
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MTJUO"W48%]JEN=H+U'&K@3[R%NV#(!`WZ9-@4%W;F#UV3CQJ7%JM(Z+#M^B=
MJWH[>XOIT1UKPQ$A;]&]I_"EM?K@Z](M>J'[0C-V654-6WVY;KOH=6^,T$9%
M8E>!*UXH<)[/VFO6EI6JK>4<](/*72LOY;?%0<W$K!9RJJK+1[^260)&"(X_
MWEL*5C:Y1Z1ZBLD[S9*GEK#*/F"H+^5C/7F1[V'J5NG39YIEDG^X*J4K\&?D
MXG'AX3":/WJS^%?%2Y-P5=H85=)KQOY4I']M2.Q:,2FH-,^HR%S_3N/$G[PL
M9K!=VOZL4DBS^4&5:7+VP)$Y<JUD`>FF4UD]L4"3?Q$O4@C@=+SD[=Z<J#%H
M(S>E<I%M<U/J5U+1]0:&:NF;ARK8?4I(J6>]KZ'[8IJ]O"@<_*)@.ZJQ5)C4
MUDWA^!RZG!V_TL2["Q,O@(?`\``=/)WZR134O[0=CV$[ZJXZ6..XW<NU8/-P
M1FGB==+$JRKM6&GZ5Q1Q?/+^'49OX<WAE$3QA]D8+ACCU`N^DB<R2_=W=2B9
MI8@HQABU!W^V;,EN;9MFC'WAC9&`XM75M#]FM<>>FG;L:=FCM_Y8+&58ZS&3
MN-T)MS<D0CB\A\85(1+#M;FW<5Z9Q&TWN7?O+5N&[";>L+@6_97>[$6YJN>*
M:*M/QF`+4&OX-XS%9>LUAC$<3=4&JP^*7:!NBI1C8KC!\MNA>DTVUBYP_ZF>
MDZJMO6\C9W6=<\V9UW$&ZM#8S+S;0-T4*<?$<!/FW0K5YFK?WRYP+S+OOAQ-
M6QX,;U9[6UHT"=JA;U.*.JZCNHYQ0`C[CS.]-72MUMHG@"55LTW5-!:[$DO>
M6FL>[(VW]F=];ZE6WYXP&1W'`-9?;>I)UI=J=3LLF9JMND/)68VDL:,ZM6U#
M]=T)TW!@6:JC24.UD49M34V<LD8UG*%JN:O3625G54AC1S7J&BNUE@:]/F6:
M&4/5L>1U[`PU:.-AF8TM++CMF](H;73L=%2%-C!*MXD.7@6!$B:/)%)&(GEG
M)2(.$(CE^#WT;)8M^>G08!JJ.715?;`Z!-\.4W0C*+]7^+M`SC7AFW;PL/J0
MDZ)\9-KKJNZ:JCULX@N1HMQ9<JYID[H?43[2Q>PL3,&C`-D]B"3:)-HDVO9X
M@VL^N9F65]4^R%N9!-V"2;>YIFG+1+4V3OX=@1NHMF:H[J")^V`O=#H0\??^
MFB/145_3R*<-+-2_BIV(U/:#[)8Z<-R&;G@IOMVCXZ'%]^SJ7$O5CUVO?,UL
M+?R](,@B"BZT2WU%=3G^+",O+X_=I=ZUNK/.]61"L!$/^3`;P2IWWO>O7D*^
MDE$X&_F!3QOVR*EGW>CH4F&]M]8<\T1F=&U3V"IQN'MY93,<-KG+UF7Z]P0V
MZ`6*3_68DGC?E7LR(Q,_4;PDB?S[E&F;)/RU-@E:(1WOAK&(Y2V6/?3OCK*-
M?0^Z<P9T`MO0T73=T3</"R\;:XN=*=^F402BJ81S8#X\*U<'KCLY$6_SX+9&
M@_!,RY53\-8@<X<I>*Y>#[.]:CM67]!N"-AT,Q0U;S96[OPI/*2\\\%Z!?D;
M@6'W>D:2DV@B#JO(ANH<%X9K[0,7'>#O!?MI%=O_TPM2>JXH7A"$S]@%^5#V
MJ.RTMUI$A^N/.=ETO><4-C1SCP3N\KE;\D:6M9*1::7/)%'F4?CDQZB9)F&D
M3)9N7]LSL6RWN'6[Q?H<*_NO]Y:H*YJOM^';K?81OR-@94=D#`M<Q3%)XJO9
M^*/OW<,:B4]BZ1Z6[N'^N#:E>_@LW<-"AU''L(=:3+J%^[2-?KF%T4#F+N'9
M@Q*$<:R,O"AZ"0'BLW80&ZH[-*2+>#\N8D-UW/7WUE/S$DLO6G]]+*\WZP+I
M1^L_C3>II"Y-,#RL!VV\9))*]TH'W"O29R:)VLK$F2J77"-76M$;]Y7$B9<0
M'&1T%]Y$?ACA-"[NV-N#[VU>Y-)?FXTS*:7&+J8@[^JUJ_##;<KYW6Y\"9+P
M[I'`K]%FQ'L<O&4:*\\D(DK$R#%6_)F2P$/H%%&N9K,4\//>GX&%Z<-?MX)D
M+"LH&V/8&G*K\H[[C?$%$9,HJX&R$J+&_E,%'L6GBUYU.:SHF&,WJURX2_;P
MLAEI7UK9&34FHY!E'OZJP"M)A,44[%U\:K9R^TC6F)95[SM@@9>^R?V\!2C;
M>\-K`1.42SJJW4?P4(I_W$3DR0_3.'A1V(E!=Y!F<ENJ\MBN<*@)Q22U]TKM
M*ZJ)\A-?TODTZ<RM\:,(\[XC(;IY.5P:!))92E4G$5WL:C2"UR0QF,8CXC_1
M2]`&-S0=-MW4VUX]"*>><UUWS,5?%V>5JO9@H+I;#SQJN),C['[%<"+FJK-M
MU;`WS^^NGN6RP>$JMCS<8LMK7KCCEH'@NJXZVNHVOS5@.+B<-A-+7@JJQ(\>
M7%OGWDNE8&Y[,FR@PDJ\8]NQP:!!O?LFICGL!@#ZH=M;Z'75&#JJ;3?H%M('
M3L\R/"+&\D?&L@7:M#4,'QIXPS!4K<FHDJZ!/U"-)@.L^L#?5_`YWO.]`)[Q
MJ>=QY,W]JEY,A\7V4'4`WXXV["N[Z-90M9P&33"[!?Y0'3JVJJ^QW7K)[YD^
MCQ,6VICB$'CJZCHRPE\;IJFZ5E/]LFP>'QAL<Z#:C97ZT:'&*;16D]9F!TT,
M:'Q)3J=I0"-'8S+Q1_ZR8_;0Z+74@0['9?\8PQJ:JFXV5=M'!]NP5<UU5=/>
M%?)NL/2^CL&M6GYM[>*46^G?5@[!_XM1N48!N"S\KX03Y<OJ#B&]H,@/K_;&
M7I+AN\/PM3V*1SY&+=6U'573&TROZ-:M#>Q:1S6<II>V8YLO6_0J[1%3<S<Y
M^8Y7S6.SN*XZ`T>UFDQUZ!:+]]U-/ASHJMF>AND&IW_)RM(XE[=LCS1WUJJN
M8ZJNVUMOLTZ#B+WE<U/5AK8Z:$]0N\'G6&'!NY&\Q@+,8Q^<AFZK0ZNW3N;>
M>EO@"#4:ZQ;I:I'7-;F5OKI:WGKQH_(^")][ZFHY,^8ZH:UTXYR0IH\T?4[,
M]+FE.0#AG#K0%3^.4S*FC0=C$CWYHZ-?8G57M?O+X8ZM6G9O+["NI;IN:\E'
M'>+WBWLO!C;O4.:+Z;JJYO8VK7&K!)C.0&^9MCK03RRK\>VC-WL@,68S>C4J
M2`Y\A+JVINJ#IA[@8Y_\&RHY.L[FKX>HT/6FQU$W[98">T?=K,3`3M?#U25/
M'6>6OH>8='>@NHV#P/W1Z>-N%66\MNRUS:BZJ<][7HVA.TZ;X&^>>MEBBY`?
M7IUDDQ#93:5F`YK69G>VBO5^([@!6F]@\^%8N89-C)5;,D_(])Y$BJFIK./2
MZW3FI6.`=/SSKQ+Q+2*^%C_+3D*'[N=?%2_;%!I;)/OZSA;+38,:M+?8K8UJ
MU>8.T="^%H*J^_CL&2,GC,_%3CD2D]MBLM2+9B]HW'/'&5UC_?:K;,FZ%"KV
M1SG$;ZQU?44Z".]6>USJ`K3='NTMF[X<XC?&4F>7?>WQD*Z9)LICE5-RI2:I
MXUNH\^J?ZBFL5;2I\PIG:*BN9NR^GWYLUQBJIC,XE]T.=5TUG.$.V^VF2%;V
ML3D%:=3-K"G+&;"G;CGJ<*"=S78'NJJ;NU"W)(WUA$I9%-8DG#>`>4-'G8WX
MVDY5;#8JME9!^V.$)4RW!]-0M2P7-(/>1Z0W7Q=9]$0I6>RC).G87SH.5=MU
M5,?:8%OM!^.'/P8V-9KJ#"N?,,O1EEK:?G5''3A^EA0_%,5M2W6&&^QC2?`3
M(CAVG1W:;8OX#Z^*D*S-`LS?`C_:X[5B19,WR62'8#)+'3H:\)DE-<OY$!TH
M;FC2>#@CBMNJ;NFJ-MBKUV!GHA_>P[R;,W$?I;02K-;`.F09?KMI1>M:(=9(
M,.HD-218'>7=^OQY]Q@1HGR"KQYCA:S(,I6L>>)@=3,._/74PK^JZ9BJ9KC[
ME*<N;?AU_1#PSH9FKQ"CJP;:[X-=.*'3,EO11O04Z&8;KJJ;&QPKIR._YY5.
M9=N.:NN[Y*MT4R17]#L]!7ETAX9J:V<CCZZININR1$YGM[JJ.0/5XK7AIR21
MU>W)3D$@7Z-/TC8V.*+/T.*KYZ$_1\18V#RZEDVU,V(ZZ8'Y[,^D`^;<P6J;
M,VMSWZGY6$Q5M\!HT,[FUB)]+*LNK]@34;6M73CAV&)YHFX4734&EJK99^,(
M/0-'R@^OR@1V#=4R6[NZY>EJAY"^$_:8&%B!IAKFV8C>>?E,#-4<#%2C4U[,
MVL"?L%O$'+JJH]<Y`<[+2)-ND56(&=BNZAIU;OX[(T;FZ/73:=!1L$XD1V]A
MAH[,T3L'L&2\2!I&W4",-(S.T3"J`_+:R2BG0&)3U]1A+0J?Q)W]O#P4EF:I
MCKM+RDXWI;+6G(M3D,Z!Y8)T[N+9[=5VS\!U7R2N,P2K8Q=EU'GIK!S(<0J"
M^=JT57=3/XDSM!C/K0^=KJO#6FQ00X3W/U_D)(=FR,$++4V\^.1%HT?%U&D:
MG"6G71QUVL78?\(_*TI&RV2BO^(/4W4CIV3(*1E%\$YX%H&<DG&&4S*JFVG5
MP"7\4$[*:#8IPUR:5]#U21G&0$[*J+N.G)3171_*B4_*P(:_Y^/6U`?.CEZ"
M7FW7'=CJ0#N]2M+3'94Q&*J.?C:5W09L=U@KVG\2V[5,1[6-UL(,]:1*SLHX
M@;Z7AJ/JMJTZYE[[9N\+ZY*:BZ&9,YJ7<=JD!,$T-6O?38B[<QST9F;&:;/=
M:\NV5$O;4,ZV?]QTK//UB1-='ZK&IHB^I/EIT=QR#'6PJ6/BD8E^A%M)UT=M
MG#A7&C9H(E>U-Y6Z2VUT6G2W75UU=3EPXZR(#L(^'.BJ96^8\MJE4^@@KNJ>
M5?E)L+H6^9`S-WK.)!T%JP[OTB2<6K/U.KQ1"5;75)J<=Z&KINZHIG4V8<W7
MA@.7`K>%TIE^[%=7C:&K6L:&,=G]%<43[;]HN4-UN%./L%YM=V"H@YUJ&GNU
M6QMOJ/KIE7"><%-&()BCJ[:[BQ[MUX9KQ&].:+>J!<?DT#Z]8_*$&Q,-;!/,
MUSH9HW66.R'$Z-I0=629^3)B'+`S-/<@'",]O/WT.W04K!/Q\,J.C6<(EC2,
MI&'4#<1(P^@<#:,Z()]^Q\:!KKKVV?CYS\M]80XUU=B4ZM3#,_IL.C:^-EU;
M=6L-XSFOD^F\`@.O31,LM].9M"F[0%:>30-+M08;$A1/AZE9Q/U<=JN[AFH.
M6XKMR=Z.Y]/;4>2QK<`/#N_;"4-]Q<N>VR_>XQ\W%#OW54*^KB5CL0WF/](9
M$<.@91?,XW;!E-TL93?+$G@GW'U1=K,\PVZ6O<"D[&1)9"?+??Q&=K)L\]W=
M]`.==B=+6QNH[OFX-7'@M38\F]39H6.H[G`7CU<W9?)D.UE:0"_M;-C3L(>J
MX9Q/;%335=TYO<3N;9M=]HATO&&=KI]-K&1HJ8--S19/9[=(WR%F9)W>6=FX
MZ5./R(9-5DS#4`TY%+HBD\X<@@@?)(+?*\08<`48:.K0/4CVI:R^:.6<D&`=
MCIUD?YV>,TE'P3H@[];GSXH!A:4`NN3*$P>KFU;[Z;7WP=[;1C^&M%2/Z*O8
M<O[@BNN)HQJ:O)I4,`-@1MO)T=EIL3W15D"VI:F:=3;N:=V%[;IGX_%SP.31
MK99FP7=()D^X%Y`[`#5Z/@&4UXZFVE:=8/5YG:=#=Z#:QNFYKD^X,-XVU$&M
MVHSSXN37NC50G5K%P>>&&-=5+;..[;4S8J3+NI^>C(Z"U4FWWZW_73K]SA>L
M;MH[I^;T,U0'6Y6>3_>+U[:MZH8,N5<P@CX`\Z6.*[27(GNB#C]=U<SACLUH
M>[5A`^]EKGDNV]55PP4%;<L&X#TBF@&*U%6UG08I]&K#Z"PQI+.D@A',X4!U
M=AJ9TDWI/6''GZ/9JNO*F'!%*J^MVJ;T_"TAQAW`$6W6L4EV1HST_/73G=%1
ML$XD656V"C]#L*1A=(!C#EN)M6H:E1;L.7*D<73NQE$=D$^^7?C`MM1!K4:T
MTMEQPI(^T`S5M'?QS'93?L^GL?@`G56U8H'GQ=EG%G-X;9F6J@T.8LMT7N1/
MMK,XUI[;NX1[>[7;VF'_D]BM:]8<753C))9]Q;O25_P$4;8?1/4>)T4!7]?A
M^J;85?R6S!,RO2=1EB0I.XO+SN*RL[CL+"X[B_<-G[*SN.PL+CN+R\[B1_Z-
M["Q^RO[>H6VJEGXVI1^6H:O:&0V74PW'4JT3+#H_V=[B%]K%V7"G/E1=ZWR$
M<>?M-A'%'UZU*HP;>FB=0W/QH6JZ0W5HU!FZ?!(,>V;-Q8>J-3156]NEE50W
M#\M3;RZ.9:NV*7,6EI,Y3#ARM(/DW?4+,<9`-6U;M4XU)[%G:=P2K&X?,CU#
MD`2K:^PDF]7WG$DZ"E8GNU95-*M?SLN0K'GB8'7S*GAJS:MT=6!HJJ&?C5,&
M.TS6ZU9_&MM5A[JK6L;I];XY[9Y40WNH#MVS:7Y#V[Z>C0YR@;BJ6<MWTB^9
M/.%^5+JJV[;J[D2T7FWXG`*I+="VFP)Y8IT4BBYHT[54L]8]L,YRIX,8.$H=
M9Q=SKU>[?6T`&]B6#$-TX<HNP>K:B='8]_;9GTG7V[F#U4U;YM1<;V"^N#J<
MU6=S[=4M2]6&>Y\T]U-[P)<:;8&=8=KJL-;8G@YF()ZQ,TU7AZY3<^#224B:
M:1NJ;IS-=@W5L%QU.-S%,NGFF7?"#C53M>'JY@[.YZI*>Y[)+,L*1K#JS@GL
ME_2>L/=-5W5-4\U:E6_GQ<ZOT9?L#&3O^PJ>,>R!JCD'08UTUO73]]!1L$XD
MR5,V>3]#L*1Q)(VCSJ!&&D=G:1S5`?GDF[R#7L`:=GOO+O"N;%BZ/%9*NS88
MJ`.G#B><J+2?3TMXT])`N<MA!V<>I=!U=5CK>.^7'7\.?=Y?6R#`!]'5_4)+
M_8C^V2%FJ)JUQOFT>;KOJ<U\[UM2WU>PSGV&--IL^B^_I/'%@^?-?^7-3M%C
M=A?>1'X8_8MXT0?JJ;B#%[T)X);RMQ]>_:71#P"),P3S*YG\]<>W[.]O@T_7
MWS3]VS^\V3=#T^T[3?O&_N_NRS=3^_:/=.'S'_]6HNLB719Y1V#M)2@@E7[V
MY$6^-TL6/GTFR.;YAZOHAY[(B\>%A\-H#@<!4,M+DW`5CVPB<P5G;*#Q"LZ@
MGTZ\J1^\_%K%[;5'`Y2Y^M+V9SE;R3;EW6I3OH=^R0H'%W>4+)$@*?93-BF4
MK'9]&A82:$&,23EWMNJXJ7A155B@]/(-)^(Z7-7?EU'W-7O<0<>1DW=N/]P.
MFEP&*N3G0+)2:X_O_9DW&_F@*+-8U3$XH4LH^8AI^!\`%UT1B>/J5B9F;T.X
M7(Y$'_K35D%=P/=MWO2_<RJMPK_Q?T8C0B:3*FW'<61;YJ*A%Y!)LADSN"(S
MZ)5XHXH2!!GBN^JL7(-%RANHLVBQ6N+`4+(UM\-R@[<X*QKKUWJ/KEK&0!UJ
MPXYLQMT#&=S#D,'9C0RVI1IK[.)];N80#M4]*)B6"%AGF;=A3/.&;KV`IY[O
M$:#MT-:DW*?6@@[<U71+:QG,E@C2'S3:EJ9JUFK]VBU97F,\]$.:MX-R17U)
MY^#<*FFNULI#=Z#:?,#'^4C[_O#I#AQ5<PZF/0\9$STAN?\8QK$RB<*I$I;;
MOG8.TM;/I=?8`7#(R\[:@_/G<T&?;:BNMMI>;P=[\C3?6JKOR22,B$BM3KSO
M73W3]R/9`[-MD_.<)%M48796LENY<__PZO"2G0^`V@Z/6"Z!91+GPHQ2EGLE
MRRM2CSJ?HE+*IZ"?]"1IY2()YT6P%T(O_"$Q@[F4#E7,-UM$X(5VJ6?L'HC4
M*?C#KQ``/Z-^5895*5]-ILJ<>JK,4BK,K?]]AT28A?'A54R^0WQUA_R6%@$[
MSE;K9ZOL#%@'DU16[6&+))06Z7;(G=;.+=DO7^Y9!S5,&>F;5!\$>_420`ZJ
M)=K-^U@R<X49?('?;^/_*68-;)?<41NF)AD>[61PM)6A0=<QZ-A1PQP<"!AW
M"S14)QVTE2$AT.#HJCU8'3'9!9C#>5O:$Z4F2K'."]?G,&Q[KV]\;^?Y+H8+
MU+8;W,PW<=NA-Z"90W5H-W#,="=N?QP>W0Z$&I'YG2B_?1L:0S6'`]6QG([P
M\"X[L4Q7U8RN,'.S:'2?N+E6O/FPFNRU.S!4;6`T?,^R!_G`8#O:0#6-U593
M/;"EVEW#J'5"J`=G5EUU^("B7C&KK;KND9FU\U;L=B"LC`A*UNP-:^Y'CY9:
M/HZPY>,D:_DH>53RZ!H>W7[H1&]YE+:=4[P9IFB$<VJ:*GX<IV2L@!F`<<<G
M?W1T"V!@.*II-<B[ZY;?8&!;ZL!L#7RI=C=9)Q'Q8C1A%6\T@JTG<:FOVO$8
MP=!,U5D3_NTX'^N.J0Z'#<H%CN\PZ"T7OR,Y%Z]N$7C$X]G4<7[7KL?SP<$>
MH/MN3<!!6KXMJ^#*OGA'U&&N.NAO!,(<`O1-9:Z.`FZ2PK@F2Z^<KE9,>#0O
M3?A/(?_OY5A9CQP_<>)%RSQ]R$3(I5S&E7F+)0)6I1MFF8H[-W1[D\:`R#B^
M&OTG]6,?;P37\%?R\@&3&6"U^`.]'GR)\'^1:3ZG."#UR^063R?^;67'M[=I
M#/O"IF]7\^B;H6G#4M,WW5K^_$<EG?EL%7KXQ3^"/AGY@/P8,P/_IAOVP+6'
M^7[;`;^($/;S3R1Y#,<?9D^P!"+SR_.,1/&C/[\A$>9Y>`^D<L]7\;<OD\JM
MU=CR/(U(<<,&;/A2T_+=UH:MN"&ZT3?8:/QMH<_X511A*U/\_9N7_)$;[P4_
MNGKVHO%[SX_^Z04IN0(D3=EE\?K[G*88O?.??)"A\5=@MDI$O/]7L=V?66[W
MIW\#<Z?\^7HT:"4T['U'74.?M0)]UIFA[ZL?__$^(D0(-[[LDS_SI^ETWTQH
M,2PZ[I[PN&9K'47G3DS)T>GNBRT[@T[O^^&X4[>,0Z*3;:VCZ&R!.W7+Z@`Z
M[S>_\[Z)HKXCT51OAQ__=F/_:P%#>X&V,SBIP51_NS'_-?AT%*RT?:3_,PQ@
MF0`LSM.Q\LI[ZAX*>V#I'16%![+VZ,W+M@^*R7V;)[LB=%?6U"]UYQP0>AB+
MCR+4T0^+T#U;?+LB='<.-8?'1NA-%#[Y,?SD?1B]"]/[9)(&5R*JV3)/_7;[
M;L&_5C@[U@'2(L"-:-8*P%=!$#Y[LQ&I>.XK&1'_"=V$;],HPM#*:B=?%7)W
M17HCV/:[J?8(L_6F@*)S$B4O-X$'HC4;H_MSCF+V6TQ@C8_^I!V3ZMM7%.FK
M[W[\C4OD)X).8C#FG7^5&&P3.,>&GIUX&?3F]M#S@CN@3_@PHW[US^294\V?
M/<!J,_AS1!7A)U!ED>\%UY,)*+EW)!Y%/E5[+5VI/I('+U!BDB0!BW=BI@?\
MWQ2!4<A_4O@V"97DD2@/$4%@,"*J:W_"_R%OPW0>9D'U6'D@,\S*)V,EC)2?
MM$O340`QV7-C/TXB_SZ%!RZ+<946T%'F#C+W_/&'69Q&*!N'4#0#QS"*#%&&
M8&?H=M08^E!SS4;@?3V0@K8URUT"[.N2LFH&4YL'7PF@<!Y]%Y]1R7E/2/5)
MW/XY5OGNW8#:E:LPD+T&L(WJ\>\15DD<`'VF:5G#&OJ:`G1PT+^M?,N;E[N7
M.3M_T%`&Q1EEW_&3:-VV#<,<:/W>]OLT@OW!?0*^?^]_Q[_B&CO7=6UX+(+O
M*%6F-M"<SH*^-U[575MW^[WM0_,JV$CI-`W0WGI'YA&L2:_1\'=`Z'UZ-KZ:
MAE'B_Y=^OG+A0VA@?6BZ!8]*6Z`?#1V['IV.XUK[14=QH?U[-^R!4>#AXKMW
M@&E')-NN:6Z&Z:TW]Q,O\/_+G%&HMV[#2?+L1>1@]HFK68Y>.*DWP70$^+^]
MAPMP0C[Z3P0N#@G<B_W[`-UP)(G?O'SR_AU&;P,OCJDF_)W<4]?='1D]SL(@
M?'BIHP=M2R\2[/20\&5&:N!AH!EVT9U_>GBX>P[K\(,UU`;'%(I==;SN.KIQ
M3$+6L&M.7ZKWCH2>2/7>\5!/JBT+SKKV\5"PH(J6TB$.;]C1P-)K[6@%E`?8
MXXZZ;&":EK;S'JFG:,U//TSGGA\=ZDIR8;O:T.3^JUI0[6$/.])E/WLHW35(
MY(?C]@,/7YY(I'@8'H#E,9B0SC'0,`'EH[P0+XHO-^]J+9QUA6J3)+5Z3=)-
MS1BZ]>1H"P71;"^[VC>NX=2TSU;M9<V!<[B[E\G<V'5A:AW^'<G0$OPWH+!G
M!T3[T'&+(:D5D+0%[,[N&LTUG4;0?DD>2=0%_AX8MEO(MJL%UWXVLBNC:X9F
M[+"1-<\>T7K476M03(UJ#N4!]K@CY0RX_`SM7?=(K8$O+.?K[Y$WPV3MD!8G
M1N3Z^RA(8UB0B>-7+%V-61EBK?I)72OMT!A4?-[D=L2UPM)]:+GR\L/G]X`@
MK1!*;;[%K;!#T^C64+\2!_O$344H;+`E6NC>2KF47D"^3&B'GCLL1_9&U+^^
M*G'\L.P!Y-?M"\VZ,(OYY2LAKBOO!?%A9:TM6>ZW2>0AEB^P3%R9TJ4OZPGW
M$DCU]M)R5M>/?[O1B\EG=5Z\!=*O6;_=SPAN&`"R'NZ>2?!$/H5TELDADFN<
MH6,UILQZN(^#B%W=%_;`JC;?VD'$QGI]MA]DTK3B&EGY>39(Y,,L3J*4ID"S
MX/HL3@/,C+MZB`BI#*^O.V86LK`KRO1K[L9<+7(5G_L)ZK,/LS$6,Z=>0/?R
M93+Q1R2J"[^E:Z:UF$:^TP8^>5'E!BH^K]S`W2.0H.$NQ&'?G5UPEO+J<Y)N
MM[V'1E[JM@5#/]YNJBGRSL=Q,V%MGG*TP6)%51N";:\0;+MM^'7#WHM(+&U@
M^?.5[,3<6?"#/_!<&#_Y<1B]-&8MRV[,6C<1J),;$M'/NG"<P('Z;4ZB;Q2@
MY5J^%=LK;6/7O1Y,0ZS?ZW"%E"WME5Y9?O>PHBFY_DZBD1\3\9"_PA3/;QV[
M*O2;P&/Y\E</Q7L&K2G?`-DA@5]%IULR2B,_\4E\DT:C1R\FB_2JO96*ZU0#
MECO$5NJRGE%].5PM97O><;:/(^V3!8?"Z=2/L3(MWM`]:M_"M;KZT:2EXZXC
MXEE5("_D,4:@4NB8H?SA6O5E^]Y:A5/6*9M.:X'/JQ4XCWR9<.G=Y*7;]\96
M'-Y#S=)-5Y0X+`%=$C=DTJO96'S'SH5W(!2S!Z:.J%/J)N(]'!>?WX"`6S+'
MC>IE!&@5GV>M*ZF[B4L/E]$(Y/--&02&BOQ7K`\:!O#"&:)*)'1/PUGA^?6A
M'=NVBH'!75%S0#0?7H!T7=<,7>\1MAH741Z?(TT+L+PGCKR>SH/PA9"OA$8M
M/OK>/1:AP[X.HK+7>B`J0C%665]OA+Y4:L$J\04):=O'V8C@8+P#U*,/%@+=
MZZ#9">K!IR+4]J+*Y7<K>[]09]]6\&5U^X35@=A6R6":CKTD2\T!W==><UW^
MGMPOT\\8+G_>Y^TVY=556N0YY#JDUIGE.@/-/@1.V!W[@/R^PA"T'0WX8...
M-X*;6<!7XS$M=?>"W\/H#UB`NYO6!60SUK56L'0=";X88(EA,=Z\"I1=8&TG
M<K,%K._3('AYYP?88V!-_'\GC"[S"`+JE`!=AF,[$+=$Y/8@YN52]\DA#_@+
M"XP3=R&LL`1$<PA;/<R;`;AUEZ-BJD/\@:>VUE5WC6+&JT)4NE/AMFYW*\?'
M5!L'@SETEB,7YX>H;_0E624T/1Z+$&*E:EVGBVU7!(/.$*4M1=9<>RDTV#XR
MBY[X6+CB-P4*#IP]8!</OR58M]R%\>W+**G<Q=+G-2%L"<`]V,#U\(='XE<R
M)JP[W\=P]I"0:(J?7K&F4GL-G/_3!VAJE>,5=[,)YE8V5WD;:W1+6RG[;>PO
M\^"/<3(X]5'<A;F]?4,;1G%SNW#]V6R!Y0+/B+@PN,.L^GR3R_"JRF6X/A=.
M+ULTNVQSK^@ZC'MUO<]CP<H]<URUZXK>$VYOHG!$R#A^'X53\="7"2"*CE*[
M#Q:<V1V65,,=ED6UX=;:QDH'!%)?S+?;`27KG'5L`8S8EA;+@_NG(H6`T*%;
MUZV[$2NU'9G;X?<88KGJNBN,P':V>V#$+91QF%6?[RJ\ZS),>XBX/><='!5Q
M98"*4[9JYQ(=3B`K!U+HI2-A\V[VLOM#2%47=W\XT>C.[EL_ZOO#]@<W`UO?
M.H>#NVZ^1+16,IO9F:G(MUX0D/&;%^'BX0_6BU(=[X0U%P^*';=[(,Q5Z8MC
M'[']P%P39^&>S.&!Q%S;=[4#2K=/Q_S^FD_[771JTYSSSEB`*]/FT6?REU_J
M[:;E?1]"WZ_;MWGP?1].6W=AWP>W][K`Y,=P^/5XTY4J7NCEZMZ8*\M_C$O#
M[O6&5S3!7+EA[1+;P?5YPYA_OD6)5_TMBQ/_+B)>G$8O5(:RDYZ:"_]#@M8*
MLO=D*NH+]LN&W71PXSO=+K;:.,VNR^HI"_Z\W,U'N:1ZOO`1:+].D>L+68-U
M]M5I9&Q]JBU5C6^%CSL"ZBCRHA>FG;#PD,Y*^#(1GI"M?-M&U>?M!SD7P\`U
M=K/:BY6G=M3)0N';,U98L,8AM[U^'RWOV%RQ8_/4=MRDDW_[.W:T;7>\:W+B
MES2)$V\V]F</[&"IA21C!9+RSVL<<M;0TMM,6EW:RO'QU$9BN:X/*UKMG!:>
MVLBUU$VMW;SR7N*IS:QRJZK'4U<1>OU][D?T-UFJ]8$J/RX,RW%;U605>SD^
MJMJ0T0MCT"Y+[1E3!8[]G:`3G(ROP+KV'LAFW\%.9^9Z_X?;QESX9EOL*E:;
MMOM<AU5'8G7+"M0UEU93[S96XT;5.XTQN]LHC#J>D0/NL+N(;9%A';/_N!4K
M=XYOFQS]K6ZRT^AMAWM/"+U+1ETG^!?4PX5^V<A\;7FK'4=S:UKX0KLTW9Z@
M>=6K67R&ER"U><UJM7!\L55/F[M=0N/]YH7O%Q<N/HX57-6QFJ;BOA4.*UHY
M6N[27:R531X-=7MBOXJ2-<<8:M9!<+<-/W\.9TQWL.!2'FK;F\>\7NY`_>[@
MAN.TXVII@(I.HKY)1*<5U+-.,!+U[67,U$;]T&;=9R7F]YB-5C<G7B)_#YEQ
MJPPYB?IV45^9H]<MY-,^)>V_++\LK1SVMN_,5QSOYEQH]H4NVK'L>YNGB,]<
M?2`^!Q>:<:$[$I^MZ`3.H>9A,;I'#<.'1+9SNV[5J-NO9N7[[@QV#VTRBWD-
MO4=QD]YNI\7"I89R'<'PH=GXPMZ_$78H/+\/HPGQDQ3V>34;%WS77>#L[['_
MZ\P/_OHC0$M^_*7#J#@X"_(+\'Z9<"5&]B[\G6+#)?$W]N[M["JN#\_GAU"U
M)5SOR<!>G4]T7)_^YG+/@R.DNU38FZK90(7]W?OZ2(6]*:'UR5H#][2HL/"F
M#ES*-Z0;'10/743\D1C?.%W<BVO6V7.]0$0G47\4OM<NS?T9/QW`OC!Z.\GZ
M+/T1TZ,/C8Z.DN`H(G!A7%H'U$"')\%;;,P=!%V3@PJ_5R?Q<1RFU"^M@RGF
M(D)63&\'U,3^F##6_4I&Q'^"=Y'H#H"(O5$'4+DX9Z["=]AH.T5$?)G31V</
M'PG@.'Z?HK?PDS_SI^E4S%)]EY):LW:W+`A;'*UB6'HA3[89@%ML[</L[CG\
M%_&B/<P)K)B3XABZTWAW.8Q;;/`0V])U=V#:C?=5:L@9SK"I+F=</_XC[[+;
M3A[W^MZ_Y6*-=<`<%.AO2V]X\_*&S$:/4R]B?42N@N!+\D@BUGBG:L)L9:=C
MP^[E;E%K>K.7JWJ;-`=]WN2;FI0T^KS)M_4VJ3E]WN2[FIOL-;M>U]SDX=FU
MT>'6E;.AAD6YK[/A"&JSC=TV.QN,?I*TV=F@=U'8VCX;^KW)FF>#WFMVK7DV
M--DD=2"L>>@N3+S@`(<#@[H6-"7:L`OK>X)W]>#.^W[]'1T@!-!')G[U37NW
M0O7%>E2]W/!_/3SM@K[C;=.TW*:P4_KP!S[,1G`8YH_%_#F@UM1#C\S5;'SG
M3^'V^LZ?3`@L/:HUFF]'@ABNE8^4W0740^UW5Y_!0#OL?NFT03")PF?T"NZ?
MH!>&9M;>81FXO6UI5YH-W1UV).1UQ0_Y[Q!P?Y8"C;D7J:TTPK4[*ZB3YN#M
M?7,[DJVUS;WCO6;AAU=Q3)(X=_2%<?S6BZ*721BAA[Z>-W57E>FX9NDD:`#?
M/K>U([D,=VCL95LHDBS$LE9E')Q*RW#M8QM[ITK#;7PF;;69KBO\52"T`F)[
M^FD3B$>4S`O[Q[\-APNAMWJ2N/JICV#-)$S1?IG]UE(ZS8]_H]%XHDRB<*H8
MFN$HR6,4I@^/\`_3@G]XB>+!]]Z3YP?>?4"4)%3"R000KDQHL$9)O._T"Y^>
M%)=U=KRXER(&KL%<&R7^$\E.'IRD>(CCL-K%56@G4Q^TXH8^^MZ]'_C)R_LP
M^FTV]_SQV\#SIUAIP?_(1L_S,_8KF8=10L37]3OK+VRWXO.UTF4MY."W`WD1
M%V_2V)\1X(9P>N_/**X8^AX('3B11Z2S=]>(*&O?_I%2<MN+^U_Z?+W0+G6;
MV![>'7>]7D=]\J**[59]?IO>Q^0_*5+H"?XK[[!4_KQ.6ZK=45.2"M0)XOG1
MRSMOZCV0^!95#[L0[-_8=8VR=V`C2$5O4N+C/L76?!)_)0$H@_%=>)6._>0]
MX3T.VQQEV\2_U!"^LC<P3KY,_AZ&8]C\BKE&YB<*^M4\JM0[7.YJ$L(QX=&2
M1Z\$P+YA^_8V(I11L2*>20=@Q8O\\"8B3WZ8QL&+4&PU!,6V-,T:MK:;P:<U
M3-(4T[KAZK:M'PVXEE&M:^9P:*_'-14(.+!QW!4!D:+_^V'VE8#>2PG-&KOQ
M7J@%LW?T7YBZ[C@#+J6U@#K"%EHFTL5@.'`&6M--9REKF*S&>D"^2R/0S:P/
M)'T\KLX+W#!OBB-BZ?1<_KS1Z?GMSD\PN^[#;(RCHE(OH,^^`_-ZE(11_29[
MY>:9S;>?IY%6_#;T^6_?>ICPN*(<I8"L-*A&UM+GS9#U'FR&V<A'!Y-(R61Q
M(&\.5X,`+)D_X$YW-7[RXS!ZN7J("$V)K,%OU(H5>:-U,+`BW[,\$T]T(=V4
M[9ECCAMC2\?Z\N?9[OB\)S$T^2:-1H]`W=6[7]5_PZ3_J<S[W+BM)NFO7SJ&
MCZHCHFD.[)>5R*`::O.\@_H;K=88-P$P)MT^FG#+J1B;B[B6(<9]C(G_ZQ6L
M.\:UWY%X%/GSE70K'QHU+E9_^S)3/GDOBJ4J^(6J/!-EXJ.">?:31R5Y)$I.
M2<6;C97K[T!-L+454%Y3/\;Q@HJG1.3!CWEH5(E%*K0"_X!;Z%2YO="5U^]A
M7>5S>*D`DV/P9&AH/\,+'_W1H_+LP>JX2WCS_0LL.(_(!1$W=_8579$!!^O"
M7HBB"["3D(-`(@ITB.$C"F\,C`/_5(:6J^JFJS#APT_"%!O)X3!U@!CX2E5^
MTBXU35?F7J0\T=L,$(S]0,4?,%"'FK6P4'$1ZG<!M*3T8$_G\#G"0T0Y%2[#
M9[5>_O#J#K[Z6D1=ED5.,0),$L!Z8R7'!"`'URL@/\/%@"&#+NO'R@U851>9
M\T/)>(B20$>,X4*"/+]<`=3*/0%MRW$,#_BS49".":7O$VWWXN$U1`GG_@Q?
M3?U/B$8?"#='ZL'R])$P4I7__?@/Y?_QIO,_X_\K5W$<PLF1D%A5/GZ\N52N
M@D")<]ZB%(,W/,)_(P<`&ADTX@O*9V.X#[W@/U@/0'^6@F&CW'NQ'U\JOQ/Z
MLUF89,R`"W@S6&X,0`'(7NF=*4",_+(&6PQ.P`A%#-R_@#M>N.<,09@1ID4S
M<2E)`E`;/@.R%U[Z#+M!]N8VF8(>&B0K[&/%DOSM;+&,8I=_^665;@"]`9KC
M_W=Q`0^'">"#2C%=].("E0JL]\>O$_[=1_B'\IU^E,#Q_]<?09-02?R1?QJ%
M`7SZF"3S7W_YY?GY^?+[?11<AM'#+X:FF;_@U[_@@S_BTK\LK4T_Q9_XO^)_
MPS___U!+`P04````"`":@CY'`1-GF*8*```3D```%0`<`&]P<G@M,C`Q-3`V
M,S!?8V%L+GAM;%54"0`#(T0,5B-$#%9U>`L``00E#@``!#D!``#E75MOV[@2
M?E]@_X..]W4=Q\G>&FRZR'5AP*D-)]WV/!6T-(Z)2J(/*<5Q?_TA)3FQ9?$B
M6Y&H+@HTCC-#SLQ'#F>&%/7G7\^![SP!99B$YYW^T7''@=`E'@X?SSL?'VZ[
M?W3^>O_C#W_^I]O]?#D9.M?$C0,((^>.T\PP>,X21W/GYEOWQL,1H<X_:5M.
M_^CTZ/CHQ.$?'^8Q91Y:_>R,W(A,@3K'_9^=D^/^KT[_Y*S_^]GI+\[%G=/M
MBHY\''Z=(@8.%RQDYYUY%"W.>KWE<GGT/*7^$:&/O9/CX]/>FK"34IX],[Q%
MO3Q=T_9[G^^&]^X<`M3%(8M0Z+YRB6:*^/KOWKWK)7_EI`R?L81_2%P4):;2
MRN5(*<1OW3595WS5[9]T3_M'S\SK"!M0XL,$9D[2_5FT6L!YA^%@X0NQD^_F
M%&;G';*@SUUAQ^/?3H\%]T]7)/0@9.#Q#XSXV$,1>)?(%RK?SP&BCR&*.5#@
M=1S1R\?)X$65T7CRN2>^[)5HI2?D=9'OQGYBF"&7;DMN>(Z`M^:M)1<='-9E
M,DJ(N]6++W`A=-L\62>)\6>(31,$8M9]1&C1$V;K@1^Q]3>)(;O'_0R(G[*O
MOUPP!A&[BBGEPW[=@8^FX"?=?BFFZ]4LY15B\XO0$S]N_A?C)^1S*=A%=(4H
M7?')_`_R8U!(;\:?1_N";BN(J+ON@W_<@GIW&F04/18'0=):E\,;K/EGE`0J
M`Z_[)?OHX1#J`>7^CKN[F(&824(`Y'><)>#'><3_5#N$%ZY+8B[L!%S@@D]]
M^`"1P;A3L=D/F%KK#*<3FW`:4U@@[-T\+X3#T@-43&\_,A(],TA.;8)D%,V!
MIDHI@-BDZKVO4[Y;'')`AO@)O$'(XX]'S,=Y*@D?[0J1-8Q<BZ:&4(')\P-(
MI[69$ZYW%5W@"/GXFXA#@D4<`;TGLVB)**AQTC#:C9-.:S,G7"=.]^#&%$>K
M:U@0AE7`Y"GM1F)'+S-G6W\XK(V#FS2TVL:YM<\^)S2F9`$T6HUY\A/Q6%;$
ML0N1<ZM=D)+-6C34RAIZ'CM5VYKO]DWD(493[.,(@T%R6T!<L]O)TH0Q6HD<
MX8$BSR#T5G$U.&[DII=E1X5JV^>Z<N).P!=EG#&B9J/,B+V-N$D,85]@Q>6F
M,7BE?(.<IRU0R52NTFGOUFK%-U\F\`1A#/=S'FQG@T5N<1V'U?;6JIM9^Q=[
M9L,US(`+YV52ZZ>"A,%J7'3*9K#\:@\L]Q%QO\Z)S^5B(EZ,5JH$<)>XYIH"
M"0(2)F)HB_!YT@8'CMS(.^6#'07M"TS&-!O=1C@44;<"BD(U[8LR/B%*D=B6
M";V)D("-XDALRXI=9P4L2K96X*-6W+X<\<+S<"K#&&%O$&:50E4P*.%H!3Q2
M=:L,322!8")E%A+)0K\M&JLM6J"2?7'$.N(116\(6:*Y-IY0,%F-B(G2&42_
MR2'JUHW1!"*$0_!N$`VYDV0\6XN#.,FFN2;851;_#9A;@9F)$3+L?K=G>FVD
M'GR]*Q6T:UGMR*B4:N5!5!08=(%RVU0MHC2,0GNYLV3O?_SA]5_5!^/N(_Z_
MV&Q@H]EH`33IE>U_1$[7WIL>EM-U7O.1C+\I86Q,R4SIH3>IZCXTDA4Z5'N9
M+R2-GM8I,.7N"K'6I=J3;095R^Q\D$FY<DUJJS7ENNF]5[>!4T_I+`\?,S&5
M9Y]V:&O.)/VD<>ZFA%TO$<M%H-)!5+*!)L]WR.#823,-;6%?&>T:%A1<G-HV
M]"X"0B/\+?E5F3+)N=J`EU)K^ZIK0QZP/2;2W4,4^4E,H)]?*JXV@*34VK[*
M6G(XY(JPY,Q+*N:+JBHWKF)K`TQJO>W;`GP1;A"Z)(`ACQU,5MD-:AM0V14^
MC\M65&1Y6EI"K8)Q:1C*U3G(/I"0;.ND]]=RGGIE'X014$CF<S*W4UD4@DL8
M&AQ/6O/G1Y5,9_L"MK6D^O&4IVPC'F73M7J16/NJ6Z[P%0FY=C%7\+54<PDS
M0B&E>T#/P.YP2,1I\(WAMMU*6EN[@VA.^%^>.$E2_U&B7)\4#8Z@!HPM77DV
M%RG+%U8+S*:8^_9E6A\@,@H+M^F:]*Q%`N]ZTQI'@8U+9J96-O`N(01U$5O&
MT0Z@"S0U73X;VZP1CW??^F19T5Y-07.U;=44]%US&5D\;\V%X,G?$^8*7:X^
M,O'`YLL"=N%&^"G9!%2[.--&ZBZ3[^NE&]RC*`_)SCJZK;2-]QV\13&YU9A5
M4&<^<%\OV;@?)2VS`6,Q>+>$W@-]PF[A[#=@:BDF)N;05Y4;V!3\&^%0S/E1
M>(U9\A0QEVDT2Y]#[*NVXM6,+<71U"SZRG,#6!;O#RHPE#"T'#N9&<Q.E-8+
M&5]T*7!1KR'].0AW+[A1IQ)Z]I;#:68BP[.H3:.[?4E.*61SK-\=JGG3Z$^H
M6H%H[M'=O2;KZQG][PS3'>-DH/Y1VW$SS2,21:0M14&N>F;T=_;/I-R3U64G
M4YZ]I4B6,]%+KFYW7)-[7K@4M'G>[P[7'>.L0;6J`B/1/"W0'UCY*VKDP$?D
MQC%UY]R\;#1;7QNT>6.0;$G0L35;IB\)P-;BH#6(ONQ78A]<A@J*>%_IXZQ2
M"#9I6FSO+54K/60@,>XGF#*NTC5W(SY)0!5GYZ1VEI&WU^12`Q@6WRQPI[<X
M1*%[H#LM:J3V:^E<`"_9SA7%4'$S]VBV<?F#0BD]KWTC5`%;P25V.M/8M\_-
MLXED"_*6T`DLLI5D--,^FZGF:S>.:I,<N"U^P(;X=BF%78OG@7VFVO.6<%2U
MK2UIOKTW<=<O]2!D,<U>1:$1^)6TT41):6[)[>$;6MJX!YU).3$:-Y/&[VW?
M!X')&URD+TL%TAZ'\(C\6Y#O&._0V6]4B7[&E^$7K`D'K0=IMH<VLCVC14'.
M5MW*(.^C]LG]%A<I6Z)#\L#./EJDC`W/.#TPQA=%9X:P<779NJ?E]6P/_^Q#
MP2$?J8H*F"OKHG4#HCKCFC_<7ZT7_P33Y%3#`[CSD/CD<67@P^5,57EP>0^U
MO]/JK=[&88T>.B^N96UTVIH!5.)U(Q;[<H74&Y[(\!#K'HU]7T!+35;Q12N2
M1$4AV2#@(3Y5[2>9,;<(KS(F:2KA279>>$Z1O`$A0/2K41%,SE59NB/OHF8'
M]7;O&+-&#]UJJ65M=%*:`53B)6H6KY8;4J<SI`QV6QSMAFQ;>1O?9IE<8'#`
MG#/C;R&*AH:Q\768"JG+QZI[--9"M/<QF?DS(]4&0R\GTX;BL)E)("3AJ"H(
MDC3?U'6(J12W<113N..X!G&PWMF]5AY4-&VAL8L>U7+I-T!+-M3H/"X)I_3^
M#4.;V1A%&>HP"!^6Y+^`J-'59,9M_0O0W[2<<7!6K3/?N$7#P)$74%?EQ`N:
MKCML`8X`\B774A1=1*(*6\HW5GM),?4]F:1E;AS1<38;@.T-XTX!46>@6BZ[
MENC#,BG&0`,40K*I](`#KM@UGLV`"ZYX9OZ@-EN.;@5&K:=*K)$Q>;V6N,MY
M*3G%M4<C_P)H\V8SOT7AK1?>?KF5=_=.A.J6WG[=:^_Z@24NA$G-N)"\_@MD
M<D*\1GV$L2M$Z6I&Z!)13Q4HE&FET>FI@DCVEB<CT]B8^NPH(-Q&:G.%QRW#
MW5XLBTQQV!F6GNAXRC,E_LO_`5!+`P04````"`":@CY'V]\]#5\B```Y5`(`
M%0`<`&]P<G@M,C`Q-3`V,S!?9&5F+GAM;%54"0`#(T0,5B-$#%9U>`L``00E
M#@``!#D!``#M75ESXSB2?M^(_0_>FM=QN6157Q73.R%?O8[PH;#=7?/&H$E(
M0A=%JD'2MOK7+\!+I(B+(B"`+KUTNVP`S"\3YX?,Q+_^_;8,CEX`BF$4_OIA
M]/'3AR,0>I$/P_FO'WY_NCK^^<.___>__^M?_W-\_)^SAYNCB\A+ER!,CFYQ
MF1D$_M$K3!9'EW\?7_HPB=#1'WE;1Z./XX^?/IX>X1^?%BF*?7?]SZ-[+XF>
M`3KZ-/KGT>FGT0]'H],OHY^^C#\?36Z/CH_)AP(8?GMV8W"$!0OC7S\LDF3U
MY>3D]?7UX]LS"CY&:'YR^NG3^*0L^"$O^>4MAHW2K^.R[.CD/[<WC]X"+-UC
M&,:)&WJ;6J096KW1+[_\<I+]%1>-X9<XJW\3>6Z2J4HHUQ&S!/G7<5GLF/SJ
M>'1Z/!Y]?(O]2BY<QD^JS]0;^.$D_^,'HBX7>2@*P`.8'14__OYPW:X&P^3$
MA\N3HLR)&P3X2T2&+\EZ!7[]$,/E*@#E[Q8(S)@0R^\3R7\@,O^#M';20QK\
M,PA)KSGVP<Q-@T2A;.VV%4D:+5T8ZA$T;[J7G%D3QTNPQ,--I9"-=OM(N,#"
M("]]!L<5<(5RTEKO(VT8)1.E0Z9H,).I%$C4>+1";\=DVOSTX_A3ULIY%/H8
M'?#Q#W$40-]-@/^8X/^2.?I^]IA$WK=%%/AX4K[\*X7)^L/1-N;[Z<-_3C*0
M.[364_YVBQ<@<6$0\\1D5^JMS>42)@1K/`F)$A*\"N+5$()80BR)VCWE>P!Q
M:0P)>2BE^UHK72Y=M,8=`<Y#O/A[;IA,/"]*,ZA3W&-J8)_`6Y*Z`=>0N[37
M$\,417AF2-9NZ).^LY)4)J]:3XF^@N<SO`_PGX"W"*,@FLN,`7:EOOK!709;
M(?2?D.OC#0_ZMF4`OIK$M7N/@8#,2E,7&P-_)(Q=C^S'9`:HJ*J"V2,*L\E)
M<K;8*MV[9X,90(C,V+A17Z9/TRJHF-'O5YEB<3_XZB*LZ:30L4P7DFN@[YAK
MM,H?:5M%U7YYU.'3(\7?EK$&JTI/26[=/R-TGL9)M,2+N(05Z!5ZKV?/,?@K
MQ3/6Y0N0ZPVL*IDD^(`!0TAZ[@W^;$,@K#>`-U=^*1)I3,T.+#LS1U[C:P$Y
MI4:(NC7-MJ4S-W[.]J9I?#QWW=4)T<L)")*X_$VFJ>-/H^)8^H_BUTXE#(8(
MKO&/<?F5P'T&0?9MAUW8^92KRH3$3^[SID_PI,T*.J-MHTY04V9\-BA;*XX)
MG<[=,Q0M)=15?C(2"'L4(=PK?OV`:Z0Q(-V=R$PV8/G1XXN'=Z2X&UX&634\
M1L"<_+#Y>Q#ACO?KAP2EP)R1\EZ-5\=5%&9;Z3<HU<-H]9Q3'2;D'%PY)JW,
M)#`G`P?3NOLVU)9\%PT6A&(@:GEGK,,P+&Z&8Q66MNE&8F%Y;\9Q+NI,F38C
M-:D^W5:J0%ECK>;^^[9!U5&,12ON?-9B(QIYV+8/<SC0[<*0WQISU$YD0ENT
MRCH_#,<0-.%+*XR,FZ$X<0A-T"CG_#@<]6\+7JK^U+CJ)[X/\T]/7>A?A^?N
M"B9N(#0%MY[STW!,(P)2FFK<PU3M8RCYC9,-QZF[)MM$IL(9)9V?[5<Q6_12
MJ9^-]_^+8H$B8/`F);OH?5RX"&14*Y8[(_>%PZ%+,\XO]IMN1URE77\P;M<'
M0M*$P+]T40C#N=B"]`K.Z--PC,6&4-KE1^-VH=U.<D[ZVX6=D1:*1M(>W<@:
MFNSV[+FR41S?IPGQC2&N/SP[;)=U1EIH%AUFH(ENS_8KZR77<9P"_R)%Y`84
M(!CY?[A!"BZ7JR!:`W`&0JSE9!JXO'-]QY:<D1X^1M-`Z@9,]YZ-(0TA\-,@
M(7<GW(V<N+HS,GG(E[%.5S3V[/AX0N>_OHK0(T`OT`-\&KI#.\[()%F@:KA1
M8=FSYV.(GB\!"DS+:,@9F60B%-B6@\NRC2.C7]XG"^[>7EC7&9ED+%0-SPI*
M:;6?;+5:L2O;S6RURL[()`VB;.A56$K#_;RWC<O]K$8-9[T(SP!3_!>4E>VX
MCQ&TYHQ,4A]]MS42X$K[_6+&?EEO4F:_=FO.J4DV1*G]Z.`VQW-;9\ZLW]V!
MU^PONVY/J_K.Z:#H%!DXE0DMH%AX<WX/&VXUX)P.AHR1QE-9T6Z*INZX>OD&
MD`?CC;]?QT%);<LY?0\T#1-:9>8^3,T>!JLB.W,:<TYM9WSZ8:LL;9X`FOA_
MIG$>M/,4,:Y_BPO['";W&KQC6\[I4(B@G:!59N[#!G7=`6>_R_[Z`.<+(N[]
M;`8]@+K2L+RFG%/;69X^R"J[]2%Z&'9[`%[@QG$6[$7:Q+ONR[<51*`*]&"9
M25S3.;6=N.D`I#)"']Z&8029T5R(-`G]!^`##$QHH'ZM.J>VLS>*0%:&[</K
MZ/-WF1!)YYDNOL)D<1WZ\`7ZJ1O4"V&$)$JEHP],EZ:=4]O9(95(JS[1ARM2
MN/4M^^T].G>#@+*)%VUWA0TX8]O9H^YX-IX$]ELQWZ'W,6/>@C,>%&DD!Z@R
MI'G:Z`XDUZ$7+<%-%//,U2CGC(="`K7$KE3/X'I.FC&6:J(NV0DE]AV"0#:&
M193GC41\);6\B1!+;P'\-`#WLTZKX>6;%Z3$#ZOM18HW3],H3A!(\%:*_*;P
MZHG/UD\P(5_:-(/+XM]BC/3/"\,^K1?>0"@JJV>Q)M<AZ'#8$;)MU/S(6&IY
M&R)B!]%5Z-V<I5-K8MA:`A(E9GE/"`F[@*NGZ#),R`(G"@WMV)+IB%ZF920-
M*41W,+$U<<&Z;:TR4IC!P$T#U\NFJLF<&U+$+FPT\G>'X4/ATEBX]*G]"?\5
M%%0W7^?MDD8C?-4HG`I*110*0]T;MV^^LK?+&8WF5:-J"B05@28,1?\!/2B8
M1&I%C$;DJE%O$XV*$`\UB[-H;J&6,QJ^V]L>+$CV!'E<X&.!A]L6!^XV"AH-
MS55FEA8F%2$:K.7UM;I'%JRNVP7-AM8J6EUIH%3$3+!N<><(Y-LG.A'0+J0I
M8/;='__IFM2X<:J^Q3S#T8KI"L05'L(9^N$I<2.QOMW^SEHT?,[MH\X]G%T?
M@9<BK`\03U/D+?!0K,00)"X15303A\SLF!2%2T&PABK:2E9*YCU1.D5Z#4TA
MR.]^X9!0JT7I!]I""BE$9AU=,<[R*1XY*I<VT@:+S6.ZEY4LX735FLN^7(];
MT@J/HM3RAH/+N>-#RD@;&-88Y@J&;NA!-[@.\5*0<LY3@AJ:PL:_FS62HU9[
M^+WLV0@,C>@E3XV`M78_H\@>$T7$]#^);^84?D976+ST2LPS+./&3C%\:R:;
M878?2[8(QOO1'L[69<)1%WT#>/+U7V`<H;7D^5JJLMFT"\I'-NWJ358-&BF2
MED-I\7#*Y!F#<+V$94)A1;-9%R2]`N6A6)0"<6\>\T;2+'0P"6,G+X_.FN6V
MGLN*9[A:,3/Y$_I;9PN"QKL)6E!I!`OSG[L>(!V#.[^)*IO)<["S#;H!LXCO
M<\GQ+1/\+B4ZP?^H=:/KL/9&'F_T=&C&3&*#_J.K(T1[SJLUR8E'$L1B96?Q
M!^`!^((G\NY&%K=C)JV!2BO+853AX<*89(N`X3)KQA1!#^3++&MF9=<PDZR@
MWW3*1V-1EM%-GREES&8&N:'4J&(F>X'*4=."H]'YY0(\)V0WNLQ:O(G">0+0
MDOQVLB3O![.&B:B>F30$_0:+#"8564"97K[+)8P)AQ-CXWOXB.W.F;D&J87-
M!/OW4SH3B(JTG8IR&WD>PML3,D+CC;CG*4*`.D"DZID)W.\]30DQ:<S66;J*
MW,]$*53:)<W$U_<;&G04MJ73K+TMS<A4UWRPKE9>1`+U:-I,Z+X:=J@G;)N2
M=9(=3+:=$=%&62%G/"C"@@[`HBR;Y4L>F0LV\&^@^PR#S.M.O'@)ZSKC07(0
M4KAL2Z&YCSQ"P^0:I,%9E"M3=_[^\:!XBF[`E.3"',+C&>-ALA@RN)3DQ53T
M='3AGE4P+T1R-_3`>11S=Z>\:LYX4,R'+"0E>33WD#R\\KRKN\S]AOA9OW9L
MT1D/BF]1@-:BI)O\E-DJNX&P2>?S(+F</G"59-IDIM4MT\%^C=`W+%?AB<1B
M>UCEG<_#XWQX6)3DQ63H_"H-@O4%#%)\)F)ZZ#!*.I\'Q;5P4%B4L))<.\AN
M1UIEG<^#)%*H.$29+!5<#W.?GZ`7=#X/BOU@@ZC4RZ`ZM"0*S6X.DC(PXCP*
M$SS3@="#(#:4,93D36W(<2.1-I1=R4#NT)8PHGR=]`H&<F1RU<B8*IC"#SLY
MI;I(8_,)*MDF8FQ'F4CL<815&C1J.-4C1]_2!K(OK:-B$UD2LZ/25N\UJ-?H
M6U^\H2%E(959&Q5M*(JKL?55A'X/5R[TSP,7+K,=6_Y#]89+\03'`UA%"!^H
MBC^S',C4?L!H/LF=MBZJ8-L3]'.6QA@W4<7R&8894U1I)6DX`5?@Q3?0NS=J
M-._E+EVB%U1[(B%V@*'6_D8S<N[)\%;EZ6QB7E^X2W<.XL<HG2\2D6."L*[1
M?)[]#Z5T1!J#';)/DXY3<VHIW%R>HDGJP^0*@/@ZE/$N[MJ2T22?76RU.SY!
MM(06HNP!Q.4K0(>G=+J=*:H4+IDH9^M,,/DW;%JUAO1X#$WX81-CYPADR^`%
M'@T"1FR[J`54F,`R='-2<%AS-BPHA"JI1/5664RD%2>(EJANFAZCJ9]U;26%
MYOLRGB7$F6HK6DB>X1V*BV`T1>`%1FD<K$NZ0,RC":H:I=1D1Q5K+11"L\:"
MM4W>AOH1&H]3RR@EUL]N?%3V,%X5JEIFI6D4Y\IF)R?J4MTHB]5UZRF'QQ[[
M33R/L*AQGI2`;,3N0"(5TLFL9I1\DC4`W7P"6/H2?#V`%Q`67J=3=TV^S#:"
MH(91NF@W_8L1V3-BRE2DA;CBL4*O8)0HZC=*F(#L8>`W[J-3%_K7(=MS5E##
M[$,R/6<S-B1[F'-:9M_<FT]B2+4K:7J29J_CBH[*GO>O'@@#&P+_TD4A#.<Q
M7C7399JQQA@"]"!O-A17UO7LS#Y,*(?.GGQ#UZ$7+4&%66+'SJAAYJF5'7?I
M'`SV+&'%ZLIC>,LBFIY3D50^3YNL4;*1VQKV@3C:W\]^BR(_?HP"7G[/K9*Z
MGB;1I7V*^/;LKN]7V3U_."]<?GC=OU76['L6W2U!!6#/#%2)ER.[X0<-4DIK
M>L)"OSV:$.S9+&_DNL)P\ZO^E&0\7Q7>,?$9F$4(Y.6>W#<0W\(P0G@+>1TF
M`($XF81^LY5\AWD+DD6$__("<JJ19^D]2J'KL0E=/6C/JM'H1%-G8XKI28:*
M*HJ:?15`WFX\^>W9I=^!1&H*;I0SF]F_^]!I":\BVZ?R2XYS-UY<!=%KW.UR
MHU7-3-;^_K<:5"`J%DA>=OC[K+DB"=Q5A/*7/MBAV=Q*9C+R2ZN2,C\)X5AS
MAL(#&`$W!A<@__]UV+Y1X6\LA-7-)//?T7Q=@6E\9J$M`N6^A36@I"J;2<;?
M9V!)P[+G3-86>>LVIM/PVJIK)M&^\K%%067/$8Z>3X:WBZ!6,).$OZ>IV%#V
M=)`13'/4T6^)-X/TI,8`8<)K_S%=+EVTQAM-.`_A#'HN/@GD"Q_)LA0%L);I
MHDC>L6^__BF*\-D\64\#(ESHD]/V:IF%1(B=_,65C7K\,\63=__G-V$@%D!*
MY:SY1Q[6L*,$'LB[O(+P@*J,57$!8L,PKI1J:*PY#F5"B1U8-Z5,^_HWM,A1
MM'V^_#NHVA+/_*XZM\_S_M9]@\MT*=1^HYQ1G_JM3DS7^K:X]N@;*TQ*W_5R
M1GWAY?2]):[.-R=WV)@*G]KMT:91%_===E0J$-OC=(`U\`+);'T5H8LH?4YF
M:5`2=/S=/[.:$2=X)5:A#TX!5FOFQDF`S\@D;R9%S@W7*A'@T*4=(Q[W&HW=
M%;Q5(YD^E_T>`PSB!LYXQUZ)VD;<]O6.:PG(]O#?!;N%>V$TS_5_!UYK:D!1
MB'_TLD/YK9L`!-W@<C8#7G(!8@_!E8!M5=*^F:`!C;U$F58$/+P6%K+LXFZM
M=QM*(G(@&P]DX[LC&YGPSM82>7LE:K\+@E(.IS7[:#9,F42R$K5-4YV2]NAH
M3#MS`>_!F):0J?JM:A_]2N[24[SGJL05$H.,&D8I6<DA1;<<&Y`U5KI*$=9I
MB@#&=@7?R$^QT%#L2D;IW%ZVXF(:`),@>CR+7W%P3*\T+'M,UPBZ72'@P3SU
M%5@%(--XZ$^6$4K@W]GOF<AX]*"B3QC-E=*G.RA4@#WD$E/*.\#K#+QJ1I.Q
M:!GO.2@31,Y7\)PY#SX!;Q%&031?&Z)QK@@0<`-?@'\=)FXXA_CH-XECD$@]
MER13W2B5PQ%0GLP1-6*`SI%4O)#0D8`V;$J'`_!L?>O^&:$L@DA`[71HQ2J*
M1\:\C+UM)\3VG$W88F^$OG.78JZ@8TNF2:".]NIL=`;F@^&M(8S,]`"5)!+K
M2<_69HG)-G#+&R6%=AA:30N)H.U3__<AVT%55,4HW:/+"G5T&IW]VA]^>HVZ
M6J*J8I3`T66).CI[CN-%OD+X=QXO1@C>QVB6O+H(B$@X456CO$N_8X@$-'NH
M.(ZP-0:ISA3M9E1&8T;9%VUF9H-5,799CRJQY;E>KER(&(RI?&6C&7%W,U8G
M</;$(',DYC.=_(IF<^5J&VX%,D&(LA[7-3S&,_;U";D^6+KHVY;KWH'Z/%"?
M!^KS0'T>J,_A,6`'ZO,[-?R!^K3*?R[?9(F=L1KEADV+LB!98Y,LY5V>Z^XB
M123$!"`8^5E2F_@.O&9_XBW`<@W82JO*;,ED`6ID5HN<A+\A-\Q?#/;^2B')
MH>H%:8QQY=WK`<X729P+QB((NK=D*P\K8@MV0JJ1U^DB#^LE\]T:&B`'NS-0
M>[B?,HZW2`U6O/8]=1%Y^UO^X3=>]0&SKI+P['F+Y]&M7E-^PATR=KW,#1-+
MS5L<F94&R,%*@;(GES<'9)W,S].][W;J:+<S9&:V,U![\H:S19=*1R!3W>Q[
M9[HLV\17&O0GBPW:Z(O%(P)WX"UYB`(LQ?SI%00OX#8*D\6.M*%\^V;?3]O+
M8!<KH.PS/^_QMJ:V6UC7EJ#8D)<Z0QR9:QI15:-7-"PUGZT;?Y&^K>G0GH&+
M&PE3""]MNB$\W-\,]_ZFHZ4/5SF'JYS#5<[A*N=PE6/A=OEPE3.8JYP>F[3#
M-<Z0S&;V"L=.RMCD-4Z/@<<#I/%!.X/W;2:O9?8PU$J0]ES.[..NS>2%S>ZC
M3Q*:B4>+SJ/E,@JSB<$0<4=]G9/33UBO>9JCZ#)1SM:98/)$7*N6`;JMZ\NH
M7.&'S:0]P80`NPY]^`)]DB>8SYE1RUO%CE%M1#<L"XPUQZJ6@%]ALLCF4;)@
M+N#J*;H,$YBLA:1'QY9,LUU,RT@:4HCN8&)K>"W=MMY#'H9IX.9YT2=S+C7%
M+FR4G]IA^%"V\2Q<^M3^A/^*Y9Y!#R"^SMLEC5)):A1.!:610CK'LN%QY'*2
MSU++&:5_U*B:`DFCN^X?T(."2:16Q"@WHT:]333V^-&*YA9J.:,43&][L"#9
M0[A<0`0\W+;0*LV"1DD4969I8;+*Z=4-/>@&UV&,S[+93D#H@$&KH<F15?]Y
MDH/'GFPM&8<W`RB>A/XC0"]XZ@WG65#PMNPQR?0=T_\D/HTH_(PN_]<NSA=,
MPS).*8KAVW->'63WL>2H:[P?[>$L7&R5L9B3.3Z?<-^JX%<PZ^.L?`2SCQ5T
MZ!I-E.?!N771-^)S[;_`.$)K67/)5'9&>@A$BTPGJP:=+QR#E8NR+:2D[9@5
MG)%1_FD/]N)"UWB6GZ;(6[@QD+00H[@S,DI7[<$^'.`:'34>@9<B2.ZC.]I)
M6-$9&66]]C*B)%2@@C;@L63%-"QI-4X59V241MN#O03@[2$2:LX9N6?=)$T6
M$2)I^W@.$NQ:SL@D)=?1VT"`PQXBH2;HU$7WZ#$A[CV9@]84H$QV.7.Q:CLC
MDY3=[F;CX;''0[35SW('Y2XC+*_AG)J,.^\[NC88[+EV:`EYGR9QXH8^7A2Z
MV*=6S3DU&4+>UTA;0.RYBY`<.<VN9I+5Z.KZMB6X/9N$NF13!#V9-8=9QSDU
M25?TL$D+A3UY,6J#F.7BSBKJG)ID(W:?K"KA[4EF<0'PJ0+E^:Y!&.>)%?Y*
M8;+F79PR*SFG)GF(CI;APQ`DC]CG5+:GX+E3DXQ$UTE.&E)IQU\T/"KC(A*3
M<OD&$#XZ@W*RA=2<38(:SJE)?D%2^Q(8-N=/\^-F$]TEO0-@5'%.!\00\$!4
MYC'/#S"&<+9(YK^^BE!.=NTRN]';<4X'Q!ET1E995\?;+W@?`V-RCQUC,3P0
M)NZ<&9=(+>R,!T`$\,6O%&R>!)AX'L(]@`SV>".O5$`ANYXS'A`-($1264O#
M[4)YIW$_*]9#9CQ\NZ0S'L`1GR-[I5<+COD$Q23T2_$8L^44%7O][?*B=:5'
MT\YX2*2!`K!5MS!/+EPN5T&T!F5,\0UTGV$`Y2*NA76=\8#H!RDTE>7,$Q)3
M=YW=518(23]T0P^<1S%WL/*J.>,!D1(B()6IK.4ELHDB.W!D#XS6V171BYT[
MMNB,A\]<R&"L;-^'R]@#)Z74^,(FG?$`F!,5(#=WP^JWLQ/?AWE;7R/T#<M5
M.(*P-K6L\LYX`$2)$$&E:0U.F5=I$*PO8)#BU9B?2*M=TAD/@+W@R%[IU;Q[
MPP5X3F0W%ZVRSN<!,!E<Z2M+F"<RZ+/>A)PKYID/VMEZ4Z38'DU>7>37\T+%
MUV$^DPI7&?5?<SX/B#31A+_J3QJHEO*,6=XXB&Y7-@6=ST,A6JBB5TKMP[,P
ME$IFA0?@@V76XDT4SA.`EN2WDR7)RL72L:B>\WD`K(<TDLH"#$I#SX//#9+%
M/^0?.^0?^V[SCV5NLD2<NDX$8>/,.D/-0\8#9$W@;UTV8?ANN[#IC&)<'=/-
M0@7Q?NQA24RT(L/8EZ?^$>^@03QIKO;"I"6<6D9SA-$'`V,^XV*PS$!G.QF(
M6LMH3K'N!F)AL"?$J)H;<K=-<J*-0G)[(KM#H-73DXYLC[L$!BA[S+8EH'!U
MHI;7E-:L^X:!I6[&?2P#BS6SGB+CV+9[4&(E^S81M>@"X<K4*FLT$QUS(##V
M=!3AK;'"OCST!W#[TQF1/<L2[V:^AQ&;]<V^PJS05Z&!R)ZPY8G_9QHG>2:$
M:'/'.W6A?QT65[PU6+)7@'V:-?L\<U>GVIY`[8F2GJ+(`\"/K[!*2C'O9^=1
M^`)00EY8:QYO>,YEW5HRFY>LJ[]9=VP6A5=SYJ<<`MDE-N!LLM+L.),+VS6;
MVTSA#"^%U**(;]Z.0T-OD&S8;.HTE;LV*:CV!)@W)ZX+DE@9A/X#/@]RXY>Z
M5#>;=JWS3"\'R)[@]`)@X1MQC[(GWNY2HA4,N^IVYVX0`/]L7?I0%`4E;JMW
M;=EL\K:N"0CZ8U4="Q\#[^,\>L$*>`%Q0CK$N/B9=(5QK2ODOW6NL_^17>FV
MHTP6X4JQM%Q%LUG=)`TI#T5%K+NJ--#`C5.TSK!5G2U;1OX/!+Q<.(*:@\K5
M)H'%HGCYS%&TRA986^$W"W_6TT8<ZTFW,:CD;9U0V19B;VETY)"RPJD`JR0V
M7]'D#):K"+EHG7/P)(X:)-FVOMP5<I]X%-<>5#8Y23P6A?XW^]G&AY7IN2M7
M<5"9Y\101-'_6GQW,VD*5_G:!)`_(OR$&TG=_?OR[NSS?R/A^-N_<;->PB+Q
M8Y;\'7R*^WW#@`>R$J.R%E.%>AFV<W,.!7]%X*[4*&>7$W-_"S*NH;8@VW/5
MOS/B#:30GP9N>.<N@="[1L?G3+M:MVS+F"?T0#_T))7JM,3-RVB7LL\K+-N%
MUB$2D<6>R^Q:1EW+=4T$G+,^4PMVF7@/+F<F+[BT[D)EX5ODGS;X0'F3MV9:
M.Y,67=GC5+<SOGHN^A*>CCY'^X[1=\^M[&T,+=GCLM=W'-7>`<EOVS3.;ZUO
M&?6FM[*_<31ED0\A$?U9C.YY&UV].'%_Y5V+JON(T1@`[;U,E8H$7HE:J/\F
MU[]_DK^,=)(B[5N%39#PI1!")KU1T`0=3E,7\V"Q)>RP.6H](;86<-@M,PG,
MR<!A#2&@)F[3EBP<+&W3C<3"\MZ,8PG;JM9**NE3?@:Y^Q#PW__=+F>4]F1V
MZJ9V68)KU^;3:R2ES:J<42YQ!VW6!5?!`@K4B0O)=<]:2:.,VBXJ;8C^#@BN
MNRC,3[FY,FJ/;>^%B^CP>;-T6)<-]'Z4H9K7MR>FP2@/)6%H:1@JY@?&I*N^
MDUV^K2#*6KG`*F!-X;J_:Y8>DC#^OK0@(+7WP0"-#A30@0(Z4$`'"FA@+,.!
M`K+8.`<*:"_6*I9RH<]<H]P0Z"*6X-9H7N_Q[R$*@JL(D?+&SN,U&<RZUUES
M*&]JY!UXW`V(%AJD3]XNO<H@V_3CNYY>,^]%ZJL\^C\Z3"<_J[OO1K/O>B+F
MO2:UC\\.TUW0ZIY;U^V[OEO"RIT!F*0(D"#S#?>IQ9]_!S&&Z:1H==_FZ?H=
M.'#S!K6AWEW7L=&DS>^S0V^I5X5#^-[N^KX"DAH/^),7@-PYJ&ES\HS+N![S
M^403LIC-/VWP4E!.-8.Z9:YAV$*WOQ['EL%,YFNSO6<O/9FO<GVN?MJURN8.
M]OI],SF[OX..RU:W1H]*[3#*@Z:Q;EL*8":Y^/?7;^OZ'M1^H86CW'0;[+JE
M"&:RIW^/G;>N<15D@:GN>TY>)PD"LQVX+H291/#?7Q?>UKF`+=B'=Z>I9)[4
M/*D<9HR55]5@RLWM-TUYO![W)=1].X%V31O-?\;UX!1JHU.H^J=W#QZB!P_1
M@X?HP4/TX"%J[26C41>F`;TAIE4+0V8$;>&Q!_`NV;X58I$GD%OM*\\CO(QB
ML3+8#\`#\`7C!.@)BQWCDS:=X-BM(:,^DETGF*[(3,1YWKI_1N@\C9-H"9"I
M?%]3%/FIEUR'LP@MW0*.D`W@U#+*";3EDF<&&'4-\`-\[0I9`C:087,%>"23
M]T6+D0QC?*H^`Z&W6+KHFX`N$%6UBC'@V(]N>@ETUNRZV[*6D@H/JJ*JI@D%
M&3/(&K"%[/LPH"6D@TY+[B%/&=D+N^%ZPD\#U2QEE%*0Z?^4W7\+@7:5GDFI
M],R"1&7]5+I!H/$T77SK7$JGYQ9D*NNGTPT"C:X?Q;<NI'1:E#)[L.NETPT"
MC?X(Q;<NI71:E#(:EM5/IQL$&IWI)T%PGRS`YOC+5RZCN-$`H1VUS(8BR#:^
MQSW>`W@!(?_=G[*(V9B6G4[*=='MB4UM=:<I/COB7[AS[DOIO&IF(S9VLHT(
MCF#IU/,8;_H<@[]2<@?Y`@QFYF^*(4/3L:J8X.B:H@AI.4IQ$^G:V`IDT7!T
MP8?-O&V#6@O?FF74L(%G8QA(SIQK"Y^2;8LH?L635<<TA\;1M[2![./,%)O(
M$I9,I:WL<\S9$E;\["FMO-D'3WE#0\I"]CGM/,&$7)%<ASY\@7[J!H)UB%I>
M#S&G<15BH;#G]-*2\"M,%@\@=[6/%W#U%%V&"4S6PGFO8TN:"$'I!8MI&DE+
M"M'9._3V9V)+%CS=MK9O$;R`"'BX;>'JURQHE%'>88C1[=?"9(U9RD?(!8M?
MO9@>0EKCFK<EO#WN=\T7X"747_0S/5RU]$*UK4^^UBN9K>OSG=5NR>*QF_[W
MX"UP'7HH(YV$[YJU2QIF_UN=E7+?0A?:FFZ=^:CF;VE?I`B&\_P][<QK.;X#
MK]F?^)%P,@T83M[4G4:51F7/&8@K<_[[JP@]`O0"O=U-VFK(3+8D3::EHK-G
M[>?*3@]&V-7.]-;,9!C29&PVQ.[N^"?D\^11;_R/_P=02P,$%`````@`FH(^
M1Z+A^!WC8```\?4%`!4`'`!O<')X+3(P,34P-C,P7VQA8BYX;6Q55`D``R-$
M#%8C1`Q6=7@+``$$)0X```0Y`0``Y;UM<^.XL2C\_5;=_X!G[X?L5FEV=[(G
MR=FM<W)+MN5996W+1];,)C5U*T63D,TL12HD98_SZQ^\D!(EDB``DNBV\R69
MM8`F&NAW-+K_Z_]^V43DB:99F,3__=7[;[__BM#83X(P?OCOKSZN+M_]YU?_
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MO_\CA_]_BC]?>?<T^HKPD1^7\U9T?CR")2=]]V?B8H6W-`V38!;;+?5DMM,U
MW^5>FO=8=66^HW6ODMR+K%9<F>EHK3?4;F_W\USM*1.$U&Y/#S,'7&M>7Z?Q
M1AYVD$MJ_N\K]OVCE=$O.8T#&I1KXS,5TE(`%E)6"/_$/P(6<7&;I,=X)MOT
MRSNN/;[_XP_?"TSX7_Y>:J9IS-@^#_.7>;Q.THT0U]/[+$\]/R\!B:4+\'__
M\)\___'''W[^X>?__,,O?]<']-V?RQTX6G!*LV27^M0(>WD(QROS[O\^__XO
M__G^#W_YPU^^_].UP<JX8F-@N/ZF\;N/=U_]>:^SO3@@<B*IS/PON8(]0M/T
M^!"\U"]7Q_[9@5$QXCL_84IVF[\[0FZ=)IM>NUZN*^FU0]]IDUJ!ID`QH_ZW
M#\G3=P$-&:KO_X/_@Y/A?[S[_GVAO/\/^]/?Y7>7]"'DGXOS&V]#&^CNES_]
MZ?+#AP_O?_[Q\O<__N&7^0_S#_._M\YW0&[7/_[X\WP^_^$O[W_^C_=_NOZ%
MK>F7]@75J:P@K,,XP@="$)?9UI[0E-DVN""E<T;/J1?-F53]\@M]Z9)A[1-=
MRRP5"BW44PPD8B1A0\&%4^<Y-`JCKD,8BV*F3/@%7`!>1MZ#B=0YG@@I;DY1
M.*64_>^$#T`E7QIWOU.P-&W]Z/1Q03,_#;=<+^H(E,9Y$/*D!8%V(JF,0R%+
M5"?0*DH4VS\6I926U(J!-1$D1_,@Y<@)`JU&,?\=E11IVOE.(=*P[>-:)9=A
M1--SYJX^)*F!37(\#<XB.5U^BSTBAI%R'`H!HMC^#E.D:>_'%A_[.-P%^ZZ-
M'#D&@$&@G*+4*EGD0.9Q!X0/12ED&L]'6]HT'8XI1:V][%[@M<O>/7C>EI/5
M'[ZC49Z5?Q'!G@I]%7_^^UW.OLJ7L5A?AK$7^Z$7W299:!+Q,8+E6EP9(GI*
MB/MI)%F3_412SB2?R[G_#URPV1QIH[2S.$]W!#O-,IIG"M)L9->6V5"BL!69
MF@U^-."4Q'HO^HFF]\D^PC[TVN_N9JL[-!);34!*<:VD'M>D?[Y+4QZ=-13.
MS9.AI'$;*LWT?S+.-1OTPJ`80>1X-$I"24M*K:`B)'>\<.YEC],XX/\W^^<N
M?/(BMIILFI][:?H2Q@^?O&BG;2N;`856&KJHURB131#75^(?E:D3XN6DG$W$
M=%2:IC?"/O\'/4P='+MM+6?!$8;3NY_)].:"B'_,_N?C_-/T:G:SNB/OR-GL
MP_SF9G[S@2PNR>UL.5]<C(3W(;\$'NL9^W,KON"VAY'4TC))3$260TO%]Y,=
M6\>2^I2MZ3ZB-S0O5(:VP:*"`6:WJ!&KF2_%<'(8/R%LQH04<W"8,I9(I?OQ
M>,P:#<)36S?=5.>.C6Y3NO7"8/9E2^.,MO./4N8T`X$V8MI0.R6V8API!H['
M.'DEU6P<5$2:']D6"%$Y?'A;I(^E97HJHR&15Y(I(4\#W&)0B@`M"T'%_T"Q
M"ZN8!8Y815>,PBTG6*U74OYKB$N8QR,`5'3"G*#\Y99ML<B89$;XEL?,F=E@
MKJD5L.`5MA+1NH:0PR=$3)!IL^4480,C4WQ6V`FTZ`&M>`2T^JC"L9!"H!:[
MV4Y3.W;RG#MALL@?:=IYP=4H-YNF0BG,9C1.R:UA%`IOV&#UV)2G@GZ4*K2=
M>-S1_F48ASF]"I]H,(]SMM4A\[WEFBQ4:0<T:&7:B>PIN<D)[\0,<IA2$.`X
M^M3>(S9&[];+N2V:A@^/>2;T3WC`T2MP'$.Y]K$9^F&)S5AP=F;@MH.>I-&R
M'K3$C,M+T6W(SC_\%PW.D\UVQSCX+EGGSUY*FV5HHQ;I@`)E570B5[_^VT\@
MY0Q23@%Q08;!ZU=Z3P+Z1*-$&*K$3S(0<3(8-N_X&_Z`Y-1_C),H>7B9@`D.
M&X;0L;"T>,IAUB?U=VF8OUS0+<_G,[6N3J=#FU-U=&IIG,<C4-D1^JMG;-^X
M?'"5VD)/6CJTF9A`G&X+9QN#DZUVKA$H!?5:93P:NT-MZD@#W;"8BG)W5*R1
M6=MZN8+(3VHGX\5J>D50)ST;R64@,KX*O?LP"O.09M,XN,L3_[?')`IHFO'0
M;/YB&AC5A@<ER`T0/B4YW:DH_)P^>,ZG9_.K^6H^NQ-Y?W>KQ?DO/R^N+F;+
MN]^)!,#5W]#H#%,"5BH40^H%8=/N!PE*T:2`!*V5E$@JF!'XO<)P.)5)`I5)
MZ%1;-R5JJ;M.,G2?/7OKO?`$Q%7J!8KD/V4>9!,(Z-S99K3:LDP;1J-09W;8
MD*T<3MZ1G,]`H[4T:$XK;[:=X,#X9TDC41?22RO,;>PGZ<"$UE>:B+<29S%O
M0HJ9I)@*EJX^*K8'5DP+=+=L+DB!BOZD9^39Z=.R4Z9-=S2HJV$#E=<"`%#A
MM:+40)5\;-720O=(Q!@9R*QJ0QK1U'%*"NM1>'5)GVB\HW>/7DH+MC145%U@
MH'13-WJGU%,,)F)TJ9-0:2![G#*!4Z%Y!L<E*$K*>$TEZ89#9OKPD(HJR\0O
M'PT_\6>&Q,MXE93\D9)[+^(5XAF^E.8DX&.+7Z(#]Y!UDC+=V[`SHB!^&),D
MIN2%>BGYFHWDLV->B#8B/&>3(<D^[+_XW&`)UR1*X@>:?O,M&OVMR=A*E:W'
MU>ZT]`5=4_;EH%B2H8INF0VEGUN1J56C*@:28B0NS6R.1L%S:-2RFJJ4.EE)
M4I#AT/YA4'!W4LO6<V*PVE_7:>$@;Z!?5Y"S9W`3H-!<WYL\A'=W1K=8R._G
MK''Y'9'#T:B3GG=NB&[9SI/-)HG%@NP*&IW.AU8I#0C5[IS$$"+&3&0UH@F9
M9QGSO!$]<=!').-CI(,T&AZ]JBO98().0;9QBEX1G68V<5KH0YJQ2E9O%'9-
M4Z'483,:#<4C"C_$"8_;Z$)31(`Y0YLP=-1?.T&YXX=?O92WA^$Y+TOQOFBQ
MRWG/0=Y2T50'*F%!Z\,.1&N/)13#42D50[P$J9'G8A(ZY:)#CEJ*1H,6'=ZX
M!8$HY>Q%MUX8S./BC8KV?5O+=+#;ME9T:O'KYI$H-(\-%H37]WD7QN_\9D3@
MKMO4%*:^;%.25X^K-B%KBC"ZT>7:T430Z[03%)JEZ>U(ETSF/A/\FNTOQK26
M7=Q:(;MZ:B+T[LNF!BIW?[W$WTC2.!/')4,PIE=,#1"@KYD:D6J]HZF.;@FP
M@=XVF6$C'22_,F<X9)KZ:P,C`WZ3ULY`6K=IK=SC3A0L:>Z%,0UF7AHSZSB;
M^DR$[T2F&EMEZ)N_6M:`".T.:B%=SRWIFH3*-;3"L3*(!$,CI2=`0)`"=WWU
MV5#+`=;F0<B+2?L+2407D9J7=F2:YVEXO\M%VE6>\)1O'&5,M5"2-_<ZMY&]
M,=#H\6"/QQE]"&/.$67FG/M6#?:+GXGX5=O*$5T#6U[_HGL#W2.WJ!D>M-VC
M@;`B[VA?7'8$KA\D\T@7)UE"`.MKYWXD9F(E:-(K2!X&TX^+5'1&#,3=V"U-
M16*NKM&@`PJLQ)H6FLW9`<I9*"(7?;`K?/ZMER*[Y36@3'6!,FVR!.$ZL8!L
MNLL?DY074>N1"%4#!:W\U&@JN.UT-"HWWP8KR643^1:$J?56S,#5G09IFF8>
MM=`E(+O)A!P+Q78T'8$R.T%'G7$H!Z-*1S)&Y9B/PD9,,*BL)CK355,-1`;(
M*ST2E)2PT"DG=2)/,RMAS5*R0^Z8N9)VW/!I*=N\)0T2A4J6[>N/:4+#D5)K
MX+?H342AWOKC6`H<?/Z9&;$:).:B\=*.E]774>N`!JT..Y%5LR%JC\T>M]?C
MM^D1JVY?Q6Y*A65#,P=.`0&']NOP?=H'(]1RNKC@=N6ZB<Y`HX$Z=$U+Z>'3
M=8'#J,?4SD\;16+V?S0/U5K<0WI!\]A/-E08@!MU]=U&SFV;#B7IV]$Y)40Y
MDNR'DL_EX/^'1BYV'(Y2**I/QF4"IJBH8MQ18#\/6L95$&@IQS5"7P'K!^6*
MU8HD)U2N@F*Q-[,56<X^S6X^SM#I@U.2UDQ9/*+G@8K\%>W8N\1UZSS7<EJ!
M@+I^7S'.+:=9+UT2+KG[>;J<D=E?;V<W=S4R=NH]6.R[K*1'1]KWKJ=42%=O
M\4AD:+IQ;HUT"9U&,Z1#XKBS/SZD29;=ILG:_*5'=2JT%7*,QBGA5'Y%I>`[
M5KU<W-V1Z^GRP_P&4<:E_:+!+9,&8M<R3NJ4[K!Q7EF$M9`0YCWK6P&`-=53
MH%1KL;>O05L.5GBB#LT=&UP*C072M\R0-'1<Z"["`N"1<]ZD=QH'&KRB%!3=
M`*$5G@[*[;PD)LF$?FBN&A%+R,+X/<G+1#OI$JO#FC>1`$X#8=J>\;[31V^=
M];QR0VA@%7%TD:T]3"TG2A^^Z,]]7)$`W*WOC:4(Y!>XH7S,;T:LZFHZ)I3J
MLM['-J5^*-;`Q,-TDZ1Y^*_&T$*7Y%*!@E:):C3K=28.HR>$_5=$!<MQI5B=
M.B$W2;Q-DV#G#UM0H[=RM,=7(.E5QJ/RBD?$"USS:["BEL[OYD.7[VCS\$%\
M^H[F>23NTPQ5O`H$7,=@%5KUA[+E:'(8/D&DP`W1\9ZS79B3;#\6C;[6(+>.
M9K]=M.;0<>6=[+G9?K#:]]:\L<^J@@6MFSL0K?EP?+CP4JM.ZH3LYR!2PU:H
M):_`2=6@33W_M)LP`<.IUF%4/.%3K;`I`A5DMO`VQG!Z,6RT]-O9<KJ:WWP@
M;8'><6]MK!<NR_N,N?,]B@<.L_-X0NQVH74X.2D3Y:Z2S#A%K0D$N!W2B%:[
M$"K2(+_F`[_!9'1HX7'%[V(OEXMK4G#(XF9XF=3'U==#X^@0"&>XTGY*XN'5
MPS;)F(?P1%=C'P[[\^C(V%_S:Q[-S?GB>L:.AE':-UVD!F_2M@LULYN6FD1S
M[#+>)'%RO)9"41@G!^A!`S-U=9%M]K*J,_>BO)C\S9@WGE8FIC6NJY]G2U)R
M8F$!U905G`5D1+!JL\B$6ET^$F&*G`K_5JQ0KLK47&J!`FTQM2)7U])RH(C8
M2/Z38Q&93>;(A`.C,$`5Y*&0`%?':K[1TLA*IG$O`0RO/4ZGP3T+.UU^*RGA
MN=`P6'1+GCO@P[5&<NEXL-9$*^Y(O%7MFNJY=D#0JDZ%8NT!ELJT1.3&F>`D
M"^-6S4ET*J.3"K6T1A<)NGY?S!W)2[8!YTG,EK1CJUKL0P)G=)VD5(Y;>5]H
M=AW&21KF+Q75=PQ%5N^]IOECPGYY8D/X%:?V18?+)<&^@W:U[1KQK,,2R&$-
MY%XLHNPA($&3"NQ)*7G$"GFV`7.`DC0(8R]](?.<;C*1OL0X+F>;%$E9)=>/
MPN>%/0<1'CV;72Z6,W*[7'R:W\T7-X3]9^E,KZ9_'>$2IPPPOJ:=XK'*@AJE
M,T%R_@D$%US`K"P)Q8Z2@`LG.-4Z&L487*H<UQJ>K;DP,<YH3"T>6[:!@;:9
MV]%KT7IL:.E$DJ^+T<,;S'TNI?11PL7J5O1C%FQ1T:!#5Y3FREOI1IEW/`G*
M\#Q=>LVMI/GQG;.SSE'&\1<=5")QQYFD)'^D1/9&0F%WZJR]L'.^CD:Y^K<R
M`HVW_(5Z*<P%>:_U(S`K.Y<Z6Y&CRV\TQEVC=%2:7TVBT9TT_Y6&#X\Y#::,
MD;T'>K/;W--TL:[5?COSLM!OD/9*M6<&'-J8,MV*4Z(LYY,"`)$02+(NBL17
M:\1/B`"#Z':N-_JS^8>?5[,+,OTT6TX_S,C-Q^NSV9(L+F7)F#NR^+BZ6TUO
M+N8W'WXB9].[^3DZ0\V*';3,-QM>`!<#%V&T*Q]4=I0*;92&IF"A#$-S]'LR
M?P$9@2$Y`.IFC'_Y\>KJ;^1B?O61S4&CMRT90*G9[:C?'=.7#8K+LOI"]$SC
MH%B@J;;O`@>MW[O1K96,*680-D6R<:&V198-"`\/C&'-D":WC',%VQ8J6K3G
M++B5?!TG)*-;+_5RX5$6E>R\3;*+<_8?R7-,[JGO[3(J7:&0USG)PX`O@#DM
M('9Z+Z(U4?%Z#`#'WZ;IJ:WSH=2T`J%NUL55N<H`%06/HE&?7:2FU),==`:L
M$`=1@SB5GXG*PZ[F&G#!Z6(JB<Q>SX`S2[O5J"4Q'%J)6D+(S"K$X\_IXX'-
M!>L@*",5`F5R[5L:+-;UENZV]1#U@$)K&%W4ZR7*RB87/%92F?F[,O4*MOG%
M`$=C(MQ-#AN`KE?\)E17QI_,@A+MM<6WD^!G,01/DY7F?5>*PL9-!Z`42;&\
M`E\2\]R?Z9?0^!&[&A@:B=>":LUPD.+L,(Y)-C82L513G:&9-%,<H$.3]7@1
M%\G&"YN*,#:;)XV3P<S5%E2Z:(Y\ED/QB#CEH:B-/L6)0'75NZ8\R&\JYQIA
M0(NW%L0Z&A23SW(DID+6EI@4%W=M"(&+:17E6?3[.R([=_Q3Z;O>RCR-@J,^
M$4H8-Z%P2EQR#"B/#+-V!%RA20XZ.J2-B!RF7GAIZL6YG>(XG@RM,4Y1J64*
MR-\QJHBNI4O:[T(`7"4T$I->?E(#)3GL61`$(7]JXD6W7AC,XW-O&^9>9*80
MU$#`.A1TH%9K3+`?3_B$=V%,BBF8U(8#K.!Z$N@0H[H5@08E]FBR*831K??"
M`SQF>J-M.I3F:$>G60`7HS!I$'0H='6O'`2+K1SU+1H-V,$82AVHY@J7K4*D
M.U9M6W)H9L+6)AY1FBE%(YA0.M(0\7H7BL)OK\Z?'#7V*6%@TJ%#82TY\JAU
M$3J=:D/:2A5K0=<N^\KG7AC3H+R6MG/N6J!`>WFMR-7;'<N!9)\Q@4AM&V,S
M]9E:W46B91@COM`/$?N!:@+4[`FOH#Z`^\0KMAA15,7X]ODP$_P&NHJ$XA::
M#Y,59/!(\/:#T+N./CT%AR2D\7Q)?1\*\5!)?:^J\2Y'CIE4'QX-_QI9O"IG
M9YSF5M)7!X\S^A#&7`21>X_]X-.)?'8P0O%Q@<TLMJL,JH/+3/S0A0BX^NA\
M[V2X$>Z5!K.(YUFVH\'%+F4KN!4G^\F+=G2VV4;)"RWK9]RRD]#7*&9@X=2-
M*?K-3KX$020,(H%,B``S(24@4D`B'!0"KZH_\GPR9T^>D)B)C4BVH@[23[P$
M""U@@'#M(&2II[9M2+UO3+/E@^=L[W<1$R:-=10[PD$:,.&CGUJ(ZS.IY%%2
MF8[`X^J)K9HK_1%1[1E0M<)6'B!'55ZWA_*4`WG*AX(^)[ACC,?J,[5FD%:;
MHW$8'/+/ETEZ1].GT-=O>F<&%*.QT82ZA:E1_,CK*I6`D!L:^HB'!]RRL7"S
M*=+5%[NJN/9E_I"0VC^-BVK`+))8W+U^V(4!7X`KA#^D_,'[-DU\2H/781RV
M2B9KT[!-+(%+8NF3ZHCBCLQX(^C@82+3S3`1SF5\"5PZN]B"!C$]6ABJ3_G4
MWNCJR>W1<`_"S(^2;)=2A?QV?.!>\!1F2?K2JK7@XW560D_S!8^%Q`,7]T(9
MB9Y$0QC;$A!&`[M$T<*H%E.1F]%MZ'4)*5YPB_V,WI!NPZ^2+7GD_T_($Y_V
M*HS+(^ZS-BBKK`<N58J+C1:Q8B^AG<D7>TEO(VCV%Y#N)<WPB&J*G-=G%)K*
MH-=E_#1*H;Z;-=9EQV)=>8XDQ!\SK6[9+ZD8VV7*]`'MVKCIMPT&-R&+-3EZ
MOB8#ZPP@$1#E)$`S:-B-4$LI/TE3ZHL$4?;[5N`?CH)_UY7)Z+1P?%]2W)6<
M;(HTIL3.5/8"Y`IE,#Y6V5O]Y</((D_(V"Z19WS;U/4)C+>_W=O20P3*<IB@
M(M#!AEB*PO$B6T/?(MO2B)9H+$P^#+)Q<(;O>]NL)U#`O54AQ6_HL_AED$OG
M`S",L;`JJA;Q,#9=#L!^MZS"LT/H>=DC^IA8]S&6L3`Q_'7<M-;8T#H@=LJ#
MX&)&.L8J.6/OO3L5./91`5O)4P;(H$3/F!B73'KWRL)A_:3K:,:C3EK+2,?I
M1<P0/,'XM=W[*A$LHIM\?[TH>B'LOVCZ5%S^AL69H[%\[<1Q_]`G.L4CU*'X
M;2$3@6=?:.J'F7X-<G/`&.W>MBVPL('ED`(6V0-#;A#K;H!:?#\7M9UH`>%5
MV)5*\K>V,56T#\[V4AKI\KV]"`43`/8B6EL25`IC')6-F'(6>)"/D.]?F@IH
MD"GC$R8PBJ],]D*"*]!"G+P6(W8<N?'Z;H!U]Z%5'^"VA;1DY-"[Y[Z`WC]V
M62YJGJR2EO)C18D_B8BNC60.&*[0GOD6U),>]C#XRZJ3JG7D4+5NLJ\%.6_,
MB@`PD8;`7_Q0BC09_J>R@GCJ-=A$(,'#(?`L#P\NI64@9M,Q]6Q9>(S;7O$W
M\>N2-T=E"UJLUZ'/B'V8JUX%?)SWO,H-,;ODE<PKQTA@9)60$AP"JVS`G9"X
MRKO*5.+*Y'4R%JXC7-Y:''S;S6VHW(S7<FG;+1IZW-AVRH4>PFY)_<C+LI#!
M$_1QF:2S+]LPI4$A53LO7W7!@&3I::%7K_UV/$FDFQ332M,)\J)U0,R$D51@
M]CP69N8)=>,AAR1#3I_MVK/AM'FNAWC0,;^*CT[C8$D#2C=*T=$N6WM^"M1"
MZKU-*E]N5??EYH<*Y*5<8G!)"1A(2#G<GSWMO^PYG+>U3\L-`)-E0#3"3";O
M0"/;PM_W"QI1;A$R$VL8B=-M;0TB;F#+:U<BWK^&^>,\#L*G,-AY4740PX']
M4[OM9>_O8"K#;;A!6J6YC^X9GAE4<@`[.1Y90$807AMA<XI?R@).W*F#?&(^
M#C'K1*@&XAC'=Y.E0%NDYUX4-=RC6MU'=D-%<0>I@WQS%&-O83'70LYMS$9`
M8'?U1EC.J2;30Z3@CH-;<735'*E#O;KBH3K22AG:C*M_.ZC+M8A$E+R^-,J5
MT@`'FB&EA:ZM5!HID]4R%\H*U69Y!)6Q,#!R2H&$QIXR9,ON'"YMG@3HV;!8
MGS/ZNHR2YVQZG^6IY^?F-I$"%KPEI$2TO<,#HTL^@8@9Y',Y!U\C$9VC-.L$
MWWZ.[@CTAN9\$;=IPEP*&IR]?,QH,(\76YIZW`V;^CES-O*0JLBVD;TM($-I
M3*M-."5I<R`HM,P@N)]/[WXFEU>+7^_(Y7)Q31:WL^5T-;_Y0*;GJ_FG^6H^
MN_L)C>*QIWFE#K(F>*#<N"7EFQ=&E"U\'OO)AEXE&?M[?WF@E*.CK`%:_8VT
ML8H@_6"?0>6#N]]'?MF1EA\B,<U)*#Y%OH[8Q[[A/_,_BB=MV^*C/"/\ZQW/
M!0_C;TA2?IIX^V^#"#OW;&=B]HS(]WW3\XJ<99DM8U">7@,"7#4I!5+-?G_1
M1`)='7;L*/TH48KI`^^(.#9*_-;5`"W`DDU=7-51F:F#I=P931^\,.;2:1%?
MA-DVR<3=[F(]S3*:9^]-S9\.:-"&3">RM6+_;`+Y^DKHRB0FE5G<M9?S4)D8
MQACRP1RU0`SW(HZ7-S!>>C($"B]PXT6/!;7,$"W^<]R14S1JKE[F:E]%-,\&
MNWEH0T;WV26&*P5M'+B2*G#PQ\3!ZN[`Z"3(6?T![%CI)CW:TO0]&9ZYUH03
MW`V(DOG5%QXJSG<GOICOEE*VB@LJ_Y]Y:[PN\,%E$V)U&@=7H7<?1L)Y8RZ?
M;>RH[^>@K:O^VU5[_=,/(BK+;/C=.7_DB5/\03Z^@,Q`K*-E]`S#-Y!B9>K[
MR2[.LR7U:?CDW4?:.:A:L*`L)DU$N[F^/@V!+66)G>1:GG+N%<-YA'8LM&S,
M*TO$I@[0D2[-$UVY.JURVM%Y;;V78;&S"+*-?UA@AJ.)?%2:D0;"$5+ZWZ:4
MOT)I?WU@J&E/X.$S"VL(MW+=U^6D;T39(3EO>.]M@`"5!98E.H7CAB\PI4NJ
MEE9:(YUB,,-NI7SO;X.5@/`98`<4]:VOVZ'5WB@V2CMFTP[]C5#AG5"BI;8[
M)L->%1">:+RC(CS3SB3M#Q:;YH,^1FY&J)Y.+4;)%./AK;]^[X7U4*C:L:D3
M=&QB)7C.I(=%,#02L&^,%2S?_7"XG=^!U7RZH]5H4"]-?PH+E;*O(ZJE[T^F
MX57YW?@5@T"M;'MBLE;\S50)R7;EX]]"*/3W<T\!XG-TZRAW<]_)'`1F1A_\
M#G<4)"A+!*0C83;L[4PW;A=C(Z05[1R-)'7.#&&(HD7,6,8HFF4,QA=,NC:,
M`43\+Y8:R%=_,@JKIA^NLQ41KY-NEXM/\XO9!3G[&_GZXQW[Q_SFF\:'2L/K
MDR3WHE>%\BMXFJ5E]QES,KC8FL=/-!OFH97%%Z#M0ZM-T11O"B"H[*Q!]N#T
M0>;\YM/L#L.#S*$IUL1VL6:('O'@6T8ZC\Q.RA9K]ETF=_*7:1S,_KD+M_PI
M5)=)H@4#Y(U1-V*URSSU#/@'.3U0DJV3Y1SQ1(>VH07S($>3#-N?Y.C18!]&
M86<5Y[(DM=&-R=%$T*N2$Q1JQ%+Y&4\87FO112UU-`JCE6*Z`^X-Y-*#:G^E
M]UF8,V_XB4:)X(3S)-.L<MXV%T2<MR-2:QC2/!)>?!NC0,3_!(?QQ&_"!$9B
M=U!6NZ16DQ5&!V<\Q^85.32]'!FW(8L1,2Y#%T6THM%O0:.%["E]8'<%"V]?
MAK$7^V-4C5)!1A:#56^")H\K@&".R9KA?AJDN)S?3&_.$00IAJ+,'B'*;H)W
MQ^UL;3ZE07;)-JCL`+I8GXO^G^*MI:D"[P8(K;=U4*XG*\LYA!,2J;9*E?-D
M/S)$M]4V2,KWPB?M7U'%3_L?7;5FZCAH#I!-[PY-</M*6_YHF56ZPF>0GH^U
MXM?[<C9<Z&N%";2!P96:TD-5T<+QI(.CF%XV=[P49:C=UXH?%->9;!V[9[G&
M0$-OC,Q;H_5`21[2OJQT68S*RT03#V;+I(>^::)Z'O]'-=B2Y=X#)>Q?PKI!
MTDK-E'4[BECI\RVT.7>;%GD\8MWRORC[1?SG-#;NPC;0UW`:@@:;I6\E[H%*
M0W%"#G#+O_";)43=V,;;I.*VJ6*:<-2W^QW*]K7PVGJS(;5:3-FLATECR&,.
M!9#W(LJ`,@&XI-OBJ!=KJ2-U`T5J(%`QH2[4ZM=K<KQ0CH<9G.[E'!31'E.L
M>".&S;:L`=C.P"C*`[A"#BQPI<5NRAB5#J]A##X/=+'4!!G:+C':A(:@LVRZ
M44X7!:T_E@6M]T#(:[IATD2]*3FV*?",SIXP)_L^MTSM-.^.T?FZF)W"_X^+
MFB<OXD)(^E&G[Q!TS08CF%!6A"'B330^OSE?SJ9W,_+UQ4S^ZQM^GRI(?WIS
M(?\Q^Y^/\T_3J]G-:OBD=QL[8TB\39`%4\TV%*[4U!;D[;#6[6Z[C43G(R\J
M.Q_-8V;Y;F2;4]N^6)I@H56V/OJU2*G>3%37,#VP_7A[>S6[9HPZO2+[.V+&
MT)>+Y?5T-5_<X,M<-R1MO3YA1G3M\MUR3ADUY;RYN:[:/9H#]_S_:.'U5YV'
MGU&HPX[U"@M>E,<2C1Z+P6AT6Q.9=#S2K]&(T\?XR8:NO"\T:Z'KKD>V1].A
M=4T=G88WS-41J'1']^I/:5]T;,KY!'2JH86R=%];-Y"56P^,JYT;AC_[YR'U
M,`X:',2+,/.C)-NEU#3KK_=W(#VUGAO42-H<YH044,D>K(@S-H5GR`&THH?J
MN%=$KC;HR#Z\F-^=7RWN/BYG9'%);A8WPF"LI`TS]P]W7N%0/-;I%P[`8(Y[
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M)_AD%H>ID7`R"TK;UQ;?DGB-RB?N7+2P-1^3*&"@6_+`P.R(9G)1&@2-M.+8
ME2QV4R[E)LGI`"I;'S"T+C;9`A4Q_JZ@1L*GOP+-V0?O\\7U]>*&W*T6Y[_@
M\\QM#Y-C\_/BZF*VO!,9$:N_H5/GQORJ[[\;,*L[^718@WB&MF_FN:013V85
MU3O$LTO1T;3,Q315V#V_`J7@>V^.JN'M/OOZ'2FZS0NW0<;DJG\I4^4Q.O;#
MD(]2@0]".XY[:A^Q.K/%#PUSR_79ZWU3^.#JWWQ#&MGFU`H0S%)IY;WG)ZSF
MP`#[\/.4^<G,+YY=D-OIW_@MU!T7'[?<,\:7-&S+"GHJU8X/'%Y?)YM-F$MA
M%#,Q%?,K+\I\\%YWU49`P2ZF#5%ONM\IY@LV/X*@=]L,=Z-J<^SJZU.+,T=&
MYM;:SA`ZM*XSW@Q[RL>IY/IOP.*&ITXPS4:NYM.S^=4X5?'[N,`#X'A]/5])
M[2U>")0XGV-\^F/'X%HZW(J[W8FVHC\C6U/1)H<7'4[3)#U/TI3ZPD,S5>!&
M,*'TMR'B]4>J67G)@%%#VQRK4D%;G"DN(K96SV;`H;6SZ5:T-*CER8]EWRRN
MHP4(4H&!53GWQ7\YNUM-5R+Y$9V6LB)S+25E0^,0['V;1*%O4?14`0%>_S0@
M57^?MMEXZ0M/L;@+'^)P'?H>4SP59BV!X%9&;>>GJ7I:#L]AX/.P^?55V8<[
M]:!"JQ9MY&O4VT6R.%6)/;X?KZ^GR[_QM)Z[^8>;^>7\?,I\O>GY^>*C\(+(
M[>)JCM(1,B-PO2"F"77WZ6^24OY>:5;TV-55$<JY,(U_6A&IESH3(TDY%)/P
MUSD313<<Y8$,1R7&,EL-!+8[3CMJW80SI@BV"4098[2<W4[G%V3VU]O9S=T(
MT;2NTI^#8+%ZE/4Z4TJ"0QR4/_O8%B=6MA`'J>9IP1$ZFD*'IYQ6[Q3=MVXC
MKK$J+;A,G8YN0&!%]#10;"BK>6B^MI^`2>,8'Z"Z))OFZ2$@S`'NH(Q@0SLB
MAAO11LD3(@"<$+2K^Z>>%?A[;<"2MRA>_4U<S/`<Q5N4X2X;>M>MYFI*[/TZ
MV(ELC17U'^,D2AZTGP)T38?J8]>.3D,?N"(3\#`<D\K0/"!E+SCUZ0Q*.';>
MB@H.J,.B1E"/EG"%CFS0FIV]D]ENJ]GYSS>+J\6'6L8XH/-BADR[__+,3D_F
M,.9[2,A\&`U^ZW9CNIG-G<'X(4F"YS"*F(J;L[./'\+[B$ZSC.8]LO/,@$)Y
M.*:HMW3EY:;A*O4"NO'2WU"%UWJ=L=+QL3E@I[7Q6I9D[?OH@(1V>?30;BBX
M5\PB<MHKR*ZSP_1VNN+I=-RA62VG%[/KZ?(7?+<K!L2K6;U,EW+=,>B2/M%X
M1Y?43Q[BL*/L;*-(4T"`4B=*I.JI86(PJ8S&J#FZ#TJI)CI/R>'[OJ(M1+&D
M`52"!D1HC:"%]"EIEI-(2:/X]8$=GK/+V7+)?*KE[-/LYN,,G2;0)UDM1:!-
MKR[U@'BZ>.NE^0LSH>/,LTLF[H0#IQ,Z$:QK!C&%B#FD.@FG@M`[P0XUH75\
M\'0Y@-8P`0VM/LRVP8"0\6N4GJC/KIBOP=^F\AL4YFS<W/&BIQC?IEJ0NI:V
M,:=SEY>DU9Y\*E9NN3MNG@YW4]^&3D-*3[6Y)2#S]45D61IOC95A`-,*E)35
MD4R@(BN$E5"&J>/0]W/02K+_=M4<DX-V3-:D"I.4.E5`G;RJL@_#[Y-@_;+H
M@PCK_3I=,ET+TUIJ5"(W\O,&8:@^=])%G1ZY$+8.LSQKQ7289`85.K6;6H0U
MBC0/19'`T'4B`Q"+9=I";39LLD(#,NT4@DM.ZR/0(F0A$Q!,]CUG@[!E%;0Q
M@48N00L'N+,7KW@;0^.0W<DL*-^IMOA:=>LM33WQ%$T.Q238U2>@=#8:M]\U
MS2S65S3+Z!"7,=T`H?T$'91/B:\@.>8%R%FO('!F@R;/-)Z*-X]7O&LL/O-=
MFURU#'1=6NUA55U[_TC2\UV6)QN:&EG?S3-!#.\V)$[)1XPCY4!,`KK[+-J-
M;M5!#$49=D9W"PA0R[L5K2YBP25%#7&9_F6Q).<?[U:+Z]D2DT%N>!Q^>1S<
M-B?W?"PR"UW--MUFNI)G`!JLVN?VJD#`]116H=7<=)6(AIZ8M(7!(76T\.TZ
M(5""ZY&#JX`%;=YW(-I.@Z_`IC?%[>:<Z2.RFOX5H2FO0Y!F78$QW&C?[>XS
M^L\=T]6S)YN^!*WSH22Z`J%ZW:MR*)%C,<KTK@-2"O2.TX$C,_MJ5JV`H.6X
M"L5Z#:>SN]G_?.2/"G@*Z0@A\1Z%J8;$`UQJ=Q*>7I6I#JKKX5:+#J2+]4GQ
M*N5CW'JDH!,(2!A&`[53@I+]6!?K:B6WSW(:P9%RU`^SDTZSSAWO05`Y3C/Q
M#B>UE0?%7^3>E^AN*^B"N.86W-(98M/D-W?ZM65!W;)$*3PUH4)K7FWD6WGR
M,'5""FD#+G7&0;DB5P4,=`K;C)*UM+<1&;OL^U%I-VNH];5@P#6O42)6[]A1
M&8Z'_X9`[38-8S_<1O(J]F@RN"HT(<..[CJ=-.B0J;SLD7?"8/_'"R\]>1&W
MUWOJ03V@T&I0%_4:_[$)LE4._T=E*AY>=(LW.IUH1-1Z?6,,*-H=\UYZ8?K)
MBW:TTFU]'F=Y*GR:8GFZJE$/&)2.U$7UE&CY/"(F<HVRGTHJ<_&PK6O,T>A4
M(T)6*E<3*G;YS-6G3&C<,\-&%#!BHF21/]*T,+&SP^_3*$J>V;+I99)>)+O[
M?+V+RE&M_-SQ[G#`;T/K[($WLOZ2=@]^(DM-"84G/E$ZO1DYC)J0_6=$%*?\
MT'XL'MD"N:T-.R?VM6/ST-D58["QYAO?P7D80:5D2Q]>&QZZ@MXZ#K"B&C(>
M83(6VL?XHC%/3"G8KI0YM#=1KR'5,PS0#1#>G.A&6:.@&![&=(&M8-+R[^)]
M:]FY!*'"UB1I32VL1\\`27^6JK1U/GA^:3=E'A+[\+#?<#A1/,YY%Y'II<A"
ML\K'C"[6LRP/-UY.,U-5=C(;6F_5D#DE)#:`1WWV0_"PR+!XH=,XS62FI5X:
M:<SI]:K/K-!4EK`(L]_.4QJ$.?^7P>UJ*PC`RU4%6@UWJX?1A`^:$#FA^`\L
M;#0XKOR^]8`H'NVC099=MZT=-.G2P\HHVPM^DW3!;,DH$7Y?83S;1G>[04)K
M*SVTZYZ'G"7<C<J\TMG`PXL.D4>G[PQ(6M/'TJ5GA\GX^QI.U2I/BZTHL\W[
M,G`!$SY1'M$QO'2U`0WV4L1J&VHI\)5*:E4X$R(A"8K?PQ)AT`P-ISO:E[)4
M&!HEW(,#U.]MK,G?'??/O#0.XX?LEJ9BN3V#HEW@H)5U-[JGE%O.(&R*C`>^
M$M5LCNI5DDDT&;EN"EE5_/.0%B3W`)VFUJ1C+2VM1\0.XZ";K1>F7&8NTHLP
MVR:9%RW65TG\<,6D1R#[L=C&2&U@@\5/[3:B%H?<@R'\8KX`),HC,5#O!*RB
MB1$>7G>U(0V;@$91]V$$=1S7G@O<B8$;^EQYM)`F,?NG3RN)7SUUMS%\:&5N
ML2&GE,]`5!\7'@/!P_QC;P//L(GSZ(7,LVS'^?ZP)1]V8<`S;M!I?%MVT#(!
M+'G!:;`M]W*QHE5RFX9)^C?JI<5]E*D1H`<,KOF-'JH-4:9R'LD3(F82/I44
M%Y&?5R)7#Y=*M\7VSG^DP2X2%TCI`08:W6U$L!UM?O2I%:;=0;/C/^45=A^D
M$#E[J95.GSY[:6"MO(?^/+1N'WX[U>_6VP)WI/H9<O_2U"N!B&^!BQ/@_;S;
M;39>^L(W4V1-R2WRJWNYYH\VGL2C#8\9&AL9$MW0_#$)1/]J=$;&2%QMW(!A
M.);N49SD-J7,30J*ZXI,D+M991(U!)"R)%U(-?0^XN/+>[K,!=L_T?0^,:E(
M8HI4U7C8%@C28C*"JB2FZ+`!NXC9><&1B#]%#$G]$2VN:B\^HL-2"%Y#6!LV
M&A"A;14MI(W>0B`0*L-C?"QD*D\B*.23B+[$9Z+1M6FYAY(N=WFQ/O>V8>Y%
MX;^*9DWSN,@Y"..'7^F]L!16U'^,A>EEH<T'^A2(VA]LFUJI?+$F%="RU1J9
MQ^0`G3#P1,`GAP^`NQ$0>\4D@E_9*U_L51B3X+!7S_2^\+KR_0<0F":C[4VS
M#6.S2TCLG&$%4[M!-*A4<IB&M5_VG-%?_!#RYZ[BWHDIB@])$CR'4=0II-75
M+RT^`6U;V6V+2M`<X!37F\(&*4&!BU_'NW'KY;2P/L7;ZXV7PJ1'#TZY)H:9
M/6=`"(CF8)!H]RN3R[*IGX=/86YHU`WX);`LSB$V2<4O[0F>LA5V`7M"2NC@
M`@5FG[)*##@I4E\+..#FR/`<I4X#'8J=0&0-7]QC$@6,Q+B[FK_<)#DMNT4N
MTF7X\-BG@+OUA_`8)N9;I!0P%6B_(Q(>X0`G9-]Z-$F)!`HN7$"VZ'F_#[L\
M8^HZ8/8\8I/%DH4,#1<[_ADDT"1U8DVN%=^VLT6&^`1P8,ER6U0!I0K(XUOJ
M`BA2JV/DC3F(A%8;`S0R-!"^940H.S6SWC5<M9]N"+H@4!^AH1/\Z2$Q(.RL
MY>$=X%!!GG:0>&PG%=HJ?E]6GLJ"RSJ'N"(V<SHIV-"@Z2+?04R7HWZ:V9R9
MDD]AL/.BHAA2+YO%##:PL6*Z$2HKY;@W+K_T*J'M"VM!LZR3K6"\NSGJ2\MO
M:_9;D4IPJ"R5OJBS`74;I7L/T!DG5F)!QRJQD0D0YLALO:;<1*+["E=++Q>U
MX6(_C$)!6T/9*1;?PF/`6&V42F+L`9)*;U<.DQP#!1>A+C?HD@8T9?(BE%N2
MLRVYIW&X#O&E#`W!0X:6DC4#04B6"[JF:4H#MLK]#=M5Z-VSA>:A:5)Q7_#P
MUU2FVZ$2'24L(3(J=]L5>.!28^3MV&\!%Q$>KM?+/7E`\X[)A@%ZN%(W7BX>
M*)SMLC"F679!<R^,1)R9F36*_M&-0M0$))0-8(9V[<&QF,B]I'(J*>:28K*B
M[32`0A\$VZ0!VZ^+V=^@T>`6]*Q4U.;$[+!#:+&<J?_/79B):L_RTF@>,QJA
M/%E.O`1?I/S_N<RXV6WN:5K$58M?==7S0%^#TM:#;5:MXVC)%!7(D_+.MP1>
MOLEG/G0)?D+D!_8)*<,_TC%7XJ/MDOR9A'(;[E_(\G)^,2%7>?`MV>Y2!DL^
M\/:*I!/ZQ7_DS^*(]Y!27(^@AV4[I44P*,\YK$<FUG@MGH3.XR>V3E&5Y3EF
M]/@8;F]IRBM5>`]4UZ0P!PP=7##9@EJU,BD[Y&1RF#TA^_GD``"!?3$$TH<?
MQ96HR,-C_TC8Y+V\0&-E6!.Z7NDR0RJ'C`"TO&3^-<P?#X'1V1<_VO$$G]KK
M9N[8W";,?J)YF(J99S2FZY`_A5Z%N4SF+<&PL>RO#,?FSPNOR#[8@`X3/'$-
M=%NC&4)IJP%!GMG**S=:S%PK%]]4&D(&8(XQ("4*$RZ<!!;R7<+^6H3/X3\Q
M5-H7)2,Y-1\147@#X=G;1%+0H>%:=-=7^24T[C'2#`3:UFI#K7:QV<"EG_E8
M$/ZSV&@3(T)U5(!4QQEN22/!"-R8626S.&?6SD6R\<+:37>;F#(%"Z5*S=&O
MUS\[#.;^L1Q./LL)>!2'Y4$KI;C=*?>IC1-YLC[@]('+_&O*?6FCL'<S!-`H
M=QM2-0>L'$?D0/)9#D43P#9'Q%,C`AND5A);=TQ:16D]6&#%?F4\MPY]FK;2
M?SWKIF$:2"Y<X_)K=@`?1(I14'3>:^WT"_5W(K\D&1T+X[I5!GATKAXFAZR=
M"=K3PUHYH`<SGC,UMXMR+\XM5%%M,J@6:D"EH=E7,02=ZAEF];#ZIHV8NE5-
M"R7U(.Q/H1^VFU=UAJR.!]$KQPL^/7OQ*QH]HK-6-,I"9[%%"1AR[65L*\CE
M+@Z0*8P&>F[7%'5B=N>/=UEVRJ"$<_M.&>#HLC"*WS'IDJ&6#AZ>4MI&!JB[
MK^^=4I_!UE,]+;.@@DFUQ=>+8<L!&#21]J(7NSP+`TJ"T1=OHIN&VW.PB%PS
MK2L#;HV$WB>8\)R47K:%`U.?#>K!-"%3\VJ?D^ZX`JP;T'HFW7Y`VX'TH)!I
MF=W5<AM5-[6.9X`X`Z>+/J6"_>^`MTM=&]=II3;M\Q`'W7K1TTZRIW-!Q4`=
M$<7Q`][2Z&^G-O\WGT.?)]S4WZ7B1<,M.[A'+Z/[3Q@$![JAP#S+UD"NEL6R
MGT/*2:1"3O!FG6/,@)X0ZY*EXK&P)DTZ3-W;W6?TGSM>C^&)%RMGW[/)`&D#
M`QT-:$>OWN*F'$G$4)FAA30/I./4]-Z8*H\,E`+-LC[:`8"E2BI0TJ0[;(D<
MG:>D3KSK."(P:K.+>#8#02;KVG7N*<6A\TBU#LM&R`$IV<LP]F(_]*)YG.7I
M3M>Q[9H.)=[:T:G5=BA'DL-0+-ZOYN$HY9KZ9!SF4Z9>G*V9N3Z-@SN:/H5^
M&#\LU@W+R[CLS9I_,O/!1_DVM`P=>"-U^"'#%P\8DZSTLI2'IZD^^3;RHOG:
M2W_C-1>"IS!+TA>;F(0>))"XA"Z2M027_2V\F$C*F2X"%,9I!0!(PL0JC$BV
M/5YA0J_NM-UYY&59417[*HSI/*<;XXA%,Q!H_=.&6HT@^;A]27GRF8\E8C`^
M+:(\+BUUH#JK/G'F6EGU[M(V#6'!3B@P<68-Y&J>865.6:H"NG+->)B!5JFQ
MH:/N\+(F*3H,MZ@KRJB]?\?U8=2!!)TZ)I.BG@NBG+*N=7M%A\9DL_%B65\!
M53?:CO5/@T"4/V$"*JN6DD&G!%4U7O0W8!B5)X%=[%+F5-W2-`D#^9%SSZ=1
MU%WZR0`2G.K30+)1290EF>1,(J<6E9A(.1G>D['%\5!<JN"7.,G)/6UAF]YX
M612LMD1L2;=L``^GQ*<H,NFY"6,OEX6V?"^60+!4IC9AR0[=K\F/#O6_M^]?
MU%2":AZ+2`]O9%(GCTZ1:@(;W'XPVX@V/2T`U$O$E4(KC$D%#B8S9!CTJV9*
MP=WX-+T%R>M9`N;T#L+H_%U8R&MZ\X4LJ4_#)QHL.CB]^=+9""C8;;\AZAV\
M?02#E$!(,BYKVV3!#X4XY^JDY.HG+ZHWSH!+>[`A:W4JA`5-]S#XBYY8LR\T
M]<.,WJ:A3YEE$";:[G@7&-"T6R5ZI_16-M(K1Q,QG,CQ*+Q>>YQHB=-6X+0=
M!Z<N<QX"*=BLZ6[^ZDZ@[F0N$#5>+D/8&!8:^W@^`N5\BE"''MX+!VEC8].X
MNMA(K;IG(&DU8]2OC?2FJTJ;B*V'UKR@]_F2!G0C.G=?)?$#CR'POTXWR2XV
MZWG0"0Q4@VJ@6F_$<9^3=#]G0CPQ$H&[.3)&L*I&ERB[%8XF1?8J4;/9A%G&
M"[(IRWHW9"XTSH1)B6E!HE[C93\.K`#W,*O?CK=Z\TBP+@)^(P)(HKM*1E`D
MWBBXP)TU./7]=$<#KF>SPXK.=VE*]76@'C#H^&P7JK6+1SF>B`GD,&-"BCD(
MM*$M;A7B0Z,!C4A2*YRJ0X]]BH86#_P6Z\*]TWO'WC`-1/<U+K]64K-\LKE8
MDW(8M-HS6SASD)['6KBYQK->.Q)EUT[S[9JNE>`=!CVX!SF-@W(!)[>H81)\
MXD'IV[2HVGXZWOCBLN_WH)7E`!O6G'O!FR.4@^J)&`SNA`C(/#I3-DZHST2D
M>D?8J?*G"=Q5R;C4;70G.@PK.4Z(%-$J[9#J8098$+6ZZ,;41QDM15!83+G4
MV=%]`KC.;*<)==CSE"`<=G#;;*/DA5)1;9]6>\]:.H7=`*%UG0[*-3HKYKQ+
MY:1JE^;Q',0^:;9]L"1G2;S#YREJTZI>\S5-0G7'BV4+HN(&1'1Z9+MUGF3=
MKJ86#"AMTX%8S1\JNW'M7T.5,XB8@D`I&6)T7LV'*5JCKI.44/EN)2S1\YO0
M`]-B.O2HU&L:Q.C8)VRQ)@]MP*K]NSZD26;G"EI\!EHKVF^/9M)]U=>K]MZK
M@IP0`12;NS?(MNR5ZSU7KI/F'`1P'=N32_1=/&L6`9<8,D773&0T>PFV\,&\
M1OL-,1$2Y=,[5%)B[`TY%0^?<&7-]F0%M?O;CP_Z%*O=/S;\-4E_8U\NRB,8
M90.U`H$M7]N.FN+)93&V[,2!0!'W0.:Y0,8?"1G[W-E!\`&Y(K)@`QW30(>1
M>O#YY2Z*7B[":,<<?2E6M*YN&Z:!7-TV+K]6B8H/(L6H0H="7]T:+#PH%M[\
M!@S@ZE9K[>N&M2.YNFVG^?:KVU:"=]BYA=[G79$OI0=3!P#M6C>AU)BO>A3F
M0A5-UD%AUA#,0J.B.LE+RW-MHZW^S[FR\B9+KU9#?1:(8FI:?-OM]OZ1%H):
M"T;K+M\L,<_TM!`!`C5EAPH.%=5*^^T:JHWP^U10V7N8^WBUR*+/1*FER%/4
M#FNWAK6!@CJ)!J@W)PG(X,QV?V$C9Y//194J/*7KK$ZZVV4Q/&9W9M15DF7G
M29PS+XK&?DBSE7<?:6>HM,R&BCNV(G-*E'P@.1K)2)&/A2_BJ7<PRCB9\E0`
M2>O*MF*G`A*TS:Y$4H?LKA#7[^P^02UKN//X'-)DD;WQ<IFD'^.M%P;GD1=N
M>+7IXA_!/W99SB7T[`N/(M,EW28I<W.+G]L>@3;S\#!?`Q.G0VU6C0]*P"*Y
M08(F<HY(YRW^>0!/"O@34GZA&#,A4X`7J&YWJ]B-+4US+XQY8#=/2.!MO`=>
MX2PA<1*G]"'D!H0H'-/J=<#ILD&Y3JW[AF0Y=W+I;)<QF<C%Y.:>%ZSC[Y%*
MB9D?58O9(VB9=]GC2]"ZMM<FG7)5"8Q4H$T.RCD_KL8TV2=RON!,XQQT;RZ$
M<"%E#BN3,5<7U[\C&;E/J><_<@F3/U+BE=7@\=PP#<=/6I9-;V9"+6%TS1P;
MT%`VC=TV#"8\$-@IP^Q`743<7BQ_Q\PW4;T,C^G1@^R5=H8]S4,YX"_RR+*[
M9/?PF(NTH7Y^>!-`:!-!!^4.KYPI^&(:D?-:<JS&9=UQL#SV(:[3;\EU&.7,
M9_@UC+;L_[@[=A7FX8/T)#*:YY'0\.@4O#9M6T0HV@F[5UT<!IX+A\H#DN))
MR2J9[H(POZ0TF\?&17.,P0)5U+%`O_X\H@!2?59%"C!DE1`!B'!(9!ZCJL@S
M%/9Q#?V*"O8$^FN.?AAC*^DSZ/E'9AN`)-7&7@:HZ@59"@"'^?'^(PUV^XI]
M9R^BJU/;19/ZV8$"%+3MH4:S=B]:C#X\7KM_(;*Y%^!5E/7FFVC;[D-TV%$N
MI4*(73"&,>G,6YL'Y=`V(-#0("-)<\)'8&O!V[;]2M^K9>]=YAZNO5V4[SN/
MWC%%2&7C4?8/N\[B6C"A19PFXNW-;_<3R"735<P-D42)M0VNR4%K)@9JG[)+
M_4QC+PV3VY0^A<DNBU[*.Q&]!K?:<,#>HW4C6'M;OA\J:=9Q9[<1T,@$&GBZ
MU9I2G_IIF![IN>.I)<U*UC[<.-II!A4H:(6@1K/NOZ4IQ=:@R`R%PY`,E)6L
M*<9$6W53GD-#/<GRQ?I#D@3971)U9K^W30,STVO+KS-'EG-G4(PA?!`"E:._
M;%%-%8U2::$6M5O12"H]0K[SV&>>2D8OJ/S_>;RD3S0NBA?<>B\F$1`#B*"I
MXKI(G])1.8^4$WD$MYA*BDIS<C("W=$+TSV"84S2`D&1L,7SXT=!T/X!LBV.
MEUZ8RBJ5ATXD,NF?>%GY#D!<-V4T?0I]$<:-`\K+>N+))C'GXNZ7`"8L[+@X
M9:UZPI2_H7D0^O_LI?:$8?KLI0$_:'%#-LVRG>PJP7/MKFG^F`1)E#R\*)[%
MM-=$''DIH.4T1]_FQB<X#?512.7#//I<'5=\G(BO3XC@9[$`4EF!2-:MK(%\
M+E=1LXDAW.6WO=EH;"V'LJ.[.JH3P?%*Y3)/>/9S&ER$3V'`M.V2^7;&%W"C
M+P@ZI.%BRYT)C0DI5T#*)1"^!@0V-.1^[S<E*#?E):1UAQL\D..,_?7N;1WQ
M_BL5K\LP^^TRI<RB9\Q`LYQC=!W&X6:W`;%]5>MY$P:P>L,=REB^$,)70LJE
M""$[(<5JWIHQ;+;Q8G?6?'?"<G=2?NN[:=Z<MV'':@@#=\9LMR1X2R+7^](B
M<MVI6M6ZWI1]JSX`%")8KN:M&KQF!]`JBILWZ6W9OQK"PKT9W"TI'(OF^V[$
M[DWL^Q5--^^-[-]Q5@!J\8ZUJ1!Q!/YM+`:MJWW=(U_<8>4->P!KMX[*MMV6
MZI@\^TIMTQ*53TG$P/`'H&CBK2=+>E,6:>NV0\C*PR+^+:*NG7N^VJ5Q\D33
M[]9)NJ9AODNI,$#?MN&IE@1PH==&,?"FI"UD^%6]HC<1@.W:=`0B]\W&8$WW
M?K]!3X<->M,16"V)X"X&JR,.WI;L11"'5:_LW\#N!8G%*F3QVP[&FIY!HTS^
M=PC%:DD,+(8Q6#AV_TS^-DUXY9Z76T8]^30.>`>-+<?$J%BW-CRX9YK:"-??
M.<H)$R*FB%S)_21TM;U-3[;CZ:/1L3I\`LE9L*6F@OKYVGXBM(:NHE"[2^._
M`=93T-Q"$V%ZNO&.:<7LM7EU"I3$.EYV"X4`%C?HW#@=`5/?:'=T4>A>NX?3
MQY.A9<DI*J?44OR.]U5QXUEHR96F@W!(0]+'-I,NQY.@Y,OITFLT(W_'5]2A
M<<^54J9IP]W12*OI=&7;LT0#(K1$TD+:T-*^0MS.1/^0M:2:]@GWZ3FVVVR\
M]&6QO@L?XG`=^OQ3OL][%/#^UTD4\GXJ%S3WPB@KFFGI/KCL_P&02J(]MZ06
M!Y/@R&)-*@#)`2(I09(")BF`XGCM..:>)/I[\G4!]1MP%308W[37W!R`:9RJ
MMJ<P"Y/X,DDODMU]OMY%Q6)ME%H[+`3J3(5H@R*3PT49@G)"2>2.6V(/B=B9
M%Y"`MPFFLL$-1CW<29&Z&KB+'-WQV32*DF?>\+=A,4OJT_")1^':N_8TVM%F
M0*'<%%/4:T6UROG-K$@.,,9KOF-^G3\LUD&)M=<B@,!\.2O"5OIZ-E2-P!?\
MF%&VT*MP;9S%J0,2@?K40-O('9P0.9?PR;@4:@]43W&<97FX$;4U=Q+;*'R"
M*876FP8'<7]K-.VRZJ8HI<1D2,(,<WZG>T.?*Y9YFL3LG[ZX&+YF1Y:&7C1;
MKZF?7]#,3\-M4X&LUCCZ(!\#N[H8:*OJQ<9E1;,*X`EAH(^\QRIPGA4BP1,)
M?T(J7T"@Y\?>J?0`6(B6HYIPF7(WX.Z0AF0T]>W3@%SFTH:@O/?H/,YV*3=T
MS`V&D_GPUD$-H89:TZ*1[WX,J@:9&@BT+AR![FXF)TU%W4A+SIEA:>#W5J=`
M:<CC9;=1^W(,9[2#T"V6V[1,,.W10!!*'5"GAAY7*@6P*_K@1;PUDJYH;IX,
M6FNW`94V,A5C1&<T%%)9=_GB-T3U<#66+#N(\[L3+\MH7FU/YE?[@A)Q+B&S
M^8*G?10H$L<D&ICECUY.MCS"&;#_8N9/G&Q"G]S3F*[#/"//8?[(9Y/U3KRC
M8\Y8F`3\NTE,R0OU4L(`\C[-<9)N&%3NKGG"_O9??!Y*"]<D2N('FB*KN-O&
MH=W%=5O8$T'LZ.QEQ;YMTF%*!Q2<:M1!TS!6Q&=BZT]E<)X=&DSW,!'0*E^1
M3%H<+,Y9`0GOR>B@;46[6-M8&9QTO]!?[9A=]@?9;'?,_=^OQ2S?KVTZ7+^0
M-G3J#3CDR&H65DLZ($#PS`(/VHD'8%L1)9%UM!=149@[1KG<I;&HO,`8]S+\
MPO^5V>57*R!!"WDEDK5F%>5@(=7+X4!<-!9:ZRZTP+54-V%J*:=.JD1@87U(
MDZR_(R"AH/,!2N0,32@Q#8'&LL9+($0/"-WM[O,DKX<O\#DS1^1HY\=4:=%A
MSI7O[S8[$5^YH-N4^J%L#$RW$17O@.-@NDG2//R7^'OKZDTUWV#?A=:3`VY@
M+0YV`$VJL/F%9@%=<$P5_H2<"(G)L91`$;MTO'=!!?;PXI$+J'\_['^4V,?T
M@7_DM>(/;K$-+7ZU[+N!96^OFZ2V,(C%0QQM8""/;@Q0;36/I-4W/7HOAN\I
MS1"8'K^)0_8TQI1JVY_!&)*L.[.P*A=,3;NCN=#FV0DB]4ZB(YH&?4PC@W6C
M?:721$1:"JJ!@B"*!EV&<9C3J_")!O,X9]L?WD>\V!'-,\NR09T0X0L':2!=
M>^Q83.8WYW+Z.S&?'``0"0%Q'2'=P]:L)*1YT@Z#UNT+.GNY]OZ1I.>1EV4V
MU89,0$/K`[-MJ`6$U=1]_T($"")@8*UL9$$)>F%C8S)`0?V'E=UXF_9;^T;Q
M80H62KR;HV]&^9,CNN>`\!5MLB0!I;RW._\>#O.O]%[485Q1_S$6C77-+A[5
M0$!3,16HG1(C&TK$6'(8C.FRT12?Q38/-^&_Z/(+>:;W1:G8W`%J]FF<AJ=5
M5LF-(NH+GX69BGZ9KK!-DX?4VV3%VYTB;.?EWE$&)PECY@SOQ/2,YX)Z>PC(
MLB^[F+0["[.#0P<5((M8LVQ@YWR0N)H:(2W)P29@2/BQ0.?.VVPC>GV!3&P,
M@Q9'ZBT*#C.FZHPA=G/DH.)B]9P,8G(<X""S.JH(:HD/-N$5&!\JM/9BY/??
M?H],E`R%8B9%2H'@6Q0K=LS7PR0YY6`4WOR5HMJDJ5MXY;+.I*E_>:6H,-D5
MA+V"+3%I?PX]??+3`W686^]MP]R+F(\7E%G,=\DZ?_92VI;)J(SA=<*#CK-J
M(%Q+7S],(?M4]G(22';CT!C^VJ!:8;,<^Q&92718DV)1L&0E0:::"*.K4BP@
M@SV2L=D$0\:M)F-5(2'(5!X$_2I^WBCXZ27;P6,(]ZK(FI?5#XYL&;F'QZWX
MYGRS]<+4)-O:`"*H%ZZ+M*'D.<Q%8#?T0G1$3.P]<%MD#O4=GE/NIP3)LW3`
M*Z>Y=\:S`F)9Y(O_&,:B*D,8LU&49&SIHG@5,K?;B).['7`3-D9A1=W07#=_
MUQ`:0FOI&-DFP[]^8=F:L8M1CS:<IJWNK!_E./KR*(E=U'91UZBT8F7U1[!J
MU:ZM,5*T1U8]D>``2U`ZV9`F5_[(-BZJ"8V[#Z/H;M.MJ/S:K<4;MNCUJ&TM
M@=)+D^M($Q3*?>BX"/9@2+\(R.N)>JCQ;`Y@'O$TX&.$7D37-QY@%P08_3[,
MZG:A$Q[T[8(&PJ8)K-BN%RQ0O&5^,/.KT_#A,9>7U^$!3U%*$5]-?5W2[9N!
M#G/'4%F0/)Q6?NRZ$SV:CN`Z^@0=);<58_$4*-''HV"I@*ZY4F/V;(:HK4P'
M=>G>DC>0ECL.6>2/-!U:?^D!A59BNJC7LL7YO(Z'=OCTF2VVO/'%5E*H4&EY
MZ@5TXZ6_X=-E1K2LI=!,"!F%N=GSYMP",@)=J+\)ID8IXJOS0?!'?77N%$,,
M1H0A,]MFX?6_.A^HMJ#4*G:5.X\G0YL2IZ@TF[$H"W)V+7V?FUZ8XEAK;S92
MDUXMZ`92ZG$AMA"Q8F8:>#'CL%4R]?^Y"U,Z^^)'NXSQH_S<4@0)[D2#K"[M
M;`L6Y#V8%?I-#S)Y5G\!A:P24L`A>T`E04I01,*"?CXV"/9W>>+_1A()"L'C
ML4&/]*$X4OY@HSA2NC_2[5$$3;:/0_)&S)ZMVY^.6?.T(_'TR8MVVHW?+*&#
MWM#;;,8`LDJ`0F`##+8'DCC)$__9O<1R<[X&@DOL`[)K=6N^[[Y/MV5ZAS7%
M/%X32NC5%5MEYHE7@Q=L7;J1$04$L)IA*J3J9KRL#R:&3TAE`N$S$`0TC-"9
M?=ER!@P:E@Y7RZR3R-2UR[HH#$>`L1(QN*;Y8Q(,>+G=`!S:LS?="N,(8S5W
M0T)!8!@,A7TQB'?LDQH2C4[L1>I]+\-;Z1P#BW_,Z'H7785K;=VH!0O?/<$1
MHD9\.R%R+N&3$:A.2QP+)*(&)!"&P^MT:1D`KQ$E!JX[D@DSF<-W0[_DRR1B
MJWA8/=/HB5XG<?XX9#:9P4=?B2+NW+I>"KJ`/B$</BD^0.07B/S$Z]/>QELV
M19)OZH#J1U#X6GP&46Y[*2OMW'II_E+Q0+*SEZ-?["IOFP"'+\)MMA6J>MS%
M>"(F5-UN)EKN7TY^QEN=VX(V-`MUFQ.&.]YH6=N5HL:14B9UPH-6LAH(GQ)[
M*X&#ESGJ=Q0FDE_S7/N\LF0<L8MRIBRF#RFE^MV!.V:#7!&KD*GWU"W'DOU@
M-,5"1T,$YHJSD\C:;S*[**P'Z=_1K9<*RZF;]-NO/]JA@%Y`JI"KF17[L>"L
M`(`0[.U9)Q%VWY)U46"?-F[L<!^]C-KHAK:Y,$W:6A&I9=05(\%9P1$20)W6
MU(2E:*RFI*H>I/XI],.L>`?:1Q^HX(!J!#6"IQ0D1I-B.#@O0&$%JQLT2+);
M.W33H\.0D,CFF6?9CODT:>C36YJ*OVF'?5H!@(5V%"BU)#/)P;R?,QO.JZK(
M%%,$UST]D-GR6B#\3S)'"5S+:).<.IK406^.64=4FN(%"FB<28,O3=F9")8^
M>SD,N?5>^)^FSUX:5'.HLGE1>\3J\>482X".2XVSK8V\\JXL37_X#JE\B`=M
MJ^.*CQ'QM0DIOC>1V:`9KY17UF/"]B#4S9X628&H>KNZP?PD;W3P'=@F69B'
M3YBWH%`^+3L`'@,>45AKA8W'D]0.%5Y9_%.TVBOR%UN:F#9K_E8`8+:B`J5:
M5%<T7"SS:@$[CAKNK995U7$R#NN@51;0VB!474J_#@':IFE$JHN^`)MZFNZO
MB21L/1Z'@HP)49I-;QE(FJ8T$&O1BZ/J@``39DJTZA%Y/II,R7Y\27A8PI(&
MQZ46;IUGY9KTSC1)3VW2*$!!"SPUFBVD>(:*%*WWWL@L[#Q#=Z0Y#?ZQRW)N
M!&2K9!H$(3<\O>C6"X-Y7(0KQ?ID\(7_K\=V\)S7Z=(5F[V^`257>VY,+:7R
M`(X_,#P`)!PB#R,4,"<%%Y0!O1(P.6\JC080G!QX8_;XX2K]-@1?*/73`$SA
ML))+FOB4!MDEV[1R)8OU>1(_T33G6;#'LLQ4J9F"AU9TYMM1NQ@N(!!.A@<>
M9WY`!<JI9D046^R_`S=4-/J4N\#PSAK+>X#K?$O*UZM+8T7V+D,_>_%SL4O#
M^$'&H<0+;[G*C,FLHQ7?49^-S,/NFC?#?`0NA-1O:YHKPDB`1$+<WRL(H!-R
M`'LJ)@Z0$9@'0^_,009*"4'"PC!JKD4!&(H;@%DZPG7].05<>,@;`QOIH7;-
M^GT-VJ#HO5DF\D1"Q2A0W.Y1Q;HZEBQ(39%A.$HO0C$$.[ET3ZIVTD7(N\?'
MP=++>9Z(SPL+/6BG-FG!@C([-!%54+JL#E/.)'SJA!PF(S`@;''<_RAZ),D"
MJ+QR4U!`<)VA,!YR&=V$[[PXWGG1'KN,;+T7_H8.C4%DPI1*N\>`(YW?6/[J
M\<O\?)&*XE<W.Q[#7:P/HO#<BR(:G+T4X[)BH'D[^IZ?@S9P^F]7Z\5I,98D
MJ:R^-R$2KKA4W4,F$C3/[BJ![V=@LG*&WZ@]NM*\06?6#,1))M?0/=G(5,ID
MU/_V(7GZ+F2V4I9S&?-#\6\N77ZH2!?YU[_/Q?_QV'"Y@MD7)NK"C(KDURY3
M1A.*:R-&&[G:%<%^QIYW)Z2<)-.W`>T6:[3V&&R;,'"NM\UHKU%C&Q&>.UV]
M2JF7[=(783_LN5WX,C_3R+B^71<X:%W;C>XI)98S2O>@HD"E9\SG(5*2/3#,
MFBY2P'6@)H5JZ3@]\G3'?1?T/I_'69Z*$K^5@,$ACB#$PGM=#UT?()2;;H)R
MO=GO?4X.DR?5P-Q1S`Y:[PV!;`4='$K0FFB5'JPIQ3I4C72S35(O?9G]<Q?F
M+U/?3VDN(GNEGVWLJNJ`!%>16FC7RBG&`?4CC\?1]F$75.]>QD,+7D/J$ZJ>
MEM2F4J@P]I(&;(WBP<@FV<6Y70"[!@5'Z+H!N<Z@]6$.D9,01G0U\%HE_,T[
M%J:S(2'SH&T+%;Z>9[N+79[E7AR$\<,RB:++).4_&M]2C[,*:&TZVN:.^7ZW
M\E'RF7^6%-_%4%+#^<X>/'ZLE]^C,K"3UYQ*[GV5HE!2C7:FW^`?!BTV,O`6
M.I)U97`/0>#`Q2Y.G[PPXM?B9)VD\IUZ6WY/[QW8RAR9W$MS=/MP1A_"F*NZ
M>R_BB>8C;\(L-NL$[&(+9E+7LPW@>=:065Z.I*..F3Z63'X]ZDPTFA)S]H46
M7)OU34MX[39]\[:.J>0J7SQ4Y7E#MKS>CLJ^:?BR/$9D4R?&>SN/OAY15Q'6
MOU*>T$*#Z1--O0=Z=#_/G9-U:X!C;.6EN[(W8/OK'X(SYZ!<$BG6=))F0SY/
M[[,\]?P<L@@OJJ/8[YA7[!C%E=8#+SQ<&:!FDN/-B6W`8+1R6:_=DM7??BQ2
M&B*R@?0(JG$/Z?8_F\GK\0,B2'?N-%QBN&^OWN$PE+JN;Q`T1"XB#9<9%;HT
MU')VYLZ`2T+KB@RZ[3;:+;.OINQ:QXW@?HRZ_47=992"&9PC!_$\!I<0KT@@
ME\NWE<G]5/.PJT/O@`Q]&*-*ZOUBT`IKW(=1_HY3<F/BVT$MZS%$RJN2Y[7K
M"Q16MNFZ7JVI;7X`(TOQALM29'(<ZT$45ZPHY3<.+G5B?MN)#H<R>]\!W1[5
MHW[KVN;U8!\&MYP'W,*:."U@[U\Y]Q*MY+/X#L*:Y4-3H9XY-C`).JR'+C[-
MOF+2XN9X$EC%\I.EUW)A!:'R`=C:V#1NNKIZ=L..OP9S_+#N.+AEIW/C;:A=
MPYM1U@`N\,?9V)H%)]Y\EI(;:\N=,:EL9*>ZD\0<UZ&MKI^OQ[#MCP($:`'J
M5K2:R\$>F39\/(:.ZG8(\;I9I&#C&EIH])H&[757?%82'B*=UR8+KL*8SG.Z
M<=?G]O!%]/I,9],&3RLBGSEX(N"_0K6G36CCYF2<4MDK8$7QUZ*-MN*QR[#Y
MHXT?11O'-=RZ$5+^Y)?*VNU`+UG@-@^TF[`#RA\U*5K!:X[%TWWWZN]/5U\=
MSOM<-56$ZU8=PWP9A>4PU":.(*6.IO'O8+OC'VOOCA#W&Q#'84`-RG_ZAM20
MS*<CL9)M^D7(H>__^,/W0@KQO_R]+/`<4SU/OWF2:R.E;>DM%;T)&X/!@S==
M=C+FLH/$%T46!36-L?*-&/0MN'6BI/-&ZT)%Y/UY;?6<F'4T;IX,I7?;4&DC
M!38&B/<&67X^YO*[>'`H#$"8T("6=;2GB@L&8$HVR$(%5J=!*L'CY;>R(A^%
M31'J+3T?=^G6RM!@];@T80/!=^K".K6_@E#>31++/"AY"7*H+JU5GVV<`*S)
MFE#XU^-O_`B>-UO`.[F"\@*LL@8$M=XP;ONAO&7!\R#5WS#NS.D#Z;?R_KG?
MKAP_?D9C9D)HC7$OT<Q51@^C>/A5'G*0+[R\\]6$FT6`&.P.MK91E9(SM2H]
M*U1I,>[X&IQ]F[1ITLH+"<(7`.U6`&SPV#M@[IV`49DTQ/PJE7G'!EM6&;<M
MJ,P35!;S_MJ2RJBDLO!`9?2PQP%;`!)GRI6@;'?-'$G)M^+H+0%Z$A@O[&V[
M?,NQ.Q?H^WT=_0S>N/G:P`L(;-@Z([QJV5-4'QD]>:Q[!:\NDTQG4]V+CP_-
M25>O*<O,9F/'0MNFDQ0&Q%]?DIVVC!HGXTY70+UJ:;^O68+`N#RLY0W:D]6-
M=J\#]E]_VQ<&JDUNW8*W:#37V!K*3C[EZ5<M+)F5OZ9AOF-\,HV#2I4*0&.Y
M?4UOR'Q6;;Q[85I9#6$N8+7BSMLTLDVV_YQ?JT61^/TMFZ"=LL"U4=HE"%ZU
MY%7+6O?:U:F4=:^S8>4KF#S%M=%OKM^3$7O#&:PV@M-96L))';1*&+ILWP.4
MJJ"QL#>2OJ!U!(Y3&FK5':MW1M4K(T6;I[=R(:W/(BXOJ;7Y`Y6X:6]+8?06
MR.G"0-\9.3X"QV*F*E5.10X"4PW#"2#MUX1A:[H[-B%)4<:P65U-FA`][4,A
M\T;+XTLJ,N_T$)`]4X30_]U/(`&4/RH;ZF2)FODU;A?S-EVSCJP;=^X8AB0<
MZ"UO[6H%FJ'S[[,K&'+R#?ES-)U^NMF3LC+9$#S^9C/]U8H,,)ABGH\%I?Q+
M[Q`X>M*VJC<6.FG??'![H%S+VXV:Z&]^^1,")8AS@YQKP[+;T9OW;SO$,X1S
MJY;-N)5;>76*P[FMK.=M^K='&XY`I96K>?->KG+C6YO(_3NX=!HDZ52/E:OY
M=W'*ZC(8T"^K"6#,VJN:N(K+/3M:V=MVT4X.`5RGJ;*9WZRKUG$(U9\1*#F\
M&^5<W?F5]?R[N6Y-XAN!^]8@NQTFXGNB3Z=L-15G84"E-EY2GX9/#"&:KABF
MF>?K.&V64,&>(9DB7V-?KV@ART'PM@@5(*2$PENXD`H<',_-^Z)^FR8^9<AQ
MSB;/14W84/0>`;>C^Q&W^E6.#66[8^?%5JPG?KBB3!QEESO^V.<ZC,/-;E/(
MINQB1\]W:<K^:?I.QA`Z]+L7X\TXI?$]`"(A3(B$00H@I>&8$09F0F[H%UX:
MGD9/;$02YX^8WJ;TWHR_42\E-`X8SU\P8A<E57]X/R&<$M$8$OWX0.M!B143
MH),`\WCUG/`CU7Z8;`X82JW;;($UZT\X[_-&;;PGA("&X('O$#N@X/<_HM'P
MUM2N5/*VI(Z.RT=2\*]%L_=5Z<-S<I)[T9CJNP'C%?\FB?@T'F+8A#D?_%HU
M]ABJVKW3[3_28,<=">9%!3L_G\?K)-T(1V+EW4>=M:3U`8&YUAHHUKSI8@[W
MJ(M9I#*-?!83X1\E&A^CVJ/4/$-WY'G.]R+."\<VS'X[>SFCL?^X\=+?IE]"
MX_(*G?"@U8D&PO5&D)4IA,\A^RGD,Y^$K_*J[KEJR5;-0X6DVG(Y%\G&"[5C
MEYUPH$2J!H)F5"JGX9&GNB>H%*>:Q]?CFIE?`WCQR]2BX>')5-"+VAH:3;UN
MV0`R1=?J$,/2[>\<]5>/[(*NF?"[;]`:J;X_`YX9M#8\F0*2ZU=;=MNYGZ%I
M9XAAR>89;/JK1I+RU4S0[5E9C=3<GZ'.[37:.2*-=MYY[N=8-1KHTGMK-(W5
MX]1HYY8:[7Q@!KPPUV@7"#3:1>>Y7V#3:*!+MM9H&JO&I=$N##7:Q<`,-;/7
M:#-$&FW6>>XSK!H-=.F]-9K&ZG%JM)FE1IL-Q8#3*%KDCS0]WV5YLF$D9*#:
MVN:"Z+AV1$Y)@HTD8BC9CT6C]LRP2`06_OA8F&O"7H@@48X=O-&N)=6,X2[4
M7K^HN@IC.L_IQOAN2`4*^EI(C69#0FS]QI)/(&(&ONL@C5/4N@GJ/D+`2Z!;
MFO(_>`_TO?4%4!4&FLN?8\1.B7%)GVB\HV2['X4@*\T.AXS<MB*!YZJJ@<[,
MKJGJ1-;+_6F%+M*!#!VB#F#`+E(GJAJWHH=)1,S"XT498R?SO=+Q!4`?[ZKG
MF:7\S`ZH$9%7A\X3T^-!'=],BP'=:=E+RI^]1//89U;HROLR^\+?Q=$S&M-U
MF+/EYF&\"^.'(O\NB3/=S@,#?`%*0_?:E%-R+X`1"8TP<*2`1[XN('XCWIL5
M0,D!JJ)\/X#.'V570KDK.=N5>PF(>'F>AO>[G"?,,7'P$QI+H3^O*.V(WHSB
MT#:7+V**%=?6:NHY=H&#]AZ[T:WI.#F#E&3>R/4(+)/^&"9[:D2CLPVI5"]'
M4HM$>]CY+=R?%1]@=L+&B_E[]#A8A1LF!B["]9JR-?FT\]U7_P^`Q&M[;HF^
M(LY(`9+L81(&E$BHI`(6.O@[\)8<T/4:T25?QW0$.64>*QZ)%"K6!RU)H31#
MMD=[D\N]"0Y@:SZ*_;;\*+<EI@]>3EN;5R"E!IC`^Q#BLCTZ/X"L'$\5?/*B
M'9U&4?+,JXT8Q7_,((,&@TPWP4;:"R!D#P6!/38(ZGQ`47IH--3L(T9#':Q*
M=C^)@]UC[UQ4@YXM;*S,2GAU!\YL)!?F*-IXT;-7%#4;-EKF]HGW>%MP0YGQ
MF29/8<;9?)VD9%T3>>!&6'_*'S@6!G`_O=DFW`C,%NL+RJR_E`9LI=,LH[DJ
M2-[QKE,'*'@\3!/UIDP[.8^_"R]G"B:7<\$"WJ.@NT>0VR@>'XTBMCT``1I%
MS@Q(VAWWUE9R*#"19-FYEZ8O:]E#65M5FX"$TM%F:+<2](%C)Z12AH6!($<P
M$-Q:]<.8Z^)DCV#$$?3YE.2)IFATL`4M*Y6O.2$#\NW>(3*.B)B`A-:X>FAK
M\>O!@\04^.B'Z*@1CQXN_^A8@=L+!ORH92WH,R.@S&%:P=HHX'/1:'^)B);8
M$)IP[49Z&/O=FHAQ'(*:48Y7CU?HS$QA'X@,HHZAA@&M63\.PF[6+$.G83SB
ML8S'P.E@#+?A!*Z<].U@VPW"PV17X2:4MS'9(O[8V'.TH^QJ)T3X(L`:2)LP
MX814`!"FTSZZ;M$Y)KZ"045/+,JT7N:GX;:I9P&"@K^ZM*Q9Z5>3D-UQ[6R]
MIGX>/M%]/'O)7`G-:R&EA#.`#*TZC3:AUF6OG%R]&.+S>6L.1GMA%'JR0U&1
M4(](OPZ$>,JQ919X>>'MYS#M.8:B1Q,-;$SF#@L`[^XS^L\=([G9$_L?LYJ_
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M[,'-[!Z\HV6-6S..W"@F5'[[,_LW^S].7NR'_Q]02P,$%`````@`FH(^1P#H
M5,ND/P``LYX$`!4`'`!O<')X+3(P,34P-C,P7W!R92YX;6Q55`D``R-$#%8C
M1`Q6=7@+``$$)0X```0Y`0``[7U;<^.XDN;[1NQ_J.UYG>IJV74N=6+.3,BW
M7L>Z;(7M[IIY8M`D)*.+(G5XL:W^]0N0%$6*N)*@DF#YI<MM(T%\F0D@D9E(
M_,=_O:V##R\H3G`4_O.GV<^__/0!A5[DXW#USY]^>[SZ^/>?_NL___?_^H__
M\_'C?Y_=WWRXB+QLC<+TPU?29HF1_^$5I\\?+O_\>.GC-(H__%[T]6'V\^G/
MO_Q\\H'\^/B<Q8GO;O_]PYV71D\H_O#+[-\_G/PR^\N'V<D_9G_[Q^GG#_.O
M'SY^I!\*</C]R4W0!S*P,/GG3\]INOG'IT^OKZ\_OSW%P<]1O/IT\LLOIY]V
M#7\J6O[C+<&-UJ^GN[:S3__]]>;!>T9K]R,.D]0-O3T5[89%-_ORY<NG_*^D
M:8+_D>3T-Y'GICFKI./ZP&U!_^_CKME'^JN/LY./I[.?WQ+_)\J#.`K0/5I^
MR#__CW2[0?_\*<'K34"'G?_N.4;+?_X4;>*WCY2/O_SU]!=*_6\[\<Q#_S),
M<;J]#I=1O,['_-,'VN]O]]?5X.\6]__]B?[RDY#N4[\QG4>AC\($^>2')`JP
M[Z;(/W,#*H:'9X32WT(W(\J#?-$(-7H9>KP+-R:L>D8I]MS`S.`Y70Z!Y"$E
M_Z6R3NZ6=QL4YS).NL.0]3<HAKOE0QIYWY^CP"?KSN6_,J*ZW1$P>QM:!N=N
M\GP51*^&1,#HKB>"6S?-8G2W/,L2'*(D(6O$F9M@\JU%C!+R5>GJHMA#SW'J
M:8)Y23\\DTE,<"%_X6X+:6SRN2`<!I>HM]ZMUSC->R3L)MJ2DBV=;.T8"<<C
M(NLYHGN4[/14-()ZL[X2R=9K-]Z2:8U7(;%6/)?L<)X793FJ!9D^,G8H]M!S
MG&06;%SL7[YMZ-06#NBP:>\O1V3)3K=TWR>38",3#K-]SS%\0T_Y!'A$WG,8
M!=%*.&\9K?OR@&A;;OD\QJY/;+SXNU@"C.8]1W"!EBB.D7^/7E"8(:&A=M"T
M]YP,Z`9"S(]T2_"$B>M)ERPNC8$5*PKS=5FV0NV:]9]W!3>E'SUH:6*G*M=Y
MHDC?W)BP,14O1!R2OG-/X=.FOE4:A^'J!KF25>ZP:<\O?W7_B.+S+$FC-=GM
M11\^:-GSN]?D)+U&C^Z;&&V]6>\=[RE!_\K(`G7Y@F0J==C6S&X;B?=*C5U7
MM2=S=LFC^Q2(A]9N?!2NR0>FU8]9>T4^.#:!(=O%K=DB*D/A4AFW8^2CX=(8
ML6G<NI&BP!HNT3#[G8)2"PD-[7T*4C+ZW8/-3?YY-H'1/5$^"&9[<_NC?`#M
MQD?Q:UR@U,6!<&1Z'1GW<BB,D$\TE,]#95`RVN$\(`JC4Z`V9W<HC(?1^BB6
MAXH@M3HZBD^G_-@C>DLS-^COX3GHSZS]I,!B#L4`%I328/AD`_BCU&6I0&W<
MQE/@%Y]HJ-&4:+N-JB(V;X.J*!>?RKR?3X-="M1FO8`*O.)0#.035-JDQ*3F
M/(2*._A!:Z/^0E]IV680#'.:4C4#^91#CDMEBJEU8.C4I[)NF^7/07<SC4_/
M#'];:7_@D)@]_2J(@4-A]/RK,`PVP0"C4!&.D,[<J5R!+8S6QK\OG"JLYJ9'
MH"(2/I%AG[[2B8Q-HC425OY:$,?%%T*THCL]S5[[0K/79G_-QUK^^L9]0@Q+
M_3`5[DNCKX+HTW]^.,8(%RC&D7\9=AOJ`?51Q_R0$NNJQZAK]$<:]V.4ND&G
M$=<HCS366]2-MQ7=L7A*EGW4C:=[2H-C3=OCU&;DGH-DE=K47*<W9!B-`9*5
M%84^S90K?DL[T,UJS9.-(Z_1;T#3>Z-8MB+3WSBBSN=/21J3L\^NHX`"R[MW
ME&F=7XKE6FF,)?2<K0GR?EY%+Y]\A`E[9Y_I#W3\GS_^,BNSC/^-_,HIOGR/
M5IA^,$QOW35B#)C7U"FWV;J@YG%SK&[L[7HD/S:DU$Z++EM\VN2YL!^]9QQ4
M`E[&T5J??[NQ1%(D'Z+81_$_?R(T68*HS&E7.W_1P"(X)TAB-[@F&OWV_]!6
M*(.#MLZ)O4)H0]E)879D,<P)#)]"N0K<%8?]C3;.J8UL/X2P8_<)%+LO4.+%
M>%.D#XNY7FOJ?+::^4TD.QF<'ED&.R"/I%L.[^M-G+_8R/,#!#M>?P99Y:]P
M@.)S8H&MHEB\QC=:.G^UD?-L(#L!_`5(V:MCVP49DT3K&VV=O]DH!!Z4G1C^
MRA;#IT/3^Q!Y5W-<XPI7)W58NLE3SN(L^;ARW0W5B;]\0D&:['Z3F_$UY2A_
M[=1N`%WAD(P'N\$B2K#$EM<A[VS.=T<U3Q*4)@KC;S8$,NPUF7F@[UPH7,O^
MPV87G+DI.,(=?S[X%Q0_1?N#,X0DS[.8,E!9H`?M@<X*?,F()-@>^R0$26_G
MT70B\@_-4'AQ@SS!*#UWXWB+P]7O;I"Q=B8M>J#3B52`;'FK0IJ$_,O,HN0>
M>8A`?0K0+4I+5HGFLX`,Z#C44=H2)'P/@$U2;F9KR<7+;`]TY.HH5QX$OH_!
M)H$VF*&Z[P*=W+I.S(.A\QT3FH)+ZS&<8\_#(A]P$;C%^6F7%$C6'.%TY),!
MG01UC2@)A&DLLW?I,XJ5#SF,UL[?K1`F>^336%G)$8\<^&_P"_*O:=KG"A.3
MH,`JGJ1B0N<+J&0Y$F.+5XID$I;ON;O!9"/`?U+WSWJ3I2A^B);I*^&G6-!B
M0F?VBSV2ED.9QL+\@+PLSB\9;:CC1N0Y:[9T9K"^)RUI,L8^C36YQ@6U_=29
MP;J6M,1V,.XIV+E26>W@CL$QI.H!I*.=@G!NL/N$`YQB1)/:VS<Q%4Q7U2Z<
M&:POJ)_K7@?E-/;)&F)UWSZ?R)G!NHRT!"C5`0:X21C".P_HPMU2]V=^G4S=
M`\R@<F:PCB:)S,1^8`Z>*4JZ=CENSRIUD3/)G1FL/\J$[+G`IK'($[1Q1@;:
MXI18]&P:9P;KLNHJ;SX:Z",3)[N[O%*;UZ@H]90O-@F%,X/U1FD)30&+,:L<
M=%X>7)Z63THV@7,"ZX#J-"/Y4/@YDC;)5FNQ9:Q+)[!NJ$XR9</@IUS:<X+N
M=&86'#].8+U5!HY)8G#3L)MJY1ND65$'39T36$>71#R<X``#Q"2.0<TB&#)9
M,EH[)]!NK0[BY."8QMS<U88@Z]<]7CVGR5V6TG=5Z+,Q`MF*R)P36.=5)R'+
M`$$?;@R=8'T?%\->N-B_#LLPINC\RJ9P3F`]59UD+,`"?1#BG%USF.6QC7=:
MK;=Q3F"=2%IB88[>V*DEK5^.ASF/TLP`%":Y$';/F$C/I&TBYP364]1IKHGA
M]#_+L`N.'%?.][062XC\2S<.R3:1S#TO6V>Y"Y3`QYXP7T).[)S`.ILZR5T-
M%O_>FDV[*>N9(HU3K',*ZV_J)%\VC)T\_V:Q;T)VF.\1U7=.1^.%,A#.Y4(T
M9B,?:@'</5;.:W[OEUK-NH4(F^_B?)A^?KY>H#B/6*AYBGC45E]_5<,W";=2
M#6J.*YEGZ7,4T^1:-04XI`*^'VM,\`Q<T_`ZM3!>)TFF)^V"`OB"K&%)5YBF
MX6UJX5/S+8K(@*_(&I9W$QBT#VJ(&$&'C5VM`^`[M?T401GB-&+X3;@:6[R8
M$/A6KDD58$`S%NX?G>BE>SV?"/C.KGF15["FX1%C053;]"64P/=[S0N^B<V8
M_RR`<IK4'ZXOR_R3OX)Y3(H2[M6@%)PD'`H`OTB9RB>Z!;9K`NSAX/.,&QVH
MQ@WLN5!(%BXKH*AD"9=-@?T.RN(0C-^8?P$P_OIK'"7)(HZ6P@!<K16P%T%[
M&C6'/IC;_8@BJUZ&V;V+IU(&A$<#["30%J<(B+E[LW#SL<)W'B5YAE47(?-H
M@1T!0ME)Q"V`9&IW!)3Z/,@[)Z9A]3IL(QF$N[OJ=0#L!5`2)EL/E/%-0!DN
M$!DJ.37ET@G]^3J*4_QG\7P'7P,$5,">@!YB%X.:@OUU0\[%JQS0`TK3(-\%
MY=-=0`5\^N\A;#$H<Y8;X.9.B[!0QNSY4O%+M*\+R*!+?G47MP35I(RY'5=T
M+'3P&E\]1,O"8BY;>01'K^+<<D..EBHBW;<&+_75PP1OHC"W^0**DRY!MU$8
M-2&6O%&MKBGM`+I0F/XA6QG6-(*NUR'9)%"^$^70"[A"!SB+`+K2F(;8V'+G
MPYK`L6H'3FY='[2$KB]F3*PU/%,X.G%9(A`MEP:ZBEAO(0N13<'MO3<_K@CW
MSJ.0(,T(V'T$]0PMHQC57J3^BL,HSM^.JM:U9B]%/OY7E#Y'Y"\OI$D>EI6&
M/H\R"N@*9]IFPY%Y,X4B'Q4KRLEZAD(D#L5Q**!+HG54%B:.:>3WW*)4Z938
M:`==Z4Q;C*W13^%ZVS=$RQH@?TX4R%VAVVS]A.*[92L;Z<Q-L"<0K58_T/72
MM$6OC6ZG&G^WV.CD@+[`0;:+3JF6!='K";KBFBGU$.';*<@7BQ5D=YE[EYF>
M:S\Q:TK<`H604$*79]-6``4\^V/HA"2NX#?DD4`7:>LM8V9!-IN=#$PEUIW$
MT)79A%+2F+PFB[.-2*;Z2W.UA,%Z!@W(M89D,)\@4'8],47;A2G@JA%TK.>I
M0`^0=U^-ZY%3;HO=<#Q5!H3<Y,R=%A93:V$`L@Q6<`K\-)\N"JES;?Z&10X+
M(=U8R@E4(I*(DH/!;LD>@+J(UBX6Y0XRVX^E7`!/0IS]C0/%;H$V;\5]1?0H
M+9`GJSEPHC]7+FPQ<A!,P/BL%3:0RK'5%CB!7U.(K.%/(?!<UK^5BJ_1#CCW
M7E-TAT.?0O8MIZ2M5(Q".N#<>DVQRJ#`)MTJ%/;E"HO3$C@;7E$\_,%/M<3O
M_AH/09Q']*734*<;X*QXS5FIB<Q<W@.<3AR6OI5*GTT`G2.O*6@^"&,I#X`R
MK4YL-P3C-?E1R8E0-89.C==V'31&;LRNA?(%]2O/#)SASI$)3X"LX9LZ6FY0
MC"/JA(Y3H&FHD8/0CL(#I[#K"9(U>F,3$5Z05$^+HE<764S@+?(1Y77O+M>;
M(-JB7=;<(G!%_CW-GJ`3WO5GLQXVV,.LZ)3#P4'#6UF0NNS49!URZ#1W)='J
M`IK"55$1W.+75U'\@.(7[`FOD6KU`YUA;FRB,Y%-XVX:!W:])&(OS>!T!)U/
M;D(U!-"F43%4-"7R"T4=%XJ<%CH5W=CB4*&9QB%;H.H=95XCADY"-S?M*SCF
M+B0,;^W=+0_?0R7KUH+\)<[;:AI_DMZ@,\I[VX(*^&"O'/00?J[$QH3?[@TZ
MF]RL\-GXIG"=0+2QW:+7_"]=SP,5/73:N;&MOH%H$I<+A'M<#P4XZ``Z0]W<
MOM^`9.X*PFCM_/QO=SFJY/(-Q1Y.A*GLVGU!)[D;6QRXZ"HML3F[13@I#"F)
MH#/XA\Q-+2!<>)6:V.QGG/M_9&4-A<>(DPY4)G])WQ[1[@O^)70-)>F$KM(1
MF(0=W0-'_KO\K_?TLBX!>K=<8H]\6ONTP>\*_J'UWD<-,;A*Z#`9.=SG&;S`
M31),QIESG!R/+M\VF`REU%JNC.64\,^LJXI4#4LE01C7($>"*BM0"68>^O?(
M1X0G4NGVZQ7^H755R??'66D%C.MPN.S+.<6XRMGX#:?/UZ&/7["?N8%>T?F^
M7<,_ZJYA#I@`6RF4S150BFVPG"YW\;D;!(S#ENQP(>T`^AUX_0.%$J1*!:QW
M2HK@%B>I/CI0]."<VN:85,.TST"R6`NZ%3@[M<C1V!IY);?^V87YBX@OD!.X
M1[KOJ6TNP=;P*TGV]OD5>:*7H6]CNN^I35X[UN@K.?9VRK'D"/<NZ+F;/%\%
MT2O<LZ"U8AG58/0JEK3(``J5D"6<#F,11\0R1_[9]C?"].NP>M1@[I%5F*S$
M2@^LZ7<VGH(G+&'PMSU]F,!OE$*:-+`V:C=IJ1@\YB[%C"7@<8^\*/1P@!I`
M'R-S2\00GP.NQ&)2P09BC[%+/Z"KC_F'_V#-]*&$S7/0B?@PSB>TZ[%FE5Q^
M.1%PA9CCB%R)#?W7A"^%R$.THM8YS)KPJXM#RK6[\`(GA=,@"N^6\R1!:3(3
M+`MB0N!J-,==&:2LZ'\A<`RJPGX:5^8.:!$`5[0YKFIP63"%.X6$8S$BV"Y0
M\2_A$;T4L6=4/@'(7GF#W2<<Y"PCC%:P<GOV#%R5QZ1!VY\3QFXC`S^A=\B'
MN>=%&9G%9`XC_"(I$ZM"#ES4QX"D556(B;VW!3N&/:J-=1&CC8M]E5?YQ*30
MM8".J!]MX-,P=ODSH:R+UFD%*6FAZPL!K!\UY-"[##=)\06%&<K-,+Z,>4VA
MRPX9%ZD(:'^+=+13/":']QJ+=&?Y`3ET#:/C3G0&^&D4OFBCW:7@E1-$2TT.
M:*%+'!U11QC(IU']0OT89R2D"UTZR7"<3P.U.5\(W)..',3%D[*&\@`$G8VF
MTI*)1``)3NA@',?47&2Q]TQ6Q.1N20`134^W9'VE&6$;RAB>V2DA@ZZ3U%%$
M#+-3`2BP"X(G6-)7F!87L[A2K+6!+FQD4&0'J*"]`!P!?4-/"4Z)2?*"@BA7
MIO,HX<N*TQRZ-)$YL0D`3B,2I<XJ(YLL="$C(YK1#?:$3;,K'+JA9\@T$W0V
MFDI()DPS"4YH+Z`9A2&@/83\Y(KPDF9^$,2H40Y*H!]26NA:2!T%R]82);0C
M3HW*\WKXU5XIHX194@KTT)6/C,A;&S'T&6W(A:#Y=ESQ?XC\)?]?<J017)`W
MTS%TQ:0C+"$ZK)C"VV&[1WC(%+I'F_*D?+>4WIT3TD'73#*K)S*DTXA?J?/,
MB)$*73')J(KHP3;W]!G<T8;"):LA_8=.A!<WH%.DV)@/(S4"?='I9C35EK2.
M,[H(C9U[0>T7-NHYF25QO"430E9)0XE^-+6:#"@$`YJQ90+\O9\C:<-(ZC<-
MH0T&WT:$OM6?;39!SB<WV/'I.EQ&\;H0F,(];+4>1E.#24L?-,`9>_0!.!F&
M''Y0DM+J9<*\EWTS\`)*&C+BY;(TT4SBBGEQC>71?4.)5)B-EN"UD`S(LP5H
M&GZH'3MNH]`C/^YC-:'/.-Q<X,0+HB2+D<(RWK?KT=1;TM[O^Z*&???%>%%O
MT5W/>C/HVDQ&1,?9]0]@#K<?#%;WY]9-"=:[Y5F6X!`E-,/SS$UPGG.S[_W8
MI7[NXI4;EG?E]P6)BGOT]7'=+4L1NL&^5I'"(F:D?X#B0;W&O5?M1Z(<9X$X
M+FGZ4\"%ATQ)G+,2#,"MH4K=#+:4,&KX'7EZ%%]5F/_-A@`3N<VKVRA%>C-4
MN0_@J==BMF@W5<1CX4Z[O]F_BTR5M4*./4OV',TS+ZHB`_<HH&&L//4O'^Q3
M?;`*LZI?QQ"SD`ZFH7%DN6[+26DR:G8%/"=[BXHWA_798-T^1[.5<%$0A+J`
MHY">)A#9T]'1I[)@*'J'>IU^`":JTOA4IJE>1\"35%<J/-^%+F8+-]=[<J8O
MS>ECS\'R;COAZ?DS?7R!,ODRCJ/X/"*<\O(M7J5.HT8W`#-097@J$U"K'^#Y
MIRD2SO3316S=?OB0K==NO+U;/N!5F+]K%*9[T`MR%(;8&MLCT)J$AT00UJF(
MG4HVJ5('HYED#);SK$Q58-;-I68A'8U)P[N*V.Q/,`5$S;647VTD(OT5M@=2
M5PE[#A15AL!""XMY1?GXZ?7Y&!8!G?FU@2@L[5):@!6>.R:]0XU.-\"KO8H4
M.(N^)DH+I]@W])1[21Z1]QQ&0;32<*#S;SH?="G;`O@4)G:!=N_2C4!``KD7
M"/G$V@[$..RS5/*K_F0>/L:NC\@!X/O13?Q?H\A_Q4%`!G%-T(0K_!2@HE"1
MEO=+JQ^`;8(_*)7=08$:>%/0Y3]G@U`#:MU$.RPR=F3E*S]+"U^30Y=BKB^?
M"&#Z'#!0;_;(B8$GCY#5G)FB!,JZB5+&KA8N,1+)IA0FK@<27^6-0VG>B$D!
M9@]O2'K32*,7\/DD%0%G5NEAM&YZU<M9O.?UO.?UC#JOYY@.VUK=@?>)P7=U
MU?FDYM5B4EBB]/S16Z?B]7>MZM5*WM/6H`XTJ@/6SF+KV?-$D]KZ<\6Z.:\_
MR7D.W[*C@H>$A=(8))_"B`.Z[%WN=CYL".IL%O&$Z6QFC-XZ):RJ?]_0*AM'
MWW"*KRIL(,V&`!M",8"[Y0U*$J1YVI#2`B_J+>9R%FD5'-;-@*_N'U%\GB5I
MM":?[+T8-[J3K</,QB:6X$;'TG68W1IR,>8QAK4.<T=OG2K6[LH?>R&N/JT5
MU1-0@<3P6J-1"][QR8`79C%_N3$Z(1[K9L5#]I2@?V6DF\L7!'`H/OR^4AT>
M-@F$M_1@*$K>41X-\'00L)7G%Q4@L7`BY$G@D3@)_$=,!N=80665A8./R-.A
M9'06I7.KXAEJ,AQ1`3DHY3+7Z\"!K<C4)9=?&9BQRDR`:M`H#:$N?!&9`UM.
MJ8O()7"F4)Z;4SY67>(J]`YL8:5.HE?$9>X9&3@=N')QG-<!K15]N0X)A[+U
M'K1`!Y3H'=B*[5UT0!67N7K;<#IPCSQ$M/PI0$F>)TUT/W]7=?<@]O[O\R"(
M7NE;!E=1?!%E3^DR"ZIGLV6J8O(S#FR!]RX:91B^L9J]D.]#\&[+J.]!JETX
ML/7=NRB,!C1CY7I!5Z'#'&%U+9#2.K#5W+NM%W),4ZC667E;U<7-(W%@J[1W
MD;(`RDZX?[=8N+_EK]DD*5Z[J?!QEV9#9P9;7[V+)-L(=@+\8K$`R3'8(PR+
MBUPBG'P_)X/&*?U)[`O@43DS>WQ_BG#V3A^+!7U/I$$X20^^M2=VR[H`"K:]
ME-J9V>?W4X15*8#-;K]]<F`]?;!(J<TO/=(I@%\0-4?EA[T.O3DS^[R$'6%6
M"F.S^_#2C4/"+/K>5,X&=?M-0NG,[/,9*D"JA&ZSO_!ZO7%QG#]-$%_@9!,E
M;G"WO(G"U0U1<[^XU*QAR7?HSIG9YT[LBK/2&9O]B[?HM<:S.`K)CQZJ^5'5
M]46W*_IDO&VZT@5CI2?&W8''J(;YF'M%WVMB#F375VR.%C&.XO\A)FWI=E!R
MK2G0CR:?HT\-3%6D$TU[@IZ$ME;`K%^\8A\'YO2:RZI8P<^VK4M8\U<W]G4O
MOAGXTF@FK?K6:)X#UDWFPX*-FK/6NA*<%)]V'<X&D;W%.`]A6%@N<!?$=&OQ
M2YB=YH>IR]DK;`X]:W0XKALWMWPJ,6HSFEG\QU9_\\%[1GX6T(OL[@:G;H#_
M+"^P7X>E&YY8#1QV2/<*,[U;5=73&&3[K*6\`*A;+P`*L_O\*&5`]ZIV.#PR
MXMW@I1.U1V_3*!/:#;AUTY-3M0=FBK[7[FEK'_N0W1!;\2JQ?/,UU_E$*_@8
M88QU2T#7.3^V4C[&9QZS(.%NL'?Q/5X]*UY&[MJG+<6$3``%O;XI/0?E"\+'
MUHI0`E)>@@WT"G1YLUN!J=Y0![O.>:QR5#"6E#U%J?8:<K]/[.M@RG"I+2E,
MI8;$.N.B69K*D(DQC@)5>XDU05Z'/EG+_,P-R@LDNKN"5G>VE+CJ#L\ZG:_5
MP()9_:=0"6NO+Y?+)<T@>4'5`._)*8_>R@H]'.!<5!TV#/UN;:RDU1/O!&JJ
M[#FP>\^$0*\\>3?8?2+H4ZP0Z.[9(W#5E9[JHPO5/L/]UDUSC])9EN`0)11@
M675F4>O]`J4N#HZ^I-_%*S?$?^9#:!1&(:.L#Z]6+.%AETNG<@XPTK\)J^I0
M"B6_J6H1&T%F[*E1`R_DIGC-,K.4&3"!E;V:J-Z_,ISD%[0+5]-U2$:%:'`U
M23+DW\7T7[I`W6;K)Q27SHCRKX))8>8#D`X;=75@K__&.#`!=2N`?T7I<^1?
MAR\$?'Z;Y#4D0WK&FP6*Z54S=X5$]ZY4^P"JUV5$:71`VF<FM#W;0":!/:_Z
MM*U(3L+P-YP^[QT"EV]>D/DX7+5?S:`[943PH!3'.>49"M$2TXSC1YP64?M=
M-]2.VSX2C.S/YY:KEK4_ML%;\M:1%8PTM4\%(%M4&_4;%M7\8+8'/J?:H29L
M%>?Q<V):13F?YUK01`BRHS]&EV%*-\)H[>)01]_$/0$7+>5*4U'X4G!0:L&[
M^!&XQ2W7^8I.FZ^(6O+<"Q^LQL"E1CM(@'&$YB$;8X+"(_DK0;S$'HK%\FJW
M!*X):D983%C&#A7MNP5]A$5]/5F0NF$J%M5A.^!2FV8$Q0`%6\&9(Z3?L8<E
M2U^M"7!12S.B:>*90DUEV8K(;`=<H;*W+'F@C!5(AK$^+S`M(!#)A=EL"%R)
MTI@T6ZA@RP[S[)#7J%0[R=K9:@A=:-*0&<*"9:PFL"'[?KXBME)NV+*]`NU&
MT*4B;?0%L+EHS"0UK0O<,SNK&50%20Y/18S?#WADI^P'Y&5QGC.QR&+OF2AG
M-6;QTBDEA"K?R&4\0SY*("80+#QXM8VN(A)?+(<"NA2CC4NP`DN-G3UAC&(&
M,JGSE4L#7<Y1)"9EP>ZAV.UL/X`F/?4PVT,7713+1TFF>R!VRY/Q=I%D(^!0
M.#-87Y/-&X&`I<;<74"Q.<+VA(R2,O,!Q2_8(ZQFOYA%N9>P_R0/W!G\C#.#
M=;2)E($3V3.,?F0GDK(DS5<W_D[SNOT7G$3Q5O%4HD3LS("]<:8%R`IPJ#)B
MN,)71UQWS@,W2<IKWC<X1-<I6HLV-69[YP36]V?SEL9E*)B[G^?O:.5+*N;R
M2PF=$UCO)%\$+,>'"IHI.#XHSGODTU7/OXO/W2!`_D46TRJS*,:17R2&BTXT
M:CTX)X"^2#5I<@XZZO@FL54H7K9H7A@`]&3VDNT!B)%FHN00BU%6BA?A4O'.
M70]1E12NRS)BYP3&;=E9@GK0C+D/86>F6Y7J85W;N0YSN]G-R_>+9JY&-\X)
MC*^Q_\S6!#F%-)H:9IJ^A7U4/L"7/Y1,-B]]!9'WXYS`^"Y-:H@:2F.6NMG-
MH2S)=/F&8@\G:!%C#Q6&"6]'X%,X)S!.RW[;@!B/L02<L:S].WSY>J8VC1LD
MS@F,0\_DC&T!,I:\8W9R7J"GE)X=UOEHZ/-E9']8T]_.U_0Q#]X4E=$Y)S`>
MNGX35045[`O=W%3P]1HG"4TQ$]X;YC=V3F%\9_T$QH4RA:>VYYX7$U.0KBK)
M'NAY%E-^"M95(9US"EC@J\_B*D4%^S@W[PY4F95TM]S5NN3-RG9+Y]0RCY0`
MQR1>U,YY4JMJ?G"R)_;<[VZ0$?NNQ'/87N:D[-&U<VJKA\L`\.F\UIV;C3*G
M9M[(.;7,(<:&,(UWL]>;(-HB5-:+KY4QDV_64EKGU%(/EQ(R<T]HPYY^93&8
M?!'K$Z3*.W!.;?5E*<,S]SXVO$*T][+"Q7N7/HMS,*7$SJEE?C`]:.8>OQZC
M$N2ZWE$']K3.J:U>,A5DE09`^<O,:,`NCZ?T"N9%[4(/Y2_*"(0O(G-.+?.L
MJ8*J1`[C61M^RK,?`?HUCA+IR5"_1^>S9?X\`W@K#;+9ZR?<(8VJD+1+Y[.E
MOL(^@"LE&I4?<>[[N!C%MRC^3A"5Z<$\;R*OO?/91I^B",T^=69,\KK*@F![
M@8.,G'RY&8J<ELYGRWQY`AR5=&QVS=$`H*KIUFKK?+;44<=$4LD3*E--\DK@
M+L="EENR;^A\MLR_QH=1"6<`9]IP]8];EQ[*%S&!RB!/X=%87IHNC]6YT@6N
M]`:%(OW$GG/5Q6[W!6.V>2R+2;4((%\IT)&5($C%PF1*MCY:XC"W:7_-L$^W
MV(&7V3QE(MU=*CN/0OJD)`H]C*`66M&(=-X9T^H'H%K]#3E8-D8EJQ#/)@!>
M5'6YS)E87&R6+YK&RO/`%DOGBX>S3G)13$Z>/>KAP)8=%\A(6:C@)<;'5`P'
MN("62#I*`C5>@1Q&F*VUZD:A;@"?"+A\N>[**P0"5AW2D&3+5*'M513_%FY<
M[)\'+E[GAD?Q@_]'5KP"53YL?8\V44S/=L6?>5<7S'X`N(ZZ6`,X6F,*^`0J
M"^R>(R.6[1,.=Z\G%NQ,&S?N*J[)T_FZ=PI<^KV+-O4""WV5'4R)S&H/<)7Y
M(ZE-K>R\S8G"36YM+]RUNT+)0Y2MGE-9AJB4%KA"?:?M2`$3[,5W_M,K*:;J
M6LMJ+MW+C]$\\W%ZA5!R':I<QM/M";K"O8Z@>T`T=IO]:"]YWJ-D]ZPRD$MU
M[GG4/J,)$L^TUABUZR[C.(K/HY@^^T!]X`H>59UN0)__S,.G9]N\<);ZNYLM
M*F#7JB:[>8=\(3Z[C_KG,<J%<D&FE\2O>MAT-*]/,J7"%B4#@]WRNT!+-PM2
MQO/S%*+\)1X%<F`G*TMDO+0:)3!V"_R!;.1NC*-%C%YPE"7!=N='D/M<):3`
M[E=5\?$6:2FX"7A6:H;0WI\D%;R`"M@WVT_F8ER#/5A_S.W92/%>X"<&.FW4
M'""6^]\K_:[5K5Y$29ZNHG!\4"$']G9R!<=9MM40V;UGE\>0I*@O1Q7_%J5*
MU6:X9,#.256QL84N`09<2Y?CF+I'+R@L+THMW"T=-5^$$@I@AV(WZ<DQ32/P
ML"OQ7D*5SU,V`;0SL=\4Y6.:1D'=_;VGA8O]ZY!_Z4M"`?[P9K^5F`_*6'1@
M%).YGFQ<7`=1F-!M(JAG-<U.:C8NZ"*WID[(J4O,3O_2C4,<KA)B:V3K+`^)
M$/C8PZ*57$X,]7*G&050PS>-LKG7H1>M4<4OA=,5AP+Z74_-$Y4`A>6'Y](6
M$?D_=DV@'\H4"8$W-?<CM_NT2V^!W2U_C2(_>8@"UG513DOHMS#UA<8`,`6O
MX]TFSQ(*5V6FHFC&M=I"OWZI+T4FA"DD157`"I[<B&N9,%I#/P#90Y9-$,8.
M,YO<UGI!CW!2W2.[(@PK\H4R^DKBILSM2\[0,HI1T>[1?4/)5QQ&,3'SKT.B
MC2A)YZ'?[*4X!7Q%Z7-$_O*"BE"*2%N..`KH-RGUM?#(S#%V<MMI]P`NTW)M
M5?&5EDVAWYQ4%[L(P30.4[<H5=I#&NV@7WW4G[>MX1M[6V0$^T;-=7#N)L]7
M0?2JDK(H(H-ZV;%_L)$)Q9C-!W/PZCA)1^/08LM$::::R^KJ-5%%CSB6A3**
MVGE745R\;LVO7B8D@GJTL:/4U`#U/SI_*608HE5>%QW*/(^1FZ`+5/Q[';;#
MW6*[6DH.]31CSSFK"LW8,CS$7&Z#8(3$>7-:B1CJ6<4^<UL9V!0>VVR#/8B6
M:TWO`UJH=QB-SVT&+N/G5$AKVE0QK]$D<NF(FP_&V'E7UX963]O2R->">FRQ
MSUK,@='_*,NUKH:K8)FMUVZ\C98/>!7B)?9<<HRO[G0MH@`#5EEK#T3K`N`A
M$<1U/^8LGM/ZIZM<Z\ZVK8)_\U<W]J]<'.>WB.?$CB^>]*17ZPKG9!1$JZV*
M8V'XKX_F^B%#V%HKJVFN3.`JC%%&48>M1[-@\`OVR<IT3U:X8ZDNZ]O0=RN/
MHX1'F`$<YK[K?Y--]SCY?A4CM(L^439]Q2%>9^MC30/!$*#+_$UF-HAY/(74
ME>'9Y;Z!SXIB"-#5$J<]*RH>3R$1:%^37<RN)YTM]1'%ZYEL'@SR4>!+R_":
M/Q17I^"='<1\_#T*2#>T7AK$R:#Y=>CKW.#:/SA[!RN0-:UI<.0#@G`0P+?>
MISXI]EPVYM^?^-PX[C%!.`CH6@%3GQL5EXUE"QZML&(98+E3"K"4#ZB]QUFT
MUYNJ`LXBCC8H3K>+@#(Z]&E2]X;JG'J-17$7-D8\U*'9?3'NGJXYDB*+51OH
M"("&4-ABK2.9@-SD1=;VK8#]U0W."X0SD8J(Y?XK%5"C';#S](#_;"$=#MAR
M,15'"+F8ZNV`/7UJ8CH8L.6W[+GK_8U"_4$Y,;3WJO>^I@013`=X-Q`ZV/G2
M-VM[]`GLKE&3(2.WKB?F":0=$-:]X(2,^BJ*+Z+L*5UFP2Z-7[PP<,F`_!-&
M!,I=(T1H)Z`&\R"(7NGCN@R$^]L<"C4N=?H!*ILXH*+HPI]"B@9W\?TM003^
M#5Z*'"$*U%"5%X==4%103R%7H4Q?)]H?K8IWO&_1:XV#<122'[W<>?O5)0/%
M;G"Y7"(OO4")%^.-Y!Z&D?ZAJCX.J&+&^#)8$L%@7O!%C.B#C;OR/]KW"3A&
M]T&W,GN:TQS`7UV.Y#I,LIAN3L+EN-D4R/\L82!W56T-'KCVM%'YW8M-KUHK
M(&=S+ZF5XX:N.2V>^S=HY0;T#3;)I*_:`;F.]23!&_DT2D,WV2`_PC#;`_F7
M>\VH%@)S.WF4NL%Q=O+"3G9K)C+0]4"NR:X0O9;2O@>Q(;R#[[%LN7:?;1_)
MMR51;@5JZ^/?:A@GJ@44X46T=K'H)*Y`#1Q)5Y2AI@(TX-FM`#2I+B/G]`J;
M-+S+H0".QRO*BBUH/J0)./JOLCC$:18CPI4K_$9_2J1"YA,!!_1[R5F(:M*>
M^??0OP6A_X%UX-=87%523&AAP%\9V`16^<9#,&34'B[>7$:;`.6B"OWY.HI3
M_&?^>RY+Q!G91CX!?)NACR899,$T:F5R$=ZB3NX10@;\M.(@"TT!RUQP]]C>
MN#H6V+LDXW'*<>,&/--$+2E/E=X^%YLNO`GLRO5-0J"8]6:PD3QUX;!7P`,D
MPP5C!UOROJ&G_"KA(_*>P_R.HJEL@G;/LK6`3P$:/KC"Y!2-;O`+\J\)M\,5
M)H>N>9*@-%$/(,@Z@<Q#$/)=&CA00&:WSU``\&S[U?TCBO-G'20A!(U>1A-*
M4!$MQ_6DA7:R^K%'>NNNY0$&S9Z`@PV:,M96%`YD*&51WN:XWF9A>^"`0@<Y
M,,Q=`3A0\U99=G<A_^*LC`0X5#"4!.OX8(,&RE)\?(UTI5B1`#O]AY)B'=\4
MLNX%?%()_JB00Y=H&M8,J\.T/`1T[FYPZ@;XSZ)H#@UM/T3+])6P618$DI$"
M.^]5Y<>)\\O!3<#I)$!9BU_4XQ3=]('3&;#_?C`-X<.%#N5PS``!ENOUQL4Q
M)]ZG3@QU3Z^?K/7P3<$V$(`5Q^G$A%!WZ`:?ZB4V^[+GN<[KTH%_]!QZ,9,5
M8G9J'9@(W(F6_GI,'\4X\L4W57OU!QS84V:XYJHJPSQQPZN_M56W.8`?;>ZH
M(OHH!W.O#)<Q00PXNA?YC['KH[4;?X=ZW>S7*/)?<1#,P];N>($3+X@2F@@K
M7X&U^@&(2PJL`-EA5T8*O!3K<E[?Y[%#.8'%MX:RF(,ZTJ]3`"^NYH5^`&X*
M>>YWZ3.*>TQ\)7K@:*(A15"%.H5SK@"FON=+OS/@B.7PVP4?=_^C\ABRF070
MQ7X2,2%P''1XO2@PFGMTY6CIS?G..&<8ZU#^DA_%:/\QD@D-S\#W%,/W%,/W
M%,/W%,,?)\70T)VAX@`LO?3>:&=[^B$/U+1</8.E.@$_4'JL5"?K'SMX2"/O
M^W629,B_R&):YC2/+>5/@I%SR6O^)Y$VJ'4PWB3(ABPY=J,J1.#:F9S`[%WQ
M=MNOL1O2EVZCN?>O#,?H\LT+LH2PI%CA[O'J.4T*3+R0K'Y/P"F/W>3>'>LH
MTYEUD.0/_ID0?]Z1#<F._:6_@SH%#_"N]/["W=+=\1[ESLJ%&Z<8)0J/&2B0
MVY#?R-T*%`$:RWP"K0/[X%(+*M_]'LE$2%PO+]8A>?^;2V1%MB/?"!#BFL*#
MV:+`12U:4;P^VS'PT^K'BAQ(KE)H0YW"X]%\T$KOEZB0.S-8=^)06M%$.-AK
MR:-0AL8,*"MKWZ*W]#X*R"A6CZ\H>$%?HS!][NAL4._?F8W6ZVAND9&S8*=O
M?[,F&_"B'%7Y-`M0)F#[81B%""*?""!<>,!'N2'/)@`.`PI9RID\7"`6EM:I
MG3:V-1L4*D&6-QRER2$F!8VH\P9WMFW\13FXKM$?^`23BD4:6M=#:W=@[,>-
MLFM*^3W@_AYP?P^XOP?<(0/N,*+D+)0J<789Z6AB[$8V`P6T[Z%V"T+M*G(<
M29C=4,&V'SB^KB]L6V/KXXRHP<;7>TQU$238./KXDBA@X^5'F.([F(.]FSVQ
M!`K@.'KW::^*SE@T/3B"5_8\6J^C,%_+@!RQM,Q\*BJ&SFX(ZF3-^76VS4^%
MZJ[4%A6PP[3%4*E[E(7`[A/N(TXIL.O0QR_8IZ\<B-V=S/:C<6PRY<,6*@_(
MQ,3Y#:?/^4I-]_-GO'F,+L.4:+W44:G9$["CDBM-1>%+P8WLU+H(7`_E#\ZL
MA+Y&?F-@AV,'"3#L5!ZR,587?R1_)8B7V$.Q6%[MEL#.0C/"8L(:9<[].4&5
M!:DK>`^8V0[8>6=&3`Q0HSS3_XX]+%GX:DV`76UF1-/$,XTT==F*R&P'[#KK
M+4T>J"DDHE_@&'FD;ZE$FPV!'67&1-I"92QI''2:7N'0#3WL!M<A.2YGN<TE
M38QA44#[OSH=%@58+`]KYBY`,LID'OH/*'XA.TRXRB]>'P).'LE8$O:?Y*=)
M@Y\9P:43KC)PCIN&T8_L,%I:C`33?$5,?#I8);NY30!]<\2XH/CV-1O\&`^N
M9<'BKV[\G5Y:\%]P$L5;55&K$$/?\#B*V%4986Q#,5N'X`$17A:"49,\E\"9
M`;N>CB!M(?A1'J<76>P]NPE2E"ZGN3,#]E0=0;8"Z+`Q<.[,];(8TR"MIHRE
MA,X,V.%UE)FLP`38<[O(059N.XH2%Y`X,V`/VA%D+8$_A>O?^6FW//O>**0Q
M,]L[,UC_6Z<S/!>)L>T8Y@1?RV`ILBWG6?H<Q?1]$9%<^53.#-85QQ<41[!B
M*,!EO8P+>>'&=_%#2G.O\M2[!8ISV&K"YE$[)[!NN1Y"%T&"/DP--,6+/'N=
MZ5U0."?`SVOUG=I[&,96[7%)]BY+$_J`$C%N=,1;(W-.@-_'ZBOC`RS3"',J
MSMNFEL-ZQ70%>3AV8X>BT0AN$6-/9;_ETC@GL*ZO/B)M`9G$<6B_^/#N??":
M.B>PKJX>ZVPU_BG4L-K5B*&/*:(P*:HIY9G=HMP#+I%S`NO3TA6K&(FQHE&P
M:_"1[MZ>P+JXM%=G950[-?A[7S7PT1(7Q9M^S;#OAA[J[Z?\YL;TGMGE&XH]
MG*#=/H.992HE%,X)K&=*580*,'8R^V+WU-W?%56VGC@DSHE=?BD1CKU?PF[I
MLE>@W+XH?GT5Q86WOLOZS.['.;7+5:4-KE*.WEZK(99K:D?B)*%ID02(1P6P
MXMZ79C9V3NWP0HD15%*RO&)\3!20+E7)'JG236<^G7-JEP=*"J82]:CB^KMX
M]-VR-"2XE4G:+9U3.WQ+@N%70K$Y63YGP#ST=\`XV\1BA^>PO6Q/[=&U<VJ9
MK\H`WDJG;/9I7:XW0;1%NP(--]A]P@%6JV`AI75.[?)Z*0&JQ-[;#P9JC2_<
M;9[D4K*'3@!J\IU'B7"A$)$YIW9YPV18*DD;KZ(^DE-7?L(\(YMEPR&8/W/?
M\?PEZ-$YG83#3`5FI3B]76CC4YS"86A4<Z1=.J=V..I,X*QTI[<KS^3Q8>[[
MN!C%MRC^3A"5B8^\0P2OO7-JAUM."F*?43(F,5UE0;"]P$%&K!=Q_<EV2^>S
M'9XRP?`KH=A<./("/:6JUEBKK?/9#F^9$$`E1KO3M=@+_9P>(%=YLOC9=M^D
MM$7GKV[LUPLJ)M=AL7E(]U;S7W,^V^6:&X@%E3KV=NAMHH1L*"^F5ON=,V(7
M$Y2%0/<-G<\6>?28HZ^$`I4PQI$)7=#ND8_6^6ANHG!%MI(U_>U\30MB\D0D
MHW,^V^%@4P93"="X]VRP\I]-;Z#_7@%4LO^]5P"=7`70_.8$W3?KZX&DM@N7
MQL9*H"(P=HNV#DA:HJ7=&+BFIU`N;%$R,=@MPP=BN:)DWMRHI+6U!%3`A3_9
M(N+,3"&**<CUK)-<F53`-4+UY<I#87E%K6K9*HP+>FZ-0AJ34MU3673`E47[
M[:L<0);+^0"5=']EM@<N2RH5$2>HSH%B]XI<NR`C78=;;8$KDG(EPK&3&,.W
M7'A&ZEK`1K(,EK7X8NY^--0N>IPK/\#52+G2ZQ"%;H`"+20X?)I+#PUHTD,7
M$S6C`&U,TRA\,??_R)*T*.H4[6/W"Q?[UV$9NJ^Q1#7&VJ=;Z!*EF@K3%RIL
MK4)#>9%QY"'D)U>$F3N`=\OS*"2ZG=*'CIL'45&JI%Y/T'5--76E`[HI//HG
M6E,+\/0Z2(,1^Z*`'?<?:;_015(-[DM*6*?P\H'0.AM`DQ0[AJ[):M+&50([
MA<(DS:7V@CY*@4+_WDV1\-*E#CET]5;MW4D-TA1JFI2L*=-D[N+\I=W;C'IJ
M",,J93]W@P#Y9]M=.DW94,'OT;5GZ"JPFCIC`*VQ"BJ]U2E!WL^KZ.43)LM>
MDE)E.BU_IFIT6E.CXK?.=?X/M?T/\ZWR>@0,+5$CA"[_JJ@$ZF",E4<!7#(>
M8^0F6;S-N5*I>+YI_E\4L/((%2G'60Z6.^45T!BKK`*=4E[5M:Z90GL+*5?O
MF4#PRGV,LS@L5P6T<)FKQ`)]\ACI-?)1EIP5GSYZPC57OP5R/T'K312[\;;,
MD?2\&*7YN6MG>@N?"9=3C[-.+7]?44-DKBH,[%7RAG[O$[^Y&>]JA.,L::MX
MY&2!,5<9IBWNP9+><S3E!9G:TG4!D_U^@1,OB(C)EON:]Y=\RHH->20BM]^>
M:G=\$H5L^7X=0V37][SL5"N<?1\%P544TS^*]O9!/@B<T]];[#S+8"AF32%4
M;XXWQ9'M.$I;?`OZSL)@>C6X'E?\,Z7"F\+5G[IQ:J<BPU_P!;ZS89DRLSEH
M+'D&VB7`+5A2LP!%5XV[=P9\R^3H>MB%0=-XPJ8OJR_?-KAX*K6:AP,NF8RO
M`5^<L6W)9'-P$HE`5ENQP#>$+--B%O^,Y2`59NQEZ%NOQ]\0#80C?TZV&'>%
M&I%3*J?E,7T,BH,!OE-E@?]!G9&3L(2/PSCX.0!\!PU&04$GB\%K<^-W?21:
M9^FAIHJY44#?]K-INACE^@^QJ<@XMF,*^(31&@CT?<E)31IMSD_A,I8!KK7\
M#W!31VLHT'=-)S9YM'G_[J.RZ3`#?,_6JLEBCN6#^L!@,IH>22>9^Y[8-(JR
MH9V7?8TBH_V^,=7T)8/\L;M44`&%?$52D*W1#CI)R*3TV`IR"-=N(7=GTYX/
MH;\(W/#672-I<;<A/@><RM/2!].&O!"YY=I'[9$Z/R@^>7%//M78TVDZ"EF0
M3,/EPX^<+GNC4-FN?^?0"3'#[W5&>&1Y_=)C5=BS-"^E(>D.27]U!IA:LOSJ
M;-#A.?=Q^)_@$Z2!*^X.J8^#<&L:E00[\Z:8S65UO`'S4UG?L36A8TA=Y?#I
MAPB-C3K_U-)LBB.LJRQ>3286]23GR],A7^K-J4-35*3$W$>LS5U055%C7!JL
M&.-@`:#.=]@E[S`6WGAB<(OB,A(*B(#+[ET':=2DT1`H]"'G'_<`=C!ZV[V&
M0[P<`QRX:(E((DH.!KLE:^:MF)$\Q\:3$%NP/"A0`A4O^'<AXKKIF>V`'?-<
M[C:%P1LZJ"]=+(G'UTA)$E4[8*]U!TG4APZ;$RT1!6FD-BUJ+8']OEW$T1C\
M)!P*NR5;*6[4:@SM*M4U'>H#MSTXT_6L>!N%A=>AF`#[,IC'\0YI?![:N<G4
M&L,.(#UVC":R/9Y*T\!.104=408RRAW>O&;O\_(O"/-X]L+0WP7W]2EHSM$8
M,9@I<RQWWNS=G_?NS[/0B'OWY[W[\][]>38(M%RMI"FZC79V^/YX0[=;8'U=
M&\`IKMU=&_;GG0YZF+X?MO"U[AB@LU^9^@/AY&CRQ/*UYP=PSEF:)=M%%P%]
M?G_[@<I'Z?,KST<6UR4>[*/0WNE)3H`];W^($E#Z#%*JQ3W@9Z'][9/4^CIW
M)Q%5-L\B(I8EPFGN)0S]6FF?X\X#[C#`PPF3G!A"=D\F0=[T8@(T-QKBL;2.
MV:AGPP&#!\O!MUO_1W=0MK5,V:CG`I/-NQGQ%[#R_$=+HCBHTE9CARQL#3$6
M9S:22);`RPG*'#"/_=$4EE]A\'B*RA^#,X.)U,$JW5$F@)CI(_!N0JW9?.?E
M4;_OS&`BG3^`ZO,9_H.D>G)JR8*I_&X`S@PFZOKCZ7R=X["N33BEWYW:`=5^
M-P1G!A.V_1$5O\YS6%\EE.J?TP)D00"K_/5!.#.8H.V/I_Z'7(=U5KZ?<LL#
M%TST]@=0?S'3!W5,'NN.C?XK"1.]:K.O/DO+>YYMSP,W231>'SBDLNX2CA"*
MY9F;4[R1(Y:7)+'\_7K.^_6<\0OT_7J.90++UZ!R1;I1N*'#;`]]2:?+PLH#
M\GYI9U39W;#7<KA*<O1,;'-7<3I6]_[1PW.P]VP4%?'8+)E(R7FWVCO.HS#!
M!%+.LGOD(?Q">(3B1P(Y(:<QM@>U6T?`-U=TUS9=;,;"3&W=&,S5<K?)486K
M&T0FAWZ18C/Z6'Q<X7W)9D,`'\P!OZXRFB/^%8=XG:UW+QY>9.@\BZE&"I#H
M=03\\F.+[9PIHPUJ-'7%!M>(Z_#Q-?H?Y,:BLX9V7\`.'L-ZT<`UA7MXBKC[
M:P2P1\BP'M2<0OU3-J+4#8ZQDWYU_XCB\RQ)HS51.%/5_AN]RJ(5S,:@@8I%
M'/F9EUZ'RRA>Y^Q5#U=P:"&#%CP&2^,5?"R6.].BT"-,*PUCG'P_VYZAT'M>
MN_%W2>!"1CJ:V(5`=AQ'FQS9U*2^@R>-9\A(@3<R%=&I"KT%;&3O"E!?B1MN
MY^+RZ<U6P($+%28S_$,M#&-\7*`<Y)F2.,Y&\;!`/W&<C?N%@7*4YTKR.!_%
MRP+]Y'$^D@<&Q/*X4))'V0K:A]U+'GL,HTSB+4=YJ22/LA6T`[B7//881IE3
M.@^"N_09[8^@8L%PF@.7V>DH(3X88PF0@%ZD]@'D1B%O04`%7C.F^]E*@LKR
M7(9[]()"\=/VNR;0E4YD@F"+KS[Z"?C^6\O5`L7T%^X*B1Z.%9%!5^WH)E<9
MHL$L_*.Z<XTEHA_9J\NUX+A">Z1><[Y-)Z:SP$.KBF.H-6HPM;T./8+\T7T#
MB^57(R@R^Y,L1@J!?0$50`#C"M%DCZ`:U.4;S2I"Q!A%2YP2O4EQF.%P5<:S
MHE`E=Z%[I\#1?[%L.#M"+[13,`V*'(>2#2T&B*P#,25P7*2?7#G6@Q3Q&!VV
M'$XDY:C)9K)V:7K]//0?\9JPY`(OR5#)@99IX/?N$SAT8E(Q3/"BO\GYI="9
M$*W<%)FJR"9!];L;9&@>!-$KO<?<44V:G0#';(ZM%RWP_;W9_10!RB0Q:HH`
M1YJ&V'4Z,<&<*_Y8>4GM$X'&FX7O1X*]AV-WR_%N>5$*FHQMGB0H5;'^E>AM
M-/15@4W`IF_!V^<S1DER[L;Q=EF4I!4MOAJ]`-OZRJ)E:X8>T"GJ![5%"J$)
M+#H-:O#L*+/ZP`0(;;</I`JW2+0[L)J#YUJ9%7:!R+Z\[I;]I!\%>+>BVA<`
M-#9,P;9AH;TD1#.!39"/[P:O<2&CY"[\C5F-5;\38!/)L`HPT$WA'M3E<HF\
M%+^@BEWW9&O6=%JH=P)L)G72"2UT@R5H#K:+/F1/"?I71KJY?$'[TF['WD,/
MAZ&P@?)((.Y5-8<BO4K%:`Z\8PJ8R9D7'!!V7Z`Y!$6^)ROSQJ:`OB3%$8Z:
M*/<8)B=-Z3TH+@UT;3>^C)2%"G[A:1"Q2BN\,=L#'^*%TE$2Z$2JOCWBE.8;
M7X<^?L$^.;Y+UEMF>^BJ;UJK+0^!Y2G2+5C?</I\CXJ"W\DSWCQ&E\1F3K?2
M)5BS)^"[75QQ*DI?"L[N^7V!8W)\BF+I*MUL"'Q!K(.4.-[60U03<"0M`C>\
M==<RR[C>#/A^F=X"?3!P8V=ZF`FX0R-==IL-@>^;'<I`+*EJR".[R7\=>G%>
MY_`N1.);?^V6T'?!VKQMRD`P;+MWK(/%XD;A2A^/!/HN6"\W0`.%L?0J()G2
M8I'729(A_R*+<;A:%*]#TN*CR2UZS?\DKN:OT@'T'3&A!#E"5P8V`<M%"+;X
M_544/Z#X!;-SP;MU!/[8L6&U8`(T=GSUJ^#,KQGV\]R<4>D)NZAQ5V5A]P;U
M^O!0&L-'>>S:O)_HX)_(2,C__']02P,$%`````@`FH(^1]GMJ=5F$```GKT`
M`!$`'`!O<')X+3(P,34P-C,P+GAS9%54"0`#(T0,5B-$#%9U>`L``00E#@``
M!#D!``#M75MSV[82?N],_P./7TXZ4UE6G*2-)TE'MNR.9YQ88ZM-WCH0"4EH
M*%(%0%_ZZ[L`[\2"HFPGH<2\)#+W`NRWN.T")-[\=K?TG1O*!0N#MWN#_8,]
MAP9NZ+%@_G;OC\E9[]>]W][]^,.;__5ZGXZO+IQ1Z$9+&DCG/?#,&/6<6R87
MSNF_O5./R9`[?\:ZG,'^X?[!_G,'?DX6$1<>N?_9N71E.*7<.1C\[#P_&+QT
M!L^/!K\<';YPAN^=7D\5)-P%71)'$CZG\@-94K$B+GV[MY!R==3O7XZO/O65
MZ,&K0U57GZK:G(5\.:(S$OGR[=X_$?%UU?8<,"X01^&*W]D4:(Z,>'M[NW][
MN!_R.;`<#/J?WE]<Z_JDJGP6?"YQWTVYG_(?]A5Y2@1-V175DYE`D?EE/R9F
MK'Z-WD\7H+BHE-4PLT!($KAY)8Q*)R8.7K]^W=?4E#6@<R*I9U7^NL]#G_83
MME0J$KTY(:M,:D;$5$LD!`UW[V#0.QQ41'I$2KL8$#F;1I**5,P-HT#R^S*@
M@KK[\_"FGQ!5:8?ETMR(<VC5-KF$J@1?E`4]RG`9("#L],Y=X/R*@L#`@ALJ
M)"X2TQ!K`L)<@<MHDA(9E$4$<W$!("#LX`!YOZ("=8VF(+8(N>*60H""E,+I
MS-K07O6!FGMAQ:F[IF$2[NJV.2.N[-&[E4\"`N/1_1G\G2$7!D&TQ)5XDO>5
M:7U@Z@$7Y<S-Y-8+)0)J!"-!$$HB81!\]X:L5BR8A>JQZF='JHH3$'#4CS^N
MSLO#DC8@'6&'@7<:2";OST$!7VJ%>PX##&HYLJ(\.F,!T]6`H<SIY4-WX2<)
M/"?6X124O.E7-:1*(T&]R^"=_@U.$:!#2ZCQ*9%*6#")7&$S?I?X;N3;"^B7
M,-T$Y),P\&@`BN"'"'WFJ=9U3'PU;EXO*)5_!"2""4T-<@KR#?AQ!SP'U*\!
M*YIX(%/H%#4ZB4I'ZW2>95I_^NX2.28P3,L%E0PJL:E_+,*XLPX?Y*Q2$3]]
M=YZ702@N9Y<KRG7!HHGGUDGB;GO1S&VY<B><.;GZ[Q[+<;^<7<O0_;P(?0_6
M\Z?_1#!#-/$7*H=[Z^6&WE+.*BK_OQ.K[[JKH(N<$+$X\\/;C?L6(H@[Z]5#
MNI;2[FCUW>I:'XB,.+V<'4>"!50(6*<=$\$`[W'!JMA%#7EQK_RBEG),N'XH
M0`G\$6M3V*?Z]`I/:U1/BSIWWP^V(:SQ$/5K%=^B9&>&G^L%+&R@"5%O3.[C
M@6.E)\P$32L9!_6U`:I2X&@-3JK"<9Q$R^[C>Q(NETQJLZ'WPW@J63"G@<NH
M2(=Q.P.*\>"@BG%!A1X12DIV'^(K*M*9*8:T^`"'<%"%L""R^X!=1\LEX?>P
MG&/S@,T@H@GDT-49-F@V8YCP\^;9D!>'^;DQ&L3:]&HOU^?D"IU4X^Y[`:;K
M%6'>Z=U*K;42N*L/<5P/J[@F8DXJUP7T0HCMY+U*D\%4O<I[/TK!<7QAXAC+
MQJFS5'KWT?Q(IWJ*GE!W$81^.$\64\AS',F7521!,IGU<]G=QW$,<XA.W4XX
M\2@,=9_3?HT0<"1?&6U2B^H6F0OO/I0C.J.<4^^*WM`@HDERO/(0A]"(G%(Q
M)Y';??2NJ*]B]C&!P0Q:32"(6UC56ZDXGD:DE,@[6H%3U+#[R*K%=ACH6#%?
MP*</</R,H"@6B0/.W4<,%B=Q]RN`5GF&XO;<"'0RJ:Y`I\U,8F68/#X2#GU-
MBD*F`R'B8!HACQ9/`W$]O:0:=A_7,I!KD#.BF.[@E.R?!/,+2K(8I?H01\V(
M43(Q)Y;;??3>D[]#?A()&2XI3\"K/,.Q,^(2+>5D8KL/W7G@@J43<I<VNN(#
M'#0C!(E%'"VS^XA=1U-!_XF@^J<W-)\CJD]Q[(R@(Y=S8L$N`*AS4V%]I@O-
MCC65P<$WPI7F63+G6?JK`SMOA1SMA$Q]*HQL;_(8AQF)8C)!YUDLV@$4FS79
M(L`;2>#8F]M"&S3QSKBFDOPM^@`GH6`?8F%3*3O<*4CCA"XI)(/+N%KI.+A&
M&(6GC#L$L9DC+@)LI>+PFK$6DD?N$+AQ\I<4\\:EYFLEX_":&T=8<KE#^%IR
M**7IKY8%Q]D(X.S)E@Z!C:';"$YS=ZE[X%6R+D4,<1(.I1'I5=,R'8*TG(LI
M(HI2<$"-Z*V2J^D0GH4<31%,\S&.I!&@%1,X'8*QV:G1$96$^6*3@Z:I"`Z_
M$:-M<M[4>98H[X!_S!.F)5_8R2CN+XQP#3F'VBEX;4=.RRBOX\+!-G?!:L^G
M=@GWFH.H)>0;\.'8&[%=[;G5+D%?R$26H$:>X]`:<5TIM]D=()NE*LL#R48B
M./QFN+=!>K-SWEESECC!8T+O9$3\34XA5R1Q7QFQY`-\Y21%=,!GE<1SJ>M8
M:#CNYKE&(RO=G9Z`I9TKT-H9<'R-.-26F.X>RD,3Q-+HTH`/Q]R(6-=@WJ%Q
MP\S[E]JWG8PC;02G^+Y`=]JV%<"DB:W#.6-#\7YI!*6U>*?MN@O`(ULNY9';
M3L>A-G<4\3V9[K1MY&4)M'$WX,,A-R+1>LB[U+PK;UB4FK:%AF-LA*35ES"Z
MU*)M+UQ4HOUZ)AQG(_:TOYS1)<0+;V48V:O*<QQ7(TXLOK31)23+KVIXE0`0
M(>%X8O%?\66.+D%J.5)@;B/8>7"0S:.D-><.ON.M`2BO*9JQXNCC7Q2I1;]+
M2PNTF3=KUV;XU\%67(%J@`(XP!%\909T502=0?<PK`3+%B*.J!&WF8AVJ'-7
MSB"5^KB%AL-JQ&;F`:7N=/GR.:02J#@)Q]2(Q8PS2MV&M#P,U'+@`*][8:^+
MTWWAV%>IX2+/<5!K7^CK4I,U$1O8H+1-_T;TA6+9B26``5JY]]O).+)&R(4A
MVZ5^7WWEM'+:`B?BV)H!5?6UU)T9!M0_ZG*)*SIS]*T-1Q+(;_<$6ZY\==N#
M?K;0G]575U[TTELN_@*3]N^6?LJB--?<'Z%=5$4A*3A5D7QMO_Y6"5"B]SH9
M%?VT\GO])[`'`-_4GK*/6F6-3Z:;6@,BU&^=(="N-S6DTA6>UIQ^>OL"_,KO
M9``"6!)RZ03&[3)UEZG$%]-<A*Y64R.B_NJE<CWUJ#=XWCL<[-\)+Z[8!N5G
M%FU8?BJW6?GX!34-2TX%5)$O&Q16>TV,I4Q='BK8I[X4Z9->KJJIU377KM35
M!1%+?O=R%9O6`;O)IDDEBG+I'X^I!G8Q3J-Z%`6SOWJYFDUK8ER?TZ06F9#^
M]8@F8=ZJTZ3X7"K^V<L5;%J!ZBT]38I/9=2/QQ1=O;NG4=FID/ZU6>GKKIQJ
M,ACYG)>DU(CT6@V"@U>/J4'#H;!0NGQLR?6W&C6M35'+::YDL\K5WG_5I%6D
M,NK'9F-!_9U+C6"H2CW",?A-49M5(@P^/*0>]?=P/7S.U+K0$3*Y8$_7I?[F
MJ>%42*Z;I8KBU,KPKV;L\?)2WVIW!,]8,#^7=*E"GSV')%QO]R177_B,N6"Y
MQT)OHN6\*+Z^9<\)F.^K%P!37@&1(!0:*>KO/(Q6:2$,U(-UCF%><NQ$O_`S
M)O=*V8F>O(I&U3$535F&T/\)O\>,F4&<CUH3+QME2IK&-PR]W7,Y]9A\"AOU
MAF-2[X)5Y<=;8$?1#<GY<(N3,NJCK<K;6L4LCTZ?WCOOZ7)*N<5'*3&V*;[8
M[L@+EX0%WZKWZ.J="Q%1;Q2I;CS6!?U)_(BJ6V(B7^8?5,P-:B+QY3SWQ!W+
M-.9R5CA/I"T["_D8*%SSKD=CK8)=`4=WUL>`@RDH32Z*+AX(S1?$0#_3U"LV
M7T@Q"2]G,^9F'X2L!Z!.>AN:QA5U?2*$?JE*28$#8<1FH+_\"=9D7%_/O`U&
M#[V_(Q&_USH)AYZG,Y/$'Q/FG0<G9,4D\1/#8/%T13T*TA@@CU6T+7-B<D(J
M[@#@]6O*;Z"1&SW$SK<-S0)96]:O/+?#K''$W84ZF*$^-F&[E$.;N)9S*\S5
MKPK$HW'1MM+C;3#D(YT*((Z@W?FA=L!)*$HV63FVP;Q\2C56G]GXH>XP1&?A
M=2+;`$#E[5PD@K=RM"=HKW[WDM[)8S^[10"SHL!2"I]D^OR;+1'-=_$0G]0Q
MM<<MR%<=$<_4<K7-.>G93WW<(.)HAZEC:I%STD_J82XQ:2US1.GT'>(#"[T]
M\)<JB/G`QM`R1R0?$*M\9@/MZ.M96V8;]CGE)G-+A:]E5EV["^I%/E57/^O8
MD/VK;H>&)=MYD"SBP#>6+_)BYC^5PM;BI*.MGJ[]2;A43M:%)*/DT)7LALDF
M^#Q,46MQ*1^!/@\\J+X7$3\)4AL`LJ&&EB%1_9YB^8T09%9J*M">:6KL$U?_
M/9RK_)*Q'V&AMVA+8K+@E";I4*/Z&+%%=<\W0(R:FZ06U?M/YC*SK92>MJBV
MD]LL76XV$)/6HIH/YYS&O>^.E3+"Y>=?>3CQY)''H'0!C\_75GVD$<0JGU):
M!/@U=2/.U#G3-$N9U=;<JEW/VR++DJ7;>\(_4RF&W@T3(;^W6]>0OT46FE_<
MM4_4#7C;,T=CVX(A\_1B4YS`_.S[ZM1<[38BPO^$V<LGRU:<WE$.DP@=<QB2
MX\2KF;9`F8K6I!7[9M:,Z%2J?;BEWJFZ"(.YI'RIG@Z7*C8NGI]:R[H%!W7T
M)WR%F@\$^,-5+Y7,:6DQ@]*3P0-&CE7\]-ME`I(1_'*&[+]BQ!:=.<AWA#^&
M_#-T]V3H+NT@VUB^6.-ZLJWAL\CW[T?,CR1-AK""81CQD:[)#'JZ%&PZ8"%C
M69'6HC9E_:ZZGB9]@DVIC47:,[/J3XVKP/:"D2GS]6(N^7#6)!Q&T&G.*'@A
ML`QJFPNW9\0[#V#X!V^-:/S_>5!_,*$A_S:<-7G`5Z2Q]OXH->WI`TER^X+.
MB:\:K)GW+I#:/UVD1TK&/HD/I6?W^5D]V5RD/5XSL^U&!&=G:5'09E;R,C!/
M1==RM=J:R6W8P)H"5XNL*>WV+%>PQN+7X4S>PGA_OH2!@5<.=C7D;_\84F,(
M!&5<LG\UQG'H.:+"Y6P5@]X$BS4JFHTQ7V6-D"S@?E<+5;VH<6%D5"];N'XD
MV`TMGG8SEN8/$6[1"GB3ZNNS80\T/9'=@DX1;TA`>ZQ)&MIY6C2N7<.J)M96
ME]RU\K3(DO5)ZFU(3>M]HV3`M%M2R]4B:Y+`'EW&&*3VU1M=L!BD%M9;[?1:
M:UXDMJCN><ZD>%QDJ.H\UWS']T9:90AK".]#&,233+QY<0Z#/]>OX>KW0+26
M$4PR:'KF2Q55RL##DQ8DKY[*U(]4S=74&]Y03N;T,I)JLO74/%>7"/N:Q;<G
M-'UZ^PL&5Z#XHK#7%5M*Y&F]WRK)_,6;6[*,_9HM/"ORD3"WNUE7C$YW`KXF
MT'F9W4(ZG;F^+M9YJ5U"^T0%HK[_U?$NE]LBQ)6])+@?(N%SF="BE6I2M6-;
MG8_;6^<36YU/VEOGD:W.H_;6^=16Y],6UGGH^Y=R0?.SZ4;EK1PMLN(D#-0F
M<JSPBHG/^5[S)"P?`5G/VIZ]Z3/JP0CN9]]@3E^\.:8!G3$)-5^2@,9WOK$E
M+,]';#:CZ@.$Y<,ACU+SY7:RG^[<U1H+=6X9VG%X&W_>M"DR5;EM@$*?3]!1
M&Y)XPXC?M!OWX^^XO?OQA_\`4$L!`AX#%`````@`FH(^1W13*7>#Z0``4CL.
M`!$`&````````0```*2!`````&]P<G@M,C`Q-3`V,S`N>&UL550%``,C1`Q6
M=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`FH(^1P$39YBF"@``$Y```!4`
M&````````0```*2!SND``&]P<G@M,C`Q-3`V,S!?8V%L+GAM;%54!0`#(T0,
M5G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`)J"/D?;WST-7R(``#E4`@`5
M`!@```````$```"D@</T``!O<')X+3(P,34P-C,P7V1E9BYX;6Q55`4``R-$
M#%9U>`L``00E#@``!#D!``!02P$"'@,4````"`":@CY'HN'X'>-@``#Q]04`
M%0`8```````!````I(%Q%P$`;W!R>"TR,#$U,#8S,%]L86(N>&UL550%``,C
M1`Q6=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`FH(^1P#H5,ND/P``LYX$
M`!4`&````````0```*2!HW@!`&]P<G@M,C`Q-3`V,S!?<')E+GAM;%54!0`#
M(T0,5G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`)J"/D?9[:G59A```)Z]
M```1`!@```````$```"D@9:X`0!O<')X+3(P,34P-C,P+GAS9%54!0`#(T0,
F5G5X"P`!!"4.```$.0$``%!+!08`````!@`&`!H"``!'R0$`````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>19
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0````(`+R"/D<0.^RA'P(``+TH```3````6T-O;G1E;G1?5'EP97-=
M+GAM;,W:2V[;,!`&X*L8VA86S6<?B+-INFT#M!=@I;$E6!0)DG&<VY>2DZ(U
MW")I8^#?6):'G!EII&_EJV\/@=+BX(8QK:LNY_"!L=1TY&RJ?:"Q1#8^.IO+
M:=RR8)N=W1(3JY5AC1\SC7F9IQS5]=67/<78M[3X>`Q,N=>5#6'H&YM[/[+]
MV)YD7?K-IF^H]<V=*UOJ7$K3FQ*O%K<VYL_6E13L,+`Y</SD]11GKU,PA4BV
M31U1=D.=\L-`Z5S]8^2I\@UM[-V07U3X\=[5D89Y3>KZ\%CJTZ%D2>6W=56B
MZ5D53C?^K;/>34,+X_:W'=/Y/U[+R4W<N^$FVOO^I,#^8F.:CK6S_7AN5/<^
M[KY[OWO-QX2FJVJI7898%L;<GWE*RN+;$DVLI/ZOVD]/2N,C/:O@M/""+T5G
M([5?<RSS/?]N_+K@<GU,<YV__VGH<S"Q^7!!)%[4AP#I0X+TH4#ZT"!]&)`^
MWH+T\0ZDC_<@??`52B,HHG(44CF*J1P%58ZB*D=AE:.XRE%@Y2BR"A19!8JL
M`D56@2*K0)%5H,@J4&05*+(*%%D%BJP215:)(JM$D56BR"I19)4HLDH4626*
MK!)%5HDBJT*15:'(JE!D52BR*A19%8JL"D56A2*K0I%5H<BJ4635*+)J%%DU
MBJP:15:-(JM&D56CR*I19-4HLAH460V*K`9%5H,BJT&1U:#(:E!D-2BRFI^R
MLOE?B]<_`%!+`P04````"`"\@CY'2'4%[L4````K`@``"P```%]R96QS+RYR
M96QSK9++;L)`#$5_)9I]<4HE%A%AQ88=0OR`.^,\E,QXY#$B_?N.V(#"0ZW$
MTJ][CZZ\#JFL#C2B]AQ2U\=43'X,J<K]VG2JL0)(MB./:<&10IXV+!XUE])"
M1#M@2[`LRQ7(K8[9K.?:Q<[51G;NTQ1'E):T-M,(9Y;AFWE89.D\^(GT%V-N
MFM[2ENW)4]`'_K,-`\]YEE<>QW8OG*\M"_V/Z'D4X$G1H>)%]2-F`Q+M*;V"
M^GH`A3&^.R6:E((C-Z."N[_8_`)02P,$%`````@`O((^1W<<V,4_`@``"2D`
M`!H```!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<\7:2V[;,!2%X:T86D`D
MW@>3&'%&F63:=`."35M&;$D06;39?50/"O>A@PX,G(D,6<#E/_H@4'SJ<[/^
MDDYM.0Y][HYC7OTXG_J\GO_?5%TIX[JN\[9+YS;?#6/JYZ?[83JW9;Z=#O78
M;M_;0ZJE:6(]7<^IGI_^G+UZW6VJZ747JM77=CJDLJF^#]-[[E(JN;[\A+MY
M@?GQQYC^9_EAOS]NT\NP_79.??E'1?UK@:I>#I+E(*$$Z7*04H)L.<@H0;X<
MY)2@N!P4*4'WRT'WE*"'Y:`'2M#C<M`C)2@T0,:&DX2PYF@=`->!XW4`8`>.
MV`&0'3AF!X!VX*@=`-N!XW8`<`>.W`'0'3AV!X!WX.@M0&_AZ"U`;R&]:Z.7
M;8[>`O06CMX"]!:.W@+T%H[>`O06CMX"]!:.W@+T%H[>`O06CMX*]%:.W@KT
M5H[>"O16TEX)VBSAZ*U`;^7HK4!OY>BM0&_EZ*U`;^7HK4!OY>BM0&_EZ&U`
M;^/H;4!OX^AM0&_CZ&U`;R/M=:/-;H[>!O0VCMX&]#:.W@;T-H[>!O0VCMX&
M]#:.W@[T=H[>#O1VCMX.]':.W@[T=H[>#O1VTK=*]+&2H[<#O9VCMP.]G:.W
M`[V=H[<#O9VC=P1Z1X[>$>@=.7I'H'?DZ!V!WI&C=P1Z1X[>$>@=26=-T&$3
MCMX1Z!TY>D>@=^3H':_TSET[I=U;F8[](=^ZYK?A\)30%=ZY?)S2[5,N4V'#
ME=9E7BG5E^O-G;Y,_1E2_W7J\?D34$L#!!0````(`+R"/D>&E]&N;@,``+`/
M```0````9&]C4')O<',O87!P+GAM;+U736_;.!#]*X1/Z6$K-TVS:>`(:)P`
M6Z#=&+6:G"?4V.9&(E62,NS]]3N4;%>V22KQ87,)3;[Y>O,XA$;2#*\G6E6H
MK4##5F4AS35MW@P6UE;726+X`DLP[PDBZ72F=`F6?NIYHF8SP?%.\;I$:9/S
MX?`RP95%F6/^1[5S.DA'+LJ7JBH$!RN43+\+KI51,\ON5QR+47((:"S(\Q1Y
MK85=I\,6T]UJ,%,.!8XI5CJ#PF"+^KW98,:JK$"ND_;7-R%?S,\J4W=@L6NU
M?]!Z7X#&G(+N>=]M-IB_UE1GX6S'"Y!SS+O8X\,M%X^HC:OTP_G[(?WM*-CN
MM[X1<B'G$Q#:I*.EO5XBMTIOVK2TIW8I5]PUW3QFE)\9L&<PZ)8W@R5H`=(.
MF!'_TL_S01NVW6W6166L3I^4?C$+1&M&R6ZS67:QW;6X2"^O&@2M]I')KK)T
M0]M>W6XG$[9`\S";@+;_$Q5-35LB+J\&G>JW+AC(G-U+2W)D7V4;BIK7I62W
M&BNZ%])@SFAE5"%RDEG.;J$`R9&=8//Q+3932_\HYQ-L/IU@<^FU^1MLK9&I
M&;NMC9!H3,/@+1AA:-=K,[6*ORQ4D=/%8/>_:N+:CW/7TKFB)":P=NTQC+&'
MRG7$!$HH2V%;I,N#"K$D.Y2<QI;7X@>:#8_6GT1=EJ#7KL*IF$M!>B.%LR^<
MJYI\>VTF&BL0I*-5Y?CT!][,Z'6K.&*A"N;PA,\;&C+D"ZD*-?<S-J%*-AK.
M-.1T:^A.>Y%W.$--0X_]P"7*&@/<%(T"W!5=.X_2`(^3KR1KVAOB91,UC&E.
MMCUN*GD"39&M/V;T\($(!M=_]@TAU(?O\`\-G7%MK"I)D%[,5\GID&6P"CB9
MUL\&?]6._/LEAO*):NG\SSY]LK,,GFEFOCO!^>=7"34>P:_8N(U/NCU1?!KN
M*3VHF<8N*IRXYT,%Q=$'4HJ#NYJ*(Z,S]J._LYX9R\[NT((H0B1&IVWH-8N,
M6W;6+^AX1C%%7UR<8.-_]XYO032MT#78&+W=YN+J#5<GFEK4A&5ON6]Q"J(V
M?JT<OC@](<)O3V/8^P#U-G'O*>I38F3`A)*)VGP*M+SK-=+F0QC[\%I@1I]S
M-80<'X^[:!Y'\^X4]#:E5PS)J'LO-$2,#]S#S=$3[\_GZ,OGX#LGV?\^3_\#
M4$L#!!0````(`+R"/D<'-7YD/P$``&D#```1````9&]C4')O<',O8V]R92YX
M;6S-DTU/PS`,AO\*ZKU+LVF3B+H>`'%B$A)#(&XA\;:PYD.)IZ[_GBSK6L:X
M[,:MKOT^?ATGI7!,6`_/WCKPJ"#<['5M`A-NGFT0'2,DB`UH'D:QPL3DRGK-
M,89^31P76[X&,BZ*&=&`7'+DY`#,74_,JE(*)CQPM+[#2]'CW<[7"28%@1HT
M&`R$CBC)JE>S-;8Q)1GT51D=USS@PDJU4B#OVJ'L,A4[(W@=CG*0??OT]T\/
M*4.RKG(?5%_5-,VHF:2Z.#`E[XNGEW0VN3(!N1$054$Q;!W,LU/GM\G]P_(Q
MJ\8%G>;%;3XIEG3&QI1-Z<=ALC-_@V'=#?%O'9\,INVBPAJNW&W2R+3<])E`
M$H+PRJ&RYBI<POP0)UC8?7Z!P.M!G3!=MBVTC?4R5.E^#='AY<25K:UOCZE?
MT=FKJKX!4$L#!!0````(`+R"/D>97)PC$`8``)PG```3````>&PO=&AE;64O
M=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?A1%8
MC6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@V2_;
MUKNW+][@5S(D$4$P&:>O\,`*I4Q>M5II`,,X?<D3$L/<@HL(2W@4R]9<X%L:
M+R/6ZK3;W5:$:6RA&$=D8'U>+&A`T%116F]?(+3E'S/X%<M4C66C`1-702:Y
MB+3R^6S%_-K>/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1TDB`
M@LE]E`6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP'`3@
M4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG`J-6T_3:W?=TXZ)
MQJW0>`V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@`%AP=M;,
MT@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9`%#@`WQ-%,4'RO
M0;:*X,*2TER0UL\IM5`:")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']IJP&G
M[;N;SY/\<^CDGZ>3UTU"SG"\+`GQ^R-;88<G;CL3<CH<9T)\S_;VD:4E,L_O
M^0KK3CQG'U:6L%W/S^2>C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZY!$X
MM4D-,A,_")V&F&I0'`*D"3&6H8;XM,:L$>`3?;>^",C?C8CWJV^:/5>A6$G:
MA/@01AKBG'/F<]%L^P>E1M'V5;S<HY=8%0&7&-\TJC4LQ=9XE<#QK9P\'1,2
MS90+!D&&ER0F$JDY?DU($_XKI=K^G--`\)0O)/I*D8]ILR.G=";-Z#,:P4:O
M&W6':-(\>OX%^9PU"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:<K46
M@;9QJ81@6A+&T7A.TK01_%FL-9,^8,CLS9%USM:1#A&27C="/F+.BY`1OQZ&
M.$J:[:)Q6`3]GE[#2<'H@LMF_;A^AM4S;"R.]T?4%TKD#R:G/^DR-`>CFED)
MO816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[`?_1VC?"J_B"P#E_+GW/
MI>^Y]#VATK<W(WUGP=.+6]Y&;EO$^ZXQVM<T+BAC5W+-R,=4KY,IV#F?P.S]
M:#Z>\>WZV22$KYI9+2,6D$N!LT$DN/R+RO`JQ`GH9%LE"<M4TV4WBA*>0AMN
MZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KTL<QP
M3A[+##MG/)(=MG>@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K34I!O
MP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'>7M?
MF&>5QE`T%&ULK"0L1K=@N-?Q+!3@9&`MH`>#KU$"\E)58#%;Q@,KD*)\3(Q%
MZ'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^:CVT
M%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON<K2<15.+]%,[82EQB\X^;'<4Y3
MN!)VM@\",KF[.:EZ93%GIO+?+0P)+%N(61+B35WMU>>;G*YZ(G;ZEW?!8/+]
M<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4<!A87,N10[I*0!A,!
MS93)1/`"@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E$A2*L`P%(1=RX^_O
MDVIWC-?Z+(%MA%0R9-47RD.)P3TS<D/85"7SKMHF"X7;XE3-NQJ^)F!+PWIN
MG2TG_]M>U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83+$.D
M?L%]BHJ`$:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'?!^2
M!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5`Y3_;
MU`UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%`````@`O((^
M1R>K!.I;`@``;@L```T```!X;"]S='EL97,N>&ULS59=:]LP%/TK0AFCA1';
MV9JNJVT8A<!@*X7F86]%MF5'H`]/EC.GOW[Z<.S$D*;)TI*\Z.KHWG./I.M<
MA95:4?RXP%B!AE%>17"A5/G-\ZIT@1FJQJ+$7*_D0C*D]%067E5*C++*!#'J
M37Q_ZC%$.(Q#7K,94Q5(1<U5!+]T$'#Q=R+#$7RZ^/BG%NKV`W#CZ--HY#]=
MW@[Q"[MP"8'C^)%%,)A>0>_UI&/?WTUL%@?DTP/)7^(>4%\?1OT"\X#XJR'V
MVI./PUSP_@(FT`%Q6#V#):+:/S#NJ:!"`J5O6"NP"$<,.X\[1$DBB0%SQ`A=
M.7AB`%L4K1\C7$B;VV48YAG[?299)!'TV]_KTR4]NQW,]@BEV]O30!R62"DL
M^4Q/0&O/5Z7>'!<<.Y'6;X]W(=$JF%QM!-A!YTV$S+#L,@=P#<4AQ;G2`9(4
M"S,J41KI0BG!M)$15`B.J*%<1[2&IDTQI8_F$_R=;W$W.7`^YHY]"(R*M:D/
MHC7[,K"'ZFVR.>Y-VLE1O*#)NP0Z&I4E77VGI.`,.[$.FHEVMH\^V$$?AVC-
M"A9"DF?M;PHAU0"6$"RQ5"3=1/Y*5,YQH]H*]II\E\)CM_R6FDY_:KT:78+O
M?3Q')[?0?<T2+&?V;_%P29^O]U^9_3KA0.;[5LT1$DYP.*9CGJVTZ?E*>YN:
M.D6UWYRK,O,6^3]I7MNS-AKC5EOL4)#4A"K"UQJ0><C<&]UTJV/U+5%S9DW?
M#>VJ0HE^_&YET609SE%-U0-9"F47(]C;/XW\8-IYS3N*"/;V+YR1FMU8!?T+
M._X'4$L#!!0````(`+R"/D>0U'Z4!@4``-04```/````>&PO=V]R:V)O;VLN
M>&ULE9C)<MLX$(9?!<63YS(25R\5I6J\S(RKDMAEJ>(S1$(6QB2A`*"7//TT
M*"GY*;65^"1QZ1_=P->-)CZXLV=C'^?&/(J7IF[=F9U$2^]79Z.1*Y>JD>Y/
MLU(M/5L8VTA/E_9A9!8+7:I+4W:-:OTH&8^+D56U]-JT;JE7+MJHN=]1<RNK
M9.662OFF7HLU4K?1QP_N;*%K]5591\)"KE9?9*,FT4L=B5HZ?U5IKZI)E-&E
M>5:#&[9;G7>Z#A?Y.(]&06P;ZJT5I:G46FRVU.Y^\R`2E5K(KO8S<G8[[B2*
MDRQ)BK5&>.VK5L\.!<,-(4NOG]1,SB?1.!*R\^9O77ME+Z57_UC3K73[0%J1
M6&CK_#2$V[_9Z%8W^GOPFZ[<TCS_:ZS^;EHOZVEI35WW5N%!;T0CN!]WR$>O
MR\&+7L[OPDI,HF),@D_:Z;FNM7^=1/W_6H5(1CNA]-/_\Y]H^\G9+K&0;26N
M6D\JXKI=+QY-3?"!7KZN^H'MF:8_]KJ*UU.%0A>FK53K5"7HGS.UKFA6*G$N
M:]F62H!0`D+)>X52$$I!*/UMH:FG'PH9A#(0RMXKE(-0#D+Y>X4*$"I`J-@7
M^B)]9Y4P"W'>.=TJY_KU.Y=..[H+0L<@=+PO-/6F?%R:NJ),$%??.EI^,#X!
MXQ/&>"G)"1J48KB5KP$C)X2X6?55`G1.0>>4FY:FT7YM'L*@R?&42JHMM4*9
M>(P(CO>%[JA"K!?7H]F`7`;=:=<TTKZ&Z9SJAU93Z9.4$7^5I>G($Y1"=F,&
MWENK5E)3)KVLPD(/O$=<8X;76TNETU+^]:E(:[':#00YC1E0[]5\LQPS52Y;
M4YL'7,X8\8P9/F]I\C:E8&9E1>7</@Y"0"QCALM+M5#6TOAWZDFUG4);)#%F
M4+P+VTM/4I@#&K]UH>`.28H1R9AA,K!$.TG/-=HA@C'#("W<QO5=TP2I2QCJ
M>H,M]?WDW4M+[GMT/$$($P9"SF90*1G:;H@7&5)%?%)R2%N"M"4,;9_E?\:*
MB\YYTU#RHREBEC"87;<EV8B9?!D.B7@E#%[3;N[4MRX@=O6D=F)%M!(&K8-)
MFARC%)*6L*3]*!/BB#;;6KD_T!X92[BZ=]"54Y1"[!(>NT&]X/Q)$<"4`9`O
M'*P44IAR%#(5A!5"-%.N$'*EA%4:[.(,J&^G5R^'4@ANRM5'--SU`^E-&7IW
MDXT508I3AN*=K&,U$-^4P1?3CQ5`?E.&WX/=0XK\ILAORO#+]`_BZ%)YJ>N!
M3QDRG'%%]&`O@>UCA@QG;"=ZH)T01RB%%&<,Q8-*P86%\&8<O(=*19:AU*`)
M9>`]+(5=:(8H9]P^OU=UN-B0Y8QA^:VRL]%"*40Z8Y`^*)6=H!3"G3%P\Q6,
MBP_9SABV#RJ)&;;]2'?.56B^&C)>Y4AWSM!]6`H3)4>Z<X;NW6Z-=P@1SQG$
MW^[;>CV40L1S]D/K9_/&.S/XP.+)QC:.%T&P<Z[5.+#C[$2$8.=O?5^])94C
MV#F"G7-@HP][,2',.0?SKK6(T;Y`@@N&X'W[F7KQG1RZ42"]!4/O_B;*!%,@
MN`4#[MXNRHD@M\6O&^"MR#8NE$)NBU\TQ+PSR&W!<,LJ["S1X$R`P9;3X%<)
MJ2TX:G<;=3XH)+8XV9PY]8_[8Z9*+:BYJ,(AG.N'*&5=AI,Y^EE_3&=Y^"X+
MUY]-1>.&([5(++JZOJ![-^TG(\-[&^7M6=S'_P%02P,$%`````@`O((^1SE)
M#SC^`0``_P4``!@```!X;"]W;W)K<VAE971S+W-H965T,2YX;6QUE-MNHS`0
MAE\%\0`UYY"((#5=5=V+E:I>[%X[,!Q4&[.V"=VW7]L02L&]B>WQ_\\W=O!D
M(^/OH@&0S@<EG3B[C93]"2%1-$"Q>&`]=&JG8IQBJ9:\1J+G@$MCH@0%GI<@
MBMO.S3,3>^5YQ@9)V@Y>N2,&2C'_=P'"QK/KN_?`6ULW4@=0GJ'%5[84.M&R
MSN%0G=U'_W3Q/2TQBM\MC&(U=W3Q5\;>]>)G>78]70,0**1.@=5P@R<@1&=2
MY+]STD^F-J[G]^S/YKBJ_"L6\,3(G[:4C:K6<YT2*CP0^<;&%YC/$.N$!2/"
M_#K%("2C=XOK4/PQC6UGQG':"8/99C<$LR%8#*FY"32!3)D_L,1YQMGH\.EN
M>ZS_0O\4J(LH=-"<V^RI0H6*WG(O0S>=9E9<)D6P4OB+`JG<"R"P`2[!SA[8
M[:&UOM#80VM]7^R1U1X9>[2RAYOC[161'1!;`?'.'F\`DR(VBFZZORA*H_";
M6TRLF&2'23:8O>)@!QRL@,/.GFX`>\71#DBM@'1G][=?VB1)UI)O+NEH11SW
MB&"#L$A".T*_9=M[\?89HNV+L6CB#06M'B@%7IL^))R"#9UI>ZOHTNL>34=`
MG_(\ZW$-OS"OVTXX5R95FS"/N6),@BK%>U#?7:.Z\;(@4$D]/:@YG_K3M)"L
MO[?;I>?G_P%02P,$%`````@`O((^1]GD7/"K!```4!8``!@```!X;"]W;W)K
M<VAE971S+W-H965T,BYX;6R-F$UOXD@0AO\*XC[CKNKOB"`M6*O=PTJC.>R>
M'7`"&HQ9VPFS_W[;QF&@JCR3'()MGFJ_77376_;B7#??VEU9=K/OU>'8/LYW
M77=ZR+)VLRNKHOU<G\IC^N:Y;JJB2Z?-2]:>FK+8#D'5(4.E7%85^^-\N1BN
M?6F6B_JU.^R/Y9=FUKY65='\MRH/]?EQ#O/W"U_W+[NNOY`M%]DU;KNORF.[
MKX^SIGQ^G/\&#[E6/3(0?^_+<WMS/.O%/]7UM_[DS^WC7/4:RD.YZ?HABO3Q
M5J[+PZ$?*=WYWW'0'_?L`V^/WT?_?9ANDO]4M.6Z/ORSWW:[I%;-9]ORN7@]
M=%_K\Q_E.`?;#[BI#^WP?[9Y;;NZ>@^9SZKB^^5S?QP^SY=O;!S#Y``<`_`:
M`.:G`7H,T!\-,&.`(0'992I#(O*B*Y:+IC[/FLNO=RKZ10(/)J5ZTU\<,CM\
MEU+1IJMO2W"+[*T?9T16%P1O$+PGUIP`?X_D`A*N2)8D7G6BJ!.'>'T;'^5X
M+<;K(=[<3D*1>5X0/R#'`='.V.`#F:W`&>.BUV3*G`.`@$;+NHVHVW#=0'1?
M$'M[GPC!W.3GHIMS"$KI0,;+A?$L@%<3^;:B;LMUDU6SLNP^WFE/5M^:4QA4
MI+GF5%+L05;L1,6.*R9W63EV%^N,<O277PN<]=88NBDXA\Z`QXD5XD7=GNLV
M1+?GV4FJ";46*`Q`,RU05EDO*PZBXL#V,EHY/HKQD<^8UJS(5$8%)I*EOA8P
MK8(EF<DY%H*-5LFB>Y^1*JWBLCTMM8K=R:!1WM*"RSFKC#/TQY+&4R8&-Z%\
MPB.`*P]4.4B*:`GZ$)7_BKK7+/L%(-<<J6;D:UEKY8"E6P"-4=8XJEP`,=H8
M)M8WR&8%W*TT=:N1N;V5BP&B8^;,0:\P!,7$<U!'B]Y-B9<="PS;WGJB$(/L
M'<#-0U/S`*'B>X1`2['`I9Y7>Z23%\8+P>NI52=["'`3T=1$0'`'K](?5?XQ
M+O\U=Z]<=A'@-J*IC0"O_6EETYHJ4&B-99M<LIMIU;*30."J+54=A-X@JAC9
M+A=`J]+ZIPV2!&+PUN*$>-G&@/N89KTWMQZM'5)77@M<RB;0JI$+'*)#/Z$<
M92M#;F6:6AERZT'T$0VM3Q)H('C:+^;BB,%8-]$NH>QF"+P^33V*3#R+<&_1
MU%M&QM^)O6T9QLE+6'"T410P,`$FNBZ4706YJQCJ*A)#-_@'F/SGS+U:V4:0
M/_G0I;,:F;OL@=7(MO9'P5P`(:143[8?*%L8<@NCS=D*!6ORR9;1TMTMDJD!
M=8I658%,+F;!3G@XRCZ&W,<,=0/DO@.@,26+JG<LI]&E-HLVJ\*`$VZ`LH<A
M]S!#W0"Y[7Q*Q89O3&$LMLB%L="G/GRJFLHFAMS$:&.Y0FXYG]#IJ($],(^H
MOT<!#9MD+HYJDS7JJ0<ZE*T,N971A]T5<NLQJ1'U]#W,6@(=*!7H8YD`@G,!
MU43^M>QFFKL97<.KD;E-JMQM"Z#<;0N@W&UG-Z_R3L5+^5?1O.R/[>RI[KJZ
M&M[=/==U5Z9!U>>4BUU9;*\GA_*YZP]].FXN+SPO)UU]>G]_>WV)O/P?4$L#
M!!0````(`+R"/D?YGG//40(``",)```8````>&PO=V]R:W-H965T<R]S:&5E
M=#,N>&ULC9;=CJ,@&(9OQ7@!]0__&FLRK=GL'FPRF8/=8]K2:D;%!5IG[WX!
MK:M`6GM0`9_WXY&28M9C\DE+A)CUU=0MW=DE8]W6<>BI1`VD&]RAEM^Y8-)`
MQKODZM".('B6H:9V?->-G`96K9UG<NR=Y!F^L;IJT3NQZ*UI(/F[1S7N=[9G
M/P8^JFO)Q("39\Z4.U<-:FF%6XN@R\Y^\[:%YPI$$K\JU--9VQ+R1XP_1>?'
M>6>[P@'5Z,1$"<@O=W1`=2TJ\9G_C$7_SRF"\_:C^C?YN%S_""DZX/IW=68E
MMW5MZXPN\%:S#]Q_1^,SA*+@"==4?ENG&V6X>41LJX%?P[5JY;4?[L3)&#,'
M_#'@3P$//`T$8R!8&P!C`"@!9W@4N1`%9##/".XM,OQZ'12;Q-L"OM0G,2A7
M5M[C2T'YZ#T':>;<19T1V0^(/T/\)7'0"2]>(H4!22;$X8J3IV_T]&4^F.5#
MUYP/C/E`YL$\[RG/.2")1%J)N!O75:C#*JIX12V,@=$8Z,;*NN\'))S-$KKC
M1[%>319KR(5]:+0/=?M`L0^UF7P_!6GB*1OP8`*3*`Y4L-!!#R1>#-+(K!X9
MU2-='2CJT5IU$VA4U\'GZK%1/=;50T4]7K7+5U'%*VIAG!B-$]TX4HP3?6G,
MFWPM6*P`%^JI43W5U95_O;V.`'6E7R-%JNE&H5E4''&F/WE75TT450.CN:Y@
MBI%Y:NO,3J<.7M%/2*Y52ZTC9OR@D\?1!6.&>#UWPRN5_(UEZM3HPD0SYFTR
MG.%#A^'N\4HRO1?E_P!02P,$%`````@`O((^1V6I--0T!0``OAD``!@```!X
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MJC.3#;`SP)/!:1[90'<&^L/`?&I@.@-S[0RV,[#7SN`Z`_=AX#XU\)V!)S.,
MCNJVL9EG=389E\7;H#PFU"%K\A9N?8K^8W.R#7;[6XI.E<[^FM@X'OUJQNF0
MZ1'!,\2I2V3.$;@DEL(@'\@HN7CR$R4_I\CL\7*&&2<<0>9?#K+X>I`E1\!?
M(BL!"?+%:C$HNK77YUYHV=Z(]J:U-^?VA@3UB/@6V7=7H:RQY%)F`F?0!16(
MM)S3$+4"DBD+SJ$'A]H1E3GGK,)(H['BG'$^>M.37%;4RW*]+-'KB-BS>4)`
MC50NCODD@J'W"\?`Z>`=474A<!C!6GIW<4XC@M4DZBMAO.!`@Y/5<J):CJM%
MHC=U7"W4H(D,,XZYZ!Q58<ZQ)(%!0V]>@4N4"R262\YI#`DE\ZXXE[!@T,IJ
M>5$MS^]E+]L'T3YPM8F?R\"O&SPR?5:<LZAU0-F=*+H3N3ND7LRC$*ZH-;E5
M%@(&-M`@+#F&SFAZ1ZTB7Z>B]K%G&6BZ$ZD8*G9UGDRT[)ASAXQJ_HA#PEA]
MBQ+TE&;@WK"R"EP>XU/XZ9W?@1<+KW;!AY["!&(9O@?D/I$TFW;,N4\Q*$?[
MBIG`A>@LTGP2.&C67IIX"P%$'9PWGJK&0:.5]]91U3BH5;"QKW<!N9Z#YJII
MJIIF4_T!UC,Y9B(88W!`=1/`))JB16LA@:G2*M;ZB%,K=)HMG?+<WNJ>2@-R
M(P.&K9YGF7TY@ES:@==V3VL[".53&2H[AQ`UE9Q#3@&56ZK6D4K-H:@M55GP
MR?0I+!=SX-7<TUX,>"%DJ]UGR*4?<ID$S_WP-$[^FCAQ2(@3AX0X"=/Q.'%(
MB)/@4V^<Y#8`>!_@`]4GL#6^64(0+=5(`F-,+2C520!3]Y]V`%0K`4RKI->:
MZL6;D&8)L3IJ*II`IB4$8U]BR0T+\([%LQTN9PQ0S;YFYE<PBRN8)?"FA]UP
MGR&7^VFYUT'>GP0RR;1CODXH$9022@+%A))`,:'$J<6$DN?N3RB4VS+D;5D`
M*IS0EF%$$X!6<XG4:-)FW%/IQ#'!.[H.+"12:6L=VS>*8Z8=@0&ZA`DD&!V"
M@I[=#,H-)/(&,M`&4F#8[7@%,[^"65S!+%'H*U//'[1E*2:0`-&IV+/:H]PP
M(F\8`TO\(Q//TUG=T'JXZL%Z-GTH]V'(^[#0TX>AW(<A[\/HOGS:,=15%OJK
ML/EUV*('Z]GCH]Q%(>^B`GTF(C`\J[]FYE<PB\^9XQ6-SAX1[_+RI7W\7PT>
MB]=]W9B>G3V]8KC'YA$S.3^%VQD(Y^=PNY#.+^%V=7RQ\#'M9'S(7O*_L_)E
MLZ\&#T5=%[OVL?1S4=1YNB1UD^*TSK.GTY=M_EPWASX=E\?7"\<O=7%X?UMR
M>F4S^1]02P,$%`````@`O((^1\>%3N2<!0``;1P``!@```!X;"]W;W)K<VAE
M971S+W-H965T-2YX;6R-F4USXD@,AO\*Q9VAI?[T5)*J!>+`8:NFYC![]B1.
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M6+QNFN_5V[+LQ]!Y>%]MZN[OZ/ZU;JKMN\EXM"W^'#[7N^[S[?`?YWLSV0![
M`SP:`)XUT+V!/AKH\P:F-S!'`\S.&MC>P'X8Z+,&KC=P'RZYLP:^-_"?[2'T
M!N&CA_-AS7J#C`QZ>IB_;O8715/<7.VKM]'^L&1?BG9GP-<LKJ_[]F&WG+K_
MQ?FOX]/?-\%?37^W[?3([(#@*1)29"X@68HL.)*I%+D5$$B17$`P1>X$1*?(
M4D!,BJP$Q!Z1:0SI,:XHQA4[>W-J[TA<#XCOD%V'@%$F!#*@.>=(X!922ZA)
M.[><BD>>#<K2('/0@3/.D0'<771L>9%8<6*")FA4SLOAUF*X-0\W6<;S`V)/
M1V5)'#G2Q=&<3%WBBQ%],=P7LE]FAG7D/9+0Y!>@Q!,K>F*Y)V1;SBSK)'CT
MQ-^<4V"<`;+"EAR;V`RTD7UVHL^.^0R*1&;FN#O*&AK`A6-K*Y!MG@LM&0B6
MK/0EQR;:V:')\.+`O#`PLO,6GL^&46J@FR!V$X1NR#S-`NN&ABZPT%DZ"SEO
MQ2K#L"7')E;9P5%EXJ@R853D5%]D@C]JL)\V!9+T4`D]D54SZZ%S`>R1Y$RF
M6L9;F<"`LP/B#8*S]%#KH72W#$9%5C/@<@:*ZED/G8G*K8!,(&O=01H<3E(P
M=5S6!>#"`(HE./S<UUH!S2R6E[G4)5D>@.L#*"H0P`__"3J/-&=:?0),G9*5
M`KA4@*):`8(,.!>03MZ\!\^E+`(")H"G"T;H,D10F8PN&$')@K=@R7ZX$T!Z
M9`G(!+TR#FGT)="J+--V('T!6?5`D#U0-*Q<AE@*(S!=7`=S&)#5"KA<L2P&
MN%RAQT"/R_PREWHD"QMP96/9#%Q4MEQ`P,7YHDM`D*V42WV690LDW:+9#'#A
M,G%?>3JS&=\Q%,J%MM`%FJC="5A,Z$[*NK3"D:42):FD&0URD8M>*S=43,E"
MAX+0`>EJAESH@L^LHH70H@>3Q%!KDD[D4G-&!4<7W9T`:A\&)18'"D9!8NF\
M+9"K8NOYJ?-I7[(JHJ"*H&DX]>6ZDR/&D+3@%KEJ3EQF@`=<J-`R[<+`28JR
MO*(@KT`3..2JR<;&$6.L'URXLJZBH*M@J3<7Y?(6!1V,`H%T$^0".*%DZK@L
M2"@)$KO!X&)CO=*>2NYE+G5)EB04*BB:,,R0:PV+)4?BT6YB$D9/BEQ`&9FZ
M+FL72E49<YU+#@:OZ47&\C*7NB1+$PK2!%3AD>O$Q*FTJNHOJ;@ZL1W%D4F@
MMV*YU*7-L@R&T@4MJY,6U`G(T3W70@G&;X4$*/JMS<`!KV4-TU*Q1@.NN99,
MXN:UFMYAKCY#IF[)NJ,%W:$W*3/-=<>XF,G0^Y2YOGQ9*2"(@68RMQ(&5F-&
MIB>70&\SZVC]<B>0<1J5H]?#EP>Q$I!8=@$:;X=6Q<#%I2#%"#2J7!E95#G2
M156?K/G4'UD^]6>J4RT6G<'@0(VA97'4@C@BO:O27!R-5\AO0J<GKSQ>BJ?R
M[V+_M-[5HY]5TU3;[AW'8U4U96Q4?8F-/I?%P_''IGQLVJ\^?M\?WH8=?C35
MR_O+O>,;QIO_`5!+`P04````"`"\@CY'0!1&)*H%```Q'```&````'AL+W=O
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M\^F7:(9BN``/!?BUP&L[N(`="MBW`N[=`FXHX-X*A'<+^*&`%RW,3MK[R*VK
MMEK,#\WSY'`:[L>JFU5TY?/8W'0W^Z'H?\NQ.^:[/Q?$=C[[V54T,,L3P^?,
M);'61'A#9KD#K[U@U(LEJ_)\V<)*$T$@:XU0<8F4`(FXGQ9&R_;E[46T'*[`
MP0I<7X&[J,"+<)^8HF?V/?.)0W0<1$@`EP(55@S?&G!DV-LDP!(V7'`R6*&'
M"CT(4<`5!%A!4"$*243HA/BSCI)/UHK17@&,?.0HXJ,Q#LXZ(Z(#:DNV2"/S
MO(#:"C#\HM?+0K5C`QDYVU<:"UQ8[X0XC7'!T0BLU%AR*8VLC0BU1:!-ACIJ
M;9S$_"\U-#(!$^Q'TO-'=&.9P,0PQHIIM@)880+)S4]C,25G1:.EQISU@1AK
MZ]P-;=<&+*\T4L7(CD\J0"PD+0?F0GJDI"8AX*QA-G)K!MPG'V/>7$20$!CS
M5*2194;03[X0:XTL-;)NRN7=P4J-@+.&DIS;B*-@9;LEX'RPL1@1B(V(K%YM
MUDB%5O>((T4YSP''QA8D]Q+`458H;01A>3MU(RY`V"E)6Z653CDPET-#5`1I
ME0ATY'+<I40-,GDF:0:`H[P^4N%'1&*S)*]%.BG2@WGE@XE2(^+R@<!(B9K+
MP^.35*BQ<%[9I3QLY:2]W`8I#]@O975J&2+_#5YEHAK+V4X@IY8AJ*\H#(\I
MQ(9.P-&MVDT+E5BQRYF:VDVU"W\BEPKGI4@`YKGLU2S5')'EP"/&3MC9*6K3
ML6.^A4V9M"N3W#B6`'(D8Z1M-*^&I`P'8"%%F?8`;&3\&?LQ&Z!+KN`!NDBL
MG9>'D]6`7?0YY<&2VS#B<O[BY5HH(>A--MX1C3AA8)TPD-J*&1BWXT).R17B
MNIV3@E0)0$[L])D.U>BB"6,CB5,&UBD#J<UJ@"Y'LLB')*D2Y`),-EIU9D5)
MB$G)R^T*UIAB<&-CB?,&!B=8.Y)Z,#9F!F=8F>PN`:26,@,/-:<_&25-QB)Y
M(\-9`G!L%F!#9FW(),\%2P!I<=B-70IC`X8ME+6%DCR:+@&D.P2,,8AH7W8(
M.QX#QY.-K1D8E&QL&#%-CO4'FQ.#<Z<T^R6`=(#TN9/1)%M_%"P!.*8-NR8#
MUW32-0?H?$_*AY-DO-2GO8Z=S4FPS"X0:#D6\GQ1`C!:F^*(2(LMU`(+==)"
MK;8RZUS.MV6:"$`BBBS#MOXH6`*0NZ=Q=D0E-E$+3%3F=<L!.A]*&YR/A<SU
M$>CSWJ(.I18<T%'<2@#*<%S*Q"YJ6?O+V,'/CCQC!4=;)Q^2`4@MZ`\P:ZO/
MJG*6OXM<"L*&:8%A.FF8`-*"_I]9V_<<<!#T89.TV"0M>,;K1AY"66QK%MB:
MS!77`U2\IT4C7!@7Y.ED=O8^9%<?[OLW4<?)3?.T;SLE9W=?WW9]X>Y]BKB_
MI*L5@?MKNBI/[[+>JE_,'ZO[^L_J<+_9'R??F[9M=OV[EKNF:>O<??,Y1_*A
MKFY?OVSKN[:[+/+UX?1&Z_2E;1Y?7M"]OB5<_`=02P,$%`````@`O((^1Q93
MT52Z`0``3`0``!@```!X;"]W;W)K<VAE971S+W-H965T-RYX;6Q]5%V/HR`4
M_2N$'S#XV=DTUF3:S63W89/)/.P^4[TJ&1`'L,[^^P6TUEJS+P*7<P[G<KEF
M@U0?N@$PZ$OP5A]P8TRW)T07#0BJGV0'K=VII!+4V*6JB>X4T-*3!"=1$.R(
MH*S%>>9C;RK/9&\X:^%-(=T+0=7?(W`Y''"(KX%W5C?&!4B>D9E7,@&M9K)%
M"JH#?@GWI\0A/.`W@T$OYLAY/TOYX18_RP,.G`7@4!BG0.UP@1-P[H3LP9^3
MYNU(1US.K^JO/EOK_DPUG"3_PTK36+,!1B54M.?F70X_8$HA=8*%Y-I_4=%K
M(\65@I&@7^/(6C\.XTZZFVC;A&@B1#/A6_!?0CP1XA6!C,Y\7M^IH7FFY(#4
M6(N.NI*'^]C>7.&"_J+\GLU,V^@E#],P(Q<G-&&.(R9:8NX1IT?$[@8AUL#L
M(MIR<8P>^-'JA$=$^+Q]0KR99^SY\5V>T;9`LBF0>('D3B!>7=06)EDELH5)
M5T;(HGH"5.U?M4:%[%O?0XOHW#@OD:_^#9YG':WA%U4U:S4Z2V/?D*]T):4!
M:R5X2C%J;&O/"PZ5<=-G.U?C:Q\71G;7WIU_(/D_4$L#!!0````(`+R"/D=?
M+S,UNP$``$P$```8````>&PO=V]R:W-H965T<R]S:&5E=#@N>&UL?51=<Z,@
M%/TK##^@*"9IFS'.--GI[#[L3*</[3/1Z\<4Q`+&[K\OH#'&V'T1N)QS.)?+
M->ZD^M`E@$%?@M=ZATMCFBTA.BU!,'TG&ZCM3BZ58,8N54%THX!EGB0XH4&P
M(8)5-4YB'WM122Q;PZL:7A32K1!,_=L#E]T.A_@<>*V*TK@`26(R\K)*0*TK
M62,%^0X_A=O#RB$\X*V"3D_FR'D_2OGA%G^R'0Z<!>"0&J?`['""`W#NA.S!
MGX/FY4A'G,[/ZL\^6^O^R#0<)'^O,E-:LP%&&>2LY>95=K]A2&'M!%/)M?^B
MM-5&BC,%(\&^^K&J_=CU.S08:,L$.A#H2'CX/R$:"-&,0'IG/J]?S+`D5K)#
MJJ]%PUS)PVUD;RYU07]1?L]FIFWTE(3K34Q.3FC`['L,G6*N$8=;Q.8"(=;`
MZ((NN=C3&SZ=G7"+".^73X@6\XP\/[K*\P>!U:+`R@NLK@0>9A>UA'F<);*`
MV00S(V12/0&J\*]:HU2VM>^A271LG"?JJW^!)W'#"OC+5%'5&AVEL6_(5SJ7
MTH"U$MRM,2IM:X\+#KEQTWL[5_UK[Q=&-N?>'7\@R3=02P,$%`````@`O((^
M1Z""22*A`0``L0,``!@```!X;"]W;W)K<VAE971S+W-H965T.2YX;6QU4]MN
MW"`0_17$!P3?DE0KKZ5LJJI]J!3EH7UF[;&-`HP+>)W^?0%['2=Q7X`9YIPY
M,PSEA.;%]@".O"JI[9'VS@T'QFS=@^+V!@?0_J9%H[CSINF8'0SP)H*49%F2
MW#'%A:95&7U/IBIQ=%)H>#+$CDIQ\_<$$J<C3>G5\2RZW@4'JTJVXAJA0%N!
MFAAHC_0A/9R*$!$#?@F8[.9,@O8SXDLP?C1'F@0)(*%V@8'[[0*/(&4@\HG_
M+)QO*0-P>[ZR?XO5>O5G;N$1Y6_1N-Z+32AIH.6C=,\X?8>EA-M`6*.T<27U
M:!VJ*X02Q5_G7>BX3_/-?;[`]@'9`LA6P)<D"I\319E?N>-5:7`B9F[MP,,+
MIH?,-Z(.SEAWO/-"K?=>JO0N+=DE$"TQISDFV\:L$<RSKRFRO12G[!,\VX?G
MNPKS",_?*?P/0;%+4$2"XAU!_J'$O9CB0Q*VZ:D"T\71L:3&4<=!W7C7Z7S(
MXIN\A5?EP#OXR4TGM"5G=/YE8_];1`=>2G)S2TGO_\]J2&A=.-[[LYE':C8<
M#M</LO[2ZA]02P,$%`````@`O((^1U*S-X&\`0``3`0``!D```!X;"]W;W)K
M<VAE971S+W-H965T,3`N>&UL?53;;J,P$/T5RQ]0<\FE&Q&D)JNJ?5BIZD/W
MV8$!K-J8VB9T_[ZV(800M"]X/#[GS!E?2#JI/G4%8-"WX+7>X\J89D>(SBH0
M5#_(!FJ[4D@EJ+%351+=**"Y)PE.HB#8$$%9C=/$Y]Y4FLC6<%;#FT*Z%8*J
M?P?@LMOC$%\2[ZRLC$N0-"$C+V<":LUDC104>_P4[HXKA_"`#P:=GL3(>3])
M^>DFK_D>!\X"<,B,4Z!V.,,1.'="MO#7H'DMZ8C3^*+^[+NU[D]4PU'RORPW
ME34;8)1#05MNWF7W`D,+:R>82:[]%V6M-E)<*!@)^MV/K/9CUZ^LHX&V3(@&
M0C02'H/_$N*!$,\(I'?F^_I-#4T3)3ND^K-HJ#OR<!?;G<M<TF^47[.=:9L]
MI^%FG9"S$QHPAQX333&WB.,]8G.%$&M@=!$MN3A$=_QH5N$>$6Z7*\2+?<:>
M']_TN5D66"T*K+S`ZD9@.]NH)<SCK)$ES*^9$3(Y/0&J]+=:HTRVM7]#D^SX
M<)[\_2)7>)HTM(0_5)6LUN@DC;U#_J0+*0U8*\'#&J/*/NUQPJ$P+MS:6/6W
MO9\8V5S>[O@#27\`4$L#!!0````(`+R"/D?R_D]RN@$``$P$```9````>&PO
M=V]R:W-H965T<R]S:&5E=#$Q+GAM;'U4VVZC,!#]%8L/J,'09A41I"95U3ZL
M5/5A]]F!X:+Z0FT3NG^_MB&$$-H7;(_/.3[C\9#V4GWH&L"@+\Z$W@6U,>T6
M8YW7P*F^DRT(NU-*Q:FQ2U5AW2J@A2=QADD8/F!.&Q%DJ8^]J2R5G6&-@#>%
M=,<Y5?_VP&2_"Z+@''AOJMJX`,Y2//&*AH/0C11(0;D+'J/M(7$(#_C30*]G
M<^2\'Z7\<(O78A>$S@(PR(U3H'8XP0$8<T+VX,]1\W*D(\[G9_5GGZUU?Z0:
M#I+];0I36[-A@`HH:<?,N^Q?8$SAW@GFDFG_17FGC>1G2H`X_1K&1OBQ'W9(
M/-+6"60DD(GP*_R1$(^$>$'`@S.?UQ,U-$N5[)$::M%25_)H&]N;RUW07Y3?
MLYEI&SUET29,\<D)C9C]@"%SS#7B<(MXN$"P-3"Y(&LN]N2&3Q8GW"*BS?H)
M\6J>L>?'5_QO+":K`HD72*X$%B;W:YAXD<@:)ED8P;/J<5"5?]4:Y;(3OH=F
MT:EQ'HFO_@6>I2VMX#=552,T.DICWY"O="FE`6LEO+L/4&U;>UHP*(V;;NQ<
M#:]]6!C9GGMW^H%D_P%02P,$%`````@`O((^1Y;Y^G^D`0``LP,``!D```!X
M;"]W;W)K<VAE971S+W-H965T,3(N>&UL;5/1;JLP#/V5*!^P`*7M5%&D=5?3
M[L.5ICULSRD8B)9@;A+*]O=+`F5LXR6Q'9_CXSC)!M1OI@&PY%W)UAQI8VUW
M8,P4#2AN;K"#UIU4J!6WSM4U,YT&7@:0DBR)HAU37+0TST+L2><9]E:*%IXT
M,;U27'^<0.)PI#&]!IY%W5@?8'G&9EPI%+1&8$LT5$=Z%Q].J<\("2\"!K.P
MB==^1GSSSM_R2",O`204UC-PMUW@'J3T1*[P_XGSJZ0'+NTK^T/HUJD_<P/W
M*%]%:1LG-J*DA(KWTC[C\`A3"UM/6*`T825%;RRJ*X02Q=_'7;1A'\:3;3K!
MU@')!$AFP&T4A(^%@LP_W/(\TS@0/5YMQ_T$XT/B+J+PP=!W.'-"C8M>\GB_
MS=C%$TTYIS$G6>3LXCF%.?JY1K)6XY3\PL?[=?QF5>,FX#??\+MU@G25(`T$
MZ3>"_8\FUW)N?Q1ABUM5H.OP>`PIL&_#4UU$Y_=YEX2I?*7G6<=K^,=U+5I#
MSFC=;,,$*D0+3DITLZ6D<3]H=B14UIM[9^OQ48V.Q>[Z1>9_FG\"4$L#!!0`
M```(`+R"/D=Y&G35I0$``+,#```9````>&PO=V]R:W-H965T<R]S:&5E=#$S
M+GAM;&U3VV[C(!#]%<0'%)ND339R+#5=K=J'E:H^=)^)/;ZHP'@!Q]V_+V#'
M=;M^@9EASIDS#&0#FC?;`#CRKJ2V1]HXUQT8LT4#2M@;[$#[DPJ-$LZ[IF:V
M,R#*"%*2\22Y8TJTFN99C#V;/,/>R5;#LR&V5TJ8?R>0.!QI2J^!E[9N7`BP
M/&,SKFP5:-NB)@:J([U/#Z=MR(@)KRT,=F&3H/V,^!:<I_)(DR`!)!0N,`B_
M7>`!I`Q$OO#?B?.S9``N[2O[K]BM5W\6%AY0_FE+UWBQ"24E5**7[@6'1YA:
MN`V$!4H;5U+TUJ&Z0BA1XGW<6QWW83SA^PFV#N`3@,^`?1*%CX6BS)_"B3PS
M.!`S7FTGP@33`_<7481@[#N>>:'61R]YNON1L4L@FG).8PY?Y-RE<PKS]',-
MOE;CQ/_#I[MU_&95XR;B-TO\/EDGV*X2;"/!]@M!^JW)M1S^K0A;W*H"4\?'
M8TF!O8Y/=1&=W^<]CU/Y3,^S3M3P6YBZU9:<T?G9Q@E4B`Z\E.3FEI+&_Z#9
MD5"Y8.Z\;<9'-3H.N^L7F?]I_@%02P,$%`````@`O((^1[+]C1ND`0``LP,`
M`!D```!X;"]W;W)K<VAE971S+W-H965T,30N>&UL;5/;;N0@#/T5E`\HN<VT
M&F4B=5JM=A]6JOK0/C.)DZ`"3H%,NG^_0#)IVN8%;.-S?(RA&%&_F0[`D@\I
ME#E&G;7]@5)3=2"9N<$>E#MI4$MFG:M;:GH-K`X@*6@:QWLJ&5=16838DRX+
M'*S@"IXT,8.43/\[@<#Q&"71-?#,V\[Z`"T+NN!J+D$9CHIH:([1?7(XY3XC
M)+QP&,W*)E[[&?'-.W_J8Q1["2"@LIZ!N>T"#R"$)W*%WV?.SY(>N+:O[+]"
MMT[]F1EX0/'*:]LYL7%$:FC8(.PSCK]A;F'G"2L4)JRD&HQ%>85$1+*/:><J
M[.-TDN4S;!N0SH!T`=S%0?A4*,A\9):5A<:1Z.EJ>^8GF!Q2=Q&5#X:^PYD3
M:EST4B9W64$OGFC..4TYZ2IGGRPIU-$O-=*M&J?T!SZYW<9GFQJS@,^^:,RW
M"?)-@CP0Y%\(=M^:W,K9?RM"5[<J0;?A\1A2X:#"4UU%E_=YGX:I?*:71<]:
M^,MTRY4A9[1NMF$"#:(%)R6^V46D<S]H<00TUINWSM;3HYH<B_WUBRS_M/P/
M4$L#!!0````(`+R"/D>SK>=AI@$``+,#```9````>&PO=V]R:W-H965T<R]S
M:&5E=#$U+GAM;&U3P6[C(!#]%<0'%-M)FS1R+#6M5KN'E:H>=L_$'MNHP+B`
MX^[?+V#'=5M?8&:8]^8-`_F`YM6V`(Z\*ZGMD;;.=0?&;-F"XO8&.]#^I$:C
MN/.N:9CM#/`J@I1D69+<,<6%ID4>8\^FR+%W4FAX-L3V2G'S[P02AR--Z37P
M(IK6A0`K<C;C*J%`6X&:&*B/]"$]G+8A(R;\$3#8A4V"]C/B:W!^54>:!`D@
MH72!@?OM`H\@92#RA=\FSH^2`;BTK^P_8K=>_9E;>$3Y5U2N]6(32BJH>2_=
M"PX_86KA-A"6*&U<2=E;A^H*H43Q]W$7.N[#>++))M@Z()L`V0S8)U'X6"C*
M?.*.%[G!@9CQ:CL>)I@>,G\190C&ON.9%VI]]%*D^UW.+H%HRCF-.=DBYRZ=
M4YBGGVMD:S5.V3=\NEO';U8U;B)^\TGC?IU@NTJPC03;3P3W7YI<R;E/OA1A
MBUM58)KX>"PIL=?QJ2ZB\_M\B&-D'^E%WO$&?G/3"&W)&9V?;9Q`C>C`2TEN
M;BEI_0^:'0FU"^;.VV9\5*/CL+M^D?F?%O\!4$L#!!0````(`+R"/D=/]Z4I
MHP$``+,#```9````>&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;&U3VU+D(!#]
M%8H/D(1$W9W*I,K1LMR'K;)\V'UFDDY"R24"F>C?"R23B9H7Z&[ZG#Y-0S%J
M\VH[`(?>I5!VCSOG^ATAMNI`,GNE>U#^I-%&,N==TQ+;&V!U!$E!:)+<$,FX
MPF418\^F+/3@!%?P;)`=I&3FXP!"CWN<XG/@A;>="P%2%F3!U5R"LEPK9*#9
MX[MT=\A#1DSXQV&T*QL%[4>M7X/SI][C)$@``94+#,QO)[@'(0*1+_PV<UY*
M!N#:/K,_QFZ]^B.S<*_%?UZ[SHM-,*JA88-P+WI\@KF%ZT!8:6'CBJK!.BW/
M$(PD>Y]VKN(^3B=9-L.V`70&T`7P*XG"IT)1Y@-SK"R,'I&9KK9G88+ICOJ+
MJ$(P]AW/O%#KHZ<R_9T6Y!2(YIS#E$-7.3>7%.+IEQITJ\:!_L"GM]OX;%-C
M%O'9%XUTFR#?),@C0?Z%(/O6Y%9._JT(6=VJ!-/&QV-1I0<5G^HJNKS/.QJG
M<DDOBYZU\)>9EBN+CMKYV<8)-%H[\%*2JVN,.O^#%D=`XX)YZVTS/:K)<;H_
M?Y'EGY:?4$L#!!0````(`+R"/D<XUJ>FI0$``+,#```9````>&PO=V]R:W-H
M965T<R]S:&5E=#$W+GAM;&U3VV[<(!#]%<0'!-M[2U=>2]E44?M0*<I#^\S:
M8QL%&`?P.OW[`O8Z3NH7F!GFG#G#0#Z@>;4M@"/O2FI[HJUSW9$Q6[:@N+W#
M#K0_J=$H[KQK&F8[`[R*("59EB1[IKC0M,AC[-D4.?9."@W/AMA>*6[^GD'B
M<*(IO05>1-.Z$&!%SF9<)11H*U`3`_6)/J3'\S9DQ(3?`@:[L$G0?D%\#<[/
MZD23(`$DE"XP<+]=X1&D#$2^\-O$^5$R`)?VC?TI=NO57[B%1Y1_1.5:+S:A
MI(*:]]*]X/`#IA9V@;!$:>-*RMXZ5#<()8J_C[O0<1_&DTTZP=8!V03(9L!]
M$H6/A:+,[]SQ(C<X$#->;<?#!--CYB^B#,'8=SSS0JV/7HOTVRYGUT`TY9S'
MG&R1LT_G%.;IYQK96HUS]A\^/:SC-ZL:-Q&_^:1QOTZP72781H+M)X+#ER;7
M<NZ_%&&+6U5@FOAX+"FQU_&I+J+S^WS(XE0^THN\XPW\XJ81VI(+.C_;.($:
MT8&7DMSM*&G]#YH=";4+YL';9GQ4H^.PNWV1^9\6_P!02P,$%`````@`O((^
M1^H^66FE`0``LP,``!D```!X;"]W;W)K<VAE971S+W-H965T,3@N>&UL;5/;
M;MP@$/T5Q`<$F]W<5EY+V515^U`IRD/[S-IC&P48%_`Z_?L"]CINZA>8&>:<
M.0-#,:)]<QV`)^]:&7>DG??]@3%7=:"%N\$>3#AIT&KA@VM;YGH+HDX@K1C/
MLCNFA32T+%+LQ98%#EY)`R^6N$%K8?^<0.%XI#F]!EYEV_D88&7!%EPM-1@G
MT1`+S9$^Y8?3/F:DA)\21K>R2=1^1GR+SO?Z2+,H`114/C*(L%W@&92*1*'P
M[YGSHV0$KNTK^]?4;5!_%@Z>4?V2M>^"V(R2&AHQ*/^*XS>86[B-A!4JEU92
M#<ZCOD(HT>)]VJ5)^SB=[!YFV#:`SP"^`!ZR)'PJE&1^$5Z4A<61V.EJ>Q%?
M,#_P<!%5#*:^TUD0ZD+T4N:/CP6[1*(YYS3E\%7.7;ZDL$"_U.!;-4[\/WQ^
MOXW?;6K<)?QNA0\SM4VPWR38)X+]/P3YIR:W<OBG(FQUJQILFX;'D0H'DT9U
M%5WF\XFG5_E(+XM>M/!#V%8:1\[HP]NF%V@0/00IV<TM)5WX08NCH/'1O`^V
MG89J<CSVUR^R_-/R+U!+`P04````"`"\@CY'Y>]1R;X!``!,!```&0```'AL
M+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q]5-%RHR`4_17&#RB*)NUFC#--.CN[
M#SO3Z4/WF>A5F8*X@+'[]P4TQAK;%X'+.8=SN5S37JHW70,8]"YXH_=!;4R[
MPUCG-0BJ[V0+C=TII1+4V*6JL&X5T,*3!,<D#+=84-8$6>ICSRI+96<X:^!9
M(=T)0=7_`W#9[X,HN`1>6%4;%\!9BB=>P00TFLD&*2CWP6.T.R8.X0&O#'H]
MFR/G_23EFUO\+O9!Z"P`A]PX!6J',QR!<R=D#_XW:EZ/=,3Y_*+^TV=KW9^H
MAJ/D?UEA:FLV#%`!)>VX>9']+QA3V#C!7'+MORCOM)'B0@F0H._#R!H_]N/.
MPTA;)Y"10";"0_@M(1X)\8*`!V<^KR=J:)8JV2,UU**EKN31+K8WE[N@ORB_
M9S/3-GK.2!BG^.R$1LQAP)`9)OJ,.-XBME<(M@8F%V3-Q8'<\,GBA%M$=+]^
M0KR:9^SY\9R_^4(@615(O$#RZ:*2Q47=8J+-CT4B*YAMN#""9]43H"K_JC7*
M9=?X'II%I\9Y)+[Z5WB6MK2"/U15K-'H)(U]0[[2I90&K)7P;A.@VK;VM.!0
M&C>]MW,UO/9A861[Z=WI!Y)]`%!+`P04````"`"\@CY',HS]0*,!``"S`P``
M&0```'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6QU4]MNY"`,_17$!Y0D<VDU
MRD3J=+7:/E2J^K#[S"1.@@HX"V32_?L%DDG3-GT!V_@<'V/(!S2OM@5PY$U)
M;8^T=:X[,&;+%A2W-]B!]B<U&L6==TW#;&>`5Q&D),N29,\4%YH6>8P]FR+'
MWDFAX=D0VRO%S;\32!R.-*77P(MH6A<"K,C9C*N$`FT%:F*@/M+[]'#:AHR8
M\%O`8!<V"=K/B*_!>:R.-`D20$+I`@/WVP4>0,I`Y`O_G3C?2P;@TKZR_XS=
M>O5G;N$!Y1]1N=:+32BIH.:]="\X_(*IA5T@+%':N)*RMP[5%4*)XF_C+G3<
MA^GD;H*M`[()D,V`NR0*'PM%F3^XXT5N<"!FO-J.APFFA\Q?1!F"L>]XYH5:
M'[T46;++V24033FG,2=;Y.S3.85Y^KE&ME;CE'W!I[?K^,VJQDW$;Y;XW3<$
MVU6";238?FAR_ZG)M9S/1=CB5A68)CX>2TKL=7RJB^C\/N^S.)7W]"+O>`-/
MW#1"6W)&YV<;)U`C.O!2DIL=):W_0;,CH7;!O/6V&1_5Z#CLKE]D_J?%?U!+
M`P04````"`"\@CY'*CQ_ZZ8!``"S`P``&0```'AL+W=O<FMS:&5E=',O<VAE
M970R,2YX;6QM4\%NXR`0_17D#R@V29-NY%AJNEJUAY6J'KIG8H]M5&"\@./N
MWQ>PX[I=7V!FF/?F#0/Y@.;-M@".O"NI[3%IG>L.E-JR!<7M#7:@_4F-1G'G
M7=-0VQG@500I25F:[JCB0B=%'F//ILBQ=U)H>#;$]DIQ\^\$$H=CDB77P(MH
M6A<"M,CIC*N$`FT%:F*@/B;WV>&T#1DQX57`8!<V"=K/B&_!>:J.21HD@(32
M!0;NMPL\@)2!R!?^.W%^E@S`I7UE_Q6[]>K/W,(#RC^B<JT7FR:D@IKWTKW@
M\`A3"[>!L$1IXTK*WCI45TA"%'\?=Z'C/HPG^\T$6P>P"<!FP%T:A8^%HLR?
MW/$B-S@0,UYMQ\,$LP/S%U&&8.P[GGFAUD<O!4OO<GH)1%/.:<QABYQ=-J=0
M3S_78&LU3NP_?+9?QV]6-6XB?K/$[]@ZP7:58!L)ME^:_/&MR96<+/U6A"YN
M58%IXN.QI,1>QZ>ZB,[O\Y[%J7RF%WG'&_C-32.T)6=T?K9Q`C6B`R\EO;E-
M2.M_T.Q(J%TP]]XVXZ,:'8?=]8O,_[3X`%!+`P04````"`"\@CY'!3O]P:,!
M``"S`P``&0```'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6QM4]MNY"`,_164
M#R@)DUXTRD3JM%KM/JQ4]6'WF4F<!!5P%LBD^_<%DLFD;5[`-C['QQB*$<V;
M[0`<>5=2VT/2.=?O*;55!XK;&^Q!^Y,&C>+.NZ:EMC?`ZPA2DK(TO:.*"YV4
M18R]F++`P4FAX<40.RC%S?\C2!P/299<`J^B[5P(T+*@"ZX6"K05J(F!YI`\
M9OMC'C)BPA\!HUW9)&@_(;X%YU=]2-(@`214+C!POYWA":0,1+[POYGS6C(`
MU_:%_4?LUJL_<0M/*/^*VG5>;)J0&AH^2/>*XT^86[@-A!5*&U=2#=:AND`2
MHOC[M`L=]W$Z8>D,VP:P&<`6P$,$T*E0E/G,'2\+@R,QT]7V/$PPVS-_$54(
MQK[CF1=J??1<LBPKZ#D0S3G'*8>M<NZN*=33+S785HTC^X;/[K?QNTV-NXC?
M?=+(M@GR38(\$N2?"'9?FMS*R;\4H:M;56#:^'@LJ7#0\:FNHLO[?&1Q*M?T
MLNAY"[^Y:86VY(3.SS9.H$%TX*6D-[<)Z?P/6AP)C0OFO;?-]*@FQV%_^2++
M/RT_`%!+`P04````"`"\@CY'3Q.+VZ0!``"S`P``&0```'AL+W=O<FMS:&5E
M=',O<VAE970R,RYX;6QM4]MNW"`0_17$!P2;O6KEM91-5;4/E:(\M,^L/;91
MP.,"7J=_7\!>QTG\`C/#G#-G&,@&-*^V`7#D3:O6GFGC7'=BS!8-:&$?L(/6
MGU1HM'#>-36SG0%11I!6C"?)GFDA6YIG,?9L\@Q[IV0+SX;87FMA_EU`X7"F
M*;T'7F3=N!!@><9F7"DUM%9B2PQ49_J8GB[;D!$3?DL8[,(F0?L5\34X/\LS
M38($4%"XP"#\=H,G4"H0^<)_)\[WD@&XM._LWV.W7OU56'A"]4>6KO%B$TI*
MJ$2OW`L./V!J81<("U0VKJ3HK4-]AU"BQ=NXRS;NPWC"CQ-L'<`G`)\!QR0*
M'PM%F=^$$WEF<"!FO-I.A`FF)^XOH@C!V'<\\T*MC]YRGNXR=@M$4\YES.&+
MG'TZIS!//]?@:S4N_`L^/:SC-ZL:-Q&_^:!QOTZP72781H+M!X+#IR;7<HZ?
MBK#%K6HP=7P\EA38M_&I+J+S^WSD<2KOZ7G6B1I^"5/+UI(K.C_;.($*T8&7
MDCSL*&G\#YH=!94+YL';9GQ4H^.PNW^1^9_F_P%02P,$%`````@`O((^1R'2
M(8&D`0``LP,``!D```!X;"]W;W)K<VAE971S+W-H965T,C0N>&UL;5/!;MP@
M$/T5Q`<$F]ULVI774C95U1XJ13FT9]8>VRC`N(#7Z=\7L-=Q4U]@9ICWY@T#
MQ8CVU74`GKQI9=R)=M[W1\9<U8$6[@Y[,.&D0:N%#ZYMF>LMB#J!M&(\RPY,
M"VEH6:38LRT+'+R2!IXM<8/6POXY@\+Q1'-Z"[S(MO,QP,J"+;A::C!.HB$6
MFA-]S(_G?<Q("3\EC&YEDZC]@O@:G>_UB691`BBH?&008;O"$R@5B4+AWS/G
M>\D(7-LW]J^IVZ#^(AP\H?HE:]\%L1DE-31B4/X%QV\PMW`?"2M4+JVD&IQ'
M?8-0HL7;M$N3]G$ZX8<9M@W@,X`O@$]9$CX52C*_""_*PN)(['2UO8@3S(\\
M7$05@ZGO=!:$NA"]ECS_7+!K))ISSE,.7^4<\B6%!?JE!M^J<>;_X?.';?QN
M4^,NX7=KC3S;)MAO$NP3P?X?@OQ#DULY_$,1MKI5#;9-C\>1"@>3GNHJNKS/
M1YZF\IY>%KUHX8>PK32.7-"'V:8)-(@>@I3L[IZ2+OR@Q5'0^&@^!-M.CVIR
M//:W+[+\T_(O4$L#!!0````(`+R"/D?%5;$_I`$``+,#```9````>&PO=V]R
M:W-H965T<R]S:&5E=#(U+GAM;&U3P6[<(!#]%>0/"#;KW50KKZ5LJJ@]5(IR
M:,^L/;91@'$`K]._+V"OXZ2^P,PP[\T;!HH1S:OM`!QY5U+;4](YUQ\IM54'
MBML[[$'[DP:-XLZ[IJ6V-\#K"%*2LC0]4,6%3LHBQIY-6>#@I-#P;(@=E.+F
M[QDDCJ<D2VZ!%]%V+@1H6=`%5PL%V@K4Q$!S2AZRXSD/&3'AMX#1KFP2M%\0
M7X/SLSXE:9``$BH7&+C?KO`(4@8B7_AMYOPH&8!K^\;^%+OUZB_<PB/*/Z)V
MG1>;)J2&A@_2O>#X`^86]H&P0FGC2JK!.E0W2$(4?Y]VH>,^3B<LGV';`#8#
MV`+XED;A4Z$H\SMWO"P,CL1,5]OS,,'LR/Q%5"$8^XYG7JCUT6O)V*Z@UT`T
MYYRG'+;*.61+"O7T2PVV5>/,_L-G]]OXW:;&7<3O/FG,MPGR38(\$N2?"/9?
MFMS*.7PI0E>WJL"T\?%84N&@XU-=19?W^<#B5#[2RZ+G+?SBIA7:D@LZ/]LX
M@0;1@9>2WNT3TOD?M#@2&A?,>V^;Z5%-CL/^]D66?UK^`U!+`P04````"`"\
M@CY'WR<%\:4!``"S`P``&0```'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6QM
M4\%NXR`0_17D#R@V29LV<BPU7:UV#RM5/;1G8H]M5&"\@./V[PO8<=W6%Y@9
MYKUYPT`^H'FU+8`C;TIJ>TA:Y[H]I;9L07%[A1UH?U*C4=QYUS34=@9X%4%*
M4I:F-U1QH9,BC[%'4^38.RDT/!IB>Z6X>3^"Q.&09,DE\"2:UH4`+7(ZXRJA
M0%N!FABH#\E]MC]N0T9,>!8PV(5-@O83XFMP_E:')`T20$+I`@/WVQD>0,I`
MY`O_GS@_2P;@TKZP_X[=>O4G;N$!Y8NH7.O%I@FIH.:]=$\X_(&IA>M`6**T
M<25E;QVJ"R0ABK^-N]!Q'\83=C?!U@%L`K`9<)M&X6.A*/,7=[S(#0[$C%?;
M\3#!;,_\190A&/N.9UZH]=%SP=@NI^=`-.4<QQRVR+G)YA3JZ><:;*W&D?W`
M9[MU_&95XR;B-U\TWJX3;%<)MI%@^X7@[EN3*SF;]%L1NKA5!::)C\>2$GL=
MG^HB.K_/>Q:G\IE>Y!UOX!\WC="6G-#YV<8)U(@.O)3TZCHAK?]!LR.A=L'<
M>=N,CVIT'':7+S+_T^(#4$L#!!0````(`+R"/D>4%>(/<@(``+T)```9````
M>&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;'56VXZ;,!#]%<0'+-A<<A%!2K:J
MVH=*JWUHGYW$2=`"3FTGV?Y];9/;FN,7?.',.6.8&4]U$?)#'3C7T6?7]FH1
M'[0^SI-$;0Z\8^I%''EOWNR$[)@V2[E/U%%RMG5&79O0-"V3CC5]7%=N[TW6
ME3CIMNGYFXS4J>N8_+?BK;@L8A+?-MZ;_4';C:2NDKO=MNEXKQK11Y+O%O&2
MS%=D9B$.\;OA%_4TCZSS:R$^[.+G=A&GU@?>\HVV%,P,9_[*V]8R&>6_5]*'
MIC5\GM_8O[OC&O?73/%7T?YIMOI@O$WC:,MW[-3J=W'YP:]G*"SA1K3*/:/-
M26G1W4SBJ&.?P]CT;KP,;XKR:H8-Z-6`W@VFJ7-\$')N?F.:U944ET@.W_;(
M["\D<VH^Q,9NNG.[=\9197;/-<U(E9PMT16S&C#T"5,^((FAOVM0I+&B(WLR
MP?89]#%S]MD7^Q(3Y)`@=P3YET-2[Y`(DV&1`HH4@"#W1!"FP"(E%"D!0>F)
M($S@>T^@R`003#T1A)EAD2D4F8X)\M0309A`Y,V@R`P0^#\>80(_WN8WRJ%T
M1$&FF9]$8Q#-\X!.(%<)H"A\'00*9`N!^;HD=$Q!1^<!H#P09@3G-<D`A1]H
M$!2(-(+3GX#<+OQ8@Z!`L!%<`0A([\(/-P@*Q1LN`@1D>.&7&@@*U!J"ZP`!
M25[XU0:"0G&`2P$!>5Z,X@"!0G&`JP$!J5Z.X@"!_#A(GJ[7CLN]ZR)4M!&G
MWC4M3[OW3F5)W?7\@-?5D>WY+R;W3:^BM=#FDG=7\4X(S8TOZ8N)E8/II>Z+
MEN^TG4[,7`[=Q;#0XGAKENX=6_T?4$L#!!0````(`+R"/D<%@J>0NP$``$P$
M```9````>&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;'U4VXZ;,!#]%<L?L`9#
MLE5$D#945?M0:;4/[;,#PT5K8VJ;L/W[VH800MB^8,_XG/&9&0_)(-6[K@$,
M^A"\U4=<&],="-%Y#8+I)]E!:T]*J00SUE05T9T"5GB2X(0&P9X(UK0X3;SO
M5:6)[`UO6GA52/=",/7W!%P.1QSBJ^.MJ6KC'"1-R,PK&@&M;F2+%)1'_!(>
MLM@A/.!7`X->[)'3?I;RW1D_BB,.G`3@D!L7@=GE`AEP[@+9B_],,6]7.N)R
M?XW^S6=KU9^9ADSRWTUA:BLVP*B`DO7<O,GA.TPI[%S`7'+MORCOM9'B2L%(
ML(]Q;5J_#N,)C2?:-H%.!#H3O@3_)403(5H1R*C,Y_65&98F2@Y(C;WHF&MY
M>(ALY7+G](7R9S8S;;V7E.YI0BXNT(0YC1BZP(3WB.P1L;]!B!4PJZ!;*D[T
M@;_2D#TBPN?M&Z+-/"//C^[XGTB,-P/$/D!\5ZAH5:@M3+Q*9`NS6PDAB^X)
M4)5_U1KELF_]#"V\\^"\4-_]&SQ-.E;!3Z:JIM7H+(U]0[[3I90&K)3@:8=1
M;4=[-CB4QFV?[5Z-KWTTC.RNLSO_0-)_4$L#!!0````(`+R"/D=A\JV\I0$`
M`+,#```9````>&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;&U3P6[<(!#]%<0'
M!)O=>-.5UU(V5=4>*D4YM&?6'MLHX'$!K]._+V"OXZ2^P,PP[\T;!O(1S:MM
M`1QYTZJS)]HZUQ\9LV4+6M@[[*'S)S4:+9QW3<-L;T!4$:05XTF2,2UD1XL\
MQIY-D>/@E.S@V1`[:"W,WS,H'$\TI;?`BVQ:%P*LR-F"JZ2&SDKLB('Z1!_3
MXWD?,F+"+PFC7=DD:+\@O@;G1W6B29``"DH7&(3?KO`$2@4B7_C/S/E>,@#7
M]HW]6^S6J[\("T^H?LO*M5YL0DD%M1B4>\'Q.\PMW`?"$I6-*RD'ZU#?()1H
M\3;MLHO[.)UD7V;8-H#/`+X`'I(H?"H497X53A2YP9&8Z6I[$2:8'KF_B#($
M8]_QS`NU/GHM>);E[!J(YISSE,-7.5FZI#!/O]3@6S7._#]\>MC&[S8U[B)^
M]P&?;1/L-PGVD6#_H<G#IR:W<AX^%6&K6]5@FOAX+"EQZ.)37467]_G(XU3>
MTXN\%PW\%*:1G247='ZV<0(UH@,O);F[IZ3U/VAQ%-0NF`=OF^E138[#_O9%
MEG]:_`-02P,$%`````@`O((^1^8:NR6E`0``LP,``!D```!X;"]W;W)K<VAE
M971S+W-H965T,S`N>&UL;5/;;N,@$/T5Q`<4FZ1)&SF6FJY6NP\K57UHGXD]
MOJC`>`''[=\7L.-:K5]@9IASY@P#V8#FS38`CKPKJ>V1-LYU!\9LT8`2]@8[
MT/ZD0J.$\ZZIF>T,B#*"E&0\279,B5;3/(NQ)Y-GV#O9:G@RQ/9*"?-Q`HG#
MD:;T&GANZ\:%`,LS-N/*5H&V+6IBH#K2A_1PVH:,F/#2PF`7-@G:SXAOP?E;
M'FD2)("$P@4&X;<+/(*4@<@7_C]Q?I4,P*5]9?\=N_7JS\+"(\K7MG2-%YM0
M4D(E>NF><?@#4PNW@;!`:>-*BMXZ5%<()4J\CWNKXSZ,)_Q^@JT#^`3@,^`N
MB<+'0E'F+^%$GAD<B!FOMA-A@NF!^XLH0C#V'<^\4.NCEYSO[C-V"413SFG,
MX8N<73JG,$\_U^!K-4[\!S[=K^,WJQHW$;]9XN^2=8+M*L$V$FR73>Z3;TVN
MY7SODBUN58&IX^.QI,!>QZ>ZB,[O\X''J7REYUDG:O@G3-UJ2\[H_&SC!"I$
M!UY*<G-+2>-_T.Q(J%PP]]XVXZ,:'8?=]8O,_S3_!%!+`P04````"`"\@CY'
M/D8BH*,!``"S`P``&0```'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6QM4\%N
MW"`0_17D#P@V=K+1RFLIFZIJ#Y6B'-HS:X]M%&!<P.OT[PMX[;BI+S`SS'OS
MAH%R0O-F>P!'WI74]I3TS@U'2FW=@^+V#@?0_J1%H[CSKNFH'0SP)H*4I"Q-
M'ZCB0B=5&6,OIBIQ=%)H>#'$CDIQ\^<,$J=3DB5+X%5TO0L!6I5TQ35"@;8"
M-3'0GI*G['@N0D9,^"E@LAN;!.T7Q+?@?&].21HD@(3:!0;NMRL\@Y2!R!?^
M?>/\*!F`6WMA_QJ[]>HOW,(SRE^B<;T7FR:D@9:/TKWB]`UN+=P'PAJEC2NI
M1^M0+9"$*/X^[T+'?9I/\@6V#V`W`%L!CVD4/A>*,K]PQZO2X$3,?+4##Q/,
MCLQ?1!V"L>]XYH5:'[U6[,!*>@U$MYSSG,,V.0_9FD(]_5J#[=4XL__PV6$?
MG^]JS",^W^(?BWV"8I>@B`3%/TWFGYK<R_E<A&YN58'IXN.QI,91QZ>ZB:[O
M\XG%J7RD5^7`._C!32>T)1=T?K9Q`BVB`R\EO;M/2.]_T.I(:%TP#]XV\Z.:
M'8?#\D76?UK]!5!+`P04````"`"\@CY'T=8<&:,!``"S`P``&0```'AL+W=O
M<FMS:&5E=',O<VAE970S,BYX;6QM4]MNW"`0_17$!P3;>]7*:RF;J&H?*D5Y
M:)]9>VRC`.,`7J=_7\!KQTW]`C/#G#-G&,@'-&^V!7#D0TEMS[1UKCLQ9LL6
M%+</V('V)S4:Q9UW3<-L9X!7$:0DRY)DSQ07FA9YC+V8(L?>2:'AQ1#;*\7-
MGPM(',XTI5/@532M"P%6Y&S&54*!M@(U,5"?Z6-ZNFQ#1DSX)6"P"YL$[5?$
MM^#\J,XT"1)`0ND"`_?;#9Y`RD#D"[_?.3]+!N#2GMB_Q6Z]^BNW\(3RMZA<
MZ\4FE%10\UZZ5QR^P[V%72`L4=JXDK*W#M4$H43QCW$7.N[#>+*?8.N`[`[(
M9L`QB<+'0E'F,W>\R`T.Q(Q7V_$PP?24^8LH0S#V'<^\4.NCMR([[')V"T3W
MG,N8DRUR]NF<PCS]7"-;JW')_L.GAW7\9E7C)N(W2_SQN$ZP72781H+M/TWN
MOS2YEO-5)5O<J@+3Q,=C28F]CD]U$9W?YV,6I_*97N0=;^`G-XW0EES1^=G&
M"=2(#KR4Y&%'2>M_T.Q(J%TP#]XVXZ,:'8?=]$7F?UK\!5!+`P04````"`"\
M@CY'S%;;P*8!``"S`P``&0```'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6QM
M4\%NW"`0_17D#P@VZV0W*Z^E;*JJ/52*<FC/K#VV48!Q`:_3OR]@K^.FOL#,
M,._-&P:*$<V;[0`<>5=2VU/2.=<?*;55!XK;.^Q!^Y,&C>+.NZ:EMC?`ZPA2
MDK(T?:"*"YV418R]F++`P4FAX<40.RC%S9\S2!Q/29;<`J^B[5P(T+*@"ZX6
M"K05J(F!YI0\9<=S'C)BPD\!HUW9)&B_(+X%YWM]2M(@`214+C!POUWA&:0,
M1+[P[YGSHV0`KNT;^]?8K5=_X1:>4?X2M>N\V#0A-31\D.X5QV\PMW`?""N4
M-JZD&JQ#=8,D1/'W:1<Z[N-TLLMGV#:`S0"V``YI%#X5BC*_<,?+PN!(S'2U
M/0\3S([,7T05@K'O>.:%6A^]EFQ_*.@U$,TYYRF'K7(>LB6%>OJE!MNJ<6;_
MX;/]-GZWJ7$7\;LU_I%M$^2;!'DDR/]I\O%3DQLYA_13$;JZ506FC8_'D@H'
M'9_J*KJ\SR<6I_*17A8];^$'-ZW0EES0^=G&"32(#KR4].X^(9W_08LCH7'!
MW'O;3(]J<ASVMR^R_-/R+U!+`P04````"`"\@CY'Z0OA&:0!``"S`P``&0``
M`'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6QM4\&.VR`0_17D#UALG$U6D6-I
MLU75'BJM]M">B3VVT0+C`HZW?U_`CN-N?8&98=Z;-PP4(YIWVP$X\J&DMJ>D
M<ZX_4FJK#A2W#]B#]B<-&L6==TU+;6^`UQ&D)&5INJ>*"YV418R]FK+`P4FA
MX=40.RC%S9\S2!Q/29;<`F^B[5P(T+*@"ZX6"K05J(F!YI0\9\?S+F3$A)\"
M1KNR2=!^07P/SO?ZE*1!`DBH7&#@?KO""T@9B'SAWS/GO60`KNT;^]?8K5=_
MX19>4/X2M>N\V#0A-31\D.X-QV\PM_`8""N4-JZD&JQ#=8,D1/&/:1<Z[N-T
M<LAGV#:`S0"V`)[2*'PJ%&5^X8Z7A<&1F.EJ>QXFF!V9OX@J!&/?\<P+M3YZ
M+=E35M!K()ISSE,.6^7L[RG4TR\UV%:-,_L/GQVV\?FFQCSB\S5^S[8)=IL$
MNTBP^Z=)]JG)K9S\4Q&ZNE4%IHV/QY(*!QV?ZBJZO,]G%J=R3R^+GK?P@YM6
M:$LNZ/QLXP0:1`=>2OKPF)#._Z#%D="X8!Z\;:9'-3D.^]L76?YI^1=02P,$
M%`````@`O((^1R30P,2P`0``&`0``!D```!X;"]W;W)K<VAE971S+W-H965T
M,S4N>&UL;53;;J0@&'X5X@,4Q3EEXIATNMEL+YHTO6BO&?U54@XNX-A]^P5T
MK#O+S0`_W^D7F&)4^M-T`!9]"2[-*>FL[8\8FZH#0<V#ZD&ZG49I0:U;ZA:;
M7@.M`TEP3-)TAP5E,BF+4'O59:$&RYF$5XW,(`35?\[`U7A*LN16>&-M9WT!
MEP5>>#43(`U3$FEH3LEC=CQO/2(`WAF,9C5'/OM%J4^_>*Y/2>HC`(?*>@7J
MABL\`>=>R!G_GC6_+3UQ/;^I_PS=NO07:N!)\0]6V\Z%31-40T,';M_4^`OF
M%D+"2G$3?E$U&*O$C9(@0;^FD<DPCM-.GL^T.(',!+(0#FD(/AF%F#^HI66A
MU8CT]&E[ZD\P.Q+W(2I?#'V'/1?4N.JU)(=-@:]>:,:<)PQ987;9`L%.?O$@
M,8\S^8^?[>/\/)HQ#_Q\G3$C<8%-5&`3!#;_-+F]:S*&V<5-ME&3;41@?V<2
MPQSN3/#JZ`3H-MQ0@RHUR/`>5M7E$3R2</3?\++H:0LO5+=,&G11UEV@<,R-
M4A9<E/3!9>G<,UT6'!KKIWLWU]/-G196];=WN/P9E'\!4$L#!!0````(`+R"
M/D?"4=;ZI0$``+,#```9````>&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;&U3
MVV[C(!#]%<0'%)ND:1HYEIJN5MN'2E4?=I^)/;ZHP'@!Q]V_7\".:Z5^@9EA
MSIDS#&0#F@_;`#CRJ:2V1]HXUQT8LT4#2M@[[$#[DPJ-$LZ[IF:V,R#*"%*2
M\239,25:3?,LQMY,GF'O9*OAS1#;*R7,OQ-('(XTI=?`>ULW+@18GK$95[8*
MM&U1$P/5D3ZEA],V9,2$WRT,=F&3H/V,^!&<E_)(DR`!)!0N,`B_7>`9I`Q$
MOO#?B?.K9``N[2O[S]BM5W\6%IY1_FE+UWBQ"24E5**7[AV'7S"U<!\("Y0V
MKJ3HK4-UA5"BQ.>XMSKNPWC"]Q-L'<`G`)\!^R0*'PM%F3^$$WEF<"!FO-I.
MA`FF!^XOH@C!V'<\\T*MCUYROG_,V"4033FG,8<O<G;IG,(\_5R#K]4X\6_X
M]&$=OUG5N(GXS5)CNELGV*X2;"/!=DGPF-PTN99SVR5;W*H"4\?'8TF!O8Y/
M=1&=W^<3CU/Y2L^S3M3P*DS=:DO.Z/QLXP0J1`=>2G)W3TGC?]#L2*A<,!^\
M;<9'-3H.N^L7F?]I_A]02P,$%`````@`O((^1[;3W9NE`0``LP,``!D```!X
M;"]W;W)K<VAE971S+W-H965T,S<N>&UL;5/!;MP@$/T5Y`\(-NMDFY774C95
MU1XJ13DT9]8>VRC`N(#7R=\'L-=Q4U]@9ICWY@T#Q8CFU78`CKPIJ>TQZ9SK
M#Y3:J@/%[0WVH/U)@T9QYUW34ML;X'4$*4E9FMY1Q85.RB+&GDQ9X."DT/!D
MB!V4XN;]!!+'8Y(EU\"S:#L7`K0LZ(*KA0)M!6IBH#DF#]GAE(>,F/!'P&A7
M-@G:SXBOP?E5'Y,T2``)E0L,W&\7>`0I`Y$O_'?F_"P9@&O[ROXC=NO5G[F%
M1Y0OHG:=%YLFI(:&#](]X_@3YA9N`V&%TL:55(-UJ*Z0A"C^-NU"QWV<3O+]
M#-L&L!G`%L"W-`J?"D69W[GC96%P)&:ZVIZ'"68'YB^B"L'8=SSS0JV/7DIV
MSPIZ"41SSFG*8:N<NVQ)H9Y^J<&V:IS8?_ALOXW?;6K<1?QNK9&EVP3Y)D$>
M"?)_FMQ]:7(K)_]2A*YN58%IX^.QI,)!QZ>ZBB[O\X'%J7RFET7/6_C-32NT
M)6=T?K9Q`@VB`R\EO;E-2.=_T.)(:%PP]]XVTZ.:'(?]]8LL_[3\`%!+`P04
M````"`"\@CY'+E;-CK(!```8!```&0```'AL+W=O<FMS:&5E=',O<VAE970S
M."YX;6QU5-MRI"`0_17*#PC*W)(IQZI,4JGLPU:E\K#[S&BK5+@8P#'[]POH
M&#,A+P+-.:=/`VT^*/UF6@"+/@27YI"TUG9[C$W9@J#F1G4@W4ZMM*#6+76#
M3:>!5H$D."9INL6",ID4>8B]Z")7O>5,PHM&IA>"ZG]'X&HX)%ER";RRIK4^
M@(L<S[R*"9"&*8DTU(?D/ML?-QX1`'\8#&8Q1][[2:DWO_A5'9+46P`.I?4*
MU`UG>`#.O9!+_#YI?J;TQ.7\HOX4JG7N3]3`@^)_665;9S9-4`4U[;E]5<,S
M3"4$AZ7B)GQ1V1NKQ(62($$_QI'),`[C#ME-M#B!3`0R$V[38'Q,%&P^4DN+
M7*L!Z?%H.^IO,-L3=Q"E#X:ZPYXS:EST7)"[38[/7FC"'$<,66"VV0S!3G[.
M06(YCN0;/]O%^:NHQU7@KY8>R3HNL(X*K(/`^DN1VZLB8Y@?7&ZB2381@=NK
M)#',W542O+@Z`;H)+]2@4O4R],,B.C?!/0E7_PDO\HXV\)OJADF#3LJZ!Q2N
MN5;*@K.2WC@OK6O3><&AMGZZ<W,]OMQQ855WZ</Y9U#\!U!+`P04````"`"\
M@CY'5:%0L)@!``"B`P``&0```'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6QM
M4\%NHS`0_16+#ZC!0-I&!&G3U6KWL%+50_?LP!"LVA[6=D+W[VL;PB81%SPS
M?O/>\QA7(YH/VP,X\JFDMKND=V[84FJ;'A2W#SB`]CL=&L6=3\V1VL$`;V.3
MDI2EZ88J+G125['V:NH*3TX*#:^&V)-2W/S;@\1QEV3)I?`FCKT+!5I7=.EK
MA0)M!6IBH-LEW[+MO@B("'@7,-JKF`3O!\2/D/QJ=TD:+("$Q@4&[I<SO("4
M@<@+_YTY_TN&QNOXPOXCGM:[/W`++RC_B-;UWFR:D!8Z?I+N#<>?,!^A#(0-
M2AN_I#E9A^K2DA#%/Z=5Z+B.T\[F<6Y;;V!S`UL:6!J-3T+1YG?N>%T9'(F9
M1COP<(/9EOE!-*$8SQWWO%'KJ^<Z3].*G@/1C-E/&':#R18,]?R+"%L589$@
MOR%@ZP3Y*D$>"8H;@OS.Y80I(T9'3,;*S7/YM"Y4K`H5*T+%G=`:IKP3H5?S
M'_@1?G-S%-J2`SI_E7'@':(#SY<^>,^]?S!+(J%S(7STL9G^H2EQ.%Q>Q/(L
MZR]02P,$%`````@`O((^1[6RZ;<_!0``@!T``!D```!X;"]W;W)K<VAE971S
M+W-H965T-#`N>&ULE5G9<N(X%/T5%^\36YL7BE`5R"0AF51U]</,LP-BJ?;"
MV";T_/UX$8ND>XW)0S#BW$W2.9*LR3$O?I5;*2OG=YIDY>-H6U7[L>N6RZU,
MX_(AW\NL_F6=%VE<U5^+C5ON"QFO6J,T<:GG^6X:[[+1=-*V_2BFD_Q0);M,
M_BB<\I"F<?'?3";Y\7%$1J>&G[O-MFH:W.G$/=NM=JG,REV>.85</XZ>R/A3
M1`VD1?R]D\?RZMEIDO_*\U_-E\7J<>0U.<A$+JO&15Q_?,NY3)+&4QWY7^7T
M$K,QO'X^>7]IRZW3_XI+.<^3?W:K:EMGZXV<E5S'AZ3ZF1_?I*I!-`Z7>5*V
M_YWEH:SR]&0R<M+X=_>YR]K/8_=+0)49;$"5`3T;G./`!DP9L(L![S7@RH`/
M-1#*0`PU\)6!/]0@4`;!4(-0&81#>RE2!M%0@V;,NY'S+B9^O\EYL,G0.LAI
MN`D=;'(:<&*.N-O-Q78F/\=5/)T4^=$I.OKMXX;E9%Q;U<Z;UI8;[8_U9"[K
MUN\I\_R)^]UX4IA9AZ$:)M`Q;S;&]W3(PH80'?$..+E`W+J0<S44K&9&@4Q#
M/<@<PD0ZYAG`$*.</R&,4=`+A*$ZYA7",*-W;8SA97$3\6XCB#&('P#$Z+V_
MH&RYCOF$,`(>1P;/2M9Z8)H''_;`80^\]<`U#T:Y[QTF:#%9B_G#]]H_.)2`
M0PD@E-%M'\(*A<3PX1@^$,.8M`O?BN$SK9BNZ@XF<)B63P#G$]CY4"/0/+#R
M82P05CXW85H^(9Q/".1CJDMH%2X"KPX%!XK@0!$0R&1:9%=D3*N.)[=Q6D;-
M(@1*N`?DQ$QI]:SJ`S"I`4`]*VQA(4!6AE(L%.@Z&(T$,&D5,.@!ZEG!"\03
MH4!6PE!V!=)F"I03`L-20K2.,"`E1.P(HG:$#Q=,@L@8`72,&I(Y5Z#KFJ.>
MDA$U(X"<47.E(;90<8&'0H2*`$IE+@1S8FL0(135((*($(%4*$)\(/I"HN$C
M21%!H(`@,&/VSA0H&-:]%&$Y!5AN=N^,VN05?MV]2"B$NA2@+L.VAPC7Z!T;
M"XIPC0);"V8L`2\*=#UY0];^(<$04E*`E(R9P>S=!?'Z-)LBO*0`+QDWHW6@
MZ#K:`T4"(:RD`"L9LA!3A&TTO&,L$;918#EGOEDP!`K@0`RA)(,H:2C>"PA"
M](,AA&0`(;EG!K()&07X=&$((QG`2&X>@9B]2H8>)VA=V(D`6"6YR3H%TG6<
M>)0@,L$0BC.`XMQDG0(-X@%#Z,T`>G..^$!(R_SA/&`('QFTG[>F9V!OUGI$
MAB&\9<`JR849*[3W>[PG%L)O!E"78P=)A+K<N^,PBK"20YMALW^YO1DF/5M<
MCK"20ZQ$Y(HC;./W',"Q$SA$(J/F=VZ?P7N/X!PA$H>(A$@,1XC$[R`21XC$
M!Q#IE=M$XL2[[AP]%D(D#FTWK5CVJ;<W%D(D#IU[A1DKNNM`)!#""6`9Q#:+
M`B&<(,/'4B!$$M!9T=C;/@M[><.WM@*AFX".@*$9B=GR0.W7*0`L\'QD;R40
M[HH!W'T3M[G;G?('`/6LL!=MT`G5RLH^H0+=M+@)TS-")$-`[^6LC.P7<\2_
M?N^D,@)@#'T])1`!$H``"63[(Q!A$7?LK`4B&`(2#&L0[#=@)`I\SZS9O;K.
M2&6Q:2_V2F>9'[*JR?.J]7QY^-1>L1GM,S)^)4#[.QE_=%>#%_?3R3[>R,^X
MV.RRTOG*JRI/VYN2=9Y7LD[?>ZAGSU;&J_.71*ZKYC&HGXON@K#[4N7[TWWG
M^=)U^C]02P,$%`````@`O((^1RK4>N14`@``30<``!D```!X;"]W;W)K<VAE
M971S+W-H965T-#$N>&ULC95+DZ,@$,>_BN5]1_"=E+%J8AZSAZV:FL/NF20D
M6J/B`HFSWWX!C5&DIG(1:'__;IKFD;2$?K(<8VY]567-5G;.>;-T'';,<878
M"VEP+?Z<":T0%T-Z<5A#,3HI454Z+@"A4Z&BMM-$V=YIFI`K+XL:OU.+7:L*
MT7]K7))V94/[;O@H+CF7!B=-G$%W*BI<LX+4%L7GE?T*EV^^)!3PN\`M&_4M
M.?<#(9]R\/.TLH&<`B[QD4L/2#0WG.&RE(Y$X+^]ST=(*1SW[]YW*ELQ^P-B
M."/EG^+$<S%98%LG?$;7DG^0]@WW*032X9&43'VMXY5Q4MTEME6AKZXM:M6V
MW9\`]C*SP.T%[B`8XI@%7B_PGA7XO<!_"/QO!4$O")Z-$/:"\-D(42^('H+P
M6T'<"V(M@M.50Q5S@SA*$TI:BW8;L$%RG\-E++;+41K5[E#_1#F9L-Y2+W`3
MYR8=]<RZ8]P1$X(IDLT1."6V<\(+O"FS-P1ZN'%$'D,RKBF9M3N/`;5DLCFC
M$9LY$6K(UA`H\*?,SL0$6L)S!D93Y,V`Q.8U\8P%]I3>FTPC-#OPC0Y\Y<"?
M.-`FN>Z82#%UQ\3`U7/)YAB$`'@+K0`&+`(AU'?4'/L!01B&D5:MW1ST@1\M
MM(+MYUB\6/A>K!7$X$VLZ&B?=6OJC$Y@A>E%7<?,.I)KS>5RCJS#C?_JRA.L
MV3.XW$"#?0N7.Y-]+UZ.[J)_A$V3!EWP+T0O1<VL`^'B/E&G_DP(QR(K\"*N
MMER\;<.@Q&<NNY'HT^ZZ[P:<-/?':WA!T_]02P,$%`````@`O((^1YW;EQ8G
M`@``UP8``!D```!X;"]W;W)K<VAE971S+W-H965T-#(N>&ULC579;J,P%/T5
MQ`?49C%91)":M%7G8:2J#S//#G$"*L;4=D+G[\<VA!!R4S4/\7:6:U]SG;9"
M?JB",>U]\:I6*[_0NEDBI/*"<:H>1,-JL[(7DE-MAO*`5",9W3D2KU"(<8(X
M+6L_2]W<F\Q2<=156;,WZ:DCYU3^6[-*M"L_\,\3[^6AT'8"92D:>+N2LUJ5
MHO8DVZ_\QV#Y'&`+<8@_)6O5J._9X+="?-C!K]W*QS8&5K%<6PEJFA/;L*JR
M2L;YLQ>]>%KBN']6?W';->%OJ6(;4?TM=[HPT6+?V[$]/5;Z7;2OK-\#L8*Y
MJ)3[]_*CTH*?*;['Z5?7EK5KVVXEB7H:3`A[0C@0@N1;0M03H@LA_I80]X3X
MIP32$\B$@+J]NY-[HIIFJ12M)[MT-]3>JF!)3&YR.^E2X=;,V2DS>\HB,D_1
MR0KUF'6'"4>8)!@@R,@/'B'DL0YO^,'LVF)S"PFO$4^WB"B(KS'/`(;$<*01
M>!J1$XBN!!:P0`P*Q$X@'@LD>!)EAYDY3.TP,<'F!_L0T(<`/L'D3,F-3X#Q
M?:,$-$H`HTEJULF-T2)<W/69@3XSP">:^$"8.^F=@R9S0(#``@M08/'S^V'+
M$_2]82"&9'+7>]#5B4*90Z.OG#-Y</55>;DXUJZ<CV:'&OX8NBIQ@6=I0P_L
M-Y6'LE;>5FA3:UQ%V`NAF0D'/YB;5)A79AA4;*]M=V;ZLJN[W4"+YOR,#&]9
M]A]02P,$%`````@`O((^1X-8LE5M#0``,%```!D```!X;"]W;W)K<VAE971S
M+W-H965T-#,N>&ULC5S;<AM'#OT5E=X5]?VBDE45\:(A.5N5RL/N,VW3MBJ2
MZ"7I./OWBR%IF00.Y,Y#+%%G@.X&&CA`]_#V^WKSU_;+:K6[^.?YZ67[[O++
M;O?UYOIZ^^'+ZGFY_6W]=?5"?_FTWCPO=_3KYO/U]NMFM?RX?^CYZ=H9DZZ?
MEX\OEW>W^\_^V-S=KK_MGAY?5G]L+K;?GI^7F__=KY[6W]]=VLL?'_SY^/G+
M;OC@^N[V^O6YCX_/JY?MX_KE8K/Z].[R=WO3ISI`]HA_/ZZ^;T]^OA@&_WZ]
M_FOX9?;QW:49QK!Z6GW8#2*6],_?J]'JZ6F01)K_>Q3Z4^?PX.G//Z1/]].E
MX;]?;E>C]=-_'C_NOM!HS>7%Q]6GY;>GW9_K[]WJ.(<X"/RP?MKN_W_QX=MV
MMW[^\<CEQ?/RG\._CR_[?[\?_A+\\3'\@#L^X%X?>-6#'_#'!_S/!\*;#X3C
M`Z'U@7A\(+8^D(X/I-8'\O&!W#KI<GR@M&JHQP=JJX;!Y@?+F58=]M78/ZUM
MT]N/_#"W=4S+]<&Q]FXY7NZ6=[>;]?>+S6$O?5T.6];>T%,D?/AT[^C[/Y)G
M;NG3O^]\RK?7?P^2CIC[`\:=8)(YASQ(B#U'S"3"1W^.60!%/\5<TT1>9^/@
M;.Z=$.#.58PDPL=PCAE+3&)B)D",99@I4A79NOURP-VO!S-KF-.\83`+B;',
M%7H`*=A"'ON;WPOP)P*BP0("%A#V`L+IBC%7NS]`\A[R<AADM278RHPH<37%
M9-BR3"6L6.MR8:9LU#IO$[>0,&>-\85-M@=JH[795+RJ$:]J%*OJV3+<'R#Q
M5)&MIE:&&T4Y()=#<&P=QA)7LJN%P1X:U79MXF:-HUL`M=&XG/CR`YPK.4:'
MES_AY4]R^1-;_B04>9^<92%T)&'6EAKXX@-IAKR&.>%$PH+/D6^X*5":K/4L
M3CVT3:%K&]NL;:;SMK$M`,P9ZUF>ZR7,N>2R8NV,K9V%M0-;@_LL]>1BDN,I
M<P2`)11/OLHLCB3Z4C+?(1,(-,$9E@NF$EABS3GPP-@ZEZYUB+/62<\;A[C(
M,MCF6"D7,,T]$$B[W9ZDTC,'*-@!BG0`'FV+]$=2Q-QQ(E%7(;N4V+"G`$=1
MJD1FTH<FK?-&:0LP31X^I2B734C*?JIX.:O4PZ-G!4-.OGJ;&7*$D3$&S]QU
M#)$FF5*YF1`REF1#Y)P1(FVPAB>>A^89=<WCG#7/?=X\SD456XMD6A>$6_50
M)F5Z?^)89^XPE%BPIC&"9":OB-#*(@LR,HL:]T?0V7;))@:^$48(6&P-/)&.
M$3"X5`Q/S`CH*/LY!IQ"()F*AX@'`/2V4N9E9NH`T&6;'&<L,P`,T4<1)^9(
M8JTE\EV\`,!$0;_RBJA'JE.N.2CEI,7UY._6`3?@7.H(.E5&"=,&L7`29UVE
MW*$-2BFAK!>#DB6[%[HJY=Q8N6=*G*4151'L`+!0M<1Y\P0)#(6,*1P3`$U.
M%!>X8P)@<=YQ.W0`Z'Q).63NF!)(!3-M,\L=$TE,1%D-=TP)#-[D'!-W3*#:
M$"?1^AQ6J8*M+(-]-MP)@HRH-F9AM#$$T@X420<!R1!4&'%;`"!M4\-WZ@*J
M-I1U>"3KL>X<3^+.^=(II:X%M6[F+00KZ[IAZ2AR\J5#P%J3YRP8`<GER.WX
MT@$@^4?F6W(!51NBU=7SI8.ZJ3Q66B]6*5,MJ%.SXTLG:Z0R[%>1%"6NQN)E
MY)$X%%XG`!>)8EE>K"(<;0J^IQ\`SI)9,Z<!'0*RN'Z,.ZAZ#+44WJS#$EW@
M/9D%`'KG;/2!>P"02-O;6VWS**6KE;6KS[QXM;)*@IMGA("NALC+X3&4"';9
M!`$SQ1W>+IHB(/E*YBOW`,<(]RT`HGT[@Y-Q5&QRYCY'2,KAU8E0@$3B4`"G
M\T8H4$I86P3']CDH,I2ZS<K"#3@3*""P,Z'Z`3H3`&)G`D#L3`"(G0E66,B9
M`!`[$YH,=B:`Q,Z$1&)G@M/1G<DI!9LSPA$LSQ</1]!9K$M6,(H.X)++XD1D
M`7`NNV)XZ`2X&H@<*5-4"DH'"DI!=9TL6ZZ&0E'.$0"]<8XWP!8`&`MQ8EXP
M`=S02[7:\9M2+SE0+XE^A)-UT)6GW9*57.24.LC).LAGYC43!ZH'<GE.]1\`
MSMED"N]10GE)I'H`NZ(ZR/.(,$?RK"V%5QA0H"%^(RP)!.9LG+8EE0+#H0*#
M!T@G*;DOQO%3PP>`L\-A%J_@$"[3),7JPJ(A)>'7<X`,)N0J@H'$E5H#3PD]
MDN>)9BH-2Z?4(`[4()$O+B#M?OB/)Y4C,//]E,3&`Q*##3'QI`*`Y),BHP!8
MRL49W@($`R2.*JKH'JJMJ6:EN^Z4,L6A,D4Y#W4*T759\!OMH-HI%,G)_C=O
M^$V<;(#GFC,G-U.$*Y1GA;^WX7J`LS&EFA0*YQ0*YP"%X\3,2097J$+AYA\[
MR2:B296[4]>(FS7J[8$\<CN?M)Z,5UB,ERR&]T1'`,//1,9>$HY`)N3!%\!L
M*MFR\#!%..]XI.S:M,X:)C!OT]A#C=K!N5=XE9>\BA/^T1%S%G^*I[I;=',\
MZFU[0UR>7P""2*KY,S\RG@)D":$ZWG/JFI7/FB<T;U7>(V`F+F^TZST*`_22
M`?*SS8D'!)#JM,!/6Z<(Z/S06.73;`3V"K`&S>VT:TR2>_+3BI$'E,W%;%/D
M/C+&4.^<LXDO'H2Z5",/O%,(#85LRHNAKGT`L_9IS=L'T&-HLLEIS-4KS-4'
MD;FUTS^OT#,/Z!EO^XT\8"N)*C`K@@H`DKL['JDG".B'+@*_>0&!%"IX8[\#
M0)<I3/'[FS,`#+Y2X2`"B@1Z&U(P_*0#2:PQ&ZWCZ!4RY]'=*'Z`X4%/-QC#
M[WET`&>-+Z>G4^>#4MBAEVU0?@0W\K+3AH_6`+!2X.7'.1,D,)`Q*S]:0P(I
M-?#.1@=PCJQN^-'+#`!]K*'R\Z$YDDB)W_%*KT?`FGW5.D=>X=A><FQQ#C;V
MX,)*)&XCU@/@J/ST3G-9A11[U-<4+`_TSJ(\@^P0+IM8JS*HH+#3`-@IIV2C
M("D9[8W"/6P,<&B_30!N.._@%'R*Y+EJ>:G;`1S?OP>/1<!"A96X>X"`CL(9
M/RGO$3"G')Q2G`:%L`;4".2,-:#^7@V>IXPQ`@(OFB`<)6S/D]44`6V@:IV?
M\"(@\\NC*9#$H?O#O6`.9TU6XQ2D!T!*NR4H]X2"PE6#$TQ!/<,("A$,J`DI
MS`G(#38G`$)S`APV)^Q#(G,"(#8GDHC-B68-S8EZKV^84WLS0+8LQ2E"%V0#
M+\60Q($IP-D:U2$I1#(`(LDI51<`FQONO8H(!-IW-1*ATC*!PJ@":H_Q7F&0
M3.DJE923DJ"#PI0".C#F3?H`F$T*01Q[`)POB5^RF0'8U5EGX>B?`$:TAK?>
M>R@N&J.MA$)5`J(J(F%*"N(3.9YP8XE#;CP#N.%XH<K%`(JM*?QPL$<X8FU5
MJ9^#0I'"K_N&DP"8CZ]$H,4&0B>;Y[YZ7`TD,1C'CV_F`)A"%>V5'N`H%GI3
ME"P2%7(6`3DKBG]%A5A$*[*9UK&.2D*,LGDC.M81W&),61Q830'.%1%GYFVP
M'L"N8G3:O?NH9.L(LK5X?PG<Y7/6\/>XQ@#G4S*%UYR-N%FCWA[@*J55I5D=
ME609P?D>;V!%=&P'7B8".!>+$P4LPB7R'-[>0'I#+GP[=XUZ9XWSF#?J[9'>
MX>Q=VVT*.8B2'(C6=90YOX3$$^BX#38!,!N(9PD#M.&Z-K6S-MB\46O_:]SY
M\BLT*$H:)#K5$;`@6QSWB"G"$5GD07'>B.L1SJ>H>IA"OB)XTTQL<G3'C.*)
MX6TJ!,S[^]5\T0`P5EOYM8`I`KKAJH+PLT;5L];)S%M5]P@8BK=>\S:%_45Y
M7T[K2D>%,T7`F417.LI#3UNKX^W9<417M[+`33"N\JPT13@<M%'?*UHG3`FH
M50C$2+DE&Q7W>";9:;<+DL+5DN1JHO<+,.*8-\F&TE!Q<]P$X%`(`K#JJSAD
M1%JC<[S#,--P/**UJ>W1)(:WU!76DA2.FU#SC#<QDSP=':[R\&.9!-Z,JN:T
MDCFN/WCIB)9?O`,->E*2R'8(-IS>\2LX`.>C$_V,>9O:'L#>((U)J0\2NMXG
MWD"75+W6+/K?`$;[-HD.[00"31%)<XJ`,)U`8(S1<^("5<<H;E;-6U7W"/A6
M.DE*(9/D]VBHK<NDE``)7?$3U@1?DH&L*6&*->'5/61-(!%;$[T7!*T)7X="
MUD02H34!\$UK*I5`DI6`V.E]DK0WQZ"]/)BT;YI`S3_>UDCH%1FUV$X*^TPM
MK;^$7OH7]*(#,$0:`.P*L@8`A*0!#>^-4B\I["^U]/X2>OM>)/H.P'`&5W`B
M@TL<S."H,ZE6)$GAL*FA[Y<DA04)MP,PG$DE#F=2(`]E4@E#F?3ZY!NXGE>;
MS_LOEMM>?%A_>]D-JWCRZ>N7U_WNAF_P8I_?VYNI!9\_V)L.?3ZS-W/T^<+>
M](>OLOLYG+O;K\O/JW\M-Y\?7[87[]>[W?IY_V5@G];KW8IF:WXC>W]9+3^^
M_O*T^K0;?LST\^;PA7:'7W;KKS^^G^_U2P+O_@]02P,$%`````@`O((^1S%9
MZV$P`@``?@<``!D```!X;"]W;W)K<VAE971S+W-H965T-#0N>&UL?57;;J,P
M$/T5Q`>46P(D(D@-JZK[L%+5A]UGATP"JHU9VPG=OU_;$)*XT[S$]OB<,V>,
M,RX&+CYD`Z"\3T8[N?$;I?IU$,BZ`4;D$^^ATSL'+AA1>BF.@>P%D+TE,1K$
M89@&C+2=7Q8V]B;*@I\4;3MX$YX\,4;$ORU0/FS\R+\$WMMCHTP@*(M@YNU;
M!IUL>><).&S\YVA=1:&!6,3O%@9Y,_>,^1WG'V;Q<[_Q0^,!*-3*2!`]G*$"
M2HV2SOQW$KWF-,3;^47]Q9:K[>^(A(K3/^U>-=IMZ'M[.)`35>]\>(6IAJ41
MK#F5]M>K3U)Q=J'X'B.?X]AV=AS&G3R<:#@AG@CQ3(BRAX1D(B17PL)6.CJS
M=?T@BI2%X(,GQH_1$_/-HW6B3ZXV07M0=D]7)G7T7"9Y5`1G(S1AMB,FOL&D
M5TB@Y><<,99C&W_A1]E]B@J!Y'B*!"TCL?SDKHP8%UB@`@LKL+@32)QSP#`+
MIY#'F#LC2]3($A%8.D8P3.H8P3`9;B1%C:2(0.X8P3`KQPB"686XD0PUDB$"
M[A7%,+%C!,$DWYQ(CAK)D23N'4$P7^[(8\R=D15J9(48<9)L,8QSCRH,D^)&
M3"_$VD>(2&1N_\!`SE6J4-#*,1/<M#4&XFC;O?1J?NJ4:1\WT?E)>8Y-6W3B
M6_/4V'9YE2F+GASA%Q''MI/>CBO==&UK/'"N0'L,G_2?JM&/X;R@<%!FFNFY
M&)^'<:%X?WGMYB>W_`]02P,$%`````@`O((^1T8U6L`A`@``_P8``!D```!X
M;"]W;W)K<VAE971S+W-H965T-#4N>&ULC57!CILP$/T5Q`<L&$A((H*4I*K:
M0Z75'MJS0R8!K8VI[83MW]<VA`UTDN8"]O#>FS?&'F>MD.^J!-#>!V>U6ONE
MULTJ"%11`J?J1310FR]'(3G59BI/@6HDT(,C<19$83@/.*UJ/\]<[%7FF3AK
M5M7P*CUUYIS*/UM@HEW[Q+\&WJI3J6T@R+-@X!TJ#K6J1.U).*[]#5GM2&0A
M#O&S@E;=C#UK?B_$NYU\/ZS]T'H`!H6V$M2\+K`#QJR2R?R[%_W,:8FWXZOZ
M5U>NL;^G"G:"_:H.NC1N0]\[P)&>F7X3[3?H:YA9P4(PY9Y><59:\"O%]SC]
MZ-Y5[=YM]R4E/0TG1#TA&@B+\"$A[@GQ0"")J[1SYNKZ0C7-,RE:3W8_HZ'V
MGY-5;%:NL$&W4.Z;J4R9Z"5/PC`++E:HQVP[3'2#F9,!$ACY(4>$Y=A&__!)
M.DZQ0R`+/$6,EA$[?CPJXX['!!5(G$`R$H@FZ]!A4H>I'6:R4KM'B)&)&6IB
MAIB()R9F_S7Q"#$R,4=-S!$3R<0$AIGA25(T28H(S'&!!2JP>/Z'+U&!)>)@
MLBNW&.;.MK2]`CM>(2*QO"-QYX22YTLEZ`'<D.B)8C$0F>Z<X*:O<)`GUV^5
M5XASK>WYO8D./7WC6OHDOK6]WO6K3YD\:^@)?E!YJFKE[84V7<_UIJ,0&HS'
M\,7L[=+<1L.$P5';86K&LNO/W42+YGK=#'=>_A=02P,$%`````@`O((^1]P#
M&X+U`0``R@4``!D```!X;"]W;W)K<VAE971S+W-H965T-#8N>&ULC531DIL@
M%/T5QP]8!%&[&>-,-YF=[4-G=O:A?2:*T5D4"R1N_[Z`QAID.\U#@,LYYYY[
M$?*1BW?94*J"CX[U<A\V2@T[`&39T([(!S[07N_47'1$Z:4X`SD(2BI+ZAA`
M492"CK1]6.0V]BJ*G%\4:WOZ*@)YZ3HB?C]1QL=]",-;X*T]-\H$0)&#A5>U
M'>UER_M`T'H??H6[8VH0%O"CI:-<S0/C_<3YNUE\J_9A9"Q01DME%(@>KO1`
M&3-".O&O6?-O2D-<SV_JS[9:[?Y$)#UP]K.M5*/-1F%0T9I<F'KCXPN=2TB,
M8,F9M/]!>9&*=S=*&'3D8QK;WH[CM!-G,\U/0#,!+02(_TF(9T+\OP0\$[!#
M`%,IMA%'HDB1"SX&8CJ\@9AO!.ZP;G5I@K:S=D^W0NKHM<`0YN!JA&;,TX1!
M*PRZ1QRV")C=0XX>R)<%`K3'Q2CR&D66']_Q([]`[!6(K0"^J]2M8\)D%M/?
MDCS&3BE;5)HAY/>"O5ZPQXN3Y3!ADE66R/&Q1201?O3[2+P^$H\/[/A(-EE@
MI'^.ERWJD\-)O492CY'$^0S33=NS-,Y2Q^X6A3Q'N$5!F&70L0Q6MV@@9_J=
MB'/;R^#$E;Z0]MK4G"NJ%:,'77NC']9EP6BMS#33<S&]-=-"\>'V<B[/=_$'
M4$L#!!0````(`+R"/D>7>+/=-`(``&T'```9````>&PO=V]R:W-H965T<R]S
M:&5E=#0W+GAM;(U5RXZ;,!3]%<2^XP?F%1&D)E'5+BJ-9M&NG<0):`!3VPG3
MOZ]M"`W@M-E@^_J<XW,OUG76<?$N"\:4]U%7C5S[A5+M"@!Y*%A-Y0MO6:-W
M3ES45.FE.`/9"D:/EE17`$,8@9J6C9]G-O8J\HQ?5%4V[%5X\E+75/S>L(IW
M:Q_YM\!;>2Z4"8`\`R/O6-:LD25O/,%.:_\S6NV0A5C$CY)U\F[N&?-[SM_-
MXMMQ[4/C@57LH(P$U<.5;5E5&25]\J]!].^9AG@_OZE_L>EJ^WLJV997/\NC
M*K1;Z'M'=J*72KWQ[BL;<@B-X(%7TGZ]PT4J7M\HOE?3CWXL&SMV_0X)!IJ;
M@`<"'@F(_),0#(3@60(9"&1&`'TJMA`[JFB>"=YYHO][+367!*V(+O7!!&UE
M[9XNA=31:TY0E(&K$1HPFQZ#[S!XBM@N$2B>0G8.2#)"@/8X&L5.H]CR@XG1
MV"T0.`4"*T`F`LDLCQX36TQC,0&,X#P5!RH@Y$$VQ&F&.,RD,S,])KP[YA.*
MXY3,W+A@29`BMYW0:2=<V,&S8S;A(FD$HWB&VH8+,P@G*)A9=J!"&#[XFY'3
M<;0L((9N@=@I$#]_GQ*G0/+$?4J6B:;A_$?OEBB,@^A!-JG33.HHQX,;8-J@
MJQ'`YPN"'O02]$1)!M#D(B&8)/-V\3]8;PC<];F6GMEW*LYE([T]5[IEVL9V
MXEPQ+0E?=(4+_?:-BXJ=E)G&>B[ZUZ!?*-[>'K?QA<W_`%!+`P04````"`"\
M@CY',AC$F<@!``!%!```&0```'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q]
M5,N.FS`4_16+#QB#(4D;$:1)1E6[J#2:1;MVX`+6^,'8)DS_OK8AA*2H&VQ?
MGW/NRY=\4/K=M``6?0HNS2%JK>WV&)NR!4'-D^I`NIM::4&M.^H&FTX#K0))
M<$SB>(L%93(J\F![U46N>LN9A%>-3"\$U7^.P-5PB)+H:GAC36N]`1<YGGD5
M$R`-4Q)IJ`_1<[(_91X1`+\8#&:Q1S[VLU+O_O"C.D2Q#P$XE-8K4+=<X`2<
M>R'G^&/2O+GTQ.7^JOXM9.NB/U,#)\5_L\JV+M@X0A74M.?V30W?84IAXP5+
MQ4WXHK(W5HDK)4*"?HXKDV$=QIM-,M'6"60BD)F0;/]+2"=">B.$TN$QLI#7
M"[6TR+4:D!Y[T5'?\F2?NLJ5WA@*%>Y<9L99+T5&2(XO7FC"'$<,66"VR0S!
M3G[V0=9\',D__&1W[^*T`OFR[B)=32,-_/0NC71=(%L5R()`=B>0/=1AQ.P"
M1@;,YFN:/F2R`MJ2QUSPHCT"=!.>K4&EZJ7U95A8Y\EX)KZ]#_:CFYCQ@=]D
MBKRC#?RDNF'2H+.R[O&$%M=*67`QQD^;"+5NIN<#A]KZ[<[M]?C,QX-5W75H
MYS]'\1=02P,$%`````@`O((^1\@'U,)V`@``)`D``!D```!X;"]W;W)K<VAE
M971S+W-H965T-#DN>&ULE9;-CILP%(5?!;'O8(/YBPA2)U'5+BJ-9M&NG<0)
M:`!3[`S3MZ]M2`KXIDDW@,TYUY\O]C59S[LW43`FG8^Z:L3:+:1L5YXG]@6K
MJ7CB+6O4FR/O:BI5LSMYHNT8/1A377D^0I%7T[)Q\\STO71YQL^R*AOVTCGB
M7->T^_W,*MZO7>Q>.E[+4R%UAY=GWM5W*&O6B)(W3L>.:_<S7FUQJ"5&\:-D
MO9@\.QI^Q_F;;GP[K%VD&5C%]E*'H.KVSC:LJG0D-?*O,>C?,;5Q^GR)_L5,
M5^'OJ&`;7OTL#[)0M,AU#NQ(SY5\Y?U7-L[!$.YY)<S5V9^%Y/7%XCHU_1CN
M96/N_?"&D-$&&_S1X%\-^-^&8#0$CQK(:"`+@S=,Q21B2R7-LX[W3C=\O9;J
M18)71*5ZKSM-9LT[E0JA>M]SXH>9]ZX#C9KG0>-/-/Y<L;$5.)Y+MH`DN4H\
MQ7@%]4%0W_B#&6@$!PC``($)0&8!%I";01,;33-`XC3&2]W6UJ6(Q!C!/`3D
M(0!/LN`9-.%DG$]1$!"$%SR`CA`4$0P#A2!0"`"E"Z#0'BA,41(L>.[*9C@1
MB!/9.`%:K,S(^@[$)RA>+.!-9.&$B$1D26W+"")I<F.5Q2!U#%#?^`H)&"!Y
M?)VG8(#T@76>6C/%(<'!,B%W93,<75^A"H.`E/@W0MPH4OCQI&"X?&#_@;2,
MHNF$(^2'=BV[JYLCP04)`Q7I9F[A&H+)?R0&WO48VO968D)[HZF]$5N)L768
M)"A:%D9O<CRU],2^T^Y4-L+9<:E..G,>'3F73,5$3RIFH7Y9KHV*':5^C-5S
M-QSB0T/R]O)/<OTQRO\`4$L#!!0````(`+R"/D<_1'BUV0$``*X$```9````
M>&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;'U4VX[;(!#]%>0/6'Q-LI%C:9.J
M:A\JK?:A?2;V^*+EX@*.MW]?P([7<5%?#`SG,C,&\E'(=]4":/3!*%>GH-6Z
M/V*LRA8844^B!VYV:B$9T68I&ZQZ":1R)$9Q'(8[S$C'@R)WL5=9Y&+0M./P
M*I$:&"/RSQFH&$]!%-P#;UW3:AO`18X77M4QX*H3'$FH3\%+=+QD%N$`/SL8
MU6J.;.Y7(=[MXGMU"D*;`E`HM54@9KC!!2BU0L;X]ZSY:6F)Z_E=_:NKUF1_
M)0HN@O[J*MV:9,,`55"3@>HW,7Z#N02782FH<E]4#DH+=J<$B)&/:>RX&\=I
M)TMGFI\0SX1X(239?PG)3$@60N0<\)29J^L+T:3(I1B1G/Y%3^POCXZ)Z5QI
M@ZY1;L]4IDST5J1)FN.;%9HQYPD3KS"[:(%@([]XQ#Z/<_P//]H_6EP\D(/?
M(O&6D3A^\E!&YA=(O0*I$T@?!':;/O@P>[])YC7)/`*'C<F$V3L,GSKQ'.]W
MX:9A'E@2QH?G33IX=0X8R,;=#X5*,7!M^[V*+E?P);;G:!,_FZLYW:1/F2+O
M20,_B&PZKM!5:'-*W5FJA=!@L@R?3)JM>3R6!85:V^G>S.5TGZ:%%OW]=5B>
MJ.(O4$L#!!0````(`+R"/D<?;*67'`(``&L&```9````>&PO=V]R:W-H965T
M<R]S:&5E=#4Q+GAM;(U5RXZ;,!3]%<2^8V.;5T20.HFJ=E%I-(MV[21.0`.8
MVDZ8_GUM0R@Q[B.+^'7.N>=>/R@&+MYDQ9@*WMNFD]NP4JK?`""/%6NI?.(]
MZ_3*F8N6*CT4%R![P>C)DMH&(`@3T-*Z"\O"SKV(LN!7U=0=>Q&!O+8M%3^?
M6<.';1B%]XG7^E(I,P'*`LR\4]VR3M:\"P0[;\./T6:?&H0%?*O9(!?]P'@_
M</YF!E].VQ`:"ZQA1V44J&YN;,>:Q@CIP#\FS=\A#7'9OZM_LMEJ]P<JV8XW
MW^N3JK19&`8G=J;71KWRX3.;4HB-X)$WTOX'QZM4O+U3PJ"E[V-;=[8=QA6"
M)IJ?@"8"F@D1^2L!3P3\OP0R$8A#`&,JMA![JFA9"#X$8MR\GIHS$FV(+O71
M3-K*VC5="JEG;R7!>0%N1FC"/(\8M,"@1\1NC8C21\C>`\EF"-`>9Z/(:Q19
M/E[R<^07P%X!;`7(,E,"G3Q&3&HQG<7D&.J?D\L_80]VB-<.\=B)'#LC)E[$
MB5*88[>T:UB6YCGVNXF];F*/&W>3XU68'"+HH/9K5(+B//:;2;QFDK49E#EF
MDE68#RB!*(L=.QY<E),$_^'LI5Y#J:<ZV+DDZ?I,P(CD[I9Z8!AF,7%LKV%9
MIJOHGC"PN.8]O;"O5%SJ3@8'KO2+8>_UF7/%M"1\TD6H],L_#QIV5J:;ZKX8
M'\-QH'A_?]KG[TOY"U!+`P04````"`"\@CY'JDX_"'("``"F"```&0```'AL
M+W=O<FMS:&5E=',O<VAE970U,BYX;6R-5M%RHR`4_17'#ZB"H$G&.-.DV=E]
MV)E.'W:?J2&)4Y4LD*3[]PMHC)7;;/M0`<^YY]P+N9A?A'Q3!\YU\-[4K5J&
M!ZV/BRA2Y8$W3#V((V_-FYV0#=-F*O>1.DK.MH[4U!&.XS1J6-6&1>[6GF61
MBY.NJY8_RT"=FH;)ORM>B\LR1.%UX:7:'[1=B(H\&GC;JN&MJD0;2+Y;AH]H
ML4&)A3C$KXI?U&@<6/.O0KS9R8_M,HRM!U[S4ML0S#S.?,WKVD8RRG_ZH#=-
M2QR/K]&_N72-_5>F^%K4OZNM/ABW<1AL^8Z=:OTB+M]YGP.U`4M1*_<_*$]*
MB^9*"8.&O7?/JG7/2_>&HIX&$W!/P`,!I7<)24](!@+&=PFD)Y";`KE+H#V!
M3@A1E[NKW!/3K,BEN`2RV^XCLZ<*+:C9F](NNJUP[TSME%D]%X20/#K;0#UF
MU6'P")/$V4?,VL>D:(!$QL+@`T,^5MCC$T(G&CX&36P\^1#\$;$!@LQ@HPE8
ML,3QD[%1G,(!"!B`N`!D7,UDDF@'R1RD=1":Q>9ODNS78)O_PCZ8IJ!IZIDF
M))VXAC`9+)*"(BD08#81@3!S6"0#13(_`)U4;)UY%4MI2B9G;>.C:#;+"&QF
M!IJ9`68^^=G,P0#SKY]&VR^A!A!['A#"TP[0@>@HUR3^_`RA3WH-`M+UI)`G
MA>])@>WD$6%`*IE*86\'D_2.%-P04`)(>2T4`M&)3C1JV@V7>W==JJ`4I];=
MSJ/5X4I^=-=*=(,7^9'M^4\F]U6K@E>AS=7A&OQ.",V-E_C!U/9@/AJ&2<UW
MV@XS,Y;=-=I-M#A>OPJ&3Y/B'U!+`P04````"`"\@CY'O+9NVPH"```>!@``
M&0```'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6R-E=N.FS`0AE\%\0!K;'-(
M(H+4S6Z:7E1:[45[[21.0&LP:SMA^_:UC4.)055NX@/_]WN8&9R\X^)#EI2J
MX*MFC5R'I5+M"@!Y*&E-Y!-O::.?G+BHB=)+<0:R%90<+50S@*(H!36IFK#(
M[=Z;*')^4:QJZ)L(Y*6NB?CS3!GOUB$,;QOOU;E49@,4.1BX8U731E:\"00]
MK<-O<+7#1F$%ORK:R=$\,+'O.?\PBQ_'=1B9$"BC!V4<B!ZN=$,9,T;ZX$_G
M^>](`X[G-_>M?5L=_9Y(NN'L=W54I0XV"H,C/9$+4^^\VU'W"HDQ/'`F[6]P
MN$C%ZQL2!C7YZL>JL6/7/\&9P^8!Y``T`##^+X`=@!\%8@?$CP*)`Y)'@=0!
MZ:-`YH#L46#A@(4'@+X<MI@O1)$B%[P+1-^`+3%]#E<+W2X'LVF[PS[3Y91Z
M]UK$29J#JS%RFN=>@T8:=*_83!4PNY>\3"4XB>\UKU--ZIVTG;&!GN;[3#2+
M>\EN+IIDT`"=LB%O:#9OR!K@\1G+=-X`SQI@:Q"/(_#SWDLR*VEZ"4X1Q%[R
MIS*((H@CKP`S,KA8QDNO!C.'1A!F7@*W4UF,LP1!KQ13&4(IRKR*[69B2R'$
MR$LH&'5U2\[T)Q'GJI'!GBO]@=@V/G&NJ+:,GO2W6NK+>E@P>E)FFNFYZ.^O
M?J%X>[N-A[^$XB]02P,$%`````@`O((^1T<V2]PP`@``)`<``!D```!X;"]W
M;W)K<VAE971S+W-H965T-30N>&ULC57+DN(@%/V55#Z@0QXD:L54M;93,XNI
MZNK%S!HCFE1#R`":GK\?(#'F@8XN!"[GG/N`7-*&\4]18"R=+THJL78+*>N5
MYXF\P!2)%U;C2NT<&:=(JB4_>:+F&!T,B1(O`"#V*"HK-TN-[9UG*3M+4E;X
MG3OB3"GB?S>8L&;M^N[5\%&>"JD-7I9Z/>]04ER)DE4.Q\>U^^JO=C[0$(/X
M5>)&#.:.#G[/V*=>_#BL7:!CP`3G4DL@-5SP%A.BE93G/YWHS:<F#N=7]6\F
M717^'@F\9>1W>9"%BA:XS@$?T9G(#]9\QUT.4`OFC`CS[^1G(1F]4ER'HJ]V
M+"LS-NU.E'0T.R'H"$%/\..'A+`CA#="])`0=83H60+L"'!"\-K<3>7>D$19
MREGC\/:X:Z1OE;^"ZFQR;31'8?94[82R7K(()JEWT4(=9M-B@@$F!#>,I_1[
M)X'-R2:8"401'#O9SC'!&/$V1_B32'<6R,(>:&BM1FCXX:@:=P0BJT!D!**1
MP'*2:8M)#*8R&)@`]9ND^QQL]U_8*&IHC1K.HX[O",16@?CYNB56@<02@3^Y
MABT&#C(-P?U,%U8_"\OY3.[99C'S$SSPL[3Z65K\1!,_-@RT.]&]SO;Q`HM$
M./UZP>R&A+$E'V_0,BCF)].LA9.S<V7>AH&U?Q!>`]-R;O`LK=$)_T3\5%;"
MV3.I&I=I+T?&)%;A@!=5V$(]6?V"X*/4TT3->=O$VX5D]?5-ZA_&[!]02P,$
M%`````@`O((^1R=EKV5?!@``QR0``!D```!X;"]W;W)K<VAE971S+W-H965T
M-34N>&ULE5K;4N,X$/V55-Z76%)+LJF0JH$0,O?4/.P^>\!`:I*8M<TP^_?K
MBQ+BO@3#`W&<T^JCR^ENR9Z^Y,6O\C'+JM&?[6977HP?J^KI?#(I;Q^S;5J>
MY4_9KO[E/B^V:55_+1XFY5.1I7>MT78ST5'D)MMTO1O/INV]53&;YL_59KW+
M5L6H?-YNT^*_RVR3OUR,U7A_X\?ZX;%J;DQFT\G![FZ]S7;E.M^-BNS^8OQ!
MG:]<W$!:Q-_K[*4\NAXUY'_F^:_FR\>[BW'4<,@VV6W5-)'6'[^SJVRS:5JJ
M/?\;&GWUV1@>7^];7[3=K>G_3,OL*M_\L[ZK'FNVT7ATE]VGSYOJ1_ZRS$(?
M;-/@;;XIV_^CV^>RRK=[D_%HF_[I/M>[]O.E^P5<,.,-=##0!X.#'][`!`/S
M:@`G#2`8P%`#&PSL4`,7#-S0/OA@X%\-3H]2'`SBH9228)`,-6CFO)NY:+#)
M8;+58)/]="L]V&0_X6KPC*O]E*O!<Z[VDZX&S[K:3[MRR&32B:25V#RMTMFT
MR%]&11<7GM(F_*CSVJINO+G;BK;]L5996=_]/0.GIY/?34L!<]EA]!'&1+Z/
M65",ZB-N*,*]0B8URP-5S5*]U`R-I._DBL$H1&3.85"7KSF,05VF&-3*#44H
M-&Y+!A+W(1\Y+M#'?.(P41_SF</8/N8+Q8!#_?[*M&-1.]^X=A#G[QP&M;/B
M,(Y?-89?X*9MP?1:\'P+P+<`;0MPU()%$[WH(+:%[#I(%/[0DAB,7`Y!]NA;
MGKZE])$B%ATD/G(5G441%O`@U/(M5(^RXRD[2ADMPBM'1L=8P.I:4)36"22Q
M0G'CA@/&SAL,7%*@@EAY2(15Z?D>>MI#)(^%'\J=`[+<*?`T]YCG'A/NX%#,
M6G08WR=OL1@X5.QPB*2HEC;/.>$Y)Y0S"C7SA+CY"[QV#HWB(J&C&'O2-<8A
M5@IM2/N(9-^O#"\=^]@*`]#44&RBCYAIPTLI@(Z=@7)D1AB8BBQH(3`IJ?90
MA!)9M(L`.AXF9YC`^C:NSXDO,CXH33EIY.LR@([[;TR]!@BG-W%]3D(*4X;A
M1,HK0_.%CVIO@B\AV2F:[8S&=4T`]?K%Y;#/`X!]5D(.4S2)&6TP*TM&P/.L
MW@;V60EI2M$\930.XXI)+8GE%K"CT1`!^ZR$U*)H;@%/G-%<8&*Z@I<,3JL&
M)Y$2<H:B2<-H%(&O`HB4/)B[`),H"2E!,2':2SL2(:CJ:'AUJ84HJ&D4Q`7:
M*F".JRIUEH"@;2W$-DUC&ZZK5@'3FW!Y;+40L307L5"-<*-IQ%)TNE<,[!0C
M(:YI&M?J[(X9=:"D-\PQV9-P*&DJA("FN8`FE&%:"#_:O6/Q"<%",X4H6GS?
M`Z;?7VD7IH4`H&D`P&OONZ;"!I!G6M"UIKHF:^^CIL47R%'-"/(W3$WEC="&
M('^CAL^B$81MWA;V%\,(FXFNW][&]2E)VVX:`<@NX5L`^5XD/S$-@K8-HVU\
M(&%H)5+O?.(H%EP)NC6,;HV0-(R@6_,.W1I!MX9+\JCTF!N:O&/3_@G.!.T:
M)GD;AYUQ(*E7@G0-(UU#>I4PX4CSCD`0+@S8#,V!V^6<JA-!D#@P^QPC)`P0
M)`YZ^*(!09/`9&4RCRQ(<B2=F#&;"!-C1QPH$1P)<@1&CA!A1Y;,8^)/S*(@
M6V"J?;RGGP.M]N,(E-@O0=Y`Y6U`8U^>KD^E(JV$>`2"O($YT)&VC2`H%Y+A
MR],*HK14E"1QSP.(5(/2F:@@2<M(DIP(!5!O1P8G?`G2M<R1`@CEDQ6D:]]Q
MC&T%55IN:T_&EQX[JQ/IWTJ'SE28X*4^"X*S[\B35A"2Y82$-R*6"LF=/&@7
MA&29%`B"\JT@)/L.(3E!2&Z`D*X=%1*HZ'AP^KX$(3E&2'AC?^WHV=RI';L3
MA.2HD,!+8R,(R;U#2$X0DF.>".'#*,?H2(LG?TZ0D>.VB7CY.NXX"S])^\2@
M3A&2GLS0)$C*^AO'G&09)>T8G2!=-^0<RS'/-!+KA.SE!.$Z3KCXD8:CSR'X
M*#$Y>OB^S8J']OV8<G2;/^^J9N4=W3V\@_-!-P_OT?U+=7ZMF/LWZGS9O6'S
MVOQL^I0^9%_3XF&]*T<_\ZK*M^US_?L\K[*:?W16#])CEMX=OFRR^ZJY]/5U
MT;UGTWVI\J>+\-K0X=VEV?]02P,$%`````@`O((^1_7N9;1K!```9Q@``!D`
M``!X;"]W;W)K<VAE971S+W-H965T-38N>&ULE9E;<]HZ$,>_"L,'B"VMY$N&
M,'-"RDE*.M/I0\^S$T3PU!>.[83VV]<W*))VC<I#L,U_+]+*OY6=Q;&L?M1[
MI9K9SSPKZKOYOFD.MYY7O^Y5GM0WY4$5[2^[LLJ3ICVMWKSZ4*EDVQOEF<=]
M/_#R)"WFRT5_[6NU7)3O3986ZFLUJ]_S/*E^W:NL/-[-V?QTX5OZMF^Z"]YR
MX9WMMFFNBCHMBUFE=G?S?]CML^@EO>)[JH[UQ?&L2_ZE+']T)T_;N[G?Y:`R
M]=IT+I+VZT.M5)9UGMK(_X]._\3L#"^/3][7_7#;]%^26JW*[+]TV^S;;/WY
M;*MVR7O6?"N/CVH<@^P<OI99W?^=O;[739F?3.:S//DY?*=%_WT<?I'1:(8;
M\-&`GPV8F#2`T0!<#<1H(%P-Y&@@70V"T2!P-0A'@]#5(!H-(E>#>#2(70VZ
MF@^5\YU-SL5FSB:G<C.SWMZPL/IE^9`TR7)1E<=9-=Q+AZ2[9=EM:]4Z[Z[V
M"[W_L5V9=7OU8RG":.%]=)Y&S?V@X9HFUC4K1!/YNN8!TS!=\PG3<%VSQC2@
M:_[%-$+7/&(:J6N>;`U(0_,9\Q/HFHVM8:$N>48D?RKAM64\UY+CM>2]`[C,
M(PAQ#X![@-Z#T$9BI+D9-&&O*7I-%,;2!XY'$G@D@40B1BMQ#])]M`'N(4!R
M,-;U9M#(R]%"_\$CA7BDT&%>0WM>R3`1'B:RP\0^[B'&/<3ND]H!#B6*?WU:
M[T?1Y;QR"&0<F<BP=4P&X`<F-A!=&(1!9&(!TT',N8D&6P>2F`>*K.QZT1]'
M4:C%\;N/R2%*:++HJDY/GD`)X\A28F;RW)HDR20=BX`.0Z@36P6QL</C:"(8
MP1V&@"<&,YA`JN]/S"*!*":18%87LD40"+-]3(OT;`C<,81WL30#V<`+_*FA
M$\1C-O)`6/-L,X^;^4Q)]$P(*#*,BE9[CFPN3(V:P">+D5@FZ$?1Y9`8'H83
MB.4(8BUTCB)7$G`"8QS!6&S@_(D[TLE1]XSHPHER<&I#9%-,DCX(.G%P;XF<
M@`['=COF#IK;T&'&W;F>UNBY$$SB")/,MK0>1=H2Q=K2QD&H9T6PB6-L8F8P
MFTV3*YI`$T=V8V:_V7";.XQ-!2/HPS'Z@%EZBCZ^69?K0CTK@E,<XY0PL[)%
M5F-:NX@V5T3ZDPG!/,"89]P?*T"V=^A$(D*8FD@@Z`@V':TVMP*$>F8^5R4;
M1$)T0B!P"-BFSNR$8&_JICHA4$^2V*;.>I0<1/%EK!N"9T"P%6RV2I_HIT`P
M$?[B61((@H'#T^0#(+NK((Z,UOT)D84RE,3S,1"<`X>GSA78G`N$D,+LR(@.
MII8%@4/`<&AR?A2Y[ER`@!S8U)&^R7E`-F-,1C$53!!X$@YXVHB_I(X@J",P
MZA@C6PF;%Y&4(C!;.*(#P9B5DW?Q3O&0O*DO2?66%O7LI6R:,N_?(>[*LE&M
M3_^F'>)>)=OS2:9V37<8ML?5\!Y\.&G*P^FU_OE_"\O?4$L#!!0````(`+R"
M/D=)',;/H0(``&8)```9````>&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;'V6
M38^;,!"&_PKBO@%C/E<$*4E5M8=*JSVT9V_B)&@!I[:3;/]];4-8L(?-(8!Y
M9^;Q#!Z[O#/^+LZ42N^C;3JQ]L]27IZ#0.S/M"5BQ2ZT4V^.C+=$JD=^"L2%
M4W(P1FT31&&8!BVI.[\JS=@+KTIVE4W=T1?NB6O;$OYO2QMV7_O(?PR\UJ>S
MU`-!50:CW:%N:2=JUGF<'M?^!CWO4*PE1O&[IG<QN?<T_!MC[_KAYV'MAYJ!
M-G0OM0NB+C>ZHTVC/:G(?P>GGS&UX?3^X?V[F:["?R."[ECSIS[(LZ(-?>]`
MC^3:R%=V_T&'.23:X9XUPOQ[^ZN0K'V8^%Y+/OIKW9GKO7^3A(,9;!`-!M%H
M@-(O#?!@@#\-3.J"GLS,ZQN1I"HYNWN\+\:%Z)JC9ZPRM]>#)E'FG9J94*.W
M*@EQ&=RTHT&S[3711).B41(H]V.,"(JQC1Q[E,U#[`!)#H?`X#2PL<>S:<2P
M@QAT$!L'\<Q!8N6AUR1&T_60*`_5SYH,H(OS&$UT,Z`$!$H`H-0"2IQ`.,\2
MA\>514C+%GA2D"<%>*PJ;E,GT$*(#`R1`2%R*T3FA'B*4J`&D"[.BL4BY"!1
M#A`5%E'N5AN'0!4`G?7US(`*$*APOW.TX$!W+VC!A^Z<$+)7?"\JII5<%?:B
MA54+ZQ8M]!\$X$0VSM"EPFGR5AFV>9";X@48L%%M4`3`.-TP^N(K'T"^DLQ!
MX':&,``2VR#8S<I3N,*%38/=M;"4%[@Y(J`[(KL[#J)B5B.,;!A7-?NR>IQ@
MLGVUE)_,MBZ\/;MV4F\3D]'QZ+")]/9GC6_UD<)LBY]NJO)"3O07X:>Z$]X;
MDVIS-5O@D3%)%62X4KDZJT//^-#0H]2WF;KG_3&@?Y#L\CC5C$>KZC]02P,$
M%`````@`O((^1QNI1_5H`@``%`@``!D```!X;"]W;W)K<VAE971S+W-H965T
M-3@N>&ULC59;CZ,@%/XKQA\P`MX;:])+-KL/FTSF8?>96EK-J#A`Z^R_7T#K
M>,%)7PH<O\LY>(0F+67O/"=$6)]56?.MG0O1;!R'9SFI,'^A#:GEDPME%19R
MR:X.;QC!9TVJ2@<!$#@5+FH[373LE:4)O8FRJ,DKL_BMJC#[MR<E;;<VM!^!
MM^*:"Q5PTL09>.>B(C4O:&TQ<MG:.[@Y0J0@&O&G("T?S2V5_(G2=[7X==[:
M0.5`2I())8'E<"<'4I9*23I_]*)?GHHXGC_4?^AR9?HGS,F!EG^+L\AEML"V
MSN2";Z5XH^U/TM?@*\&,EES_6MF-"UH]*+95X<]N+&H]MMV3,.YI9@+J"6@@
MP.!;@ML3W"^"]RW!ZPG>C.!TI>B-.&*!TX31UF+=VVNP:A*X\>169RJH=U8_
MDUO!9?2>^C!(G+L2ZC'[#H-&F``.$$?*#Q[(Y+%'"SX,IQ8'`R2:0HY+B#^2
MF:3A&DMUM8`[$8C,`IY1P-,"WD0@GNU5A_$UIM88-PI]`&;U+F$(*A@PY^,;
M\_&7^:"9T=Y?&$$7&!(RX&`$P!QW-."\R(-KB0?&Q`-#XBL=%1H%PN=?9604
MB`P9H-G61<M2U1M:*S4V&L5/]$R\,/)]Y*_YJ&/,]"&#A9,7SKNA!TVLW'#=
M:N7,@$\T7@\:6ZDV6;4R'AT[B`Q6[MRJ`X7CKRE$$?!F/6[`Q5X<SQO'&9V=
M%6%7?0EQ*Z.W6J@#:!0=+KJ=ON=F\3W<'+KKZDLF31I\);\QNQ8UMTY4R)-=
MG[\72@6168(7N66YO**'14DN0DU#.6?=I=4M!&T>=_#P1R#]#U!+`P04````
M"`"\@CY'&*1#A3$"``!W!P``&0```'AL+W=O<FMS:&5E=',O<VAE970U.2YX
M;6R-5=N.FS`0_17$!P1L("$104JVJMJ'2JM]:)\=<`):&U/;"=N_KVT(RX9!
M2A[P[<PYXQ.-)^N$?%<5I=K[X*Q1>[_2NMT%@2HJRHE:B98VYN0L)"?:+.4E
M4*VDI'1!G`4X#-<!)W7CYYG;>Y5Y)JZ:U0U]E9ZZ<D[DOR-EHMO[R+]OO-67
M2MN-(,^",:ZL.6U4+1I/TO/>/Z#=$<46XA"_:]JIR=RSR9^$>+>+G^7>#VT.
ME-%"6PIBAAM]H8Q9)J/\=R#]U+2!T_F=_;N[KDG_1!1]$>Q/7>K*9!OZ7DG/
MY,KTF^A^T.$.B24L!%/NZQ57I06_A_@>)Q_]6#=N[/H3G`YA<``>`O`8$(4N
M\5[(I?F-:))G4G2>[+UMB?T+T0X;(PJ[Z>[MSDRBRNS>\@3'67"S1`/FV&/P
M!+-&(R0P]*,&AC2.>!:?X`0FB,`D(T<0?R%8PP0Q2!`#!)N'6_:8Q&$:AT&A
M^\%""2B4S(2B.'H0ZC';B1!>+?FQ!E76P'72!Q4(LX5%-J#(9DX0+7B1@@3I
M$Z:G,].39<NWH,SV"<NW,\O#5;K@ABUBJ%#")TR'0-%"K:"%@D0`!5Z@`.OM
M@/`3S@^@)ZU'<&&B>67.S1]`4_?1:NE&</TBJ(!GY@.@*'K0"28/(Z?RXMY_
MY17BVKAV,]D=>\P!NX?U$YYG+;G07T1>ZD9Y)Z'-\^P>T;,0FII<PI7QM3)=
M<%PP>M9VNC%SV?>%?J%%>V]S8Z_-_P-02P,$%`````@`O((^1ZO^=ZG1`@``
MK@H``!D```!X;"]W;W)K<VAE971S+W-H965T-C`N>&ULC99-CYLP$(;_"N*^
M@(WY6A&D3:JJ/51:[:$].XF3H`6<@K/9_OOZ@R1@#]+F$(QY9_S,V`Q37GG_
M/IP8$]YGVW3#RC\)<7X.PV%W8BT=`GYFG7QRX'U+A;SMC^%P[AG=:Z.V"7$4
MI6%+Z\ZO2CWWVE<EOXBF[MAK[PV7MJ7]OS5K^'7E(_\V\58?3T)-A%49WNWV
M=<NZH>:=U[/#RG]!SQN4*HE6_*[9=9B,/06_Y?Q=W?S<K_Q(,;"&[81R0>7E
M@VU8TRA/<N6_H]/'FLIP.KYY_Z[#E?A;.K`-;_[4>W&2M)'O[=F!7AKQQJ\_
MV!A#HASN>#/H?V]W&01O;R:^U])/<ZT[?;V:)WDTFL$&>#3`=P.3B46#>#2(
M'P9$1VK(=%S?J*!5V?.KUYO-.%.UY^@YEIG;J4F=*/U,1C;(V8\JB4D9?BA'
MHV9M-'BB2=%=$DKW]S4PM,8:._8HFR^Q`20YO$0,AA%K^W@61@([(*`#HAV0
MF8/4RH/1)%K3&4B4)9'\6=$`0HRS;"J<(24@4N(B1392XJR41P3%A07DRA9(
M4I`D!4BL'5RGSA)/"90;5[>`DH$H&;!/-DKFHJ#(_"P8UQM9.-DY2),#B<DM
MFAR@@1(#Z!*\?&8*$*@`TF,#%>[IS!/@T``Z^[C/B%2YA"I,!+R;Q8*+A2*%
MW+!(9%<I(RHFO#C`=J&!50NE`H'U[`5A``?9.$:DHG_D+\`V#O[JZX#@PH=B
M@`7;++'+$@63`CG"Q%^&@8LH`JHHB6T8XL(\X8#8,,39J"<49/$"$%Q"$5!#
MB?-Y2P`@%!`G/:ZSI6J!X#J*@$)J+[,>1<7LW*3VRPFH9J?=X(23-J!E_5&W
M1X.WXY=.J,_M9/;>@KU@U498\VO5FNGVXN&F*L_TR'[1_EAW@[?E0C8INI4X
M<"Z8A(P"F;&3;![O-PT["#7,Y+@W[92Y$?Q\ZP[O+6KU'U!+`P04````"`"\
M@CY':.PXE_(!```O!0``&0```'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6R%
M5-N.FS`0_17$!X0[R48$:<FJ:A\JK?:A?79@N&AMS-HF;/^^OA#"$JM]P?;X
MG#-GQMC91-D[;P&$\TEPST]N*\1P]#Q>MD`0W]$!>KE34T:0D$O6>'Q@@"I-
M(M@+?3_U".IZ-\]T[)7E&1T%[GIX90X?"4'L3P&83B<W<&^!MZYIA0IX>>8M
MO*HCT/..]@Z#^N0^!\=SJA`:\*N#B:_FCO)^H?1=+7Y4)]=7%@!#*90"DL,5
MSH"Q$I*)/V;->TI%7,]OZM]TM=+]!7$X4_R[JT0KS?JN4T&-1BS>Z/0=YA(2
M)5A2S/77*4<N*+E17(>@3S-VO1XGLW/P9YJ=$,Z$<"$$Z3\)T4R([H185VJ<
MZ;I>D$!YQNCD,',6`U)''APCV;E2!76C])ZLC,OH-4_B-/.N2FC&%`83KC!I
ML$`\*;_D"&TYBO"!'^R_ICA;(`=[BLA:1J3YT8H?IWN[0&P5B+5`O.Z#O^V#
MP20:TVO,P8^#Z&E3RR/,MSM)K$Z21R=QL'%B,$^K%,$NW-@PF/W_;:16&ZG%
MQN;4BO0A1;#-X:U^1`*LT1>4.R4=>Z$.?!5=WH#G4/W(FW@AWP9SE>\R>3:@
M!GXBUG0]=RY4R&NB?^::4@'2H;^376CEZ[4L,-1"3?=RSLR%-@M!A]OSM+R1
M^5]02P,$%`````@`O((^1ZP4U!>O`0``"@0``!D```!X;"]W;W)K<VAE971S
M+W-H965T-C(N>&UL;5/;;J,P$/T5Q`?4X."DB0C2IM5J]V&EJ@_MLP-#L&IC
M:CNA_?OZ0BC-^@7/C,^<<\;&Y2C5F^X`3/(A>*_W:6?,L$-(UQT(JN_D`+W=
M::42U-A4G9`>%-#&-PF.<):MD:"L3ZO2UYY45<JSX:R')Y7HLQ!4?1Z`RW&?
MYNFU\,Q.G7$%5)5H[FN8@%XSV2<*VGWZ*]\=B$-XP`N#42_BQ'D_2OGFDK_-
M/LV<!>!0&\=`[7*!!^#<$5GA]XGS6](U+N,K^V\_K75_I!H>)']EC>FLV2Q-
M&FCIF9MG.?Z!:03OL)9<^V]2G[61XMJ2)H)^A)7U?AW##MY.;?$&/#7@[X9@
M/`AYFX_4T*I4<DQ4.-J!NAO,=]@>1.V*?FZ_9XUJ6[U4I+@OT<4139A#P.`?
MF.V,099_%L%1$>P)5@L"G*_C!*LHP<H3%$L')+MQ&3`;C^D]9HV+_#XN4T1E
MBHA,?B,3,&0A0S8XW\1E2%2&1&3PC0SY;YH\WZY7Y$8'+>YYH"?X1]6)]3HY
M2F-_&7^QK90&+&5V9SD[^S#GA$-K7+BQL0K_:DB,'*XO;W[^U1=02P,$%```
M``@`O((^1V0<DM(5!```W1,``!D```!X;"]W;W)K<VAE971S+W-H965T-C,N
M>&ULE5C);N,X$/T5P1_0$HOB(L,QD*732>P!&GV8.2LVO:`ET2/)<<_?CS9O
M9#%F+EJH5Z^*K(4E3@ZZ_%UME*J#/WE65'>C35WOQF%8+38J3ZMO>J>*YLM*
MEWE:-Z_E.JQVI4J7G5">A1!%/,S3;3&:3KJQG^5THO=UMBW4SS*H]GF>EO\]
MJ$P?[D9D=!SXM5UOZG8@G$["D]QRFZNBVNHB*-7J;G1/QG-(6DB'^'NK#M7%
M<]`:_Z[U[_;E=7DWBEH;5*86=4N1-K</]:BRK&5J-/\[D)YUMH*7ST?VYVZZ
MC?GO::4>=?;/=EEO&FNC4;!4JW2?U;_TX44-<V`MX4)G57<-%ONJUOE19!3D
MZ9_^OBVZ^Z'_0OD@A@O`(``G@9,>7(`.`O0L$'\J$`\"L:\`&P28KP`?!+BO
M@!@$A.^DY2`@?34D@T#BJZ'U>>^YR%<'.3G[[&WRN;?)T=T$#"UA'UA=6#ZE
M=3J=E/H0E'TN[=(V9<FXD6K(V]$NT+N/3616S>C'E#$Z"3]:I@'ST&/@`L.C
M:\@/&T*N$:\V@IJ*9HBB,TW83.0T&T!G\P`6`5RK>+01E,77F"<;PPV:[P@-
M,3#/F"IFK-M-@U]N&_/J,:<W#V-F-H:(:\@<@4C<0Q2/-]H1T*MXBW&&&&>(
M.X;X@D%*(V![B.@@Q3"1B,7,F,TC@I,DB<&(W2<$%P.7D:'W.X(#V?`9N&<,
M!XSPQ(@.&T=)0B-B9-^+C0-!.%!N!(J-BQEETER7-X0O222+#;Z9C>,L@L0,
MT#FBEXM$Q([D9KCCF>5X9H6PC:&1@9E_CKFRA..6<,02CC,(G$'XIX'$&>3-
M-)A)),Q$TW\9M6&.X(3@$AP&);A!B8=[,(Q98C",H\:T>RRZJ44(1^+@<&V,
MQ-]%!-^.[@G<=M*`N5S])C428>80@B,1HQ0<240<!9A0#S]A('//GZ,@ES6.
M8D[L:LXNRL<UAZ,N$/8%3SDRFM@I;7N*VYX20,%:%QO7%)A$1@Z3'"6""!]'
M(2#;41B(.JQQE!MBUQO&78OLJ!`D\7<4.%(;[-2V'#5@KO:E.!:1F5((#H2,
M$T>E`$>E`.+A*`1$K4*,,7''U@2.F@-VS6'<L3F!HT;`%[HT<&0VW.[39H`T
M$"`O^X)A76R<(!%U)!0XZ@3X-!`("/$3PL2%PQI'Q0&DB>".?0X<)0*^T$:`
M(['!HY$`NT,`*A/"J;DP2"O1=*Q,NA;'42G`IYE`0=*T"`%Q,\'#B]_E7)7K
M[A2H"A9Z7]1M.WHQ>CIINH?V=]L8?R#C9X*,_R#C%VS\E8S?L/$9&<_[<Z>S
M.=/)+EVKO])RO2VJX%W7M<Z[/_>5UK5JYAI]:\)RH]+EZ253J[I]%,USV9\^
M]2^UWAT/TTXG>M/_`5!+`P04````"`"\@CY'Z]\NF*<!``"S`P``&0```'AL
M+W=O<FMS:&5E=',O<VAE970V-"YX;6QM4]MNXR`0_17$!Q0;.XD4.9::5JO=
MATI5'[;/Q![;J%R\@./V[Q>PX[JM7V!FF'/F#`/%J,V;[0`<>I="V1/NG.N/
MA-BJ`\GLG>Y!^9-&&\F<=TU+;&^`U1$D!:%)LB>2<87+(L:>35GHP0FNX-D@
M.TC)S,<9A!Y/.,6WP`MO.Q<"I"S(@JNY!&6Y5LA`<\+WZ?&<AXR8\)?#:%<V
M"MHO6K\%YT]]PDF0``(J%QB8WZ[P`$($(E_XW\SY63(`U_:-_5?LUJN_,`L/
M6KSRVG5>;()1#0T;A'O1XV^86]@%PDH+&U=4#=9I>8-@)-G[M',5]W$ZR?(9
MM@V@,X`N@'0?A4^%HLQ'YEA9&#TB,UUMS\($TR/U%U&%8.P[GGFAUD>OY>Z0
M%.0:B.:<\Y1#5SG[=$DAGGZI0;=JG.D/?'K8QF>;&K.(SU9X2I-M@GR3((\$
M^9<FTV]-_LS)]OFW(F1UJQ),&Q^/194>5'RJJ^CR/N]IG,IG>EGTK(4G9EJN
M++IHYV<;)]!H[<!+2>YV&'7^!RV.@,8%\^!M,SVJR7&ZOWV1Y9^6_P%02P,$
M%`````@`O((^1QA1%X\.`@``[@4``!D```!X;"]W;W)K<VAE971S+W-H965T
M-C4N>&UL?51-;Z,P$/TKB/O6?--$!*E)5>T>5JIZV#T[9!)0;4QM)W3__?J#
M$`)N+]@>O_?FC8VGZ!E_%S6`]#XI:<7&KZ7LU@B)J@:*Q0/KH%4[1\8IEFK)
M3TAT'/#!D"A!41!DB.*F]<O"Q%YY6;"S)$T+K]P39THQ_[<%POJ-'_K7P%MS
MJJ4.H+)`(^_04&A%PUJ/PW'C/X7K7:X1!O"G@5Y,YI[VOF?L72]^'39^H"T`
M@4IJ!:R&"^R`$"VD$G\,FK>4FCB=7]5?3+7*_1X+V#'RMSG(6ID-?.\`1WPF
M\HWU/V$H(=6"%2/"?+WJ+"2C5XKO4?QIQZ8U8V]WDF2@N0G10(A&0IA]2X@'
M0GPCF`S(.C-U/6.)RX*SWN/V+CJLKSQ<Q^KD*ATT!V7V5&5"12]EFD<%NFBA
M`;.UF&B"R<(1@I3\F"-RY=A&"WZ8WZ?8.2"/[A2QLXS8\..[,F*W0.(42(Q`
M<B>0S,[!8G*#:0TF3E9!$,QJ6<)6X11UYR9UNDD=;M*9&XM))VE^A%FPM./`
M1:OD2T.9TU#F,)3-#&4.0X^.\UGBHB#^TD_N]),[_,S^J6V^N(>YD^\0U@2:
MO",*_&3ZB_`J=FZE_E\GT;&%/47Z'<[B6]7:;">ZR91%AT_P&_-3TPIOSZ1Z
MY>8M'AF3H`P&#^J4:M5\QP6!H]337,VY[4=V(5EW[:YCBR__`U!+`P04````
M"`"\@CY''MR`E,D!``#0!```&0```'AL+W=O<FMS:&5E=',O<VAE970V-BYX
M;6Q]E$N/FS`4A?^*Q;YC'B$D$4'J4%7MHM)H%NW:@4M`8V-J.V'Z[^L'80AC
M91._SCG^KG&<CUR\R19`H7=&>WD,6J6&`\:R:H$1^<0'Z/5*PP4C2@_%&<M!
M`*FMB5$<A^$6,]+U09';N1=1Y/RB:-?#BT#RPA@1_YZ!\O$81,%MXK4[M\I,
MX"+'LZ_N&/2RXST2T!R#K]&A3(W""GYW,,I%'QGV$^=O9O"S/@:A00`*E3()
M1#=7*(%2$Z0W_CME?FQIC,O^+?V[K5;3GXB$DM,_7:U:#1L&J(:&7*AZY>,/
MF$JPA!6GTOZBZB(59S=+@!AY=VW7VW9T*\EVLOD-\62(9T.T>6A()D.R,F!'
M9NOZ1A0I<L%')-RW&(CYY-$AT2=7F4E[4'9-5R;U[+5(LUV.KR9HTCP[3;S0
M1-F]I/1(/E*P)I@Q8B]&;/W)'<;>'Y!X`Q(;L%D&[,)5'4Z364UO-?%^I^_S
M2E=Z=-D^6>KN@#9>H,UGH&R[`G*:=+'1%S^13_@(*?4BI9XSBE9(Z:?:URR/
M%`X"+R[?0,[PBXASUTMTXDK?8WO;&LX5Z+3P2<>U^GF9!Q0:9;J9[@OWCW,#
MQ8?;^S$_8L5_4$L#!!0````(`+R"/D=,$0OGS`$``(T$```9````>&PO=V]R
M:W-H965T<R]S:&5E=#8W+GAM;'54VXZ;,!#]%8L/B,$!-HT(TF:K5?M0:;4/
M[;,#PT7K"VN;L/W[VB:P-'5YP/;XS#EGC(=BDNI-=P`&?7`F]"GJC!F.&.NJ
M`T[U3@X@[$XC%:?&+E6+]:"`UCZ),TSB.,><]B(J"Q][464A1\-Z`2\*Z9%S
MJGZ?@<GI%"71$GCMV\ZX`"X+O.;5/0>A>RF0@N84/2;'<^X0'O"SATEOYLAY
MOTCYYA;?ZU,4.PO`H#*.@=KA"D_`F".RPN\WSD])E[B=+^S/OEKK_D(U/$GV
MJZ]-9\W&$:JAH2,SKW+Z!K<2,D=82:;]&U6C-I(O*1'B]&,>>^'':=Y)E[1P
M`KDED#7A$'OCLY"W^94:6A9*3DC-1SM0]P63([$'4;F@K]OO6:/:1J]E=B`%
MOCJB&^8\8\@&DR<K!%OZ58.$-,[DG_PL_1(FV`=-[CW!?D-`2!HF2(,$J2=(
M_ZIR?U?EC$GFHQ`>=-@=XNWSGZJSH&86T$SO-$.8+"R2!T7R`$%^)Q+"/-R)
MX,U]X:!:WQ8:57(4O@DWT;7S'HF_;Y_PLAAH"S^H:GNAT44:>VO]W6JD-&"M
MQ#M;<&?_#>N"06/<],'.U=PN\\+(86G^]0]4_@%02P,$%`````@`O((^1^#"
MW=0%`@``^@4``!D```!X;"]W;W)K<VAE971S+W-H965T-C@N>&ULC53;CILP
M$/T5Q`<LYA9"1)`VJ:KVH=)J']IG!X:+UL;4-F'[][4-(6SB724/L3T^Y\P<
M8T\V,OXF&@#IO%/2B;W;2-GO/$\4#5`LGE@/G=JI&*=8JB6O/=%SP*4A4>(%
M"&T\BMO.S3,3>^%YQ@9)V@Y>N",&2C'_=P#"QKWKNY?`:ULW4@>\//,67ME2
MZ$3+.H=#M7>?_=W11QIB$+];&,5J[NCB3XR]Z<7/<N\B70,0**26P&HXPQ$(
MT4HJ\]]9])I3$]?SB_IW8U>5?\("CHS\:4O9J&J1ZY10X8'(5S;^@-E#K`4+
M1H3Y=XI!2$8O%->A^'T:V\Z,X[2SN=#LA&`F!`O!_YH0SH3P2HB,TZDRX^L;
MECC/.!L=/GV,'NMO[N]"=7*%#IJ#,GO*F5#1<QYOMYEWUD(SYC!A@A4F1,F"
M\93^DB2P)3D$]P)^]#')T89!]B2AU4EH!,(/3E*[0&05B(Q`M!9(T<U13)C8
M8#J#29'ZV=/$UC2Q)8UO%]A8!3:/&TVL`LD#1I,[HU'\J=&M-<WV+DT8?R*0
M6@72QXWJIVJ[W<AB-;BY>3-H[=4/XCNOWNI)4>"U:37"*=C027UQ5]&EG3T'
M^DG>Q`^ZS9FG>I7)LQ[7\`OSNNV$<V)2/7CS+"O&)*@JT9.JKU&->%D0J*2>
M)FK.I]8T+23K+YUV:??Y?U!+`P04````"`"\@CY'XE3$6<)>``!IJ0$`%```
M`'AL+W-H87)E9%-T<FEN9W,N>&UL[;W9<N-6EBCZW/X*A$,^I8R`:`P$2;B[
M*T(I*5VJ2@TM*>VNJ#@/$`E)*%,$"R!35L=YJ'^X3R?B],_5E]PU[0'`!DEE
MIFMJ/=A)D<`>UE[S7L._U?7*6R^*/ZWSHW*]6/W[UTD:?^W]_#A?U/_^]<-J
MM?SNVV_KZ4/^F-6#<IDOX)>[LGK,5O!G=?]MO:SR;%8_Y/GJ<?YM%`2C;Q^S
M8O'UK_^M+G[];ZM?'Y?3]6.^6'G98N:=+%;%ZMD[7?`(1;GXMV]7O_ZW;_%1
M?GSDG96+U4,-C\[R6?O7WZX7`R\.?"\*PJ3]HPQ^E=\7]:K*8,KS[#%O/W6Q
M7!6/Q7_E5S][1V6U[!GD"%9<97-8Z2S_V?M=_MQ^[A#V-*-]O9MG]^U?5]6Z
M,[%YXSBOIU6Q=&W_8N&=9<_>D'?H>T^Y=U?,\YGW5*P>O-5#[EWGTW55K(J\
M9HC^/'W(%O<Y;.;QL:AK&-/+O$I@@%-X]2I;Y30Q_/$.`.]='X3>_CL8USLO
M`9YQ?!`%\20*WL"$#\7TP7O*8'1<+\Q\^PP#PB$?Y'=W^715?,SY)QJ1%P?C
MPLGD7JB6O2IE"7E%BR[AU8K66V=S_-.;#%,_C%.O?L@JV`I\4ZXK;PJ;H!67
MTY]\;R\8!$'H+;/*^YC-U[FWA$'H!1]?X*5.@F%K('L0#[[T`"SK[!;F72_A
M>UQ/_G->38N:5O*458@L]>"K&_CERH;<M88<`F263^<PW,PS@`#8X'`6[#4H
M1@P+'+6HO<NR7AV<Z/<,+N`!A`@O'$<=SK>'L&;O-B\6]P)A>*!83.?K64ZG
M^Q'6/O.R]:R`0UT6"YSYKBH?"8@%'-L2SPZ)#A\I*]_[W?O?>O\K>US^*_[G
M'=9U.2U@<[7OO7]_.?`.YW.O-IA%YP4S/,#_\?P!B+P:]0-AV2R?9\_X!QX<
MT,UB7:YAV5E=U`/OQYQ>6Y0KC0HX0+:`X6:P*%ARUIAS#2M&;-D`+5XG0(0`
MD\-+R^R93K98X!(6^`(L31-+@P[@K.$[.'1KTB?8#2+WQP*6/G^&\0K">-A'
MSY`R.P^F3VS0)F3-]FZ>EQU6<!WVL!VDR<H[@H.Y+ZL.S[E^S.;X^U6^+*L5
MK@(0;PD0[9W\$H!>(MN=><<P:!\[_>I?_L7%4(]*1"+$-/A4E_-B!F/,O+?9
M/%M,@1,AS_?V/RP(R?+9&^_`^W!][.WOO>DL*)_"1,P>AIM^C#MK6%<5[@0P
M-E_5G5^S^H'8RA0_Y']:%\`HX/'.@X?3*0JW&C!BFL-#@#/M1RZKG$X__WF)
MF^X,<5.N`&$WK^>R`@E9P4'BFG`Y2SP&WUODJPZG!_2I^H8!.,,<57'_L*J=
M;_^8WP+Y?<SG)<T`F%KW/"GRXAD>7Y9UT?F=M[5I-3<7-X?OO</KZY.;Z[[C
M>5]DMT`82%.]H%>T>N`!1<ZZ\K'[7`4,!C$.),"J*X&G4Y"R_>=U!>!9@-`@
MP:`&[>(>\#-D:!4_[8;.AMU=HY1Y*.?`N^I?>2=PY-V5'MD"B229`_=D'?T/
MH4KV7;W,IOF_?PT<J\ZKC_G7O_:<"])"K0,TPWH1V0^*Q<$T6Q:P2?<XEUO`
MQLL%B8MGX%3HX)C6CVL^QUE^5TS[4'`72#(JOC\]?'OZ_O3F].3:.SP_]JYO
M+HY^]YN+]\<G5]?PYG]\.+WY_:?QLLL,L?DA7Q73;/ZFQ=OVO&]%R^C"2FM8
M=\##%S!D`3NZ1'I#X?&'PUN40M/5_]Z(&EK1V?24KS2=;+UZ*"O09#M:LO-Q
M5()V?+1<KT!G7,Q`PO0CZC6_TKOF%DKOL.R^-]PK[WMZP^)[<$"?'FF/%\#`
M"9'KW41;O-%@":.=[9F.7#Q=`%WEEA+:CT;G)S?>U<D/)^<?3CILD+_VKG]S
M>'7BG?SGY<GY=>>A[Z\NKJ^]L\.K[T_/NP83`02TC3Y.2ZAP`'H?`',3*SC.
M@6^AVDE&"DC([!'UF/]R/OP^>ZJ!!8"RMEK-:?]N"5IN79Y(N*W/G9X?79R=
M>/OO`19OO'=7%V?>Q>7)U>'-Z<5Y1_!=W/SFY,I3KPA8.\AQN@"U-P<#NZ"S
M[/U9EN1F=_94/6O&)7MO3]Y=P!%?7EW\<'H-:_;@3[7"F\/_/.GL8?<G$;\:
MX.GH(R>GW__FYN38._P!(/;]B7?^X>PMK/KB'2/>M7?QX>;Z!KCUZ?GWWWEO
M#Z]/CSYSC'<?WK__O7=\^OX#O+-UP1Z<)`\CLY/DD+>]_44)B`:\#$C-6)F(
MGZ"1P!_ETP(,H&FV!NMA7M;(DP"!5\6LF*_11.G`8\/\[4>=L.C9UC8.A@S,
M)4?[V1<1QQ8N#]*16.L?SO+'V[SJ$V([/<L/_<CJ2>]3EIIRR6H*&$6DIFP9
M6/25WJ>.FQL[LKA5_V(L#>:8-9C>9]^"P;E8()>Y%<TB0W^/,7"BK6\82;GE
MS5-T:^`4<.BL0)3D4ZJ_0W=!_KB<E\^Y@\UM?`U,WGH]7[ET1_M%V\?RG7=7
M`L6`/EI,-T_7_Y;?HUEM>_LC,'7X^1-?^[19IR5@T%2Y%)9@85>LHWRA8?I6
M=87^I[HN``,987$4D!P%XG.?PG_"DD6=*^)9WTF=@P9,S`W'1>?&<YY574?%
M;`-V=\SWYN-]J-UY;0ODP-A_^1N?=-8"5NTP_+RW-^%;KH^0SY7Y=I7U3)H+
M[;*/`"FWO`/$`)[?BS;/&EE0]X)_<Y`9_9AS10^H$^N#N_NIOHUNQIZ.!KP;
M]FQY#1_?>&^PDUE`GJ9W\_)I1[/@Z/#Z-]Z[]Q<_7C<TR?/OO<.CF],?R'C]
M;BL%+LE_UY6.?US7*UX:>=J!N*?HS5_D2M/T]G&<-_@S?DGXOZS*CX5X]/?7
MN-]B\<;2GS/TMI*3H[,PEI:(-B(KQ"C;R/G?XTZ`(&9%O2QK$-T`QLSMQJ,K
M#'2Y=F9N>X5<BA;!FI398]#EWOX>3N@:/IR>OW&"?=M1G9[_<'*][:@NU]7T
M`2R>FIFWR^VWT:OG<.C5@%(>_:_CV>O=M6S4N>9M^WQW>GYX?K1MGU4YS?-9
MS=<+10^[ZU`@<R_]N',3"H368`B_9<L7AM]MXE&/2R5#^P?9"6M<\.C1ZZ].
M#J]/$.XT"%H2]`%=3S\<OC\Y=SA*^QX$%O+V!,SN<YP83!U`V-.+KN*_X?43
M^+KWQ>L/EY?O3\[@4;`D-0;`TL'D.R/3MG/DQ.K(%8[478B-NNTIXCJK[&>'
M>\!>PO'I]1$81!_`4(4UGU^<TYHL](7-[(28#<^9Q8WNUJMUE?<K.1G]#-CR
M=ET7B[SF:]2W>&F%WUZB9W6Q<KHD7O+N)F?-X8UL_^V'Z]/SDVOV8J(=>$T'
M":8N`@L/I_/NQ<V)%WI_^?/_Y[UD&*]UZUW*E1B:L=XJGSXLRGEY_^R!]%O3
M#U.^6`*(3DE2R+WI0Y[-5P\@3O!6=3$#*50]#[Q3%)&W?Y3;NH*$TBW=]MWF
M*[P"SJ93!!9^S5_0`""&YJ2)W^.C!?)XX*-5D:^RZME>%;PGLHO$2?[(%\D?
MX34^@7J]Q!LQNJ0#4W'Y\%R#E98M^-<E[)5DY5-^Z[&7:@G6'(8@@-W!UZJX
M@I,Y[*`J%\74^PWO$U2GLIKQ*)<\BG<)$V7S&G:]`%F9S>?/Y-9>H%J%T'S,
MJI]REJ?HX9K!!E=%C7\KF*X>JG)]_T`[)K7\$2#RQ/S?MTYJ`"_XZGZ9W@1N
M">,C$LIDCJ.K%:RJQD2S`HT-`J6"CG[%]ZXSL!;SL^.!_N3!SE#9L6`)[V;K
M58EQ&U/>-PCV><92;X;WK,7M&D48#>%]+-?3!]!'\>=OR=XY`!D._^`M?.WE
M&MHTEAP=7<XC':D`"7U4O/2L>LRF=$.-#IF';'XG-[%%I<]YX.%%OMZ(QNFB
M)F9V7Y%Z!Q_+QG2W=*U;V6APEL]P>08/ELNY&%^`.;!90&20-_.Z1+G-E^)+
M&2VO_O+G_XM!`_5/JW(YL"FP<U0MNJI7Q4H>H&MGF@/(9I$1@;$*IF(&\"Y-
M^4H`/^JY!(802ZQ1X>*;?@DA`7Y9*>0$.F+:XT.&`6;5^E[.KU9R]`!(<K$B
MURZ?'(V^4FNO6T1.6'\')S;C.S,F7T6"&,?PB&_FS8=\H!0,-B!]'=7,]0H%
M"I&9!PB_L`G#3"T(D:\))7%#ZSM@N4`@E<#NMH3_&>37],8XVZ4)C*99Y'-6
MP1]+.(\<[2I<_?R9-(SU@E!`8`A+>2SI+T'"JIRMIROA2\RC&"&GMG%QIR^)
M:F-F**T?Z#9G,-3%S["(!6R!+0$@&XK)H1`39<_0DV@'P?EC3$J>+_#<EA2K
MPK$,"`H`J42,+-<5ZF4KA4+56AUWE=^CHXM03R(<ML<;\1EAE(]$HL";A%HY
M7WX#?</I&I-ED2.B$(\OB5PHD"@K*@`PQJ\8V"SE`LV'A:'W@N.$]`6-;Z[^
M[XA99?2`&SC\<-.PJO'S@F'J6]![S&8Y'EH)RJF]<CQ"X',XR0(#V.8"-(`0
M$Y5YUG'FRAZE6#E9*]BQY$C4MJQ/3)Y6`2P<R'W&FC<N6JS.[:.N'L#FQ9\'
MWA&(GPP8:V%"[FC1BQ+MC**>@IVX1J.:-P1'('%&R"'I.(`>UMG<C;$:S>!9
MH'^D9UP+4=Y]OH"#PA&1,RQQK1D;<\1R`&#3@OB,@?M46^)P3.5C`7QE1H"L
M=R&?&E!\#@#!L)]L)O$[?UPOK`">C'ZRXG><`RGX$'I4N8F]TC`Y9)AP((X.
MJPN#@]]I#+L#V,(CZ$,3HG6<-1S7B\/[&+.<!/&I',37H5J*-@M"A!EQNH^Y
M@I::E!0YNK2:KG)#5'?K.6_8H%W5\EG6+2KS1.:S^Y.72')S^W$S-U>J`0XR
ME6`4:YBEI9)W8K0V*]-NE=GOU9EKH^!EU7VN9$*/SGP!6/0).K-2Z51D&E*2
MR%:_H_=N$HYJ(+,16%-5@#KP.2HMQW"V5=JGG$]=J:ZD>FU37C/4U[UY!O3[
M@`P!1OXR.FP-"#I]\(D#<50R8`ALZV-6S.GN2/174&<!:ENTV"^GANI%$MY^
MGE)*?)#4TEN,%Z5XB(-L7BYRI8_:;VW133>B4;9)B9)KCEU5)C0DC6IGDXU"
M"D+&7,Y1K8^.2XVMSD4I/`^D@9G5$7*C#IQK-1>="(2FGZ'7*FG/U(#!PJ6A
M)6113$H*SI5W_5P#'Z/HVR/%`\GAC'AT5DP?BON,@XD!W*@JL<P(1@0D]+8P
M1V*1U/OVQ715HL2)(GI[S#`BB3(CLW"1H=>F[&%V@!D+[Q`(9>Z%%)(>3'SO
MZMWI,:Q[-1L`R.#I.3P\0UYL\4CF`8^T/HI7AK,#^L^!+U:HDN8+"0<65L#7
M[;D2=ME]E4O<M9*+M76KS6$Z;NYLZ[8<(+[[VWH!,])91>B);TFL$A5;Y$G8
MG+I"[1T3:2#THV3DI\FD+TH=_K;!6N4BMW"B,`B^46O9N``S@G=(4_#)L9!7
M)T?<15T5659066%L;%W<(]<7NA3MFQ_#EQNH<ZM\8`WTH?'53S;^)%W\$4$O
MF,RXB+2C9MF,E]>H4Y(^I5$3N$.!?+4$@A%DH_%*I/05ZO@KB6BG*92$KA7I
M&+K2`?4:OV$QY_G';)8I8X31MZ%XF+V`D%\3CT0'DR!B'\IF,G"3A(J:Q4+6
M&)E?@./H'TS3?^,=7@+I+D]`"//G@_()C[I>@Y">%<AB]E<EJ"T`(-_[V@S_
M-4WWM>6&^OI-1Y.R8TYZ0C?E2J#?+6I'<?8$<9+"%I'"YG@:S5#%+G7VC%!O
M&/E)$/21']Z>`F6A-#G6U."(_T<E1#W0C!U9@A&F@(Q"AE5Q^[ID!#Q`+P!#
MC/X$"T7Y0K>]&;RG1E:6ISQ+*0H5"7N6(BI8E"-=^#*T:5B01:ZR+`@,YOV%
MG7[1`(O/@9PS''(O'/GQ.'%.=X;ZDYHKX2M`7BK;!0+R0I&^-L,WS!;3;+15
M\SK9*'H.HE2\ZIQIT,&B."T$MOLNOZV:1T]"QJB;BE^R-ENC'EO4R"F,M)F6
M'R5+Q4-=B6PW-B;LLQ6+)PW\8"-*&5`(#U+8HDQ:^X!M8`B<2./0F3<2*\EL
M4>(%/5ROY<^@D!Z^^!AXPX369[)>K-D,C/DP!69*V"J?0N<\U_=@OG!>$VD\
MEJ"&/0*X'T'G6:G3FZO#,`E3>A#F8FQ48KX@;E%6K!9:@`Q&FU0O@>=<43BG
M@@`O$='[?D'0H=?@J[V$*8Y]H1T@MB&W:NR&='19-F&7!M/0A5I60M%276KJ
MP5PZ"0P!BO;,F_AQ'.-_&_+@"-GVPD$4-/+?*N^^P@OVI;J@A5?W0L))_&_@
M7<Y!:>?,RWLRF$5840H7`H-383AF5WP+-=Y>`W1Q5TL8^><"=3@XQW0P)B6D
M.:=/:T.6<@^[O4?!-[52X>Y:@^RE8UZ?=>E2Y<7C+<"GZ0(%[:/*LQIX%/(<
M5.3QEAV`D>M8V=JQ0S)Y]+9T/`TJZNI8UDO\LYLTV(&Z\KSK5$'@9<S)6V?!
M=$K(C[\FQ#;$(M!+Z-"X'\)916%HNQUM)I^[;M"9:$0@<$Z=RL7KR?@D3^`3
M?C(TB`FFT<0A*90?I0&X%HP)_0G.=/=+SM?;<K&62(B]:,ALD89")Q3`;[H6
M)Q)KG3[3!B<U4BA3%#1XZ>9WU=T&R).D_5IFQ2_Z?1E\=F@5'Y.<.(!=CHAO
M">72$UW3(C4D#U5^N*?@+G11V7FS>Z.8EX7TAKQ*L7N.)JY?=N!-79-9G^M)
M!OX@34`%GL^UF[`%V:9_L`M>7ALSW7PA<&:G0K99"R%'_()Y\9_6>;WBNP=)
MMFU/DZTH$11TS)PR1>F.&9_%8"6;HS48%@D^H4;1!A3;K:Q`$/['XK\FF5ED
MW`\%C*$CBL\RRE-^MR:!E&D/P$S=G"`;,)=NAL,;&]&VRU20&II6Z,%G#ZJU
MUH=\3K#A5="1T+F*-D,G.3)\G!!TVYC:0<T^Y`J_.\1X-O+5X0EU,G?DJ;>;
MG[)CN_U&+$X#%CU:4'.K(H#$C."=*55#`-DX?V)TA!H43%E6/]EV+\P-%JI<
M$5IZ/]WT=)%.H\[,2Q11-%+EO'6M#$+D:G,T;36ZW>4<^V%?!-BLDA:A_1>*
MS-1$ZBG?&P+7CX>]?@!+.>-M*0V8V:YFF\QYPG3LCX*$_.[/WD<FN@TB#?GJ
M4^FDQUHQ\99N^DOP`S<7:*GP0^>.XWC<LN.Z50.4-Y8YLD"E>'S,9P6K(;@V
M]T.VACOT=X)70U2`G,C11:CC,AE50>%DM%+>\I))-V_K1[%BWN0T:.$[+'6.
MT)RMIY3^ON80C/G:.G7,U6\,.=8C\A-_J^-U6O(I6?)'%V=G%^=LT/<YT?!.
M5(BI973MM4I$-(L_Z%S#ONM6@@=LE0@OBOS):.S'8<KFZM"?A&-_F([TJ'9"
M8L<CZ++$U?5S3))\R1K8_)D<6%;)C+@9Y].V7$WL?LLS>@ZX]@"O@03S#MF>
M!29SNI@.B`=]S"JL:Z"#X9CEJEFZ6M@F@S;3\G@FWC)&Z05Y<UHCHW[8'K[I
M>6A.A@[B9W-72:("Z.9^T70"F]U7^2)_@F%8G2>5!BB5-&^U-/TPK^VNJ(BP
M&R9F4RNWCD!<D];^\:)<+JXQ1F4C-!KJ8#A(A\FW-.._:J-7'!E?:CELE20!
M3Z/T4[4TI2GZPOJ4^BF6%/J+FUZA[JJ,#X"P^C:_*ZN\=28M%X"IC6*D/;W<
MY_883!(F@\[>-D*B9[,6B06[T-AV[Q"AX4UV/\>C?5N5Z"K=3FTM[Q)=B+2<
M2QHK^BAS.-SB:E*KTEX-98TZ"*$7_*/1!O`[8=T\?VV;/E48N8$.@+L7KZCK
M_1MRV1[*7;$+N5B\IW$;$.URW)+LV3`46/G7&MX2B]!P%IT<7R>#RJH*@W=\
ME7=T<M'"U\TL-^G(LZ8N$S4MW+86HWX&4E,*L"W7&E+>DO`=?+/<9V2P+5:%
M*IN$NKGHNFWA9IQ61@AN1+$D8`<?3K\7CD&\!A,=KB2YMNP-9($]ZZ\RT2//
M8U9>=`@5*TDNUVG=KQ&TW'T;L>B%?C][K%X'X$9N]^H,_"LX`ZT3^%7]S^@6
MY+"JSW0$-B36+^T1_.K5(_C/XQ$TIE"/,\"6F7^GOD$;^U^=A']#)V%6_\_V
M$>H8+]Z6Q>\:V_EK[::UF3CQA^%XU[VT/(!NFZC/%?@_T@VX+#&I&"-5/]4A
MV%>]25??8V4`4$+ME61:`NH;QFS,UI5"HDVQ[GV.Q^=\U3%--@H6DW?U(M^R
M`Z%F)2<E;`CI(;SNA`;1@%T]`I@7AP&%J9^,DH851#BKXOPSX>6B.J"8COUP
M-!H`-^9?X+NQ'[3&:/E@.A$U\I1%K]LCA6SEJ6B&3W6#O$BM?4N(<LEBJ/8\
M<MD"R]GIZ0/U-,W+507L;WY4G&E#F!C5,7M[B(GOEX>_/Y,DZ(M+9YDN\C/'
M'#'F>A%_D%?E'M(H>'P\C_GJH20BD.P5#GBBI7>)AFXS->[NH38?Q*FR>`-_
M%(:LA%J(ID)95"K$#IE>36^R;Y-JJT`#5]7%6Y+:HG-`$N0:'_/F2A!]D5`+
MK2O4>G7]4V#&+:5OL/N5Y+"V=I%""ZYLP$X3Y?-BB8%Q;GHX->7*"JG$,7W]
MB"*C5MPE,1Z[.@4&T,)<S@?%'6Q.6$=(8>9EM69,I;C1;#Z5ND]&4KX%.^BG
M@^OI0TG!XY*D"K/A`X_E+)\/[/KF+2Z*^9CK1UFEU.!@UD&O8N!1G1.*`9_X
MHLE&'7*FC**5R7@ZHA+.8-M-'65.-SX,G%'ED6TJ=7EQ=G9ZPV1'E0PNSC'C
M_^3\R%5G`>EVJ.^'>M_SWH-J>\^0OK%D*\!1SIP2F3Z6\X\&&^Y*S`O!\YKG
M]Z@ELB[)J9JG35^B7$06E.R-YS@W$V;W&:(,ECR;5:3_@K6PR)\;<D:E(5&%
M:700^FH9'P;7`P3="I!G!8^OJY7ZZ83,CH7YU8[KIYP<M@+)K4)YV)AX;:':
M`R%2U\<Y\,ZJ@5XH6B<Y1EK/LL?LGDRE!K(NRL5!NX2V,JW1&'K@>&U%E5E-
ME7KQJ;[Y/8DP+UI0C@?>!ZG_S:YB;>$I+R]=!TN66GD[QS/@A38*S5LVT!,F
MNZ"<A__D!3'.9J!XE<2I20TQ2@17>&>["4!1Y'<F^7)*YT/J"3N6U$L9JFDZ
MS;#U_)+J"I.UW@`\/29%TU6""GH+<X(<K*)XK%MG]:"3!5''7Z,GDIY32\%A
MU#FB3C$47;Q[INTCI<,RU\-TB)2`6.4-*F+?/]!Z2==U1#9UW728)MO)Y?WQ
MF?=]5:Z7G/U"Q16.K[SS?(6Z;B,EYL4D4M?P3-'>\VU%`=:@(\+<OIX15<LU
M9?=@A7QUT:'KC7:QUI@GXC6S)](T;FV9U#V8<T";IA/,5#W_.6(9>R`+*J"A
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MBRLQQN!!XC+)[P?D4),F3`J\C>$JG9'QIP8=5*[YU$JR*>NGP@KQ8-7MV+K6
M'B>+,%ITH!(.@;?@<H`#S#/)'+>PT+6/3\7,/K3D2@]_(^3\RB#G5]WCSD@V
M*DEAI6B(/%OH9C.4JI45"XU7FJ5/,X[VMQ+#==S'E`JQ$4"!X<XJP#]Q:N4N
MG*X_&9]]G5@*W/Z/P(.GN<3IH14FO6]Z!E:Z^D;!!9B%-V;BH\4-^-ZT(-F.
M=@<^^RZ?85T%[X_P?`TK6(FC"%^`DX2Q-;/4R?4DJ/'E*I?^):):F1S[/F`1
M6!&E[E%DD^*VXKL]@99:>T]Z_4B4>%':;QK5^]^3_OW+*^[S5[7]56W_9U;;
M?T$5?%'H:JCUJR[^.;JX[7UN:A$XZ<N5\O[Q_NK:N7UA2SSDY5JZ]=K?4$-/
M)<KX'U$[WX%2_X[4]+:P[:KL@%1?Z=L:TMWKOR?E_:4(NT%Q;U'RWP?RNK3W
M/*LXJW?86#/LL^+"$9@?#N+OK)BOX%!^+.9XI/M_^?/_PV_YS[_\^;_?M/"/
M)**H0"C;R]N51`%B$&"&"P)M^YY;3F*462N4+$IU?`VLRAKX>DW7#153@>^=
M`!IA:@&<`A8\@(=A:;^5H6EABLJHDN,L9XG4"@J3$`=S_G@[A!8,/:2&HV]G
MK<A>!+'>RBR_E7Q_ZRT<U\094M$7.&R%?_UKHIZ=H"0![Z:>)7C^4VN]C:6)
M!CE_MJ5FYF;.G$.:*7:@EQ5J`%Z;US130&"V@E^7RUP5BR-BF.IJ=$I!PKI`
MK.Q]S*;*PM.+1N9`!6/G9(PL9HWRK1R]NS+3T!<XP/4:`P/4Q84R,.FV=('C
M2?UNK`R$3=54?"Q&^]"CQ1TH6]E,'C8V:W5;*'4LXQLC+2^%IEV`<5HJ?)#(
MJ)56WF:/`AI<&L.F=:)8XV]52^SN2A=EM:Q)AC=-KV^'NM?BC-8$!KFLGI;+
M9[98CKGT+E+@H;5YA@ALV=`XHY60AM&-+:[F!LV%'0,RM$UJM3X#?CIG4V\0
M'SH\/%15U7AJVK>UU,THM!^^X7.7U695R?>RA.VZ'D-664<LA;2H<!A(WC5'
MQI,.R!KDOWK[T1L+DV:%UKLLI--DP$YV`^@&EL%W^_&;!EK6-!A;QG+0/#);
MQS.\E%.N!UAK"2\J=<S"X9(*KMD=`OK/J*'K`:X"$$%TWI<5MU"E"V*,NO)L
MEO]_C7DDC1D/.$Q6&8IU8]P'*IFQ6-$/=+PJNZ*_2G/--;4(2KI^6F[7>GZ2
MZC\JLY!"<#A8UZ.6JB:Y0/I!XJ-<R'+%8!0MI;;4"`2Z%-.CV!_1-72NG=DA
M1RYQ$59IW-&RCI8J4H)*TE2D;RQ,E"MJ1X^Y^+N>J,R;L!SQ_6%M.GW:-$]Q
M9_TQRSE!AQ&E8C\`H`&1I0HMU"J4_>5CCEDQ4RGKB-&B-=;[P<8]:]1#:B\,
MONFX@*YR'7.\X:<-E\97)]<WAS=4/+[UD[L=)OF<$G(Y6:]R4`;--VN5F&T7
ME*RXFAVY2!A1..I#`@P5``K"-.OP^@)"?(U)JL89A5/X4CF6?Y+\"ZWU<B7-
M`DAANC((63>Z45?YW9S+;_:D9PQ[BIOR[E!9D9%-4,2*V-AM#JQ$C<_*L%H*
MST2#2QA':QD%Q5X`*>DJI0ST_G9E5K]%"2SH>=#JP+*AS*DK;H8+K1I&S34\
M:V&:]7>P5!RG_WV,>%4=HDU[3[.Z]T!1WBG\@4FK%8/CFC<N31S-V:FVM*$_
MC$:4`0.?DJ$?P32=AX]*KC9\G6&PR9XWAA6%PP`^)1A5/YQT7^GV.?0FZ<A/
MHM1+1V,_&`?==ZA3"_</-Z>Q!^(P3?W)*/3>X!])Y*?!$#Z[7Y>40+L1A!IB
M%$_T$*-)Z!I"=[[I?>5ZXPG_$B<4^>-PY$?Q"#^-0S\9.4#7/J'0CU)X-`GI
M<Q!/_$FRVRE%?CP9^>/A&#X-8S!H(L=[?2>5CB(_&$4,LW$P\N-H]-*C2D>A
M/XYC-4;BIZES#/NL>MYI$*Y5H/LS7MVI!1$,-8K&?CP<XB>@JE$\[!T1-H9Y
M1:3@9>WFTWN`5C$@``X4CF-_,DE[!P+.JP>J7%VG<8=Q"-L=CWB[(SQI0*?^
M[=J+F[6:5..2@$0(QP#!1LFHW05Z@W`,QQWI:"M>*KPC5UW"))11"3SEU"E6
M[,3GVHEH>5!&H!$Y4BNZX8N0QX:J@!N9G_)82_I:I<)MN0M:`@C6J:JWO!`W
M`2DSQ:(A="1/7#PZ):@S>C..?$)+E!<+#`0O*[%AE&1RY'_Z]J#.DU<UZG6#
M*Y?,YQ+YY525D=\MI#I6N^V,9^]:BNURQV_E60;X5"L=2AR+A9]75DUOKJNF
M*V>J1R7S9[I:4VG;*9A"12[5U"@ITB2?FLLZQAW)3Q.%H-"J1*P"'!U\NVXU
MZ+:XO(QC]T*[4H/KIF&<_B<DB!Q\Y*>C(<F5Q(^2A*@1OD?:#%+/V3*>G@C3
MV!^-D.#@PR1E[AY-QL#I(Z_=1!Y^!'D./P`3B8`O1P%]`EDRCKQ6!W:*!I;0
M_CUOXH_AL3$H!3#^<.(/QV/Z=C)._!"6NZ'O.FXJBF,_'8H4B%'H!_PY&@?^
MD,2#HQT[/0"L$H6=>F$XB?TP'LO;B1^`3(Z3<9MA6<K;E;7W-`%%(QSQS&/8
M-@,:YABG(.'"%J!5B#'"=`PZRC!*FH`&'<2/83R'U`3`^BGPYS1%((=TD,07
M_6"2^",8X+S3%`_>"1-_,AQW=PJS1VF'+UNJYZ>.9O59[1%<F#5`@\!9#XFW
MIP#)=-*?H`&[A&,)4D0T.6T`<@S;#B//]-0SPJU!#OMI$F#6`:U5R`&^G>"L
M(6I<1UVFY2",`"$];)Y7"`IG"H=NC>"08?M2[_%-@TY"0!C\U&0A9)E0BP<.
M[>!J=B[;2&R4M>K1:,D:^V9K:3@)>90&WB4;--2GW?+/B889>_MZR#???1I;
MZF,OXPFJUL0N)GX\1KJ9`")'XXF+M0`31CZ"#&(,E$$P`_H(XZV\93A,X=6P
MQ5N2=`PT.=F%MP1CP6S0K,83Q5N`"TZ(-?3SE@GPGTDR-,PH"@QO"8>@*).5
MT<=;V#X[L[5_QP$9#@3<`EA"`"8/FA,")F;U$4XX:K-ZPX'`3@)0#NVS2(";
M)6'@YC[I!%-P!/_3L:C]XQ&`-W$RBWW<;A*-';`8(O>*$4KG:*[LOE_@.4.8
M,1BU]QLA`P&V,MK`<:/1T`^2U-XQ&C%HA"1]'!<0$`RCU-XUF"\@72.`DW/7
M\21%<\JQZU&2^FD4OY#G[CA@/^<,`2/A(6L'PP"P.AWNPO=&0$D3DE(:9J/Q
M!)80;N-YP)U3H1R+?N'@)_!M@P4URBP/?TGV@PR`-A."P,)U`%!&"966<_&?
MT43LH@@^38(Q"1T@D2C<S(#`,`,=!C`\:'`@M-<`\GA\6U@0NDF&H*8Q&0&X
M1TI;`70<C=(-+`C$VPCD:YP(_P(;/0T-"T(%8YA$+V-!K0-JL)\0C=`QHR;,
ME`KS`9P=@EG?1XQ#(-9)&)`5"^!'I$QP92".G80(/Z%?(B5UD>%!7\(TZ'5P
MTLTHB6%Y`H<PF!A&/D8?0IJ\E!!W&["?$&&#H"_:.X@G6`-CO`LA[L<I$)0<
MJP;:/A=5&3:5&)<9#;P/]6+"0C@F4L/0$1-ZEYY-C$UGTR]'BTD`FA,KL,!-
M@PF>[`2P.YVD3C,#%0=\)DH`>&,"7@"Z`&@.VT@1:2X,<>L3U,L5)4[P_-(-
M=!2#IA8IOCM&]\.8Y3H8+L$(F&I7?=Y,1DW0VE2DW*),15$P$AD^A+^"H)^,
ME&\4#S,0_5AY3MU"7!RCY(@"<<D>3^4V=6*]]DN2Q`6;+1%N@M[+(7DOT6.Y
MTTZ->Y$-TS`2B)(#<AAODM[*PX@H`$M*8\_V0?:(;^5>Y'U$L@_C@'3NV+CH
M"!$2X*:R9?3D)?&+)?AN`_8R#N7>:VYB%,`VDG@GWF&\<#;T]H<Q*$2C\5;F
M(:XW,I[PR$B5&+?%>$=Q&_YRW&,"K'A(\F,8`6HP/P.^`$PN<O*/@^"`U(^)
MGPY3Z]-FY@$J#PHJ4AD,\P!Y#L9O`G9,/_-`?$YB$0\C`&`:Q,I6AF,#P[>+
M1B^T`YHL9!2A*"'=!N@R"EB[G80HA_O=$$!0P,>0/HB8R1L!7U&=KAY!C)I-
M&L<&IOH;M_8*5G8<,IG#'&-20/<C^#89QKL9`/9&8;`4W<NT4:P6.(GH6U!X
MR#;KYQ\35/Y(_,9``6%$1^E'J-^"5>_<+!PR^@C(&\:DQP<*WP^9*[KM'C\,
M`MBTG#ZI@N)]V.<&2<&X<P&PC8?L/F@O'\&:6X"(Y*ZSM[./5ND(L#O:S1>R
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M()ANB=/<&D5[$(.CP`?\@$VR/F9S@L<[;(@J]:MTY/A4YJ-[,0<4F[%RU*^8
M^R;"RF%'#P"&>0&3S)K%+J1^F4J6HD:=6%&.IK5B(S"&6'<EY>O*W"QYX+W#
MJAH_J*H:YD+GU)J,$*!1?0/'\5U>:I_)%5:KQ(_?N:GM?D.L1=WG80#5L\^D
ME)MQI$I:BQ$WHJDY`:^JGJ5QT%KG,-0V!MMPG*US">0JL`ID6:T.J/[C@DII
M"7AXVT5M]UCEJ#VLCL)7<::1L92OY,CX;)ZKN+VZSE=?(88@=.A7PL"[O.)0
MS7FAVE1R3#K>4:(/W,)3'=@NE0PIMAW(-K/"A![S#,MZZ**1*@Q-%HQ4CN6*
ML%4ZQDS//L++V7V.@7HR*L?J8#DF7#)AD%I:IQ*+Z>!LE5[1E;7LTBDTHFO=
M#+HU7YRKLBQ$.IWI.9NF-3!6U4&)J`+R,)X65VI5QV0::Z*P&K3(=1]J*6>C
MB5#G;6%Z'NA5=!>!LJ<JZI^L(%2,3P-6Y4T!,RE.L/ZI4YR34(=X@%X%K\IT
M]%:!@1+U1<&N]J+1EKB=%\A][*\?"EAI-7UXEI+6\W4F":;+-;%2:2,(A)2A
M7LIG:-ZB2D`%5MN5R#%^3]K<(BN9`['-FP738+15;M?)E;=4@1S&PN9^2<"6
MMWB!1D2O,V`1)P;>"2:N-,HX&43606H\.E;C%O[:6*'>JQ4U*8&Q&&M;K_A!
M7JR$G]>4GJ94*L&AOF4T([95N*C,#MO[SGM/$W"+:H$)1R#7BB>`+4D6(EUT
ME<3Q*KI0I/Z#,QQ\VN)2P`)F2@&BG$FI>3Z0Z:(-T]F[:P"?'N8$,H#$HK48
MNRB9[,D$CFY:-UZ1@@0%K:FQA6*A"[4S;Y$,4]X0QUQ00251^0T>4]/I`C,O
MK4)5*!WMG=D,81.:X?*D$AW&KI2WTI+W]ME^19X%]IGQG2]H(%B>L2`E;:7"
M/1L%TI%9U3:W*G)]/G'[?(S&MUY8\U(<[_-2FAXK]0IX#C!HSM#`K*MZ)?(.
MQ<87YK!M!L_+I6`=BD"S"(L+;-EG9IV479C=67(+]`(*7.)`71U&I7_D$%'&
M(S-N0[\E:-2->_I&(=/,5&KFM<[E,/@@I`.TTA?LRF*-&8SB(&>,D]C20_I,
MHM"H5R_6CI89,5(.+L=\PEL`,JRS7!++4>6B?TD=R@VGL`$GI:#>8K;V1W7"
M?)4OX50*88Q*)GJ5Q4V-OL7:5D-Q)?9B,0U,52?EE;C4$]8X7934%+@@QMTB
MC'()$I;$4[,5!SZ*K`:@4-82^VVQ#K(*<NQOJ6NC(I,PLAPQJ2#`J)SS/G5R
M8.*8KDS@!@+]$,,B2'=`?G)<KF]7P$+,XZ[X)RZJ*5(OP\@XK$A*/XG^@&5U
MD0FHP9E#SM3H"D6L7L**>;1C!>U"AG*J<S'E&$E(`O/3#B.3&]9GU8P[]R`&
MH#3''%*94$7/%ZK2!QAXP-R4R@N[*!J[M]2-S%NLR7"%A["//77,L;/([(7;
MGH-&EX/?%!@A2")*YE;Y.4!`.88.6I7LB6*J(J=>"C4;6JO\OB+O:J6C6&1S
MDJ5-%3OLY+PMQ^)044U[AWO0I5'[1YY3*_>":7N-W;RQ\`MJG\;;6HC50#&1
M))'ON,9XKG'@,7N6W("OW,?`Z&T?!,55<LJ3ECT#[VT^S5Q)P5-0;<I'LF#)
MGP+/5P4:L5EUGW-<J:FN.Y-\QP(7^*!/B(5LE9NV$%2^#):XPFR';$9YF(JM
MP5I:WW"]V\`T:K;R)NJ^<HNZ\9-T@6E0;.?PU!3<D^(6.-3&$2\IP4N2_-!G
MP-R=)1"[Z95TT?V#9]A3?LI)Y:HI"Q8JUB0,X,<E82F$VAC^5*08B%9V:^I@
MHE\0I<S!'%W54B457M/S4&8@;/:V+'^R"G$K5_25%:]*_>7E>ZX;>R*@OVHR
M#-7C%]-AF6MSXK$>UE:(*&>'0N7!HKK.,)+U[)A51%4/W;3C!3VA0*CH_"[*
M(ONA!"&"V*<RO#*3]X4+5VGEL&^3<5;QRWV):JR`E//R_EDEW,$;^R@L%OE<
M9WR]H;8>M'ZD%Z9.'2[(68H4G<NN<MBBSN:FHL6DBI=WC2PR79V6X(C9ONNE
M=Y?GEA:M,UA)#V<V11[&Z;Q@GSP7W)>8:(`J8,%"&WBY`31&9W.2,T'V6?+S
MN.Z$P(UL"@DRMI+O>&&D&67KA:$X7@,S!IF9?%<B</34/!/(3V9TC3-%(M;'
MBCON2>0SHZD$PL;*43%KG1@Z#BWWRAM?N%_#-=BL;;WHB$3!<-$YL'PU$96%
M=(:$R+72"(A75;&%'5I"C[U+F!;:0&#,^[1^LUHE`!WGW*M`;'1!`--UR5P2
MSJ5VDDXWE]8KO)M:[Q$7;,J-2#BZU_"%D(:B'-S8"@APB'N7Y06AM%C@4YVO
M@"D#6/B<T8S;R"RI^'I)3YL),ZHOHXN\+(ASF1GQ7ZK3(,!7&\;\R%6!$%4F
M.I$,):\^H!R:L7M4:LK;ITAG*E']ZAD!QJ!1]@J/8@J:/D*>=""&(/4(@@W,
MUM.51M\F$Z#LU8\9F#:WE#S,"$QM,5OXJ5JNLY_",`]TA4NZZ12M,L5'1,,7
M,"`ND8ZQTK6261M!M=&-Q`T7C]4+B+_7]VC+>;&RH&YZ4J'K$W4#>YB/Y7S-
M--'`?`T*00.+EAV@,/5TGG+%@ZGTA7VS1PDI<E.82W(NOVWZ$NGL"LVAA"T9
M(E6EK2C)>)'?EU+8!;`>:W!G]\;Y9+EF&<.DA0HAPVW>\$W29](^+>]BBRFW
M5,(GNJWL[O+R^.I;*IW2+E!&6@=76K,*0S1JG#1J\=P#XUFQU`D#ZA"E:KI4
M2CH;R8Q]K()!/":^HYZS>/%`)9[=4'[:J9VLQGGCC\MULS0W.R!L@_I9%!.[
M3%G_4[ZQ9DUN7)^=GC7]%PU<GQ4H)7,B#[MZC)T=9?,YG.8VJ[43QCF?W"F*
M!]'>MRF8![R2LW=@P(J\.BQ$G]"8M+Q@1ATMK*Q_G3BN+SLT/"Q`(*GYEFC1
MO"?'4;C-I+CC6ME$2B[!:7!UGA/M?+JA^P13>0Z-,]<E(=7.IS!^/+:7W=J*
M:F-;^KBPQ^PGRQ1A.+?]8!FG&[`IJVQHJ>6SX<CX#;M;HCLE>S'K'5I3#NFC
MRO-B98A9\HO,UH$%U?9>C#'[F,TDM9`Q6(VFM'<\3VT)B*-6[W&U@T%C3#YT
M8V"ZF+['G9(#D6G$=H)8YN!120T*##(<L0/EBAPHML.`5`2LV$,R?:IN4]M7
MD[C7VVSQ$VZPK+%*3-.;X=-A@;8%7Z!1F_^,A26!#<\$MV`&HCHJ[%%WG18*
MW=G,GU'Y0HQ283.#(2A3_JOW4#YA$1)?'W1!K72D1B?AB7MB6MLMM?+@6R-^
MFG9F9K>]C`CF8HIYBVQ\U3E%+2.,CBW'H+T=C665_;3M1K1[*`)Y(?L!O+M8
M5^85U0`GH_(CT[5P"ZHIH;M@69[TV?,B>RRFJD(E(BJ)7-W>!ET@A@JUK8/G
M6DKU%_8!$A66.#I@-J^*_0;/WGV948L%K$F3SY>J/!XQ:11<&2YZIF(K2%>D
M.]`9NIK9:U(@LE.SF*6R]YHYKFQX/9#%-V6GA:6^6;I;_@SJ`,+-TF^*[@4^
MEIHD1,!:4WJE3]DS;0/+<GC</T*4*Z7V%(_(UW/;W/35VW`:50-?V+)YTL/F
MBWM43(K%;(T"6:>2DJ*$#];K)76C((U>07'!M5B-;D3[-M!1U;)H``4(@HJ4
M?..R)\@7!NP'D*L`W3_&&2:S6[,61_!73R<0W4Y/NV))7Q957QL<MGY86&U<
M"'N:\9,'5ORD;H@K7D9AY>R(,%`A,Q&)17E(F\LD/U3VE%6SIA]6*2`B<N@Q
MJCHSH'@2]$QC^3^=8J'AU^AF6+2N9YNM#NV&P*I:56M>U@;UM'*AHCSMML^I
MT5;%V]16A3F#"8ZRY!KY\97;N94T:.3A#(V';&4K<(U=&H^A>5`Y,5VW1.H@
MZ^Q1GZ;$<AC%Q[K4$RCP<7:>:+>XP18V%#U6V]B"0Z%/@&#1?D7%=EHJ5Z<U
M;X-ZK!W3[:3M89<CT/W@;G-@RD7)?78H!$%T7V8_S&QQ!A),=^@[I*))?(??
M0BBJH7Q3D2K[[#T7V`$0Q,A'TDDDM[/E`M$H)4B3\2\"EX8=HF&@^C'JM34D
M-I=^P_NS64&JZTRNM,J\MM1755:)O0WJ085L:X[L(5.)LO).U.3J6=E>X'U#
M_UUI\*BK(H93,$B#;P["P7`(SPW&*7V.OC'C69OQXH'TD_6202"?;M;5`G'R
M6V!Y=WE!S?MX9)E9CV1A=QB.O_$.O#">?..%24*?Q^$W!"QGIR-C0S!1DD^"
M1%[^<\'5C/G2E?/]16L0XT(NC=5%AY!^BP%S=$)IJ]_2+8X:]+&#A]F8-GE)
MRZ#^=RH*BDF?W37NI6N#@!;!01SEG:_'DW`Y($&L,(KZ2(DQ"UQ=[F.3`37O
MCS3^2?\U<J\9H`]TX&%U];/CVIEVB^(&;;D*@3IMA)50ES\V,%=*?RYK!_`Z
MM2>(6YD=\)[M?;!JKD(<T:0R*E<S=HB8Q(#KR5SFE6H!*B46\:.)912?OO)W
MK5=:K<?(UBGY\,FEC*X`U<617A$_5<O.?\KQX@$9'E;R`SW%W.C9;S<:D[>+
M:@Q<RU'-$S<NJ,'(-BQE^QJ\Y7S=:B]MFRQR-T%'@G?&N:E2KKDRS*,C%.R9
M#+!6BLOR!*(A:3-.EJT"/;0GF+?;`=J%PBP3%\&E471SV&753.)L]0]N=1-U
M0EP*`TH(H+I'$O\O`:[&!G;J!HM1E"Y65\4!C0C8/?!.T0U6J4R"]V`2'+RG
M8,I#-F5M@6`KVG`:!5X+>U0#OFX3T;2HINM'Y?V4BQ@.^`,[`1EN*VJ4C#JT
M2`[F-+U8TFC*,5S(9_I1\:P?\7*+#$:9OZSZI[>BS%O=+>V;7CV^5FFZR[E]
M;C@#GA[RU8,H.-VH%MLC\%2`:F\V87E>P=@S03F:*;+(M&H=P4F)`U3UOC22
MU2Z)!"?,P<<87]98EQV=BYR05]:^!-?7$7@!;W"#ZE&UHA%M4[PSB]+[NH8#
MSSM0",8J&+9YH$@1=!2U@C#P)8PEK'HGZTQ%(.`&WW0W.Y\/*#R$Y,(I5Q:Q
MT@N^7Q><X6!C>T?#P;7/1$R2TTG&4TU9;7]:N8#/4U,SD0@\:P;!-,H%VJJS
M%<MO(@U\RU]!WAFYF=)GWZDK>2F!3W)-W$EQ:?^^(9'E\NKD\O#TV#OYS\N3
M\^M.NLJ&2EH<A]=^W[ML!66I6*Y<%UPT%@K?]_=?]7]G*9:GZ`BBHZ14Z8"2
M%4?^.(K@_`'HF'>6^,$PE:XJ(?>1P*]ON'5X>V&4M,?C4'&RL)-DY`XTV.VI
MC3"_N#RYNOD]]7,\^8\/IY>.`I]V#TCW"PV<YNR.7,]N+EDY[*T96/>YAW'$
M6DEE3<@5?"CG,L)B&('W#C1RUL.YN._/^+E&6&-BM_QSO;YEOA<'_B@8>W'L
M#X>35@ZE%5*Q'XZI2L4;*H$0IYAOUC@`O2*.Z-K#)L&3D`X9T"/!*@O6<(T8
M%TY8Q$'@XRB:Z!N!W4)=FEUI.T3[8WXKOJX;[9+:Y9D-B/3CR=L#[NA[<W+T
MF_.+]Q??_]Z)1EP2UO5XM^QP(YZH7DG.'MDQQKOUE-_:<:KB7_NB.&:E)[EF
MHP,=^F$<6Y]TT(+S#4R.3L*Q_E<_'8$5Z7QC.`RH3`?F(0:`T@I;???C6/II
M3(F/*193"8,&'H-,`R7QOP2/1XCI`:+O/LXRHJQ[2V?;3U(@$$R&-9]^=$*=
MT3R!&4=#!`86<DDG(^_0GL\*.=P:Q802/K-<+MP9Y@YM)J*$@7?,BG&W?#H'
MK.2<>+85OFR%;#MHI$VV;EEMR54YOH#PAJ\?8'=X%T*A.@U];="$@R)X1=K.
M&1GOB2=@/0Q,DB>N$`*3BB;IE^4+EQRSC$_?H/V*MDA7HKL>VB1B#F]00J"\
MN+DZ/#XY.[SZG3L5E1N4.9_'<O2'8!/-L;@%`;RE9$\E6(JT5XHKYXC0A8ZP
MT9=PH![INNN@,.MN**H0./JL%^8.UD0?\<;)],,\+FYPSVYSM).P"C<57S0!
MQSA&S*U`M!5ZU[0S6375CD.YJ`1MO6H%8LWG/+B=?12IL6VWA6)^@%\%MYX3
MR$D%?U5A4F+#X<\]D)$X#A.!W<->GA']D;U^G'T&;R5CGIU17UUH&G&/40PJ
MBET<@HU`]JXGT,GQE^L*P%FK*WJ\"3>75JW3^<*,_](.XI>,.[#W[LF^%JL+
MBTTP',PG>8^62G7G<2O8=3Z-Q]YD[*=I3+U1>-%REVN(*<4:6A%6T4G29`/C
MCD;(!!+20-*AE&K>8<V*4>-RL1C<GC>9@,:1!*V4@'L.+\$9=42V@'D7QDT6
M7#>J]8ZL-!!ZQ+-\KZ3H!ZZECFXP"F!4/>H+;NE()$]1-,S&5IUU\NTG,5V"
MMA6PK8Y!4(&W8'H"X-,&?6T4I+03,:H%#CO*+,9U)09:6Z<K"#B?@F^E>#5.
MT4!\'PN`#<>B#([]R7CX9;F^KD8B@5+=_@#=..%^=G]\\N[DZ@H4NZN3'T[.
M/YPX.3U7/FX_VF$'JD&(-)HS[1LHW,1$I"MPM`,JK2!*8KL4>TK1O.PH-]6#
M5;(C)S:I5@O$;3^BI:?:<3^K)$[VI-F\3D5SH7D^%P30L7C2E8F;KG!&1+=8
M\!*+/7#AYW4M"9?G)3#;<-`M&<,J012`LBDJ@:IKNXW!;4&'*R&<2V31*.)U
M;-_N3V[L(_$>!/PQB'FT(D'"GU\?'MV<7IR[=8*)U,CN>TGI?]J3ZR:&OYVZ
M4)@<$OL>[56+^&):1!MOY-:#"LUT?KLX.[LX]ZYO+HY^YW!5"8TY7[V\4NS*
M]?:F.N^!<D_9[V/W/KS\/O3,O#OA<C#QO3BQO?L6I*V"QGM8`DH.!+V1Y+!2
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M%?EVM`L?E6*PC=GHY+#H2T[AJ'4^7?,-,2C3W`[RV<HN,M$RI&Q+?@[J:X`$
MYKY+:>-<;8OI(&PB%Z5O9))LT2)%A2PZ!T3)FE(1BWBN5"?HLK$GJ9C`2\'*
M4'TXP2>N0M)M.A3^;ZX15AJ'57H0/-*](&U13*MTDXS:QENZ@1+`(9;NA?;!
MTMG91"17="K)D.Z5]=.VA%P]-$+V&4/FC`?P)59@D0P4'EC=(S>GID(0?-'.
M72!5$3\4+-RK@A%2Q5[[S"B>:1$F\XN75/*_7.7E037:MBJQ/&)V0]48N.;2
M*ZL'?>]OB?EFXUZ^UEZ4#<I`^<M6`1.&#EFU#O41-J6C`D$?)+0'!=6FFW;3
MZB8%4L._,Z#[,'(H3$3';TL,<N,6WV(<"1^.L.9].FG=^5,W\V?3*10S1`VW
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M']9\7DZ5J\PU+&T5"\0ZGN\H9&K:`5T_KYXWP94@T1FN`PJ+1J2#2%\AUG`[
MG9"U[NG&4O\X9+-]XD\DFU\6TR982GBT*Z:-AEAV]V5X=IWGPIZCOXFQ]O;5
M6'LUUEK&6A<G_FZ-M4$2O-IKGV*O?9:%,$[\<?(W,1"P\=[DTV;^)>V#<!?[
M(/QE[(/X"]D'J<L\>+NS>=`I[$UT?6&5P/M1A%[G27(H7USRC0A&3OQX>'5U
M>'[S@AC*D&M;]@_5./X:;](P,CMKY/05E"R,/+V1D+><`W?]:8&U5"4MBQ-T
M6$,\LA^]Q$?W\9&__/G_X1]_^?-_OU%B$]4"72TUUS5`&=GQZ"@CL*S:8H]%
MZU+2,.6M!OMO/4^WSHM<';^)AP[;[FW6+;E:,S=119A*T1XEMM>ZY`%"PJ=<
M`=I0DF#/LJ"9<$+W'W*5XWL)-G0R\SF>P,T-)<:4[YRM4@"X#LG_NY'Y.6.\
M;FP8."5?RY@3;-T&8:U<3.TJ[@HMU/2/HDTLK7!&NAWS/4>J(Z^D9R))G2,E
M5F^`H[Y62F<5EF_G)MJI$G@QVPQ/[^95VEF2EO0M=`K?]D52&KCHLH!"^/73
M0RF!Y53FC4+%#D@"Y8_+>?F<=Q0R5V4"/HA&JN(`&(P-?K4.T?W4O1\9-\^R
M'*N6'O>*);CH1?MF3?@D%QDB.7O/Y<NERZY.+<E60%F+_)EN!LL>65=637+&
MN[ABM<IS4V"2DZK432LB,%9_Q2@+\Z6OBTFNIW8&@$RX!1PJ5G[5P!!._M!X
ML1DGX%$^!I6#M@4E6>EHO,H8I#+>)%^NQHC$M8S1SAIU%CCN`:<`Q,'Z^K(U
M>3W$7T5W8KF/^?5S*06CEHF1EF0B6\#E"@?LHLXD#T:J@*RJ<D[)Y:J0NJH[
M"9-1#X*RDHQ69MWJ/MUP1+,7G<<LTPKO),5-%XY%Y,#TDH94%NU^RJGO6,`$
MQEH^J(*P-API#%T2&J42H<HJS^ZQAH5N<&*%$:D5O33XAB(UL$_C)."O][B=
M;"L.`W#:+G9SFR\`F!P5955RDGT6[5;P5#>@E0?_U(JHHWI!.H^:EZ\;8[35
M.XZ-,&%S@LA2M.^YG9"V'1#?>>?:AE%*S8_MI+V6^^+")-+YWF^S!>EXHI91
M>[TAN;'V,&=WXGTOJ'/`OT=^..;K[7``_SN1H?7O@8=?+LG<0]6'>\M&_G"<
MTJ@853>@?Z4UE-_5#3'.>L*B=Y".]0IDN*$73UAZAX-Q;*U`_^Y8PY#C^K@?
M[WXPB---*QABC\.`)]F#:>)NZDB?UJB^WQ35_W(UDFJ6.W7&!^.+5=X;WRHD
MRJQD(05<.<)+*C54&=?I-14C22<G:[H;+97Z2J?&0ELRXP2;[`$HS<RJU8;#
M8Q8.HL`H%+YK:6@Z!]XCUFI%CPAKLKC.7+D9C*]8E;:L)`=_A2'B6&J^8<'[
MQF?@JV^HC*WI1*83NXWW:S/1.C-2>^+#;/K4J*%0%IGX-&=49>9RC++.."7W
MO&@0)5X8?)M\"Z.-O41]'PPFJ1=]&X[Q^Y$^"$16@'(L/Z2[[>0+\1^]O\]C
M0-A^=VQOO\6!F+IW8CM)-%8D3[QB,],)_;'`%Z9UL!T%9`*Q@^WL)XG-83""
M^`@GF\_5.H?8052?+CP6#8;X;Y=9A6:H<#!,MC&K26+.?Y1VF)7I<_8^SQSY
MA.W?-S`O3%0[I-Y5[T\.N_F$PJ\X=[#];-/8Y?!31+4Y3JK=)>K^FH/X/.*(
MGO):`].X*D'=J]%3H-L8(>4HJ(CO1JP9N[ZZC(K)7PA:9$54M%)9)=P<B!=#
M92@H,87T$JQGP02A&)PJ5X%<!PO^L!O6KHRS>BKE'5R*60>P'%A!U%T!S\RJ
M"0PI'B8P\"5<D.X"]-V]W,Z,!@"&1?&X?O3$Q43;;`35TC;8/#5Q"VC2*B50
M:2^T@N^\W_=?FB;<AW883C8]-?*2,;6XY<Q,WAA5R%RI7,(P]4=QTL:>L^R/
M:.RH&.3-/V_`TK/#WUY<>4<?KF\NSDZN7B)I.2&S]?X6-OI(RS*1T]+/@=QL
M:U6Z3_+$\0"H>B0>/;NW=42S:)*F7TM+FV1JOS25-3F=PORMEG@HC3&!AXPP
MZ<+[AKX8CT?^)`+]:01?J&??4H/L=!RAEO$-"A]L>!R%7A193QUY8]"U8QB*
MGHH#[O,]MAXY]O"B:1Q$&)OYC1>-)_XP33U[KA/`G8D_'H;\R!C[NP*WA8_8
M>HS#QPT8L6$K*(VCF!>,R7>QGTS&'LB$;P2U,$4X"2(_'>&T."@V[$QE#OR[
MC1IVV<U-OVW`KM/S(T`+[^;P/_OX'^=CVL^A:N52$)HAU(A;U*=`,V1*WZ>,
M-T0=K(C%)1F;_&0RF&BUB;!/`HS)@(X"D&:J:$$4Q$//55F7*I.1FYXK$X"Y
M)!UA$"9-G4@8HW:T!B..*%:.$%-Y=&KY"G$D;C>GWQM3]436/9;*HC7/B?>(
MDP*HOXLQUAIE]-6X7!DTAPU(>5@B5-J0E'`V-\=]<#X0.$N)<&T[ZF9UZ!!I
ME7>TQW74P.3153L/;)EW[RRB2K7D5<547?E2!6&4'XM:50MYQP44[?5)=I:I
ML:CYTXMLZ\A.U7),HTSH;,5N)<&>[X`MB]PV+1;VO'B8JBRND).X<BR%K7,=
M&1;'%BSVX5Q0ZS'6&K:-Y8\_."J\[H>35'X&W*9/Y_GJJR:X[KK[`!V:_KMI
MGA[^U*S0I2M[J,OG>$C%?QL5(>"<N9:/-#_!JLR(8,T*LWP[4M2V1.ZY'W$>
MQW&G7FWW&,Y[T)HO>3T,.X^4=NV/4X:8$[#F43P$_>P;FJ);.E=#E&L13_,*
M"Y>V"KIH[WVGF!'>%4MU9FGI]X15O1^*I7*+L=/J%,N*H7ZE,JB.RAG>"[$9
M&4\BL0RYDFF'52C&!(0H5<_;W)5H6C,C<A>W5@),"Q58O/7M+-($_=,X[.%6
MNV:?KTF@4A6IN/CI#DM%5KJ#?%`=>>R"U+?<DXHOF[6?4:]?MV?#I62FWCXO
M3=<@%>:%KLS:U/;&][*G9J%0TB=+XV6V=\.=4&H7#\[K3NK)]?JVSO^T1IYQ
M0B6#MCZPL;'OV^N3__B`R="8']?QPH@`GT@#W];#*%*4P<HY.\89$D;VE9(C
MEP@-`G098#CQS'B634`O0ZJH5$062';E@09.G+-$D^MQ-;F849EVZZC&<=D,
M^%^)M[?J=AV+'E7Y[3.^1E^2TX0#B]*-45`H<I](,.N&B\TP9#I@-:%*`)3"
MGD55K[QATKW?8[`5]I8XBJO5M_CP^LB;),E!.]^,&@D`)W@F-RP*/B-Y:H,2
ML,>NL+,[8:C[JMHINYNK504)K"L%UO97INH05PRBXLW22]=:C12]6I6JEZ7J
MN=<WN]5TD*01OV]\]-DM<'8'S>S<!'M??7K3'L39E'JGA_Y1.U>W-]=N9+WM
M]W^N1M?=7+[>OM<O>/2U17:C178GF;*O8_;.#_XCMM9N;VZ'3MN?\,IK<^XO
MUIS;>VW._=J<^[4Y]VMS[M?FW*_-N5^;<[\VYWYMSOV/V9S[*W=S[AY+]Z6]
MNK_0,*\MOU];?MMT\-=H^=US#*O7EM]?ON7WCB6W6<S]?7<`WZ70'^[*V1#\
MLU[V7KN)OW83?^TF_MI-_+6;^&LW<?KYM9OX_Y1NXALC&5^;BR_^>9J+MT^Z
MW6M\V^^OO<C[AOX?V8N\6^=W0VOR%SW\VL?\4_N8=ZU`=UOS79][;7_^VO[\
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M!]UW2*W@2`<[47T_3%-_,L(FS7M8.,A/`VQ"[GY=<FD+^UY%AN!VH3S$:!*Z
MAL#T::+MWE>NBY__RB<4^>-PY$?Q"#^-0S\9.4#7/J'0CU)X-`GI<Q!/_$FR
MVREA:8^1/QZ.X=,P3OT@<KS7=U+I*/*#4<0P&P<C/XY&+SVJ=!3ZXSA68R1^
MFCK'L,^JYQT#>`F8%:GP&:]>J^+]7^DZD:;=AG8)826>L1\/L=7L*,%.M</>
M$4\Q=3=C:ZL3;[M'E1/&(0Z$[7TFD[1WH./<#-2\'#6C[<<A%9OA[8[PI$?!
MANW:B^O$],*2@$0(QP#!1LFH7=&EC\W9CA^NSR`EHJ5\NZB)9*,?<NDD!S75
MJO`66!KHC;5H3\8YU-74,:I5?>F(5T4B2;!2^&A(U)[X49(0C.![A%B0-B_"
M+9!R\9O1**0&P_XD99J+L!)B$G4;F>YYP&7A!SC:"*@EHG(/TLKTL.F+]"Q?
MY)XW\<?PV!A8-8P_G/C#\9B^G8P3/X3E'C=5\(;#$S85Q;&?#H4VL8%5%/!G
M+$8T)**U.R]C+M&T6-$#@,#(@M0+PTGLA_%8WD[\`#AEG(S;:'1A6,.5M?<T
M`?8?CGCF,6R;`6V*`S4!K5RU5"4)),<P2IJ`!LG@QS">@Y=130ULBI52L4@Z
M2,)6/Y@D_@@&0$X@#&@?.0*N)`H3?S(<=W<*LT=IAUHHQ_.=YBN?,IKM47"S
M$R"TA`:!LQX2Q7%-57[9X2_'7<*Q!"DBFIPV`#F&;8>1=V1L`\==);'%!$3\
MB/F$D`-\.\%90Y2#U@A]O`9;[B"DA\WS"D$-2.'0K1$<G&5?RA*\:=!)B.4'
M(RI5@Y[$$W=;G-C;7R^R]0Q3L=]\]VE<HH_:QQ/4/XAZ)WX\1C2>A%C0:^*B
M]#`FLD9Z'0.BTA8`7<-X*ZD/ARF\&K9(/4G'0"*374@]&`NB@?@93Q2I`U.:
M$*7VD_IDS$W2-6^(`D/JX1"T"5+%^DB=E=@S6T5R')!A"$"\0*%!E)+.)6!B
MSAOAA*,VYS4,`91)`.70/HL$F$L2!FYF@#5SDD#0,1V+;C0>`7@3)^WNXW:3
M:.R`Q1"928Q0.D>=;O?]`@L8PHS!J+W?B&HD)\/1!@88C89^D*3VCE'30TTM
MZ6.`6(DYH@*4>M>@XX&PB\+`O6NL[08ZIV/7HR3UTRA^(0O<<<!^1A8"1L)#
MU@Z&`6!U.MR%#8V`DB8D-#3,1N,)+"'<QH)BKJ3WIDF_</"328L%<9D4'3S?
M8#\.@F@]_F49%+((VFX($@97"F`;`=L/$B>'&DU$O8S@TR08DY0`(HK"S2P*
M]%M0.H`&@@:/0K47S@8/>`N30FMS&*2,!R$<R$BI%X"PHU&Z@4F!/!J!0(P3
MX7!@ZJ2A85*H$0R3:"=]!'4'U-3'C)HP3BK,!W!V"+9/'S$.@5@G84"J/@`7
MD3+!>4$Z.@D1?D+C+27MC7=+7\(T:)HYZ6:$]1Y#V6483`PC'Z.AE28O)<3=
M!NPG1-@@J&_V#N))0.5$=R#$_3@%@I)#TT#;CT%8Q<1)-Y-C"+P/U53",3@F
MTHK06@V]2\\FQJ9%_LNI`@G8MRGKD\!-@PF>[&2,I=E2I]:/B@,^$R43+`"*
M[P6@"X#FL(W0D*+"$+<^0359T=D$SR_=0"4Q*$Z1XKMCM-'&+-?!C@A&P%2[
MVNQF2=X$K4U%RG?$5!0%(Y'A0ZKSW$]&RH&$AQF(NJK<2VXA+MXCLM9!7+);
M2/F6G%BOG3<D<<&$2H17H(MG2"X>=.OLM%/C@V$[,8P$HN2E&<:;I+=RPR`*
MP)+2V+,=-3WB6_E@>!^1[,-X:9P[-GX,0H0$>*5L&=T=2?QB";[;@+V,0_E`
MFIL8!;"-)-Z)=QA7A0V]_6$,"M%HO)5YB'^";!D\,E(EQFTQWE'<AK\<]Y@`
M*QZ2_!A&@!K,SX`O`).+G/SC(#@@]6,"5GQJ?=K,/$#E04%%"H%A'B"MP19-
MP([I9QZ(STDLXF$48T/46)FN<&Q@AW;1Z(5V0).%C"(4):2Y`%U&`6NWDQ#E
M<+]7``@*^!C2!Q$S.0?@*Q`I<9\@1KTEC6,#4_V-6WL%HS<.F<QACC$IH%3Z
M-!G&NQD`]D9AL!1]<+31(:#O)*)O09TAVZR??TQ0M2/Q&P,%A!$=I1^A?@M&
MMG.S<,AHLI-SBDF/#Q2^'S)7=-L]V!`$-BVG3XJ>.`/@MR@9H=GT4AZR^Z"]
M?`2&0*PG[YF]G7VT2D>`W=%NKHG]&,1.E#`;,L!$U1Z6L,TS0>X[D29\?O+'
M1!29SRGYUW>O9(9X,-%P#?#817!TG(A<_5,8ZD[>V7^Z\*AN`C-7QSA15+++
M55Z[I,9+07F*,>@D/$AW#DAZ@42+(J!W0`5D1`DH0JGWGO*4I+T=?LW5U-L+
M8"[.XY!+O]L'IR=3>[?M6J_FZM67;OJ(@W@J,X+'GDP2=A%Z(0+O'9PUGS#.
M=5?\C)]KW!-JU/+/]?J6+_J!GX[`M`2380A*8U-X6;G?^V#3H7O@#5F6P&_A
MTZ5S3UR)8@]+Q$Y"`B8<0S+N-`;*;R5<_,9D/>\"R6;!@'HE7(4B[2AF(K^U
M"]M\$IU:I1)=P]&FL`E);'W26<'.-U`S2\"J4__JIZ-!X'YC"`P5/0#(!,&T
MT"?FNQ]'-_"8N&Z*GAR0"?999H^8S/-?<I8C/.T`CW`?9QF1RF\%ZH#]#TB"
MDMA\^M$QJ3KJ!&8<#1$8Z$5*)YUKJU]?<KD<*H..47H8)[4;GW"^^=+SO+2K
M]4AIO16()&Z?S'$BJ,"JCD/JD[R',FM1JP;T(5A)*2CK$S":4]1PGJ0:D&0Q
MF?VEZ)>+T#)/TF3#>6"WKFB2$'&E0[DCWV'-"OZX7'0P@^XV`;4K"5[0"7:G
M0Z@M"=EJX[;;4;PV;OMK-&[K[<^VRQF[XA\[]<+_EOV]=EC\)V/E:SNOOY-V
M7EN[=>V"RJ0`NJO,]&#"7Z\+5(<UM]I`[;3!=A,FTW])F54OD)"O/9:^6(^E
MWL-S]Y8!L_7%)L`_;)<:;]<N-6W8=1O!O%C_^\?H)=.1ME3-&NG]K<H1QA-R
M-R'8/\Y763'OHM[ALAIXV'LK"H())U/L,)&,!@B=_XQ9]EUVQ&D9$EQS^^Q=
MO3L]]KWWJ]D`ZX-A#QA*'LNTVTVJ-.H6'1T;H5'W1+*"[J2.O4S0?@=($O2T
M;YSJ[D,YIP):)YS0J@$$\NS#];&WO]?94ZB<CN2\;O_ZV_5\H(5"E\!O!^@_
M</[X6VQBW??F!59,4O*P*QRJ_A_M83>^N7&UG3>=P.M#@Z.,5`2J"6:U.V(\
M\Z6X:`<EC8.]MM%(GN]67K#;LYAH+I6IK.8E\ZS]\HGTJ/=NR\4:5N1,OVH_
M](-K&=:JL400E3YC7T0'O)2,IW)RW#1WXEA\K_ZNE%"`4#LQJGL@?%-Q)F6;
M#U6GFD/=&N</9Z2Z=-H%;3S+7<]P6[\B/;OW?[S/6.MY.S],DGAZ%H&UMCCQ
M^7)=`2,"Y6S['-?2!@#5N$SAGQL:]J,:59W(K)ZTLR-ULE:')<ZSJ71GOR<'
M0]]2!5/:U@KG![<?%O>PB\RX\D)MU:!J/Y4.QEU^:[W:V8*"MV5B]N%Y#_V?
M-#;5_I6OQ;B!;M4/(4WB;Y'$'<5=,*$EVX`-/Q2P!J_GQV,L.&IJY*DJ*AU>
MSZOLG>.BU3&K]\&;I]*[V+9E3A=]VRPBX6D/S`X",=TH$*_SY4#?QVWZ,7:O
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MFXK='%ET[;AG;,6']"&*'3?2RQU?<(7<9UOUK=P[1($FM>#`='&4\_$.L7Z-
M[UF=G`[M;AC`K\YZ+YI_W7.1W'[,26Y]E\R/W%J].T;:'8,NH7<>./O9-3!=
M9SN^C#I?NJZYV\_$<M,]DF3"CL3LN0'OG<NZ".^!3!B.7?`-D\3UM7/@'LC$
M$^?`X]#-/E^,R)XRY_JYX0M&W>HK:)=D[Y#KYJ)_?7RR:A4*;S"F&KW-6-5L
MZ6(E[_]>:I>>,0;T<BEWR(%OE76R*[VWWQZ[-?TSQN?>26/W:]TXC^U"58=I
M=`^QJVC0J70(UQFML1N<=EFA>M/WP-H2)Z@98).^UQ?_H&[J.VC>$USAT%O;
M41Y])]43Z_$R;'H)6^@-@>DA_6,[B*2'_-VA(-M/[ATV8LREG,BIN1R7P@^;
MCLX=S;#+P=DW]QUDUR$4.\U'U_<=$W!+Z$F_LV)3^,G6MWK#4'H]#IL.32'2
MIM-#D'0&Z-=671!LAE&PLV,CV[]`7WYFE9-;+Y'-WV$]*&)Y'?[L1I3&O#U8
MW1/RL@-#VA[XT?-*(TZE:SCTQ:E\P@*<J+MYQ[O@!-U51"-R&G3N@0X9Z%2]
MA&;JFD#=)B:N$M(L+N^ZUFF/N#S<X;0U(0D0^NC-SDQV6A-UC\^<[]FIQJ03
M:G'@?_4O_^)R]NO++Z4W[60+,[>[Q(YD>)JFH/[GO+V1)^LR`I>J69H]#G4%
MD@M--^)M,/4(ZE)4YYAK<5T*M[@691')@YYP^D5AZ3S(#KNG:YD@VN`6BWK<
M8K]=PYOAIA^#T/WCT3SC6DF\RHU>JHZ+VA?0M)_\OB(W$C:SRF=]V"KE-WL<
MJ@CI'1SM/-2I7`*9VF5N#[HIY[Z;#[]N>^8[*B:YD/.?\RF5/-ON3&9?L+F^
MJ%%;>X>-7WM=5]L\NI>ZWMO.B':6/0\PYLC)+6W_:R<PC+$P=/](-X=1XO[Q
M.)_J:\7.G.?E1UA0#_NVW@PFFU8;N<E771'^X&2/#2+=S`?40-?NFYR<BD0?
M>NT#Z1OT=./UHP0^$`7U.WRMN9KWH3V/-V[*13=%Q%7>H(X6HRX2W==C-XW:
MA@Y2!K6I5B6)._2('3.F\ZRRO%%=[PL9<;L\*?!_NS/\M[Z`%XV[8(=YWW4I
M[7"X]H?46K2[YWW;<XKM*\R.UR2_9^_];39'_.K#AN_='%A'^;DUB>[77/'R
M5L7JN2?;$A^Y:0\\;*?2Y^8!9',O?N_$W)B_^$T"S\O?:\'OA:]O1Z==%&B;
M/7?YZ.=ZJS?J%6KI/0K!H6[_@CX^>J@/QSA5BN,C&NM$!TV/[H"N@$+Z+U/\
M5S..P>5BT<-N#+WH]?W;H!X:*N\A&[F?QQ;HVT,:].3_IR]XI!EE[5`,4(UD
M>Z";>2-K63V5_7XE#!`*QS+$J'<(4ISZ!B%%0@_2MP[+0@P1L]78FGUOXJ%?
MX`+FO%P<,.XJG#LUK8%].^#;^\-5.9]C37]\L[/=-J_KX!P'5#L]1TWFX=RE
M>%MZ=_E6=MF\\!?"A4UZ?9LT,>^'PJGL/=M;WN">V<[H=^;L?:Q\ER=[6/>F
MH]AAV"V<?3MBVYS;@=_"S"T\Q_N(#\#2``'W\/,9]O=U1=>P:LDWT"H)PJWD
M=2/I=^)L/8)F4\#\"Y[M<!9W^'R7L[1BYG=R\V,/%\![:BFYU1NAV\9>]D8S
MF.CX/@X8.2]@XY'K6Q,_WS=:&+G>BYS?FCC[OM&<=Y<F]K[OM8UK/^F'A.LU
M5Y!^[P#.2]4>1#`$Y\8O=5/8'ZG2C.K?X2YB][#\#O`Z4?H.>V^'"/V.DZ(;
MF]YCG6X,R]\),BRZ>Y72K='WKH7U!>.[GNU&U>^R;(LO;^2R%XZ5W+%(W/9L
M+F[;_CL)<>P2!X^":*P+MT=!/'1V<J7&4@A%J<X.>Z8?^,PZ'N\3*NR/[H%*
M-2@"(*E*\!WF--PE1*M)$_TQO@=]>EOGC0VL^+H=^)VI.&%5S]-QV)748]Z@
M<#<\H>(=5DU9:Q.#B6%MYM5OZWKUZ_\?4$L!`A0#%`````@`O((^1Q`[[*$?
M`@``O2@``!,``````````````(`!`````%M#;VYT96YT7U1Y<&5S72YX;6Q0
M2P$"%`,4````"`"\@CY'2'4%[L4````K`@``"P``````````````@`%0`@``
M7W)E;',O+G)E;'-02P$"%`,4````"`"\@CY'=QS8Q3\"```)*0``&@``````
M````````@`$^`P``>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"%`,4
M````"`"\@CY'AI?1KFX#``"P#P``$```````````````@`&U!0``9&]C4')O
M<',O87!P+GAM;%!+`0(4`Q0````(`+R"/D<'-7YD/P$``&D#```1````````
M``````"``5$)``!D;V-0<F]P<R]C;W)E+GAM;%!+`0(4`Q0````(`+R"/D>9
M7)PC$`8``)PG```3``````````````"``;\*``!X;"]T:&5M92]T:&5M93$N
M>&UL4$L!`A0#%`````@`O((^1R>K!.I;`@``;@L```T``````````````(`!
M`!$``'AL+W-T>6QE<RYX;6Q02P$"%`,4````"`"\@CY'D-1^E`8%``#4%```
M#P``````````````@`&&$P``>&PO=V]R:V)O;VLN>&UL4$L!`A0#%`````@`
MO((^1SE)#SC^`0``_P4``!@``````````````(`!N1@``'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+`0(4`Q0````(`+R"/D?9Y%SPJP0``%`6```8````
M``````````"``>T:``!X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"%`,4
M````"`"\@CY'^9YSSU$"```C"0``&```````````````@`'.'P``>&PO=V]R
M:W-H965T<R]S:&5E=#,N>&UL4$L!`A0#%`````@`O((^1V6I--0T!0``OAD`
M`!@``````````````(`!52(``'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+
M`0(4`Q0````(`+R"/D?'A4[DG`4``&T<```8``````````````"``;\G``!X
M;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"%`,4````"`"\@CY'0!1&)*H%
M```Q'```&```````````````@`&1+0``>&PO=V]R:W-H965T<R]S:&5E=#8N
M>&UL4$L!`A0#%`````@`O((^1Q93T52Z`0``3`0``!@``````````````(`!
M<3,``'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+`0(4`Q0````(`+R"/D=?
M+S,UNP$``$P$```8``````````````"``6$U``!X;"]W;W)K<VAE971S+W-H
M965T."YX;6Q02P$"%`,4````"`"\@CY'H())(J$!``"Q`P``&```````````
M````@`%2-P``>&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L!`A0#%`````@`
MO((^1U*S-X&\`0``3`0``!D``````````````(`!*3D``'AL+W=O<FMS:&5E
M=',O<VAE970Q,"YX;6Q02P$"%`,4````"`"\@CY'\OY/<KH!``!,!```&0``
M````````````@`$<.P``>&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+`0(4
M`Q0````(`+R"/D>6^?I_I`$``+,#```9``````````````"``0T]``!X;"]W
M;W)K<VAE971S+W-H965T,3(N>&UL4$L!`A0#%`````@`O((^1WD:=-6E`0``
MLP,``!D``````````````(`!Z#X``'AL+W=O<FMS:&5E=',O<VAE970Q,RYX
M;6Q02P$"%`,4````"`"\@CY'LOV-&Z0!``"S`P``&0``````````````@`'$
M0```>&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+`0(4`Q0````(`+R"/D>S
MK>=AI@$``+,#```9``````````````"``9]"``!X;"]W;W)K<VAE971S+W-H
M965T,34N>&UL4$L!`A0#%`````@`O((^1T_WI2FC`0``LP,``!D`````````
M`````(`!?$0``'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"%`,4````
M"`"\@CY'.-:GIJ4!``"S`P``&0``````````````@`%61@``>&PO=V]R:W-H
M965T<R]S:&5E=#$W+GAM;%!+`0(4`Q0````(`+R"/D?J/EEII0$``+,#```9
M``````````````"``3)(``!X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L!
M`A0#%`````@`O((^1^7O4<F^`0``3`0``!D``````````````(`!#DH``'AL
M+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"%`,4````"`"\@CY',HS]0*,!
M``"S`P``&0``````````````@`$#3```>&PO=V]R:W-H965T<R]S:&5E=#(P
M+GAM;%!+`0(4`Q0````(`+R"/D<J/'_KI@$``+,#```9``````````````"`
M`=U-``!X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L!`A0#%`````@`O((^
M1P4[_<&C`0``LP,``!D``````````````(`!ND\``'AL+W=O<FMS:&5E=',O
M<VAE970R,BYX;6Q02P$"%`,4````"`"\@CY'3Q.+VZ0!``"S`P``&0``````
M````````@`&440``>&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+`0(4`Q0`
M```(`+R"/D<ATB&!I`$``+,#```9``````````````"``6]3``!X;"]W;W)K
M<VAE971S+W-H965T,C0N>&UL4$L!`A0#%`````@`O((^1\55L3^D`0``LP,`
M`!D``````````````(`!2E4``'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q0
M2P$"%`,4````"`"\@CY'WR<%\:4!``"S`P``&0``````````````@`$E5P``
M>&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+`0(4`Q0````(`+R"/D>4%>(/
M<@(``+T)```9``````````````"``0%9``!X;"]W;W)K<VAE971S+W-H965T
M,C<N>&UL4$L!`A0#%`````@`O((^1P6"IY"[`0``3`0``!D`````````````
M`(`!JEL``'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"%`,4````"`"\
M@CY'8?*MO*4!``"S`P``&0``````````````@`&<70``>&PO=V]R:W-H965T
M<R]S:&5E=#(Y+GAM;%!+`0(4`Q0````(`+R"/D?F&KLEI0$``+,#```9````
M``````````"``7A?``!X;"]W;W)K<VAE971S+W-H965T,S`N>&UL4$L!`A0#
M%`````@`O((^1SY&(J"C`0``LP,``!D``````````````(`!5&$``'AL+W=O
M<FMS:&5E=',O<VAE970S,2YX;6Q02P$"%`,4````"`"\@CY'T=8<&:,!``"S
M`P``&0``````````````@`$N8P``>&PO=V]R:W-H965T<R]S:&5E=#,R+GAM
M;%!+`0(4`Q0````(`+R"/D?,5MO`I@$``+,#```9``````````````"``0AE
M``!X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L!`A0#%`````@`O((^1^D+
MX1FD`0``LP,``!D``````````````(`!Y68``'AL+W=O<FMS:&5E=',O<VAE
M970S-"YX;6Q02P$"%`,4````"`"\@CY')-#`Q+`!```8!```&0``````````
M````@`'`:```>&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+`0(4`Q0````(
M`+R"/D?"4=;ZI0$``+,#```9``````````````"``:=J``!X;"]W;W)K<VAE
M971S+W-H965T,S8N>&UL4$L!`A0#%`````@`O((^1[;3W9NE`0``LP,``!D`
M`````````````(`!@VP``'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"
M%`,4````"`"\@CY'+E;-CK(!```8!```&0``````````````@`%?;@``>&PO
M=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+`0(4`Q0````(`+R"/D=5H5"PF`$`
M`*(#```9``````````````"``4AP``!X;"]W;W)K<VAE971S+W-H965T,SDN
M>&UL4$L!`A0#%`````@`O((^1[6RZ;<_!0``@!T``!D``````````````(`!
M%W(``'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"%`,4````"`"\@CY'
M*M1ZY%0"``!-!P``&0``````````````@`&-=P``>&PO=V]R:W-H965T<R]S
M:&5E=#0Q+GAM;%!+`0(4`Q0````(`+R"/D>=VY<6)P(``-<&```9````````
M``````"``1AZ``!X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L!`A0#%```
M``@`O((^1X-8LE5M#0``,%```!D``````````````(`!=GP``'AL+W=O<FMS
M:&5E=',O<VAE970T,RYX;6Q02P$"%`,4````"`"\@CY',5GK83`"``!^!P``
M&0``````````````@`$:B@``>&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+
M`0(4`Q0````(`+R"/D=&-5K`(0(``/\&```9``````````````"``8&,``!X
M;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L!`A0#%`````@`O((^1]P#&X+U
M`0``R@4``!D``````````````(`!V8X``'AL+W=O<FMS:&5E=',O<VAE970T
M-BYX;6Q02P$"%`,4````"`"\@CY'EWBSW30"``!M!P``&0``````````````
M@`$%D0``>&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+`0(4`Q0````(`+R"
M/D<R&,29R`$``$4$```9``````````````"``7"3``!X;"]W;W)K<VAE971S
M+W-H965T-#@N>&UL4$L!`A0#%`````@`O((^1\@'U,)V`@``)`D``!D`````
M`````````(`!;Y4``'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"%`,4
M````"`"\@CY'/T1XM=D!``"N!```&0``````````````@`$<F```>&PO=V]R
M:W-H965T<R]S:&5E=#4P+GAM;%!+`0(4`Q0````(`+R"/D<?;*67'`(``&L&
M```9``````````````"``2R:``!X;"]W;W)K<VAE971S+W-H965T-3$N>&UL
M4$L!`A0#%`````@`O((^1ZI./PAR`@``I@@``!D``````````````(`!?YP`
M`'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"%`,4````"`"\@CY'O+9N
MVPH"```>!@``&0``````````````@`$HGP``>&PO=V]R:W-H965T<R]S:&5E
M=#4S+GAM;%!+`0(4`Q0````(`+R"/D='-DO<,`(``"0'```9````````````
M``"``6FA``!X;"]W;W)K<VAE971S+W-H965T-30N>&UL4$L!`A0#%`````@`
MO((^1R=EKV5?!@``QR0``!D``````````````(`!T*,``'AL+W=O<FMS:&5E
M=',O<VAE970U-2YX;6Q02P$"%`,4````"`"\@CY']>YEM&L$``!G&```&0``
M````````````@`%FJ@``>&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+`0(4
M`Q0````(`+R"/D=)',;/H0(``&8)```9``````````````"``0BO``!X;"]W
M;W)K<VAE971S+W-H965T-3<N>&UL4$L!`A0#%`````@`O((^1QNI1_5H`@``
M%`@``!D``````````````(`!X+$``'AL+W=O<FMS:&5E=',O<VAE970U."YX
M;6Q02P$"%`,4````"`"\@CY'&*1#A3$"``!W!P``&0``````````````@`%_
MM```>&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+`0(4`Q0````(`+R"/D>K
M_G>IT0(``*X*```9``````````````"``>>V``!X;"]W;W)K<VAE971S+W-H
M965T-C`N>&UL4$L!`A0#%`````@`O((^1VCL.)?R`0``+P4``!D`````````
M`````(`![[D``'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"%`,4````
M"`"\@CY'K!34%Z\!```*!```&0``````````````@`$8O```>&PO=V]R:W-H
M965T<R]S:&5E=#8R+GAM;%!+`0(4`Q0````(`+R"/D=D')+2%00``-T3```9
M``````````````"``?Z]``!X;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L!
M`A0#%`````@`O((^1^O?+IBG`0``LP,``!D``````````````(`!2L(``'AL
M+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"%`,4````"`"\@CY'&%$7CPX"
M``#N!0``&0``````````````@`$HQ```>&PO=V]R:W-H965T<R]S:&5E=#8U
M+GAM;%!+`0(4`Q0````(`+R"/D<>W("4R0$``-`$```9``````````````"`
M`6W&``!X;"]W;W)K<VAE971S+W-H965T-C8N>&UL4$L!`A0#%`````@`O((^
M1TP1"^?,`0``C00``!D``````````````(`!;<@``'AL+W=O<FMS:&5E=',O
M<VAE970V-RYX;6Q02P$"%`,4````"`"\@CY'X,+=U`4"``#Z!0``&0``````
M````````@`%PR@``>&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+`0(4`Q0`
M```(`+R"/D?B5,19PEX``&FI`0`4``````````````"``:S,``!X;"]S:&%R
C9613=')I;F=S+GAM;%!+!08`````30!-``T5``"@*P$`````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847685070000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2015</div></th>
<th class="th"><div>Oct. 31, 2014</div></th>
<th class="th"><div>Mar. 31, 2014</div></th>
<th class="th"><div>Jan. 31, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
<th class="th"><div>Jan. 31, 2015</div></th>
<th class="th"><div>Feb. 28, 2014</div></th>
<th class="th"><div>Jan. 02, 2014</div></th>
<th class="th"><div>Sep. 30, 2013</div></th>
<th class="th"><div>Sep. 20, 2013</div></th>
<th class="th"><div>Jun. 10, 2013</div></th>
<th class="th"><div>Jun. 01, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,949,819<span></span>
</td>
<td class="nump">22,867,319<span></span>
</td>
<td class="nump">14,817,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,949,819<span></span>
</td>
<td class="nump">22,867,319<span></span>
</td>
<td class="nump">14,817,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value, Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,950<span></span>
</td>
<td class="nump">$ 22,867<span></span>
</td>
<td class="nump">$ 14,817<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationEquity', window );">Deferred stock compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (472,669)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,750<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">270,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (287,857)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,667<span></span>
</td>
<td class="nump">$ 105,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Common stock issued for equity issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">630,000<span></span>
</td>
<td class="nump">630,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Employee bonus, Share</a></td>
<td class="nump">$ 337,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 337,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross', window );">Employee bonus, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">570,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_AdditionalWorkingCapital', window );">Additional working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_FullyDilutedShares', window );">Fully diluted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtIssuanceCosts', window );">Equity issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,950,000<span></span>
</td>
<td class="nump">$ 2,950,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">387,500<span></span>
</td>
<td class="nump">2,175,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_WarrantsExercised', window );">Warrants exercised, number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=oprx_ConsultingAgreementMember', window );">Consulting Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.945<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Additional shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, per share value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=oprx_CapitalMarketsAdvisoryAgreementMember', window );">Capital Markets Advisory Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Additional shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=oprx_SeparationAgreementMember', window );">Separation Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value, Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 505,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationEquity', window );">Deferred stock compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 174,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=oprx_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sales of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,333,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_WarrantExercisePricePeriod', window );">Warrant exercise price period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=oprx_PlacementAgentsMember', window );">Placement agents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_WarrantExercisePricePeriod', window );">Warrant exercise price period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_CommissionsPercentage', window );">Commissions percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrent', window );">Commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 970,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_PurchaseOfWarrants', window );">Purchase of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">804,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Warrants, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,110,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=oprx_ThreeOfficerMember', window );">Three executive officers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Additional shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee Bonus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=oprx_ConsultantMember', window );">Consultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Additional shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=oprx_VicisMember', window );">Vicis Capital Master Fund [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_DebtRedemptionLongtermDebtAmount', window );">Debt redemption, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=us-gaap_OfficerMember', window );">Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Additional shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">410,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_WarrantsExercised', window );">Warrants exercised, number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=us-gaap_DirectorMember', window );">Director [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Additional shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value, Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_DebtRedemptionLongtermDebtAmount', window );">Debt redemption, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_AdditionalWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional working capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_AdditionalWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_CommissionsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>commissions percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_CommissionsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_DebtRedemptionLongtermDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_DebtRedemptionLongtermDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_FullyDilutedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>fully diluted shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_FullyDilutedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_PurchaseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_PurchaseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_WarrantExercisePricePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant exercise price period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_WarrantExercisePricePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_WarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_WarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Current Liabilities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of debt issuance costs (for example, but not limited to, legal, accounting, broker, and regulatory fees).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued under share-based plans to employees or officers which is the unearned portion, accounted for under the fair value method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.30)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 35<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415241&amp;loc=d3e4534-113899<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Financing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 15<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3291-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of preferred stock and warrants for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP). Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP). Stock issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=oprx_ConsultingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=oprx_ConsultingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=oprx_CapitalMarketsAdvisoryAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=oprx_CapitalMarketsAdvisoryAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=oprx_SeparationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=oprx_SeparationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=oprx_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=oprx_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=oprx_PlacementAgentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=oprx_PlacementAgentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=oprx_ThreeOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=oprx_ThreeOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=oprx_ConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=oprx_ConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=oprx_VicisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=oprx_VicisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=us-gaap_OfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=us-gaap_OfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=us-gaap_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=us-gaap_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847876825856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaid Expenses (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_PrepaidExpensesAbstract', window );"><strong>Prepaid Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,093<span></span>
</td>
<td class="nump">$ 6,722<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidRent', window );">Rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,049<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_PrepaidLegalFees', window );">Legal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Total prepaid expenses</a></td>
<td class="nump">$ 76,376<span></span>
</td>
<td class="nump">$ 28,093<span></span>
</td>
<td class="nump">$ 11,771<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_PrepaidExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_PrepaidExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_PrepaidLegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for legal fees that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_PrepaidLegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6787-107765<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 340<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 05<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51662447&amp;loc=d3e5879-108316<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Current Assets<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509628<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (g)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6787-107765<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (g)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 340<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 05<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51662447&amp;loc=d3e5865-108316<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 340<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 05<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51662447&amp;loc=d3e5879-108316<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Current Assets<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509628<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for rent that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 340<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 05<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51662447&amp;loc=d3e5865-108316<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6787-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 340<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 05<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51662447&amp;loc=d3e5879-108316<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (g)(3)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Current Assets<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509628<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847754676400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Patent and Trademarks (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Patent and Trademarks [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Patent and Trademarks</a></td>
<td class="text"><div><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">2014</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">2013</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1191px; text-align: left; font-size: 10pt; background-color: white;">Patent rights and intangible assets</td><td style="width: 16px; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 16px; text-align: left; font-size: 10pt; background-color: white;">$</td><td style="width: 142px; text-align: right; font-size: 10pt; background-color: white;">930,000</td><td style="width: 16px; text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 15px; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 15px; text-align: left; font-size: 10pt; background-color: white;">$</td><td style="width: 141px; text-align: right; font-size: 10pt; background-color: white;">930,000</td><td style="width: 15px; text-align: left; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; font-size: 10pt; background-color: white;">Patent defense costs</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; background-color: white;">170,937</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; background-color: white;">87,993</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; font-size: 10pt; background-color: white;">New patents and trademarks</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; background-color: white;">90,202</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; background-color: white;">62,595</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">Accumulated amortization</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">(260,285</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">)</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">(194,638</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">)</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; padding-bottom: 4pt; padding-left: 10pt; font-size: 10pt; background-color: white;">Patent rights and intangible assets, net</td><td style="padding-bottom: 4pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">$</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">930,854</td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt; background-color: white;">&#160;</td><td style="padding-bottom: 4pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">$</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">885,950</td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt; background-color: white;"></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847763390464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options and Warrants (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Begining balnce , shares</a></td>
<td class="nump">1,180,000<span></span>
</td>
<td class="nump">1,484,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="nump">387,500<span></span>
</td>
<td class="nump">2,175,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired</a></td>
<td class="num">(260,000)<span></span>
</td>
<td class="num">(2,479,100)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance, shares</a></td>
<td class="nump">1,307,500<span></span>
</td>
<td class="nump">1,180,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted average exercise price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Begining balance, weighted average exercise price</a></td>
<td class="nump">$ 0.97<span></span>
</td>
<td class="nump">$ 0.98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted, weighted average exercise price</a></td>
<td class="nump">1.73<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised, weighted average exercise price</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired, weighted average exercise price</a></td>
<td class="num">(0.39)<span></span>
</td>
<td class="num">(1.00)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance, weighted average exercise price</a></td>
<td class="nump">$ 1.31<span></span>
</td>
<td class="nump">$ 0.97<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(1)(iv)(4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(1)(i)-(ii)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(1)(i)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(1)(iv)(2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28,29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847945141616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">NOTE 15 &#8211; INCOME TAXES</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">As of December 31, 2014, the Company had net operating loss carry forwards of approximately $8.8 million that expire from 2027 through 2034 that are available to offset future taxable income. The Company was formed in 2006 as a limited liability company and incorporated in 2007. Activity prior to incorporation is not reflected in the Company&#8217;s corporate tax returns. In the future, the cumulative net operating loss carry-forward for income tax purposes may differ from the cumulative financial statement loss due to timing differences between book and tax reporting.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">The provision for Federal income tax consists of the following for the years ended December&#160;31, 2014 and 2012:</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2014</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2013</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="font-size: 10pt;">Federal income tax benefit attributable to:</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: right;" colspan="2">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: right;" colspan="2">&#160;</td><td style="font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 776.666687011719px; font-size: 10pt; text-align: left; padding-left: 10pt;">Current operations</td><td style="width: 10.6666669845581px; font-size: 10pt;">&#160;</td><td style="width: 10.6666669845581px; font-size: 10pt; text-align: left;">$</td><td style="width: 94px; font-size: 10pt; text-align: right;">349,000</td><td style="width: 10.6666669845581px; font-size: 10pt; text-align: left;">&#160;</td><td style="width: 10px; font-size: 10pt;">&#160;</td><td style="width: 10px; font-size: 10pt; text-align: left;">$</td><td style="width: 93.3333358764648px; font-size: 10pt; text-align: right;">91,000</td><td style="width: 10px; font-size: 10pt; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; text-align: left; padding-left: 10pt;">Permanent and Timing Differences (net)</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; text-align: right;">(160,000</td><td style="font-size: 10pt; text-align: left;">)</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; text-align: right;">(294,000</td><td style="font-size: 10pt; text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt;">Valuation allowance</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;">(189,000</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;">)</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;">203,000</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; text-align: left; padding-bottom: 4pt; padding-left: 20pt;">Net
 provision for federal income tax</td><td style="font-size: 10pt; padding-bottom: 4pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left;">$</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right;">0</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; padding-bottom: 4pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left;">$</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right;">0</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left;">&#160;</td></tr></table><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">The cumulative tax effect at the expected rate of 34% of significant items comprising our net deferred tax amount is as follows as of December&#160;31, 2013 and 2012:</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2014</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2013</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="font-size: 10pt;">Deferred tax asset attributable to:</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: right;" colspan="2">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: right;" colspan="2">&#160;</td><td style="font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 776.666687011719px; font-size: 10pt; text-align: left; padding-left: 10pt;">Net operating loss carryover</td><td style="width: 10.6666669845581px; font-size: 10pt;">&#160;</td><td style="width: 10.6666669845581px; font-size: 10pt; text-align: left;">$</td><td style="width: 94px; font-size: 10pt; text-align: right;">2,982,000</td><td style="width: 10.6666669845581px; font-size: 10pt; text-align: left;">&#160;</td><td style="width: 10px; font-size: 10pt;">&#160;</td><td style="width: 10px; font-size: 10pt; text-align: left;">$</td><td style="width: 93.3333358764648px; font-size: 10pt; text-align: right;">2,793,000</td><td style="width: 10px; font-size: 10pt; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt;">Valuation allowance</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;">(2,982,000</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;">)</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;">(2,793,000</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; text-align: left; padding-bottom: 4pt; padding-left: 20pt;">Net deferred tax asset</td><td style="font-size: 10pt; padding-bottom: 4pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left;">$</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right;">0</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; padding-bottom: 4pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left;">$</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right;">0</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left;">&#160;</td></tr></table><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal;
 letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">Under certain circumstances issuance of common shares can result in an ownership change under Internal Revenue Code Section 382 which limits the Company&#8217;s ability to utilize carry forwards from prior to the ownership change. Any such ownership change resulting from stock issuances and redemptions could limit the Company&#8217;s ability to utilize any net operating loss carry forwards or credits generated before this change in ownership. These limitations can limit both the timing of usage of these laws, as well as the loss of the ability to use these net operating losses.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(h))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 15<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32718-109319<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 9<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847880247968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Web Based Technology (Details Textuals) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareNetAbstract', window );"><strong>Web-Based Technology [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_CapitalizedComputerSoftwareAmortizationPeriodDescription', window );">Web-based technology amortization period, Description</a></td>
<td class="text">Over a period of up to five years.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAmortization', window );">Web-based technology, amortization expense</a></td>
<td class="nump">$ 192,760<span></span>
</td>
<td class="nump">$ 130,289<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_CapitalizedComputerSoftwareAmortizationPeriodDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of capitalized computer software amortization period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_CapitalizedComputerSoftwareAmortizationPeriodDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For each income statement presented, the amount charged to expense for amortization of capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 985<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128487-111756<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 985<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847756897776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount', window );">Claims pertaining to damages to nonregistration of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Damage related to LDM' s breach of the agreement.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Loss pertaining to Mr. Milton Wilpon for Litigation settlement</a></td>
<td class="nump">$ 929,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_ContigentLiabilitiesRelatedToAuditFeesInPercentage', window );">Contingent Liabilities related to audit fees in percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Damage related to PDR's actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_ContigentLiabilitiesRelatedToAuditFeesInPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contigent liabilities related to audit fees in percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_ContigentLiabilitiesRelatedToAuditFeesInPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 35<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph b<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 35<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph b<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 805<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs of settling insured claims and costs incurred in the claims settlement process for the specified year specifically for claims that have already been submitted to the insurance company for reimbursement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 40<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6482485&amp;loc=d3e14764-158437<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 450<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 450<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 9<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14557-108349<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 450<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847763540880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Major Customers (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_MajorCustomerAbstract', window );"><strong>Major Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_ScheduleOfMajorCustomersIndividualRevenueTableTextBlock', window );">Schedule of major customers individual revenue</a></td>
<td class="text"><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">2014</td><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">Percentage</td><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">2013</td><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">Percentage</td><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 815px; text-align: left; background-color: white;">Company A</td><td style="width: 16px; background-color: white;">&#160;</td><td style="width: 16px; text-align: left; background-color: white;">$</td><td style="width: 142px; text-align: right; background-color: white;">1,270,064</td><td style="width: 16px; text-align: left; background-color: white;">&#160;</td><td style="width: 16px; background-color: white;">&#160;</td><td style="width: 16px; text-align: left; background-color: white;">&#160;</td><td style="width: 142px; text-align: right; background-color: white;">20</td><td style="width: 16px; text-align: left; background-color: white;">%</td><td style="width: 15px; background-color: white;">&#160;</td><td style="width: 15px; text-align: left; background-color: white;">$</td><td style="width: 141px; text-align: right; background-color: white;">1,776,824</td><td style="width: 15px; text-align: left; background-color: white;">&#160;</td><td style="width: 15px; background-color: white;">&#160;</td><td style="width: 15px; text-align: left; background-color: white;">&#160;</td><td style="width: 141px; text-align: right; background-color: white;">36</td><td style="width: 15px; text-align: left; background-color: white;">%</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; background-color: white;">Company B</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">797,972</td><td style="text-align: left; background-color: white;">&#160;</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">12</td><td style="text-align: left; background-color: white;">%</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">1,053,321</td><td style="text-align: left; background-color: white;">&#160;</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">22</td><td style="text-align: left; background-color: white;">%</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; background-color: white;">Company C</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">772,320</td><td style="text-align: left; background-color: white;">&#160;</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">12</td><td style="text-align: left; background-color: white;">%</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">305,980</td><td style="text-align: left; background-color: white;">&#160;</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">7</td><td style="text-align: left; background-color: white;">%</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; background-color: white;">Company D</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">644,702</td><td style="text-align: left; background-color: white;">&#160;</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">10</td><td style="text-align: left; background-color: white;">%</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">278,499</td><td style="text-align: left; background-color: white;">&#160;</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">6</td><td style="text-align: left; background-color: white;">%</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;">Company E</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">628,741</td><td style="text-align: left; background-color: white;">&#160;</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">10</td><td style="text-align: left; background-color: white;">%</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color:
 white;">&#160;</td><td style="text-align: right; background-color: white;">71,030</td><td style="text-align: left; background-color: white;">&#160;</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">2</td><td style="text-align: left; background-color: white;">%</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding-bottom: 1.5pt; background-color: white;">All other customers</td><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">2,389,163</td><td style="text-align: left; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="text-align: left; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">36</td><td style="text-align: left; padding-bottom: 1.5pt; background-color: white;">%</td><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">1,193,587</td><td style="text-align: left; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="text-align: left; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">25</td><td style="text-align: left; padding-bottom: 1.5pt; background-color: white;">%</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;">&#160;</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 4pt; background-color: white;">Total</td><td style="padding-bottom: 4pt; background-color: white;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">6,502,962</td><td style="text-align: left; padding-bottom: 4pt; background-color: white;">&#160;</td><td style="padding-bottom: 4pt; background-color: white;">&#160;</td><td style="text-align: left; padding-bottom: 4pt; background-color: white;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">100</td><td style="text-align: left; padding-bottom: 4pt; background-color: white;">%</td><td style="padding-bottom: 4pt; background-color: white;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">4,679,741</td><td style="text-align: left; padding-bottom: 4pt; background-color: white;">&#160;</td><td style="padding-bottom: 4pt; background-color: white;">&#160;</td><td style="text-align: left; padding-bottom: 4pt; background-color: white;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">100</td><td style="text-align: left; padding-bottom: 4pt; background-color: white;">%</td></tr></table><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_MajorCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_MajorCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_ScheduleOfMajorCustomersIndividualRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabbular schedule of major customers individual revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_ScheduleOfMajorCustomersIndividualRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847760364704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Patent and Trademarks (Details Textuals) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 26, 2010</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrent', window );">Accounts payable - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 570,000<span></span>
</td>
<td class="nump">$ 570,000<span></span>
</td>
<td class="nump">$ 570,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationMethod', window );">Amortizing patent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Straight-line method.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths', window );">Amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,874<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">SampleMD Patent Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock: for cash shares</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_OptionsGrantedToAcquireExclusivePatentRightsShares', window );">Stock options</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_OptionsGrantedToAcquireExclusivePatentRightsValue', window );">Shares values</a></td>
<td class="nump">$ 360,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockTransactionDate', window );">Expire date</a></td>
<td class="text">Apr. 30,  2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_OptionsGrantedToAcquireExclusivePatentRightsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Options granted to acquire exclusive patent rights shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_OptionsGrantedToAcquireExclusivePatentRightsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_OptionsGrantedToAcquireExclusivePatentRightsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Options granted to acquire exclusive patent rights value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_OptionsGrantedToAcquireExclusivePatentRightsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(k)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amortization method of a major finite-lived intangible asset class. A major class is composed of intangible assets that can be grouped together because they are similar either by their nature or by their use in the operations of a company. The straight-line method is the preferred amortization method, unless another method better reflects the pattern in which the asset is consumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 35<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713198&amp;loc=d3e15372-109273<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockTransactionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the subsidiary or equity investee issued or sold stock, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockTransactionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847755847712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Detail Textuals)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2014 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">$ 8.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLimitationsOnUse', window );">Operating loss expire description</a></td>
<td class="text">Expire from 2027 through 2034 that are available to offset future taxable income.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective rate of tax expected</a></td>
<td class="nump">34.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 13<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(h)(2))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 12<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLimitationsOnUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLimitationsOnUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847754549184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Details Textuals) - Warrant [Member] - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Granted</a></td>
<td class="nump">804,139<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted', window );">Granted, weighted average</a></td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Proceed from warrant issued</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award non option equity instrument weighted average, grantedPayment Award Non Option Equity Instrument Weighted Average, Granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(1)(iv)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847683794848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, Subtotal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,607<span></span>
</td>
<td class="nump">$ 33,448<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,794)<span></span>
</td>
<td class="num">(18,391)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 10,674<span></span>
</td>
<td class="nump">12,813<span></span>
</td>
<td class="nump">15,057<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, Subtotal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,519<span></span>
</td>
<td class="nump">22,360<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, Subtotal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,088<span></span>
</td>
<td class="nump">$ 11,088<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.14)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 7<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847763488704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Based Payments   Options<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share Based Payments - Options and Stock Options and Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">SHARE BASED PAYMENTS - OPTIONS</a></td>
<td class="text"><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px;"><font style="letter-spacing: -0.1pt;">NOTE 3 &#8211; SHARE BASED PAYMENTS &#8211; OPTIONS</font></p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">We use the fair value method to account for stock based compensation. We recorded $110,039 and $170,611 in compensation expense in the periods ended June 30, 2015 and 2014, respectively, related to options issued under our stock-based incentive compensation plan. This includes expense related to options issued in prior years for which the requisite service period for those options includes the current year, options granted in the current year and options repriced in the current year. The fair value of these instruments was calculated using the Black-Scholes option pricing model. Information related to the assumptions used in this model is set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts comprising shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income, and compensation-related costs for equity-based compensation. Includes, but is not limited to, disclosure of policies, compensation plan details, equity-based arrangements to obtain goods and services, deferred compensation arrangements, and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847890568928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Leases (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Operating Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">Year ended December 31, 2015</a></td>
<td class="nump">$ 62,418<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">Year ended December 31, 2016</a></td>
<td class="nump">57,217<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total lease commitment</a></td>
<td class="nump">$ 119,635<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 840<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 40<br><br><br><br> -Subparagraph (Note 3)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 840<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 840<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 40<br><br><br><br> -Subparagraph (Note 3)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 840<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 840<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 40<br><br><br><br> -Subparagraph (Note 3)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 840<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847684245984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restatement (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="5">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Mar. 31, 2014</div></th>
<th class="th"><div>Sep. 30, 2013</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Sep. 30, 2013</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">$ 1,918,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 965,605<span></span>
</td>
<td class="nump">$ 811,278<span></span>
</td>
<td class="nump">$ 1,918,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 811,278<span></span>
</td>
<td class="nump">$ 2,100,381<span></span>
</td>
<td class="nump">$ 1,511,709<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_RevenueSharePayableCurrent', window );">Revenue share payable</a></td>
<td class="nump">1,190,995<span></span>
</td>
<td class="nump">$ 1,274,429<span></span>
</td>
<td class="nump">$ 872,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,190,995<span></span>
</td>
<td class="nump">$ 872,989<span></span>
</td>
<td class="nump">$ 1,274,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,502,761<span></span>
</td>
<td class="nump">1,287,552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">336,213<span></span>
</td>
<td class="nump">118,949<span></span>
</td>
<td class="nump">301,178<span></span>
</td>
<td class="nump">437,521<span></span>
</td>
<td class="nump">161,132<span></span>
</td>
<td class="nump">336,213<span></span>
</td>
<td class="nump">301,178<span></span>
</td>
<td class="nump">118,949<span></span>
</td>
<td class="nump">161,132<span></span>
</td>
<td class="nump">120,130<span></span>
</td>
<td class="nump">226,272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">27,806,253<span></span>
</td>
<td class="nump">28,483,502<span></span>
</td>
<td class="nump">27,388,789<span></span>
</td>
<td class="nump">27,304,207<span></span>
</td>
<td class="nump">8,597,748<span></span>
</td>
<td class="nump">27,806,253<span></span>
</td>
<td class="nump">27,388,789<span></span>
</td>
<td class="nump">28,483,502<span></span>
</td>
<td class="nump">8,597,748<span></span>
</td>
<td class="nump">$ 27,595,609<span></span>
</td>
<td class="nump">8,875,155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationEquity', window );">Deferred stock compensation</a></td>
<td class="nump">18,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(472,669)<span></span>
</td>
<td class="num">(287,857)<span></span>
</td>
<td class="nump">18,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(287,857)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">270,462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(26,393,176)<span></span>
</td>
<td class="num">(26,355,433)<span></span>
</td>
<td class="num">(26,060,890)<span></span>
</td>
<td class="num">(25,861,452)<span></span>
</td>
<td class="num">(25,141,061)<span></span>
</td>
<td class="num">(26,393,176)<span></span>
</td>
<td class="num">(26,060,890)<span></span>
</td>
<td class="num">(26,355,433)<span></span>
</td>
<td class="num">(25,141,061)<span></span>
</td>
<td class="num">$ (26,124,750)<span></span>
</td>
<td class="num">(25,099,357)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,705,457<span></span>
</td>
<td class="nump">1,819,421<span></span>
</td>
<td class="nump">1,426,808<span></span>
</td>
<td class="nump">1,289,428<span></span>
</td>
<td class="nump">1,225,169<span></span>
</td>
<td class="nump">3,193,010<span></span>
</td>
<td class="nump">2,716,236<span></span>
</td>
<td class="nump">4,535,857<span></span>
</td>
<td class="nump">2,998,546<span></span>
</td>
<td class="nump">6,502,962<span></span>
</td>
<td class="nump">4,679,741<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsSold', window );">Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">730,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,291,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="nump">980,659<span></span>
</td>
<td class="nump">1,155,933<span></span>
</td>
<td class="nump">896,529<span></span>
</td>
<td class="nump">1,489,858<span></span>
</td>
<td class="nump">1,076,475<span></span>
</td>
<td class="nump">1,823,269<span></span>
</td>
<td class="nump">2,386,747<span></span>
</td>
<td class="nump">3,542,681<span></span>
</td>
<td class="nump">2,366,210<span></span>
</td>
<td class="nump">4,307,756<span></span>
</td>
<td class="nump">3,085,961<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(157,529)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(199,861)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(269,027)<span></span>
</td>
<td class="num">(962,062)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,026,328)<span></span>
</td>
<td class="num">(267,536)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before income taxes</a></td>
<td class="num">(157,225)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(199,638)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(268,426)<span></span>
</td>
<td class="num">(961,733)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,025,393)<span></span>
</td>
<td class="num">(267,290)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_RevenueShareExpense', window );">Revenue share expense</a></td>
<td class="nump">882,327<span></span>
</td>
<td class="nump">958,333<span></span>
</td>
<td class="nump">730,140<span></span>
</td>
<td class="nump">561,411<span></span>
</td>
<td class="nump">557,510<span></span>
</td>
<td class="nump">1,638,768<span></span>
</td>
<td class="nump">1,291,551<span></span>
</td>
<td class="nump">2,249,884<span></span>
</td>
<td class="nump">1,292,435<span></span>
</td>
<td class="nump">3,221,534<span></span>
</td>
<td class="nump">1,861,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(157,225)<span></span>
</td>
<td class="num">(294,543)<span></span>
</td>
<td class="num">(199,638)<span></span>
</td>
<td class="num">(762,095)<span></span>
</td>
<td class="num">(411,734)<span></span>
</td>
<td class="num">(268,426)<span></span>
</td>
<td class="num">(961,733)<span></span>
</td>
<td class="num">(1,256,076)<span></span>
</td>
<td class="num">(659,923)<span></span>
</td>
<td class="num">(1,025,393)<span></span>
</td>
<td class="num">(267,290)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfCashFlowsAbstract', window );"><strong>Statement of Cash Flows [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (157,225)<span></span>
</td>
<td class="num">(294,543)<span></span>
</td>
<td class="num">(199,638)<span></span>
</td>
<td class="num">(762,095)<span></span>
</td>
<td class="num">(411,734)<span></span>
</td>
<td class="num">(268,426)<span></span>
</td>
<td class="num">(961,733)<span></span>
</td>
<td class="num">(1,256,076)<span></span>
</td>
<td class="num">(659,923)<span></span>
</td>
<td class="num">(1,025,393)<span></span>
</td>
<td class="num">(267,290)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_StockOptionsIssuedForServices', window );">Stock and options issued for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">361,062<span></span>
</td>
<td class="nump">627,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272,804<span></span>
</td>
<td class="nump">94,998<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Increase in accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(181,962)<span></span>
</td>
<td class="num">(302,202)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">588,672<span></span>
</td>
<td class="nump">894,911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_IncreaseDecreaseInRevenueSharePayable', window );">Decrease in revenue share payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(311,776)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Increase in deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">192,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">216,083<span></span>
</td>
<td class="nump">19,651<span></span>
</td>
<td class="num">(148,334)<span></span>
</td>
<td class="nump">111,880<span></span>
</td>
<td class="num">(106,142)<span></span>
</td>
<td class="nump">177,020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">380,217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,039<span></span>
</td>
<td class="nump">170,611<span></span>
</td>
<td class="num">(1,066,672)<span></span>
</td>
<td class="nump">404,794<span></span>
</td>
<td class="nump">899,438<span></span>
</td>
<td class="nump">435,612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_RevenueSharePayable', window );">Revenue share payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(333,334)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (311,766)<span></span>
</td>
<td class="num">(414,563)<span></span>
</td>
<td class="nump">11,876<span></span>
</td>
<td class="nump">678,201<span></span>
</td>
<td class="nump">$ 215,210<span></span>
</td>
<td class="nump">1,196,975<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreationDateAxis=us-gaap_ScenarioPreviouslyReportedMember', window );">Previously stated [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">797,725<span></span>
</td>
<td class="nump">782,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">782,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,566,964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_RevenueSharePayableCurrent', window );">Revenue share payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 853,410<span></span>
</td>
<td class="nump">506,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">506,901<span></span>
</td>
<td class="nump">$ 853,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,193,661<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">42,908<span></span>
</td>
<td class="nump">168,714<span></span>
</td>
<td class="nump">13,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,908<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">13,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,252<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,398,825<span></span>
</td>
<td class="nump">27,304,112<span></span>
</td>
<td class="nump">27,155,730<span></span>
</td>
<td class="nump">8,449,271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,304,112<span></span>
</td>
<td class="nump">$ 28,398,825<span></span>
</td>
<td class="nump">8,449,271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,726,708<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationEquity', window );">Deferred stock compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(454,409)<span></span>
</td>
<td class="num">(233,077)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(233,077)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(233,942)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,716,530)<span></span>
</td>
<td class="num">(25,322,216)<span></span>
</td>
<td class="num">(25,269,535)<span></span>
</td>
<td class="num">(24,870,854)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,322,216)<span></span>
</td>
<td class="num">(25,716,530)<span></span>
</td>
<td class="num">(24,870,854)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,616,220)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,620,215<span></span>
</td>
<td class="nump">1,454,214<span></span>
</td>
<td class="nump">1,317,347<span></span>
</td>
<td class="nump">1,373,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,771,560<span></span>
</td>
<td class="nump">4,391,775<span></span>
</td>
<td class="nump">3,146,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,957,016<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsSold', window );">Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">540,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,038,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,155,933<span></span>
</td>
<td class="nump">967,070<span></span>
</td>
<td class="nump">1,471,598<span></span>
</td>
<td class="nump">982,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,439,028<span></span>
</td>
<td class="nump">3,594,961<span></span>
</td>
<td class="nump">2,272,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,973,990<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52,904)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(706,326)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52,681)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(705,996)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_RevenueShareExpense', window );">Revenue share expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">858,898<span></span>
</td>
<td class="nump">540,048<span></span>
</td>
<td class="nump">498,810<span></span>
</td>
<td class="nump">529,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,038,858<span></span>
</td>
<td class="nump">1,897,757<span></span>
</td>
<td class="nump">1,264,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,767,425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(394,314)<span></span>
</td>
<td class="num">(52,681)<span></span>
</td>
<td class="num">(653,315)<span></span>
</td>
<td class="num">(141,527)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(705,996)<span></span>
</td>
<td class="num">(1,100,310)<span></span>
</td>
<td class="num">(389,716)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215,847<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfCashFlowsAbstract', window );"><strong>Statement of Cash Flows [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(394,314)<span></span>
</td>
<td class="num">(52,681)<span></span>
</td>
<td class="num">(653,315)<span></span>
</td>
<td class="num">(141,527)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(705,996)<span></span>
</td>
<td class="num">(1,100,310)<span></span>
</td>
<td class="num">(389,716)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215,847<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_StockOptionsIssuedForServices', window );">Stock and options issued for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">654,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,547<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Increase in accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">173,889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(950,166)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_IncreaseDecreaseInRevenueSharePayable', window );">Decrease in revenue share payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(686,760)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Increase in deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,656<span></span>
</td>
<td class="num">(4,252)<span></span>
</td>
<td class="num">(35,980)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">361,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">654,634<span></span>
</td>
<td class="nump">1,118,952<span></span>
</td>
<td class="nump">310,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">399,092<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_RevenueSharePayable', window );">Revenue share payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(395,935)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(686,760)<span></span>
</td>
<td class="num">(340,251)<span></span>
</td>
<td class="nump">649,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,103,084<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreationDateAxis=us-gaap_RestatementAdjustmentMember', window );">Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167,880<span></span>
</td>
<td class="nump">28,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55,255)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_RevenueSharePayableCurrent', window );">Revenue share payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">421,019<span></span>
</td>
<td class="nump">366,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">366,088<span></span>
</td>
<td class="nump">421,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,891<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118,949<span></span>
</td>
<td class="nump">258,270<span></span>
</td>
<td class="nump">268,807<span></span>
</td>
<td class="nump">147,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">258,270<span></span>
</td>
<td class="nump">118,949<span></span>
</td>
<td class="nump">147,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222,020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,677<span></span>
</td>
<td class="nump">84,677<span></span>
</td>
<td class="nump">148,477<span></span>
</td>
<td class="nump">148,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,677<span></span>
</td>
<td class="nump">84,677<span></span>
</td>
<td class="nump">148,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">148,477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationEquity', window );">Deferred stock compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,260)<span></span>
</td>
<td class="num">(54,780)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54,780)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,520)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(638,903)<span></span>
</td>
<td class="num">(738,674)<span></span>
</td>
<td class="num">(591,917)<span></span>
</td>
<td class="num">(270,207)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(738,674)<span></span>
</td>
<td class="num">(638,903)<span></span>
</td>
<td class="num">(270,207)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(483,137)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 199,206<span></span>
</td>
<td class="num">(27,206)<span></span>
</td>
<td class="num">(27,919)<span></span>
</td>
<td class="num">(147,860)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55,124)<span></span>
</td>
<td class="nump">144,082<span></span>
</td>
<td class="num">(147,860)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(277,275)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(70,541)<span></span>
</td>
<td class="nump">18,260<span></span>
</td>
<td class="nump">93,971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52,281)<span></span>
</td>
<td class="num">(52,280)<span></span>
</td>
<td class="nump">93,971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_RevenueShareExpense', window );">Revenue share expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,435<span></span>
</td>
<td class="nump">190,092<span></span>
</td>
<td class="nump">62,601<span></span>
</td>
<td class="nump">28,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">252,693<span></span>
</td>
<td class="nump">352,127<span></span>
</td>
<td class="nump">28,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,891<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,771<span></span>
</td>
<td class="num">(146,757)<span></span>
</td>
<td class="num">(108,780)<span></span>
</td>
<td class="num">(270,207)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(255,537)<span></span>
</td>
<td class="num">(155,766)<span></span>
</td>
<td class="num">(270,207)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(483,137)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfCashFlowsAbstract', window );"><strong>Statement of Cash Flows [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,771<span></span>
</td>
<td class="num">$ (146,757)<span></span>
</td>
<td class="num">(108,780)<span></span>
</td>
<td class="num">$ (270,207)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(255,537)<span></span>
</td>
<td class="num">(155,766)<span></span>
</td>
<td class="num">(270,207)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(483,137)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_StockOptionsIssuedForServices', window );">Stock and options issued for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,451<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Increase in accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Increase in deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,124<span></span>
</td>
<td class="num">(144,082)<span></span>
</td>
<td class="nump">147,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222,020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52,281)<span></span>
</td>
<td class="num">(52,280)<span></span>
</td>
<td class="nump">93,971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,520<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_RevenueSharePayable', window );">Revenue share payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62,601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 252,693<span></span>
</td>
<td class="nump">$ 352,127<span></span>
</td>
<td class="nump">$ 28,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93,891<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_IncreaseDecreaseInRevenueSharePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of stock option as payment for services rendered .</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_IncreaseDecreaseInRevenueSharePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_RevenueShareExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue share expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_RevenueShareExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_RevenueSharePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_RevenueSharePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_RevenueSharePayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for revenue share payable within one year (or the normal operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_RevenueSharePayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_StockOptionsIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_StockOptionsIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.3-4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph a(1)<br><br><br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 4<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.30(a)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs related to goods produced and sold during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.2(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued under share-based plans to employees or officers which is the unearned portion, accounted for under the fair value method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.30)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 35<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415241&amp;loc=d3e4534-113899<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 605<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 13<br><br><br><br> -Section A<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Net Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Other Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 9<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.31(a)(3))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreationDateAxis=us-gaap_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreationDateAxis=us-gaap_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreationDateAxis=us-gaap_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreationDateAxis=us-gaap_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847763162480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Summary of hare based compensation fair value assumption methodology</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: center; text-indent: 0px; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">2014</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: center; text-indent: 0px; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">2013</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: center; text-indent: 0px; font-size: 10pt; background-color: white;" colspan="2">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: center; text-indent: 0px; font-size: 10pt; background-color: white;" colspan="2">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="padding: 0px; width: 758px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">Expected dividend yield</td><td style="padding: 0px; width: 10px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; width: 10px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; width: 114px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;">0</td><td style="padding: 0px; width: 11.33px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">%</td><td style="padding: 0px; width: 10px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; width: 10px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; width: 104.66px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;">0</td><td style="padding: 0px; width: 11.33px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">%</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">Risk free interest rate</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"><font style="font-size: 10pt;">0.90%-1.44%</font></td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"><font style="font-size: 10pt;">0.79%-1.42%</font></td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">Expected option term</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"><font style="font-size: 10pt;">3.5 years</font></td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"><font style="font-size: 10pt;">5.0 years</font></td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">Turnover/forfeiture rate</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;">0</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">%</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;">0</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">%</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="padding: 0px; text-align: left;
 text-indent: 0px; font-size: 10pt; background-color: white;">Expected volatility</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"><font style="font-size: 10pt;">117% - 138%</font></td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"><font style="font-size: 10pt;">155% - 171%</font></td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of a stock option or other award plan under which equity-based compensation is awarded to employees, typically comprised of the amount of unearned compensation (deferred compensation cost), compensation expense, and changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan.  Disclosure may also include nature and general terms of such arrangements that existed during the period and potential effects of those arrangements on shareholders, effect of compensation cost arising from equity-based payment arrangements on the income statement, method of estimating the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period, cash flow effects resulting from equity-based payment arrangements and, for registrants that accelerate vesting of out of the money share options, reasons for the decision to accelerate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847757068016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restatement (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Restatement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestatementToPriorYearIncomeTextBlock', window );">Schedule of restatement</a></td>
<td class="text"><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify; text-indent: 0.5in;"></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding: 0pt; text-indent: 0pt;" colspan="3">Three months ended June 30, 2014</td><td style="padding: 0pt; text-align: center; text-indent: 0pt;">&#160;</td><td style="text-align: center; padding: 0pt; text-indent: 0pt;" colspan="2">&#160;</td><td style="padding: 0pt; text-align: center; text-indent: 0pt;">&#160;</td><td style="padding: 0pt; text-align: center; text-indent: 0pt;">&#160;</td><td style="text-align: center; padding: 0pt; text-indent: 0pt;" colspan="2">Previously</td><td style="padding: 0pt; text-align: center; text-indent: 0pt;">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding: 0pt; text-align: center; text-indent: 0pt;">Financial Statement</td><td style="padding: 0pt; text-align: center; text-indent: 0pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding: 0pt; text-align: center; text-indent: 0pt;">Line Item</td><td style="padding: 0pt; text-align: center; text-indent: 0pt;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding: 0pt; text-indent: 0pt;" colspan="2">Corrected</td><td style="padding: 0pt; text-align: center; text-indent: 0pt;">&#160;</td><td style="padding: 0pt; text-align: center; text-indent: 0pt;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding: 0pt; text-indent: 0pt;" colspan="2">Stated</td><td style="padding: 0pt; text-align: center; text-indent: 0pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 543px; text-align: left; padding: 0pt; text-indent: 0pt;">Income statement</td><td style="width: 18px; padding: 0pt; text-indent: 0pt;">&#160;</td><td style="width: 543px; padding: 0pt; text-indent: 0pt;">Revenue</td><td style="width: 18px; padding: 0pt; text-indent: 0pt;">&#160;</td><td style="width: 18px; text-align: left; padding: 0pt; text-indent: 0pt;">&#160;</td><td style="width: 175px; text-align: right; padding: 0pt; text-indent: 0pt;">1,426,808</td><td style="width: 18px; text-align: left; padding: 0pt; text-indent: 0pt;">&#160;</td><td style="width: 19px; padding: 0pt; text-indent: 0pt;">&#160;</td><td style="width: 19px; text-align: left; padding: 0pt; text-indent: 0pt;">&#160;</td><td style="width: 177px; text-align: right; padding: 0pt; text-indent: 0pt;">1,454,214</td><td style="width: 19px; text-align: left; padding: 0pt; text-indent: 0pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding: 0pt; text-indent: 0pt;">Income statement</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="padding: 0pt; text-indent: 0pt;">Cost of Sales</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">$</td><td style="text-align: right; padding: 0pt; text-indent: 0pt;">730,140</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">&#160;</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">$</td><td style="text-align: right; padding: 0pt; text-indent: 0pt;">540,048</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; padding: 0pt; text-indent: 0pt;">Income statement</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">Operating expenses</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: right; padding: 0pt; text-indent: 0pt;">896,529</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">&#160;</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: right; padding: 0pt; text-indent: 0pt;">967,070</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding: 0pt; text-indent: 0pt;">Income statement</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">Loss from operations</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">$</td><td style="text-align: right; padding: 0pt; text-indent: 0pt;">(199,861</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">)</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">$</td><td style="text-align: right; padding: 0pt; text-indent: 0pt;">(52,904</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">)</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; padding: 0pt; text-indent: 0pt;">Income statement</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">Loss before income taxes</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">$</td><td style="text-align: right; padding: 0pt; text-indent: 0pt;">(199,638</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">)</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">$</td><td style="text-align: right; padding: 0pt; text-indent: 0pt;">(52,681</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding: 0pt; text-indent:
 0pt;">Income statement</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td
 style="text-align: left; padding: 0pt; text-indent: 0pt;">Net loss</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">$</td><td style="text-align: right; padding: 0pt; text-indent: 0pt;">(199,638</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">)</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">$</td><td style="text-align: right; padding: 0pt; text-indent: 0pt;">(52,681</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">)</td></tr></table><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin-top: 0px; text-align: center; margin-bottom: 0px;"><font style="letter-spacing: -0.1pt;"><b><i>&#160;</i></b>&#160;</font></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="3">Six months ended June 30, 2014</td><td style="padding-bottom: 1.5pt; text-align: center;">&#160;</td><td style="text-align: center;" colspan="2">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center;">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center;">&#160;</td><td style="text-align: center;" colspan="2">Previously</td><td style="padding-bottom: 1.5pt; text-align: center;">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;">Financial Statement</td><td style="padding-bottom: 1.5pt; text-align: center;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;">Line Item</td><td style="padding-bottom: 1.5pt; text-align: center;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Corrected</td><td style="padding-bottom: 1.5pt; text-align: center;">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Stated</td><td style="padding-bottom: 1.5pt; text-align: center;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 543px; text-align: left; text-indent: 0pt; padding-left: 0pt;">Income statement</td><td style="width: 18px;">&#160;</td><td style="width: 543px; text-indent: 0pt; padding-left: 0pt;">Revenue</td><td style="width: 18px;">&#160;</td><td style="width: 18px; text-align: left;">&#160;</td><td style="width: 175px; text-align: right;">2,716,236</td><td style="width: 18px; text-align: left;">&#160;</td><td style="width: 19px;">&#160;</td><td style="width: 19px; text-align: left;">&#160;</td><td style="width: 177px; text-align: right;">2,771,560</td><td style="width: 19px; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Income statement</td><td>&#160;</td><td style="text-indent: 0pt; padding-left: 0pt;">Cost of Sales</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">1,291,551</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">1,038,858</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Income statement</td><td>&#160;</td><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Operating expenses</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">2,386,747</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">2,439,028</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; text-indent: 0pt; padding-left: 0pt;">Income statement</td><td>&#160;</td><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Loss from operations</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(962,062</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(706,326</td><td style="text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Income statement</td><td>&#160;</td><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Loss before income taxes</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(961,733</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(705,996</td><td style="text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Income statement</td><td>&#160;</td><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Net loss</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(961,733</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(705,996</td><td style="text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Statement of cash flows</td><td>&#160;</td><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Net loss</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(961,733</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(705,996</td><td style="text-align: left;">)</td></tr><tr style="vertical-align: bottom;
 background-color: white;"><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Statement of cash flows</td><td>&#160;</td><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Stock and
 options issued for services</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">627,344</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">654,634</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Statement of cash flows</td><td>&#160;</td><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Increase in accounts payable</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">203,714</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">173,889</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Statement of cash flows</td><td>&#160;</td><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Decrease in revenue share payable</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(311,776</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(686,760</td><td style="text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Statement of cash flows</td><td>&#160;</td><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Increase in deferred revenue</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">19,651</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">38,656</td><td style="text-align: left;">&#160;</td></tr></table><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; margin-top: 0px; margin-bottom: 0px;">&#160;<b>&#160;</b></p><span></span>
</td>
<td class="text"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The following items were restated in the 2013 Annual Financial Statements</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><div>&#160;</div><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center; padding-bottom: 1pt; padding-left: 5.4pt; text-decoration: underline;">Balance Sheet</td><td style="padding-bottom: 1pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"><font style="font-size: 10pt;"><u>Previously stated</u></font></td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"><font style="font-size: 10pt;"><u>Adjustments</u></font></td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"><font style="font-size: 10pt;"><u>Restated</u></font></td><td style="text-align: left; padding-bottom: 1pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 713.81px; text-align: justify; padding-left: 5.4pt;">Accounts receivable</td><td style="width: 79px;">&#160;</td><td style="width: 16px; text-align: left;">$</td><td style="width: 173px; text-align: right;">1,566,964</td><td style="width: 16px; text-align: left;">&#160;</td><td style="width: 79px;">&#160;</td><td style="width: 16px; text-align: left;">$</td><td style="width: 172px; text-align: right;">(55,255</td><td style="width: 15px; text-align: left;">)</td><td style="width: 78px;">&#160;</td><td style="width: 15px; text-align: left;">$</td><td style="width: 172px; text-align: right;">1,511,709</td><td style="width: 15px; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Revenue share payable</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">1,193,661</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">93,891</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">1,287,552</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Deferred revenue</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">4,252</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">222,020</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">226,272</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Additional paid in capital</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">8,726,708</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">148,477</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">8,875,155</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Deferred stock compensation</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(233,942</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(36,520</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(270,462</td><td style="text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Accumulated deficit</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(24,616,220</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(483,137</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(25,099,357</td><td style="text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center; padding-left: 5.4pt; text-decoration: underline;">Statement of Operations</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align:
 left;">&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Revenue</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">4,957,016</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(277,275</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">4,679,741</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Revenue share expense</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">1,767,425</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">93,891</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">1,861,316</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Operating expenses</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">2,973,990</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">111,701</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">3,085,691</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Net income (loss)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">215,847</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(483,137</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(267,290</td><td style="text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center; padding-left: 5.4pt; text-decoration: underline;">Statement of Cash Flows</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Net income (loss)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">215,847</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(483,137</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(267,290</td><td style="text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Stock options issued for services</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">19,547</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">75,451</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">94,998</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Stock-based compensation</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">399,092</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">36,520</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">435,612</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Changes in accounts receivable</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(950,166</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">55,255</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(894,911</td><td style="text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Changes in revenue share payable</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">1,103,084</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">93,891</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">1,196,975</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Changes in deferred revenue</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(45,000</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">222,020</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">177,020</td><td style="text-align: left;">&#160;</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align:
 justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;<font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">Period Ended September 30, 2013 (unaudited):</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: center; text-decoration: underline;"><font style="font-size: 10pt;"><u>Balance Sheet</u></font></td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><font style="font-size: 10pt;">Previously stated</font></td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><font style="font-size: 10pt;">Adjustments</font></td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><font style="font-size: 10pt;">Restated</font></td><td style="padding-bottom: 1.5pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 1019px; text-align: justify;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 142px; text-align: right;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 141px; text-align: right;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 125px; text-align: right;">&#160;</td><td style="width: 15px;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue share payable</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">782,902</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">28,376</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">811,278</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Deferred revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">13,272</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">147,860</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">161,132</font></td><td>&#160;</td></tr><tr><td style="text-align: justify; vertical-align: top;"><font style="font-size: 10pt;">Additional paid in capital</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="text-align: right; vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">8,449,271</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: top; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="text-align: right; vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">148,477</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: top; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="text-align: right; vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">8,597,748</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td></tr><tr><td style="text-align: justify; vertical-align: top;"><font style="font-size: 10pt;">Deferred stock compensation</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: top; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="text-align: right; vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">(233,077</font></td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">)</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: top; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="text-align: right; vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">(54,780</font></td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">)</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: top; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="text-align: right; vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">(287,857</font></td><td style="vertical-align: bottom; background-color:
 white;">)</td></tr><tr><td
 style="text-align: justify; vertical-align: top;"><font style="font-size: 10pt;">Accumulated deficit</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: top; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="text-align: right; vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">(24,870,854</font></td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">)</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: top; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="text-align: right; vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">(270,207</font></td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">)</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: top; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="text-align: right; vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">(25,141,061</font></td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center; text-decoration: underline;"><font style="font-size: 10pt;"><u>Statement of Operations</u></font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center;"><font style="font-size: 10pt;">Three Months ended September 30, 2013</font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,373,029</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(147,860</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,225,169</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue share expense</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">529,134</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">28,376</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">557,510</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Operating expenses</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">982,504</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">93,971</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,076,475</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Net income (loss)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(141,527</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(270,207</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(411,734</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center;"><font style="font-size: 10pt;">Nine Months ended September 30, 2013</font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td><font style="font-size: 10pt;">Revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">3,146,406</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(147,860</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">2,998,546</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td><font style="font-size: 10pt;">Revenue share expense</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,264,059</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">28,376</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size:
 10pt;">1,292,435</font></td><td>&#160;</td></tr><tr
 style="vertical-align: bottom; background-color: white;"><td><font style="font-size: 10pt;">Operating expenses</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">2,272,239</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">93,971</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">2,366,210</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td><font style="font-size: 10pt;">Net income (loss)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(389,716</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(270,207</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(659,923</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center; text-decoration: underline;"><font style="font-size: 10pt;"><u>Statement of Cash Flows</u></font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Net income (loss)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(389,716</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(270,207</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(659,923</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Stock-based compensation</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">310,823</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">93,971</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">404,794</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Changes in revenue share payable</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">649,825</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">28,376</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">678,201</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Changes in deferred revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(35,980</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">147,860</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">111,880</font></td><td>&#160;</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">Period Ended March 31, 2014 (unaudited):</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><div>Three Months ended March 31, 2014</div><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: center; text-decoration: underline;"><font style="font-size: 10pt;"><u>Balance Sheet</u></font></td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><font style="font-size: 10pt;">Previously stated</font></td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><font style="font-size: 10pt;">Adjustments</font></td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td
 style="text-align: center; border-bottom-color: black;
 border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><font style="font-size: 10pt;">Restated</font></td><td style="padding-bottom: 1.5pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 1035px; text-align: justify;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 126px; text-align: right;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 141px; text-align: right;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 125px; text-align: right;">&#160;</td><td style="width: 15px;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue share payable</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">797,725</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">167,880</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">965,605</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Deferred revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">168,714</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">268,807</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">437,521</font></td><td>&#160;</td></tr><tr><td style="text-align: justify; vertical-align: top;"><font style="font-size: 10pt;">Additional paid in capital</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="text-align: right; vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">27,155,730</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="text-align: right; vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">148,477</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="text-align: right; vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">27,304,207</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td></tr><tr><td style="text-align: justify; vertical-align: top;"><font style="font-size: 10pt;">Deferred stock compensation</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="text-align: right; vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">(454,409</font></td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">)</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="text-align: right; vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">(18,260</font></td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">)</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="text-align: right; vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">(472,669</font></td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">)</font></td></tr><tr><td style="text-align: justify; vertical-align: top;"><font style="font-size: 10pt;">Accumulated deficit</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="text-align: right; vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">(25,269,535</font></td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">)</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="text-align: right; vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">(591,917</font></td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">)</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="text-align: right; vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">(25,861,452</font></td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center; text-decoration: underline;"><font style="font-size: 10pt;"><u>Statement of Operations</u></font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align:
 bottom; background-color:
 white;"><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,317,347</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(27,919)</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,289,428</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue share expense</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">498,810</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">62,601</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">561,411</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Operating expenses</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,471,598</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">18,260</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,489,858</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Net income (loss)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(653,315</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(108,780</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(762,095</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center; text-decoration: underline;"><font style="font-size: 10pt;"><u>Statement of Cash Flows</u></font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Net income (loss)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(653,315</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(108,780</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(762,095</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Stock-based compensation</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">361,957</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">18,260</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">380,217</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Changes in revenue share payable</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(395,935</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">62,601</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(333,334</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Changes in deferred revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">164,462</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">27,919</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">192,381</font></td><td>&#160;</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px;
 white-space: normal; widows:
 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>P</b><font style="letter-spacing: -0.1pt;">eriod Ended June 30, 2014 (unaudited):</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: center; text-decoration: underline;"><font style="font-size: 10pt;"><u>Balance Sheet</u></font></td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><font style="font-size: 10pt;">Previously stated</font></td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><font style="font-size: 10pt;">Adjustments</font></td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><font style="font-size: 10pt;">Restated</font></td><td style="padding-bottom: 1.5pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 1035px; text-align: justify;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 126px; text-align: right;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 141px; text-align: right;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 125px; text-align: right;">&#160;</td><td style="width: 15px;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue share payable</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">506,901</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">366,088</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">872,989</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Deferred revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">42,908</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">258,270</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">301,178</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Additional paid in capital</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">27,304,112</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">84,677</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">27,388,789</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Accumulated deficit</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(25,322,216</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(738,674</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">26,060,890</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center; text-decoration: underline;"><font style="font-size: 10pt;"><u>Statement of Operations</u></font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center;"><font style="font-size: 10pt;">Three Months ended June 30, 2014</font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,454,214</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td
 style="text-align: right;"><font
 style="font-size: 10pt;">(27,206</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,427,008</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue share expense</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">540,048</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">190,092</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">730,140</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Operating expenses</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">967,070</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(70,541</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">896,529</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Net income (loss)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(52,681</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(146,757</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(199,438</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center;"><font style="font-size: 10pt;">Six Months ended June 30, 2014</font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">2,771,560</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(55,124</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">2,716,436</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue share expense</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,038,858</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">252,693</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,291,551</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Operating expenses</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">2,439,028</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(52,281</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">2,386,747</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Net income (loss)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(705,996</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(255,537</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(961,533</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center; text-decoration: underline;"><font style="font-size: 10pt;"><u>Statement of Cash Flows</u></font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Net income (loss)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size:
 10pt;">(705,996</font></td><td><font style="font-size:
 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(255,537</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(961,533</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Stock-based compensation</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">654,634</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(52,281</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">602,353</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Changes in revenue share payable</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(686,760</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">252,693</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(434,067</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Changes in deferred revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">38,656</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">55,124</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">93,780</font></td><td>&#160;</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">Period Ended September 30, 2014(unaudited):</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: center; text-decoration: underline;"><font style="font-size: 10pt;"><u>Balance Sheet</u></font></td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><font style="font-size: 10pt;">Previously stated</font></td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><font style="font-size: 10pt;">Adjustments</font></td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2"><font style="font-size: 10pt;">Restated</font></td><td style="padding-bottom: 1.5pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 1035px; text-align: justify;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 126px; text-align: right;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 141px; text-align: right;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 125px; text-align: right;">&#160;</td><td style="width: 15px;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue share payable</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">853,410</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">421,019</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,274,429</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Deferred revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">-0-</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">118,949</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">118,949</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom;
 background-color: white;"><td style="text-align: justify;"><font
 style="font-size: 10pt;">Additional paid in capital</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">28,398,825</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">84,677</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">28,483,502</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Accumulated deficit</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(25,716,530</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(638,903</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(26,355,433</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center; text-decoration: underline;"><font style="font-size: 10pt;"><u>Statement of Operations</u></font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center;"><font style="font-size: 10pt;">Three Months ended September 30, 2014</font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,620,215</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">199,206</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,819,421</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue share expense</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">858,898</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">99,435</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">958,,333</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Operating expenses</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,155,933</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">-0-</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,155,933</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Net income (loss)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(394,314</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">99,771</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(294,543</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center;"><font style="font-size: 10pt;">Nine Months ended September 30, 2014</font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">4,391,775</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">144,082</font></td><td>&#160;</td><td>&#160;</td><td>$</td><td style="text-align: right;"><font style="font-size:
 10pt;">4,535,857</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom;
 background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue share expense</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,897,757</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">352,127</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">2,249,884</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Operating expenses</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">3,594,961</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(52,280</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">3,542,681</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Net income (loss)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(1,100,310</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(155,766</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(1,256,076</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center; text-decoration: underline;"><font style="font-size: 10pt;"><u>Statement of Cash Flows</u></font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Net income (loss)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(1,100,310</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(155,766</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(1,256,076</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Stock-based compensation</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,118,952</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(52,280</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(1,066,672</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Changes in revenue share payable</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(340,251</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">352,127</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">11,876</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Changes in deferred revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(4,252</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(144,082</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(148,334</font></td><td><font style="font-size: 10pt;">)</font></td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>&#160;</b></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestatementToPriorYearIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature and effects of a restatement to correct an error in the reported results of operations of prior periods. When prior period adjustments are recorded, the resulting effects (both gross and net of applicable income tax) on the net income of prior periods are disclosed in the annual report for the year in which the adjustments are made, and amended filings of previously issued reports are typically issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 250<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 7<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56949863&amp;loc=d3e22644-107794<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 250<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56949863&amp;loc=d3e22658-107794<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 250<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 9<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56949863&amp;loc=d3e22663-107794<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestatementToPriorYearIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847754354576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred Stock (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="6">1 Months Ended</th>
<th class="th" colspan="2">8 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May. 12, 2010</div></th>
<th class="th"><div>Sep. 30, 2011</div></th>
<th class="th"><div>Sep. 21, 2011</div></th>
<th class="th"><div>Mar. 25, 2011</div></th>
<th class="th"><div>Dec. 31, 2010</div></th>
<th class="th"><div>Nov. 16, 2010</div></th>
<th class="th"><div>Dec. 31, 2008</div></th>
<th class="th"><div>Sep. 30, 2013</div></th>
<th class="th"><div>Sep. 30, 2012</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock issued, Values</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,795,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,333,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock issued, Values</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued, Shares</a></td>
<td class="nump">236,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,306<span></span>
</td>
<td class="nump">176,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">173,922<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock issued, Values</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="nump">$ 350,000<span></span>
</td>
<td class="nump">$ 350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Net proceeds of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,985,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Preferred Shares issued, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Percentage of cumulative dividend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentWarrantsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockNumberOfSharesHeld', window );">Treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionOfDividends', window );">Undeclared dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockRedemptionAmount', window );">Total Undeclared dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000<span></span>
</td>
<td class="nump">$ 350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock issued, Values</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Net proceeds of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Preferred Shares issued, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Percentage of cumulative dividend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentWarrantsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockNumberOfSharesHeld', window );">Treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,988<span></span>
</td>
<td class="nump">75,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock issued, Values</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 644,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Preferred shares issued, values</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,158,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Warrants, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 855,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 341,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_invest_InvestmentWarrantsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price of the warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Article 12<br><br><br><br> -Section 13<br><br><br><br> -Sentence Column A<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">invest_InvestmentWarrantsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>invest_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(i)(2))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 470<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 5<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928298&amp;loc=SL6031898-161870<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockRedemptionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The redemption (or callable) amount of currently redeemable preferred stock. Includes amounts representing dividends not currently declared or paid but which will be payable under the redemption features or for which ultimate payment is solely within the control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.27(b))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockRedemptionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3255-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Financing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of preferred stock and warrants for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-30)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30, 31<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of accretion of temporary equity during the period due to unpaid dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockNumberOfSharesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockNumberOfSharesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847760448992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk free interest rate minimum</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">0.79%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk free interest rate maximum</a></td>
<td class="nump">1.44%<span></span>
</td>
<td class="nump">1.42%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected option term</a></td>
<td class="text">3 years 6 months<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Turnover/forfeiture rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility minimum</a></td>
<td class="nump">117.00%<span></span>
</td>
<td class="nump">155.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility maximum</a></td>
<td class="nump">138.00%<span></span>
</td>
<td class="nump">171.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (f)(2)(iii)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (f)(2)(ii)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 14.D.2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (f)(2)(i)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 14<br><br><br><br> -Section D<br><br><br><br> -Subsection 2<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847890652400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_PrepaidExpensesAbstract', window );"><strong>Prepaid Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_PrepaidExpensesTableTextBlock', window );">Schedule of prepaid expenses</a></td>
<td class="text"><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">2014</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">2013</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1191px; font-size: 10pt; background-color: white;">Insurance</td><td style="width: 16px; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 16px; font-size: 10pt; text-align: left; background-color: white;">$</td><td style="width: 142px; font-size: 10pt; text-align: right; background-color: white;">18,093</td><td style="width: 16px; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="width: 15px; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 15px; font-size: 10pt; text-align: left; background-color: white;">$</td><td style="width: 141px; font-size: 10pt; text-align: right; background-color: white;">6,722</td><td style="width: 15px; font-size: 10pt; text-align: left; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; background-color: white;">Rent</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">-0-</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">5,049</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">Legal</td><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right; background-color: white;">10,000</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right; background-color: white;">-0-</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; text-align: left; padding-bottom: 4pt; background-color: white;">Total prepaid expenses</td><td style="font-size: 10pt; padding-bottom: 4pt; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left; background-color: white;">$</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right; background-color: white;">28,093</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; padding-bottom: 4pt; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left; background-color: white;">$</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right; background-color: white;">11,771</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: white;">&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_PrepaidExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_PrepaidExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_PrepaidExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_PrepaidExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847763484800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><table style="width: 1250.4px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2014</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2013</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 950.4px; text-align: left; font-size: 10pt;">Computer equipment</td><td style="width: 12.8px; font-size: 10pt;">&#160;</td><td style="width: 12.8px; text-align: left; font-size: 10pt;">$</td><td style="width: 112.8px; text-align: right; font-size: 10pt;">19,519</td><td style="width: 12.8px; text-align: left; font-size: 10pt;">&#160;</td><td style="width: 12.8px; font-size: 10pt;">&#160;</td><td style="width: 12px; text-align: left; font-size: 10pt;">$</td><td style="width: 112px; text-align: right; font-size: 10pt;">22,360</td><td style="width: 12px; text-align: left; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;">Furniture and fixtures</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">11,088</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">11,088</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-left: 10pt; font-size: 10pt;">Subtotal</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">30,607</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">33,448</td><td style="text-align: left; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;">Accumulated depreciation</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(17,794</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;">)</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(18,391</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding-bottom: 4pt; padding-left: 10pt; font-size: 10pt;">Property and equipment, net</td><td style="padding-bottom: 4pt; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">12,813</td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;">&#160;</td><td style="padding-bottom: 4pt; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">15,057</td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph b<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847896918896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS EQUITY</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">NOTE 2 &#8211; STOCKHOLDERS EQUITY</font></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">In January 2015, we issued 12,500 shares of common stock to outside Directors in connection with our Director Compensation plan, which calls for issuance of 6,250 shares per quarter for each Director. Those shares were recorded as stock payable at December 31, 2014. In addition, we recorded an additional 12,500 shares, valued at $16,375 as stock payable at March 31, 2015 for shares to be issued in April 2015 and 12,500 shares, valued at $13,375 were issued in June 2015 for the second quarter payment.</font></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">In February 2015, we entered into a capital markets advisory agreement covering a one year period, which called for 90,000 shares of common stock to be issued as compensation. These shares were valued at $112,500 and are being amortized to expense over the period of service. 45,000 of these shares were issued in March 2015, with the balance to be issued in August 2015. The agreement was terminated in July 2015, effective in August, and the remaining 45,000 shares will not be issued. The total expense to be recognized will be $56,250 and is being amortized over the period the agreement is in effect.</font></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In&#160;March 2014,&#160;we&#160;entered into a securities purchase agreement, pursuant to which&#160;we&#160;sold 8,333,333 shares of&#160;our common stock for $1.20 per share, or gross proceeds of $10,000,000.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Placement agents in the offering received commissions equal to approximately 9.7% of gross proceeds, for an aggregate commission of approximately $970,000, including reimbursements for their reasonable out of pocket expenses. Placement agents also received warrants to purchase up to 804,139 shares of&#160;our common stock with an exercise price of $1.20 per share and a term of 5 years. The warrants were valued at $1,110,211, have been recorded as equity issuance costs, and were registered on a registration statement that went effective May 28, 2014. In addition to the warrants to placement agents, we also paid cash bonuses of $240,000 to three executive officers, agreed to issue 200,000 shares to three executive officers, and issued 150,000 shares to a consultant, in connection with the equity raise. The stock was valued based on the fair market value on the grant date, which was $630,000 in total. These amounts have been recorded as equity issuance costs, resulting in total equity issuance costs of $2.95 million. The 200,000 shares for the three executive officers have not been issued, but are recorded as stock payable and can be requested by the executive officers at any time.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">We&#160;used the net proceeds of the offering to exercise the securities redemption option agreement, as amended, with Vicis Capital Master Fund that provided&#160;us&#160;with an option to purchase all of the outstanding shares and derivative securities held by Vicis for total payment of $6,000,000. The shares and derivative securities included the Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Common Stock, and warrants to purchase shares of common stock held by Vicis in the Company. The balance of the net proceeds were used for working capital purposes.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal;
 -webkit-text-stroke-width:
 0px;">In January 2014, an executive officer exercised 500,000 stock warrants using the cashless exercise feature included in the warrants. In exchange for the 500,000 warrants, 410,348 shares of common stock were issued.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In June 2015, we agreed to grant 197,605 fully vested shares of our common stock to two executive officers as bonuses. These shares have not been issued, but are recorded as stock payable and can be requested by the officers at any time.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In February 2014, we agreed to grant 337,500 shares of our common stock, half of which vested immediately and half of which vested in August 2014, to two executive officers as bonuses based on their efforts to recapitalize the company to secure approximately $3 million in working capital while reducing fully diluted shares by approximately 7 million shares. These shares have not been issued, but are recorded as stock payable and can be requested by the officers at any time.</p></div><span></span>
</td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">NOTE 9 &#8211; COMMON STOCK</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">OptimizeRx Corporation has 500,000,000 shares of $.001 par value common stock authorized as of December 31, 2014. There were 22,867,319 and 14,817,496 common shares issued and outstanding at December&#160;31, 2014 and 2013, respectively.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">On June&#160;1, 2013, the Company entered into a consulting agreement with North Coast Advisors, Inc. for various services. The Company agreed to issue 20,000 shares of common stock as of the date of the contract. The Company also agreed to issue an additional 20,000 shares every six months in alignment with the agreement renewal up to the two years of the agreement. The first 20,000 shares were valued at the Company&#8217;s common stock closing price as of the date of the contract, which was $1.945/share; and the second 20,000 shares were valued at the Company&#8217;s common stock closing price of $1.50/share on the date of issuance, and have been expensed. An additional 10,000 shares were issued in 2014 before the agreement was terminated by the Company. The 2014 shares were valued at $1.85, the closing price of the Company&#8217;s common stock on the date of issuance.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">On June 10, 2013, the Company entered into a capital markets advisory agreement with Taglich Brothers, Inc. for various services. The agreement covered a one year period and the Company agreed to issue 44,000 shares of common stock to Taglich over the term of the agreement. The shares were valued at $1.66, the closing price of the stock on the date of the agreement and were written off over the term of the agreement. The shares were issued in June 2014 upon expiration of the contract.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>&#160;</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">On September&#160;20, 2013, the Company entered into a separation agreement that included post-employment consulting services with the former CEO of the Company. The Company agreed to issue 500,000 shares of common stock, 250,000 shares immediately and 250,000 by January&#160;1, 2014. The shares have been issued and the Company recognized the entire issuance in the December 31, 2013 shares outstanding. The shares were valued at $505,000 and $174,808 of that amount remained as deferred stock compensation as of December&#160;31, 2013, but has been fully amortized to expenses as of December 31, 2014.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In&#160;March 2014,&#160;the Company&#160;entered into a securities purchase agreement, pursuant to which&#160;the Company&#160;sold 8,333,333 shares of&#160;the Company&#8217;s common stock for $1.20 per share, or gross proceeds of $10,000,000.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><div style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Placement agents in the offering received commissions equal to approximately 9.7% of gross proceeds, for an aggregate commission of approximately $970,000, including reimbursements for their reasonable out of pocket expenses. Placement agents also received warrants to purchase up to 804,139 shares of&#160;the Company's common stock with an exercise price of $1.20 per share and a term of 5 years. The warrants were valued at $1,110,211, have been recorded as equity issuance costs, and were registered on a registration statement dated May 28, 2014. In addition to the warrants to placement agents, the Company also paid cash bonuses of $240,000 to three executive officers, agreed to issue 200,000 shares to
 three executive officers, and issued 150,000 shares to a consultant, in connection with the equity raise. The stock was valued based on the fair market value on the grant date, which was $630,000 in total. These amounts have been recorded as equity issuance costs, resulting in total equity issuance costs of $2.95 million. The 200,000 shares for the three executive officers have not been issued, but are recorded as stock payable and can be requested by the respective officers at any time.</div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company&#160;used the net proceeds of the offering to exercise the securities redemption option agreement, as amended, with Vicis Capital Master Fund that provided&#160;the Company&#160;with an option to purchase all of the outstanding shares and derivative securities held by Vicis for total payment of $6,000,000. The shares and derivative securities included the Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Common Stock, and warrants to purchase shares of common stock held by Vicis in the Company. The balance of the net proceeds was used for working capital purposes.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In January 2014, an executive officer exercised 500,000 stock warrants using the cashless exercise feature included in the warrants. In exchange for the 500,000 warrants, 410,348 shares of common stock were issued. In October 2014, a consultant exercised 50,000 stock warrants using the cashless exercise feature included in the warrants. In exchange for the 50,000 warrants, 35,417 shares of common stock were issued.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In February 2014, the Company agreed to grant 337,500 shares of common stock, half of which vested immediately and half of which vested in August 2014, to two executive officers as bonuses based on their efforts to recapitalize the company to secure approximately $3 million in working capital while reducing potential fully diluted shares by approximately 7 million shares. Stock-based compensation related to these bonuses was $570,375 during the year ended December 31, 2014. These shares have not yet been issued and are recorded as stock payable, but can be requested by the officers at any time.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><div style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In 2014, the Company adopted a Director Compensation plan for outside Directors. In connection with this plan, 19,565 shares were granted with a total value of $23,166. A total of 7,065 shares were issued in 2014 and 12,500 shares were included in stock payable at December 31, 2014 and issued in January 2015.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(d),(e))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 4.E)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 4<br><br><br><br> -Subparagraph (SAB TOPIC 4.C)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Preferred Stock<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section E<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section C<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847756788752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Web Based Technology (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_WebBasedTechnologyAbstract', window );"><strong>Web Based Technology [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_ScheduleOfCapitalizedCostsInDevelopingWebBasedTechnologyTableTextBlock', window );">Schedule of capitalized costs in developing web-based technology</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;"></p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">2014</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">2013</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1191px; text-align: left; font-size: 10pt; background-color: white;">OptimizeRx web-based technology</td><td style="width: 16px; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 16px; text-align: left; font-size: 10pt; background-color: white;">$</td><td style="width: 142px; text-align: right; font-size: 10pt; background-color: white;">154,133</td><td style="width: 16px; text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 15px; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 15px; text-align: left; font-size: 10pt; background-color: white;">$</td><td style="width: 141px; text-align: right; font-size: 10pt; background-color: white;">154,133</td><td style="width: 15px; text-align: left; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; font-size: 10pt; background-color: white;">SampleMD web-based technology</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; background-color: white;">602,517</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; background-color: white;">602,517</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">SampleMD 2.0 web-based technology</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">440,477</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">148,060</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding-left: 10pt; font-size: 10pt; background-color: white;">Subtotal, web-based technology</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; background-color: white;">1,197,127</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; background-color: white;">904,710</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; font-size: 10pt; background-color: white;">Accumulated amortization</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; background-color: white;">(633,401</td><td style="text-align: left; font-size: 10pt; background-color: white;">)</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; background-color: white;">(440,641</td><td style="text-align: left; font-size: 10pt; background-color: white;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">Impairment</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">(59,083</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">)</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt;
 border-bottom-style: solid; background-color: white;">(59,083</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">)</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; padding-bottom: 4pt; padding-left: 10pt; font-size: 10pt; background-color: white;">Web-based technology, net</td><td style="padding-bottom: 4pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">$</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">504,643</td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt; background-color: white;">&#160;</td><td style="padding-bottom: 4pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">$</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">404,986</td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt; background-color: white;">&#160;</td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_ScheduleOfCapitalizedCostsInDevelopingWebBasedTechnologyTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of capitalized costs in developing web-based technology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_ScheduleOfCapitalizedCostsInDevelopingWebBasedTechnologyTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_WebBasedTechnologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_WebBasedTechnologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847683810384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders Equity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="6">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2015</div></th>
<th class="th"><div>Feb. 28, 2015</div></th>
<th class="th"><div>Jan. 31, 2015</div></th>
<th class="th"><div>Oct. 31, 2014</div></th>
<th class="th"><div>Mar. 31, 2014</div></th>
<th class="th"><div>Jan. 31, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
<th class="th"><div>Feb. 28, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_StockholdersEquityTextualAbstract', window );"><strong>Stockholders Equity (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Called for issuance of shares, values</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (6,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Additional shares issued, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Common stock issued for equity issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 630,000<span></span>
</td>
<td class="nump">630,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Employee bonus, Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 337,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 337,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross', window );">Employee bonus, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">570,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_AdditionalWorkingCapital', window );">Additional working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_FullyDilutedShares', window );">Fully diluted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtIssuanceCosts', window );">Equity issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,950,000<span></span>
</td>
<td class="nump">$ 2,950,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_WarrantsExercised', window );">Warrants exercised, number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=oprx_CapitalMarketsAdvisoryAgreementMember', window );">Capital Markets Advisory Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_StockholdersEquityTextualAbstract', window );"><strong>Stockholders Equity (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Called for issuance of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Additional shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Called for issuance of shares, values</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 112,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Capital Markets Advisory Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_StockholdersEquityTextualAbstract', window );"><strong>Stockholders Equity (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_StockIssuedDuringPeroidSharesCacelled', window );">Number of shares not be issued</a></td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Called for issuance of shares, values</a></td>
<td class="nump">$ 56,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_AgreementAxis=oprx_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_StockholdersEquityTextualAbstract', window );"><strong>Stockholders Equity (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of comman stock shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,333,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of common stock value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=oprx_PlacementAgentsMember', window );">Placement agents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_StockholdersEquityTextualAbstract', window );"><strong>Stockholders Equity (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_WarrantExercisePricePeriod', window );">Warrant exercise price period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_CommissionsPercentage', window );">Commissions percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrent', window );">Commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 970,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_PurchaseOfWarrants', window );">Purchase of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">804,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Warrants, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,110,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=oprx_ThreeOfficerMember', window );">Three officers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_StockholdersEquityTextualAbstract', window );"><strong>Stockholders Equity (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Additional shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee Bonus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=oprx_ConsultantMember', window );">Consultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_StockholdersEquityTextualAbstract', window );"><strong>Stockholders Equity (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Additional shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=oprx_VicisMember', window );">Vicis Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_StockholdersEquityTextualAbstract', window );"><strong>Stockholders Equity (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_DebtRedemptionLongtermDebtAmount', window );">Debt redemption, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=us-gaap_OfficerMember', window );">Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_StockholdersEquityTextualAbstract', window );"><strong>Stockholders Equity (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Additional shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">410,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Additional shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">410,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_WarrantsExercised', window );">Warrants exercised, number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=us-gaap_DirectorMember', window );">Outside director [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_StockholdersEquityTextualAbstract', window );"><strong>Stockholders Equity (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Called for issuance of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Additional shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_DebtRedemptionLongtermDebtAmount', window );">Debt redemption, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Additional shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Additional shares issued, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,375<span></span>
</td>
<td class="nump">$ 13,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=oprx_TwoOfficersMember', window );">Two Officers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_StockholdersEquityTextualAbstract', window );"><strong>Stockholders Equity (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Employee bonus, Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 197,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_AdditionalWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional working capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_AdditionalWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_CommissionsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>commissions percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_CommissionsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_DebtRedemptionLongtermDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_DebtRedemptionLongtermDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_FullyDilutedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>fully diluted shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_FullyDilutedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_PurchaseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_PurchaseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_StockIssuedDuringPeroidSharesCacelled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represnts number of shares terminated or cancelled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_StockIssuedDuringPeroidSharesCacelled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_StockholdersEquityTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_StockholdersEquityTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_WarrantExercisePricePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant exercise price period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_WarrantExercisePricePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_WarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_WarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Current Liabilities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of debt issuance costs (for example, but not limited to, legal, accounting, broker, and regulatory fees).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Financing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 15<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3291-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of preferred stock and warrants for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period that is attributable to transactions involving issuance of stock not separately disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP). Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued during the period that is attributable to transactions involving issuance of stock not separately disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP). Stock issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=oprx_CapitalMarketsAdvisoryAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=oprx_CapitalMarketsAdvisoryAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_AgreementAxis=oprx_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_AgreementAxis=oprx_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=oprx_PlacementAgentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=oprx_PlacementAgentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=oprx_ThreeOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=oprx_ThreeOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=oprx_ConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=oprx_ConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=oprx_VicisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=oprx_VicisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=us-gaap_OfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=us-gaap_OfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=us-gaap_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=us-gaap_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=oprx_TwoOfficersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=oprx_TwoOfficersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847763516512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Deferred Revenue (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Mar. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
<th class="th"><div>Sep. 30, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">$ 336,213<span></span>
</td>
<td class="nump">$ 120,130<span></span>
</td>
<td class="nump">$ 118,949<span></span>
</td>
<td class="nump">$ 301,178<span></span>
</td>
<td class="nump">$ 437,521<span></span>
</td>
<td class="nump">$ 226,272<span></span>
</td>
<td class="nump">$ 161,132<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 605<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 13<br><br><br><br> -Section A<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847750316752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheet (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 3,645,878<span></span>
</td>
<td class="nump">$ 3,446,973<span></span>
</td>
<td class="nump">$ 1,118,243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">1,918,419<span></span>
</td>
<td class="nump">2,100,381<span></span>
</td>
<td class="nump">1,511,709<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">76,376<span></span>
</td>
<td class="nump">28,093<span></span>
</td>
<td class="nump">11,771<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">5,640,673<span></span>
</td>
<td class="nump">5,575,447<span></span>
</td>
<td class="nump">2,641,723<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">10,674<span></span>
</td>
<td class="nump">12,813<span></span>
</td>
<td class="nump">15,057<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Other Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Patent rights, net</a></td>
<td class="nump">901,491<span></span>
</td>
<td class="nump">930,854<span></span>
</td>
<td class="nump">885,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareNet', window );">Web development costs, net</a></td>
<td class="nump">424,075<span></span>
</td>
<td class="nump">504,643<span></span>
</td>
<td class="nump">404,986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security deposit</a></td>
<td class="nump">5,049<span></span>
</td>
<td class="nump">5,049<span></span>
</td>
<td class="nump">5,049<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Total Other Assets</a></td>
<td class="nump">1,330,615<span></span>
</td>
<td class="nump">1,440,546<span></span>
</td>
<td class="nump">1,295,985<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">6,981,962<span></span>
</td>
<td class="nump">7,028,806<span></span>
</td>
<td class="nump">3,952,765<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable - trade</a></td>
<td class="nump">172,183<span></span>
</td>
<td class="nump">200,372<span></span>
</td>
<td class="nump">188,739<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrent', window );">Accounts payable - related party</a></td>
<td class="nump">570,000<span></span>
</td>
<td class="nump">570,000<span></span>
</td>
<td class="nump">570,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">9,851<span></span>
</td>
<td class="nump">25,459<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_RevenueSharePayableCurrent', window );">Revenue share payable</a></td>
<td class="nump">1,190,995<span></span>
</td>
<td class="nump">1,502,761<span></span>
</td>
<td class="nump">1,287,552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">336,213<span></span>
</td>
<td class="nump">120,130<span></span>
</td>
<td class="nump">226,272<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Liabilities</a></td>
<td class="nump">2,279,242<span></span>
</td>
<td class="nump">2,418,722<span></span>
</td>
<td class="nump">2,284,563<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td>
<td class="nump">$ 22,950<span></span>
</td>
<td class="nump">$ 22,867<span></span>
</td>
<td class="nump">$ 14,817<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Stock warrants</a></td>
<td class="nump">$ 2,153,295<span></span>
</td>
<td class="nump">$ 2,153,295<span></span>
</td>
<td class="nump">$ 18,148,049<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">27,806,253<span></span>
</td>
<td class="nump">27,595,609<span></span>
</td>
<td class="nump">8,875,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_StockPayable', window );">Stock Payable</a></td>
<td class="nump">1,132,148<span></span>
</td>
<td class="nump">$ 963,063<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationEquity', window );">Deferred stock compensation</a></td>
<td class="num">(18,750)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(270,462)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(26,393,176)<span></span>
</td>
<td class="num">$ (26,124,750)<span></span>
</td>
<td class="num">(25,099,357)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' Equity</a></td>
<td class="nump">4,702,720<span></span>
</td>
<td class="nump">4,610,084<span></span>
</td>
<td class="nump">1,668,202<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</a></td>
<td class="nump">$ 6,981,962<span></span>
</td>
<td class="nump">$ 7,028,806<span></span>
</td>
<td class="nump">$ 3,952,765<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_RevenueSharePayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for revenue share payable within one year (or the normal operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_RevenueSharePayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_StockPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_StockPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(k)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Current Liabilities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.3-4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph a(1)<br><br><br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 4<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.30(a)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 12<br><br><br><br> -Article 7<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 985<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 985<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128487-111756<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3044-108585<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued under share-based plans to employees or officers which is the unearned portion, accounted for under the fair value method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.30)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 35<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415241&amp;loc=d3e4534-113899<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 605<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 13<br><br><br><br> -Section A<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.32)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 7<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.21)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate carrying amounts, as of the balance sheet date, of assets not separately disclosed in the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 10<br><br><br><br> -Article 7<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6787-107765<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 340<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 05<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51662447&amp;loc=d3e5879-108316<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Current Assets<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509628<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (g)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 7<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.31(a)(3))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.8,17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 4.E)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section E<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(i))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847763192128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details Textual) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract', window );"><strong>Summary of Significant Accounting Policies Details (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionNewAccountingPronouncementMaterialEffectDescription', window );">Revenue recognition and revenue shares, Description</a></td>
<td class="text">Legal settlement in an amount equal to the greater of 10% of eCoupon revenues generated or $0.37 per eCoupon distributed.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract', window );"><strong>Summary of Significant Accounting Policies Details (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and Equipment, Estimated useful lives</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract', window );"><strong>Summary of Significant Accounting Policies Details (Textual)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and Equipment, Estimated useful lives</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_SummaryOfSignificantAccountingPoliciesDetailsTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49124121&amp;loc=d3e5074-111524<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.5)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionNewAccountingPronouncementMaterialEffectDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A description of whether the adoption of the guidance is expected to have a material effect on the financial statements in the periods after initial adoption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionNewAccountingPronouncementMaterialEffectDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847685995184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the period</a></td>
<td class="num">$ (268,426)<span></span>
</td>
<td class="num">$ (961,733)<span></span>
</td>
<td class="num">$ (1,025,393)<span></span>
</td>
<td class="num">$ (267,290)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">159,337<span></span>
</td>
<td class="nump">115,828<span></span>
</td>
<td class="nump">264,340<span></span>
</td>
<td class="nump">193,791<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_StockOptionsIssuedForServices', window );">Stock and options issued for services</a></td>
<td class="nump">361,062<span></span>
</td>
<td class="nump">627,354<span></span>
</td>
<td class="nump">272,804<span></span>
</td>
<td class="nump">94,998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Loss on disposal of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,295<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">110,039<span></span>
</td>
<td class="nump">170,611<span></span>
</td>
<td class="nump">899,438<span></span>
</td>
<td class="nump">435,612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract', window );"><strong>Changes in:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">181,962<span></span>
</td>
<td class="nump">302,202<span></span>
</td>
<td class="num">(588,672)<span></span>
</td>
<td class="num">(894,911)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="num">(48,283)<span></span>
</td>
<td class="num">(30,198)<span></span>
</td>
<td class="num">(16,322)<span></span>
</td>
<td class="nump">56,387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(28,189)<span></span>
</td>
<td class="nump">203,714<span></span>
</td>
<td class="nump">11,633<span></span>
</td>
<td class="nump">134,046<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_RevenueSharePayable', window );">Revenue share payable</a></td>
<td class="num">(311,766)<span></span>
</td>
<td class="num">(414,563)<span></span>
</td>
<td class="nump">215,210<span></span>
</td>
<td class="nump">1,196,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="num">(15,608)<span></span>
</td>
<td class="num">(12,000)<span></span>
</td>
<td class="nump">13,459<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">216,083<span></span>
</td>
<td class="nump">19,651<span></span>
</td>
<td class="num">(106,142)<span></span>
</td>
<td class="nump">177,020<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES</a></td>
<td class="nump">$ 246,172<span></span>
</td>
<td class="num">(149,745)<span></span>
</td>
<td class="num">(56,350)<span></span>
</td>
<td class="nump">1,132,628<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_PurchasesOfPropertyAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,592)<span></span>
</td>
<td class="num">(6,984)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_PatentRights', window );">Patent rights</a></td>
<td class="num">$ (4,517)<span></span>
</td>
<td class="num">(92,624)<span></span>
</td>
<td class="num">(110,551)<span></span>
</td>
<td class="num">(150,588)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_WebsiteDevelopmentCosts', window );">Website site development costs</a></td>
<td class="num">(42,750)<span></span>
</td>
<td class="num">(119,616)<span></span>
</td>
<td class="num">(292,417)<span></span>
</td>
<td class="num">(148,060)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">NET CASH USED IN INVESTING ACTIVITIES</a></td>
<td class="num">$ (47,267)<span></span>
</td>
<td class="num">(213,832)<span></span>
</td>
<td class="num">(409,952)<span></span>
</td>
<td class="num">(298,648)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">8,795,032<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_StockIssueDuringPeriodValueIssuedForCash', window );">Equity issuance costs</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,204,968)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants', window );">Purchase of common and preferred stock and warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(6,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfEquity', window );">Redemption of common and preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">NET CASH PROVIDED BY FINANCING ACTIVITIES</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,795,032<span></span>
</td>
<td class="nump">2,795,032<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">NET INCREASE IN CASH AND CASH EQUIVALENTS</a></td>
<td class="nump">$ 198,905<span></span>
</td>
<td class="nump">2,431,455<span></span>
</td>
<td class="nump">2,328,730<span></span>
</td>
<td class="nump">833,980<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD</a></td>
<td class="nump">3,446,973<span></span>
</td>
<td class="nump">1,118,243<span></span>
</td>
<td class="nump">1,118,243<span></span>
</td>
<td class="nump">284,263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">CASH AND CASH EQUIVALENTS - END OF PERIOD</a></td>
<td class="nump">$ 3,645,878<span></span>
</td>
<td class="nump">$ 3,549,698<span></span>
</td>
<td class="nump">3,446,973<span></span>
</td>
<td class="nump">1,118,243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL CASH FLOW INFORMATION:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Cash paid for interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for income taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Common stock issued for future services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 270,462<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_PatentRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_PatentRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_PurchasesOfPropertyAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_PurchasesOfPropertyAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_RevenueSharePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_RevenueSharePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_StockIssueDuringPeriodValueIssuedForCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares issued as consideration for cash for development stage entities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_StockIssueDuringPeriodValueIssuedForCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_StockOptionsIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_StockOptionsIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_WebsiteDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_WebsiteDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3044-108585<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 24<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 830<br><br><br><br> -SubTopic 230<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51824106&amp;loc=d3e2443-110228<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 25<br><br><br><br> -Subparagraph (f)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3536-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for interest during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 25<br><br><br><br> -Subparagraph (e)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3536-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 24<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 26<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3574-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 24<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 26<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3574-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 24<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 25<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3536-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Net Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Other Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 9<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Financing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 15<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3291-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Financing Activities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3255-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholder, which takes precedence over common stockholders in the event of liquidation and from issuance of rights to purchase common shares at a predetermined price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847760312576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2014 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=oprx_WarrantOneMember', window );">Warrant one [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Number of Warrants | shares</a></td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentWarrantsExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 2.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate', window );">Expiration Date</a></td>
<td class="text">May 10,  2017<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=oprx_WarrantTwoMember', window );">Warrant two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Number of Warrants | shares</a></td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentWarrantsExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 0.89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate', window );">Expiration Date</a></td>
<td class="text">Feb. 17,  2016<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=oprx_WarrantThreeMember', window );">Warrant three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Number of Warrants | shares</a></td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentWarrantsExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 1.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate', window );">Expiration Date</a></td>
<td class="text">Mar. 17,  2017<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_invest_InvestmentWarrantsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price of the warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Article 12<br><br><br><br> -Section 13<br><br><br><br> -Sentence Column A<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">invest_InvestmentWarrantsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>invest_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award non option equity instrument expiration date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(1)(i)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(1)(ii)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=oprx_WarrantOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=oprx_WarrantOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=oprx_WarrantTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=oprx_WarrantTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=oprx_WarrantThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=oprx_WarrantThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847747342736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_WarrantsDisclouresAbstract', window );"><strong>Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of warrants outstanding</a></td>
<td class="text"><table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">Number of Warrants</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">Exercise Price</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">Expiration Date</td></tr><tr style="vertical-align: bottom;"><td style="font-size: 10pt; text-align: center; background-color: white;" colspan="2">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: center; background-color: white;" colspan="2">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: center; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 10.6666669845581px; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="width: 322.666656494141px; font-size: 10pt; text-align: right; background-color: white;">1,000,000</td><td style="width: 10.6666669845581px; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="width: 10.6666669845581px; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 10.6666669845581px; font-size: 10pt; text-align: left; background-color: white;">$</td><td style="width: 322px; font-size: 10pt; text-align: right; background-color: white;">2.25</td><td style="width: 10px; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="width: 10px; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 324.802093505859px; font-size: 10pt; text-align: center; padding-left: 5.4pt; background-color: white;">10/5/2017</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">50,000</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color: white;">$</td><td style="font-size: 10pt; text-align: right; background-color: white;">0.89</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: center; padding-left: 5.4pt; background-color: white;">2/17/2016</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">804,139</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color: white;">$</td><td style="font-size: 10pt; text-align: right; background-color: white;">1.20</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: center; padding-left: 5.4pt; background-color: white;">3/17/2019</td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_ScheduleOfShare-BasedCompensationWarrantActivityTableTextBlock', window );">Schedule of warrant activity</a></td>
<td class="text"><table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Number of Warrants</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Weighted average exercise price</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 790px; font-size: 10pt;">Outstanding, January 1, 2013</td><td style="width: 10.6666669845581px; font-size: 10pt;">&#160;</td><td style="width: 10.6666669845581px; font-size: 10pt; text-align: left;">&#160;</td><td style="width: 94px; font-size: 10pt; text-align: right;">12,277,000</td><td style="width: 10.6666669845581px; font-size: 10pt; text-align: left;">&#160;</td><td style="width: 10px; font-size: 10pt;">&#160;</td><td style="width: 10px; font-size: 10pt; text-align: left;">$</td><td style="width: 93.3333358764648px; font-size: 10pt; text-align: right;">2.25</td><td style="width: 10px; font-size: 10pt; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt;">Granted - 2013</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; text-align: right;">0</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; text-align: right;">0</td><td style="font-size: 10pt; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt;">Exercised - 2013</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; text-align: right;">0</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; text-align: right;">0</td><td style="font-size: 10pt; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; padding-bottom: 1.5pt;">Expired &#8211; 2013</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;">(527,000</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;">)</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;">(1.73</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; padding-left: 10pt;">Balance, December 31, 2013</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; text-align: right;">11,750,000</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; text-align: right;">2.27</td><td style="font-size: 10pt; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt;">Granted &#8211; 2014</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; text-align: right;">804,139</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; text-align: right;">1.20</td><td style="font-size: 10pt; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt;">Exercised &#8211; 2014</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; text-align: right;">(550,000</td><td style="font-size: 10pt; text-align: left;">)</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; text-align: right;">(0.35</td><td style="font-size: 10pt; text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt;">Cancelled - 2014</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; text-align: right;">(10,000,000</td><td style="font-size: 10pt; text-align: left;">)</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; text-align: right;">(2.40</td><td style="font-size: 10pt; text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; padding-bottom: 1.5pt;">Expired &#8211; 2014</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;">(150,000</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;">)</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;">(1.45</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color:
 white;"><td style="font-size: 10pt; padding-bottom: 4pt; padding-left: 10pt;">Balance, December&#160;31, 2014</td><td style="font-size: 10pt; padding-bottom: 4pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right;">1,854,139</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; padding-bottom: 4pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left;">$</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right;">1.69</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_ScheduleOfShare-BasedCompensationWarrantActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular schedule of share-based compensation warrant activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_ScheduleOfShare-BasedCompensationWarrantActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_WarrantsDisclouresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_WarrantsDisclouresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(i))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 50<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 50<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51659978&amp;loc=d3e25284-112666<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 28<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847763419584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Federal income tax benefit attributable to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Current operations</a></td>
<td class="nump">$ 349,000<span></span>
</td>
<td class="nump">$ 91,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_FederalIncomeTaxExpensesBenefitPermanentAndTimingDifferences', window );">Permanent and Timing Differences (net)</a></td>
<td class="num">(160,000)<span></span>
</td>
<td class="num">(294,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_FederalIncomeTaxExpensesBenefitValueAllowance', window );">Valuation allowance</a></td>
<td class="num">(189,000)<span></span>
</td>
<td class="nump">203,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations', window );">Net provision for federal income tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_FederalIncomeTaxExpensesBenefitPermanentAndTimingDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Federal income tax expenses benefit permanent and timing differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_FederalIncomeTaxExpensesBenefitPermanentAndTimingDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_FederalIncomeTaxExpensesBenefitValueAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Federal income tax expenses benefit value allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_FederalIncomeTaxExpensesBenefitValueAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(h))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Current Tax Expense (or Benefit)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509736<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 6.I.7)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 9<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 6<br><br><br><br> -Section I<br><br><br><br> -Paragraph Question 1-7<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 10<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32672-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Income Tax Expense (or Benefit)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(h)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847763518464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_WarrantsDisclouresAbstract', window );"><strong>Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_WarrantsTextBlock', window );">WARRANTS</a></td>
<td class="text"><div><font style="letter-spacing: -0.1pt;">NOTE 12 &#8211;WARRANTS</font><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company has issued warrants, primarily in connection with capital raising activities. As also discussed in Note 9, in 2014 we issued 804,139 warrants, with an exercise price of $1.20 per share, in connection with a $10 million equity raise, the proceeds of which were used to retire common stock, preferred, stock, and previously existing warrants.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company had the following warrants outstanding as of December&#160;31, 2014:</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">Number of Warrants</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">Exercise Price</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">Expiration Date</td></tr><tr style="vertical-align: bottom;"><td style="text-align: center; font-size: 10pt; background-color: white;" colspan="2">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: center; font-size: 10pt; background-color: white;" colspan="2">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: center; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 10.66px; text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 322.66px; text-align: right; font-size: 10pt; background-color: white;">1,000,000</td><td style="width: 10.66px; text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 10.66px; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 10.66px; text-align: left; font-size: 10pt; background-color: white;">$</td><td style="width: 322px; text-align: right; font-size: 10pt; background-color: white;">2.25</td><td style="width: 10px; text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 10px; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 324.8px; text-align: center; padding-left: 5.4pt; font-size: 10pt; background-color: white;">10/5/2017</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; background-color: white;">50,000</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; background-color: white;">$</td><td style="text-align: right; font-size: 10pt; background-color: white;">0.89</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: center; padding-left: 5.4pt; font-size: 10pt; background-color: white;">2/17/2016</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; background-color: white;">804,139</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; background-color: white;">$</td><td style="text-align: right; font-size: 10pt; background-color: white;">1.20</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: center; padding-left: 5.4pt; font-size: 10pt; background-color: white;">3/17/2019</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company had the following warrant activity during the years ended December&#160;31, 2014 and 2013:</p><p style="font:
 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Number of Warrants</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Weighted average exercise price</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 790px; font-size: 10pt;">Outstanding, January 1, 2013</td><td style="width: 10.66px; font-size: 10pt;">&#160;</td><td style="width: 10.66px; text-align: left; font-size: 10pt;">&#160;</td><td style="width: 94px; text-align: right; font-size: 10pt;">12,277,000</td><td style="width: 10.66px; text-align: left; font-size: 10pt;">&#160;</td><td style="width: 10px; font-size: 10pt;">&#160;</td><td style="width: 10px; text-align: left; font-size: 10pt;">$</td><td style="width: 93.33px; text-align: right; font-size: 10pt;">2.25</td><td style="width: 10px; text-align: left; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt;">Granted - 2013</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">0</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">0</td><td style="text-align: left; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt;">Exercised - 2013</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">0</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">0</td><td style="text-align: left; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 1.5pt; font-size: 10pt;">Expired &#8211; 2013</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(527,000</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;">)</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(1.73</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-left: 10pt; font-size: 10pt;">Balance, December 31, 2013</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">11,750,000</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">2.27</td><td style="text-align: left; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt;">Granted &#8211; 2014</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">804,139</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">1.20</td><td style="text-align: left; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt;">Exercised &#8211; 2014</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">(550,000</td><td style="text-align: left; font-size: 10pt;">)</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">(0.35</td><td style="text-align: left; font-size: 10pt;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt;">Cancelled - 2014</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">(10,000,000</td><td style="text-align: left; font-size: 10pt;">)</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">(2.40</td><td style="text-align: left; font-size: 10pt;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 1.5pt; font-size: 10pt;">Expired &#8211; 2014</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(150,000</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;">)</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-size: 10pt;
 border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(1.45</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 4pt; padding-left: 10pt; font-size: 10pt;">Balance, December&#160;31, 2014</td><td style="padding-bottom: 4pt; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">&#160;</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">1,854,139</td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;">&#160;</td><td style="padding-bottom: 4pt; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">1.69</td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;">&#160;</td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_WarrantsDisclouresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_WarrantsDisclouresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_WarrantsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants text.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_WarrantsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847750626752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Operating Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRentExpenseTableTextBlock', window );">Schedule of Rent Expense</a></td>
<td class="text"><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom; background-color: white;"><td style="width: 1379px; font-size: 10pt;">&#160;Year ended December 31, 2015</td><td style="width: 16px; font-size: 10pt;">&#160;</td><td style="width: 16px; font-size: 10pt; text-align: left;">$</td><td style="width: 141px; font-size: 10pt; text-align: right;">62,418</td><td style="width: 15px; font-size: 10pt; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;Year ended December 31, 2016</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;">57,217</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; text-align: left; padding-bottom: 4pt;">Total lease commitment</td><td style="font-size: 10pt; padding-bottom: 4pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left;">$</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right;">119,635</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left;">&#160;</td></tr></table><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRentExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of rental expense from operating leases for each period for which an income statement is presented with separate amounts for minimum rentals, contingent rentals, and sublease rentals.  Rental payments under leases with terms of a month or less that were not renewed need not be included.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 840<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41499-112717<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRentExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847763535344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Major Customers<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_MajorCustomerAbstract', window );"><strong>Major Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_MajorCustomerTextBlock', window );">MAJOR CUSTOMERS</a></td>
<td class="text"><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><font style="letter-spacing: -0.1pt;">NOTE 14 &#8211; MAJOR CUSTOMERS</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"><font style="letter-spacing: -0.1pt;">The Company had the following major customers that individually accounted for 10% or more of revenue in any one of the years presented</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">2014</td><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">Percentage</td><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">2013</td><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">Percentage</td><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 815px; text-align: left; background-color: white;">Company A</td><td style="width: 16px; background-color: white;">&#160;</td><td style="width: 16px; text-align: left; background-color: white;">$</td><td style="width: 142px; text-align: right; background-color: white;">1,270,064</td><td style="width: 16px; text-align: left; background-color: white;">&#160;</td><td style="width: 16px; background-color: white;">&#160;</td><td style="width: 16px; text-align: left; background-color: white;">&#160;</td><td style="width: 142px; text-align: right; background-color: white;">20</td><td style="width: 16px; text-align: left; background-color: white;">%</td><td style="width: 15px; background-color: white;">&#160;</td><td style="width: 15px; text-align: left; background-color: white;">$</td><td style="width: 141px; text-align: right; background-color: white;">1,776,824</td><td style="width: 15px; text-align: left; background-color: white;">&#160;</td><td style="width: 15px; background-color: white;">&#160;</td><td style="width: 15px; text-align: left; background-color: white;">&#160;</td><td style="width: 141px; text-align: right; background-color: white;">36</td><td style="width: 15px; text-align: left; background-color: white;">%</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; background-color: white;">Company B</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">797,972</td><td style="text-align: left; background-color: white;">&#160;</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">12</td><td style="text-align: left; background-color: white;">%</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">1,053,321</td><td style="text-align: left; background-color: white;">&#160;</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">22</td><td style="text-align: left; background-color: white;">%</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; background-color: white;">Company C</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">772,320</td><td style="text-align: left; background-color: white;">&#160;</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">12</td><td
 style="text-align: left; background-color: white;">%</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">305,980</td><td style="text-align: left; background-color: white;">&#160;</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">7</td><td style="text-align: left; background-color: white;">%</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; background-color: white;">Company D</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">644,702</td><td style="text-align: left; background-color: white;">&#160;</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">10</td><td style="text-align: left; background-color: white;">%</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">278,499</td><td style="text-align: left; background-color: white;">&#160;</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">6</td><td style="text-align: left; background-color: white;">%</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;">Company E</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">628,741</td><td style="text-align: left; background-color: white;">&#160;</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">10</td><td style="text-align: left; background-color: white;">%</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">71,030</td><td style="text-align: left; background-color: white;">&#160;</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">2</td><td style="text-align: left; background-color: white;">%</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding-bottom: 1.5pt; background-color: white;">All other customers</td><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">2,389,163</td><td style="text-align: left; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="text-align: left; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">36</td><td style="text-align: left; padding-bottom: 1.5pt; background-color: white;">%</td><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">1,193,587</td><td style="text-align: left; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="text-align: left; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">25</td><td style="text-align: left; padding-bottom: 1.5pt; background-color: white;">%</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="background-color: white;">&#160;</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td><td style="text-align: right; background-color: white;">&#160;</td><td style="text-align: left; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 4pt; background-color: white;">Total</td><td style="padding-bottom: 4pt; background-color: white;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">$</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">6,502,962</td><td style="text-align: left; padding-bottom: 4pt; background-color: white;">&#160;</td><td style="padding-bottom: 4pt; background-color: white;">&#160;</td><td style="text-align: left; padding-bottom: 4pt; background-color: white;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">100</td><td style="text-align: left; padding-bottom: 4pt; background-color: white;">%</td><td style="padding-bottom: 4pt; background-color: white;">&#160;</td><td style="text-align: left; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt;
 border-bottom-style: double; background-color: white;">4,679,741</td><td style="text-align: left; padding-bottom: 4pt; background-color: white;">&#160;</td><td style="padding-bottom: 4pt; background-color: white;">&#160;</td><td style="text-align: left; padding-bottom: 4pt; background-color: white;">&#160;</td><td style="text-align: right; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">100</td><td style="text-align: left; padding-bottom: 4pt; background-color: white;">%</td></tr></table><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_MajorCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_MajorCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_MajorCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Major customer text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_MajorCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847763396848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - Subsequent Event [Member] - shares<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2015</div></th>
<th class="th"><div>Jan. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock issued for advisory services</a></td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Increment One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock issued for advisory services</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Outside director [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Common stock Issued shares as director fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of any shares forfeited. Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=oprx_IncrementOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=oprx_IncrementOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=us-gaap_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=us-gaap_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847763660800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Nature of Business and Basis of Presentation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">NATURE OF BUSINESS AND BASIS OF PRESENTATION</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">NOTE 1 &#8211; NATURE OF BUSINESS AND BASIS OF PRESENTATION</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">OptimizeRx Corporation is a technology solution company focused on the health care industry. Its objective is to bring better access to better care by leveraging its proprietary technology to provide on demand savings and support within physicians and patients web based platforms, including Electronic Health Records and Patient Portals. Initially defined as a marketing and advertising company through its consumer website, OptimizeRx.com, the Company has matured as a technology solutions provider through its direct to physician solution, SampleMD. SampleMD allows physicians to automatically display and distribute sample vouchers and/or co-pay coupons electronically within the ePrescription platform to pharmacies on behalf of their patients. The SampleMD solution is integrated into the ePrescribing or Electronic Medical Records applications, but can also sit on a prescriber&#8217;s desktop.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">OptimizeRx solutions provide health care institutions with an alternative option to the traditional hassles and issues associated with storing and managing physical drug samples and pre-printed coupons and it provides better access and affordability to patients to improve affordability, adherence and outcomes. In turn, OptimizeRx provides pharmaceutical manufacturers with both direct to consumer and direct to physician channels for more efficiently communicating and promoting their products and savings.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The consolidated financial statements for the three and six month periods ended June 30, 2015 and 2014 have been prepared by us without audit pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of management, all adjustments necessary to present fairly our financial position, results of operations, and cash flows as of June 30, 2015 and 2014, and for the periods then ended, have been made. Those adjustments consist of normal and recurring adjustments. The consolidated balance sheet as of December 31, 2014, has been derived from the audited consolidated balance sheet as of that date.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Certain information and note disclosures normally included in our annual financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted. These consolidated financial statements should be read in conjunction with a reading of the financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014, as filed with the Securities and Exchange Commission.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The results of operations for the three and six month periods ended June 30, 2015, are not necessarily indicative of the results to be expected for the full year. Certain reclassifications have been made in the prior period&#8217;s consolidated financial statements to conform to the current period&#8217;s presentation.</p></div><span></span>
</td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">NOTE 1 &#8211; NATURE OF BUSINESS</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">OptimizeRx Corporation, is a technology solutions company targeting the health care industry. Our objective is to bring better access to better care through connecting patients, physicians and pharmaceutical manufacturers through technology. Originally defined as a marketing and advertising company through our consumer website, we have matured into a technology solutions provider as we launched our direct to physician solution, SampleMD. SampleMD allows physicians to search, print and send available sample trial vouchers and/or co-pay coupons on behalf of their patients. The SampleMD solution is integrated into the physician&#8217;s ePrescribing or Electronic Medical Records applications, but could also be a stand-alone desktop application. OptimizeRx solutions provide pharmaceutical manufacturers a direct to physician channel for communicating and promoting their products. It provides health care providers a means to provide sampling and coupons without having to physically store samples on site, and it provides better access and affordability to patients.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The company was originally formed as Optimizer Systems, LLC in the State of Michigan on January 31, 2006. It incorporated in the State of Michigan on October 22, 2007 and changed its name to OptimizeRx Corporation. On April 14, 2008, RFID, Ltd., a Colorado corporation, consummated a reverse merger by entering into a share exchange agreement with the stockholders of OptimizeRx Corporation, pursuant to which the stockholders of OptimizeRx Corporation exchanged all of the issued and outstanding capital stock of OptimizeRx Corporation for 1,256,958 shares of common stock of RFID, Ltd., representing 100% of the outstanding capital stock of RFID, Ltd. As of April&#160;30, 2008, RFID&#8217;s officers and directors resigned their positions and RFID changed its business to OptimizeRx&#8217;s business. On April&#160;15, 2008, RFID, Ltd.&#8217;s corporate name was changed to OptimizeRx Corporation. On September&#160;4, 2008, a migratory merger was completed, thereby changing the state of incorporation from Colorado to Nevada, resulting in the current corporate structure, in which OptimizeRx Corporation, a Nevada corporation, is the parent corporation, and OptimizeRx Corporation, a Michigan corporation, which is a wholly-owned subsidiary (together, "OptimizeRx" and "the Company").</p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 205<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35735333&amp;loc=d3e288-107754<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 272<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6373374&amp;loc=d3e70478-108055<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=18733093&amp;loc=d3e5614-111684<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 205<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847761010048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheet (Parenthetical) (Unaudited) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">22,949,819<span></span>
</td>
<td class="nump">22,867,319<span></span>
</td>
<td class="nump">14,817,496<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">22,949,819<span></span>
</td>
<td class="nump">22,867,319<span></span>
</td>
<td class="nump">14,817,496<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847763497152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueDisclosureTextBlock', window );">DEFERRED REVENUE</a></td>
<td class="text"><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">NOTE 7 &#8211; DEFERRED REVENUE</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company has several signed contracts with customers for the distribution or redemption of coupons, or other services, which include payment in advance. The payments are not recorded as revenue until the revenue is earned under its revenue recognition policy discussed in Note 1. Deferred revenue was $120,130 and $226,272 as of December&#160;31, 2014 and 2013, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for deferred revenues at the end of the reporting period, and description and amounts of significant changes that occurred during the reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 605<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 13.A.3(b).Q1(c),(b).Q2,(c).Q3)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 13<br><br><br><br> -Section A<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847746635424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">OptimizeRx Corp<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001448431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentDescription', window );">Amendment Description</a></td>
<td class="text">On May 4, 2015, we filed with the Securities and Exchange Commission a registration statement on Form S-1 (File No. 333-203820), which was amended by a pre-effective amendment filed on June 1, 2015, to register the offer and sale of 849,139 shares of our common stock, $0.001 par value per share, of which 804,139 shares of common stock are issuable upon the exercise of warrants.
The Registration Statement was declared effective by the Commission on June 16, 2015.
This Post-Effective Amendment No. 1 to the Form S-1/A is being filed to include a revised audit opinion from our independent auditor, KLJ &amp; Associates, LLP. All securities offered hereby are being offered on a delayed or continuous basis. We are not registering any additional securities under this Post-Effective Amendment. All filing fees payable in connection with the registration of these securities were previously paid by us in connection with the filing of the Form S-1.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Smaller Reporting Company<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2015<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation 12B<br><br><br><br> -Number 240<br><br><br><br> -Section 12b<br><br><br><br> -Subsection 1<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation 12B<br><br><br><br> -Number 240<br><br><br><br> -Section 12b<br><br><br><br> -Subsection 1<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847763559520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">NOTE 8 &#8211; RELATED PARTY TRANSACTIONS</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">During the year ended December&#160;31, 2010, the Company acquired the technical contributions and assignment of all exclusive rights to and for the SampleMD patent in process at the time from an officer and shareholder in exchange for 300,000 shares of common stock to be granted at the discretion of the seller in addition to 200,000 stock options, which expire in April 2015, that were valued at $360,000. The shares were valued on the grant date at $570,000 and have been recorded as a payable to the related party.</font></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39678-107864<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(k))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph b<br><br><br><br> -Article 3A<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847750449632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">NET REVENUE</a></td>
<td class="nump">$ 1,705,457<span></span>
</td>
<td class="nump">$ 1,426,808<span></span>
</td>
<td class="nump">$ 3,193,010<span></span>
</td>
<td class="nump">$ 2,716,236<span></span>
</td>
<td class="nump">$ 6,502,962<span></span>
</td>
<td class="nump">$ 4,679,741<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_RevenueShareExpense', window );">REVENUE SHARE EXPENSE</a></td>
<td class="nump">882,327<span></span>
</td>
<td class="nump">730,140<span></span>
</td>
<td class="nump">1,638,768<span></span>
</td>
<td class="nump">1,291,551<span></span>
</td>
<td class="nump">3,221,534<span></span>
</td>
<td class="nump">1,861,316<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">GROSS MARGIN</a></td>
<td class="nump">823,130<span></span>
</td>
<td class="nump">696,668<span></span>
</td>
<td class="nump">1,554,242<span></span>
</td>
<td class="nump">1,424,685<span></span>
</td>
<td class="nump">3,281,428<span></span>
</td>
<td class="nump">2,818,425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,172,242<span></span>
</td>
<td class="nump">523,382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">159,337<span></span>
</td>
<td class="nump">115,828<span></span>
</td>
<td class="nump">264,340<span></span>
</td>
<td class="nump">$ 193,791<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Lawsuit settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">Other operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,471,174<span></span>
</td>
<td class="nump">$ 2,368,788<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total Operating expenses</a></td>
<td class="nump">980,659<span></span>
</td>
<td class="nump">896,529<span></span>
</td>
<td class="nump">1,823,269<span></span>
</td>
<td class="nump">2,386,747<span></span>
</td>
<td class="nump">4,307,756<span></span>
</td>
<td class="nump">3,085,961<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">INCOME (LOSS) FROM OPERATIONS</a></td>
<td class="num">(157,529)<span></span>
</td>
<td class="num">(199,861)<span></span>
</td>
<td class="num">(269,027)<span></span>
</td>
<td class="num">(962,062)<span></span>
</td>
<td class="num">(1,026,328)<span></span>
</td>
<td class="num">(267,536)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>OTHER INCOME (EXPENSE)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest income</a></td>
<td class="nump">304<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="nump">601<span></span>
</td>
<td class="nump">329<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">TOTAL OTHER INCOME</a></td>
<td class="nump">304<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="nump">601<span></span>
</td>
<td class="nump">329<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">246<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">INCOME LOSS BEFORE PROVISION FOR INCOME TAXES</a></td>
<td class="num">$ (157,225)<span></span>
</td>
<td class="num">$ (199,638)<span></span>
</td>
<td class="num">$ (268,426)<span></span>
</td>
<td class="num">$ (961,733)<span></span>
</td>
<td class="num">(1,025,393)<span></span>
</td>
<td class="num">(267,290)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">PROVISION FOR INCOME TAXES</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET INCOME (LOSS)</a></td>
<td class="num">$ (157,225)<span></span>
</td>
<td class="num">$ (199,638)<span></span>
</td>
<td class="num">$ (268,426)<span></span>
</td>
<td class="num">$ (961,733)<span></span>
</td>
<td class="num">$ (1,025,393)<span></span>
</td>
<td class="num">$ (267,290)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC</a></td>
<td class="nump">22,924,819<span></span>
</td>
<td class="nump">23,241,707<span></span>
</td>
<td class="nump">22,917,678<span></span>
</td>
<td class="nump">20,355,651<span></span>
</td>
<td class="nump">22,382,415<span></span>
</td>
<td class="nump">14,388,017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: FULLY DILUTED</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">24,008,353<span></span>
</td>
<td class="nump">21,196,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">NET INCOME (LOSS) PER SHARE: BASIC AND DILUTED (no separate per share amount shown because loss is antidilutive)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.04)<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>NET INCOME (LOSS) PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">BASIC</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="num">$ (0.05)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">DILUTED</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_RevenueShareExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue share expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_RevenueShareExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 14.F)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (h)(1)(i)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 14<br><br><br><br> -Section F<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.21)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 52<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=32703322&amp;loc=d3e4984-109258<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1252-109256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-04.23)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 18<br><br><br><br> -Article 7<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 21<br><br><br><br> -Article 9<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.21)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1252-109256<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 18<br><br><br><br> -Article 7<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 21<br><br><br><br> -Article 9<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.1,2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 9<br><br><br><br> -Subparagraph (a),(b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(h))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Income Tax Expense (or Benefit)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 835<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-04.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Net Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Other Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 9<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.7)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostAndExpenseOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.3)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostAndExpenseOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 16<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1505-109256<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 10<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1448-109256<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Weighted-Average Number of Common Shares Outstanding<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847755660000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">NOTE 2 &#8211; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><u>Basis of Presentation</u></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><u>Accounting Basis</u></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company uses the accrual basis of accounting and accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221; accounting). The Company has adopted a December 31 fiscal year end.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;"><u>Principles of Consolidation</u></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">The financial statements reflect the consolidated results of OptimizeRx Corporation (a Nevada corporation) and its wholly owned subsidiary OptimizeRx Corporation (a Michigan corporation). All material inter-company transactions have been eliminated in the consolidation.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;"><u>Cash and Cash Equivalents</u></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">For purposes of the accompanying financial statements, the Company considers all highly liquid instruments with an initial maturity of three months or less to be cash equivalents.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><u>Fair Value of Financial Instruments</u></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">The fair value of cash, accounts receivable, prepaid expenses, accounts payable, accounts payable &#8211; related party, accrued expenses and deferred revenue approximates the carrying amount of these financial instruments due to their short-term nature.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Fair value is defined as the price that would be received upon sale of an asset
 or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date and in the principal or most advantageous market for that asset or liability. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the entity. In addition, the fair value of liabilities should include consideration of non-performance risk including our own credit risk.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In addition to defining fair value, the disclosure requirements around fair value establish a fair value hierarchy for valuation inputs which is expanded. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of the three levels which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Level 1 &#8211; inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Level 2 &#8211; inputs are based upon significant observable inputs other than quoted prices included in Level 1, such as quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Level 3 &#8211; inputs are generally unobservable and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques that include option pricing models, discounted cash flow models, and similar techniques. The Company&#8217;s stock options and warrants are valued using level 3 inputs.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The carrying value of the Company&#8217;s financial assets and liabilities which consist of cash, accounts receivable, prepaid expenses, patent rights, web development costs, accounts payable, accounts payable &#8211; related party, accrued expenses and deferred revenue are valued using level 1 inputs. The Company believes that the recorded values approximate their fair value due to the short maturity of such instruments. Unless otherwise noted, it is management&#8217;s opinion that the Company is not exposed to significant interest, exchange or credit risks arising from these financial instruments.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><u>Accounts Receivable and Allowance for Doubtful Accounts</u></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact
 the collectability of these receivables or reserve estimates. Because the Company&#8217;s customers are primarily large well capitalized companies, historically there has been very little bad debt expense. Bad debt expense was $0 for each of the years ended December&#160;31, 2014 and 2013. The allowance for doubtful accounts was $0 as of both December&#160;31, 2014 and 2013.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><u>Property and Equipment</u></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">The capital assets are being depreciated over their estimated useful lives of three to seven years using the straight-line method of depreciation for book purposes.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><u>Revenue Recognition and Revenue Share Expense</u></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Revenue is recognized when it is earned. Revenues are generated from our SampleMD activities in which we deliver eCoupons and eVouchers through a distribution network of ePrescribers and Electronic Health Record technology providers (channel partners), or from reselling services that complement our business for other of our partners.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">We recognize setup fees that are required for integrating client offerings and campaigns into the SampleMD content delivery system and network upon completion of the setup and launch of the client&#8217;s campaign within the SampleMD system. As the eCoupons and or eVouchers are distributed through the SampleMD platform and network of channel partners (a transaction), these transactions are recorded and revenue is recognized at the time of distribution. Revenue for transactions can be realized based on a price per distribution or a price per redemption depending on the client contract. Additionally, the company also recognizes revenue for providing program performance reporting and maintenance, either by the company directly delivering reports or by providing access to its online reporting portal that the client can utilize. These fees are charged monthly and recognized as recurring monthly revenue.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The company on occasion has also resold products and or services that are available through our channel partners, and that is complementary to our core businesses and client base. In these instances net revenue is recognized based on the commission based revenue split that the company receives.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Based on the volume of transactions that are delivered through our channel partner network, we provide a revenue share to compensate the partner for their promotion of the campaign. Revenue shares are a negotiated percentage of the transaction fees and can also be specific to special considerations and campaigns. In addition, we pay revenue share to PDR/LDM as a result of a 2014 legal settlement in an amount equal to the greater of 10% of eCoupon revenues generated or $0.37 per eCoupon distributed.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><u>Income Taxes</u></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal;
 -webkit-text-stroke-width: 0px;">Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><u>Use of Estimates</u></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates and assumptions have been made in determining the depreciable lives of such assets and the allowance for doubtful accounts receivable. Actual results could differ from these estimates.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><u>Concentration of Credit Risks</u></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">The Company maintains its cash and cash equivalents in bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts; however, amounts in excess of the federally insured limit may be at risk if the bank experiences financial difficulties.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font>&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><u>Research and Development</u></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">The Company expenses research and development expenses as incurred. Our research efforts are focused on understanding the market dynamics that have the potential to affect the business in both the short and long term. Our primary goal is to help patients better afford and access the medicines their doctor prescribes, as well as other healthcare products and services they need. Based on this, the Company continually seeks better ways to meet this mission through improved technology, better user experiences and new ways to engage industries to provide new support for patients needing their products, as well seeking new services and solutions to offer.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;"><u>Share-based Payments</u></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company uses the fair value method to account for stock-based compensation. The fair value of the equity instrument is charged directly to compensation expense and additional paid-in capital over the period during which services are rendered. The fair value of each award is estimated on the date of each grant. For restricted stock the fair market value is based on the market value of the stock granted on the date of the grant. For options, it is estimated using the Black Scholes option pricing model that uses the assumptions noted in the following table. Estimated volatilities are based on the historical volatility of the Company&#8217;s stock over the same period as the expected term of the options. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The Company uses historical data to estimate option exercise behavior and to determine this term. The risk free rate used is based on the U.S. Treasury yield curve in effect at the time of the grant using a time period equal to the expected option term. The Company has never paid dividends and does not expect to pay any dividends in the future.</p><p style="font:
 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: center; text-indent: 0px; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">2014</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: center; text-indent: 0px; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">2013</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: center; text-indent: 0px; font-size: 10pt; background-color: white;" colspan="2">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: center; text-indent: 0px; font-size: 10pt; background-color: white;" colspan="2">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="padding: 0px; width: 758px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">Expected dividend yield</td><td style="padding: 0px; width: 10px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; width: 10px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; width: 114px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;">0</td><td style="padding: 0px; width: 11.33px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">%</td><td style="padding: 0px; width: 10px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; width: 10px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; width: 104.66px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;">0</td><td style="padding: 0px; width: 11.33px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">%</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">Risk free interest rate</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"><font style="font-size: 10pt;">0.90%-1.44%</font></td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"><font style="font-size: 10pt;">0.79%-1.42%</font></td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">Expected option term</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"><font style="font-size: 10pt;">3.5 years</font></td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"><font style="font-size: 10pt;">5.0 years</font></td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">Turnover/forfeiture rate</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;">0</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">%</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;">0</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">%</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="padding: 0px; text-align: left; text-indent: 0px;
 font-size: 10pt; background-color: white;">Expected volatility</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"><font style="font-size: 10pt;">117% - 138%</font></td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"><font style="font-size: 10pt;">155% - 171%</font></td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 25.9pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Black-Scholes option valuation model and other existing models were developed for use&#160;in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. These option valuation models require the input of, and are highly sensitive to, subjective assumptions including the expected stock price volatility. OptimizerRx&#8217;s stock options have characteristics significantly different from those of traded options, and changes in the subjective input assumptions could materially affect the fair value estimate.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px 0.25in 0px 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Loss Per Common and Common Equivalent Share</u></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The computation of basic earnings per common share is computed using the weighted average number of common shares outstanding during the year. The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the year plus common stock equivalents which would arise from the exercise of warrants outstanding using the treasury stock method and the average market price per share during the year. Options, warrants and convertible preferred stock have not been included in the diluted earnings per share calculation for either year since their effect is anti-dilutive.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font>&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><u>Impairment of Long-Lived Assets</u></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">The Company continually monitors events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, the Company assesses the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><u>Recently Issued Accounting Guidance</u></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company&#8217;s results of operations, financial position or cash flow.</font></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18861-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18726-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18743-107790<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18854-107790<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847890060752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restatement<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Restatement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock', window );">RESTATEMENT</a></td>
<td class="text"><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;"><font style="letter-spacing: -0.1pt;">NOTE 5 &#8211; RESTATEMENT</font></p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">We restated our financial statements to correct the way we accounted for certain items related to stock based compensation, revenue share expense, and revenue recognition. The full impact of the restatement was reflected in the December 31, 2014 financial statements at the end of the year. The table below reflects the impact on the 2014 period reflected in this report.</p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;"></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">The restated Consolidated Statement of Operations and Consolidated Statement of Cash Flows for the three and six months ended June&#160;30, 2014, as applicable, is as follows:</p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding: 0pt; text-indent: 0pt;" colspan="3">Three months ended June 30, 2014</td><td style="padding: 0pt; text-align: center; text-indent: 0pt;">&#160;</td><td style="text-align: center; padding: 0pt; text-indent: 0pt;" colspan="2">&#160;</td><td style="padding: 0pt; text-align: center; text-indent: 0pt;">&#160;</td><td style="padding: 0pt; text-align: center; text-indent: 0pt;">&#160;</td><td style="text-align: center; padding: 0pt; text-indent: 0pt;" colspan="2">Previously</td><td style="padding: 0pt; text-align: center; text-indent: 0pt;">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding: 0pt; text-align: center; text-indent: 0pt;">Financial Statement</td><td style="padding: 0pt; text-align: center; text-indent: 0pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding: 0pt; text-align: center; text-indent: 0pt;">Line Item</td><td style="padding: 0pt; text-align: center; text-indent: 0pt;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding: 0pt; text-indent: 0pt;" colspan="2">Corrected</td><td style="padding: 0pt; text-align: center; text-indent: 0pt;">&#160;</td><td style="padding: 0pt; text-align: center; text-indent: 0pt;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; padding: 0pt; text-indent: 0pt;" colspan="2">Stated</td><td style="padding: 0pt; text-align: center; text-indent: 0pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 543px; text-align: left; padding: 0pt; text-indent: 0pt;">Income statement</td><td style="width: 18px; padding: 0pt; text-indent: 0pt;">&#160;</td><td style="width: 543px; padding: 0pt; text-indent: 0pt;">Revenue</td><td style="width: 18px; padding: 0pt; text-indent: 0pt;">&#160;</td><td style="width: 18px; text-align: left; padding: 0pt; text-indent: 0pt;">&#160;</td><td style="width: 175px; text-align: right; padding: 0pt; text-indent: 0pt;">1,426,808</td><td style="width: 18px; text-align: left; padding: 0pt; text-indent: 0pt;">&#160;</td><td style="width: 19px; padding: 0pt; text-indent: 0pt;">&#160;</td><td style="width: 19px; text-align: left; padding: 0pt; text-indent: 0pt;">&#160;</td><td style="width: 177px; text-align: right; padding: 0pt; text-indent: 0pt;">1,454,214</td><td style="width: 19px; text-align: left; padding: 0pt; text-indent: 0pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding: 0pt; text-indent: 0pt;">Income statement</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="padding: 0pt; text-indent: 0pt;">Cost of Sales</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">$</td><td style="text-align: right; padding: 0pt; text-indent: 0pt;">730,140</td><td style="text-align: left;
 padding: 0pt; text-indent: 0pt;">&#160;</td><td
 style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">$</td><td style="text-align: right; padding: 0pt; text-indent: 0pt;">540,048</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; padding: 0pt; text-indent: 0pt;">Income statement</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">Operating expenses</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: right; padding: 0pt; text-indent: 0pt;">896,529</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">&#160;</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: right; padding: 0pt; text-indent: 0pt;">967,070</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding: 0pt; text-indent: 0pt;">Income statement</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">Loss from operations</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">$</td><td style="text-align: right; padding: 0pt; text-indent: 0pt;">(199,861</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">)</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">$</td><td style="text-align: right; padding: 0pt; text-indent: 0pt;">(52,904</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">)</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; padding: 0pt; text-indent: 0pt;">Income statement</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">Loss before income taxes</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">$</td><td style="text-align: right; padding: 0pt; text-indent: 0pt;">(199,638</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">)</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">$</td><td style="text-align: right; padding: 0pt; text-indent: 0pt;">(52,681</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding: 0pt; text-indent: 0pt;">Income statement</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">Net loss</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">$</td><td style="text-align: right; padding: 0pt; text-indent: 0pt;">(199,638</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">)</td><td style="padding: 0pt; text-indent: 0pt;">&#160;</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">$</td><td style="text-align: right; padding: 0pt; text-indent: 0pt;">(52,681</td><td style="text-align: left; padding: 0pt; text-indent: 0pt;">)</td></tr></table><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin-top: 0px; text-align: center; margin-bottom: 0px;"><font style="letter-spacing: -0.1pt;"><b><i>&#160;</i></b>&#160;</font></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="3">Six months ended June 30, 2014</td><td style="padding-bottom: 1.5pt; text-align: center;">&#160;</td><td style="text-align: center;" colspan="2">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center;">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center;">&#160;</td><td style="text-align: center;" colspan="2">Previously</td><td style="padding-bottom: 1.5pt; text-align: center;">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;">Financial Statement</td><td style="padding-bottom: 1.5pt; text-align: center;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;">Line Item</td><td style="padding-bottom: 1.5pt; text-align: center;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Corrected</td><td style="padding-bottom: 1.5pt; text-align: center;">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center;">&#160;</td><td style="text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">Stated</td><td style="padding-bottom: 1.5pt; text-align: center;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 543px; text-align: left; text-indent: 0pt; padding-left: 0pt;">Income statement</td><td style="width: 18px;">&#160;</td><td style="width: 543px; text-indent: 0pt; padding-left: 0pt;">Revenue</td><td style="width: 18px;">&#160;</td><td style="width: 18px; text-align: left;">&#160;</td><td style="width: 175px; text-align: right;">2,716,236</td><td style="width: 18px; text-align: left;">&#160;</td><td style="width: 19px;">&#160;</td><td style="width: 19px; text-align: left;">&#160;</td><td style="width: 177px; text-align: right;">2,771,560</td><td style="width: 19px; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Income statement</td><td>&#160;</td><td style="text-indent: 0pt; padding-left: 0pt;">Cost of Sales</td><td>&#160;</td><td style="text-align:
 left;">$</td><td style="text-align: right;">1,291,551</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align:
 left;">$</td><td style="text-align: right;">1,038,858</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Income statement</td><td>&#160;</td><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Operating expenses</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">2,386,747</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">2,439,028</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; text-indent: 0pt; padding-left: 0pt;">Income statement</td><td>&#160;</td><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Loss from operations</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(962,062</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(706,326</td><td style="text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Income statement</td><td>&#160;</td><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Loss before income taxes</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(961,733</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(705,996</td><td style="text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Income statement</td><td>&#160;</td><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Net loss</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(961,733</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(705,996</td><td style="text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Statement of cash flows</td><td>&#160;</td><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Net loss</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(961,733</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(705,996</td><td style="text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Statement of cash flows</td><td>&#160;</td><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Stock and options issued for services</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">627,344</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">654,634</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Statement of cash flows</td><td>&#160;</td><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Increase in accounts payable</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">203,714</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">173,889</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Statement of cash flows</td><td>&#160;</td><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Decrease in revenue share payable</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(311,776</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(686,760</td><td style="text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Statement of cash flows</td><td>&#160;</td><td style="text-align: left; text-indent: 0pt; padding-left: 0pt;">Increase in deferred revenue</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">19,651</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">38,656</td><td style="text-align: left;">&#160;</td></tr></table><div>&#160;</div><span></span>
</td>
<td class="text"><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><font style="letter-spacing: -0.1pt;">NOTE 17 &#8211; RESTATEMENT</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"><font style="font-size: 10pt;">The Company discovered and recorded items requiring it to restate its 2013 financial results, as well as its 2014 quarterly results, to</font>&#160;<font style="font-size: 10pt;">correct the accounting for certain transactions contained therein. The restatement relates to unrecorded stock compensation related to investor relations and consulting services, unrecorded revenue share payables, and changes in revenue recognition, all occurring during the year ended December 31, 2013. The revenue recognition relates to promotional programs started in 2013 that were expected to be completed in 2013, but actually carried over into 2014.</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">The following items were restated in the 2013 Annual Financial Statements</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom; background-color: white;"><td style="text-decoration: underline; text-align: center; padding-bottom: 1pt; padding-left: 5.4pt;">Balance Sheet</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid; text-align: left;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid; text-align: center;"><font style="font-size: 10pt;"><u>Previously stated</u></font></td><td style="padding-bottom: 1pt; text-align: left;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid; text-align: left;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid; text-align: center;"><font style="font-size: 10pt;"><u>Adjustments</u></font></td><td style="padding-bottom: 1pt; text-align: left;">&#160;</td><td style="padding-bottom: 1pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid; text-align: left;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid; text-align: center;"><font style="font-size: 10pt;"><u>Restated</u></font></td><td style="padding-bottom: 1pt; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 713.8125px; text-align: justify; padding-left: 5.4pt;">Accounts receivable</td><td style="width: 79px;">&#160;</td><td style="width: 16px; text-align: left;">$</td><td style="width: 173px; text-align: right;">1,566,964</td><td style="width: 16px; text-align: left;">&#160;</td><td style="width: 79px;">&#160;</td><td style="width: 16px; text-align: left;">$</td><td style="width: 172px; text-align: right;">(55,255</td><td style="width: 15px; text-align: left;">)</td><td style="width: 78px;">&#160;</td><td style="width: 15px; text-align: left;">$</td><td style="width: 172px; text-align: right;">1,511,709</td><td style="width: 15px; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Revenue share payable</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">1,193,661</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">93,891</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">1,287,552</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Deferred revenue</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">4,252</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">222,020</td><td
 style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">226,272</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Additional paid in capital</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">8,726,708</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">148,477</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">8,875,155</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Deferred stock compensation</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(233,942</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(36,520</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(270,462</td><td style="text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Accumulated deficit</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(24,616,220</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(483,137</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(25,099,357</td><td style="text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-decoration: underline; text-align: center; padding-left: 5.4pt;">Statement of Operations</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Revenue</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">4,957,016</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(277,275</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">4,679,741</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Revenue share expense</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">1,767,425</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">93,891</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">1,861,316</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Operating expenses</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">2,973,990</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">111,701</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">3,085,691</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Net income (loss)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">215,847</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(483,137</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(267,290</td><td style="text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-decoration: underline; text-align: center; padding-left: 5.4pt;">Statement of Cash Flows</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">&#160;</td><td style="text-align: right;">&#160;</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Net income (loss)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">215,847</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(483,137</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(267,290</td><td style="text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Stock options issued for services</td><td>&#160;</td><td
 style="text-align: left;">$</td><td style="text-align: right;">19,547</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">75,451</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">94,998</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Stock-based compensation</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">399,092</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">36,520</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">435,612</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Changes in accounts receivable</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(950,166</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">55,255</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(894,911</td><td style="text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Changes in revenue share payable</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">1,103,084</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">93,891</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">1,196,975</td><td style="text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify; padding-left: 5.4pt;">Changes in deferred revenue</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">(45,000</td><td style="text-align: left;">)</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">222,020</td><td style="text-align: left;">&#160;</td><td>&#160;</td><td style="text-align: left;">$</td><td style="text-align: right;">177,020</td><td style="text-align: left;">&#160;</td></tr></table><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"><br />&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><font style="letter-spacing: -0.1pt;">The following tables show the effect of the restatement on the unaudited quarterly information previously filed.</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><font style="letter-spacing: -0.1pt;">Period Ended September 30, 2013 (unaudited):</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-decoration: underline; text-align: center;"><font style="font-size: 10pt;"><u>Balance Sheet</u></font></td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;" colspan="2"><font style="font-size: 10pt;">Previously stated</font></td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;" colspan="2"><font style="font-size: 10pt;">Adjustments</font></td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;" colspan="2"><font style="font-size: 10pt;">Restated</font></td><td style="padding-bottom: 1.5pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 1019px; text-align: justify;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 142px; text-align: right;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 141px; text-align: right;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 125px; text-align: right;">&#160;</td><td style="width: 15px;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size:
 10pt;">Revenue share payable</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">782,902</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">28,376</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">811,278</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Deferred revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">13,272</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">147,860</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">161,132</font></td><td>&#160;</td></tr><tr><td style="vertical-align: top; text-align: justify;"><font style="font-size: 10pt;">Additional paid in capital</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="vertical-align: bottom; text-align: right; background-color: white;"><font style="font-size: 10pt;">8,449,271</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: top; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="vertical-align: bottom; text-align: right; background-color: white;"><font style="font-size: 10pt;">148,477</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: top; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="vertical-align: bottom; text-align: right; background-color: white;"><font style="font-size: 10pt;">8,597,748</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td></tr><tr><td style="vertical-align: top; text-align: justify;"><font style="font-size: 10pt;">Deferred stock compensation</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: top; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="vertical-align: bottom; text-align: right; background-color: white;"><font style="font-size: 10pt;">(233,077</font></td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">)</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: top; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="vertical-align: bottom; text-align: right; background-color: white;"><font style="font-size: 10pt;">(54,780</font></td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">)</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: top; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="vertical-align: bottom; text-align: right; background-color: white;"><font style="font-size: 10pt;">(287,857</font></td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">)</font></td></tr><tr><td style="vertical-align: top; text-align: justify;"><font style="font-size: 10pt;">Accumulated deficit</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: top; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="vertical-align: bottom; text-align: right; background-color: white;"><font style="font-size: 10pt;">(24,870,854</font></td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">)</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: top; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="vertical-align: bottom; text-align: right; background-color: white;"><font style="font-size: 10pt;">(270,207</font></td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">)</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: top; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="vertical-align: bottom; text-align: right; background-color: white;"><font style="font-size: 10pt;">(25,141,061</font></td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-decoration: underline; text-align: center;"><font style="font-size: 10pt;"><u>Statement of Operations</u></font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center;"><font style="font-size: 10pt;">Three Months ended September 30, 2013</font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,373,029</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(147,860</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td
 style="text-align:
 right;"><font style="font-size: 10pt;">1,225,169</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue share expense</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">529,134</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">28,376</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">557,510</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Operating expenses</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">982,504</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">93,971</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,076,475</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Net income (loss)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(141,527</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(270,207</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(411,734</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center;"><font style="font-size: 10pt;">Nine Months ended September 30, 2013</font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td><font style="font-size: 10pt;">Revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">3,146,406</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(147,860</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">2,998,546</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td><font style="font-size: 10pt;">Revenue share expense</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,264,059</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">28,376</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,292,435</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td><font style="font-size: 10pt;">Operating expenses</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">2,272,239</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">93,971</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">2,366,210</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td><font style="font-size: 10pt;">Net income (loss)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(389,716</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(270,207</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(659,923</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-decoration: underline; text-align: center;"><font style="font-size: 10pt;"><u>Statement of Cash Flows</u></font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Net income (loss)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(389,716</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(270,207</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(659,923</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Stock-based compensation</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size:
 10pt;">310,823</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">93,971</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">404,794</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Changes in revenue share payable</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">649,825</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">28,376</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">678,201</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Changes in deferred revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(35,980</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">147,860</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">111,880</font></td><td>&#160;</td></tr></table><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><font style="letter-spacing: -0.1pt;">Period Ended March 31, 2014 (unaudited):</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-decoration: underline; text-align: center;"><font style="font-size: 10pt;"><u>Balance Sheet</u></font></td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;" colspan="2"><font style="font-size: 10pt;">Previously stated</font></td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;" colspan="2"><font style="font-size: 10pt;">Adjustments</font></td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;" colspan="2"><font style="font-size: 10pt;">Restated</font></td><td style="padding-bottom: 1.5pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 1035px; text-align: justify;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 126px; text-align: right;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 141px; text-align: right;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 125px; text-align: right;">&#160;</td><td style="width: 15px;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue share payable</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">797,725</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">167,880</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">965,605</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Deferred revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">168,714</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">268,807</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">437,521</font></td><td>&#160;</td></tr><tr><td style="vertical-align: top; text-align: justify;"><font style="font-size: 10pt;">Additional paid in capital</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="vertical-align: bottom; text-align: right; background-color: white;"><font style="font-size: 10pt;">27,155,730</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="vertical-align: bottom; text-align: right; background-color: white;"><font
 style="font-size: 10pt;">148,477</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="vertical-align: bottom; text-align: right; background-color: white;"><font style="font-size: 10pt;">27,304,207</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td></tr><tr><td style="vertical-align: top; text-align: justify;"><font style="font-size: 10pt;">Deferred stock compensation</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="vertical-align: bottom; text-align: right; background-color: white;"><font style="font-size: 10pt;">(454,409</font></td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">)</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="vertical-align: bottom; text-align: right; background-color: white;"><font style="font-size: 10pt;">(18,260</font></td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">)</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="vertical-align: bottom; text-align: right; background-color: white;"><font style="font-size: 10pt;">(472,669</font></td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">)</font></td></tr><tr><td style="vertical-align: top; text-align: justify;"><font style="font-size: 10pt;">Accumulated deficit</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="vertical-align: bottom; text-align: right; background-color: white;"><font style="font-size: 10pt;">(25,269,535</font></td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">)</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="vertical-align: bottom; text-align: right; background-color: white;"><font style="font-size: 10pt;">(591,917</font></td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">)</font></td><td style="vertical-align: bottom; background-color: white;">&#160;</td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">$</font></td><td style="vertical-align: bottom; text-align: right; background-color: white;"><font style="font-size: 10pt;">(25,861,452</font></td><td style="vertical-align: bottom; background-color: white;"><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-decoration: underline; text-align: center;"><font style="font-size: 10pt;"><u>Statement of Operations</u></font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center;"><font style="font-size: 10pt;">Three Months ended March 31, 2014</font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,317,347</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(27,919)</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,289,428</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue share expense</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">498,810</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">62,601</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">561,411</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Operating expenses</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,471,598</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">18,260</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,489,858</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Net income (loss)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(653,315</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(108,780</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font
 style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(762,095</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-decoration: underline; text-align: center;"><font style="font-size: 10pt;"><u>Statement of Cash Flows</u></font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Net income (loss)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(653,315</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(108,780</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(762,095</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Stock-based compensation</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">361,957</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">18,260</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">380,217</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Changes in revenue share payable</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(395,935</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">62,601</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(333,334</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Changes in deferred revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">164,462</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">27,919</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">192,381</font></td><td>&#160;</td></tr></table><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>P</b><font style="letter-spacing: -0.1pt;">eriod Ended June 30, 2014 (unaudited):</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-decoration: underline; text-align: center;"><font style="font-size: 10pt;"><u>Balance Sheet</u></font></td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;" colspan="2"><font style="font-size: 10pt;">Previously stated</font></td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;" colspan="2"><font style="font-size: 10pt;">Adjustments</font></td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;" colspan="2"><font style="font-size: 10pt;">Restated</font></td><td style="padding-bottom: 1.5pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 1035px; text-align: justify;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width:
 126px; text-align: right;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 141px; text-align: right;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 125px; text-align: right;">&#160;</td><td style="width: 15px;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue share payable</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">506,901</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">366,088</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">872,989</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Deferred revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">42,908</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">258,270</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">301,178</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Additional paid in capital</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">27,304,112</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">84,677</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">27,388,789</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Accumulated deficit</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(25,322,216</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(738,674</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">26,060,890</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-decoration: underline; text-align: center;"><font style="font-size: 10pt;"><u>Statement of Operations</u></font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center;"><font style="font-size: 10pt;">Three Months ended June 30, 2014</font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,454,214</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(27,206</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,427,008</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue share expense</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">540,048</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">190,092</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">730,140</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Operating expenses</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">967,070</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(70,541</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">896,529</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Net income (loss)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(52,681</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(146,757</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size:
 10pt;">(199,438</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center;"><font style="font-size: 10pt;">Six Months ended June 30, 2014</font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">2,771,560</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(55,124</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">2,716,436</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue share expense</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,038,858</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">252,693</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,291,551</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Operating expenses</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">2,439,028</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(52,281</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">2,386,747</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Net income (loss)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(705,996</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(255,537</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(961,533</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-decoration: underline; text-align: center;"><font style="font-size: 10pt;"><u>Statement of Cash Flows</u></font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Net income (loss)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(705,996</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(255,537</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(961,533</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Stock-based compensation</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">654,634</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(52,281</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">602,353</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Changes in revenue share payable</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(686,760</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">252,693</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(434,067</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Changes in deferred revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">38,656</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font
 style="font-size: 10pt;">55,124</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">93,780</font></td><td>&#160;</td></tr></table><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><font style="letter-spacing: -0.1pt;">Period Ended September 30, 2014(unaudited):</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="text-decoration: underline; text-align: center;"><font style="font-size: 10pt;"><u>Balance Sheet</u></font></td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;" colspan="2"><font style="font-size: 10pt;">Previously stated</font></td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;" colspan="2"><font style="font-size: 10pt;">Adjustments</font></td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; text-align: center;" colspan="2"><font style="font-size: 10pt;">Restated</font></td><td style="padding-bottom: 1.5pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 1035px; text-align: justify;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 126px; text-align: right;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 16px;">&#160;</td><td style="width: 141px; text-align: right;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 15px;">&#160;</td><td style="width: 125px; text-align: right;">&#160;</td><td style="width: 15px;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue share payable</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">853,410</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">421,019</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,274,429</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Deferred revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">-0-</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">118,949</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">118,949</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Additional paid in capital</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">28,398,825</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">84,677</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">28,483,502</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Accumulated deficit</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(25,716,530</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(638,903</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(26,355,433</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td
 style="text-align: justify;">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-decoration: underline; text-align: center;"><font style="font-size: 10pt;"><u>Statement of Operations</u></font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center;"><font style="font-size: 10pt;">Three Months ended September 30, 2014</font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,620,215</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">199,206</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,819,421</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue share expense</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">858,898</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">99,435</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">958,,333</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Operating expenses</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,155,933</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">-0-</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,155,933</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Net income (loss)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(394,314</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">99,771</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(294,543</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: center;"><font style="font-size: 10pt;">Nine Months ended September 30, 2014</font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">4,391,775</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">144,082</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">4,535,857</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Revenue share expense</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,897,757</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">352,127</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">2,249,884</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Operating expenses</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">3,594,961</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(52,280</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">3,542,681</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Net income (loss)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(1,100,310</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td
 style="text-align: right;"><font style="font-size: 10pt;">(155,766</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(1,256,076</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;">&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-decoration: underline; text-align: center;"><font style="font-size: 10pt;"><u>Statement of Cash Flows</u></font></td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td><td style="text-align: right;">&#160;</td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Net income (loss)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(1,100,310</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(155,766</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(1,256,076</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Stock-based compensation</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">1,118,952</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(52,280</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(1,066,672</font></td><td><font style="font-size: 10pt;">)</font></td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Changes in revenue share payable</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(340,251</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">352,127</font></td><td>&#160;</td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">11,876</font></td><td>&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: justify;"><font style="font-size: 10pt;">Changes in deferred revenue</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(4,252</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(144,082</font></td><td><font style="font-size: 10pt;">)</font></td><td>&#160;</td><td><font style="font-size: 10pt;">$</font></td><td style="text-align: right;"><font style="font-size: 10pt;">(148,334</font></td><td><font style="font-size: 10pt;">)</font></td></tr></table><div>&#160;</div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting accounting changes and error corrections. It includes the conveyance of information necessary for a user of the Company's financial information to understand all aspects and required disclosure information concerning all changes and error corrections reported in the Company's financial statements for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 250<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 7<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56949863&amp;loc=d3e22644-107794<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 250<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 23<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6368906&amp;loc=d3e21914-107793<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 250<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56949863&amp;loc=d3e22595-107794<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 250<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56949863&amp;loc=d3e22499-107794<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 250<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 1.N.Q3)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26874127&amp;loc=d3e30840-122693<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 1<br><br><br><br> -Section N<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847763554544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Operating Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesOfLesseeDisclosureTextBlock', window );">OPERATING LEASES</a></td>
<td class="text"><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px;"><font style="letter-spacing: -0.1pt;">NOTE 13 &#8211; OPERATING LEASES</font></p><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: justify; text-indent: 0.5in;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: justify;">The Company signed the lease for its current office space located in Rochester Michigan on December 1, 2011 at an approximate rent of $5,000 per month. The initial lease term was for three years with an option to renew for an additional two years at approximately $5,200 per month. The lease was renewed and now expires on November 30, 2016.</p><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: justify;">&#160;</p><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: justify;">Minimum annual rent payments are as follows for the remainder term of the lease:</p><p style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><table style="width: 1039.33px; border-collapse: collapse;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom; background-color: white;"><td style="width: 914.666687011719px; font-size: 10pt;">&#160;Year ended December 31, 2015</td><td style="width: 10.6666669845581px; font-size: 10pt;">&#160;</td><td style="width: 10.6666669845581px; font-size: 10pt; text-align: left;">$</td><td style="width: 93.3333358764648px; font-size: 10pt; text-align: right;">62,418</td><td style="width: 10px; font-size: 10pt; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;Year ended December 31, 2016</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;">57,217</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="color: #000000; font-family: 'times new roman', times, serif; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-size: 10pt; text-align: left; padding-bottom: 4pt;">Total lease commitment</td><td style="color: #000000; font-family: 'times new roman', times, serif; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-size: 10pt; padding-bottom: 4pt;">&#160;</td><td style="color: #000000; font-family: 'times new roman', times, serif; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left;">$</td><td style="color: #000000; font-family: 'times new roman', times, serif; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right;">119,635</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOfLesseeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 840<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 840<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6452660&amp;loc=d3e36991-112694<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 840<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41499-112717<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 840<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 40<br><br><br><br> -Subparagraph (Note 1,3)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 460<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6851643&amp;loc=d3e12069-110248<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 840<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOfLesseeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847756807424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">COMMON STOCK</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">NOTE 2 &#8211; STOCKHOLDERS EQUITY</font></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">In January 2015, we issued 12,500 shares of common stock to outside Directors in connection with our Director Compensation plan, which calls for issuance of 6,250 shares per quarter for each Director. Those shares were recorded as stock payable at December 31, 2014. In addition, we recorded an additional 12,500 shares, valued at $16,375 as stock payable at March 31, 2015 for shares to be issued in April 2015 and 12,500 shares, valued at $13,375 were issued in June 2015 for the second quarter payment.</font></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">In February 2015, we entered into a capital markets advisory agreement covering a one year period, which called for 90,000 shares of common stock to be issued as compensation. These shares were valued at $112,500 and are being amortized to expense over the period of service. 45,000 of these shares were issued in March 2015, with the balance to be issued in August 2015. The agreement was terminated in July 2015, effective in August, and the remaining 45,000 shares will not be issued. The total expense to be recognized will be $56,250 and is being amortized over the period the agreement is in effect.</font></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In&#160;March 2014,&#160;we&#160;entered into a securities purchase agreement, pursuant to which&#160;we&#160;sold 8,333,333 shares of&#160;our common stock for $1.20 per share, or gross proceeds of $10,000,000.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Placement agents in the offering received commissions equal to approximately 9.7% of gross proceeds, for an aggregate commission of approximately $970,000, including reimbursements for their reasonable out of pocket expenses. Placement agents also received warrants to purchase up to 804,139 shares of&#160;our common stock with an exercise price of $1.20 per share and a term of 5 years. The warrants were valued at $1,110,211, have been recorded as equity issuance costs, and were registered on a registration statement that went effective May 28, 2014. In addition to the warrants to placement agents, we also paid cash bonuses of $240,000 to three executive officers, agreed to issue 200,000 shares to three executive officers, and issued 150,000 shares to a consultant, in connection with the equity raise. The stock was valued based on the fair market value on the grant date, which was $630,000 in total. These amounts have been recorded as equity issuance costs, resulting in total equity issuance costs of $2.95 million. The 200,000 shares for the three executive officers have not been issued, but are recorded as stock payable and can be requested by the executive officers at any time.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">We&#160;used the net proceeds of the offering to exercise the securities redemption option agreement, as amended, with Vicis Capital Master Fund that provided&#160;us&#160;with an option to purchase all of the outstanding shares and derivative securities held by Vicis for total payment of $6,000,000. The shares and derivative securities included the Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Common Stock, and warrants to purchase shares of common stock held by Vicis in the Company. The balance of the net proceeds were used for working capital purposes.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal;
 -webkit-text-stroke-width:
 0px;">In January 2014, an executive officer exercised 500,000 stock warrants using the cashless exercise feature included in the warrants. In exchange for the 500,000 warrants, 410,348 shares of common stock were issued.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In June 2015, we agreed to grant 197,605 fully vested shares of our common stock to two executive officers as bonuses. These shares have not been issued, but are recorded as stock payable and can be requested by the officers at any time.</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In February 2014, we agreed to grant 337,500 shares of our common stock, half of which vested immediately and half of which vested in August 2014, to two executive officers as bonuses based on their efforts to recapitalize the company to secure approximately $3 million in working capital while reducing fully diluted shares by approximately 7 million shares. These shares have not been issued, but are recorded as stock payable and can be requested by the officers at any time.</p></div><span></span>
</td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">NOTE 9 &#8211; COMMON STOCK</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">OptimizeRx Corporation has 500,000,000 shares of $.001 par value common stock authorized as of December 31, 2014. There were 22,867,319 and 14,817,496 common shares issued and outstanding at December&#160;31, 2014 and 2013, respectively.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">On June&#160;1, 2013, the Company entered into a consulting agreement with North Coast Advisors, Inc. for various services. The Company agreed to issue 20,000 shares of common stock as of the date of the contract. The Company also agreed to issue an additional 20,000 shares every six months in alignment with the agreement renewal up to the two years of the agreement. The first 20,000 shares were valued at the Company&#8217;s common stock closing price as of the date of the contract, which was $1.945/share; and the second 20,000 shares were valued at the Company&#8217;s common stock closing price of $1.50/share on the date of issuance, and have been expensed. An additional 10,000 shares were issued in 2014 before the agreement was terminated by the Company. The 2014 shares were valued at $1.85, the closing price of the Company&#8217;s common stock on the date of issuance.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">On June 10, 2013, the Company entered into a capital markets advisory agreement with Taglich Brothers, Inc. for various services. The agreement covered a one year period and the Company agreed to issue 44,000 shares of common stock to Taglich over the term of the agreement. The shares were valued at $1.66, the closing price of the stock on the date of the agreement and were written off over the term of the agreement. The shares were issued in June 2014 upon expiration of the contract.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><b>&#160;</b></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">On September&#160;20, 2013, the Company entered into a separation agreement that included post-employment consulting services with the former CEO of the Company. The Company agreed to issue 500,000 shares of common stock, 250,000 shares immediately and 250,000 by January&#160;1, 2014. The shares have been issued and the Company recognized the entire issuance in the December 31, 2013 shares outstanding. The shares were valued at $505,000 and $174,808 of that amount remained as deferred stock compensation as of December&#160;31, 2013, but has been fully amortized to expenses as of December 31, 2014.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In&#160;March 2014,&#160;the Company&#160;entered into a securities purchase agreement, pursuant to which&#160;the Company&#160;sold 8,333,333 shares of&#160;the Company&#8217;s common stock for $1.20 per share, or gross proceeds of $10,000,000.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><div style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Placement agents in the offering received commissions equal to approximately 9.7% of gross proceeds, for an aggregate commission of approximately $970,000, including reimbursements for their reasonable out of pocket expenses. Placement agents also received warrants to purchase up to 804,139 shares of&#160;the Company's common stock with an exercise price of $1.20 per share and a term of 5 years. The warrants were valued at $1,110,211, have been recorded as equity issuance costs, and were registered on a registration statement dated May 28, 2014. In addition to the warrants to placement agents, the Company also paid cash bonuses of $240,000 to three executive officers, agreed to issue 200,000 shares to
 three executive officers, and issued 150,000 shares to a consultant, in connection with the equity raise. The stock was valued based on the fair market value on the grant date, which was $630,000 in total. These amounts have been recorded as equity issuance costs, resulting in total equity issuance costs of $2.95 million. The 200,000 shares for the three executive officers have not been issued, but are recorded as stock payable and can be requested by the respective officers at any time.</div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company&#160;used the net proceeds of the offering to exercise the securities redemption option agreement, as amended, with Vicis Capital Master Fund that provided&#160;the Company&#160;with an option to purchase all of the outstanding shares and derivative securities held by Vicis for total payment of $6,000,000. The shares and derivative securities included the Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Common Stock, and warrants to purchase shares of common stock held by Vicis in the Company. The balance of the net proceeds was used for working capital purposes.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In January 2014, an executive officer exercised 500,000 stock warrants using the cashless exercise feature included in the warrants. In exchange for the 500,000 warrants, 410,348 shares of common stock were issued. In October 2014, a consultant exercised 50,000 stock warrants using the cashless exercise feature included in the warrants. In exchange for the 50,000 warrants, 35,417 shares of common stock were issued.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In February 2014, the Company agreed to grant 337,500 shares of common stock, half of which vested immediately and half of which vested in August 2014, to two executive officers as bonuses based on their efforts to recapitalize the company to secure approximately $3 million in working capital while reducing potential fully diluted shares by approximately 7 million shares. Stock-based compensation related to these bonuses was $570,375 during the year ended December 31, 2014. These shares have not yet been issued and are recorded as stock payable, but can be requested by the officers at any time.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><div style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In 2014, the Company adopted a Director Compensation plan for outside Directors. In connection with this plan, 19,565 shares were granted with a total value of $23,166. A total of 7,065 shares were issued in 2014 and 12,500 shares were included in stock payable at December 31, 2014 and issued in January 2015.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(d),(e))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 4.E)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 4<br><br><br><br> -Subparagraph (SAB TOPIC 4.C)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Preferred Stock<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section E<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section C<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847946937888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Web Based Technology<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_WebBasedTechnologyAbstract', window );"><strong>Web Based Technology [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_WebBasedTechnologyTextBlock', window );">WEB-BASED TECHNOLOGY</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">NOTE 5 &#8211; WEB-BASED TECHNOLOGY</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company has capitalized costs in developing their web-based technology, which consisted of the following as of December&#160;31, 2014 and 2013:</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">2014</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">2013</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1191px; text-align: left; font-size: 10pt; background-color: white;">OptimizeRx web-based technology</td><td style="width: 16px; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 16px; text-align: left; font-size: 10pt; background-color: white;">$</td><td style="width: 142px; text-align: right; font-size: 10pt; background-color: white;">154,133</td><td style="width: 16px; text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 15px; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 15px; text-align: left; font-size: 10pt; background-color: white;">$</td><td style="width: 141px; text-align: right; font-size: 10pt; background-color: white;">154,133</td><td style="width: 15px; text-align: left; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; font-size: 10pt; background-color: white;">SampleMD web-based technology</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; background-color: white;">602,517</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; background-color: white;">602,517</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">SampleMD 2.0 web-based technology</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">440,477</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">148,060</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding-left: 10pt; font-size: 10pt; background-color: white;">Subtotal, web-based technology</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; background-color: white;">1,197,127</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; background-color: white;">904,710</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; font-size: 10pt; background-color: white;">Accumulated amortization</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; background-color: white;">(633,401</td><td style="text-align: left; font-size: 10pt; background-color: white;">)</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; background-color: white;">(440,641</td><td style="text-align: left;
 font-size: 10pt; background-color: white;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">Impairment</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">(59,083</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">)</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">(59,083</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">)</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; padding-bottom: 4pt; padding-left: 10pt; font-size: 10pt; background-color: white;">Web-based technology, net</td><td style="padding-bottom: 4pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">$</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">504,643</td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt; background-color: white;">&#160;</td><td style="padding-bottom: 4pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">$</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">404,986</td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt; background-color: white;">&#160;</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><div style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Amortization is recorded using the straight-line method over a period of up to five years. During 2014, the Company launched its SampleMD 2.0 web-based technology. The OptimizeRx web-based technology was fully impaired in 2010 and has no remaining carrying value. Amortization expense for the web-based technology costs was $192,760 and $130,289 for the years ended December&#160;31, 2014 and 2013, respectively.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_WebBasedTechnologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_WebBasedTechnologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_WebBasedTechnologyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for web based technology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_WebBasedTechnologyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847763458416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Details 1) - Warrant [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Begining balance</a></td>
<td class="nump">11,750,000<span></span>
</td>
<td class="nump">12,277,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Granted</a></td>
<td class="nump">804,139<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Exercised</a></td>
<td class="num">(550,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations', window );">Cancellation</a></td>
<td class="num">(10,000,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations', window );">Expired</a></td>
<td class="num">(150,000)<span></span>
</td>
<td class="num">(527,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Ending balance</a></td>
<td class="nump">1,854,139<span></span>
</td>
<td class="nump">11,750,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instrument Weighted Average Outstanding Roll Forward [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage', window );">Begining balance, weighted average</a></td>
<td class="nump">$ 2.27<span></span>
</td>
<td class="nump">$ 2.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted', window );">Granted, weighted average</a></td>
<td class="nump">1.20<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExercise', window );">Exercise, weighted average</a></td>
<td class="nump">0.35<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExpiration', window );">Expired, weighted average</a></td>
<td class="num">(2.40)<span></span>
</td>
<td class="num">$ (1.73)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageCancellation', window );">Cancellation, weighted average</a></td>
<td class="num">(1.45)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage', window );">Ending balance, weighted average</a></td>
<td class="nump">$ 1.69<span></span>
</td>
<td class="nump">$ 2.27<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award non option equity instrument outstanding weighted average.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentOutstandingWeightedAverage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageCancellation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award non option equity instrument weighted average, cancellation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageCancellation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award non option equity instrument weighted average, exercise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award non option equity instrument weighted average, expiration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award non option equity instrument weighted average, grantedPayment Award Non Option Equity Instrument Weighted Average, Granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWeightedAverageOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(1)(iv)(2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(1)(iv)(4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements that were either cancelled or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(1)(iv)(3)-(4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(1)(iv)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(1)(i)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(1)(ii)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847750258224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_PrepaidExpensesAbstract', window );"><strong>Prepaid Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_PrepaidExpensesTextBlock', window );">PREPAID EXPENSES</a></td>
<td class="text"><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"><font style="letter-spacing: -0.1pt;">NOTE 3 &#8211; PREPAID EXPENSES</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"><font style="letter-spacing: -0.1pt;">Prepaid expenses consisted of the following as of December&#160;31, 2014 and 2013:</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">2014</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">2013</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1191px; font-size: 10pt; background-color: white;">Insurance</td><td style="width: 16px; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 16px; font-size: 10pt; text-align: left; background-color: white;">$</td><td style="width: 142px; font-size: 10pt; text-align: right; background-color: white;">18,093</td><td style="width: 16px; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="width: 15px; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 15px; font-size: 10pt; text-align: left; background-color: white;">$</td><td style="width: 141px; font-size: 10pt; text-align: right; background-color: white;">6,722</td><td style="width: 15px; font-size: 10pt; text-align: left; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; background-color: white;">Rent</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">-0-</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">5,049</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">Legal</td><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right; background-color: white;">10,000</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right; background-color: white;">-0-</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; text-align: left; padding-bottom: 4pt; background-color: white;">Total prepaid expenses</td><td style="font-size: 10pt; padding-bottom: 4pt; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left; background-color: white;">$</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right; background-color: white;">28,093</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; padding-bottom: 4pt; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left; background-color: white;">$</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right; background-color: white;">11,771</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color:
 white;">&#160;</td></tr></table><div>&#160;</div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_PrepaidExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_PrepaidExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_PrepaidExpensesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_PrepaidExpensesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847754676400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">NOTE 4 &#8211; PROPERTY AND EQUIPMENT</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company owned equipment recorded at cost which consisted of the following as of December&#160;31, 2014 and 2013:</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: center; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><table style="width: 1250.4px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2014</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2013</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 950.4px; text-align: left; font-size: 10pt;">Computer equipment</td><td style="width: 12.8px; font-size: 10pt;">&#160;</td><td style="width: 12.8px; text-align: left; font-size: 10pt;">$</td><td style="width: 112.8px; text-align: right; font-size: 10pt;">19,519</td><td style="width: 12.8px; text-align: left; font-size: 10pt;">&#160;</td><td style="width: 12.8px; font-size: 10pt;">&#160;</td><td style="width: 12px; text-align: left; font-size: 10pt;">$</td><td style="width: 112px; text-align: right; font-size: 10pt;">22,360</td><td style="width: 12px; text-align: left; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;">Furniture and fixtures</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">11,088</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">11,088</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding-left: 10pt; font-size: 10pt;">Subtotal</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">30,607</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt;">&#160;</td><td style="text-align: right; font-size: 10pt;">33,448</td><td style="text-align: left; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;">Accumulated depreciation</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(17,794</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;">)</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">&#160;</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;">(18,391</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding-bottom: 4pt; padding-left: 10pt; font-size: 10pt;">Property and equipment, net</td><td style="padding-bottom: 4pt; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">12,813</td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;">&#160;</td><td style="padding-bottom: 4pt; font-size: 10pt;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">$</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double;">15,057</td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt;">&#160;</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform:
 none;
 text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Depreciation expense was $5,933 and $5,628 for the years ended December&#160;31, 2014 and 2013, respectively.</p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13-14)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 205<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51717284&amp;loc=d3e1361-107760<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51719941&amp;loc=d3e2921-110230<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847763589296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Patent and Trademarks<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Patent and Trademarks [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">PATENT AND TRADEMARKS</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">NOTE 6 &#8211; PATENT AND TRADEMARKS</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">On April&#160;26, 2010, the Company acquired the technical contributions and assignment of all exclusive rights to and for the SampleMD patent from an officer and shareholder in exchange for 300,000 shares of common stock to be granted at the discretion of the seller in addition to 200,000 stock options, which expire in April 2015, that were valued at $360,000. The shares were valued on the grant date at $570,000 and have been recorded as a payable to the related party.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company has capitalized costs in purchasing and defending the SampleMD patent, which consisted of the following as of December&#160;31, 2014 and 2013:</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">2014</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: center; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">2013</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1191px; text-align: left; font-size: 10pt; background-color: white;">Patent rights and intangible assets</td><td style="width: 16px; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 16px; text-align: left; font-size: 10pt; background-color: white;">$</td><td style="width: 142px; text-align: right; font-size: 10pt; background-color: white;">930,000</td><td style="width: 16px; text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 15px; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 15px; text-align: left; font-size: 10pt; background-color: white;">$</td><td style="width: 141px; text-align: right; font-size: 10pt; background-color: white;">930,000</td><td style="width: 15px; text-align: left; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; font-size: 10pt; background-color: white;">Patent defense costs</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; background-color: white;">170,937</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; background-color: white;">87,993</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; font-size: 10pt; background-color: white;">New patents and trademarks</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; background-color: white;">90,202</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; background-color: white;">62,595</td><td style="text-align: left; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">Accumulated amortization</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">&#160;</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">(260,285</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">)</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">&#160;</td><td
 style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;">(194,638</td><td style="text-align: left; padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">)</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="text-align: left; padding-bottom: 4pt; padding-left: 10pt; font-size: 10pt; background-color: white;">Patent rights and intangible assets, net</td><td style="padding-bottom: 4pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">$</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">930,854</td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt; background-color: white;">&#160;</td><td style="padding-bottom: 4pt; font-size: 10pt; background-color: white;">&#160;</td><td style="text-align: left; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">$</td><td style="text-align: right; font-size: 10pt; border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; background-color: white;">885,950</td><td style="text-align: left; padding-bottom: 4pt; font-size: 10pt; background-color: white;">&#160;</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><div style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company began amortizing the patent, using the straight-line method over the estimated useful life of 17 years, once it was put into service in July 2010. In 2013, the Company began incurring costs related to defense of the patent. These costs have been capitalized and will be amortized using the straight-line method over the remaining useful life of the original patent. Amortization expense was $65,647 and $57,874 for the years ended December&#160;31, 2014 and 2013, respectively.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16265-109275<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16373-109275<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847750645200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Major Customers (Detail Textuals)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_MajorCustomerAbstract', window );"><strong>Major Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_ConcentrationRiskPercentageTotal', window );">Total revenue percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_ConcentrationRiskPercentageTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Concentration risk percentage total.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_ConcentrationRiskPercentageTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_MajorCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_MajorCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847757066880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Details 1) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax asset attributable to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryover</a></td>
<td class="nump">$ 2,982,000<span></span>
</td>
<td class="nump">$ 2,793,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(2,982,000)<span></span>
</td>
<td class="num">(2,793,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax asset</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (b),(c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 20<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51675352&amp;loc=d3e28680-109314<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847750759424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Major Customers (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="5">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Mar. 31, 2014</div></th>
<th class="th"><div>Sep. 30, 2013</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Sep. 30, 2013</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total</a></td>
<td class="nump">$ 1,705,457<span></span>
</td>
<td class="nump">$ 1,819,421<span></span>
</td>
<td class="nump">$ 1,426,808<span></span>
</td>
<td class="nump">$ 1,289,428<span></span>
</td>
<td class="nump">$ 1,225,169<span></span>
</td>
<td class="nump">$ 3,193,010<span></span>
</td>
<td class="nump">$ 2,716,236<span></span>
</td>
<td class="nump">$ 4,535,857<span></span>
</td>
<td class="nump">$ 2,998,546<span></span>
</td>
<td class="nump">$ 6,502,962<span></span>
</td>
<td class="nump">$ 4,679,741<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenues Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=oprx_CompanyAMember', window );">Company A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,270,064<span></span>
</td>
<td class="nump">$ 1,776,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenues Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=oprx_CompanyBMember', window );">Company B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 797,972<span></span>
</td>
<td class="nump">$ 1,053,321<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenues Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=oprx_CompanyCMember', window );">Company C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 772,320<span></span>
</td>
<td class="nump">$ 305,980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenues Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=oprx_CompanyDMember', window );">Company D [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 644,702<span></span>
</td>
<td class="nump">$ 278,499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenues Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=oprx_CompanyEMember', window );">Company E [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 628,741<span></span>
</td>
<td class="nump">$ 71,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenues Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=oprx_AllOtherCustomersMember', window );">All other customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,389,163<span></span>
</td>
<td class="nump">$ 1,193,587<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenues Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 275<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 18<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6351-108592<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 20<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13531-108611<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 275<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 20<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6404-108592<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 21<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13537-108611<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=oprx_CompanyAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=oprx_CompanyAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=oprx_CompanyBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=oprx_CompanyBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=oprx_CompanyCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=oprx_CompanyCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=oprx_CompanyDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=oprx_CompanyDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=oprx_CompanyEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=oprx_CompanyEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=oprx_AllOtherCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=oprx_AllOtherCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847754503136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options and Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share Based Payments - Options and Stock Options and Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of share based option activity</a></td>
<td class="text"><table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">Number of Options</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">Weighted average exercise price</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 790px; font-size: 10pt; background-color: white;">Outstanding, January 1, 2013</td><td style="width: 10.6666669845581px; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 10.6666669845581px; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="width: 94px; font-size: 10pt; text-align: right; background-color: white;">1,484,100</td><td style="width: 10.6666669845581px; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="width: 10px; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 10px; font-size: 10pt; text-align: left; background-color: white;">$</td><td style="width: 93.3333358764648px; font-size: 10pt; text-align: right; background-color: white;">0.98</td><td style="width: 10px; font-size: 10pt; text-align: left; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; background-color: white;">Granted - 2013</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">2,175,000</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">1.00</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-size: 10pt; background-color: white;">Exercised - 2013</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">0</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">0</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">Expired &#8211; 2013</td><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right; background-color: white;">(2,479,100</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: white;">)</td><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right; background-color: white;">(1.00</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: white;">)</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-size: 10pt; padding-left: 10pt; background-color: white;">Balance, December 31, 2013</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">1,180,000</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">.97</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; background-color: white;">Granted &#8211; 2014</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">387,500</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">1.73</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-size: 10pt; background-color: white;">Exercised &#8211; 2014</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">0</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color:
 white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">0</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">Expired &#8211; 2014</td><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right; background-color: white;">(260,000</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: white;">)</td><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right; background-color: white;">(0.39</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: white;">)</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-size: 10pt; padding-bottom: 4pt; padding-left: 10pt; background-color: white;">Balance, December&#160;31, 2014</td><td style="font-size: 10pt; padding-bottom: 4pt; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right; background-color: white;">1,307,500</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; padding-bottom: 4pt; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left; background-color: white;">$</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right; background-color: white;">1.31</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847763978464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Patent and Trademarks (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Patent and Trademarks [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Patent rights and intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 930,000<span></span>
</td>
<td class="nump">$ 930,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedPatentsGross', window );">Patent defense costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170,937<span></span>
</td>
<td class="nump">87,993<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherFiniteLivedIntangibleAssetsGross', window );">New patents and trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,202<span></span>
</td>
<td class="nump">62,595<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(260,285)<span></span>
</td>
<td class="num">(194,638)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Patent rights and intangible assets, net</a></td>
<td class="nump">$ 901,491<span></span>
</td>
<td class="nump">$ 930,854<span></span>
</td>
<td class="nump">$ 885,950<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedPatentsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross carrying amount before accumulated amortization as of the balance sheet date of the costs pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, or to acquire such rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedPatentsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherFiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross carrying amount before accumulated amortization as of the balance sheet date of intangible assets not otherwise specified in the taxonomy having a reasonably expected period of economic benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherFiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847763471792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options and Warrants<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share Based Payments - Options and Stock Options and Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK OPTIONS AND WARRANTS</a></td>
<td class="text"><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><font style="letter-spacing: -0.1pt;">NOTE 11 &#8211; STOCK OPTIONS AND WARRANTS&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 8pt 0px 0px; text-align: justify;">The Company sponsors a stock-based incentive compensation plan known as the 2013 Equity Compensation Plan (the &#8220;Plan&#8221;), which was established by the Board of Directors of the Company and approved by the shareholders of the Company in June 2013. A total of 1,500,000 shares were initially reserved for issuance under the plan, of which 552,500 options have been granted, 537,500 shares have been granted, and 410,000 remain available for grant.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 8pt 0px 0px; text-align: justify;">The plan allows the Company to grant incentive stock options, non-qualified stock options, stock appreciation right, or restricted stock. The incentive stock options are exercisable for up to ten years, at an option price per share not less than the fair market value on the date the option is granted. The incentive stock options are limited to persons who are regular full-time employees of the Company at the date of the grant of the option. Non-qualified options may be granted to any person, including, but not limited to, employees, independent agents, consultants and attorneys, who the Company&#8217;s Board or Compensation Committee believes have contributed, or will contribute, to the success of the Company. Non-qualified options may be issued at option prices of less than fair market value on the date of grant and are exercisable for up to ten years from date of grant. The option vesting schedule for options granted is determined by the Compensation Committee of the Board of Directors at the time of the grant. The Plan provides for accelerated vesting of unvested options if there is a change in control, as defined in the plan.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">Prior to establishment of the plan, the Board granted options under terms similar to those described in the preceding paragraphs.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">The compensation cost that has been charged against income related to options for the years ended December 31, 2014 and 2013, was $272,804 and $94,998, respectively. No income tax benefit was recognized in the income statement and no compensation was capitalized in any of the years presented.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">The Company had the following option activity during the years ended December&#160;31, 2014 and 2013:</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><table style="width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size:
 10pt; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">Number of Options</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">Weighted average exercise price</td><td style="padding-bottom: 1.5pt; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="width: 1191px; font-size: 10pt; background-color: white;">Outstanding, January 1, 2013</td><td style="width: 16px; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 16px; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="width: 142px; font-size: 10pt; text-align: right; background-color: white;">1,484,100</td><td style="width: 16px; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="width: 15px; font-size: 10pt; background-color: white;">&#160;</td><td style="width: 15px; font-size: 10pt; text-align: left; background-color: white;">$</td><td style="width: 141px; font-size: 10pt; text-align: right; background-color: white;">0.98</td><td style="width: 15px; font-size: 10pt; text-align: left; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; background-color: white;">Granted - 2013</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">2,175,000</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">1.00</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-size: 10pt; background-color: white;">Exercised - 2013</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">0</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">0</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">Expired &#8211; 2013</td><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right; background-color: white;">(2,479,100</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: white;">)</td><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right; background-color: white;">(1.00</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: white;">)</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-size: 10pt; padding-left: 10pt; background-color: white;">Balance, December 31, 2013</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">1,180,000</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">.97</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; background-color: white;">Granted &#8211; 2014</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">387,500</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">1.73</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-size: 10pt; background-color: white;">Exercised &#8211; 2014</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">0</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; text-align: right; background-color: white;">0</td><td style="font-size: 10pt; text-align: left; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">Expired &#8211; 2014</td><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td
 style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right; background-color: white;">(260,000</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: white;">)</td><td style="font-size: 10pt; padding-bottom: 1.5pt; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right; background-color: white;">(0.39</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left; background-color: white;">)</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="font-size: 10pt; padding-bottom: 4pt; padding-left: 10pt; background-color: white;">Balance, December&#160;31, 2014</td><td style="font-size: 10pt; padding-bottom: 4pt; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right; background-color: white;">1,307,500</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: white;">&#160;</td><td style="font-size: 10pt; padding-bottom: 4pt; background-color: white;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left; background-color: white;">$</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right; background-color: white;">1.31</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left; background-color: white;">&#160;</td></tr></table><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>&#160;</b></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 40<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6418621&amp;loc=d3e17540-113929<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 50<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51659978&amp;loc=d3e25284-112666<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5444-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 14<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847757125248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><font style="letter-spacing: -0.1pt;">NOTE 18 &#8211; SUBSEQUENT EVENTS</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">In January 2015, we issued 12,500 shares of common stock to two outside directors as payment of their quarterly Director Fees.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">In March 2015, we signed a capital markets advisory agreement whereby we agreed to issue 90,000 shares of common stock in two increments as payment for the advisory services. The first 45,000 shares were issued in March 2015.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"><font style="letter-spacing: -0.1pt;">In accordance with ASC 855-10, the Company has analyzed its operations subsequent to December&#160;31, 2014 through the date these financial statements were issued and has determined that it does not have any material subsequent events to disclose in these financial statements other than the events described above.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847764069584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Web Based Technology (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Web-based technology, Subtotal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,197,127<span></span>
</td>
<td class="nump">$ 904,710<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(633,401)<span></span>
</td>
<td class="num">(440,641)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_CapitalizedComputerSoftwareImpairment', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(59,083)<span></span>
</td>
<td class="num">(59,083)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareNet', window );">Web-based technology,, net</a></td>
<td class="nump">$ 424,075<span></span>
</td>
<td class="nump">504,643<span></span>
</td>
<td class="nump">404,986<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=oprx_WebBasedTechnologyMember', window );">OptimizeRx web-based technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Web-based technology, Subtotal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154,133<span></span>
</td>
<td class="nump">154,133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=oprx_WebBasedTechnologyOneMember', window );">SampleMD web-based technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Web-based technology, Subtotal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">602,517<span></span>
</td>
<td class="nump">602,517<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=oprx_WebBasedTechnologyTwoMember', window );">SampleMD 2.0 web-based technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Web-based technology, Subtotal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 440,477<span></span>
</td>
<td class="nump">$ 148,060<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_CapitalizedComputerSoftwareImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of capitalized computer software recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_CapitalizedComputerSoftwareImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For each balance sheet presented, the amount of accumulated amortization for capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 985<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 985<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 985<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 985<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128487-111756<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=oprx_WebBasedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=oprx_WebBasedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=oprx_WebBasedTechnologyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=oprx_WebBasedTechnologyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=oprx_WebBasedTechnologyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=oprx_WebBasedTechnologyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847763533120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Based Payments   Options (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2014</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Sep. 30, 2014</div></th>
<th class="th"><div>Sep. 30, 2013</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_ShareBasedPaymentsOptionsTextulaAbstract', window );"><strong>Share based payments options [Textual]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 380,217<span></span>
</td>
<td class="nump">$ 110,039<span></span>
</td>
<td class="nump">$ 170,611<span></span>
</td>
<td class="num">$ (1,066,672)<span></span>
</td>
<td class="nump">$ 404,794<span></span>
</td>
<td class="nump">$ 899,438<span></span>
</td>
<td class="nump">$ 435,612<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_ShareBasedPaymentsOptionsTextulaAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_ShareBasedPaymentsOptionsTextulaAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847686132992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statement of Stockholders' Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Preferred Stock Shares [Member]</div></th>
<th class="th"><div>Common Stock Shares [Member]</div></th>
<th class="th"><div>Stock Warrant [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Stock Payable [Member]</div></th>
<th class="th"><div>Deferred Stock Compensation [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2012</a></td>
<td class="nump">$ 1,404,882<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 14,232<span></span>
</td>
<td class="nump">$ 20,058,051<span></span>
</td>
<td class="nump">$ 6,164,666<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (24,832,067)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2012</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="nump">14,232,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan', window );">Issuance of stock options: to employees</a></td>
<td class="nump">7,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_StockIssuedDuringPeriodValueConsultants', window );">Issuance of stock options: to consultants</a></td>
<td class="nump">87,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146,412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(59,134)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common stock: for services</a></td>
<td class="nump">105,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,520)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common stock: for services, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Issuance of common stock: for severance</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">504,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(505,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Issuance of common stock: for severance, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_StockIssuedDuringPeriodOfCommonStockValueForPriorIssue', window );">Issuance of common stock: for correction of prior issue</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_StockIssuedDuringPeriodOfCommonStockShareForPriorIssue', window );">Issuance of common stock: for correction of prior issue, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_ReclassificationForExpiredWarrants', window );">Reclassification for expired warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,910,002)<span></span>
</td>
<td class="nump">1,910,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense', window );">Expense consulting services</a></td>
<td class="nump">330,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">330,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the year</a></td>
<td class="num">(267,290)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(267,290)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2013</a></td>
<td class="nump">1,668,202<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 14,817<span></span>
</td>
<td class="nump">18,148,049<span></span>
</td>
<td class="nump">8,875,155<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(270,462)<span></span>
</td>
<td class="num">(25,099,357)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2013</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="nump">14,817,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan', window );">Issuance of stock options: to employees</a></td>
<td class="nump">272,804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272,804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_StockIssuedDuringPeriodValueConsultants', window );">Issuance of stock options: to consultants</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,935<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,935)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common stock: for services</a></td>
<td class="nump">41,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,812<span></span>
</td>
<td class="nump">14,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common stock: for services, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock: for cash</a></td>
<td class="nump">8,795,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,408,699<span></span>
</td>
<td class="nump">378,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock: for cash shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,333,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock: for warrant exercise</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 446<span></span>
</td>
<td class="num">(694,133)<span></span>
</td>
<td class="nump">693,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock: for warrant exercise, shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">445,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issue warrants for equity raise</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,110,211<span></span>
</td>
<td class="num">(1,110,211)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_StockIssuedDuringPeriodOfIssueStockRightsToOfficers', window );">Issue stock rights to officers</a></td>
<td class="nump">570,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">570,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_AdjustmentsToAdditionalPaidInCapitalExpiredAndRedeemedWarrants', window );">Reclassify expired and redeemed warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,410,832)<span></span>
</td>
<td class="nump">16,410,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense', window );">Expense consulting services</a></td>
<td class="nump">287,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Redeem shares for cash</a></td>
<td class="num">(6,000,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (896)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,999,104)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Redeem shares for cash, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="num">(896,340)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the year</a></td>
<td class="num">(1,025,393)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,025,393)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2014</a></td>
<td class="nump">4,610,084<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 22,867<span></span>
</td>
<td class="nump">$ 2,153,295<span></span>
</td>
<td class="nump">$ 27,595,609<span></span>
</td>
<td class="nump">$ 963,063<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (26,124,750)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2014</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">22,867,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the year</a></td>
<td class="num">(268,426)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2015</a></td>
<td class="nump">$ 4,702,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_AdjustmentsToAdditionalPaidInCapitalExpiredAndRedeemedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital expired and redeemed warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_AdjustmentsToAdditionalPaidInCapitalExpiredAndRedeemedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_ReclassificationForExpiredWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification for expired warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_ReclassificationForExpiredWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_StockIssuedDuringPeriodOfCommonStockShareForPriorIssue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period of common stock shares for prior issue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_StockIssuedDuringPeriodOfCommonStockShareForPriorIssue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_StockIssuedDuringPeriodOfCommonStockValueForPriorIssue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period of common stock value for prior issue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_StockIssuedDuringPeriodOfCommonStockValueForPriorIssue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_StockIssuedDuringPeriodOfIssueStockRightsToOfficers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period of issue stock rights to officers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_StockIssuedDuringPeriodOfIssueStockRightsToOfficers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_StockIssuedDuringPeriodValueConsultants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares issued during the period to consultants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_StockIssuedDuringPeriodValueConsultants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 470<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28183637&amp;loc=d3e4724-112606<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Warrant<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6528364<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The compensation expense recognized during the period pertaining to the deferred compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 710<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 30<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6409875&amp;loc=d3e20015-108363<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Net Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Other Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 9<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period that is attributable to transactions involving issuance of stock not separately disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(1)(iv)(2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28,29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30, 31<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued during the period that is attributable to transactions involving issuance of stock not separately disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 4.E)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section E<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=oprx_StockPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=oprx_StockPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847763462480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px;"><font style="letter-spacing: -0.1pt;">NOTE 4 &#8211; COMMITMENTS AND CONTINGENCIES</font></p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px;"><font style="letter-spacing: -0.1pt;"><i>Litigation</i></font></p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">The company is currently involved in the following legal proceedings.</p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">In September 2014, we initiated litigation against Shadron Stastney, the Company&#8217;s previous CEO, in the U.S. District Court in the Eastern District of Michigan as a result of a dispute related to his separation agreement. Mr. Stastney alleged damages related to the non-registration of shares that he was granted as part of his separation agreement signed in September 2013. Under the terms of the contract we are not obligated to register the shares and we deny any obligation to do so. We have requested declarative relief from the court and also requested an injunction from the court preventing Mr. Stastney from continuing to pursue his claims. Mr. Stastney has filed a counterclaim requesting damages of $450,000 related to the nonregistration of his shares. The parties are currently in the discovery process.</p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">In March 2015, we initiated litigation against LDM Group, LLC and PDR Network, LLC in the U.S. District Court in the Eastern District of Missouri related to the breach by LDM, and PDR as successor, of the settlement agreement signed February 28, 2014 related to previous litigation with LDM. LDM has failed to live up to its obligations under the settlement agreement including, but not limited to, not allowing us to distribute our eCoupon programs in the LDM network, not allowing us to distribute the LDM patient education programs, and not providing other information required under the settlement agreement. We are seeking enforcement of the settlement agreement and we are seeking damages in an amount at least equal to the amounts paid to date to LDM under the settlement agreement, which approximates $1.0 million, as well as damages for lost income and business value as a result of LDM&#8217;s breach of the agreement.</p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">In March 2015, we also initiated litigation against PDR Network, LLC in the U.S. District Court in the District of New Jersey as a result of PDR&#8217;s breach of the Master Services Agreement between the parties requiring PDR to exclusively use our eCoupon solution. We assert that PDR&#8217;s acquisition of LDM and the use of the LDM network to distribute coupons by PDR violates the agreement between the parties and we are seeking damages in an amount at least equal the amounts paid to date by us to LDM under the settlement agreement, which approximates $1.0 million, as well as damages for lost income and business
 value as a
 result of PDR&#8217;s actions.</p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">In May 2015, we filed an amended complaint in the Missouri case to consolidate the two cases and withdrew the case against PDR Networks in the U.S. District Court in the District of New Jersey, without prejudice.</p><p style="color: #000000; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; font-family: 'times new roman', serif; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"><font style="color: black;">In July, 2015, the U.S. District Court for the Eastern District of Missouri dismissed the case, citing lack of Federal jurisdiction in the matter. We are in the process of refiling the consolidated case against PDR Network and LDM group in State court in Missouri.</font></p><span></span>
</td>
<td class="text"><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><font style="letter-spacing: -0.1pt;">NOTE 16 &#8211; CONTINGENT LIABILITIES</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"><u>Legal</u></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">The company is currently involved in the following legal proceedings.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">In September 2014, we initial litigation against Shadron Stastney, the Company&#8217;s previous CEO, in the U.S. District Court in the Eastern District of Michigan as a result of a dispute related to his separation agreement. Mr. Stastney alleged damages related to the non-registration of shares that he was granted as part of his separation agreement signed in September 2013. Under the terms of the contract we are not obligated to register the shares and we deny any obligation to do so. We have requested declarative relief from the court and also requested an injunction from the court preventing Mr. Stastney from continuing to pursue his claims. Mr. Stastney has filed a counterclaim requesting damages of $450,000 related to the nonregistration of his shares.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">In March 2015, we initiated litigation against LDM Group, LLC and PDR Network, LLC in the United States District Court in the Eastern District of Missouri related to the breach by LDM, and PDR as successor, of the settlement agreement signed February 28, 2014 related to previous litigation with LDM. LDM has failed to live up to its obligations under the settlement agreement including, but not limited to, not allowing the Company to distribute its eCoupon programs in the LDM network, not allowing the Company to distribute the LDM patient education programs, and not providing other information required under the settlement agreement. The Company is seeking enforcement of the settlement agreement and is seeking damages in an amount at least equal to the amounts paid to date to LDM under the settlement agreement, which approximates $900,000, as well as damages for lost income and business value as a result of LDM&#8217;s breach of the agreement.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">In March 2015, we also initiated litigation against PDR Network, LLC in the United States District Court in the District of New Jersey as a result of PDR&#8217;s breach of the Master Services Agreement between the parties requiring PDR to exclusively use the Company&#8217;s eCoupon solution. The
 Company asserts that PDR&#8217;s acquisition of LDM and the use of the LDM network to distribute coupons by PDR violates the agreement between the parties and is seeking damages in an amount at least equal the amounts paid to date by the Company to LDM under the settlement agreement, which approximates $900,000, as well as damages for lost income and business value as a result of PDR&#8217;s actions.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">In early 2014 the Company learned that Mr. Milton Wilpon (&#8220;Mr. Wilpon&#8221;) of New Jersey claimed to have obtained a default judgment for approximately $929,000 in the New Jersey Superior Court, Essex County (the &#8220;Judgment&#8221;) against a predecessor of the Company and was seeking to amend the Judgment to add the Company as a judgment debtor.&#160;&#160; The Judgment was entered in 2006 when the predecessor of the Company was a dormant shell company and the Judgment allegedly related to a settlement agreement that was breached in 2001 (the &#8220;Settlement Agreement&#8221;).&#160; The Company appeared in the action and filed a motion to vacate the Judgment on several grounds, including that it appeared that the Summons and Complaint were never properly served and that plaintiff had never filed an arbitration as was required by the Settlement Agreement.&#160; In September 2014, the Court granted the Company&#8217;s motion and vacated the Judgment in its entirety and dismissed the action.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">In December 2014, the Company was served with a copy of a Demand for Arbitration filed by Mr. Wilpon relating to his claims under the Settlement Agreement.&#160; On February 24, 2015, the Company filed an appearance with the AAA objecting to the arbitration on several grounds, including (1) that claims arose in 2001 and are barred by the applicable statute of limitations; (2) plaintiff did not properly serve and file the demand for arbitration and (3) plaintiff has not followed the proper procedure for the appointment of an arbitrator as provided by the Settlement Agreement.&#160; &#160;The Company intends vigorously to oppose Mr. Wilpon&#8217;s claims.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"><u>Revenue-share contracts</u></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">The Company has contacts with various Electronic Health Records systems and ePrescribe platforms, whereby we agree to share a portion of the revenue we generate for eCoupons distributed through their networks. These contracts grant audit rights related to the payments to our partners, and in some cases would require us to pay for the audit if the audit determined there was an underpayment and the underpayment meets certain thresholds, such as 10%.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 460<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51674963&amp;loc=d3e12565-110249<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 450<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.25)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 440<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6394976&amp;loc=d3e25287-109308<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847746725488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options and Warrants (Detail Textuals) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
<th class="th"><div>Dec. 31, 2012</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted</a></td>
<td class="nump">387,500<span></span>
</td>
<td class="nump">2,175,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Available for grant, shares</a></td>
<td class="nump">1,307,500<span></span>
</td>
<td class="nump">1,180,000<span></span>
</td>
<td class="nump">1,484,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember', window );">2013 Equity Compensation Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares initially reserved for issuance</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted</a></td>
<td class="nump">552,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Shares granted</a></td>
<td class="nump">537,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Available for grant, shares</a></td>
<td class="nump">410,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1', window );">Compensation cost</a></td>
<td class="nump">$ 272,804<span></span>
</td>
<td class="nump">$ 94,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (c)(1)(i)-(ii)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share instruments newly issued under a share-based compensation plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of capitalized and expensed compensation cost from equity-based compensation arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (h)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847750691248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_oprx_BasisOfAccountingPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;"><u>Basis of Presentation</u></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;">The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars.</p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Accounting Basis</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><u>Accounting Basis</u></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company uses the accrual basis of accounting and accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221; accounting). The Company has adopted a December 31 fiscal year end.</p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;"><u>Principles of Consolidation</u></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">The financial statements reflect the consolidated results of OptimizeRx Corporation (a Nevada corporation) and its wholly owned subsidiary OptimizeRx Corporation (a Michigan corporation). All material inter-company transactions have been eliminated in the consolidation.</font></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;"><u>Cash and Cash Equivalents</u></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">For purposes of the accompanying financial statements, the Company considers all highly liquid instruments with an initial maturity of three months or less to be cash equivalents.</font></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><u>Fair Value of Financial Instruments</u></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">The fair value of cash, accounts receivable, prepaid expenses, accounts payable, accounts payable &#8211; related party, accrued expenses and deferred revenue approximates the carrying amount of these financial instruments due to their short-term nature.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Fair value is defined as the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date and in the principal or most advantageous market for that asset or liability. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the entity. In addition, the fair value of liabilities should include consideration of non-performance risk including our own credit risk.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">In addition to defining fair value, the disclosure requirements around fair value establish a fair value hierarchy for valuation inputs which is expanded. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of the three levels which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Level 1 &#8211; inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Level 2 &#8211; inputs are based upon significant observable inputs other than quoted prices included in Level 1, such as quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Level 3 &#8211; inputs are generally unobservable and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques that include option pricing models, discounted cash flow models, and similar techniques. The Company&#8217;s stock options and warrants are valued using level 3 inputs.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The carrying value of the Company&#8217;s financial assets and liabilities which consist of cash, accounts receivable, prepaid expenses, patent rights, web development costs, accounts payable, accounts payable &#8211; related party, accrued expenses and deferred revenue are valued using level 1 inputs. The Company believes that the recorded values approximate their fair value due to the short maturity of such instruments. Unless otherwise noted, it is management&#8217;s opinion that the Company is not exposed to significant interest, exchange or credit risks arising from these
 financial instruments.</p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Accounts Receivable and Allowance for Doubtful Accounts</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><u>Accounts Receivable and Allowance for Doubtful Accounts</u></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Because the Company&#8217;s customers are primarily large well capitalized companies, historically there has been very little bad debt expense. Bad debt expense was $0 for each of the years ended December&#160;31, 2014 and 2013. The allowance for doubtful accounts was $0 as of both December&#160;31, 2014 and 2013.</p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><u>Property and Equipment</u></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">The capital assets are being depreciated over their estimated useful lives of three to seven years using the straight-line method of depreciation for book purposes.</font></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition and Revenue Share Expense</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><u>Revenue Recognition and Revenue Share Expense</u></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Revenue is recognized when it is earned. Revenues are generated from our SampleMD activities in which we deliver eCoupons and eVouchers through a distribution network of ePrescribers and Electronic Health Record technology providers (channel partners), or from reselling services that complement our business for other of our partners.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">We recognize setup fees that are required for integrating client offerings and campaigns into the SampleMD content delivery system and network upon completion of the setup and launch of the client&#8217;s campaign within the SampleMD system. As the eCoupons and or eVouchers are distributed through the SampleMD platform and network of channel partners (a transaction), these transactions are recorded and revenue is recognized at the time of distribution. Revenue for transactions can be realized based on a price per distribution or a price per redemption depending on the client contract. Additionally, the company also recognizes revenue for providing program performance reporting and maintenance, either by the company directly delivering reports or by providing access to its online reporting portal that the client can utilize. These fees are charged monthly and recognized as recurring monthly revenue.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The company on occasion has also resold products and or services that are available through our channel partners, and that is complementary to our core businesses and client base. In these instances net revenue is recognized based on the commission based revenue split that the company receives.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Based on the volume of transactions that are delivered through our channel partner network, we provide a revenue share to compensate the partner for their promotion of the campaign. Revenue shares are a negotiated percentage of the transaction fees and can also be specific to special considerations and campaigns. In addition, we pay revenue share to PDR/LDM as a result of a 2014 legal settlement in an amount equal to the greater of 10% of eCoupon revenues generated or $0.37 per eCoupon distributed.</p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><u>Income Taxes</u></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.</p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><u>Use of Estimates</u></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates and assumptions have been made in determining the depreciable lives of such assets and the allowance for doubtful accounts receivable. Actual results could differ from these estimates.</font></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risks</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><u>Concentration of Credit Risks</u></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">The Company maintains its cash and cash equivalents in bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts; however, amounts in excess of the federally insured limit may be at risk if the bank experiences financial difficulties.</font></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><u>Research and Development</u></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">The Company expenses research and development expenses as incurred. Our research efforts are focused on understanding the market dynamics that have the potential to affect the business in both the short and long term. Our primary goal is to help patients better afford and access the medicines their doctor prescribes, as well as other healthcare products and services they need. Based on this, the Company continually seeks better ways to meet this mission through improved technology, better user experiences and new ways to engage industries to provide new support for patients needing their products, as well seeking new services and solutions to offer.</font></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based Payments</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;"><u>Share-based Payments</u></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Company uses the fair value method to account for stock-based compensation. The fair value of the equity instrument is charged directly to compensation expense and additional paid-in capital over the period during which services are rendered. The fair value of each award is estimated on the date of each grant. For restricted stock the fair market value is based on the market value of the stock granted on the date of the grant. For options, it is estimated using the Black Scholes option pricing model that uses the assumptions noted in the following table. Estimated volatilities are based on the historical volatility of the Company&#8217;s stock over the same period as the expected term of the options. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The Company uses historical data to estimate option exercise behavior and to determine this term. The risk free rate used is based on the U.S. Treasury yield curve in effect at the time of the grant using a time period equal to the expected option term. The Company has never paid dividends and does not expect to pay any dividends in the future.</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: center; text-indent: 0px; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">2014</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: center; text-indent: 0px; font-size: 10pt; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; background-color: white;" colspan="2">2013</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: center; text-indent: 0px; font-size: 10pt; background-color: white;" colspan="2">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: center; text-indent: 0px; font-size: 10pt; background-color: white;" colspan="2">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="padding: 0px; width: 758px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">Expected dividend yield</td><td style="padding: 0px; width: 10px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; width: 10px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; width: 114px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;">0</td><td style="padding: 0px; width: 11.33px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">%</td><td style="padding: 0px; width: 10px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; width: 10px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; width: 104.66px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;">0</td><td style="padding: 0px; width: 11.33px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">%</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">Risk free interest rate</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"><font style="font-size: 10pt;">0.90%-1.44%</font></td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"><font style="font-size: 10pt;">0.79%-1.42%</font></td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">Expected option term</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"><font
 style="font-size: 10pt;">3.5 years</font></td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"><font style="font-size: 10pt;">5.0 years</font></td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">Turnover/forfeiture rate</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;">0</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">%</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;">0</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">%</td></tr><tr style="vertical-align: bottom; background-color: #cceeff;"><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">Expected volatility</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"><font style="font-size: 10pt;">117% - 138%</font></td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td><td style="padding: 0px; text-align: right; text-indent: 0px; font-size: 10pt; background-color: white;"><font style="font-size: 10pt;">155% - 171%</font></td><td style="padding: 0px; text-align: left; text-indent: 0px; font-size: 10pt; background-color: white;">&#160;</td></tr></table><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 25.9pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">&#160;</p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;">The Black-Scholes option valuation model and other existing models were developed for use&#160;in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. These option valuation models require the input of, and are highly sensitive to, subjective assumptions including the expected stock price volatility. OptimizerRx&#8217;s stock options have characteristics significantly different from those of traded options, and changes in the subjective input assumptions could materially affect the fair value estimate.</p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Loss Per Common and Common Equivalent Share</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><u>Loss Per Common and Common Equivalent Share</u></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The computation of basic earnings per common share is computed using the weighted average number of common shares outstanding during the year. The computation of diluted earnings per common share is based on the weighted average number of shares outstanding during the year plus common stock equivalents which would arise from the exercise of warrants outstanding using the treasury stock method and the average market price per share during the year. Options, warrants and convertible preferred stock have not been included in the diluted earnings per share calculation for either year since their effect is anti-dilutive.</font></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><u>Impairment of Long-Lived Assets</u></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">The Company continually monitors events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, the Company assesses the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell.</font></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Guidance</a></td>
<td class="text"><div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><u>Recently Issued Accounting Guidance</u></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="letter-spacing: -0.1pt;">The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company&#8217;s results of operations, financial position or cash flow.</font></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_oprx_BasisOfAccountingPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">oprx_BasisOfAccountingPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>oprx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 305<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 05<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4273-108586<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Financial Reporting Release (FRR)<br><br><br><br> -Number 203<br><br><br><br> -Paragraph 02-03<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 55<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6875567&amp;loc=d3e14489-108613<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 825<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51676700&amp;loc=d3e61082-112788<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 825<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28088331&amp;loc=SL29635902-196195<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 21<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13537-108611<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 20<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13531-108611<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 825<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51676700&amp;loc=d3e61044-112788<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=18733093&amp;loc=d3e5614-111684<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 810<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.3A-02)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355033-122828<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph k<br><br><br><br> -Article 1<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02, 03<br><br><br><br> -Article 3A<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13279-108611<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 820<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 60<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 05<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51717228&amp;loc=d3e202-110218<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 5<br><br><br><br> -Section CC<br><br><br><br> -Subsection 3<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 19<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32840-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 05<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6423966&amp;loc=d3e40913-109327<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 954<br><br><br><br> -SubTopic 740<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 17<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32809-109319<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 25<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=37586315&amp;loc=d3e32247-109318<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=37586315&amp;loc=d3e32280-109318<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 9<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=49124121&amp;loc=d3e5144-111524<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 4<br><br><br><br> -Article 5<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 730<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Research and Development<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6523717<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18823-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18726-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 605<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 13.B.Q1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 13<br><br><br><br> -Section B<br><br><br><br> -Paragraph Question 1<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (b),(f)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 275<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6061-108592<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 275<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 9<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6143-108592<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 275<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6132-108592<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.3.0.814</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>174</ContextCount>
  <ElementCount>261</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>43</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>002 - Statement - Condensed Consolidated Balance Sheet (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/CondensedConsolidatedBalanceSheetUnaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheet (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>003 - Statement - Condensed Consolidated Balance Sheet (Parenthetical) (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/CondensedConsolidatedBalanceSheetParentheticalUnaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheet (Parenthetical) (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/CondensedConsolidatedStatementsOfOperationsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>005 - Statement - Condensed Consolidated Statement of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/CondensedConsolidatedStatementOfStockholdersEquity</Role>
      <ShortName>Condensed Consolidated Statement of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>007 - Disclosure - Nature of Business and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/NatureOfBusinessAndBasisOfPresentation</Role>
      <ShortName>Nature of Business and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>008 - Disclosure - Stockholders Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/StockholdersEquity</Role>
      <ShortName>Stockholders Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>009 - Disclosure - Share Based Payments   Options</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/ShareBasedPaymentsOptions</Role>
      <ShortName>Share Based Payments   Options</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>010 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>011 - Disclosure - Restatement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/Restatement</Role>
      <ShortName>Restatement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>012 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>013 - Disclosure - Prepaid Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/PrepaidExpenses</Role>
      <ShortName>Prepaid Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>014 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/PropertyAndEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>015 - Disclosure - Web Based Technology</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/WebBasedTechnology</Role>
      <ShortName>Web Based Technology</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>016 - Disclosure - Patent and Trademarks</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/PatentAndTrademarks</Role>
      <ShortName>Patent and Trademarks</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>017 - Disclosure - Deferred Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/DeferredRevenue</Role>
      <ShortName>Deferred Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>018 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>019 - Disclosure - Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/CommonStock</Role>
      <ShortName>Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>020 - Disclosure - Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/PreferredStock</Role>
      <ShortName>Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>021 - Disclosure - Stock Options and Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/StockOptionsAndWarrants</Role>
      <ShortName>Stock Options and Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>022 - Disclosure - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/Warrants</Role>
      <ShortName>Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>023 - Disclosure - Operating Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/OperatingLeases</Role>
      <ShortName>Operating Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>024 - Disclosure - Major Customers</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/MajorCustomers</Role>
      <ShortName>Major Customers</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>025 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>026 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>027 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://OPRX/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>028 - Disclosure - Restatement (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/RestatementTables</Role>
      <ShortName>Restatement (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://OPRX/role/Restatement</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>029 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://OPRX/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>030 - Disclosure - Prepaid Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/PrepaidExpensesTables</Role>
      <ShortName>Prepaid Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://OPRX/role/PrepaidExpenses</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>031 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/PropertyandEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://OPRX/role/PropertyAndEquipment</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>032 - Disclosure - Web Based Technology (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/WebBasedTechnologyTables</Role>
      <ShortName>Web Based Technology (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://OPRX/role/WebBasedTechnology</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>033 - Disclosure - Patent and Trademarks (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/PatentandTrademarksTables</Role>
      <ShortName>Patent and Trademarks (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://OPRX/role/PatentAndTrademarks</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>034 - Disclosure - Stock Options and Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/StockOptionsAndWarrantsTables</Role>
      <ShortName>Stock Options and Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://OPRX/role/StockOptionsAndWarrants</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>035 - Disclosure - Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/WarrantsTables</Role>
      <ShortName>Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://OPRX/role/Warrants</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>036 - Disclosure - Operating Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/OperatingLeasesTables</Role>
      <ShortName>Operating Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://OPRX/role/OperatingLeases</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>037 - Disclosure - Major Customers (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/MajorCustomersTables</Role>
      <ShortName>Major Customers (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://OPRX/role/MajorCustomers</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>038 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://OPRX/role/IncomeTaxes</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>039 - Disclosure - Nature of Business and Basis of Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/NatureOfBusinessAndBasisOfPresentationDetails</Role>
      <ShortName>Nature of Business and Basis of Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/NatureOfBusinessAndBasisOfPresentation</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>040 - Disclosure - Stockholders Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/StockholdersEquityDetails</Role>
      <ShortName>Stockholders Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/StockholdersEquity</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>041 - Disclosure - Share Based Payments   Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/ShareBasedPaymentsOptionsDetails</Role>
      <ShortName>Share Based Payments   Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/ShareBasedPaymentsOptions</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>042 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/CommitmentsAndContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/CommitmentsAndContingencies</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>043 - Disclosure - Restatement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/RestatementDetails</Role>
      <ShortName>Restatement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/RestatementTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>044 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/SummaryofSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>045 - Disclosure - Summary of Significant Accounting Policies (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/SummaryOfSignificantAccountingPoliciesDetailsTextual</Role>
      <ShortName>Summary of Significant Accounting Policies (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>046 - Disclosure - Prepaid Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/PrepaidExpensesDetails</Role>
      <ShortName>Prepaid Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/PrepaidExpensesTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>047 - Disclosure - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/PropertyandEquipmentDetails</Role>
      <ShortName>Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/PropertyandEquipmentTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>048 - Disclosure - Property and Equipment (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/PropertyAndEquipmentDetailsTextual</Role>
      <ShortName>Property and Equipment (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/PropertyandEquipmentTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>049 - Disclosure - Web Based Technology (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/WebBasedTechnologyDetails</Role>
      <ShortName>Web Based Technology (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/WebBasedTechnologyTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>050 - Disclosure - Web Based Technology (Details Textuals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/WebBasedTechnologyDetailsTextuals</Role>
      <ShortName>Web Based Technology (Details Textuals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/WebBasedTechnologyTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>051 - Disclosure - Patent and Trademarks (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/PatentandTrademarksDetails</Role>
      <ShortName>Patent and Trademarks (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/PatentandTrademarksTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>052 - Disclosure - Patent and Trademarks (Details Textuals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/PatentAndTrademarksDetailsTextuals</Role>
      <ShortName>Patent and Trademarks (Details Textuals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/PatentandTrademarksTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>053 - Disclosure - Deferred Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/DeferredRevenueDetails</Role>
      <ShortName>Deferred Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/DeferredRevenue</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>054 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/RelatedPartyTransactions</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>055 - Disclosure - Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/CommonStockDetails</Role>
      <ShortName>Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/CommonStock</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>056 - Disclosure - Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/PreferredStockdetails</Role>
      <ShortName>Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/PreferredStock</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>057 - Disclosure - Stock Options and Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/StockOptionsAndWarrantsDetails</Role>
      <ShortName>Stock Options and Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/StockOptionsAndWarrantsTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>058 - Disclosure - Stock Options and Warrants (Detail Textuals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/StockOptionsAndWarrantsDetailTextuals</Role>
      <ShortName>Stock Options and Warrants (Detail Textuals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/StockOptionsAndWarrantsTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>059 - Disclosure - Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/WarrantsDetails</Role>
      <ShortName>Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/WarrantsTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>060 - Disclosure - Warrants (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/WarrantsDetails1</Role>
      <ShortName>Warrants (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/WarrantsTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>061 - Disclosure - Warrants (Details Textuals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/WarrantsDetailsTextuals</Role>
      <ShortName>Warrants (Details Textuals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/WarrantsTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>062 - Disclosure - Operating Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/OperatingLeasesDetails</Role>
      <ShortName>Operating Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/OperatingLeasesTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>063 - Disclosure - Major Customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/MajorCustomersDetails</Role>
      <ShortName>Major Customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/MajorCustomersTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>064 - Disclosure - Major Customers (Detail Textuals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/MajorCustomersDetailTextuals</Role>
      <ShortName>Major Customers (Detail Textuals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/MajorCustomersTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>065 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/IncomeTaxesTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>066 - Disclosure - Income Taxes (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/IncomeTaxesDetails1</Role>
      <ShortName>Income Taxes (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/IncomeTaxesTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>067 - Disclosure - Income Taxes (Detail Textuals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/IncomeTaxesDetailTextuals</Role>
      <ShortName>Income Taxes (Detail Textuals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/IncomeTaxesTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="oprx-20150630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>068 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://OPRX/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://OPRX/role/SubsequentEvents</ParentRole>
      <Position>68</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Info">In ''Condensed Consolidated Balance Sheet (Unaudited)'', column(s) 3, 4, 5, 7, 8 are contained in other reports, so were removed by flow through suppression.</Log>
    <Log type="Info">In ''Condensed Consolidated Balance Sheet (Parenthetical) (Unaudited)'', column(s) 5 are contained in other reports, so were removed by flow through suppression.</Log>
    <Log type="Info">In ''Condensed Consolidated Statements of Operations (Unaudited)'', column(s) 4, 8, 9, 16, 17 are contained in other reports, so were removed by flow through suppression.</Log>
    <Log type="Info">In ''Condensed Consolidated Statements of Cash Flows (Unaudited)'', column(s) 1, 2, 3, 4, 5, 8, 9 are contained in other reports, so were removed by flow through suppression.</Log>
  </Logs>
  <InputFiles>
    <File>oprx-20150630.xml</File>
    <File>oprx-20150630_cal.xml</File>
    <File>oprx-20150630_def.xml</File>
    <File>oprx-20150630_lab.xml</File>
    <File>oprx-20150630_pre.xml</File>
    <File>oprx-20150630.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847754383728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Federal income tax benifit</a></td>
<td class="text"><table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2014</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2013</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="font-size: 10pt;">Federal income tax benefit attributable to:</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: right;" colspan="2">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: right;" colspan="2">&#160;</td><td style="font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 776.666687011719px; font-size: 10pt; text-align: left; padding-left: 10pt;">Current operations</td><td style="width: 10.6666669845581px; font-size: 10pt;">&#160;</td><td style="width: 10.6666669845581px; font-size: 10pt; text-align: left;">$</td><td style="width: 94px; font-size: 10pt; text-align: right;">349,000</td><td style="width: 10.6666669845581px; font-size: 10pt; text-align: left;">&#160;</td><td style="width: 10px; font-size: 10pt;">&#160;</td><td style="width: 10px; font-size: 10pt; text-align: left;">$</td><td style="width: 93.3333358764648px; font-size: 10pt; text-align: right;">91,000</td><td style="width: 10px; font-size: 10pt; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; text-align: left; padding-left: 10pt;">Permanent and Timing Differences (net)</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; text-align: right;">(160,000</td><td style="font-size: 10pt; text-align: left;">)</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; text-align: right;">(294,000</td><td style="font-size: 10pt; text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt;">Valuation allowance</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;">(189,000</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;">)</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;">203,000</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; text-align: left; padding-bottom: 4pt; padding-left: 20pt;">Net provision for federal income tax</td><td style="font-size: 10pt; padding-bottom: 4pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left;">$</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right;">0</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; padding-bottom: 4pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left;">$</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right;">0</td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Deferred tax assets</a></td>
<td class="text"><table style="width: 1039.33px; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; word-spacing: 0px; border-collapse: collapse; widows: 1; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"><tr style="vertical-align: bottom;"><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2014</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="font-size: 10pt; text-align: center; border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid;" colspan="2">2013</td><td style="padding-bottom: 1.5pt; font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom;"><td style="font-size: 10pt;">Deferred tax asset attributable to:</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: right;" colspan="2">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; text-align: right;" colspan="2">&#160;</td><td style="font-size: 10pt;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="width: 776.666687011719px; font-size: 10pt; text-align: left; padding-left: 10pt;">Net operating loss carryover</td><td style="width: 10.6666669845581px; font-size: 10pt;">&#160;</td><td style="width: 10.6666669845581px; font-size: 10pt; text-align: left;">$</td><td style="width: 94px; font-size: 10pt; text-align: right;">2,982,000</td><td style="width: 10.6666669845581px; font-size: 10pt; text-align: left;">&#160;</td><td style="width: 10px; font-size: 10pt;">&#160;</td><td style="width: 10px; font-size: 10pt; text-align: left;">$</td><td style="width: 93.3333358764648px; font-size: 10pt; text-align: right;">2,793,000</td><td style="width: 10px; font-size: 10pt; text-align: left;">&#160;</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt;">Valuation allowance</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;">(2,982,000</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;">)</td><td style="font-size: 10pt; padding-bottom: 1.5pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: left;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 1.5pt; border-bottom-style: solid; font-size: 10pt; text-align: right;">(2,793,000</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left;">)</td></tr><tr style="vertical-align: bottom; background-color: white;"><td style="font-size: 10pt; text-align: left; padding-bottom: 4pt; padding-left: 20pt;">Net deferred tax asset</td><td style="font-size: 10pt; padding-bottom: 4pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left;">$</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right;">0</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left;">&#160;</td><td style="font-size: 10pt; padding-bottom: 4pt;">&#160;</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: left;">$</td><td style="border-bottom-color: black; border-bottom-width: 4pt; border-bottom-style: double; font-size: 10pt; text-align: right;">0</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left;">&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 12<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.0.814</span><table class="report" border="0" cellspacing="2" id="idm139847945171792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockTextBlock', window );">PREFERRED STOCK</a></td>
<td class="text"><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><font style="letter-spacing: -0.1pt;">NOTE 10 &#8211; PREFERRED STOCK</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"><u>Series A Preferred</u></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">During the year ended December&#160;31, 2008, 35 preferred shares were issued for $3,500,000. Issuance costs totaled $515,000 resulting in net proceeds of $2,985,000. The 35 shares are convertible to 3,500,000 shares of common stock and bear a 10% cumulative dividend. In addition, there was a warrant issued to purchase 6,000,000 shares of common stock at an exercise price of $2 for a period of seven years.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;"><font style="letter-spacing: -0.1pt;">&#160;</font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">The holders of the preferred stock are entitled to semi-annual dividends payable on the stated value of the Series A preferred stock at a rate of 10% per annum, which shall be cumulative, and accrue daily from the issuance date. The dividends may be paid in cash or shares of the Company's common stock at management&#8217;s discretion. If after the conversion eligibility date, the market price for the common stock for any ten consecutive trading days in which the stock trades for over $2 per share and trading exceeds 100,000 shares per day, the preferred shareholders can be required to convert their shares to common stock. Each share of Series A preferred stock shall also be convertible at the option of the holder into that number of shares of common stock of the Company at the stated value of such share at a $1 conversion price.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">The holder could cause this conversion at the time the shares are eligible for resale by the holder. The conversion price is subject to adjustment as hereinafter provided, at any time, or from time to time upon the terms and in the manner hereinafter set forth in the shareholder agreement. There is no conversion expiration date, however, the holder must provide 30 days notice for the registration of the conversion.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">On May&#160;12, 2010, the Company&#8217;s Board declared and issued 236,598 common shares as payment for all cumulative and current semi-annual dividends. On November&#160;16, 2010, the Company&#8217;s Board declared and issued 173,922 common shares for its semi-annual dividend payment. On March&#160;25, 2011, the Company&#8217;s Board declared and issued 176,768 common shares for its semi-annual dividend payment. On September&#160;21, 2011, the Company's Board declared and issued 156,306 common shares for its semi-annual dividend payment. The Company has undeclared dividends that were due in February and September 2012 totaling $350,000 and undeclared dividends of $350,000 that were due in February and September 2013 for a total undeclared amount of $700,000 as of December&#160;31, 2013.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal;
 margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">As described in greater detail in Note 10, all of the Series A Preferred shares were redeemed in 2014.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;"><u>Series B Preferred</u></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">During the year ended December&#160;31, 2010, 15 preferred shares were issued for $1,500,000. The 15 shares are convertible to 1,000,000 shares of common stock and bear a 10% cumulative dividend. In addition, there was a warrant issued to purchase 3,000,000 shares of common stock at an exercise price of $3 for a period of seven years.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">The preferred stock was issued for $1,500,000 less associated issuance costs of $350,000 for net proceeds of $1,150,000. Additionally, 3,000,000 common stock warrants were issued with the preferred stock. Based on the fair values of the preferred stock and common stock warrants on the issue date, $341,100 was allocated to preferred stock and $1,158,900 was allocated to the common stock warrants. Equity issuance costs of $350,000 were allocated to the preferred stock.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: center; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">During the quarter ended September&#160;30, 2011, 15 preferred shares were issued to an investor for $1,500,000. The 15 shares are convertible to 1,000,000 shares of common stock and bear a 10% cumulative dividend. In addition, there was a warrant issued to purchase 1,000,000 shares of common stock at an exercise price of $3 for a period of seven years. Based on the fair values of the preferred stock and common stock warrants on the issue date, $855,460 was allocated to preferred stock and $644,540 was allocated to the common stock warrants. See Note 12.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">The holders of the preferred stock are entitled to semi-annual dividends payable on the stated value of the Series B preferred stock at a rate of 10% per annum, which shall be cumulative, and accrue daily from the issuance date. The dividends may be paid in cash or shares of the Company's common stock at management&#8217;s discretion. If after the conversion eligibility date, the market price for the common stock for any ten consecutive trading days in which the stock trades for over $2 per share and trading exceeds 100,000 shares per day, the preferred shareholders can be required to convert their shares to common stock. Each share of Series B preferred stock shall also be convertible at the option of the holder into that number of shares of common stock of the Company at the stated value of such share at a $1.50 conversion price.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><b>&#160;</b></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto;
 text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">The holder could cause this conversion at the time the shares are eligible for resale by the holder. The conversion price is subject to adjustment as hereinafter provided, at any time, or from time to time upon the terms and in the manner hereinafter set forth in the shareholder agreement.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">On March&#160;25, 2011, the Company&#8217;s Board declared and issued 75,758 common shares for its semi-annual dividend payment. On September&#160;21, 2011, the Company's Board declared and issued 66,988 common shares for its semi-annual dividend payment. The Company has undeclared dividends that were due in February and September 2012 totaling $150,000 and undeclared dividends of $150,000 that were due in February and September 2013 for a total undeclared amount of $300,000 as of December&#160;31, 2013.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">&#160;</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify;">As described in greater detail in Note 9, all of the Series B Preferred shares were redeemed in 2014.</p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-align: justify; text-indent: 0.5in;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
